data_2rop_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rop _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 122.084 0.945 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 m -109.21 135.1 50.87 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.846 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.288 0.1 OUTLIER -134.5 160.08 39.13 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -120.05 134.79 55.15 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.529 2.332 . . . . 0.0 108.563 -171.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 pp -146.49 160.52 42.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -102.04 155.64 18.05 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.67 1.188 . . . . 0.0 110.439 168.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.9 mt -135.16 141.29 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 126.658 1.983 . . . . 0.0 110.822 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -97.22 129.9 44.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.366 1.466 . . . . 0.0 109.195 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.24 -19.65 50.49 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.181 1.372 . . . . 0.0 113.627 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -14.01 56.46 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.426 1.613 . . . . 0.0 113.224 174.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -49.37 -37.45 24.98 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.766 1.627 . . . . 0.0 111.859 166.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 93.1 m -78.76 -1.11 33.13 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 71.25 -60.21 0.52 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 129.162 2.985 . . . . 0.0 112.19 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -53.03 -27.57 20.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.91 1.684 . . . . 0.0 114.551 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -46.68 -37.85 8.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.909 1.684 . . . . 0.0 112.985 169.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -19.07 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -69.67 -54.09 15.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 112.143 -171.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.2 -28.59 69.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.311 1.044 . . . . 0.0 111.894 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.3 mt -65.5 -56.08 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 118.895 0.77 . . . . 0.0 109.734 167.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -39.77 61.17 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.237 1.415 . . . . 0.0 112.506 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.28 -40.94 97.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.347 0.659 . . . . 0.0 112.554 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -90.82 -28.44 18.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.594 1.158 . . . . 0.0 113.209 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.3 mm -97.46 117.49 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.149 -0.969 . . . . 0.0 109.235 -173.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.64 -17.17 7.35 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.031 1.3 . . . . 0.0 115.648 -172.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -96.49 0.74 50.7 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.506 1.153 . . . . 0.0 113.228 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.4 mt -92.08 154.63 18.61 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.676 1.59 . . . . 0.0 113.081 -169.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -51.27 -34.18 31.73 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.59 4.87 31.06 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.715 -1.603 . . . . 0.0 115.845 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.3 t -134.32 119.62 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 120.905 2.353 . . . . 0.0 109.73 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 -26.81 13.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -169.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.3 p -149.11 173.18 13.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.69 1.196 . . . . 0.0 111.17 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 tp -138.78 145.95 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.054 0.942 . . . . 0.0 110.082 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -134.78 148.17 50.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.353 1.461 . . . . 0.0 108.394 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.92 150.62 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.624 -1.297 . . . . 0.0 110.762 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.2 t -141.45 58.36 1.51 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 122.881 1.324 . . . . 0.0 110.405 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.2 mt -69.83 -26.98 64.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.56 1.544 . . . . 0.0 113.641 -169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.48 -24.02 63.72 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.34 1.456 . . . . 0.0 113.206 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -91.25 -25.11 19.64 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.751 1.62 . . . . 0.0 111.429 169.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 98.21 3.93 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.037 1 C-N-CA 132.577 4.351 . . . . 0.0 111.961 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.3 p -107.61 166.99 10.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.855 1.262 . . . . 0.0 112.578 -172.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.42 145.0 39.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.189 0.995 . . . . 0.0 108.534 167.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -124.82 106.31 9.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.806 1.242 . . . . 0.0 110.695 -169.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.3 143.53 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-O 121.188 0.518 . . . . 0.0 111.826 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -114.43 90.36 3.32 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.858 2.063 . . . . 0.0 107.235 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -115.62 154.42 29.49 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -166.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.22 117.51 65.57 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.848 2.059 . . . . 0.0 109.286 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.65 5.6 2.38 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.368 2.712 . . . . 0.0 114.672 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 p -84.81 -30.26 24.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.694 1.198 . . . . 0.0 113.585 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 64.1 m -113.43 -21.89 10.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.439 1.095 . . . . 0.0 113.63 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.9 t -144.41 179.81 7.02 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 122.067 0.937 . . . . 0.0 111.943 -169.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.8 p -166.03 164.7 11.21 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.878 2.071 . . . . 0.0 109.476 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.86 -49.25 16.53 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.334 2.689 . . . . 0.0 114.546 -174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.33 -38.22 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.13 75.09 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.588 -0.695 . . . . 0.0 111.442 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.6 mt -58.8 -53.34 59.46 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.561 1.544 . . . . 0.0 110.408 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -50.8 -53.26 33.48 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.652 1.181 . . . . 0.0 110.758 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -25.76 64.58 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.6 -60.28 2.31 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.166 1.348 . . . . 0.0 111.349 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.9 pt -72.23 -32.22 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.84 -19.42 65.87 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.06 0.845 . . . . 0.0 112.92 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.37 10.42 39.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.1 mt -60.22 -50.56 85.45 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.76 165.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.05 172.79 12.58 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.084 2.522 . . . . 0.0 112.071 171.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.78 65.47 7.59 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 124.609 3.54 . . . . 0.0 110.627 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.7 33.15 81.36 Favored Glycine 0 N--CA 1.473 1.154 0 O-C-N 121.246 -0.909 . . . . 0.0 112.95 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -107.05 -19.49 13.6 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -166.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -130.47 105.85 8.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.293 1.437 . . . . 0.0 108.603 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -99.07 136.11 39.52 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.913 1.285 . . . . 0.0 112.372 -169.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 m -99.17 156.72 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.735 1.152 . . . . 0.0 112.737 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.6 m -134.72 116.93 15.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.44 1.096 . . . . 0.0 110.159 167.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 126.896 2.078 . . . . 0.0 110.594 -178.226 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 27.6 p -144.21 145.69 32.23 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -168.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.7 t -146.43 160.0 42.66 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.543 1.937 . . . . 0.0 109.407 167.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.55 138.12 54.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.289 0.636 . . . . 0.0 109.659 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.78 160.0 41.17 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.955 0.798 . . . . 0.0 112.778 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 tt -116.26 140.41 49.35 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.752 1.621 . . . . 0.0 110.248 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 mm -127.34 139.85 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 127.647 2.379 . . . . 0.0 108.777 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -104.57 133.58 49.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.913 1.285 . . . . 0.0 110.261 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.27 137.67 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 120.533 -1.354 . . . . 0.0 110.913 -173.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.45 58.55 1.13 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.314 1.845 . . . . 0.0 111.554 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.34 55.86 0.24 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 125.222 1.391 . . . . 0.0 111.183 168.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 64.7 mtm -131.94 111.57 11.67 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.738 1.215 . . . . 0.0 109.495 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.9 t -116.0 -12.17 11.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.241 1.816 . . . . 0.0 112.989 -169.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 52.7 m -156.04 161.5 40.43 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.773 2.429 . . . . 0.0 110.398 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.64 -31.06 65.9 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.864 -1.147 . . . . 0.0 113.947 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 17.0 p -53.65 -22.26 8.47 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.364 1.466 . . . . 0.0 114.626 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 75.4 m -56.15 -36.75 68.65 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.37 -0.831 . . . . 0.0 111.97 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.83 -53.43 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.793 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -69.14 -24.04 64.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.093 0.86 . . . . 0.0 111.55 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.1 m -72.54 -51.75 18.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.323 1.449 . . . . 0.0 111.598 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.5 mt -68.87 -55.45 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 121.008 -1.057 . . . . 0.0 111.296 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -55.13 -30.73 60.39 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.704 1.202 . . . . 0.0 111.059 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.17 -62.12 2.68 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.021 1.296 . . . . 0.0 114.505 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 94.2 mmm -71.31 -38.21 71.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -169.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.1 mm -72.53 -23.95 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.056 0.542 . . . . 0.0 111.353 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.6 t -67.22 1.69 1.99 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -106.23 -3.54 21.19 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -169.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.12 17.08 24.71 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.69 2.108 . . . . 0.0 116.69 -168.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 77.76 160.59 0.21 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 127.456 2.303 . . . . 0.0 112.663 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.73 -24.46 0.29 Allowed Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.48 -1.388 . . . . 0.0 115.811 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.85 96.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 127.79 2.436 . . . . 0.0 111.165 172.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -79.74 -47.43 15.29 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.779 0.832 . . . . 0.0 111.946 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -143.97 137.07 27.49 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.688 0.795 . . . . 0.0 110.414 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.36 134.39 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.849 -1.157 . . . . 0.0 110.933 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 30.0 t -139.24 141.39 37.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.881 1.672 . . . . 0.0 109.205 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.27 142.68 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.706 1.202 . . . . 0.0 112.015 -176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.0 t -140.58 139.23 34.91 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.441 1.096 . . . . 0.0 112.736 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.08 -17.18 62.01 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.266 1.826 . . . . 0.0 115.44 174.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.26 -42.54 77.55 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.021 1.328 . . . . 0.0 112.836 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -113.17 -8.39 13.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.749 1.619 . . . . 0.0 111.355 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 76.45 48.39 9.29 Favored Glycine 0 C--N 1.343 0.949 0 C-N-CA 125.289 1.423 . . . . 0.0 112.619 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 p -141.14 146.42 37.0 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -167.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -115.22 150.93 35.37 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.175 1.79 . . . . 0.0 111.844 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.7 t -125.11 130.03 51.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.479 1.512 . . . . 0.0 108.695 169.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.75 136.85 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.741 -0.599 . . . . 0.0 111.211 -169.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.57 112.96 24.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.876 2.471 . . . . 0.0 106.628 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -118.97 158.98 24.69 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.628 1.171 . . . . 0.0 112.506 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -93.46 112.94 58.72 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.773 1.229 . . . . 0.0 108.18 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.51 -11.17 18.85 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.218 2.612 . . . . 0.0 113.005 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.07 -45.97 31.46 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.851 1.205 . . . . 0.0 110.7 168.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 69.8 t -79.5 -42.43 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.369 1.467 . . . . 0.0 113.431 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.4 tt -140.35 150.44 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.211 0.914 . . . . 0.0 113.254 -169.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 60.0 m -112.76 150.71 43.19 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.285 1.434 . . . . 0.0 112.005 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.69 -41.16 38.35 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.424 3.416 . . . . 0.0 115.009 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.43 -20.27 65.42 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.36 -31.91 60.68 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.104 1.362 . . . . 0.0 113.735 170.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 73.5 mt -60.0 -50.73 72.59 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.033 0.933 . . . . 0.0 108.876 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -51.69 -51.01 59.28 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.195 0.998 . . . . 0.0 111.522 173.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.2 -31.67 65.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.14 -38.98 69.1 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.155 0.982 . . . . 0.0 113.265 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.1 mp -70.24 -35.53 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.55 -0.718 . . . . 0.0 110.498 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.0 -36.19 83.19 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.881 -0.512 . . . . 0.0 111.739 172.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -71.89 -29.5 64.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.155 1.782 . . . . 0.0 113.797 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 18.1 ttt -65.92 -30.17 70.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.322 1.049 . . . . 0.0 111.953 172.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 124.3 13.8 3.83 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.943 1.735 . . . . 0.0 115.362 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -119.75 -156.46 0.66 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.158 1.383 . . . . 0.0 109.568 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -136.06 137.47 41.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.928 1.291 . . . . 0.0 109.009 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -131.75 156.21 46.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.065 1.346 . . . . 0.0 111.627 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.1 t -141.96 140.57 32.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.27 1.828 . . . . 0.0 109.218 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.4 m -96.05 121.56 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.452 -0.78 . . . . 0.0 110.059 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 123.327 1.537 . . . . 0.0 110.829 -177.307 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.69 153.03 18.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.237 1.415 . . . . 0.0 110.53 171.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tt -145.64 135.5 23.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.733 1.613 . . . . 0.0 110.88 -172.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -98.27 123.54 42.41 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.793 -0.567 . . . . 0.0 111.596 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.47 138.67 27.81 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.334 1.054 . . . . 0.0 113.593 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -97.64 123.8 41.68 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.9 mt -95.37 138.63 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.417 1.487 . . . . 0.0 107.631 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -95.54 142.78 27.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.548 1.139 . . . . 0.0 110.598 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.94 -4.73 83.36 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.661 1.124 . . . . 0.0 113.953 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.7 ptp -68.44 0.09 4.37 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -63.94 -13.77 48.49 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.543 1.065 . . . . 0.0 113.213 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.9 t -105.33 125.33 50.86 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.239 1.381 . . . . 0.0 107.795 165.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.73 -31.16 47.27 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.838 1.255 . . . . 0.0 114.021 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.7 m -63.34 -21.87 66.53 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.042 -1.036 . . . . 0.0 113.079 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 63.5 m -71.86 -47.21 54.57 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.095 0.861 . . . . 0.0 111.881 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.4 -23.09 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.108 0.867 . . . . 0.0 112.427 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.8 -61.35 2.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.123 0.969 . . . . 0.0 111.854 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.03 -26.4 68.22 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.532 -0.73 . . . . 0.0 112.824 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mt -65.93 -53.07 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 120.506 -1.371 . . . . 0.0 110.521 169.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.86 -30.07 69.9 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.836 1.255 . . . . 0.0 112.305 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.0 -39.78 75.67 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.008 -1.057 . . . . 0.0 112.546 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -93.69 -19.92 20.64 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 mm -102.81 123.6 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 122.314 1.054 . . . . 0.0 111.55 -172.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.37 -10.09 2.97 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.105 1.812 . . . . 0.0 114.57 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -109.5 4.55 22.42 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.839 1.656 . . . . 0.0 113.101 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.13 176.39 8.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.394 1.078 . . . . 0.0 112.216 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.7 tp -38.24 -64.2 0.43 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.325 2.25 . . . . 0.0 114.058 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.7 -12.83 7.66 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 117.073 -1.959 . . . . 0.0 115.643 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.34 112.72 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-N 121.57 2.685 . . . . 0.0 109.438 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -95.32 -35.45 11.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.073 1.349 . . . . 0.0 112.099 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 t -145.18 169.57 17.92 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.853 0.835 . . . . 0.0 112.523 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.3 tp -138.16 144.83 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.115 1.766 . . . . 0.0 108.96 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -142.63 157.93 44.18 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.083 1.753 . . . . 0.0 108.784 -172.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 m -127.53 138.69 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 120.348 -1.47 . . . . 0.0 111.931 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.2 m -124.48 56.52 1.28 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.746 1.619 . . . . 0.0 107.855 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -65.36 -30.69 71.55 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.56 -16.91 62.33 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -95.1 -5.67 43.73 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.314 1.445 . . . . 0.0 111.726 169.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt 73.39 7.38 5.18 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.022 2.529 . . . . 0.0 112.214 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.9 p -110.94 167.07 10.52 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.022 2.129 . . . . 0.0 110.787 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.97 -179.7 4.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.067 165.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -143.86 133.22 23.27 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.175 -0.953 . . . . 0.0 109.594 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.94 137.36 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.38 0.991 . . . . 0.0 111.387 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -114.71 87.11 2.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.666 1.586 . . . . 0.0 108.37 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -119.65 155.12 32.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.768 1.227 . . . . 0.0 113.478 -171.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -96.57 113.27 62.33 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.617 1.967 . . . . 0.0 109.375 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.62 -6.89 20.1 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.353 2.702 . . . . 0.0 112.88 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 t -86.08 -5.98 59.11 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.268 1.027 . . . . 0.0 111.988 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 94.2 m -119.03 -42.4 2.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.257 1.423 . . . . 0.0 113.464 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -128.51 -176.31 3.79 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.672 1.589 . . . . 0.0 110.232 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.94 154.2 18.15 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.24 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.05 -56.88 2.4 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.069 3.179 . . . . 0.0 116.21 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.7 -36.05 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 121.059 1.754 . . . . 0.0 113.438 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.43 -41.12 61.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.222 1.009 . . . . 0.0 111.909 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -36.17 74.44 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.719 1.208 . . . . 0.0 110.886 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.416 HE21 ' HB ' ' A' ' 88' ' ' VAL . 66.0 tt0 -66.89 -47.69 71.04 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.365 -0.834 . . . . 0.0 111.327 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.6 mtt85 -59.65 -28.86 67.61 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.343 1.057 . . . . 0.0 112.937 172.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.71 -56.06 12.26 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.069 0.85 . . . . 0.0 111.51 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 pt -72.47 -33.47 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -68.77 -17.99 64.13 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.35 8.13 44.94 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 120.691 -1.256 . . . . 0.0 113.977 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.5 mt -59.36 -51.06 84.11 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.018 166.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.15 173.73 12.26 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.026 2.484 . . . . 0.0 111.1 168.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -75.18 52.1 3.03 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.418 3.412 . . . . 0.0 111.486 169.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.64 37.64 92.63 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 124.803 1.192 . . . . 0.0 112.09 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -102.26 -46.45 4.81 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -168.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -97.72 101.02 12.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.229 1.412 . . . . 0.0 107.402 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -99.72 144.4 28.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -167.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.416 ' HB ' HE21 ' A' ' 75' ' ' GLN . 3.5 t -103.0 138.56 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.722 0.809 . . . . 0.0 111.744 -172.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -133.55 121.1 21.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.549 1.14 . . . . 0.0 112.121 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.549 0.91 0 C-N-CA 126.223 1.809 . . . . 0.0 112.254 173.234 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 95.3 m -143.02 136.02 28.0 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.366 1.466 . . . . 0.0 112.541 -174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.8 t -143.97 154.89 43.77 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.403 1.881 . . . . 0.0 109.229 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.4 m -114.53 141.16 48.09 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.634 0.652 . . . . 0.0 110.051 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.12 157.35 44.99 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.519 0.676 . . . . 0.0 112.415 168.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.32 136.36 41.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.357 1.863 . . . . 0.0 110.029 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.7 mt -127.92 133.68 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.717 1.607 . . . . 0.0 109.06 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.68 143.05 30.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.434 1.094 . . . . 0.0 109.842 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.04 131.8 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 119.395 0.998 . . . . 0.0 112.024 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.3 80.72 1.99 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.474 1.51 . . . . 0.0 111.998 173.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 178.49 55.01 0.07 OUTLIER Glycine 0 N--CA 1.467 0.766 0 C-N-CA 124.543 1.068 . . . . 0.0 113.996 165.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -137.41 145.47 43.24 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.4 t -151.72 -28.2 0.18 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.623 1.969 . . . . 0.0 112.387 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 77.4 m -125.76 136.73 53.49 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.968 1.707 . . . . 0.0 111.637 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.65 -27.38 6.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.517 1.527 . . . . 0.0 114.529 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.7 p -55.53 -31.64 62.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.14 1.376 . . . . 0.0 113.241 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 t -62.04 -19.44 62.89 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.95 -59.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.636 -0.665 . . . . 0.0 109.972 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -22.37 66.71 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 118.434 0.561 . . . . 0.0 112.155 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.0 m -72.24 -60.49 2.21 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.981 1.313 . . . . 0.0 112.893 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 94.4 mt -67.13 -54.48 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 120.362 1.437 . . . . 0.0 110.583 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.28 -29.96 67.95 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.792 1.237 . . . . 0.0 111.304 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.63 -62.57 2.66 Favored Glycine 0 C--N 1.343 0.948 0 C-N-CA 124.226 0.917 . . . . 0.0 113.998 173.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 82.1 mmm -70.03 -36.26 74.92 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -168.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.0 mm -68.02 -31.55 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 118.317 0.508 . . . . 0.0 110.659 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -66.11 -0.42 2.45 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -92.59 -7.38 47.27 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.389 -1.444 . . . . 0.0 113.915 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 pp -99.91 170.18 8.7 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.723 1.209 . . . . 0.0 112.046 171.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -79.05 166.34 22.42 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.76 -34.3 0.6 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.779 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.31 91.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 119.448 1.624 . . . . 0.0 110.601 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -72.71 -45.67 57.59 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.114 1.366 . . . . 0.0 111.819 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -143.3 143.49 31.72 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.455 0.702 . . . . 0.0 109.175 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -142.06 138.68 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 0.0 110.462 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 67.6 m -138.52 108.67 6.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.847 1.259 . . . . 0.0 109.701 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.71 133.9 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.728 -1.232 . . . . 0.0 110.519 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.2 t -119.71 93.33 4.03 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.142 2.177 . . . . 0.0 107.457 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.0 tt -66.83 -29.23 69.1 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.013 0.925 . . . . 0.0 110.597 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -49.6 -39.82 36.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.366 2.266 . . . . 0.0 113.629 167.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -100.26 -13.29 18.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.614 1.966 . . . . 0.0 112.123 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.76 26.93 73.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 127.735 2.588 . . . . 0.0 113.344 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.0 p -129.28 143.25 50.78 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.662 1.231 . . . . 0.0 114.27 -168.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.2 131.33 51.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.47 1.508 . . . . 0.0 109.505 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.9 t -113.55 124.09 51.55 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.66 139.83 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -165.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.25 111.22 23.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.68 2.392 . . . . 0.0 107.422 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -120.62 156.12 32.33 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.602 1.161 . . . . 0.0 112.685 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -98.6 109.8 54.43 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.695 1.198 . . . . 0.0 111.014 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.58 -13.43 30.02 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.206 2.604 . . . . 0.0 112.616 -172.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.36 -13.84 58.83 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.463 1.028 . . . . 0.0 113.719 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.3 t -118.63 -33.85 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.91 1.284 . . . . 0.0 112.481 -170.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.27 151.17 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.851 1.26 . . . . 0.0 110.504 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.5 t -104.7 144.17 28.19 Favored Pre-proline 0 N--CA 1.477 0.894 0 O-C-N 120.951 -1.093 . . . . 0.0 110.978 169.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.69 -27.86 27.77 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.698 2.932 . . . . 0.0 114.358 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -70.43 -41.73 72.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.534 0.606 . . . . 0.0 111.386 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.57 -28.05 58.83 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 170.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.49 -55.16 38.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.598 1.559 . . . . 0.0 110.4 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.08 -30.36 70.95 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.402 -0.811 . . . . 0.0 112.533 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.85 -16.12 63.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.08 62.16 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.361 0.982 . . . . 0.0 112.232 171.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.5 mp -71.84 -33.73 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.027 0.931 . . . . 0.0 110.461 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -66.37 -31.04 71.56 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.939 0.791 . . . . 0.0 112.084 170.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -70.86 -29.96 66.22 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 120.593 -1.317 . . . . 0.0 112.137 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 10.6 ttt -71.85 -27.44 62.89 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.679 1.192 . . . . 0.0 111.725 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 124.23 14.2 3.74 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.362 1.934 . . . . 0.0 116.886 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -128.03 147.09 50.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.828 1.314 . . . . 0.0 111.046 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -95.17 101.01 12.73 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 123.414 1.578 . . . . 0.0 110.525 -170.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -98.42 143.99 28.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 112.54 -2.118 . . . . 0.0 111.529 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.4 t -141.28 132.22 26.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.538 1.535 . . . . 0.0 111.812 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.8 m -86.04 72.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.329 1.052 . . . . 0.0 110.533 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.477 0.882 0 C-N-CA 124.2 1.0 . . . . 0.0 111.375 178.677 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 p -96.65 146.02 25.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.56 1.544 . . . . 0.0 112.192 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.95 126.44 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.935 1.694 . . . . 0.0 109.654 174.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.19 131.69 45.05 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.807 1.243 . . . . 0.0 110.192 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 155.48 43.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.977 169.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.91 129.66 46.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.704 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 mt -104.27 147.04 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.835 1.254 . . . . 0.0 110.923 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -96.18 140.33 31.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.956 2.102 . . . . 0.0 110.575 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.8 -8.13 73.8 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.641 1.115 . . . . 0.0 113.696 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 13.2 ptp -66.08 -13.25 59.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -54.23 -32.12 55.11 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.145 0.884 . . . . 0.0 111.85 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.61 -17.45 62.89 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm 76.31 -57.17 0.56 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.76 2.824 . . . . 0.0 112.394 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.4 p -53.79 -23.04 10.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.906 1.282 . . . . 0.0 113.822 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.5 t -47.17 -46.92 24.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.147 1.779 . . . . 0.0 111.949 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.17 -17.57 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.19 -56.25 10.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.464 1.106 . . . . 0.0 110.339 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -36.87 73.61 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.688 -0.632 . . . . 0.0 111.434 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mt -62.28 -48.19 89.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.525 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.17 -36.14 76.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.865 1.266 . . . . 0.0 112.849 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -64.95 -40.4 94.97 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.33 -0.856 . . . . 0.0 112.351 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -91.45 -35.58 14.26 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -172.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 mm -99.28 113.28 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.417 1.008 . . . . 0.0 110.686 -168.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.96 -21.68 0.89 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.477 1.037 . . . . 0.0 115.136 -170.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -108.92 -5.09 16.28 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.362 1.081 . . . . 0.0 113.34 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.72 153.12 43.82 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.992 1.717 . . . . 0.0 111.069 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.8 tp -11.12 -69.88 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 128.827 2.851 . . . . 0.0 114.642 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.48 9.76 22.01 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 115.734 -2.704 . . . . 0.0 117.469 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.42 130.62 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 123.117 3.459 . . . . 0.0 108.434 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -100.13 -43.69 6.24 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.174 0.59 . . . . 0.0 111.261 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 p -148.98 164.02 35.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.479 1.112 . . . . 0.0 113.028 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 tp -120.82 149.76 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.177 1.391 . . . . 0.0 111.625 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -142.64 154.4 44.33 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.259 1.824 . . . . 0.0 110.157 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.4 t -133.12 137.68 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 120.793 -1.192 . . . . 0.0 110.446 -171.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.461 ' HB3' ' HG1' ' A' ' 59' ' ' THR . 8.1 t -134.35 55.26 1.9 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.542 1.537 . . . . 0.0 109.435 175.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -33.36 74.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.91 1.684 . . . . 0.0 112.952 -169.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -47.89 -34.95 9.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.766 2.026 . . . . 0.0 112.504 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -116.53 23.22 12.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.023 1.329 . . . . 0.0 112.497 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.5 mttp 67.37 9.7 7.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.287 2.635 . . . . 0.0 115.481 169.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.461 ' HG1' ' HB3' ' A' ' 54' ' ' SER . 2.5 p -107.96 145.36 33.95 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.72 1.208 . . . . 0.0 112.44 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.19 157.93 16.94 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.613 1.165 . . . . 0.0 108.764 167.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -139.81 118.46 12.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.487 0.315 . . . . 0.0 110.263 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.8 p -114.24 132.55 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.782 -0.574 . . . . 0.0 111.11 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.11 93.4 5.7 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.595 1.158 . . . . 0.0 109.008 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -118.19 152.44 35.66 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.353 1.061 . . . . 0.0 112.45 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -100.33 114.98 65.89 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.715 1.606 . . . . 0.0 109.829 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.67 5.69 3.21 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.359 3.372 . . . . 0.0 113.955 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 t -68.0 -34.79 77.19 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.026 0.93 . . . . 0.0 111.444 171.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 74.9 m -114.94 -25.42 8.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -168.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -144.4 -178.38 5.95 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.929 1.291 . . . . 0.0 111.839 -173.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.6 p -152.6 161.06 30.25 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.57 1.548 . . . . 0.0 111.919 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.72 -46.46 24.26 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.547 2.831 . . . . 0.0 115.137 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.3 m -70.21 -33.52 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.208 1.367 . . . . 0.0 113.262 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.86 -38.0 79.47 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.6 -0.688 . . . . 0.0 111.419 175.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.36 -44.09 79.85 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.335 1.054 . . . . 0.0 111.409 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -53.66 -55.66 24.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.303 1.041 . . . . 0.0 110.557 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -52.79 -48.34 66.94 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.52 0.728 . . . . 0.0 112.714 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.36 -58.44 8.59 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.608 0.763 . . . . 0.0 111.935 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.8 pt -74.31 -31.13 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.65 -39.12 67.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.483 1.113 . . . . 0.0 112.533 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.23 23.08 9.62 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.0 mt -60.16 -55.41 45.64 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.483 164.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.77 170.9 17.61 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.696 2.931 . . . . 0.0 112.163 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.59 35.79 0.33 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 125.03 3.82 . . . . 0.0 112.903 171.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.28 28.02 34.8 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.191 1.377 . . . . 0.0 113.115 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -104.02 -42.74 5.47 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -168.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -96.35 117.07 30.08 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -102.16 135.51 43.62 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.363 1.865 . . . . 0.0 111.733 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.66 150.25 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.868 1.213 . . . . 0.0 111.675 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.1 t -134.13 107.98 8.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.235 1.414 . . . . 0.0 110.067 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.549 0.905 0 CA-C-N 114.482 -1.235 . . . . 0.0 113.113 -174.744 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 29.1 p -155.75 142.48 18.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.502 1.121 . . . . 0.0 112.544 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.8 t -142.9 160.17 40.84 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.948 1.699 . . . . 0.0 109.547 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 98.4 m -113.07 143.55 44.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.783 0.833 . . . . 0.0 109.484 171.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.71 165.29 27.89 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.687 0.795 . . . . 0.0 111.457 167.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -119.87 130.33 54.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.858 1.663 . . . . 0.0 110.048 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.47 140.88 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 126.292 1.837 . . . . 0.0 108.694 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.22 132.24 52.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.723 1.609 . . . . 0.0 109.952 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.86 136.79 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.214 1.006 . . . . 0.0 110.3 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.79 57.91 1.43 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.994 1.718 . . . . 0.0 112.715 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.58 52.23 0.31 Allowed Glycine 0 N--CA 1.467 0.739 0 C-N-CA 124.387 0.994 . . . . 0.0 112.533 168.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 68.0 mtm -131.71 150.86 52.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.471 1.108 . . . . 0.0 110.862 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.8 t -157.39 -30.46 0.08 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.039 1.336 . . . . 0.0 111.877 -168.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 64.7 m -128.28 140.7 51.74 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.036 1.734 . . . . 0.0 111.948 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -48.58 -33.86 10.51 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.162 1.785 . . . . 0.0 114.246 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.9 p -50.35 -32.29 16.92 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.422 1.089 . . . . 0.0 113.754 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 11.5 t -61.36 -21.87 64.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.3 t -59.5 -60.23 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 119.423 1.011 . . . . 0.0 109.54 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -62.48 -27.74 69.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.029 0.532 . . . . 0.0 111.772 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.7 m -71.71 -46.8 57.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.75 0.82 . . . . 0.0 113.139 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 79.3 mt -68.06 -54.37 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.986 1.266 . . . . 0.0 110.081 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -52.31 -31.8 34.75 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.624 1.57 . . . . 0.0 112.03 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.14 -61.87 2.57 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.632 1.587 . . . . 0.0 115.694 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 92.9 mmm -73.38 -35.1 65.87 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.5 mm -71.29 -29.07 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 121.778 -0.576 . . . . 0.0 111.272 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.6 t -56.57 -12.22 1.68 Allowed 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -84.42 -0.38 52.55 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 119.671 -1.893 . . . . 0.0 115.763 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 pp -116.54 8.46 13.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 -167.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 74.71 161.4 0.24 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.127 2.571 . . . . 0.0 115.707 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.25 -44.08 1.59 Allowed Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.345 -1.472 . . . . 0.0 113.22 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.11 97.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 127.295 2.238 . . . . 0.0 111.922 170.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.9 -61.58 1.79 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.472 1.109 . . . . 0.0 111.02 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -123.49 133.55 54.01 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.354 1.461 . . . . 0.0 108.495 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.5 tt -140.09 137.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.991 0.901 . . . . 0.0 110.799 -173.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.0 t -142.23 152.49 43.13 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.859 1.664 . . . . 0.0 109.991 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.58 139.07 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.439 1.096 . . . . 0.0 110.238 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 18.3 t -122.46 84.81 2.31 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.119 2.168 . . . . 0.0 108.708 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.7 -28.35 67.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.961 1.704 . . . . 0.0 111.519 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.2 -53.26 8.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.794 2.438 . . . . 0.0 112.887 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -95.16 -7.87 37.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.506 1.122 . . . . 0.0 111.707 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.55 42.13 64.21 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.059 1.79 . . . . 0.0 111.729 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.4 p -130.92 155.86 46.05 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.33 1.052 . . . . 0.0 111.51 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.29 129.93 38.25 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.525 1.13 . . . . 0.0 110.93 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.3 t -109.84 124.83 52.01 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.223 1.009 . . . . 0.0 108.962 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.76 138.58 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -169.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.43 114.49 26.16 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.897 2.479 . . . . 0.0 107.296 174.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -124.31 162.91 22.79 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.672 1.589 . . . . 0.0 112.022 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -96.79 112.62 60.96 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.259 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.13 -9.6 24.71 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.717 2.945 . . . . 0.0 115.456 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -88.36 -37.44 15.92 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.718 1.144 . . . . 0.0 112.084 169.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.65 -36.87 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.678 1.191 . . . . 0.0 112.209 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 tt -146.05 150.19 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 121.054 -1.029 . . . . 0.0 112.623 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.71 150.43 46.92 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.096 1.758 . . . . 0.0 110.535 -173.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.93 -37.56 67.21 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.398 2.732 . . . . 0.0 114.77 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.25 -27.68 68.14 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.56 -36.55 63.09 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.706 1.203 . . . . 0.0 112.149 172.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 91.0 mt -58.29 -52.93 63.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.775 0.83 . . . . 0.0 111.206 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -61.81 -38.74 89.24 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.13 -29.54 69.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.711 0.804 . . . . 0.0 112.469 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.44 -31.07 70.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.318 1.047 . . . . 0.0 113.045 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.26 -32.35 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.475 1.11 . . . . 0.0 111.362 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.06 -33.43 73.56 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.462 -0.774 . . . . 0.0 112.381 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -71.11 -30.42 66.5 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.842 0.746 . . . . 0.0 112.558 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 23.4 ttt -65.94 -43.3 88.44 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.123 0.969 . . . . 0.0 111.165 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 142.32 21.58 0.23 Allowed Glycine 0 CA--C 1.533 1.182 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 169.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -131.4 -155.16 0.67 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.111 1.365 . . . . 0.0 110.392 -171.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -129.44 140.57 51.27 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.426 1.491 . . . . 0.0 110.462 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.85 150.69 40.22 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.882 1.273 . . . . 0.0 114.404 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.7 t -141.8 146.95 36.51 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.252 1.421 . . . . 0.0 110.716 171.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.3 m -92.78 125.38 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.297 0.953 . . . . 0.0 109.665 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 124.384 2.04 . . . . 0.0 107.949 -177.305 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 121.47 0.652 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.9 m -99.01 164.4 12.19 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.782 1.633 . . . . 0.0 109.369 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.21 139.81 35.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.278 1.031 . . . . 0.0 110.315 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -98.51 123.85 42.9 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.753 0.787 . . . . 0.0 109.09 169.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.13 136.66 25.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.943 -1.48 . . . . 0.0 113.538 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -107.65 108.12 19.24 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.472 1.109 . . . . 0.0 110.053 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mt -92.99 145.74 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.678 1.591 . . . . 0.0 109.837 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.56 150.34 22.79 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.532 2.333 . . . . 0.0 111.29 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.98 -11.53 71.85 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.944 1.259 . . . . 0.0 114.348 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.7 ptp -70.29 -0.3 7.79 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.0 m170 -60.23 -23.96 64.48 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 120.315 1.416 . . . . 0.0 111.503 167.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.2 m -98.11 128.64 44.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.918 0.781 . . . . 0.0 110.377 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -56.49 -40.72 75.42 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.934 0.874 . . . . 0.0 112.392 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.8 p -59.39 -23.09 62.31 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.724 1.21 . . . . 0.0 113.907 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 74.8 m -72.97 -40.87 64.96 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.801 0.84 . . . . 0.0 112.149 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.2 p -74.59 -30.18 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -49.87 -60.74 2.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.266 1.426 . . . . 0.0 112.177 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.1 -24.15 66.02 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.304 -0.872 . . . . 0.0 113.266 -177.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 mt -70.5 -48.95 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.138 -0.976 . . . . 0.0 110.281 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -68.06 -26.43 65.85 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.345 1.058 . . . . 0.0 112.372 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.58 -39.26 88.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.764 1.225 . . . . 0.0 112.039 171.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -94.68 -23.92 17.38 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -172.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.3 mm -108.7 113.54 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.869 0.868 . . . . 0.0 109.981 -169.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.5 -14.76 4.47 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.076 1.322 . . . . 0.0 114.739 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -100.86 7.49 43.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.508 1.123 . . . . 0.0 113.326 174.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.0 mt -90.96 159.69 16.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.906 1.682 . . . . 0.0 112.932 -173.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.15 -23.7 62.4 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -171.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.99 3.79 6.39 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.181 -1.899 . . . . 0.0 115.067 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -113.68 117.47 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 121.105 2.452 . . . . 0.0 109.006 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -100.34 -29.72 12.26 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.7 m -147.59 158.61 44.07 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.681 -1.262 . . . . 0.0 112.955 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.1 tp -137.96 137.99 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.497 1.519 . . . . 0.0 109.707 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -141.02 159.58 41.9 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.883 2.073 . . . . 0.0 107.944 -171.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.19 152.34 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 120.627 -1.296 . . . . 0.0 110.79 168.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -125.54 56.22 1.38 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 168.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -28.14 68.59 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.386 1.875 . . . . 0.0 112.567 -168.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.16 -20.15 24.6 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 169.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -115.68 -2.89 12.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.349 2.26 . . . . 0.0 112.541 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt 73.27 15.67 4.31 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.144 2.178 . . . . 0.0 112.672 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.96 147.32 23.81 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.922 1.289 . . . . 0.0 109.1 170.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.04 158.08 16.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 166.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.73 116.86 15.38 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -168.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.91 133.58 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.836 -0.54 . . . . 0.0 110.883 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -107.61 96.21 6.23 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.02 2.128 . . . . 0.0 106.676 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -126.03 154.6 42.75 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.62 108.56 40.65 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 127.073 2.149 . . . . 0.0 107.192 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -71.26 1.73 5.12 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.672 2.914 . . . . 0.0 114.474 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 p -83.01 -23.82 33.11 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.927 1.291 . . . . 0.0 112.33 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 85.5 m -120.1 -18.38 8.11 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 t -147.88 -178.6 6.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.814 1.246 . . . . 0.0 111.422 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.8 m -168.35 161.47 8.97 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.923 1.689 . . . . 0.0 112.596 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.72 -52.9 7.95 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 124.199 3.266 . . . . 0.0 117.289 -168.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.19 -32.33 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 120.742 1.61 . . . . 0.0 113.083 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.53 -40.05 85.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.55 0.74 . . . . 0.0 111.381 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.83 -44.53 80.85 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.342 1.057 . . . . 0.0 111.875 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -55.36 -51.73 65.83 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.63 0.65 . . . . 0.0 110.019 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -67.78 -28.79 67.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.134 0.974 . . . . 0.0 113.299 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.37 -60.25 2.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.122 0.874 . . . . 0.0 111.308 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.2 pt -72.74 -32.92 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -169.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -66.12 -22.08 66.38 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.6 16.17 27.09 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.2 mt -62.31 -57.36 23.43 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.12 -1.419 . . . . 0.0 109.838 165.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.53 171.18 18.26 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.122 3.215 . . . . 0.0 111.963 172.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.96 45.72 2.07 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 124.045 3.163 . . . . 0.0 112.664 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.95 58.61 3.97 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -135.62 -25.07 1.31 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.09 98.0 5.87 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.279 1.399 . . . . 0.0 108.283 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -92.31 128.65 38.23 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.737 1.215 . . . . 0.0 110.94 -167.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.59 135.3 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.257 1.023 . . . . 0.0 112.063 -174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.0 m -127.13 133.34 50.39 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.553 1.541 . . . . 0.0 111.347 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 124.736 1.214 . . . . 0.0 110.207 176.529 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 23.0 p -155.53 115.61 3.73 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -167.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.9 p -144.7 147.3 32.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.138 1.375 . . . . 0.0 111.209 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.2 m -98.79 141.49 31.52 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.493 -0.755 . . . . 0.0 110.204 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.31 164.12 31.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 112.04 169.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.44 133.95 54.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.715 2.006 . . . . 0.0 109.531 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.4 mm -119.82 133.26 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.297 1.039 . . . . 0.0 108.662 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.53 128.91 45.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.438 1.095 . . . . 0.0 109.001 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 89.9 mt -129.69 136.08 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.195 -0.941 . . . . 0.0 110.529 -169.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -119.68 56.89 0.93 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.752 1.621 . . . . 0.0 111.849 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.57 51.81 0.35 Allowed Glycine 0 N--CA 1.462 0.389 0 O-C-N 121.865 -0.522 . . . . 0.0 112.746 169.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 72.0 mtm -128.86 119.3 24.19 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.587 0.755 . . . . 0.0 109.189 171.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.92 -41.15 5.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.62 1.968 . . . . 0.0 110.34 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 86.7 m -134.32 157.66 45.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.308 1.843 . . . . 0.0 110.733 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.47 -28.49 65.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.99 -36.66 18.13 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.1 -1.0 . . . . 0.0 111.938 169.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 62.5 m -61.27 -42.66 99.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.485 1.114 . . . . 0.0 113.266 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.09 -54.98 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -66.98 -28.86 68.6 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.6 m -65.63 -52.62 50.45 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.077 1.351 . . . . 0.0 112.074 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.95 -51.08 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.03 -1.044 . . . . 0.0 110.547 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -52.81 -34.79 55.29 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.205 1.802 . . . . 0.0 110.86 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.31 -61.33 3.45 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.125 1.345 . . . . 0.0 113.306 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.7 mmt -63.51 -41.3 98.52 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.479 1.112 . . . . 0.0 112.799 -171.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.5 mm -70.86 -35.86 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 117.759 0.254 . . . . 0.0 110.901 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -63.18 -9.2 10.11 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -77.08 -18.84 57.73 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.224 -1.548 . . . . 0.0 114.086 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -99.63 164.98 11.83 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.144 1.338 . . . . 0.0 113.514 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -76.29 151.34 36.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.04 -25.72 6.66 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.838 1.208 . . . . 0.0 113.978 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.58 96.25 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.263 1.531 . . . . 0.0 109.955 169.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -74.47 -47.17 34.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.396 1.478 . . . . 0.0 111.806 -173.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -144.05 135.82 26.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.471 1.908 . . . . 0.0 108.669 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 tt -140.13 135.66 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.778 1.172 . . . . 0.0 111.34 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.3 t -140.61 126.09 18.91 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.018 1.327 . . . . 0.0 111.487 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 t -126.11 147.58 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 O-C-N 120.695 -1.253 . . . . 0.0 111.285 -169.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.4 t -140.77 144.31 35.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.954 0.883 . . . . 0.0 112.939 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.8 -20.22 62.61 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.798 1.639 . . . . 0.0 115.019 174.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.44 -35.6 52.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.395 1.478 . . . . 0.0 113.595 -172.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -125.25 -10.93 6.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.79 1.636 . . . . 0.0 112.382 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.33 47.97 6.63 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.235 1.398 . . . . 0.0 111.365 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.4 p -139.03 144.39 38.82 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -168.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.57 142.58 35.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.414 1.885 . . . . 0.0 111.361 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.0 t -116.94 124.87 50.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.84 142.1 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 122.955 0.502 . . . . 0.0 111.841 -168.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.35 109.42 21.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.65 1.98 . . . . 0.0 107.097 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -106.08 156.06 18.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.042 0.937 . . . . 0.0 111.969 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -95.33 109.63 46.16 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.271 1.028 . . . . 0.0 108.531 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.67 -12.69 18.28 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.763 2.308 . . . . 0.0 112.518 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.04 -36.49 40.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.165 0.986 . . . . 0.0 112.306 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.24 -34.11 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.682 1.193 . . . . 0.0 113.893 -170.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 18.2 tt -137.16 152.99 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.118 1.326 . . . . 0.0 112.19 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 m -99.84 141.09 22.14 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.358 1.463 . . . . 0.0 110.892 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -51.46 -35.72 56.27 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.445 2.764 . . . . 0.0 114.412 172.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -62.49 -28.45 69.84 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -71.93 -33.68 68.45 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.896 -1.127 . . . . 0.0 111.802 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 70.0 mt -59.94 -58.82 6.91 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.407 0.683 . . . . 0.0 109.899 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -61.35 -37.66 84.13 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.009 -0.432 . . . . 0.0 112.025 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.47 -30.14 71.04 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.83 -31.52 68.28 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.18 0.9 . . . . 0.0 112.376 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.7 mp -71.72 -39.82 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.267 1.027 . . . . 0.0 111.177 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.89 -35.37 79.83 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.007 0.523 . . . . 0.0 111.869 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.92 -23.38 61.46 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.486 1.514 . . . . 0.0 113.958 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 26.2 ttt -74.7 -46.82 35.19 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.313 -0.867 . . . . 0.0 110.946 176.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.96 42.99 0.09 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.064 1.316 . . . . 0.0 115.373 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -143.66 -159.16 0.95 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.867 1.667 . . . . 0.0 109.68 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.6 142.04 50.82 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.12 1.368 . . . . 0.0 110.163 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -140.67 147.5 39.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.5 1.92 . . . . 0.0 112.504 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.3 t -138.62 134.19 33.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.632 1.573 . . . . 0.0 111.966 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.4 m -83.92 78.26 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.116 0.96 . . . . 0.0 110.444 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.475 0.806 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.441 174.629 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.81 97.06 10.76 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 166.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.571 HD13 ' H ' ' A' ' 23' ' ' GLN . 4.5 tp -112.16 165.43 12.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.102 1.361 . . . . 0.0 107.902 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.571 ' H ' HD13 ' A' ' 22' ' ' LEU . 2.7 pt20 -147.0 161.97 39.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 119.774 -1.829 . . . . 0.0 114.078 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.72 150.41 43.41 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.941 1.697 . . . . 0.0 109.652 168.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -98.7 103.35 15.3 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 mm -76.37 146.77 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.475 1.51 . . . . 0.0 110.539 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -98.91 137.22 37.78 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.984 2.114 . . . . 0.0 110.968 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.44 -9.46 75.46 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.106 1.336 . . . . 0.0 113.697 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.94 -6.16 7.79 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -60.16 -27.11 66.83 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.945 1.248 . . . . 0.0 110.758 165.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.1 t -88.58 119.62 29.2 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 166.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -58.92 -33.48 70.61 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.352 -0.843 . . . . 0.0 111.685 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 m -54.89 -31.0 59.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.733 1.213 . . . . 0.0 112.822 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.6 m -72.2 -40.48 67.83 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.974 1.309 . . . . 0.0 112.774 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.7 p -76.31 -31.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.86 -55.14 36.04 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.585 1.154 . . . . 0.0 112.235 -175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -59.97 -31.3 69.76 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.535 -0.728 . . . . 0.0 112.594 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mt -64.01 -47.76 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.403 -0.811 . . . . 0.0 109.995 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.99 -25.93 68.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.686 1.594 . . . . 0.0 113.795 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.64 -37.46 59.66 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.753 -1.217 . . . . 0.0 113.862 170.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -91.13 -35.11 14.76 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.5 mm -95.88 112.17 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 120.818 -1.176 . . . . 0.0 107.968 -170.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.59 -15.26 3.62 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.378 0.989 . . . . 0.0 115.285 -168.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -104.32 11.58 34.58 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.589 1.194 . . . . 0.0 113.029 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.9 mt -96.88 149.72 21.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.391 1.476 . . . . 0.0 113.143 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.2 tp -32.21 -58.73 0.31 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.16 2.184 . . . . 0.0 114.016 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.86 19.01 31.05 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.181 -1.9 . . . . 0.0 115.704 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -138.1 109.58 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.084 2.442 . . . . 0.0 108.873 168.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.66 -16.12 15.08 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.5 t -146.1 168.08 21.82 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.016 1.326 . . . . 0.0 110.875 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.0 tp -143.51 146.51 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.292 1.037 . . . . 0.0 111.64 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -144.16 157.92 44.02 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.5 1.52 . . . . 0.0 109.825 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.79 156.47 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 O-C-N 119.801 -1.812 . . . . 0.0 112.564 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 t -136.22 56.21 1.82 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.249 1.82 . . . . 0.0 108.04 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.03 -23.03 66.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.583 1.153 . . . . 0.0 112.908 -170.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -66.13 -14.79 62.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.942 1.297 . . . . 0.0 113.76 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -126.12 11.46 7.62 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.274 2.23 . . . . 0.0 112.5 169.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 71.16 7.33 6.12 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.765 2.026 . . . . 0.0 115.382 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.32 157.74 15.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.808 1.243 . . . . 0.0 110.412 172.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.83 144.11 47.52 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.987 1.315 . . . . 0.0 109.426 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -112.29 119.17 37.4 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -170.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.35 140.75 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 120.924 -1.11 . . . . 0.0 108.089 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -110.09 82.97 1.68 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.757 1.223 . . . . 0.0 107.752 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -106.0 152.1 23.78 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -169.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.81 103.02 16.84 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.708 2.003 . . . . 0.0 110.113 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.94 0.74 1.86 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.705 2.937 . . . . 0.0 114.944 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 98.5 p -74.91 -15.65 60.69 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.887 -1.133 . . . . 0.0 113.226 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.3 m -137.09 -24.44 1.1 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -171.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 t -144.53 178.16 8.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.355 1.462 . . . . 0.0 111.374 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.3 p -148.18 158.56 41.29 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.825 1.25 . . . . 0.0 113.008 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.7 -52.31 7.18 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.661 2.907 . . . . 0.0 114.648 -170.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.3 m -62.96 -30.16 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.879 1.218 . . . . 0.0 113.516 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.65 -46.48 58.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.474 0.71 . . . . 0.0 111.257 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.9 mt -58.2 -42.52 86.33 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.646 0.778 . . . . 0.0 111.482 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -57.57 -37.99 74.06 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.167 0.587 . . . . 0.0 111.638 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -72.2 -40.28 67.98 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.433 1.015 . . . . 0.0 112.626 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.51 -60.2 4.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.033 0.933 . . . . 0.0 112.411 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.1 pt -70.53 -28.59 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -168.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -69.98 -12.99 62.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.615 1.566 . . . . 0.0 113.326 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.0 6.43 29.06 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -55.7 -49.83 90.56 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 117.307 -1.33 . . . . 0.0 110.985 166.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.62 172.08 17.0 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.298 2.665 . . . . 0.0 111.311 168.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.47 44.35 1.22 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.323 3.349 . . . . 0.0 111.64 170.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.28 30.54 41.12 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.101 1.334 . . . . 0.0 113.746 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -95.1 -47.99 6.14 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.65 1.225 . . . . 0.0 112.22 -169.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -100.58 123.37 44.7 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.127 1.371 . . . . 0.0 109.025 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -101.46 165.48 11.23 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.051 0.94 . . . . 0.0 111.888 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.01 139.47 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.503 0.721 . . . . 0.0 111.802 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 m -110.92 134.88 52.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.656 1.183 . . . . 0.0 110.949 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.542 0.67 0 C-N-CA 126.862 2.065 . . . . 0.0 111.169 177.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 21.8 p -125.38 152.14 45.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.404 1.882 . . . . 0.0 113.148 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.0 t -140.6 149.95 42.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.791 2.036 . . . . 0.0 107.395 167.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m -99.88 142.05 31.87 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.15 0.5 . . . . 0.0 110.819 -170.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.25 145.25 31.92 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.596 0.758 . . . . 0.0 110.394 169.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tt -114.69 137.83 51.44 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.676 1.99 . . . . 0.0 108.346 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.9 mt -133.36 138.4 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.622 1.569 . . . . 0.0 109.768 -168.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.33 130.87 45.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.246 1.818 . . . . 0.0 109.296 172.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mp -126.38 122.43 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.274 -0.892 . . . . 0.0 111.855 -171.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.48 61.47 3.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.212 1.805 . . . . 0.0 111.24 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.59 54.96 0.27 Allowed Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.628 169.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 73.8 mtm -138.78 121.09 15.93 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.628 0.771 . . . . 0.0 110.57 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 t -125.25 -30.19 3.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.747 1.619 . . . . 0.0 112.513 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 11.8 m -147.74 163.49 36.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.682 1.993 . . . . 0.0 111.057 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.3 -30.51 70.54 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -172.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.2 m -57.53 -20.94 34.98 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.763 -1.21 . . . . 0.0 112.933 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 93.0 m -63.06 -44.1 96.75 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.931 -1.105 . . . . 0.0 112.286 168.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.66 -54.43 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -65.73 -24.5 66.98 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 117.998 0.363 . . . . 0.0 111.741 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 m -70.84 -53.11 16.44 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.747 -1.22 . . . . 0.0 111.792 170.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.1 -50.41 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.507 -1.371 . . . . 0.0 110.696 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.19 -33.01 68.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.808 2.043 . . . . 0.0 111.494 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.5 -61.89 2.85 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.856 1.217 . . . . 0.0 113.913 174.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -44.83 67.73 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.75 1.22 . . . . 0.0 112.844 -169.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.4 mm -70.74 -21.0 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.543 -0.723 . . . . 0.0 111.502 -173.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.4 -2.91 18.12 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 169.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -80.96 -13.77 58.59 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 119.591 -1.943 . . . . 0.0 115.403 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.25 -177.17 4.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.218 1.407 . . . . 0.0 113.445 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.99 137.18 32.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.134 0.974 . . . . 0.0 111.49 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.03 41.45 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 117.658 -1.634 . . . . 0.0 115.894 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.9 p -120.93 93.6 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.802 1.801 . . . . 0.0 110.863 -175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -49.76 28.98 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.669 1.188 . . . . 0.0 110.122 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -147.31 142.72 27.45 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.751 1.221 . . . . 0.0 110.505 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 9.2 tt -135.83 140.51 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 119.426 1.012 . . . . 0.0 110.452 169.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 12.5 t -140.16 145.26 37.28 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.898 1.679 . . . . 0.0 109.667 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.3 t -141.01 146.4 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.659 1.118 . . . . 0.0 110.579 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 77.4 p -142.45 132.71 24.78 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.147 -0.971 . . . . 0.0 113.17 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -19.64 63.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.514 1.526 . . . . 0.0 112.614 171.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -48.88 -52.84 22.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.997 1.319 . . . . 0.0 111.64 170.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -96.23 -25.07 15.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.894 1.278 . . . . 0.0 112.321 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.76 25.53 55.99 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.791 1.186 . . . . 0.0 112.319 -170.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 p -136.02 147.12 47.81 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.526 1.163 . . . . 0.0 113.813 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -99.63 145.67 27.33 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.847 1.659 . . . . 0.0 110.366 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.9 t -127.95 129.36 46.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.647 0.779 . . . . 0.0 109.257 168.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.8 140.81 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 123.572 0.749 . . . . 0.0 111.181 -168.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.15 107.02 18.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.08 1.752 . . . . 0.0 106.947 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -101.79 157.04 17.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.423 0.689 . . . . 0.0 111.633 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -95.98 111.71 57.05 Favored Pre-proline 0 CA--C 1.542 0.673 0 O-C-N 121.242 -0.911 . . . . 0.0 110.285 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.95 -10.52 23.07 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.468 2.112 . . . . 0.0 112.823 -170.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.41 -8.64 59.76 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.143 0.977 . . . . 0.0 113.168 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 73.5 t -120.93 -42.25 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.994 1.318 . . . . 0.0 111.972 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.2 tt -143.39 165.09 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.212 1.005 . . . . 0.0 111.507 -170.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.46 154.01 72.45 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.0 1.72 . . . . 0.0 110.947 -175.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.19 -44.82 36.5 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.025 3.15 . . . . 0.0 114.962 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.53 -19.54 62.89 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.39 -0.819 . . . . 0.0 113.11 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -73.85 -29.14 61.95 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.844 -1.16 . . . . 0.0 111.944 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.75 -51.3 67.69 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.552 0.741 . . . . 0.0 109.296 170.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -50.64 -51.12 51.98 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.64 1.176 . . . . 0.0 111.686 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.45 -27.32 68.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.74 -34.9 64.96 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.824 0.85 . . . . 0.0 112.146 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.7 -38.59 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.877 0.871 . . . . 0.0 111.235 171.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -64.96 -35.87 82.57 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.986 0.812 . . . . 0.0 112.693 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.96 -35.28 79.63 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.197 -0.94 . . . . 0.0 111.72 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -43.48 80.15 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.758 0.823 . . . . 0.0 111.37 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 140.56 21.25 0.32 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 117.156 1.623 . . . . 0.0 117.156 169.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -114.95 -156.61 0.61 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.838 1.819 . . . . 0.0 110.272 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -131.54 140.7 49.55 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.992 1.317 . . . . 0.0 109.179 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -137.62 150.28 47.28 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.4 t -138.81 137.35 36.56 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.258 1.423 . . . . 0.0 109.577 169.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.77 135.05 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 121.513 -0.742 . . . . 0.0 110.308 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 124.095 1.903 . . . . 0.0 107.484 175.827 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 120.93 0.395 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.4 132.0 47.21 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.932 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.52 136.72 54.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.954 1.302 . . . . 0.0 109.657 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -97.09 128.66 44.23 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.852 1.661 . . . . 0.0 110.88 -169.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.74 141.16 33.25 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -109.55 116.33 31.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 mt -76.58 133.76 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 122.413 1.101 . . . . 0.0 110.136 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.88 104.97 15.26 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.625 2.37 . . . . 0.0 108.298 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.61 16.68 25.95 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.5 ptp -64.42 -36.21 83.41 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.659 1.73 . . . . 0.0 115.141 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 t60 67.53 -46.16 0.49 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 129.027 2.931 . . . . 0.0 113.83 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 96.0 m -153.63 163.78 39.39 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.949 2.5 . . . . 0.0 110.432 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -53.81 -31.32 48.66 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.223 -0.923 . . . . 0.0 112.884 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.1 p -49.0 -18.82 0.33 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.387 2.275 . . . . 0.0 115.48 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.3 t -57.6 -44.85 85.75 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.537 1.535 . . . . 0.0 112.466 167.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.63 -6.32 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.344 1.458 . . . . 0.0 114.075 -170.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.09 -59.19 4.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.987 0.915 . . . . 0.0 110.761 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -59.11 -36.16 74.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.617 -0.677 . . . . 0.0 110.901 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.11 -46.72 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 121.229 -0.92 . . . . 0.0 111.93 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.94 -31.52 72.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.677 1.191 . . . . 0.0 112.974 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -66.44 -34.52 78.13 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -94.64 -45.13 7.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.48 112.95 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 122.178 0.989 . . . . 0.0 109.995 -165.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.84 5.93 5.17 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.839 1.209 . . . . 0.0 114.383 -169.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.62 1.69 7.55 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.583 1.153 . . . . 0.0 113.609 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.76 171.2 8.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.087 1.355 . . . . 0.0 111.502 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -54.53 -37.84 65.88 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 171.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.2 11.95 7.63 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.445 -1.753 . . . . 0.0 115.918 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.87 120.27 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.005 2.402 . . . . 0.0 109.303 169.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 -21.15 12.36 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -142.78 166.72 23.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.882 1.219 . . . . 0.0 112.663 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.7 tp -140.88 138.65 34.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 126.591 1.956 . . . . 0.0 108.433 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -125.4 129.52 50.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.169 1.388 . . . . 0.0 109.51 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -99.4 112.4 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.315 1.446 . . . . 0.0 108.161 -170.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 m -125.8 49.58 1.93 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.829 0.823 . . . . 0.0 110.613 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.62 -15.18 60.8 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.255 1.822 . . . . 0.0 114.803 -170.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -43.7 -32.84 1.09 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.614 2.366 . . . . 0.0 115.538 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -125.33 23.39 7.59 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.666 1.186 . . . . 0.0 112.874 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 63.39 24.72 14.3 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.035 1.734 . . . . 0.0 112.263 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.28 164.4 13.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.075 1.75 . . . . 0.0 110.036 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.33 151.31 41.82 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 127.677 2.391 . . . . 0.0 106.8 170.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -124.71 134.53 52.81 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.415 -0.803 . . . . 0.0 111.292 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -102.52 139.74 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 117.847 0.294 . . . . 0.0 111.089 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -102.8 95.73 6.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.708 1.603 . . . . 0.0 108.857 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -120.8 152.48 38.3 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -170.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.34 112.0 59.83 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 127.85 2.46 . . . . 0.0 109.772 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -63.03 -2.74 3.97 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.838 3.025 . . . . 0.0 115.658 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.9 p -84.24 -16.66 42.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.71 1.204 . . . . 0.0 113.019 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 92.4 m -124.43 -28.4 3.63 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 t -142.18 179.2 7.05 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.684 1.129 . . . . 0.0 113.064 -169.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 97.6 p -165.61 162.53 13.27 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.7 1.6 . . . . 0.0 112.164 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -52.63 -49.33 17.85 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.728 2.952 . . . . 0.0 115.472 -172.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.32 -37.61 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 119.326 0.966 . . . . 0.0 112.459 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.47 87.93 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.299 1.039 . . . . 0.0 111.438 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.33 -47.4 70.61 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.863 0.865 . . . . 0.0 111.778 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -55.72 -47.96 75.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.087 0.858 . . . . 0.0 111.484 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -63.94 -29.64 70.8 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.25 -62.43 1.52 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.932 0.787 . . . . 0.0 112.277 170.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 pt -72.61 -17.3 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -73.81 -35.78 64.9 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 121.64 2.018 . . . . 0.0 113.156 168.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.41 13.7 26.94 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.944 -1.097 . . . . 0.0 112.261 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.2 tp -48.86 -54.39 28.29 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 129.331 3.052 . . . . 0.0 113.202 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -91.05 176.22 2.28 Favored 'Trans proline' 0 CA--C 1.55 1.285 0 C-N-CA 124.092 3.195 . . . . 0.0 111.879 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.35 53.01 3.75 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 124.663 3.575 . . . . 0.0 113.099 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.8 52.38 5.88 Favored Glycine 0 N--CA 1.471 1.011 0 O-C-N 120.689 -1.257 . . . . 0.0 111.823 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -127.74 -33.04 2.31 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.467 1.107 . . . . 0.0 113.875 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -135.01 113.94 11.97 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.126 1.77 . . . . 0.0 109.556 -173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -98.43 173.92 6.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.36 1.464 . . . . 0.0 110.516 173.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.24 135.21 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.783 -1.198 . . . . 0.0 111.025 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -107.62 124.74 50.41 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.13 0.972 . . . . 0.0 109.831 167.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 124.239 1.016 . . . . 0.0 109.569 176.856 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.9 t 73.03 113.85 0.06 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.804 2.442 . . . . 0.0 114.835 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 60.9 m -145.37 148.6 33.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.109 2.163 . . . . 0.0 108.905 166.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.4 m -99.13 145.96 26.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.037 -1.039 . . . . 0.0 110.256 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.87 155.06 43.26 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.917 1.287 . . . . 0.0 110.978 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.0 tt -114.6 136.01 53.51 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.789 2.036 . . . . 0.0 110.745 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.6 mm -123.57 141.08 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 127.174 2.19 . . . . 0.0 109.697 -172.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.23 127.42 53.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.147 1.379 . . . . 0.0 110.706 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.23 143.72 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 120.801 -1.187 . . . . 0.0 111.566 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.85 56.46 1.31 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.195 1.798 . . . . 0.0 113.258 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.68 45.92 0.28 Allowed Glycine 0 N--CA 1.469 0.87 0 O-C-N 121.209 -0.932 . . . . 0.0 112.714 167.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 29.6 mtm -133.5 96.8 3.79 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.222 1.009 . . . . 0.0 110.024 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 t -98.99 -26.51 14.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.315 1.846 . . . . 0.0 112.939 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 95.7 m -125.62 150.43 47.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.188 1.395 . . . . 0.0 110.934 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.1 -23.79 67.46 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.918 -1.113 . . . . 0.0 113.312 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.1 p -53.55 -30.87 44.05 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.01 1.324 . . . . 0.0 113.429 169.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.8 m -57.17 -32.66 66.66 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.724 1.21 . . . . 0.0 112.3 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 41.5 t -57.07 -53.87 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.685 0.794 . . . . 0.0 109.988 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -66.31 -23.28 66.35 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.973 0.509 . . . . 0.0 112.21 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.5 m -71.19 -52.72 17.55 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.568 -0.707 . . . . 0.0 111.148 170.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 85.7 mt -70.37 -52.23 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 120.741 -1.225 . . . . 0.0 111.315 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -51.46 -42.08 61.32 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.82 1.248 . . . . 0.0 111.082 172.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.42 -62.42 2.9 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 123.558 0.599 . . . . 0.0 113.127 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -38.59 71.14 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.033 1.333 . . . . 0.0 113.026 -170.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.8 mm -71.04 -35.3 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.73 -0.606 . . . . 0.0 110.539 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -65.0 3.07 0.62 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -94.44 -11.28 30.07 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.686 1.194 . . . . 0.0 113.546 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -106.25 167.59 9.72 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.026 1.285 . . . . 0.0 112.87 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -68.38 161.38 27.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 123.213 1.482 . . . . 0.0 114.705 -174.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.82 -32.41 1.94 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.36 1.457 . . . . 0.0 114.911 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.51 98.61 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 119.106 1.453 . . . . 0.0 112.435 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -72.32 -45.89 58.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.196 0.998 . . . . 0.0 112.135 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -144.61 132.49 21.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.141 1.376 . . . . 0.0 109.783 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.71 142.3 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.745 1.157 . . . . 0.0 112.854 170.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 31.2 t -131.45 142.62 50.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.55 2.74 . . . . 0.0 109.224 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.27 146.97 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.89 1.223 . . . . 0.0 111.781 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 43.1 t -139.29 136.34 34.78 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -16.83 63.22 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.36 2.264 . . . . 0.0 113.514 171.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.74 97.05 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.783 1.233 . . . . 0.0 111.969 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -116.37 -16.05 10.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.7 1.6 . . . . 0.0 112.605 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.94 28.51 56.44 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.177 1.37 . . . . 0.0 112.855 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.1 p -128.89 151.54 49.52 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.077 0.939 . . . . 0.0 113.26 -169.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -113.32 146.71 38.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.25 1.42 . . . . 0.0 111.906 172.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.4 m -118.52 126.19 51.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.852 1.661 . . . . 0.0 107.342 168.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.77 137.33 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.321 0.649 . . . . 0.0 110.65 -171.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.25 109.69 21.78 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.75 2.02 . . . . 0.0 105.78 173.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -111.29 155.67 22.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.023 0.929 . . . . 0.0 111.993 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -97.4 107.05 36.57 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.725 1.21 . . . . 0.0 109.139 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -66.97 -15.86 48.06 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.8 1.667 . . . . 0.0 113.537 -174.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.85 -14.84 61.15 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.45 -31.67 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.165 1.786 . . . . 0.0 112.494 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.0 tt -151.77 152.31 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.865 -1.147 . . . . 0.0 112.964 -170.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 73.5 m -114.49 159.32 37.33 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.55 1.14 . . . . 0.0 112.858 171.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.8 -37.64 45.55 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.48 3.453 . . . . 0.0 115.103 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -57.82 -35.82 71.39 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.449 1.022 . . . . 0.0 113.066 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.28 -32.49 64.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.234 1.013 . . . . 0.0 111.564 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.64 -51.93 67.7 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.689 -0.632 . . . . 0.0 110.089 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -62.28 -41.82 98.81 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.733 -0.605 . . . . 0.0 111.617 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.25 73.18 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.8 -34.79 69.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.86 -38.97 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.705 0.802 . . . . 0.0 110.115 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -59.97 -46.73 88.48 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.331 0.653 . . . . 0.0 110.249 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.84 -22.49 65.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.4 1.48 . . . . 0.0 114.507 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -39.58 78.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.459 -0.775 . . . . 0.0 110.95 172.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 138.71 24.58 0.34 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.443 -1.198 . . . . 0.0 115.512 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -124.41 -153.36 0.56 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.162 1.481 . . . . 0.0 109.263 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.07 141.7 36.19 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.745 1.618 . . . . 0.0 108.018 168.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.97 154.88 47.3 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.9 t -138.88 143.53 38.77 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.024 2.13 . . . . 0.0 109.9 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.5 m -90.39 131.16 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.393 -0.817 . . . . 0.0 111.13 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 126.074 1.749 . . . . 0.0 109.903 -176.463 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.651 0.263 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.37 145.82 32.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.646 0.778 . . . . 0.0 110.945 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tt -121.4 136.44 54.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.377 1.071 . . . . 0.0 111.918 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.55 122.84 39.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 122.597 1.189 . . . . 0.0 110.295 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.82 143.04 26.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.323 -1.762 . . . . 0.0 113.203 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -113.49 118.02 33.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.618 1.167 . . . . 0.0 108.86 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 mm -83.11 147.69 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.818 1.247 . . . . 0.0 110.916 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.69 156.82 18.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.943 1.697 . . . . 0.0 112.014 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.27 -7.26 64.66 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.585 1.088 . . . . 0.0 113.957 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.0 mtm -65.7 0.37 1.73 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -58.96 -23.23 61.41 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 119.672 1.124 . . . . 0.0 112.412 167.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.9 -6.77 59.34 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.915 1.286 . . . . 0.0 113.814 171.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 tptm 59.54 -57.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 130.729 3.612 . . . . 0.0 116.123 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 m -56.32 -13.4 2.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.568 1.947 . . . . 0.0 113.589 -174.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 m -48.76 -39.67 25.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.837 2.455 . . . . 0.0 112.678 167.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.58 -20.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -172.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.63 -56.92 15.56 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.147 0.979 . . . . 0.0 112.039 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -61.91 -28.82 69.79 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.655 -0.653 . . . . 0.0 111.921 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.2 mt -61.86 -54.97 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.521 1.055 . . . . 0.0 110.005 168.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -61.82 -32.38 72.68 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.2 1.0 . . . . 0.0 113.081 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -67.75 -42.12 82.3 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.123 1.369 . . . . 0.0 112.252 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -92.75 -17.41 24.23 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 mm -117.25 128.51 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.342 1.057 . . . . 0.0 110.131 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.16 -6.17 1.74 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.621 1.581 . . . . 0.0 115.703 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -119.0 -1.27 10.99 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.853 2.061 . . . . 0.0 112.71 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.89 160.26 9.95 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.316 1.446 . . . . 0.0 110.279 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -55.22 -39.74 70.03 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.51 -32.65 5.93 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 116.876 -2.069 . . . . 0.0 115.009 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.62 118.02 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 121.235 2.517 . . . . 0.0 110.529 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -105.55 -17.4 14.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.7 m -148.91 148.09 29.43 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.491 -1.38 . . . . 0.0 113.364 169.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.7 tp -110.21 131.98 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.956 0.902 . . . . 0.0 109.866 167.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -120.52 143.45 48.56 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.432 1.493 . . . . 0.0 109.148 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t -120.09 120.58 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.658 1.183 . . . . 0.0 109.804 -169.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -119.66 55.32 0.97 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.432 1.493 . . . . 0.0 112.635 -168.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.47 -13.97 62.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -169.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -60.27 -33.4 72.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.286 1.034 . . . . 0.0 112.94 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -113.25 15.87 19.22 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.421 1.488 . . . . 0.0 111.725 171.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.0 mttt 66.89 11.54 8.38 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.217 2.207 . . . . 0.0 113.056 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.58 174.29 7.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.173 2.189 . . . . 0.0 110.29 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.04 164.67 24.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.756 1.623 . . . . 0.0 108.47 167.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -135.73 109.45 8.05 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.089 1.355 . . . . 0.0 108.048 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.9 p -98.64 133.59 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 121.856 -0.528 . . . . 0.0 110.069 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.03 96.11 7.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.382 1.473 . . . . 0.0 109.805 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -125.25 148.22 48.75 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -98.87 118.35 63.02 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.272 1.429 . . . . 0.0 109.43 171.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.57 2.16 4.26 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.836 3.024 . . . . 0.0 113.095 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 t -71.37 -28.05 63.77 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.103 -0.998 . . . . 0.0 112.289 171.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 82.6 m -113.0 -20.45 11.53 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -171.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.6 t -145.13 -176.25 5.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.853 1.661 . . . . 0.0 111.178 -171.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.8 p -158.38 155.39 25.51 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.635 1.574 . . . . 0.0 110.919 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -48.51 -46.35 23.96 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 124.132 3.221 . . . . 0.0 116.907 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.39 -32.16 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 120.472 1.487 . . . . 0.0 113.065 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.22 -30.09 67.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.93 0.892 . . . . 0.0 111.849 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.7 mt -71.9 -53.16 14.02 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.661 0.784 . . . . 0.0 111.125 169.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.426 HE21 HG21 ' A' ' 88' ' ' VAL . 14.5 tt0 -49.77 -57.32 7.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.944 1.298 . . . . 0.0 110.889 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -68.6 -27.15 65.78 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.25 -55.42 9.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.23 0.923 . . . . 0.0 111.356 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.7 pt -71.81 -31.85 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.86 -17.66 63.38 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.73 10.77 39.73 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.549 -1.344 . . . . 0.0 113.724 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.1 mt -59.17 -54.04 60.33 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.562 -1.209 . . . . 0.0 109.759 166.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.5 174.45 12.81 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.237 2.624 . . . . 0.0 110.849 168.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.74 54.49 3.53 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.142 3.228 . . . . 0.0 111.209 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.45 23.5 68.55 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.304 0.954 . . . . 0.0 112.999 -175.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -90.14 -30.37 17.68 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.554 0.677 . . . . 0.0 112.473 -169.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -109.49 116.0 30.99 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.282 1.433 . . . . 0.0 107.89 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.4 tptp -96.91 157.02 16.1 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.666 1.186 . . . . 0.0 110.592 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.426 HG21 HE21 ' A' ' 75' ' ' GLN . 3.9 m -124.2 133.81 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.756 1.616 . . . . 0.0 111.659 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.6 p -110.58 127.45 55.23 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.026 0.93 . . . . 0.0 110.528 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 125.355 1.462 . . . . 0.0 109.514 170.384 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.8 m 59.0 92.91 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.1 m -141.18 158.51 43.81 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.334 1.453 . . . . 0.0 110.804 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 52.9 m -99.22 142.51 30.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.734 0.814 . . . . 0.0 110.76 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.68 143.65 30.83 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.065 0.946 . . . . 0.0 111.312 170.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -102.68 135.72 43.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.277 1.431 . . . . 0.0 110.166 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 mm -113.83 136.04 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.552 1.941 . . . . 0.0 108.304 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -105.36 124.48 49.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.271 1.429 . . . . 0.0 109.306 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 88.3 mt -122.55 143.7 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 120.486 -1.384 . . . . 0.0 112.21 -166.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.62 56.39 1.48 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.298 1.439 . . . . 0.0 112.984 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.95 50.63 0.18 Allowed Glycine 0 N--CA 1.462 0.393 0 C-N-CA 125.17 1.367 . . . . 0.0 111.902 166.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 10.6 ptp -126.35 142.05 51.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.869 0.842 . . . . 0.0 110.637 168.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.0 t -155.72 143.03 19.33 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 128.152 2.581 . . . . 0.0 105.604 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 81.5 m 70.13 141.8 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.489 1.516 . . . . 0.0 113.422 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.41 -35.83 52.82 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.164 -0.96 . . . . 0.0 113.194 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.1 p -61.05 -25.22 66.77 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.109 -0.994 . . . . 0.0 113.373 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.3 t -65.91 -31.98 73.23 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.723 -0.611 . . . . 0.0 112.623 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.29 -60.5 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.305 0.642 . . . . 0.0 109.275 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -66.5 -20.01 65.93 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.5 t -71.08 -58.26 3.73 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.587 1.155 . . . . 0.0 111.764 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.5 mt -70.5 -49.41 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.002 1.321 . . . . 0.0 111.245 -176.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -53.16 -26.96 18.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.167 1.787 . . . . 0.0 111.775 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.62 -60.66 3.14 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.648 1.594 . . . . 0.0 113.321 167.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 70.1 mmm -54.29 -41.96 69.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.843 1.257 . . . . 0.0 114.001 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.79 -32.82 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.425 0.69 . . . . 0.0 111.97 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.0 t -64.9 1.11 0.97 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.256 1.423 . . . . 0.0 114.803 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -90.38 -30.31 17.49 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.357 -1.464 . . . . 0.0 114.031 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.86 176.77 8.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.216 1.006 . . . . 0.0 112.261 -174.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -86.84 154.45 20.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 122.489 1.138 . . . . 0.0 113.934 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.0 2.54 80.79 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 113.146 -1.843 . . . . 0.0 116.528 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.24 96.2 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 120.99 2.395 . . . . 0.0 112.231 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -65.49 -50.28 65.91 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.88 0.872 . . . . 0.0 109.922 173.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.42 141.67 30.94 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.356 0.663 . . . . 0.0 111.427 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.48 138.98 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.961 0.886 . . . . 0.0 111.298 166.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.8 t -142.22 147.07 35.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 127.365 2.266 . . . . 0.0 109.05 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.3 t -134.75 136.44 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.314 0.961 . . . . 0.0 110.566 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.1 m -113.93 99.31 7.58 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.771 1.229 . . . . 0.0 111.149 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.6 -30.99 45.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.952 1.701 . . . . 0.0 110.973 169.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -49.57 -34.21 17.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.043 2.137 . . . . 0.0 114.597 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -130.59 -5.24 4.16 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.187 0.995 . . . . 0.0 113.065 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.44 30.85 57.82 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.46 1.027 . . . . 0.0 112.355 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 61.0 p -118.66 152.98 35.07 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 117.869 0.834 . . . . 0.0 110.676 -170.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -125.26 124.3 41.36 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.675 0.79 . . . . 0.0 109.488 171.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.4 t -106.66 132.56 52.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.969 0.508 . . . . 0.0 110.18 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.82 138.67 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.068 0.547 . . . . 0.0 111.375 -171.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.16 96.1 8.21 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -98.78 159.92 14.62 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.625 0.77 . . . . 0.0 111.964 -177.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -98.68 102.68 15.56 Favored Pre-proline 0 C--O 1.241 0.653 0 C-N-CA 124.935 1.294 . . . . 0.0 109.324 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.7 -16.93 55.37 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.612 1.541 . . . . 0.0 113.075 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.21 -12.94 60.4 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 173.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 76.4 t -119.78 -41.12 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.069 1.748 . . . . 0.0 111.858 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.4 tt -137.05 149.03 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.211 1.004 . . . . 0.0 112.05 -172.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 55.5 m -112.71 153.19 45.14 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 124.461 1.104 . . . . 0.0 111.991 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -52.28 -38.94 73.29 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.453 2.769 . . . . 0.0 114.559 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.34 -29.25 68.77 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -72.05 -31.44 66.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 112.532 172.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.39 -49.93 69.64 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.512 0.725 . . . . 0.0 109.351 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -52.7 -50.57 63.07 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.929 1.292 . . . . 0.0 111.834 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.94 69.41 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.78 65.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -74.34 -39.52 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.606 0.762 . . . . 0.0 110.91 170.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.61 -29.17 69.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.869 0.468 . . . . 0.0 111.746 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.07 -36.69 82.56 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.265 -1.522 . . . . 0.0 112.678 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 17.5 ttt -67.11 -28.66 68.34 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.86 0.864 . . . . 0.0 112.024 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 118.59 20.39 4.26 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.557 1.551 . . . . 0.0 115.747 169.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -106.46 -154.66 0.52 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.487 1.515 . . . . 0.0 109.69 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.58 138.13 42.67 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.119 1.367 . . . . 0.0 109.009 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -126.67 158.49 36.24 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.4 1.48 . . . . 0.0 111.545 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.2 t -140.51 136.11 32.59 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 126.947 2.099 . . . . 0.0 107.98 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.2 m -84.21 129.73 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.762 -0.586 . . . . 0.0 109.876 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 124.829 2.252 . . . . 0.0 107.151 171.095 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.59 144.01 50.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.951 0.9 . . . . 0.0 111.367 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.3 140.27 29.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.024 2.13 . . . . 0.0 109.205 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.544 ' NE2' HE22 ' A' ' 61' ' ' GLN . 2.3 pt20 -131.01 146.21 52.31 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 173.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.6 158.13 43.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.592 1.957 . . . . 0.0 110.707 174.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.12 101.57 13.33 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -77.1 133.8 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.253 1.021 . . . . 0.0 110.814 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -97.84 136.24 38.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.472 1.509 . . . . 0.0 111.256 172.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.45 57.51 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.252 1.406 . . . . 0.0 114.256 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.2 ptp -60.81 -17.89 52.25 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -63.35 -15.53 57.69 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 119.4 1.0 . . . . 0.0 113.499 172.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.55 -9.97 59.71 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 168.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? 71.09 -59.78 0.53 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 128.68 2.792 . . . . 0.0 111.482 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.9 p -45.27 -35.84 3.66 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.335 2.254 . . . . 0.0 114.055 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -45.68 -45.76 14.35 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.7 1.6 . . . . 0.0 112.492 174.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.69 -18.43 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -174.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.1 tp -63.49 -50.92 67.75 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.203 0.911 . . . . 0.0 111.087 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -39.84 63.02 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.65 0.738 . . . . 0.0 111.072 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.38 -52.54 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.452 1.101 . . . . 0.0 109.977 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.41 -34.63 70.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.646 1.579 . . . . 0.0 113.701 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.59 -41.1 89.01 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.637 1.108 . . . . 0.0 111.68 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -94.12 -36.55 12.03 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.2 mm -98.22 114.77 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 121.177 -0.952 . . . . 0.0 109.04 -170.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.45 -27.36 2.38 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.183 0.897 . . . . 0.0 114.84 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -106.02 3.68 28.51 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.5 mt -87.78 163.67 16.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.815 1.246 . . . . 0.0 112.784 -170.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 47.1 tp -29.5 -62.01 0.14 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.802 2.441 . . . . 0.0 114.902 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.83 -23.78 13.02 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.218 -1.323 . . . . 0.0 114.626 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.86 126.3 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 120.14 1.97 . . . . 0.0 110.601 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -97.52 -40.32 8.71 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.798 0.839 . . . . 0.0 111.733 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.8 t -149.95 -178.56 6.55 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.413 1.085 . . . . 0.0 113.706 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.9 tp -132.63 145.3 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 127.462 2.305 . . . . 0.0 109.097 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -132.98 118.69 19.15 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.635 1.207 . . . . 0.0 109.561 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.4 t -104.82 95.07 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.274 1.83 . . . . 0.0 109.385 -168.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -113.17 55.63 0.7 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.401 1.481 . . . . 0.0 111.345 -174.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.4 mt -58.6 -28.82 65.94 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -168.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.5 -25.42 25.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.232 1.413 . . . . 0.0 113.589 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -102.23 -0.36 33.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.056 1.343 . . . . 0.0 113.733 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 69.6 -15.86 0.28 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 127.746 2.418 . . . . 0.0 114.543 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.64 131.28 42.04 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.845 1.658 . . . . 0.0 108.702 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.37 145.29 27.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.594 1.158 . . . . 0.0 109.698 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.544 HE22 ' NE2' ' A' ' 23' ' ' GLN . 8.4 tp-100 -114.86 134.19 55.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.705 1.202 . . . . 0.0 109.246 -169.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 p -118.39 140.46 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 119.976 1.262 . . . . 0.0 111.045 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -113.51 101.4 9.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.234 1.813 . . . . 0.0 108.499 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -128.62 -179.37 5.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.842 1.657 . . . . 0.0 111.63 -168.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -120.23 138.12 26.79 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.803 1.241 . . . . 0.0 108.569 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.57 5.51 6.07 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.966 2.444 . . . . 0.0 113.556 -169.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.9 p -75.12 -29.1 60.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.413 1.085 . . . . 0.0 113.197 -172.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.63 -21.65 6.11 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -170.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -146.71 -179.21 6.62 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.956 1.702 . . . . 0.0 110.93 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.8 p -165.58 170.24 6.26 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.969 1.308 . . . . 0.0 111.882 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -45.61 -51.28 8.31 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 124.612 3.541 . . . . 0.0 116.122 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.3 m -70.16 -35.26 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 119.714 1.143 . . . . 0.0 112.879 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.1 77.46 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.471 0.708 . . . . 0.0 110.929 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.22 -48.33 78.76 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.336 1.054 . . . . 0.0 111.28 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -52.32 -54.65 28.81 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.191 0.905 . . . . 0.0 110.987 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -65.53 -36.13 82.9 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.305 1.042 . . . . 0.0 111.785 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.42 -53.98 39.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.472 0.709 . . . . 0.0 112.164 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.9 pt -72.4 -30.34 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -172.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -66.23 -27.39 67.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.139 0.881 . . . . 0.0 113.07 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.89 8.11 42.48 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.79 -51.52 80.28 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-O 117.688 -1.149 . . . . 0.0 112.4 168.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -71.75 167.47 26.46 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.221 1.947 . . . . 0.0 111.48 171.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.16 62.81 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.074 3.183 . . . . 0.0 110.019 169.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.56 53.8 38.81 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 124.943 1.258 . . . . 0.0 112.814 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -125.7 -50.79 1.6 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -171.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -97.52 118.92 35.1 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.13 149.76 22.72 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.244 1.018 . . . . 0.0 111.578 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.2 m -123.92 142.58 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -121.38 134.22 55.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.38 1.472 . . . . 0.0 111.561 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 126.865 2.066 . . . . 0.0 110.948 174.838 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.7 p -147.92 131.7 17.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -167.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.3 p -144.22 146.34 32.61 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.109 1.764 . . . . 0.0 111.504 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -99.31 147.53 25.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.502 1.121 . . . . 0.0 109.981 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.49 141.85 27.49 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.072 0.949 . . . . 0.0 110.497 168.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tt -108.74 144.55 36.4 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.07 1.348 . . . . 0.0 110.738 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mt -134.2 137.24 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.374 1.87 . . . . 0.0 110.39 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.83 133.73 42.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.308 1.443 . . . . 0.0 109.793 172.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 55.4 mt -140.33 130.53 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 119.462 1.028 . . . . 0.0 110.866 -171.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.19 53.43 0.72 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.344 1.058 . . . . 0.0 112.755 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.41 53.13 0.42 Allowed Glycine 0 N--CA 1.47 0.907 0 O-C-N 120.932 -1.105 . . . . 0.0 113.815 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -131.1 154.0 48.75 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.513 1.125 . . . . 0.0 109.903 170.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 t -157.33 -37.13 0.07 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.841 1.656 . . . . 0.0 111.217 -169.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 57.3 m -133.78 159.25 41.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.94 1.696 . . . . 0.0 111.577 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.85 -31.99 70.27 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -51.52 -26.3 8.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.898 1.279 . . . . 0.0 113.49 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 79.0 m -58.48 -26.42 63.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.519 1.128 . . . . 0.0 113.595 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.91 -47.33 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 118.892 0.769 . . . . 0.0 109.818 173.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -71.17 -13.89 62.09 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.4 m -70.98 -56.48 6.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.14 -54.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.846 1.258 . . . . 0.0 110.614 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -54.49 -32.82 58.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.22 1.008 . . . . 0.0 111.004 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.74 -49.53 63.39 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 124.171 0.891 . . . . 0.0 112.422 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 96.8 mmm -66.86 -46.99 73.32 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.689 1.244 . . . . 0.0 111.822 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.6 mm -73.19 -54.08 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.394 0.677 . . . . 0.0 112.707 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.5 t -62.46 -16.18 53.87 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -168.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -74.8 -30.84 61.55 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.978 1.311 . . . . 0.0 114.135 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 pp -89.28 -179.37 5.85 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.116 0.871 . . . . 0.0 111.407 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -87.39 -172.55 3.97 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.112 0.958 . . . . 0.0 111.6 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.63 -45.64 1.88 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.272 -1.517 . . . . 0.0 113.711 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.1 p -65.35 99.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.213 2.205 . . . . 0.0 112.096 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.23 -39.9 24.65 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.503 -0.748 . . . . 0.0 111.713 169.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -140.16 144.07 36.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.2 1.0 . . . . 0.0 110.461 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.45 138.32 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.997 0.903 . . . . 0.0 113.133 169.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.4 t -140.01 146.77 39.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.851 2.46 . . . . 0.0 110.691 -169.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.1 t -143.63 138.03 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.913 -1.117 . . . . 0.0 111.02 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 70.0 m -124.94 89.58 3.09 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.759 1.624 . . . . 0.0 111.126 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.53 -29.92 39.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.104 2.161 . . . . 0.0 113.242 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -47.7 -31.31 4.58 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.079 2.552 . . . . 0.0 115.259 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -130.18 -3.48 4.46 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.134 1.773 . . . . 0.0 112.237 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.29 36.32 63.48 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 117.852 -1.527 . . . . 0.0 112.882 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.8 p -124.1 153.74 41.0 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.126 1.463 . . . . 0.0 112.082 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -119.28 148.73 42.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.537 1.535 . . . . 0.0 109.722 169.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.9 t -138.39 133.55 33.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.585 0.754 . . . . 0.0 110.835 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.62 143.0 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.677 0.791 . . . . 0.0 111.451 -168.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.6 106.57 18.91 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.556 1.542 . . . . 0.0 107.371 169.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -108.38 158.09 17.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.957 1.303 . . . . 0.0 111.701 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -95.9 116.62 66.35 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 121.061 -1.024 . . . . 0.0 109.536 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.41 -10.22 20.48 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.326 2.017 . . . . 0.0 113.199 -170.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.15 -7.74 58.93 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.132 0.973 . . . . 0.0 113.418 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.97 -35.44 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.51 1.524 . . . . 0.0 112.348 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.0 tt -156.66 159.2 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.349 0.977 . . . . 0.0 112.205 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.76 150.72 43.2 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 126.213 1.805 . . . . 0.0 112.214 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.54 -43.87 37.39 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.3 3.334 . . . . 0.0 114.908 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -72.22 -15.94 61.94 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.68 -30.72 61.68 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.078 -1.014 . . . . 0.0 112.35 170.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 66.9 mt -59.04 -51.6 69.34 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.796 1.238 . . . . 0.0 110.406 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -49.73 -47.92 50.36 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.181 1.392 . . . . 0.0 112.512 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.02 -23.68 66.6 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.8 65.36 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.531 0.732 . . . . 0.0 112.207 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.3 mt -74.36 -41.36 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.75 1.22 . . . . 0.0 110.646 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -63.84 -28.27 69.74 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.011 0.924 . . . . 0.0 112.579 171.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -69.88 -35.46 74.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.177 0.991 . . . . 0.0 112.645 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 19.8 ttt -73.03 -34.06 66.1 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.871 0.868 . . . . 0.0 112.433 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 120.26 35.91 0.84 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.205 1.383 . . . . 0.0 114.741 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -134.48 147.56 50.39 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.82 1.648 . . . . 0.0 110.314 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -101.37 102.36 13.17 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.833 -1.167 . . . . 0.0 111.232 -167.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -99.98 147.34 25.69 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.284 2.234 . . . . 0.0 112.514 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.5 t -142.52 144.24 32.87 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.822 1.249 . . . . 0.0 109.999 168.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.2 m -71.71 136.39 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.702 -0.624 . . . . 0.0 110.675 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 125.766 1.626 . . . . 0.0 107.57 169.858 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.05 133.05 42.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.324 1.45 . . . . 0.0 109.373 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tt -126.53 128.83 47.5 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.307 2.243 . . . . 0.0 107.952 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -96.99 135.7 38.61 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.947 1.299 . . . . 0.0 110.344 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 pp -145.06 157.56 44.07 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.427 1.091 . . . . 0.0 113.736 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -116.06 125.39 52.36 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.02 1.328 . . . . 0.0 110.476 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.3 mt -100.86 150.23 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 126.169 1.788 . . . . 0.0 111.734 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.67 133.97 41.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.797 1.639 . . . . 0.0 110.923 173.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.43 1.25 81.35 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.853 1.216 . . . . 0.0 114.287 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.2 ptm -72.37 -6.78 45.83 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 116.196 1.925 . . . . 0.0 116.196 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -60.21 -18.87 51.49 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.425 1.011 . . . . 0.0 112.658 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.5 t -89.98 119.4 30.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 165.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -19.95 62.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.254 1.022 . . . . 0.0 113.397 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.3 m -63.59 -23.9 67.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.1 t -61.52 -52.38 64.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.902 1.683 . . . . 0.0 110.862 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.46 -15.77 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -69.65 -60.81 2.08 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.426 1.012 . . . . 0.0 111.264 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -26.07 68.65 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.34 -0.85 . . . . 0.0 112.117 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 92.3 mt -64.8 -50.94 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.913 -1.117 . . . . 0.0 111.048 167.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.0 -31.32 70.94 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.771 1.228 . . . . 0.0 113.658 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -56.03 -46.29 78.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.465 1.03 . . . . 0.0 110.541 173.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -90.29 -29.15 18.31 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.3 mm -110.09 113.43 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.34 1.056 . . . . 0.0 111.034 -169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.27 -15.87 4.44 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 125.986 1.755 . . . . 0.0 114.45 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -101.77 5.66 41.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.79 1.236 . . . . 0.0 112.296 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.13 178.52 4.35 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.61 1.564 . . . . 0.0 112.142 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.9 -69.29 0.29 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.022 1.329 . . . . 0.0 111.333 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.69 -37.66 16.19 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.774 -1.57 . . . . 0.0 112.547 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.15 120.96 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 119.593 1.697 . . . . 0.0 110.126 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.29 -17.33 10.79 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.4 m -145.47 163.62 34.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.33 0.968 . . . . 0.0 111.324 169.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.5 tp -129.1 124.54 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.279 1.032 . . . . 0.0 109.045 168.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -114.13 142.14 46.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.408 1.483 . . . . 0.0 108.305 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.08 137.87 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.806 0.842 . . . . 0.0 109.687 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.0 t -136.12 55.53 1.85 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 123.967 1.842 . . . . 0.0 107.69 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.8 mt -68.9 -24.49 64.31 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.009 1.724 . . . . 0.0 114.516 -167.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.61 -52.42 63.85 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.317 1.047 . . . . 0.0 110.421 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -91.79 19.02 6.89 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.676 1.191 . . . . 0.0 111.942 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 65.12 28.01 12.32 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.569 1.948 . . . . 0.0 112.76 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.6 152.29 27.77 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.604 1.561 . . . . 0.0 111.447 -176.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.49 154.78 44.69 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -141.7 116.41 9.74 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -163.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 p -98.79 137.38 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 120.97 0.414 . . . . 0.0 111.236 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -108.3 97.65 7.3 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.812 2.045 . . . . 0.0 108.713 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -129.63 155.74 45.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.875 1.27 . . . . 0.0 113.921 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -99.17 118.53 62.42 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 125.564 1.545 . . . . 0.0 110.528 170.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.0 -2.13 2.05 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.203 3.935 . . . . 0.0 116.064 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.5 t -72.94 -22.65 60.68 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.136 1.374 . . . . 0.0 113.145 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 36.1 m -139.66 -8.62 1.24 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 t -147.91 -179.47 6.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.272 1.029 . . . . 0.0 110.833 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 p -160.81 156.29 21.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.057 0.943 . . . . 0.0 113.16 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.69 -55.68 3.88 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.747 3.631 . . . . 0.0 116.129 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 m -67.26 -34.17 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.097 1.317 . . . . 0.0 112.053 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.22 89.54 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.967 0.907 . . . . 0.0 111.661 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.7 mt -66.22 -43.81 85.59 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.849 0.86 . . . . 0.0 111.494 171.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -57.93 -44.76 87.09 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.237 0.926 . . . . 0.0 110.815 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -70.09 -31.2 68.65 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.368 1.067 . . . . 0.0 113.557 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.42 -51.77 27.09 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.952 0.901 . . . . 0.0 112.486 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.4 pt -74.29 -32.47 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.16 -30.01 69.02 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.59 7.08 40.99 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.08 -55.04 37.77 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.385 -1.293 . . . . 0.0 112.885 170.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.2 169.36 21.72 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.992 2.461 . . . . 0.0 111.492 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.12 51.95 3.32 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 125.245 3.964 . . . . 0.0 112.404 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.43 63.28 4.21 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -173.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -130.3 -58.1 1.06 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -93.22 124.67 37.36 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -97.55 162.94 13.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.015 0.926 . . . . 0.0 110.452 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 p -140.82 137.25 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.0 m -118.85 139.39 51.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.142 2.177 . . . . 0.0 110.767 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 124.575 1.15 . . . . 0.0 111.584 175.268 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.26 5.7 t . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.459 0.171 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.4 m 49.8 93.16 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 166.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 p -133.92 141.44 47.33 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.476 -1.39 . . . . 0.0 111.211 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 44.2 m -97.46 134.42 40.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.664 1.12 . . . . 0.0 110.176 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.4 158.16 45.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.209 1.004 . . . . 0.0 113.067 175.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.22 136.51 45.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.323 2.249 . . . . 0.0 111.025 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.0 mm -128.58 134.4 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.963 1.705 . . . . 0.0 108.348 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.08 130.1 45.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.185 0.994 . . . . 0.0 109.486 172.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.35 147.53 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.47 -1.394 . . . . 0.0 110.921 -168.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -134.97 58.67 1.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.29 1.436 . . . . 0.0 113.221 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.1 48.74 0.3 Allowed Glycine 0 N--CA 1.469 0.846 0 O-C-N 120.889 -1.132 . . . . 0.0 113.696 166.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 74.3 mtm -102.14 -55.51 2.46 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 117.562 -1.209 . . . . 0.0 111.716 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.256 6.0 t 67.44 -38.64 0.35 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 129.647 3.179 . . . . 0.0 114.619 174.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 87.3 m -135.47 153.56 51.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.502 2.321 . . . . 0.0 111.529 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.56 76.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.353 1.061 . . . . 0.0 113.401 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.4 p -53.19 -35.29 59.69 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.813 0.733 . . . . 0.0 112.565 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.4 t -62.89 -25.8 68.48 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.2 t -58.94 -57.29 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.93 0.786 . . . . 0.0 109.076 169.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -65.54 -23.75 66.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.254 0.479 . . . . 0.0 112.16 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.1 m -69.9 -47.97 60.47 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.647 -0.658 . . . . 0.0 112.242 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.83 -53.68 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 119.725 1.148 . . . . 0.0 110.826 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -54.43 -31.01 54.37 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.673 1.989 . . . . 0.0 111.314 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.46 -61.74 2.71 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.3 1.429 . . . . 0.0 114.469 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 74.3 mmm -70.38 -41.81 72.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.844 1.258 . . . . 0.0 114.073 -168.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.8 mm -70.85 -27.57 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.714 -0.617 . . . . 0.0 110.66 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.7 t -65.73 0.39 1.73 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -99.48 -5.35 29.49 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -104.51 173.98 6.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.396 1.479 . . . . 0.0 111.821 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -79.14 142.87 36.0 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.079 -1.013 . . . . 0.0 111.712 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 94.09 11.47 57.49 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 117.133 -1.926 . . . . 0.0 116.947 175.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.1 p -111.85 -29.27 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.638 1.719 . . . . 0.0 114.775 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 39.07 -71.3 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 129.988 3.315 . . . . 0.0 117.602 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -133.74 124.74 27.17 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.619 1.1 . . . . 0.0 110.373 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.7 tt -129.41 136.12 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.7 1.2 . . . . 0.0 111.24 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 24.5 t -136.38 126.56 26.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.218 1.807 . . . . 0.0 109.253 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.1 t -141.69 139.21 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.725 -1.234 . . . . 0.0 110.436 -168.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.1 m -145.39 140.17 27.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.211 0.604 . . . . 0.0 112.021 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.9 mt -65.63 -30.63 71.37 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.44 -56.36 5.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.754 2.021 . . . . 0.0 113.199 -170.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -101.39 -5.7 25.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.151 1.38 . . . . 0.0 111.198 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.27 35.53 77.08 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 125.248 1.404 . . . . 0.0 112.286 -175.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.4 p -116.7 139.17 50.85 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 124.697 1.199 . . . . 0.0 113.615 -167.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.65 138.72 41.37 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.664 1.586 . . . . 0.0 108.965 167.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.8 t -123.01 126.38 47.03 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 166.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.47 142.93 28.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 123.525 0.73 . . . . 0.0 111.313 -166.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -93.06 93.52 8.36 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.868 2.067 . . . . 0.0 106.601 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -94.62 158.12 15.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.96 0.886 . . . . 0.0 111.234 -174.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -95.77 106.98 30.98 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 121.701 -0.624 . . . . 0.0 109.975 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.15 -17.74 24.34 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.135 1.89 . . . . 0.0 112.856 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.71 41.0 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.457 1.103 . . . . 0.0 113.766 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.57 -27.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.097 1.759 . . . . 0.0 113.342 -171.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 21.3 tt -145.38 147.09 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 120.488 1.494 . . . . 0.0 112.457 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 35.3 m -98.5 144.71 28.61 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.279 1.032 . . . . 0.0 110.654 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.77 -33.51 32.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.315 3.344 . . . . 0.0 115.02 176.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -60.75 -28.59 68.82 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.5 -28.33 59.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.041 1.336 . . . . 0.0 113.07 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.23 -48.5 78.0 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.022 0.828 . . . . 0.0 109.104 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -52.66 -47.62 67.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.017 1.327 . . . . 0.0 111.068 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.46 -30.14 69.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.371 1.068 . . . . 0.0 113.712 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.38 -38.83 68.39 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.989 1.268 . . . . 0.0 113.001 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.63 -36.19 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.64 0.776 . . . . 0.0 110.391 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -69.66 -31.09 68.96 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.6 -0.688 . . . . 0.0 112.426 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.18 -28.76 65.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.663 1.985 . . . . 0.0 112.637 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.8 ttt -70.89 -36.69 72.87 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.34 1.056 . . . . 0.0 111.107 172.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 134.14 16.78 1.06 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.517 1.532 . . . . 0.0 116.117 169.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -113.08 -159.31 0.68 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.696 1.248 . . . . 0.0 110.216 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -128.27 140.63 51.78 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.525 1.13 . . . . 0.0 110.066 169.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -132.22 151.37 51.85 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.513 1.525 . . . . 0.0 111.875 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.2 t -133.41 132.49 41.22 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.394 1.478 . . . . 0.0 111.997 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.5 m -84.54 80.8 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.986 0.898 . . . . 0.0 110.722 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 126.654 1.982 . . . . 0.0 111.817 174.007 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.676 0.751 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -99.16 137.63 37.4 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.568 1.947 . . . . 0.0 110.002 -169.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tt -142.25 139.21 31.86 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.597 1.159 . . . . 0.0 110.62 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . 0.558 ' NE2' HE22 ' A' ' 61' ' ' GLN . 1.2 mp0 -98.35 133.94 42.05 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.692 1.997 . . . . 0.0 110.716 -176.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.11 134.07 24.01 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.794 170.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -100.05 113.64 26.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 mt -77.73 128.99 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 121.548 0.69 . . . . 0.0 109.577 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.2 107.85 19.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.235 2.214 . . . . 0.0 109.894 -171.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.09 10.52 34.2 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.676 1.131 . . . . 0.0 114.074 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.3 ptp -57.99 -35.58 71.41 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.155 1.478 . . . . 0.0 114.334 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 t60 68.06 -44.06 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 129.202 3.001 . . . . 0.0 113.294 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.8 p -166.74 166.88 15.58 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.647 2.379 . . . . 0.0 110.344 -173.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.55 -35.92 61.28 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.7 m -57.73 -23.09 50.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -172.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 t -49.39 -40.42 35.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.643 1.177 . . . . 0.0 112.004 168.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -12.34 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 117.83 -1.081 . . . . 0.0 113.565 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.87 -49.73 71.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.536 1.516 . . . . 0.0 111.884 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -40.94 68.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.144 0.884 . . . . 0.0 110.716 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mt -65.3 -52.31 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.311 1.444 . . . . 0.0 109.775 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -60.84 -33.32 72.86 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.936 2.495 . . . . 0.0 113.478 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -67.31 -45.05 77.64 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.517 1.127 . . . . 0.0 111.763 173.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -95.22 -29.43 14.52 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -170.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.3 mm -108.14 113.46 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.108 0.963 . . . . 0.0 109.577 -170.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.23 -22.55 7.06 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 125.857 1.694 . . . . 0.0 114.015 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -78.65 -10.68 59.84 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 118.188 0.994 . . . . 0.0 112.094 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.5 mt -67.81 -177.69 0.84 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.609 3.164 . . . . 0.0 112.404 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tt -82.12 -70.21 0.56 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.406 -0.809 . . . . 0.0 110.992 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.94 -44.44 78.67 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.118 -1.379 . . . . 0.0 112.483 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.14 117.82 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.65 1.725 . . . . 0.0 108.617 171.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -97.32 -41.47 8.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.153 0.981 . . . . 0.0 110.494 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 t -145.56 167.3 23.36 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.042 0.937 . . . . 0.0 112.666 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.6 tp -135.85 142.46 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.7 2.0 . . . . 0.0 108.437 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -141.48 153.93 45.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.01 1.724 . . . . 0.0 110.015 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 t -108.83 144.46 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.71 2.004 . . . . 0.0 109.926 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.5 t -140.37 54.14 1.62 Allowed 'General case' 0 CA--C 1.555 1.159 0 CA-C-O 122.806 1.288 . . . . 0.0 109.939 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.11 -19.28 65.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.081 1.353 . . . . 0.0 113.973 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.46 -24.21 44.1 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.1 19.36 8.33 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.875 1.67 . . . . 0.0 111.799 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.8 mttt 60.75 16.85 7.08 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.271 1.828 . . . . 0.0 113.788 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 p -96.92 159.71 14.76 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 123.517 1.627 . . . . 0.0 110.123 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.43 154.09 38.22 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.042 2.137 . . . . 0.0 106.813 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.558 HE22 ' NE2' ' A' ' 23' ' ' GLN . 3.0 tp60 -131.03 119.03 21.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.864 1.266 . . . . 0.0 108.587 -168.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 p -106.87 141.4 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.745 -0.597 . . . . 0.0 110.633 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.15 95.51 5.42 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.64 1.576 . . . . 0.0 108.97 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -123.31 150.64 43.33 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.362 1.065 . . . . 0.0 112.567 -173.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.4 123.11 57.68 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.544 1.137 . . . . 0.0 107.997 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.35 -12.79 6.23 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.067 3.178 . . . . 0.0 114.801 175.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.8 m -58.41 -28.32 65.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.032 1.733 . . . . 0.0 114.93 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 99.0 m -137.94 -12.17 1.48 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -148.2 177.14 9.65 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.869 1.267 . . . . 0.0 111.282 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.5 p -158.64 160.7 29.28 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.279 1.432 . . . . 0.0 111.893 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -53.99 -48.81 19.64 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.09 2.527 . . . . 0.0 115.398 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.2 m -69.31 -32.85 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 120.135 1.334 . . . . 0.0 112.938 177.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.55 -35.19 78.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.448 0.699 . . . . 0.0 111.643 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.96 -48.63 57.53 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.339 1.055 . . . . 0.0 111.213 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -54.59 -57.18 12.42 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.476 1.034 . . . . 0.0 111.555 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -60.51 -31.11 70.19 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.439 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.04 -61.94 1.61 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.009 0.924 . . . . 0.0 112.824 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.8 pt -70.48 -29.85 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -169.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -59.48 -35.07 73.41 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.996 0.919 . . . . 0.0 111.471 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.05 13.63 33.39 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mt -59.23 -55.99 40.63 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.909 166.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.56 171.27 18.09 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.524 2.816 . . . . 0.0 112.36 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.31 59.91 6.2 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.584 3.523 . . . . 0.0 110.975 171.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.32 35.58 92.14 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.999 1.285 . . . . 0.0 113.118 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -101.19 -41.17 6.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.685 0.742 . . . . 0.0 112.734 -169.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -115.78 117.02 29.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.611 1.164 . . . . 0.0 109.118 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -99.37 170.39 8.67 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.301 1.44 . . . . 0.0 111.337 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.7 m -135.26 130.28 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.064 -1.022 . . . . 0.0 110.902 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.9 m -103.75 117.78 35.16 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.146 0.978 . . . . 0.0 110.579 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.335 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 122.563 1.173 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 29.3 p -163.84 142.41 7.66 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.084 2.153 . . . . 0.0 110.958 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.2 t -144.98 158.41 43.82 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.311 -0.868 . . . . 0.0 111.094 172.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 98.6 m -98.53 140.52 32.64 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.86 149.64 40.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.514 1.126 . . . . 0.0 110.603 173.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 tt -115.25 136.79 52.73 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.986 1.714 . . . . 0.0 109.084 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.7 mm -119.66 138.07 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.737 2.015 . . . . 0.0 108.255 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.58 136.58 38.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.507 1.123 . . . . 0.0 108.91 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.26 139.2 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 120.729 -1.232 . . . . 0.0 110.134 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.39 57.86 1.0 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.359 2.264 . . . . 0.0 112.016 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.05 52.36 0.23 Allowed Glycine 0 N--CA 1.465 0.592 0 C-N-CA 124.435 1.017 . . . . 0.0 111.354 168.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.1 mtm -136.1 126.34 26.45 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.854 1.262 . . . . 0.0 108.788 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.2 t -144.7 -24.83 0.51 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.703 1.601 . . . . 0.0 111.457 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 96.6 m -116.01 142.54 46.66 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.552 1.941 . . . . 0.0 110.8 170.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -48.93 -32.81 9.66 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.112 1.365 . . . . 0.0 113.837 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.9 p -58.2 -22.54 52.24 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.6 t -61.87 -28.66 69.66 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.214 -0.928 . . . . 0.0 112.358 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.9 -51.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 121.627 -0.671 . . . . 0.0 110.722 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -70.13 -19.14 63.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.6 m -74.62 -56.09 5.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.376 1.07 . . . . 0.0 112.077 167.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.78 -57.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 121.123 -0.986 . . . . 0.0 111.153 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.43 -25.57 66.06 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.239 1.016 . . . . 0.0 110.912 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.49 -57.97 5.23 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.886 1.232 . . . . 0.0 113.611 174.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.2 -46.32 42.75 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.976 0.888 . . . . 0.0 113.337 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.0 mm -72.71 -24.09 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.635 0.774 . . . . 0.0 112.501 -172.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.9 p -65.6 -15.74 63.03 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.1 -10.87 43.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -168.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.99 -177.8 6.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.324 1.049 . . . . 0.0 113.253 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -93.63 127.11 39.16 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.256 1.022 . . . . 0.0 109.845 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 103.5 16.98 18.69 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 117.683 -1.621 . . . . 0.0 116.517 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.34 100.41 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 127.212 2.205 . . . . 0.0 112.475 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -78.12 -49.21 14.32 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.401 -0.812 . . . . 0.0 112.232 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -140.51 141.25 35.36 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.225 1.81 . . . . 0.0 108.669 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.5 tt -144.2 131.04 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.235 1.014 . . . . 0.0 111.545 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.38 122.65 13.88 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.691 0.797 . . . . 0.0 112.105 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.86 138.37 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.039 0.935 . . . . 0.0 111.854 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.5 t -141.55 134.56 29.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.28 1.432 . . . . 0.0 111.488 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.15 -17.96 61.32 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.81 63.61 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.338 1.455 . . . . 0.0 112.969 -173.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -113.41 -5.73 13.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.209 1.804 . . . . 0.0 111.566 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 72.08 49.76 20.45 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.554 1.55 . . . . 0.0 112.078 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.6 p -139.27 149.46 44.31 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -168.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.16 140.06 47.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.628 1.571 . . . . 0.0 110.741 169.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.8 t -116.9 127.71 54.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.58 141.42 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.544 0.738 . . . . 0.0 110.571 -171.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.96 108.74 21.52 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.242 1.817 . . . . 0.0 106.9 175.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -114.65 159.57 20.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.98 0.895 . . . . 0.0 112.767 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -97.84 113.4 63.62 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.101 0.96 . . . . 0.0 109.858 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.08 -7.1 17.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.961 2.441 . . . . 0.0 115.093 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.42 -37.17 20.11 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.717 1.144 . . . . 0.0 111.018 168.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 86.7 t -85.44 -32.46 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.461 1.104 . . . . 0.0 113.192 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.5 tt -148.96 151.72 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 120.268 1.394 . . . . 0.0 113.678 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.07 145.78 31.11 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.779 1.632 . . . . 0.0 112.456 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.67 -33.47 93.67 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.838 2.358 . . . . 0.0 115.286 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.74 -22.41 61.62 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.364 0.984 . . . . 0.0 113.135 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -72.62 -38.02 67.87 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.741 -1.224 . . . . 0.0 111.57 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 82.9 mt -55.44 -54.41 44.13 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.773 0.829 . . . . 0.0 109.908 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -51.22 -55.27 18.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.998 1.319 . . . . 0.0 111.299 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.5 -18.84 65.63 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.62 -33.33 68.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.942 1.247 . . . . 0.0 112.23 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.1 -39.72 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.396 1.078 . . . . 0.0 110.532 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.65 -31.77 72.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.241 0.616 . . . . 0.0 112.375 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.19 -5.11 39.93 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.539 1.936 . . . . 0.0 114.441 169.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.46 -47.98 5.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.126 1.37 . . . . 0.0 111.466 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 157.45 15.8 0.04 OUTLIER Glycine 0 N--CA 1.469 0.867 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -133.27 -163.46 1.35 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.987 1.394 . . . . 0.0 108.954 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.58 147.02 49.93 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.198 0.999 . . . . 0.0 109.357 169.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -138.97 160.18 40.38 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.0 t -138.36 141.67 39.68 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.485 1.914 . . . . 0.0 109.168 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.3 128.83 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.331 -0.856 . . . . 0.0 108.866 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 122.873 1.32 . . . . 0.0 108.733 -178.866 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.11 138.25 45.13 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.64 -0.663 . . . . 0.0 112.583 -173.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.56 163.72 25.38 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -109.71 133.25 53.34 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 127.819 2.448 . . . . 0.0 110.04 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -146.46 155.05 42.27 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.374 0.67 . . . . 0.0 112.327 171.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -116.98 107.51 14.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.557 0.694 . . . . 0.0 111.09 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.6 mt -88.62 143.42 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.795 2.038 . . . . 0.0 110.938 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -97.46 142.85 28.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.013 2.525 . . . . 0.0 110.137 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.95 -13.64 65.56 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.902 1.239 . . . . 0.0 114.506 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.5 ptp -62.12 -23.23 66.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.517 1.158 . . . . 0.0 113.925 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -69.51 -15.77 63.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.33 0.968 . . . . 0.0 113.599 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 87.7 m -75.49 -6.04 48.15 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 120.586 1.539 . . . . 0.0 112.18 166.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp 71.74 -52.24 0.69 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 130.415 3.486 . . . . 0.0 113.397 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -54.22 -23.28 14.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.564 1.146 . . . . 0.0 113.937 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.4 t -57.99 -47.41 83.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.359 1.864 . . . . 0.0 112.543 169.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -73.64 -24.63 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 118.555 0.616 . . . . 0.0 112.464 -173.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.6 tp -57.32 -53.9 52.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.021 0.928 . . . . 0.0 111.746 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -37.68 76.22 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.821 -0.549 . . . . 0.0 110.962 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.1 mt -66.11 -49.6 75.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.372 0.669 . . . . 0.0 110.579 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -60.25 -36.12 77.05 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.046 1.738 . . . . 0.0 112.914 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -68.31 -39.91 81.85 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.308 -0.87 . . . . 0.0 112.346 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -95.26 -37.52 10.97 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.9 mm -93.04 119.64 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 120.389 -1.445 . . . . 0.0 108.699 -168.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' H ' HD12 ' A' ' 45' ' ' LEU . . . 127.07 -17.83 6.24 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.019 1.771 . . . . 0.0 112.609 -167.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -87.72 -4.03 58.93 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.257 1.028 . . . . 0.0 112.443 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 43' ' ' GLY . 5.5 mp -80.67 178.26 8.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.593 1.957 . . . . 0.0 112.028 -170.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tp -59.52 -74.94 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.384 1.874 . . . . 0.0 112.31 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.58 52.42 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 117.483 -1.732 . . . . 0.0 115.671 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.5 t -87.51 113.56 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.589 2.194 . . . . 0.0 109.451 168.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -86.39 -43.37 12.9 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.485 1.114 . . . . 0.0 111.791 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.3 t -147.86 178.03 8.84 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.436 1.095 . . . . 0.0 111.649 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.6 tp -139.74 140.78 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.907 1.683 . . . . 0.0 108.611 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -129.36 120.53 25.74 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.213 1.405 . . . . 0.0 108.083 -173.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.87 86.97 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.394 1.478 . . . . 0.0 110.627 -166.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 p -98.67 54.29 1.03 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.569 1.948 . . . . 0.0 113.03 -170.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.9 mt -61.82 -26.3 68.03 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -172.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.32 -33.96 63.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.579 1.152 . . . . 0.0 113.148 173.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -94.81 -0.29 54.26 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.795 0.838 . . . . 0.0 112.572 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? 68.06 -0.34 2.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.883 2.473 . . . . 0.0 113.167 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.0 p -99.68 167.73 10.38 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 127.577 2.351 . . . . 0.0 109.881 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.53 149.21 41.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 168.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -116.0 125.92 53.13 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.245 1.418 . . . . 0.0 108.49 -172.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.73 135.0 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.001 -1.062 . . . . 0.0 111.0 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -99.26 95.82 7.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.048 1.739 . . . . 0.0 107.822 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -122.97 -179.32 4.22 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.075 1.75 . . . . 0.0 112.989 -168.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -129.22 136.12 28.66 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 125.612 1.565 . . . . 0.0 109.978 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -84.08 15.06 2.24 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.433 2.756 . . . . 0.0 113.317 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.1 t -111.33 -35.65 5.79 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.32 1.048 . . . . 0.0 111.082 173.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.1 m -90.58 -18.64 24.86 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . 0.252 2.8 t -148.49 -175.79 5.06 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.1 0.96 . . . . 0.0 112.163 175.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.1 p -153.72 167.59 13.33 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.046 1.739 . . . . 0.0 110.91 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.39 -44.09 24.69 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.593 2.196 . . . . 0.0 113.204 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.94 -37.87 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 118.92 0.782 . . . . 0.0 112.839 172.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.56 89.13 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.666 -0.646 . . . . 0.0 112.244 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.35 -55.77 30.51 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.111 1.765 . . . . 0.0 109.838 168.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -61.28 -39.82 91.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.87 0.868 . . . . 0.0 111.644 -173.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -70.8 -36.92 73.2 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.439 1.096 . . . . 0.0 112.804 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.66 -60.4 2.27 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.782 0.719 . . . . 0.0 112.681 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 pt -70.25 -26.78 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -167.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -70.81 -15.47 62.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.4 9.52 33.67 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.999 -1.063 . . . . 0.0 113.523 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.23 -47.95 97.26 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.145 165.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -77.56 171.57 17.31 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.646 2.231 . . . . 0.0 110.429 167.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -76.54 51.61 3.35 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 124.127 3.218 . . . . 0.0 110.978 170.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.16 28.51 68.14 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 120.996 -1.065 . . . . 0.0 113.756 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -97.32 -45.42 6.49 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.967 0.884 . . . . 0.0 112.459 -172.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -97.01 102.19 13.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.243 1.017 . . . . 0.0 108.73 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -96.52 141.42 29.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.265 1.026 . . . . 0.0 111.474 -170.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 p -130.27 134.66 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -172.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.3 m -118.95 144.41 46.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.461 1.504 . . . . 0.0 111.803 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 CA--C 1.539 0.549 0 C-N-CA 126.348 1.859 . . . . 0.0 112.21 -172.127 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.2 m -138.05 127.61 24.98 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.556 1.542 . . . . 0.0 111.81 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.0 m -146.34 152.63 39.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.925 1.29 . . . . 0.0 111.531 171.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 92.5 m -109.18 140.47 42.74 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.123 0.969 . . . . 0.0 109.58 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.22 158.54 43.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 168.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.89 127.46 48.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.488 2.315 . . . . 0.0 109.469 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.8 mm -113.28 136.37 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.438 1.095 . . . . 0.0 108.827 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -101.25 122.49 43.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.771 0.714 . . . . 0.0 109.33 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.66 135.2 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.065 0.946 . . . . 0.0 110.237 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -115.02 56.3 0.74 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.985 1.714 . . . . 0.0 112.09 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.02 54.86 0.32 Allowed Glycine 0 N--CA 1.465 0.6 0 C-N-CA 124.151 0.881 . . . . 0.0 112.076 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 39.6 mtm -148.35 138.25 22.38 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.033 0.933 . . . . 0.0 110.942 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.3 t -160.34 -32.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.122 1.369 . . . . 0.0 111.841 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 93.4 m -105.48 138.8 41.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.315 1.846 . . . . 0.0 109.937 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.07 -27.32 31.87 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.601 1.16 . . . . 0.0 113.751 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.6 t -56.34 -32.19 64.45 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.202 1.001 . . . . 0.0 112.969 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.5 t -60.65 -20.75 61.65 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.53 -59.62 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.005 168.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -63.31 -22.14 66.69 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.144 1.338 . . . . 0.0 112.815 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.6 m -70.65 -60.16 2.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.243 1.017 . . . . 0.0 112.153 170.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.0 mt -69.33 -51.28 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.581 -1.324 . . . . 0.0 110.897 -174.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -58.17 -30.98 66.84 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.136 1.374 . . . . 0.0 110.896 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.06 -62.34 2.64 Favored Glycine 0 C--N 1.343 0.967 0 C-N-CA 125.657 1.598 . . . . 0.0 114.615 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -44.98 62.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.483 1.113 . . . . 0.0 113.098 -172.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.2 mm -72.99 -29.51 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.09 0.556 . . . . 0.0 112.034 -172.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.5 p -64.86 0.99 0.98 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -106.9 -9.24 16.38 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -168.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.41 11.28 31.2 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -171.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 70.2 163.87 0.26 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.277 2.631 . . . . 0.0 114.191 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.98 -39.19 1.13 Allowed Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.486 -1.384 . . . . 0.0 112.977 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.52 98.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 127.462 2.305 . . . . 0.0 111.213 169.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -86.53 -54.72 4.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.853 0.861 . . . . 0.0 112.455 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -141.52 121.4 13.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.735 1.214 . . . . 0.0 109.045 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.0 tt -133.3 128.14 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.208 1.003 . . . . 0.0 110.92 -170.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.74 155.83 44.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.642 1.177 . . . . 0.0 109.9 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.69 142.31 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.433 1.015 . . . . 0.0 111.934 -171.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 45.0 m -115.28 86.98 2.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.832 2.453 . . . . 0.0 109.16 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.27 -27.55 69.09 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.376 -1.453 . . . . 0.0 111.451 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.8 -30.79 1.77 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.303 2.641 . . . . 0.0 114.824 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -118.07 -20.75 8.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.423 1.489 . . . . 0.0 111.772 173.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.37 36.56 8.72 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.592 1.567 . . . . 0.0 111.964 -174.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.6 p -128.28 140.6 51.8 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.803 1.301 . . . . 0.0 112.798 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.94 137.79 42.17 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.538 1.135 . . . . 0.0 110.736 169.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.9 t -111.49 121.95 46.53 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.24 140.91 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -169.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.03 115.93 28.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.122 2.169 . . . . 0.0 106.599 171.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -117.47 157.52 26.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.78 1.232 . . . . 0.0 111.71 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -99.75 105.79 36.49 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.716 1.206 . . . . 0.0 110.981 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -67.44 -13.33 38.86 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.253 2.635 . . . . 0.0 114.023 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.77 -10.73 58.75 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.282 0.946 . . . . 0.0 113.127 171.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.33 -34.04 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.556 1.543 . . . . 0.0 112.08 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.5 tt -159.93 147.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.886 1.221 . . . . 0.0 112.507 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.7 t -97.02 149.9 36.22 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.606 1.162 . . . . 0.0 112.528 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -49.99 -30.42 24.35 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.907 3.738 . . . . 0.0 114.19 168.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -67.02 -33.9 76.55 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.369 0.986 . . . . 0.0 112.39 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -75.29 -35.41 61.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.228 . . . . 0.0 110.404 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.04 -58.2 9.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.676 2.39 . . . . 0.0 111.48 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.54 -38.81 78.56 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.114 0.87 . . . . 0.0 112.35 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.98 -26.53 68.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.96 -30.42 63.83 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.461 1.028 . . . . 0.0 112.53 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.16 -34.52 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.306 1.042 . . . . 0.0 110.969 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -63.91 -39.34 93.94 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.674 0.67 . . . . 0.0 111.893 172.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.65 -31.44 72.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.52 1.928 . . . . 0.0 112.942 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 21.9 ttt -69.78 -37.18 76.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.156 0.982 . . . . 0.0 111.386 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 130.96 15.43 1.71 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.494 1.521 . . . . 0.0 116.306 169.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.92 -158.08 0.65 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.426 1.613 . . . . 0.0 108.923 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -133.52 142.7 48.33 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.032 0.933 . . . . 0.0 109.885 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -137.32 137.99 39.51 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.282 1.433 . . . . 0.0 112.975 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.2 t -123.07 131.35 53.66 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.834 1.654 . . . . 0.0 111.339 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 m -85.64 71.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.266 1.026 . . . . 0.0 110.661 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.582 -176.813 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 p -112.56 166.56 11.21 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.613 1.965 . . . . 0.0 112.049 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.56 137.42 31.96 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.837 1.255 . . . . 0.0 111.711 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -99.15 120.1 38.95 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.961 0.886 . . . . 0.0 109.679 168.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.25 139.21 30.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.512 -1.676 . . . . 0.0 112.825 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -101.49 143.22 31.76 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.932 1.293 . . . . 0.0 109.03 171.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mm -107.32 153.14 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.763 1.625 . . . . 0.0 109.807 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -106.1 140.27 39.34 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.654 1.582 . . . . 0.0 110.652 170.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.61 3.21 88.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.879 1.228 . . . . 0.0 114.033 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.5 ptm -70.53 -3.6 18.79 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -50.8 -26.18 5.36 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.806 1.242 . . . . 0.0 114.345 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.4 p -114.04 137.74 51.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.962 1.305 . . . . 0.0 111.033 169.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -65.07 -15.7 62.65 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -50.79 -31.95 18.46 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.992 -1.068 . . . . 0.0 113.21 169.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.1 t -67.99 -57.91 5.38 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.337 1.055 . . . . 0.0 111.678 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 p -62.79 -29.62 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.407 1.003 . . . . 0.0 112.056 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.72 -61.01 2.93 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.264 1.026 . . . . 0.0 112.289 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -65.46 -31.28 72.28 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.785 -0.572 . . . . 0.0 111.821 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.01 -52.42 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 118.795 0.725 . . . . 0.0 109.48 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -38.3 90.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.567 1.147 . . . . 0.0 113.184 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -65.76 -34.95 79.36 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.332 0.653 . . . . 0.0 111.982 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -92.91 -24.41 18.44 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.2 mm -105.75 122.85 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.385 0.993 . . . . 0.0 109.669 -171.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.25 -22.81 5.28 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 125.581 1.562 . . . . 0.0 113.956 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -84.65 -0.65 54.21 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.652 1.581 . . . . 0.0 113.165 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.43 -172.33 4.11 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.779 2.032 . . . . 0.0 113.959 -171.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 tp -68.87 -82.78 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.427 2.291 . . . . 0.0 111.974 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.32 -30.32 60.78 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 120.12 1.327 . . . . 0.0 114.241 -173.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 t -84.07 127.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.044 1.422 . . . . 0.0 110.339 169.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -114.51 -23.1 9.48 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.4 t -145.63 166.08 26.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.226 0.921 . . . . 0.0 111.069 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 tp -140.71 142.31 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.417 1.087 . . . . 0.0 110.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -142.92 156.32 44.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.656 1.183 . . . . 0.0 110.579 -171.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.28 133.02 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.312 1.445 . . . . 0.0 108.348 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.3 m -122.6 52.8 1.3 Allowed 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.488 1.137 . . . . 0.0 110.086 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -19.33 64.03 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -172.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -57.77 -36.6 72.36 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.769 1.168 . . . . 0.0 111.066 168.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -97.47 -8.02 30.25 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.036 2.134 . . . . 0.0 112.484 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 70.75 15.64 6.89 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.605 2.362 . . . . 0.0 112.28 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 p -98.78 163.7 12.52 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.68 1.592 . . . . 0.0 110.621 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.18 169.09 9.63 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -139.6 114.25 9.29 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 121.043 -1.036 . . . . 0.0 111.186 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.58 133.2 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 121.529 0.68 . . . . 0.0 111.847 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -109.74 99.17 8.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.267 1.427 . . . . 0.0 108.784 -169.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -131.45 -178.87 5.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.821 1.248 . . . . 0.0 112.25 -168.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.99 140.05 33.84 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.509 1.124 . . . . 0.0 108.258 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.06 11.41 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.029 2.486 . . . . 0.0 112.826 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.4 p -92.21 -19.04 22.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.889 1.276 . . . . 0.0 113.481 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 72.6 m -126.82 -20.43 4.26 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.703 1.601 . . . . 0.0 114.457 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.1 t -145.07 -177.86 5.75 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.16 1.784 . . . . 0.0 111.338 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -160.62 156.6 22.46 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.487 1.515 . . . . 0.0 112.95 174.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -43.64 -45.38 10.82 Favored 'Trans proline' 0 C--N 1.352 0.756 1 C-N-CA 126.425 4.75 . . . . 0.0 117.974 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.6 m -64.78 -37.67 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 119.825 1.193 . . . . 0.0 112.537 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.67 -40.28 69.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.705 0.802 . . . . 0.0 111.058 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.38 -47.64 84.91 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.758 1.223 . . . . 0.0 112.011 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.419 HE21 ' HB ' ' A' ' 88' ' ' VAL . 35.8 tt0 -53.05 -54.54 33.91 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.79 0.723 . . . . 0.0 109.775 175.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -61.89 -33.74 74.76 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.202 1.001 . . . . 0.0 113.349 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.02 -56.99 5.53 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.056 0.943 . . . . 0.0 111.847 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.1 pt -72.56 -27.09 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.86 -28.55 67.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.9 6.49 41.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.7 mt -53.92 -52.51 67.28 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 117.392 -1.29 . . . . 0.0 112.187 169.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.41 163.44 36.56 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.241 2.627 . . . . 0.0 112.717 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -81.42 50.99 3.71 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.852 3.702 . . . . 0.0 111.302 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.19 53.68 5.55 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.328 0.966 . . . . 0.0 112.103 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -132.82 -45.08 0.87 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -171.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -101.64 134.77 44.25 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.667 0.787 . . . . 0.0 109.32 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -111.74 152.32 27.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.786 1.634 . . . . 0.0 110.171 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.419 ' HB ' HE21 ' A' ' 75' ' ' GLN . 2.1 t -101.52 138.11 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.675 1.125 . . . . 0.0 109.608 168.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -110.2 113.12 25.55 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.224 1.01 . . . . 0.0 108.811 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 126.373 1.869 . . . . 0.0 109.939 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 8.5 p -137.9 126.13 23.08 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.446 1.898 . . . . 0.0 113.473 -169.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.7 t -141.02 154.83 46.19 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.877 1.671 . . . . 0.0 110.424 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.4 m -111.35 137.72 48.75 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.786 0.721 . . . . 0.0 110.397 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.5 163.53 30.92 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.391 1.076 . . . . 0.0 112.068 169.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -109.8 128.06 55.06 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.511 1.924 . . . . 0.0 110.366 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.2 mm -112.28 144.54 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.227 1.011 . . . . 0.0 109.694 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.63 122.82 47.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.709 1.604 . . . . 0.0 109.71 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.52 140.87 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.049 -1.657 . . . . 0.0 111.896 -167.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.34 66.63 1.45 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.32 1.448 . . . . 0.0 114.065 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -172.88 49.89 0.17 Allowed Glycine 0 N--CA 1.466 0.659 0 CA-C-O 118.921 -0.933 . . . . 0.0 114.09 166.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 74.0 mtm -110.86 -57.08 2.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 117.498 -1.239 . . . . 0.0 113.768 -171.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.0 t 55.32 -26.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 130.339 3.456 . . . . 0.0 118.273 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 36.0 t -131.73 139.94 49.12 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.543 1.537 . . . . 0.0 111.718 -170.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.01 -35.26 69.04 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.747 -0.596 . . . . 0.0 111.671 171.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.4 m -64.03 -31.79 73.1 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.789 -1.195 . . . . 0.0 112.105 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 26.2 t -70.59 -39.76 73.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.911 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.63 -54.52 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 119.63 1.105 . . . . 0.0 110.094 170.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -58.54 -34.71 71.3 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.029 0.377 . . . . 0.0 111.582 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.2 m -71.0 -43.35 68.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.048 0.939 . . . . 0.0 113.078 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 84.9 mt -64.49 -51.12 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.788 1.176 . . . . 0.0 109.714 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -53.14 -37.66 62.03 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.497 1.519 . . . . 0.0 111.164 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.1 -58.42 4.36 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.001 1.286 . . . . 0.0 113.467 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.0 mtp -67.91 -46.81 70.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.657 1.583 . . . . 0.0 113.677 -170.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 35.5 mm -66.58 -36.94 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 118.124 0.42 . . . . 0.0 110.066 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 t -56.67 -9.34 0.74 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -89.02 -8.49 53.93 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.475 -1.391 . . . . 0.0 113.755 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -107.82 177.3 4.86 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.276 1.398 . . . . 0.0 114.158 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -56.5 152.41 11.73 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.698 1.599 . . . . 0.0 115.314 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.21 -30.3 0.32 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.351 1.453 . . . . 0.0 116.676 169.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.3 p -78.91 92.86 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.463 1.632 . . . . 0.0 111.008 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -79.56 -40.02 30.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.872 1.669 . . . . 0.0 111.916 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -144.99 144.81 31.23 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.011 0.925 . . . . 0.0 109.478 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.5 tt -140.36 138.37 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 121.255 -0.903 . . . . 0.0 111.55 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t -139.18 136.31 34.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.78 1.632 . . . . 0.0 109.157 171.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.22 148.93 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.827 1.251 . . . . 0.0 111.396 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.8 t -142.62 148.52 37.6 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.43 -22.67 61.82 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.633 1.173 . . . . 0.0 113.707 172.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -50.86 -41.58 58.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.006 1.322 . . . . 0.0 112.372 -169.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -127.38 -1.96 6.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.007 1.323 . . . . 0.0 111.906 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.06 42.26 37.25 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 125.487 1.518 . . . . 0.0 111.981 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.5 p -130.93 146.07 52.22 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.404 1.102 . . . . 0.0 113.053 -168.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -118.84 119.69 35.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.757 1.623 . . . . 0.0 112.037 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 t -99.32 112.26 24.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.962 1.305 . . . . 0.0 107.8 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 139.11 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.588 0.755 . . . . 0.0 110.885 -168.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.95 107.96 20.29 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.97 2.108 . . . . 0.0 107.117 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -113.17 162.9 15.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.147 1.379 . . . . 0.0 111.762 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -94.79 112.16 57.03 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.846 0.859 . . . . 0.0 108.941 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.51 -10.54 17.32 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.035 2.49 . . . . 0.0 113.051 -173.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.4 -32.9 25.91 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.259 0.936 . . . . 0.0 112.618 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.68 -46.97 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.865 1.266 . . . . 0.0 113.448 -173.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.5 tt -124.75 149.41 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 120.384 1.447 . . . . 0.0 112.094 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.9 t -96.99 146.96 32.2 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.203 1.401 . . . . 0.0 112.833 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.33 -26.12 42.17 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.09 2.527 . . . . 0.0 113.49 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -68.23 -35.66 78.29 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.526 -0.734 . . . . 0.0 112.548 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.46 -31.83 67.62 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.148 0.979 . . . . 0.0 111.643 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.04 -57.65 11.61 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.198 0.999 . . . . 0.0 110.035 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -61.23 -41.67 97.28 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.779 -0.575 . . . . 0.0 112.307 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.44 -34.08 70.42 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.15 -34.73 71.27 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -73.56 -39.44 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.281 1.033 . . . . 0.0 111.579 171.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -62.92 -32.25 73.5 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.182 -0.949 . . . . 0.0 111.641 172.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.93 -13.9 60.97 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.713 2.405 . . . . 0.0 114.503 169.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 14.7 ttt -83.62 -20.95 32.77 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.986 -1.071 . . . . 0.0 112.148 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 111.82 19.03 7.53 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.949 1.737 . . . . 0.0 114.934 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -115.09 -159.06 0.69 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.215 1.406 . . . . 0.0 109.878 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.77 140.32 51.09 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 124.554 1.142 . . . . 0.0 109.555 170.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.01 147.71 42.47 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.126 1.37 . . . . 0.0 112.348 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.1 t -142.74 140.49 31.48 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.174 1.789 . . . . 0.0 109.011 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.2 p -90.49 130.56 39.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.327 0.584 . . . . 0.0 110.811 -171.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 166.743 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 121.058 0.456 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -109.26 134.86 51.24 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.195 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.02 133.04 43.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.152 1.381 . . . . 0.0 110.724 -174.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -96.19 137.59 35.04 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.148 1.779 . . . . 0.0 111.576 -171.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.73 152.18 39.99 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 173.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -100.11 113.91 26.88 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.498 1.119 . . . . 0.0 109.683 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 mt -88.46 140.81 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.714 1.205 . . . . 0.0 109.973 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -99.11 141.26 32.1 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.46 1.504 . . . . 0.0 111.341 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.14 -13.09 65.13 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.511 1.529 . . . . 0.0 113.809 -176.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.7 ptp -63.85 -14.63 54.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -60.06 -24.4 64.55 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.45 1.477 . . . . 0.0 112.384 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 59.2 m -78.4 -4.66 49.37 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.929 0.892 . . . . 0.0 113.372 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.55 -56.37 0.51 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.649 3.18 . . . . 0.0 113.224 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m -55.11 -25.16 29.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.64 1.176 . . . . 0.0 113.246 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.4 -50.12 70.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.003 1.721 . . . . 0.0 112.361 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -77.14 -30.71 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -52.73 -57.19 10.93 Favored 'General case' 0 C--N 1.345 0.391 0 C-N-CA 124.309 1.043 . . . . 0.0 110.916 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -60.02 -45.25 93.41 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 118.591 -0.719 . . . . 0.0 109.866 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.81 -36.68 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.919 1.236 . . . . 0.0 111.133 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.98 -22.26 64.11 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.978 0.911 . . . . 0.0 112.317 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -71.9 -52.96 14.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.78 1.232 . . . . 0.0 113.024 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -93.82 -17.39 23.14 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -167.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.9 mm -96.23 133.03 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 119.813 1.188 . . . . 0.0 108.042 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.08 -5.7 10.31 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 125.317 1.437 . . . . 0.0 114.749 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -126.68 17.02 7.49 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.2 1.8 . . . . 0.0 112.329 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.14 156.63 18.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.864 1.266 . . . . 0.0 109.971 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.4 tp -21.96 -64.56 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.534 2.734 . . . . 0.0 114.714 173.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.86 -15.92 20.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 116.527 -2.263 . . . . 0.0 116.011 175.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.6 t -82.64 124.0 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 122.588 3.194 . . . . 0.0 111.123 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.45 -31.9 11.41 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 172.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.6 t -148.62 163.58 36.83 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.063 -1.023 . . . . 0.0 112.705 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 tp -132.6 130.64 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.58 1.952 . . . . 0.0 106.445 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -129.91 161.73 30.18 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 172.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.47 164.62 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 120.954 -1.091 . . . . 0.0 112.84 -172.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 t -140.57 70.85 1.36 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 123.264 1.507 . . . . 0.0 109.37 170.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.9 mt -61.52 -21.57 64.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.642 1.177 . . . . 0.0 112.814 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.01 -30.82 48.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.694 1.197 . . . . 0.0 113.818 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -108.9 -7.95 15.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.469 1.908 . . . . 0.0 112.53 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mttm 77.05 15.96 1.8 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 127.576 2.351 . . . . 0.0 112.743 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.15 150.15 21.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.6 1.191 . . . . 0.0 110.806 177.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.82 151.06 40.08 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.415 1.886 . . . . 0.0 107.172 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -137.56 124.14 20.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.472 1.033 . . . . 0.0 113.446 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.8 p -97.12 136.12 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.52 1.128 . . . . 0.0 110.615 -170.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -110.67 102.4 10.96 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.625 1.57 . . . . 0.0 108.221 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -135.38 160.01 39.79 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -168.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -93.59 113.41 60.2 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 126.065 1.746 . . . . 0.0 108.218 173.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.33 -3.7 12.92 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.025 2.483 . . . . 0.0 112.761 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.4 p -81.75 -11.8 58.86 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.703 1.601 . . . . 0.0 112.388 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 37.3 m -121.74 -33.03 3.67 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.778 1.231 . . . . 0.0 113.044 -173.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.4 t -145.06 -179.36 6.57 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.886 1.675 . . . . 0.0 111.32 -174.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.9 p -160.8 155.19 19.71 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.457 1.103 . . . . 0.0 112.821 -170.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.9 -49.16 15.78 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.14 3.226 . . . . 0.0 116.668 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -70.22 -33.51 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 120.332 1.424 . . . . 0.0 112.638 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.66 81.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.481 0.712 . . . . 0.0 111.099 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.16 -46.89 75.81 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.321 1.448 . . . . 0.0 112.342 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.476 HE21 HG22 ' A' ' 88' ' ' VAL . 12.3 tt0 -53.58 -52.26 60.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.401 1.0 . . . . 0.0 109.778 175.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -65.65 -24.94 67.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.776 1.23 . . . . 0.0 113.676 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.39 -60.67 2.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.315 0.961 . . . . 0.0 112.581 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 pt -74.02 -29.71 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -167.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -71.28 -23.56 61.99 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.496 1.044 . . . . 0.0 113.705 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.16 17.8 9.05 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.001 -1.062 . . . . 0.0 113.675 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.75 -58.74 15.16 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 117.715 -1.136 . . . . 0.0 109.955 166.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -69.82 168.15 22.45 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.498 2.798 . . . . 0.0 112.337 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.4 42.16 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.459 3.439 . . . . 0.0 112.434 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.99 63.83 2.34 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -169.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -148.74 -16.71 0.31 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 -169.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -124.43 130.6 52.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 169.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -110.4 142.48 42.04 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.867 1.267 . . . . 0.0 111.766 -173.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.476 HG22 HE21 ' A' ' 75' ' ' GLN . 13.6 m -117.56 134.5 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 120.084 1.311 . . . . 0.0 111.178 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.0 m -128.97 120.93 26.94 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.916 0.865 . . . . 0.0 111.975 176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.033 0 C-N-CA 127.727 2.411 . . . . 0.0 112.202 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 58.2 m 48.41 82.11 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.038 2.135 . . . . 0.0 115.715 168.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.3 p -133.13 143.8 49.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.596 1.959 . . . . 0.0 112.929 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.6 m -98.1 129.46 44.92 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.015 0.825 . . . . 0.0 111.18 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.63 164.6 21.68 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.608 0.763 . . . . 0.0 111.162 169.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.16 132.13 54.55 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.251 1.421 . . . . 0.0 109.982 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.0 mm -117.91 137.99 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.067 1.747 . . . . 0.0 109.014 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.6 125.46 49.33 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.527 1.531 . . . . 0.0 109.215 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.1 mt -126.21 127.15 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 120.393 -1.442 . . . . 0.0 111.241 -170.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.07 74.21 1.03 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.796 2.039 . . . . 0.0 112.609 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -179.12 52.89 0.09 OUTLIER Glycine 0 N--CA 1.466 0.677 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.938 165.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 65.4 mtm -137.54 91.85 2.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.47 0.708 . . . . 0.0 109.826 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.5 t -94.57 -29.19 15.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.672 1.189 . . . . 0.0 113.191 -173.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 91.6 m -125.11 154.56 41.23 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.514 1.526 . . . . 0.0 110.112 175.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.15 65.69 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.3 p -54.91 -24.32 22.99 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.079 -1.013 . . . . 0.0 113.615 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 95.2 m -57.13 -29.27 63.43 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.693 -1.254 . . . . 0.0 112.592 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.22 -49.88 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.612 0.765 . . . . 0.0 110.523 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.14 -21.05 66.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.255 0.934 . . . . 0.0 113.228 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 t -74.1 -62.11 1.62 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.453 0.701 . . . . 0.0 111.304 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 47.4 mt -70.78 -48.54 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.83 -1.169 . . . . 0.0 111.494 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.19 -26.15 68.67 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.223 0.609 . . . . 0.0 111.711 176.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.35 -59.77 4.05 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.531 1.062 . . . . 0.0 112.178 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 92.7 mmm -71.57 -39.5 70.57 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.923 1.689 . . . . 0.0 114.208 -172.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.3 mm -70.96 -32.45 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.366 -0.834 . . . . 0.0 111.084 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.7 t -65.36 0.55 1.42 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -96.35 -11.24 26.09 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.479 -1.388 . . . . 0.0 114.589 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 pp -93.07 166.04 12.55 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.485 1.514 . . . . 0.0 111.429 174.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.18 138.23 31.69 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.449 -0.782 . . . . 0.0 112.537 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 101.16 15.6 27.66 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.556 1.55 . . . . 0.0 115.029 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.8 94.43 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.705 2.002 . . . . 0.0 110.502 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -68.0 -56.98 6.94 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.165 0.986 . . . . 0.0 111.02 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -140.0 131.44 26.92 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.475 1.11 . . . . 0.0 109.147 -171.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -136.47 131.33 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.865 0.866 . . . . 0.0 110.452 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.1 t -138.25 138.77 38.79 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.239 1.816 . . . . 0.0 108.686 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.5 p -143.45 145.55 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.962 1.305 . . . . 0.0 111.73 -175.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 t -135.19 135.38 40.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -172.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.93 -18.91 64.7 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.058 2.143 . . . . 0.0 113.959 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.19 78.98 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.545 1.138 . . . . 0.0 113.114 -176.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -130.87 -8.05 3.97 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.419 1.488 . . . . 0.0 112.336 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.6 41.3 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.595 1.093 . . . . 0.0 111.502 -171.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 71.3 p -130.17 145.86 51.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.513 1.156 . . . . 0.0 113.559 -168.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -115.06 141.19 48.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.915 1.686 . . . . 0.0 112.459 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.1 t -110.39 124.19 51.26 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 167.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.27 136.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.828 -0.545 . . . . 0.0 111.366 -171.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.15 101.86 13.63 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.932 2.093 . . . . 0.0 106.485 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -104.18 164.2 11.88 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.597 1.159 . . . . 0.0 112.629 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -107.02 93.34 8.96 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.089 1.356 . . . . 0.0 110.849 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.19 -19.19 50.93 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.586 2.857 . . . . 0.0 112.26 -172.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.15 -15.87 63.01 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.77 -38.5 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 126.463 1.905 . . . . 0.0 113.422 -168.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.7 tt -141.93 151.71 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.878 1.271 . . . . 0.0 111.53 -171.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.9 t -101.07 143.38 26.48 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 170.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.37 -26.49 27.95 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.784 2.989 . . . . 0.0 113.935 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -70.49 -40.65 73.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.462 0.705 . . . . 0.0 111.551 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -78.23 -24.29 47.06 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 168.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.23 -50.8 72.61 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.955 1.302 . . . . 0.0 109.325 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -50.62 -46.63 58.29 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.371 1.468 . . . . 0.0 111.433 168.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.07 -21.35 66.49 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.58 65.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.449 1.022 . . . . 0.0 112.367 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.2 mp -74.27 -40.43 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.216 1.007 . . . . 0.0 111.158 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -65.71 -27.58 68.43 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.996 0.816 . . . . 0.0 112.846 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.24 -42.53 68.75 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.0 1.32 . . . . 0.0 112.362 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.1 tpt -61.23 -31.96 71.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.071 0.851 . . . . 0.0 111.434 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 109.0 44.16 1.13 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 126.584 2.04 . . . . 0.0 113.187 172.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -124.24 -159.73 0.89 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.92 149.6 47.43 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.692 -1.255 . . . . 0.0 109.212 168.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.55 155.0 44.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.502 1.144 . . . . 0.0 113.542 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.9 t -142.62 138.27 30.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.379 1.872 . . . . 0.0 108.99 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.3 m -88.11 128.68 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 121.47 -0.769 . . . . 0.0 109.108 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . 0.288 2.7 p . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 124.698 2.19 . . . . 0.0 107.675 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.41 150.95 22.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.317 2.247 . . . . 0.0 111.86 176.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 tt -146.24 143.65 29.35 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.264 2.226 . . . . 0.0 112.135 -169.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -95.2 121.76 37.18 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.387 1.089 . . . . 0.0 110.454 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -130.69 127.45 38.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.118 -1.401 . . . . 0.0 113.296 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -106.84 110.27 22.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.058 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 mm -77.15 157.37 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.236 1.014 . . . . 0.0 109.935 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -135.54 147.63 48.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.542 1.137 . . . . 0.0 110.959 168.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 11.24 84.72 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.63 1.109 . . . . 0.0 113.353 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.4 ptm -68.01 -33.07 73.92 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.993 1.396 . . . . 0.0 113.912 -169.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 69.08 -51.77 0.59 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.693 2.397 . . . . 0.0 112.474 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 31.0 p -173.37 -173.74 0.93 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.829 2.052 . . . . 0.0 112.388 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -46.44 -33.41 3.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.941 1.697 . . . . 0.0 113.503 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.5 m -53.25 -30.05 36.12 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.553 1.07 . . . . 0.0 113.703 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.5 t -64.46 -42.07 96.15 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.965 -1.084 . . . . 0.0 113.817 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.269 4.8 p -73.62 -6.31 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.34 -59.09 5.17 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.186 1.357 . . . . 0.0 111.712 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -61.33 -31.66 71.52 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.263 0.938 . . . . 0.0 111.989 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.1 mt -59.44 -56.5 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.33 -35.48 73.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.034 1.733 . . . . 0.0 114.424 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.01 -41.01 97.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.305 1.042 . . . . 0.0 111.534 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -96.35 -33.65 11.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.2 mm -107.09 111.92 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.616 1.166 . . . . 0.0 110.346 -167.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.08 -18.64 6.97 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.497 1.523 . . . . 0.0 113.877 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -85.53 -6.01 59.23 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.5 -1.0 . . . . 0.0 112.542 169.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.8 mt -79.49 -179.13 6.65 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.9 2.08 . . . . 0.0 113.538 -170.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.81 -77.97 0.06 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.306 2.243 . . . . 0.0 111.806 170.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.5 -36.47 58.96 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.589 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -92.51 118.59 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.246 1.523 . . . . 0.0 110.249 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -101.7 -24.62 14.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.742 0.817 . . . . 0.0 113.179 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.8 m -149.97 156.06 41.06 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.587 -1.32 . . . . 0.0 113.661 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 tp -125.94 147.06 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.011 1.324 . . . . 0.0 109.914 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -142.8 166.92 23.32 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.356 1.862 . . . . 0.0 108.471 -172.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -139.38 160.52 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 119.687 -1.883 . . . . 0.0 113.365 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.0 t -140.95 56.61 1.56 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.39 1.876 . . . . 0.0 108.244 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.7 mt -61.52 -33.99 74.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -168.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.17 -17.11 64.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.162 1.346 . . . . 0.0 113.388 172.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -104.02 -1.4 27.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.657 1.583 . . . . 0.0 111.807 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 70.12 9.57 7.09 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.27 2.628 . . . . 0.0 113.586 173.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.51 152.79 18.64 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.701 2.001 . . . . 0.0 109.325 176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.46 171.7 7.26 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.012 1.325 . . . . 0.0 107.551 165.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -141.92 137.79 31.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.915 0.486 . . . . 0.0 110.367 -169.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.35 132.65 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 118.795 0.725 . . . . 0.0 112.059 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -105.36 94.2 5.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.727 2.011 . . . . 0.0 107.702 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -131.23 162.73 29.34 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -168.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -97.57 114.12 64.43 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 128.106 2.562 . . . . 0.0 110.919 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.29 25.24 0.53 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.564 2.843 . . . . 0.0 113.617 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.8 t -117.82 -26.36 6.53 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.369 -1.457 . . . . 0.0 112.8 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.6 m -93.66 -29.01 15.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.128 0.971 . . . . 0.0 113.524 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -144.6 -179.07 6.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.97 1.708 . . . . 0.0 112.223 -171.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.6 p -157.81 163.0 26.09 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.133 1.373 . . . . 0.0 112.47 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -51.21 -50.68 13.14 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 124.771 3.647 . . . . 0.0 115.82 -171.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.28 -37.23 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 119.216 0.916 . . . . 0.0 112.59 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.57 79.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.257 0.623 . . . . 0.0 110.855 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.7 mt -64.37 -45.06 89.34 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.571 0.748 . . . . 0.0 112.142 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -52.06 -55.82 18.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.879 0.872 . . . . 0.0 110.545 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -70.21 -22.56 62.91 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.01 -56.47 6.09 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.316 0.962 . . . . 0.0 112.273 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.6 pt -71.54 -31.4 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -172.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -60.71 -30.23 69.83 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.29 13.79 26.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.6 mt -62.41 -49.27 84.54 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 117.305 -1.331 . . . . 0.0 112.662 167.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.61 172.07 16.43 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.707 2.938 . . . . 0.0 112.997 174.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.94 63.0 6.73 Favored 'Trans proline' 0 CA--C 1.541 0.847 1 C-N-CA 125.462 4.108 . . . . 0.0 111.109 173.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.87 32.5 82.15 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.011 1.291 . . . . 0.0 112.986 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -105.49 -48.17 3.74 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -166.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -95.6 128.53 42.54 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.01 157.56 15.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.51 1.524 . . . . 0.0 109.384 173.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.24 136.85 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 119.533 1.06 . . . . 0.0 111.636 170.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.3 m -124.36 140.37 53.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.686 1.595 . . . . 0.0 112.919 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.615 0 C-N-CA 126.462 1.905 . . . . 0.0 111.556 -163.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 5.7 m -144.03 138.8 28.61 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 p -142.35 154.82 44.98 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 127.44 2.296 . . . . 0.0 110.266 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 54.5 m -101.64 145.39 29.14 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.554 -0.716 . . . . 0.0 109.978 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.16 150.88 38.75 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.201 1.001 . . . . 0.0 111.058 172.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.76 137.96 50.3 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.583 1.553 . . . . 0.0 109.054 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.3 mm -119.12 137.29 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.554 1.942 . . . . 0.0 108.525 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -100.33 128.05 46.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.109 1.363 . . . . 0.0 109.288 170.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.02 136.21 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 120.702 -1.249 . . . . 0.0 110.909 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.68 61.7 1.23 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.965 1.706 . . . . 0.0 111.755 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.31 56.23 0.19 Allowed Glycine 0 N--CA 1.463 0.459 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.721 169.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.9 mtm -138.74 74.9 1.49 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.205 1.002 . . . . 0.0 110.499 -177.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.2 t -79.84 -19.99 47.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.72 1.208 . . . . 0.0 112.513 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 95.0 m -128.23 153.02 47.39 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.454 1.901 . . . . 0.0 111.06 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.77 -24.46 61.76 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.361 -0.837 . . . . 0.0 112.848 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.6 p -51.11 -37.36 45.49 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.987 -1.071 . . . . 0.0 111.97 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.4 m -54.15 -36.32 63.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.779 1.632 . . . . 0.0 113.336 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 t -59.85 -56.3 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -69.34 -17.61 63.72 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 m -72.52 -54.84 8.08 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.617 1.167 . . . . 0.0 111.788 167.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.81 -58.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.778 0.831 . . . . 0.0 110.198 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -57.32 -28.63 63.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.997 2.119 . . . . 0.0 112.014 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.62 -56.96 4.76 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 125.842 1.687 . . . . 0.0 114.239 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 13.1 mmt -71.29 -45.79 62.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.909 0.884 . . . . 0.0 112.093 -172.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.7 -39.68 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -169.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -2.25 2.7 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.96 -16.65 27.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.041 1.336 . . . . 0.0 113.814 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -95.75 162.55 13.55 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.908 1.231 . . . . 0.0 111.844 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -77.1 166.37 23.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.279 1.038 . . . . 0.0 113.596 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.9 -41.84 1.77 Allowed Glycine 0 CA--C 1.531 1.077 0 O-C-N 120.822 -1.174 . . . . 0.0 114.069 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 p -78.14 97.44 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.135 1.468 . . . . 0.0 111.394 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -68.87 -52.24 31.85 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.304 1.441 . . . . 0.0 111.545 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -143.52 144.68 32.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.868 0.867 . . . . 0.0 109.94 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.9 tt -135.93 140.17 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.14 0.976 . . . . 0.0 110.077 172.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 42.0 t -138.95 136.44 35.42 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.641 1.576 . . . . 0.0 109.946 175.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.5 p -143.79 147.39 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 119.665 1.12 . . . . 0.0 112.394 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.1 t -143.45 151.37 40.26 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.838 1.255 . . . . 0.0 112.658 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.6 mt -72.85 -29.3 63.1 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -46.21 -38.85 8.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.816 2.047 . . . . 0.0 115.303 -168.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -125.0 -1.14 7.82 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.194 1.798 . . . . 0.0 111.383 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 68.28 50.95 35.43 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 128.228 2.823 . . . . 0.0 112.019 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.8 p -141.66 145.12 34.56 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -114.99 144.87 42.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.043 1.737 . . . . 0.0 111.506 171.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.3 t -120.98 127.69 52.03 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.792 1.237 . . . . 0.0 108.208 168.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.26 140.18 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.024 0.93 . . . . 0.0 111.461 -167.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.34 116.25 30.17 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.431 2.292 . . . . 0.0 107.774 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -136.7 158.77 43.67 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -96.93 116.57 66.11 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.35 1.46 . . . . 0.0 110.606 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -82.25 -0.43 10.23 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.956 3.104 . . . . 0.0 114.121 -173.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.05 -37.48 12.14 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.678 1.191 . . . . 0.0 112.311 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 82.0 t -89.87 -31.69 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 126.668 1.987 . . . . 0.0 112.436 -176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.459 ' CG1' ' H ' ' A' ' 172' ' ' SER . 14.6 tt -138.2 -178.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.522 1.129 . . . . 0.0 110.773 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' SER . . . . . 0.459 ' H ' ' CG1' ' A' ' 171' ' ' ILE . 21.6 t -140.6 148.2 52.2 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 126.497 1.919 . . . . 0.0 110.23 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.57 -27.12 31.49 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.684 2.256 . . . . 0.0 113.664 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.51 -31.53 69.83 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.982 0.81 . . . . 0.0 111.385 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.03 -36.52 64.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.971 1.709 . . . . 0.0 111.615 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.6 mt -58.04 -57.14 14.15 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.049 0.939 . . . . 0.0 109.743 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -38.9 93.0 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 177.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.91 -30.44 67.82 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.97 0.804 . . . . 0.0 113.034 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.57 -31.9 69.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.367 0.985 . . . . 0.0 112.45 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.07 -35.67 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.979 0.912 . . . . 0.0 111.256 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.38 -29.11 65.68 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.866 0.757 . . . . 0.0 112.895 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.51 -29.61 63.77 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.643 1.177 . . . . 0.0 113.078 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 53.4 ttm -69.63 -48.84 58.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.848 0.859 . . . . 0.0 110.257 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 134.76 43.46 0.12 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.051 1.31 . . . . 0.0 114.882 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -140.8 -155.67 0.61 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.467 1.507 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -133.07 143.83 49.59 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.511 1.124 . . . . 0.0 111.368 172.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -141.5 145.0 34.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.756 1.222 . . . . 0.0 112.337 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.4 t -133.23 141.2 47.92 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.41 1.484 . . . . 0.0 109.95 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.9 m -82.48 132.23 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 O-C-N 122.042 -0.411 . . . . 0.0 111.2 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . 0.264 5.0 p . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 124.673 2.177 . . . . 0.0 107.212 169.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.4 m -126.97 134.84 50.3 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 123.357 0.663 . . . . 0.0 110.909 -168.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.56 166.75 23.87 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 115.591 1.701 . . . . 0.0 115.591 175.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -120.45 128.17 52.91 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.088 2.155 . . . . 0.0 110.938 -169.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.05 138.35 29.87 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.74 109.91 22.58 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -177.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 mt -83.25 134.21 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.254 1.422 . . . . 0.0 109.293 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -101.69 127.45 48.43 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.371 1.468 . . . . 0.0 110.882 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.4 -5.76 38.47 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.192 1.377 . . . . 0.0 113.626 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.6 ptp -61.15 -10.41 6.4 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -53.35 -12.99 0.48 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.216 1.407 . . . . 0.0 113.623 167.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.2 t -119.41 127.88 53.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.409 1.884 . . . . 0.0 108.893 167.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -58.24 -31.68 67.62 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.941 -1.099 . . . . 0.0 113.343 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 m -50.32 -30.65 12.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.719 1.207 . . . . 0.0 113.617 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.0 t -63.48 -58.19 7.8 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.546 1.138 . . . . 0.0 111.759 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 p -70.01 -25.35 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.231 0.923 . . . . 0.0 111.82 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.33 -61.34 2.7 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.041 0.936 . . . . 0.0 111.885 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -62.88 -32.5 73.77 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.969 -0.457 . . . . 0.0 111.673 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.05 -50.37 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.751 0.705 . . . . 0.0 110.32 172.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.66 -31.84 73.14 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.949 1.3 . . . . 0.0 112.528 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -70.18 -46.94 63.6 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.256 -0.902 . . . . 0.0 112.067 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -91.46 -13.13 32.8 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -170.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.9 mm -105.16 121.79 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.924 1.238 . . . . 0.0 111.421 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.98 -19.77 7.74 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.899 1.714 . . . . 0.0 114.185 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -77.35 -3.19 38.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.767 1.227 . . . . 0.0 112.599 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.7 mt -84.52 -175.76 5.93 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.88 2.872 . . . . 0.0 111.966 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.9 tp -85.82 -79.85 0.24 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.066 1.746 . . . . 0.0 111.256 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.54 -30.98 65.9 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 117.857 -1.524 . . . . 0.0 113.576 -171.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.38 117.39 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 119.173 1.486 . . . . 0.0 107.734 167.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -108.09 -36.46 6.32 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -170.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -147.62 168.12 22.82 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.31 1.044 . . . . 0.0 111.229 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.5 tp -140.68 141.65 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.546 1.138 . . . . 0.0 110.085 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -137.24 155.4 49.54 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.954 2.102 . . . . 0.0 107.47 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.4 m -123.66 145.63 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.627 -1.921 . . . . 0.0 110.914 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m -128.15 54.45 1.73 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.574 1.15 . . . . 0.0 108.135 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.13 -30.04 71.13 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.685 1.594 . . . . 0.0 112.365 -171.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.68 -37.41 63.19 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.4 0.68 . . . . 0.0 111.994 170.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -102.51 2.53 36.44 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.608 1.563 . . . . 0.0 112.925 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? 68.18 12.38 8.74 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.149 2.579 . . . . 0.0 114.209 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.1 p -99.92 162.75 12.79 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.723 1.249 . . . . 0.0 110.273 169.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.1 161.93 14.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 165.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -137.08 127.15 26.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -169.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.16 140.48 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.444 -1.41 . . . . 0.0 111.915 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.36 108.85 21.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.067 1.347 . . . . 0.0 108.601 173.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -131.09 178.64 6.54 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.132 1.373 . . . . 0.0 110.26 -175.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -124.44 134.49 25.58 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.53 1.132 . . . . 0.0 109.445 170.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.49 20.06 0.8 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.215 3.277 . . . . 0.0 114.307 -169.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 p -121.96 -51.76 2.0 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.813 2.045 . . . . 0.0 110.586 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 90.2 m -77.46 -25.32 50.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.562 1.545 . . . . 0.0 114.463 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 t -145.28 -177.36 5.51 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.42 1.888 . . . . 0.0 109.318 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.7 p -149.57 162.17 29.37 Favored Pre-proline 0 C--N 1.321 -0.674 0 C-N-CA 125.211 1.404 . . . . 0.0 110.155 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.19 -56.37 3.11 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.42 2.747 . . . . 0.0 113.05 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.25 -35.64 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.42 -52.68 12.86 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.378 0.671 . . . . 0.0 111.606 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -37.47 82.97 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.212 1.405 . . . . 0.0 111.071 -177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.9 -57.86 10.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.523 1.129 . . . . 0.0 111.539 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -63.29 -32.16 73.5 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.49 -52.71 64.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.299 0.64 . . . . 0.0 110.659 174.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 pt -73.41 -31.37 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -70.17 -23.91 63.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.64 10.63 39.45 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 176.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 mt -56.71 -59.14 13.23 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.063 168.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.09 173.28 14.36 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.623 2.215 . . . . 0.0 111.001 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.89 67.5 5.82 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.731 2.954 . . . . 0.0 110.135 169.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 56.22 46.03 86.88 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 125.594 1.568 . . . . 0.0 112.741 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -115.39 -21.22 9.94 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -165.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -133.12 116.78 16.72 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.154 1.382 . . . . 0.0 110.75 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -99.19 139.42 34.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.21 1.404 . . . . 0.0 112.091 -173.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.5 140.43 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 120.5 1.5 . . . . 0.0 112.932 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.8 t -122.94 128.69 50.61 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.225 1.81 . . . . 0.0 110.89 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 125.79 1.636 . . . . 0.0 112.598 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 24.7 p -157.01 132.88 9.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.607 1.563 . . . . 0.0 113.56 -168.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.0 p -148.0 145.26 28.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.905 2.082 . . . . 0.0 110.041 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 90.2 m -105.26 135.58 46.37 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.471 1.032 . . . . 0.0 110.499 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.68 149.23 44.92 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.987 1.315 . . . . 0.0 110.974 172.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tt -96.46 141.21 30.03 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.095 2.158 . . . . 0.0 110.042 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mt -127.91 134.4 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.626 1.571 . . . . 0.0 109.246 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.2 130.76 44.39 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.27 1.028 . . . . 0.0 108.266 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 90.6 mt -132.94 136.09 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.48 -0.763 . . . . 0.0 111.144 -168.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.07 72.27 1.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.882 1.673 . . . . 0.0 111.882 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -177.49 52.13 0.1 Allowed Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.242 -0.89 . . . . 0.0 114.399 167.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -104.41 -58.08 1.94 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.274 5.6 t 54.84 -56.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 129.433 3.093 . . . . 0.0 115.757 -169.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 92.3 m -112.99 150.82 31.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.744 2.418 . . . . 0.0 111.095 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.6 73.43 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.865 1.266 . . . . 0.0 112.614 -177.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.5 p -43.49 -47.53 7.2 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.218 1.407 . . . . 0.0 112.385 169.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 5.6 t -71.5 -25.08 62.11 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.54 -53.39 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.43 -33.29 73.47 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.1 m -67.17 -51.72 50.28 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.708 0.803 . . . . 0.0 112.898 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 83.8 mt -62.01 -46.54 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-N 119.965 1.257 . . . . 0.0 110.665 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -58.74 -28.77 66.18 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.814 1.645 . . . . 0.0 112.164 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.48 -61.05 3.28 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.969 1.271 . . . . 0.0 113.281 170.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -47.74 69.74 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.319 1.448 . . . . 0.0 113.139 -169.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.0 mm -71.67 -34.67 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.157 -0.339 . . . . 0.0 111.735 -169.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.0 t -50.96 -21.99 2.04 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.487 1.915 . . . . 0.0 115.313 176.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -86.18 -19.82 29.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.122 1.769 . . . . 0.0 115.163 -167.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.1 pp -92.92 151.28 20.04 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.181 0.901 . . . . 0.0 112.403 -173.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -59.38 135.22 57.59 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.952 0.882 . . . . 0.0 112.49 -169.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.27 -27.56 9.21 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.064 -1.965 . . . . 0.0 115.343 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.97 94.05 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 121.214 2.507 . . . . 0.0 108.778 169.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -74.84 -44.07 51.11 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.345 1.058 . . . . 0.0 111.374 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -141.95 147.18 36.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.476 1.034 . . . . 0.0 109.96 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.46 148.54 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.109 0.956 . . . . 0.0 113.272 175.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 47.5 t -134.39 136.84 43.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 129.031 2.932 . . . . 0.0 108.513 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.77 143.9 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.616 1.553 . . . . 0.0 112.766 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 42.0 m -141.51 148.71 39.83 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.195 1.398 . . . . 0.0 113.233 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.43 -26.43 55.49 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.813 1.645 . . . . 0.0 114.133 172.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.25 -33.48 58.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.834 1.653 . . . . 0.0 113.894 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -123.83 -10.54 7.75 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.276 1.83 . . . . 0.0 111.087 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.72 44.61 19.8 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.406 1.003 . . . . 0.0 110.793 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 49.0 p -133.74 146.63 50.93 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.073 0.949 . . . . 0.0 111.863 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -121.82 161.2 23.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.77 1.628 . . . . 0.0 111.057 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.8 t -141.46 139.21 33.32 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 124.191 0.996 . . . . 0.0 109.173 168.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.63 142.86 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.226 -167.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.38 98.62 11.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 173.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -100.22 154.52 18.39 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.9 0.88 . . . . 0.0 111.67 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -98.81 109.11 52.31 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.161 0.984 . . . . 0.0 110.087 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.78 -10.88 23.64 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.438 2.092 . . . . 0.0 112.472 -170.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.26 -17.42 46.01 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 93.6 t -120.45 -29.12 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.911 1.284 . . . . 0.0 114.02 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.3 tt -141.1 147.25 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.186 0.903 . . . . 0.0 110.324 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.63 150.04 36.32 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.939 0.895 . . . . 0.0 111.004 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.43 -39.47 36.1 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.246 2.631 . . . . 0.0 113.924 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -65.01 -25.25 67.78 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.7 -27.79 55.64 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.614 1.165 . . . . 0.0 113.875 174.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.6 mt -59.77 -53.76 54.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -65.2 -34.68 78.95 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.18 -27.63 68.56 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.05 -36.44 72.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.89 0.768 . . . . 0.0 112.723 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.4 mp -72.41 -37.45 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.286 1.035 . . . . 0.0 110.837 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -63.43 -34.05 76.9 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.817 -0.552 . . . . 0.0 111.485 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -71.88 -24.4 61.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.008 1.323 . . . . 0.0 113.336 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 21.2 ttt -74.85 -29.46 61.05 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.673 1.189 . . . . 0.0 112.609 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 115.5 30.99 2.08 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 126.084 1.802 . . . . 0.0 114.875 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -133.76 -158.51 0.89 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.842 1.657 . . . . 0.0 109.18 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -137.57 143.17 41.41 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.287 1.035 . . . . 0.0 111.459 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -140.88 152.22 44.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.027 1.731 . . . . 0.0 112.065 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.5 t -141.36 130.99 24.02 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.006 1.323 . . . . 0.0 112.232 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.55 81.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.127 0.971 . . . . 0.0 111.412 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 125.025 1.33 . . . . 0.0 112.457 179.526 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -118.36 144.9 45.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.501 1.121 . . . . 0.0 111.399 -170.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.38 128.71 19.98 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.496 1.519 . . . . 0.0 109.85 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -96.3 135.69 37.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.355 1.462 . . . . 0.0 112.237 -176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -142.87 146.91 34.54 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.92 109.62 19.85 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.449 1.499 . . . . 0.0 109.146 174.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.7 mt -85.41 147.21 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.199 1.799 . . . . 0.0 111.676 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -98.19 139.84 33.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.984 1.313 . . . . 0.0 111.07 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.27 -6.89 81.04 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.196 1.379 . . . . 0.0 114.101 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 ptp -64.19 -15.75 60.53 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -63.82 -13.5 44.99 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.62 1.554 . . . . 0.0 113.223 170.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.1 m -77.03 -14.72 59.79 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.15 -1.594 . . . . 0.0 114.155 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 70.8 -50.9 0.68 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 128.139 2.576 . . . . 0.0 111.955 -172.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 m -60.0 -17.97 42.49 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.766 -1.209 . . . . 0.0 113.583 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 t -64.38 -53.05 54.7 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.548 1.139 . . . . 0.0 111.565 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.72 -27.92 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 118.638 0.654 . . . . 0.0 112.281 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.1 tp -53.65 -49.54 67.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 112.376 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -39.18 88.51 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.478 0.581 . . . . 0.0 111.914 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.1 mt -65.51 -49.5 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.263 1.025 . . . . 0.0 109.264 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.69 -41.6 98.12 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.68 1.592 . . . . 0.0 111.938 -176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.7 -39.22 87.97 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.031 -0.509 . . . . 0.0 111.49 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -91.6 -25.01 19.39 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -172.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.8 mm -102.91 118.64 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.874 0.87 . . . . 0.0 110.431 -173.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.23 -17.5 3.57 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.866 1.698 . . . . 0.0 115.215 -177.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -88.54 -5.33 58.27 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.091 1.356 . . . . 0.0 111.919 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -76.4 170.4 16.43 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.006 2.122 . . . . 0.0 111.247 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.57 -62.88 1.31 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.427 -0.795 . . . . 0.0 110.964 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.04 -43.13 17.85 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.853 -0.97 . . . . 0.0 113.237 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.26 123.92 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.221 1.511 . . . . 0.0 110.502 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -94.74 -46.22 7.0 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.186 0.994 . . . . 0.0 111.31 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.8 t -149.41 172.04 15.59 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.563 0.745 . . . . 0.0 112.481 -169.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 tp -142.39 125.2 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.561 1.944 . . . . 0.0 107.434 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -120.23 149.45 42.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.554 0.741 . . . . 0.0 109.65 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.8 m -106.62 155.87 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.201 -0.937 . . . . 0.0 111.03 -170.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.4 t -139.73 57.82 1.62 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 123.138 1.447 . . . . 0.0 108.182 175.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.86 -24.13 65.22 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.611 1.564 . . . . 0.0 112.714 -171.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.21 -11.88 35.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.003 1.321 . . . . 0.0 113.61 169.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -122.84 7.59 9.35 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.172 2.189 . . . . 0.0 111.649 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 mptt 62.2 14.17 6.46 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.383 2.273 . . . . 0.0 113.746 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.73 167.14 10.08 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.634 1.574 . . . . 0.0 111.76 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.67 152.79 45.64 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 127.157 2.183 . . . . 0.0 107.207 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.63 133.65 46.31 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 172.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 p -96.22 136.86 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.519 0.676 . . . . 0.0 109.732 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -107.19 87.89 2.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.59 1.956 . . . . 0.0 107.51 -172.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -116.33 -179.3 3.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.481 1.512 . . . . 0.0 110.42 -175.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.13 142.17 36.05 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 168.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.08 7.19 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.388 2.058 . . . . 0.0 114.308 -168.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -74.96 -51.38 13.85 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.28 -1.512 . . . . 0.0 112.369 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 90.0 m -95.46 -15.81 22.69 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -172.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.9 t -147.81 175.69 10.73 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.647 1.179 . . . . 0.0 112.448 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.4 p -155.46 161.54 29.23 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.606 1.162 . . . . 0.0 112.754 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.85 -45.71 38.98 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.131 2.554 . . . . 0.0 115.583 -170.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.91 -41.18 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 118.814 0.734 . . . . 0.0 111.945 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.48 86.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.954 0.901 . . . . 0.0 112.268 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.56 -40.56 92.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.989 0.916 . . . . 0.0 111.799 173.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -58.69 -45.64 89.04 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.256 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -61.59 -36.79 81.66 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.542 1.065 . . . . 0.0 112.892 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.18 -60.33 2.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.23 1.012 . . . . 0.0 113.43 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.6 pt -73.2 -32.65 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -169.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -70.0 -19.62 63.32 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.84 0.856 . . . . 0.0 112.684 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.59 11.21 37.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.997 1.319 . . . . 0.0 113.934 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -60.61 -50.46 85.29 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.371 -1.3 . . . . 0.0 111.631 167.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.25 172.84 12.35 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.583 2.855 . . . . 0.0 112.22 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.56 43.25 1.18 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.217 3.278 . . . . 0.0 112.236 170.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.41 58.05 5.23 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 121.155 -0.966 . . . . 0.0 111.149 -174.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -133.8 -42.33 0.83 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -97.9 115.53 28.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -102.4 158.46 16.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.016 0.926 . . . . 0.0 111.772 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.86 139.25 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.364 0.984 . . . . 0.0 112.037 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.8 t -128.9 130.5 46.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.012 0.925 . . . . 0.0 111.945 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 CA--C 1.552 1.021 0 C-N-CA 125.355 1.462 . . . . 0.0 111.461 -175.887 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 87.1 m 58.53 92.63 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.237 1.815 . . . . 0.0 112.758 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 t -140.15 154.04 46.85 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.882 -1.136 . . . . 0.0 111.727 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.1 m -99.27 129.84 45.52 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -176.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.82 153.59 43.85 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.087 0.946 . . . . 0.0 110.126 168.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tt -102.55 130.5 49.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.705 2.002 . . . . 0.0 109.447 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.3 mm -115.12 138.55 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.174 1.789 . . . . 0.0 109.187 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -104.51 125.04 50.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.923 0.889 . . . . 0.0 110.044 169.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.9 mp -115.85 139.85 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.457 1.026 . . . . 0.0 112.369 -169.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.31 70.55 0.72 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.229 2.211 . . . . 0.0 111.539 171.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -176.2 54.09 0.11 Allowed Glycine 0 N--CA 1.466 0.659 0 C-N-CA 124.86 1.219 . . . . 0.0 112.753 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.9 mtm -134.98 157.78 46.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.514 1.526 . . . . 0.0 109.869 170.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.8 t -174.94 -45.34 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.593 1.557 . . . . 0.0 110.74 -171.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 67.0 m -104.68 146.05 29.48 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.863 1.265 . . . . 0.0 109.127 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.89 -27.69 68.34 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.622 -0.674 . . . . 0.0 112.605 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 79.9 p -56.06 -23.9 36.47 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.913 -1.117 . . . . 0.0 113.468 172.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 73.2 m -56.16 -27.82 55.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.372 1.069 . . . . 0.0 113.49 170.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.2 t -54.33 -52.58 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 118.91 0.777 . . . . 0.0 109.492 173.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -70.6 -14.8 62.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.232 1.013 . . . . 0.0 113.098 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.3 m -73.41 -56.14 5.44 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.064 -1.023 . . . . 0.0 109.65 167.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.5 mt -68.17 -59.23 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.695 1.198 . . . . 0.0 110.568 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -54.55 -29.52 51.21 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.646 1.578 . . . . 0.0 111.63 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.58 -62.65 3.15 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.373 0.987 . . . . 0.0 112.727 176.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 86.6 mmm -75.56 -42.49 52.09 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.771 1.396 . . . . 0.0 114.771 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 31.8 mm -72.32 -30.51 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.596 0.759 . . . . 0.0 111.829 -172.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.6 p -63.82 -9.37 14.44 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 175.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -107.92 22.95 15.22 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.028 1.331 . . . . 0.0 113.577 -171.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 pp -115.56 163.72 15.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.759 1.223 . . . . 0.0 111.544 169.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -65.57 135.8 55.56 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.12 16.57 74.17 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 117.891 -1.505 . . . . 0.0 115.89 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.75 -23.56 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 125.507 1.523 . . . . 0.0 114.292 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 42.65 -76.31 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 129.841 3.256 . . . . 0.0 117.37 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -128.28 127.91 43.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.55 1.523 . . . . 0.0 111.375 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.6 tt -134.6 137.66 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 121.188 -0.945 . . . . 0.0 111.164 -169.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 21.9 t -143.26 133.37 24.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.869 2.067 . . . . 0.0 108.248 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.58 143.62 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 119.785 1.175 . . . . 0.0 111.711 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -141.38 133.45 27.72 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -59.05 -22.08 60.16 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.041 2.137 . . . . 0.0 113.23 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.06 -31.17 62.93 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.792 1.237 . . . . 0.0 112.724 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -133.3 -16.7 2.4 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.185 1.394 . . . . 0.0 113.555 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.1 26.74 65.72 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.803 1.192 . . . . 0.0 112.112 -169.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.4 p -121.42 148.85 43.85 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.64 1.176 . . . . 0.0 111.693 -171.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.64 137.48 50.85 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.786 1.234 . . . . 0.0 110.771 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.0 t -112.66 121.13 43.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 167.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.59 141.28 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 121.906 -0.496 . . . . 0.0 110.614 -169.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.31 101.93 14.64 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.637 1.975 . . . . 0.0 105.887 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -97.65 157.8 15.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.293 1.044 . . . . 0.0 111.718 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -101.42 94.49 4.16 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.713 1.205 . . . . 0.0 110.267 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.55 -35.71 94.87 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.118 2.545 . . . . 0.0 111.372 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.57 -8.18 18.63 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.36 -28.98 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 126.181 1.792 . . . . 0.0 112.535 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.8 tt -155.91 158.02 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 119.943 1.247 . . . . 0.0 112.351 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.5 t -98.1 145.27 29.51 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.854 1.262 . . . . 0.0 113.104 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.42 -33.23 66.06 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.102 2.535 . . . . 0.0 112.546 167.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.42 -27.07 66.76 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.982 0.81 . . . . 0.0 112.432 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -76.38 -37.07 57.73 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.323 1.049 . . . . 0.0 111.953 168.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.43 -53.59 56.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.286 1.834 . . . . 0.0 110.641 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -59.83 -37.82 80.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.74 0.7 . . . . 0.0 112.809 173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.63 -23.91 67.32 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.26 -35.63 71.47 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.111 1.323 . . . . 0.0 112.731 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.65 -38.18 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.574 1.149 . . . . 0.0 110.191 171.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -69.39 -26.76 64.8 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.41 1.084 . . . . 0.0 112.734 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.66 -44.51 64.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.182 1.393 . . . . 0.0 111.393 168.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 22.6 ttt -61.72 -27.67 68.88 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.654 1.582 . . . . 0.0 112.396 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 115.23 38.79 0.99 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.478 1.514 . . . . 0.0 114.024 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -130.7 -160.54 1.05 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.236 1.414 . . . . 0.0 108.266 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -131.51 146.86 52.44 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.904 -1.123 . . . . 0.0 110.335 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.93 141.53 31.49 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.8 t -124.36 135.5 53.36 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.5 1.12 . . . . 0.0 112.021 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 m -87.07 80.63 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.908 0.883 . . . . 0.0 110.768 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.476 0.839 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.603 -178.082 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -98.85 153.46 18.77 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.479 2.711 . . . . 0.0 112.927 -174.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.5 tt -143.96 139.31 29.02 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.221 1.409 . . . . 0.0 112.991 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -98.46 110.33 22.94 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 122.689 1.233 . . . . 0.0 111.928 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -138.17 133.73 33.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.472 -1.695 . . . . 0.0 112.667 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -98.6 119.38 37.22 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.7 mt -96.83 137.34 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.031 0.932 . . . . 0.0 109.146 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -96.64 117.8 31.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.904 0.882 . . . . 0.0 110.913 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.62 -12.36 12.13 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.306 1.432 . . . . 0.0 113.689 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 12.9 ptp -56.52 -22.17 31.1 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.939 1.87 . . . . 0.0 114.075 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -58.64 -25.97 63.28 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 169.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -80.42 -8.49 59.56 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.606 -1.309 . . . . 0.0 113.52 173.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.7 tptt 70.08 -56.0 0.59 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 129.025 2.93 . . . . 0.0 111.781 -170.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -48.86 -27.35 2.98 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.718 2.407 . . . . 0.0 114.567 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 t -53.59 -49.06 68.57 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.951 1.7 . . . . 0.0 113.265 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.9 -28.24 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -170.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.69 -51.86 45.5 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.215 1.406 . . . . 0.0 111.343 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.19 -54.12 49.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -60.69 -37.0 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.591 0.756 . . . . 0.0 111.34 -173.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -64.08 -28.65 69.93 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.402 -0.811 . . . . 0.0 112.399 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.24 -50.3 34.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.24 1.016 . . . . 0.0 112.085 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -92.57 -24.29 18.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.549 1.54 . . . . 0.0 115.076 -171.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.4 mm -98.86 125.84 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 120.345 1.429 . . . . 0.0 109.746 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.403 ' H ' HD11 ' A' ' 45' ' ' LEU . . . 125.41 -14.24 7.32 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.039 1.78 . . . . 0.0 114.636 -174.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -96.65 -1.88 45.82 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.749 1.274 . . . . 0.0 113.092 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.403 HD11 ' H ' ' A' ' 43' ' ' GLY . 5.6 mp -71.03 178.59 3.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.567 1.947 . . . . 0.0 110.71 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -58.6 4.31 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.854 -1.154 . . . . 0.0 111.569 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.74 -31.28 7.49 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.729 -1.595 . . . . 0.0 113.519 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.74 113.08 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.938 2.369 . . . . 0.0 109.46 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -98.4 -39.8 8.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.066 0.946 . . . . 0.0 111.894 -175.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.0 t -147.36 159.72 43.37 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.489 -0.757 . . . . 0.0 112.165 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -133.59 121.14 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.414 1.485 . . . . 0.0 109.214 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -110.14 177.43 4.71 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.248 1.419 . . . . 0.0 108.695 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.8 166.96 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 169.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 t -141.48 59.81 1.5 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.324 1.85 . . . . 0.0 110.378 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.31 -22.77 61.74 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.685 2.394 . . . . 0.0 115.664 -173.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -61.52 -35.76 78.62 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.691 1.132 . . . . 0.0 111.058 171.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -104.25 -2.27 25.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.252 1.421 . . . . 0.0 114.049 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.1 mttp 81.98 4.5 1.23 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.122 2.169 . . . . 0.0 112.37 173.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.26 155.16 16.99 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.902 2.081 . . . . 0.0 109.976 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.48 -179.71 4.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 165.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -145.52 105.11 3.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.444 -0.785 . . . . 0.0 111.686 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 p -101.7 132.14 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.432 0.634 . . . . 0.0 111.544 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.0 94.96 6.55 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.085 1.754 . . . . 0.0 109.832 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -120.16 148.98 42.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.007 0.923 . . . . 0.0 111.957 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -96.06 115.62 65.68 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.157 1.383 . . . . 0.0 108.832 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.97 -8.94 24.86 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.036 2.49 . . . . 0.0 113.186 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 t -77.86 -11.15 59.86 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.855 0.752 . . . . 0.0 112.23 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 66.0 m -130.27 -18.33 3.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.3 t -145.14 -177.68 5.67 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.899 1.227 . . . . 0.0 111.177 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 p -151.82 161.34 29.8 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 125.195 1.398 . . . . 0.0 109.352 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -50.09 -46.0 30.44 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.332 2.688 . . . . 0.0 114.228 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.0 p -67.84 -40.96 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 120.429 1.468 . . . . 0.0 111.763 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.23 90.2 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.917 0.887 . . . . 0.0 112.273 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.37 -47.0 58.98 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.976 0.51 . . . . 0.0 111.86 173.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -68.41 -41.52 80.3 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.37 -0.831 . . . . 0.0 112.549 -169.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -56.79 -30.71 63.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.466 0.706 . . . . 0.0 112.291 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.96 -55.59 7.19 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.107 0.867 . . . . 0.0 111.674 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 pt -64.93 -30.04 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -168.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -59.85 -34.48 73.17 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.88 13.0 30.23 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.1 mt -55.92 -56.03 34.89 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.937 168.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.423 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 86.5 Cg_endo -73.02 -179.98 4.83 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.872 3.048 . . . . 0.0 111.768 171.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.02 41.4 0.47 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.766 3.644 . . . . 0.0 111.989 168.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.47 27.13 64.06 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.849 1.214 . . . . 0.0 113.196 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -95.81 -40.62 9.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.272 1.036 . . . . 0.0 113.538 -168.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.423 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 24.7 m-85 -98.17 113.94 26.01 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.027 1.331 . . . . 0.0 108.182 173.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -97.38 164.02 12.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.19 0.596 . . . . 0.0 109.963 -174.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.99 141.56 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.123 0.969 . . . . 0.0 110.067 171.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.1 t -128.18 128.57 45.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.475 1.11 . . . . 0.0 112.59 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 127.69 2.396 . . . . 0.0 111.057 174.838 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 20.5 p -162.51 118.03 1.88 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.03 2.132 . . . . 0.0 110.92 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.0 p -141.91 142.56 33.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.577 1.951 . . . . 0.0 109.228 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.7 m -102.73 139.99 37.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.664 0.665 . . . . 0.0 109.454 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.43 161.85 35.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.397 0.679 . . . . 0.0 111.141 169.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 tt -114.03 132.38 56.02 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.316 1.847 . . . . 0.0 109.287 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mt -127.79 134.6 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.519 1.128 . . . . 0.0 110.083 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.75 127.71 43.9 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.109 1.363 . . . . 0.0 108.766 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.3 mt -129.43 145.88 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.248 -0.907 . . . . 0.0 112.101 -167.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -113.99 57.73 0.69 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.283 1.833 . . . . 0.0 112.277 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.73 53.27 0.44 Allowed Glycine 0 CA--C 1.524 0.642 0 O-C-N 121.553 -0.717 . . . . 0.0 113.842 168.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -138.2 98.97 3.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.417 1.487 . . . . 0.0 108.274 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.7 t -93.42 -31.37 14.64 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.228 1.411 . . . . 0.0 112.327 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 5.2 m -144.04 169.36 17.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.872 2.469 . . . . 0.0 110.594 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.94 71.46 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.231 -0.918 . . . . 0.0 112.512 172.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.0 p -50.44 -36.16 32.0 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.874 -1.141 . . . . 0.0 113.048 169.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.7 t -72.53 -34.96 67.93 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.257 1.423 . . . . 0.0 112.521 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.29 -52.58 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.915 0.886 . . . . 0.0 109.249 169.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -61.47 -23.27 65.76 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.1 t -70.69 -51.12 29.7 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.612 -0.68 . . . . 0.0 112.114 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 52.5 mt -63.4 -54.08 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 120.822 1.646 . . . . 0.0 111.055 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -59.26 -25.41 64.05 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.589 1.955 . . . . 0.0 110.918 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.8 -62.46 2.37 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.829 1.68 . . . . 0.0 114.056 168.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 89.8 mmm -70.56 -40.7 73.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.239 1.416 . . . . 0.0 113.817 -169.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.9 mm -70.67 -31.51 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.387 -0.821 . . . . 0.0 110.315 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.6 t -66.83 1.83 1.68 Allowed 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -87.13 -18.14 31.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.432 1.493 . . . . 0.0 114.09 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -102.6 165.85 10.85 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.972 1.26 . . . . 0.0 113.4 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -64.31 163.33 13.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.319 1.533 . . . . 0.0 113.779 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.87 -36.35 0.39 Allowed Glycine 0 CA--C 1.533 1.161 0 CA-C-O 117.847 -1.529 . . . . 0.0 115.283 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.0 p -70.42 93.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.493 1.647 . . . . 0.0 110.458 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -73.83 -45.55 50.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.98 1.712 . . . . 0.0 111.221 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -143.41 140.9 30.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.301 1.44 . . . . 0.0 108.299 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.9 tt -133.9 130.99 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.465 0.706 . . . . 0.0 110.822 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 43.2 m -131.88 104.2 6.74 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.825 1.25 . . . . 0.0 110.44 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.69 138.55 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.689 1.196 . . . . 0.0 111.737 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.0 m -133.85 142.74 47.94 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.747 1.261 . . . . 0.0 112.423 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.76 -15.67 59.69 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.613 1.965 . . . . 0.0 115.348 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.98 -46.03 71.56 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.312 1.445 . . . . 0.0 111.943 -174.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.7 -14.94 8.99 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.041 1.736 . . . . 0.0 110.897 172.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.17 39.67 7.82 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.881 1.229 . . . . 0.0 111.722 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.9 p -129.2 148.43 51.14 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.124 0.97 . . . . 0.0 113.015 -169.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -122.13 129.93 52.77 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.384 1.874 . . . . 0.0 111.777 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.2 t -103.72 122.76 45.74 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 167.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.99 137.5 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 122.018 -0.426 . . . . 0.0 110.748 -169.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.27 114.12 25.83 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.998 1.719 . . . . 0.0 107.935 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -114.4 155.98 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.882 0.873 . . . . 0.0 112.523 176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -96.48 110.42 52.73 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.883 0.873 . . . . 0.0 109.758 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.26 -14.23 20.65 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.941 2.427 . . . . 0.0 112.554 -171.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.47 -17.27 60.8 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.456 1.026 . . . . 0.0 112.951 170.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 99.1 t -117.49 -34.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.538 1.535 . . . . 0.0 113.078 -170.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.7 tt -145.71 154.04 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.446 1.021 . . . . 0.0 112.59 -174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.8 t -101.65 151.79 37.95 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 125.829 1.652 . . . . 0.0 111.7 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.37 -32.47 42.23 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.232 2.621 . . . . 0.0 114.112 168.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -73.82 -24.21 59.76 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.778 0.717 . . . . 0.0 111.645 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.72 -38.02 58.92 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.941 1.296 . . . . 0.0 111.441 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.7 mt -56.36 -55.5 32.73 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -52.35 -51.53 58.33 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.625 1.57 . . . . 0.0 111.29 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.15 -25.14 68.21 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.52 68.14 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.713 1.597 . . . . 0.0 111.769 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.36 -38.2 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.443 1.097 . . . . 0.0 111.045 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.29 -40.12 95.3 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.696 0.68 . . . . 0.0 111.271 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.4 -23.53 62.78 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.163 2.185 . . . . 0.0 113.022 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 26.4 ttt -76.42 -40.83 49.63 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.733 1.213 . . . . 0.0 110.875 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 125.39 34.47 0.66 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.994 1.283 . . . . 0.0 115.661 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -129.02 -153.51 0.57 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.628 1.571 . . . . 0.0 108.68 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.52 148.29 49.11 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.356 -0.84 . . . . 0.0 112.118 169.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -136.07 151.52 49.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.038 1.335 . . . . 0.0 112.368 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.2 t -140.24 122.92 16.32 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.005 1.322 . . . . 0.0 111.357 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.4 m -84.39 78.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.651 1.215 . . . . 0.0 110.54 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 CA--C 1.547 0.843 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.751 172.991 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -98.0 142.13 30.1 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.683 1.593 . . . . 0.0 110.601 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tt -143.63 148.06 35.27 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.156 1.782 . . . . 0.0 111.886 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -96.51 130.74 43.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.452 1.12 . . . . 0.0 111.829 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.08 140.72 31.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 113.46 -1.7 . . . . 0.0 111.332 169.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -99.43 121.42 41.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.29 136.09 23.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 170.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.85 144.82 27.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.543 1.137 . . . . 0.0 109.094 171.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.1 -2.64 64.65 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.887 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.404 ' C ' ' H ' ' A' ' 31' ' ' CYS . 6.4 tmm? -73.32 -63.83 1.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.612 1.165 . . . . 0.0 109.825 174.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.7 m80 58.47 -12.75 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.781 2.433 . . . . 0.0 115.528 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.404 ' H ' ' C ' ' A' ' 29' ' ' MET . 32.0 p -164.39 155.62 15.54 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.837 1.255 . . . . 0.0 112.251 -169.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -32.38 23.23 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 175.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 m -60.16 -35.57 75.61 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.863 -1.148 . . . . 0.0 112.439 -174.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.8 m -74.75 -18.05 60.55 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.82 -8.61 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -56.89 -62.77 1.51 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.797 1.18 . . . . 0.0 112.387 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -53.84 -34.4 59.17 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.612 -0.68 . . . . 0.0 111.294 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mt -63.39 -50.14 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 O-C-N 121.122 -0.986 . . . . 0.0 111.093 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -62.3 -32.48 73.23 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.289 0.95 . . . . 0.0 112.465 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -65.0 -54.59 28.04 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.541 1.064 . . . . 0.0 111.88 173.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -83.47 -33.75 25.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.185 1.394 . . . . 0.0 114.113 -170.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.1 mm -104.01 121.69 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 122.087 0.946 . . . . 0.0 110.47 -167.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.42 -28.55 5.0 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 125.807 1.67 . . . . 0.0 113.326 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -79.12 -0.55 32.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.619 -0.93 . . . . 0.0 112.692 174.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.39 -173.58 4.13 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.16 2.584 . . . . 0.0 112.756 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.02 -78.52 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.752 1.621 . . . . 0.0 111.932 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.61 -25.31 18.56 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.446 -1.752 . . . . 0.0 113.486 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -77.92 110.55 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 121.194 2.497 . . . . 0.0 107.819 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -104.41 -31.53 9.47 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.483 1.113 . . . . 0.0 112.137 -169.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 t -148.69 174.08 12.54 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 tp -144.79 136.78 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.83 1.652 . . . . 0.0 110.55 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -141.64 -178.08 5.48 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.675 1.19 . . . . 0.0 111.247 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.53 148.08 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 120.988 1.722 . . . . 0.0 114.581 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 m -130.36 57.88 1.7 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.657 1.583 . . . . 0.0 109.656 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.4 mt -64.93 -24.03 67.4 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.124 1.77 . . . . 0.0 115.333 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.77 -29.8 65.12 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.753 0.821 . . . . 0.0 111.963 170.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -120.7 13.05 11.54 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.817 1.647 . . . . 0.0 112.668 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 72.64 4.87 5.11 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.303 1.841 . . . . 0.0 115.298 168.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 p -96.47 152.74 18.33 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.604 1.192 . . . . 0.0 110.646 177.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.75 157.13 17.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 164.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.31 112.21 14.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.515 -0.741 . . . . 0.0 110.438 -168.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 p -96.74 136.15 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -117.83 82.9 1.9 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.535 1.534 . . . . 0.0 106.871 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -117.89 153.97 32.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.349 -170.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -97.1 109.42 49.26 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 127.332 2.253 . . . . 0.0 108.705 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.49 -3.15 10.47 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.339 2.693 . . . . 0.0 113.458 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.7 t -80.16 -18.77 48.82 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.39 0.995 . . . . 0.0 111.974 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 14.6 m -122.86 -16.03 7.23 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 t -146.3 -175.63 4.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.638 1.175 . . . . 0.0 111.409 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.7 m -153.87 156.34 32.0 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 126.567 1.947 . . . . 0.0 109.611 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -52.96 -56.9 2.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.26 2.64 . . . . 0.0 115.775 -169.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.16 -36.84 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 120.961 1.71 . . . . 0.0 112.711 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.84 -41.42 71.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.651 1.18 . . . . 0.0 112.256 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.94 -38.28 76.13 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.925 0.89 . . . . 0.0 111.279 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -69.78 -41.19 75.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.53 1.132 . . . . 0.0 111.848 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -50.18 -35.91 28.22 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.744 1.218 . . . . 0.0 113.13 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.17 -61.92 1.59 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.162 0.892 . . . . 0.0 112.198 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.4 pt -60.68 -21.22 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.937 1.695 . . . . 0.0 114.659 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.36 -25.39 65.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.345 1.458 . . . . 0.0 113.227 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -126.66 25.62 6.4 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.6 1.56 . . . . 0.0 113.397 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.3 tp -53.56 -55.62 33.18 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 127.248 2.219 . . . . 0.0 112.473 168.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -84.45 -179.5 3.89 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.189 3.259 . . . . 0.0 111.163 172.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.76 56.72 2.4 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.681 3.587 . . . . 0.0 111.855 168.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.14 15.92 65.97 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.197 1.38 . . . . 0.0 114.183 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -83.92 -34.01 24.59 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.953 0.876 . . . . 0.0 112.387 -168.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -121.56 129.77 53.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.04 2.136 . . . . 0.0 107.688 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -120.09 173.16 7.26 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.299 1.44 . . . . 0.0 110.309 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.06 131.48 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 119.964 1.256 . . . . 0.0 113.479 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -118.37 118.43 31.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.491 1.116 . . . . 0.0 110.617 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.958 1.303 . . . . 0.0 111.38 172.578 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 26.3 p -156.2 117.35 3.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.312 1.045 . . . . 0.0 113.358 -167.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.7 p -145.29 145.04 31.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.623 1.169 . . . . 0.0 111.381 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 88.3 m -96.98 140.91 30.8 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.41 149.98 36.95 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.418 1.087 . . . . 0.0 110.692 173.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tt -117.58 142.41 47.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.002 2.121 . . . . 0.0 110.331 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 mt -134.1 135.28 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.105 1.762 . . . . 0.0 110.754 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.88 128.57 45.96 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.769 1.628 . . . . 0.0 110.467 171.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.51 118.44 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 120.958 -1.089 . . . . 0.0 111.241 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.05 55.94 2.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.525 1.13 . . . . 0.0 110.917 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.54 53.29 0.32 Allowed Glycine 0 N--CA 1.462 0.415 0 C-N-CA 124.612 1.101 . . . . 0.0 111.139 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.8 mtm -145.36 145.6 31.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.676 0.79 . . . . 0.0 111.097 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.8 t -163.34 -43.94 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.425 0.69 . . . . 0.0 112.425 -168.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 83.5 m -114.26 152.03 31.95 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.393 1.477 . . . . 0.0 110.516 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.54 -25.53 68.09 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.872 -1.143 . . . . 0.0 113.14 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.7 p -59.18 -22.26 60.7 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.236 -1.54 . . . . 0.0 113.274 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 74.4 m -61.18 -30.22 70.28 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.754 -1.216 . . . . 0.0 112.052 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.73 -53.29 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.646 0.778 . . . . 0.0 109.914 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -65.27 -25.18 67.54 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.469 0.577 . . . . 0.0 111.847 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.5 m -70.58 -59.95 2.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.623 0.769 . . . . 0.0 111.943 170.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.1 mt -69.09 -42.28 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.056 1.342 . . . . 0.0 112.854 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -56.4 -34.28 66.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.358 0.663 . . . . 0.0 109.831 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.58 -34.31 67.45 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.037 -1.424 . . . . 0.0 114.088 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -47.42 72.52 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 121.244 2.522 . . . . 0.0 110.389 172.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 mm -75.52 -50.63 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.489 0.716 . . . . 0.0 112.192 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -71.32 -5.97 36.41 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.4 -1.438 . . . . 0.0 114.65 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -85.7 -21.7 28.19 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.24 -155.95 0.53 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -167.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -117.63 149.99 39.77 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.738 1.615 . . . . 0.0 111.816 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.56 18.91 59.34 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 117.638 -1.645 . . . . 0.0 114.584 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.0 p -112.03 97.22 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.844 2.058 . . . . 0.0 111.305 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.73 -47.56 8.15 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.195 -0.941 . . . . 0.0 112.53 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -142.48 145.58 33.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.607 1.163 . . . . 0.0 108.385 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.29 143.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 118.53 0.604 . . . . 0.0 111.036 167.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.5 t -140.37 149.75 43.07 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.049 2.14 . . . . 0.0 109.834 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.42 140.93 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.291 1.036 . . . . 0.0 111.329 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 67.2 m -121.87 77.69 1.39 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.116 2.167 . . . . 0.0 108.1 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.8 tt -53.59 -29.03 35.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.723 2.009 . . . . 0.0 112.383 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -41.48 -51.12 3.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.858 2.463 . . . . 0.0 112.882 167.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -90.43 -29.42 17.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.553 1.941 . . . . 0.0 111.125 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 93.09 27.93 12.77 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.143 1.83 . . . . 0.0 112.741 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.3 p -132.99 139.02 47.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.232 1.016 . . . . 0.0 112.457 -168.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.92 147.24 29.0 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.092 1.357 . . . . 0.0 111.113 173.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.2 t -131.29 133.89 45.83 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.509 1.124 . . . . 0.0 109.484 172.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.92 142.93 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.505 1.122 . . . . 0.0 110.927 -168.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.22 103.22 15.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.115 1.766 . . . . 0.0 106.773 169.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -108.9 156.66 19.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.002 0.921 . . . . 0.0 112.845 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -99.08 110.17 56.87 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.874 0.869 . . . . 0.0 111.148 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.08 -11.54 21.34 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.247 2.631 . . . . 0.0 113.761 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.89 -11.21 59.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.222 1.009 . . . . 0.0 113.356 171.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.3 t -120.09 -42.89 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.495 1.518 . . . . 0.0 111.895 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.1 tt -134.52 143.6 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 123.685 0.794 . . . . 0.0 111.596 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.9 t -97.11 151.49 37.73 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.404 1.082 . . . . 0.0 112.695 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.14 -28.96 53.74 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.729 2.286 . . . . 0.0 112.672 167.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -67.57 -30.82 70.54 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.414 -0.804 . . . . 0.0 112.857 173.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.08 -31.81 64.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.538 1.135 . . . . 0.0 112.044 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 63.0 mt -60.59 -53.39 58.09 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.082 0.953 . . . . 0.0 109.447 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -57.28 -49.21 76.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.857 0.863 . . . . 0.0 111.605 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.69 -27.59 66.56 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.63 -41.04 80.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.655 1.116 . . . . 0.0 112.073 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.69 -39.03 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.473 0.709 . . . . 0.0 110.835 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -65.3 -24.46 67.29 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.99 -21.55 59.95 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 172.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -50.06 9.21 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.185 0.594 . . . . 0.0 109.572 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 131.28 50.73 0.1 OUTLIER Glycine 0 N--CA 1.467 0.755 0 C-N-CA 124.658 1.123 . . . . 0.0 113.81 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -136.34 -167.18 2.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.326 1.85 . . . . 0.0 108.72 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -127.14 129.57 48.14 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 121.016 -1.053 . . . . 0.0 110.212 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -116.26 149.15 39.67 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.301 1.44 . . . . 0.0 109.472 172.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.3 t -140.66 133.67 29.3 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.34 1.056 . . . . 0.0 109.325 172.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 24.9 m -84.73 121.97 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.38 0.609 . . . . 0.0 109.432 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 126.171 1.788 . . . . 0.0 109.51 -172.627 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.0 m -120.46 151.36 39.44 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.475 1.11 . . . . 0.0 110.523 -171.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.96 176.42 8.95 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.182 0.993 . . . . 0.0 113.453 172.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -112.76 136.91 51.82 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.727 1.211 . . . . 0.0 113.093 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -147.17 142.43 27.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.636 168.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -104.77 111.98 24.92 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.914 1.286 . . . . 0.0 108.361 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 mt -85.12 139.43 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.657 0.783 . . . . 0.0 109.593 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.99 123.05 43.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.047 1.339 . . . . 0.0 111.304 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.14 -9.36 24.89 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.884 1.23 . . . . 0.0 114.886 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.2 ptp -57.35 -7.64 0.62 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -56.87 -24.65 53.13 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.828 -1.17 . . . . 0.0 112.839 168.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.8 m -97.38 119.18 35.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 167.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -58.04 -28.04 64.13 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.522 1.055 . . . . 0.0 113.454 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.6 p -53.13 -28.55 26.34 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 170.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.25 -51.52 68.59 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.877 0.762 . . . . 0.0 111.215 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -74.6 -27.64 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.54 -56.19 24.42 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.088 0.955 . . . . 0.0 111.847 -175.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -65.15 -33.94 77.2 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.732 -0.605 . . . . 0.0 112.285 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.3 mt -58.96 -47.95 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 118.885 0.766 . . . . 0.0 111.012 169.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -63.32 -33.8 76.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.578 1.151 . . . . 0.0 112.518 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -68.48 -41.37 80.22 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.34 -0.85 . . . . 0.0 112.295 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.62 -31.2 15.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -170.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.3 mm -96.35 119.14 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.78 1.173 . . . . 0.0 109.293 -171.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 132.54 -8.16 5.28 Favored Glycine 0 CA--C 1.541 1.719 0 C-N-CA 125.72 1.628 . . . . 0.0 113.626 -168.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -100.95 -13.88 18.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.502 1.921 . . . . 0.0 112.574 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.42 149.81 30.01 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.08 1.752 . . . . 0.0 111.539 -167.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.6 tp -17.46 -64.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.65 2.78 . . . . 0.0 114.411 170.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.29 19.1 13.4 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 116.333 -2.371 . . . . 0.0 115.868 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.3 t -115.47 118.19 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 121.683 2.742 . . . . 0.0 110.444 169.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -90.82 -40.54 11.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.777 0.831 . . . . 0.0 112.503 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.4 m -147.91 166.21 28.34 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.796 -1.19 . . . . 0.0 113.855 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.2 tp -126.82 145.67 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.996 1.318 . . . . 0.0 111.5 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -142.16 159.31 42.49 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.103 2.161 . . . . 0.0 109.774 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -140.71 144.29 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.338 -1.476 . . . . 0.0 112.206 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.0 m -138.77 58.32 1.66 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.184 1.394 . . . . 0.0 111.136 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.13 -30.14 69.09 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.817 2.047 . . . . 0.0 115.212 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -61.71 -20.36 63.4 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.654 1.116 . . . . 0.0 113.147 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -114.63 1.22 14.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.469 1.908 . . . . 0.0 112.303 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt 57.34 22.2 7.56 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.901 1.68 . . . . 0.0 112.876 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.77 153.13 18.06 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.343 1.068 . . . . 0.0 108.565 171.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.1 155.82 27.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 168.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.72 128.24 45.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -169.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -117.74 134.99 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 121.843 -0.535 . . . . 0.0 110.352 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -106.12 79.07 1.36 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -100.39 175.39 5.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.305 1.842 . . . . 0.0 109.53 -172.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.45 142.64 40.9 Favored Pre-proline 0 N--CA 1.477 0.89 0 CA-C-N 121.528 1.967 . . . . 0.0 111.501 168.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.89 5.67 6.28 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.972 2.448 . . . . 0.0 112.637 -172.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.2 t -87.39 -48.41 7.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.446 1.021 . . . . 0.0 110.168 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 85.1 m -101.3 -16.28 16.99 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.7 t -145.76 -178.35 6.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.381 1.072 . . . . 0.0 111.079 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 p -162.47 158.31 19.79 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.786 1.234 . . . . 0.0 111.83 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -46.79 -43.51 23.57 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.699 3.6 . . . . 0.0 116.368 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.8 m -70.64 -35.84 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.267 1.394 . . . . 0.0 112.388 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.42 85.45 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.153 0.981 . . . . 0.0 110.934 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.58 -48.2 73.16 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.257 1.023 . . . . 0.0 111.888 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -56.43 -52.06 66.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.121 0.873 . . . . 0.0 110.364 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -53.2 -42.95 66.79 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.649 1.18 . . . . 0.0 113.214 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.31 -59.24 2.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.602 1.161 . . . . 0.0 112.697 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 pt -71.94 -33.48 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -168.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -70.19 -12.01 61.29 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.26 0.624 . . . . 0.0 112.55 174.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.7 6.74 30.01 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.561 -1.337 . . . . 0.0 113.699 176.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt -56.42 -57.71 21.4 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.283 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.34 169.88 18.6 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.972 1.781 . . . . 0.0 110.459 168.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -76.21 55.65 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.269 3.313 . . . . 0.0 110.656 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.86 27.02 71.42 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.095 0.855 . . . . 0.0 113.898 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -100.46 -14.22 18.38 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 -167.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -135.26 114.03 11.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.051 1.34 . . . . 0.0 108.88 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -93.68 157.25 16.26 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.178 -0.951 . . . . 0.0 111.054 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.28 136.54 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 118.219 0.463 . . . . 0.0 111.859 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -111.38 121.54 45.49 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.195 0.998 . . . . 0.0 111.822 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.555 1.162 0 C-N-CA 128.241 2.617 . . . . 0.0 111.023 179.174 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.6 p -150.79 128.07 11.3 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.418 1.487 . . . . 0.0 113.609 -168.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.2 m -143.94 143.23 31.16 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.371 1.068 . . . . 0.0 111.649 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 84.8 m -100.2 144.31 29.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.546 0.738 . . . . 0.0 110.221 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.11 167.52 21.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.429 1.092 . . . . 0.0 110.903 166.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.04 133.45 55.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.457 1.903 . . . . 0.0 110.142 -176.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.7 mm -120.82 137.06 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.278 1.831 . . . . 0.0 109.306 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.03 125.44 48.72 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.957 1.303 . . . . 0.0 110.391 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.44 131.33 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.182 0.993 . . . . 0.0 111.52 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.44 53.68 0.87 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.815 1.646 . . . . 0.0 112.581 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.0 53.76 0.33 Allowed Glycine 0 N--CA 1.464 0.525 0 C-N-CA 124.926 1.251 . . . . 0.0 110.963 173.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.5 mtm -133.3 142.94 48.72 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.849 0.824 . . . . 0.0 112.01 -175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 t -165.28 124.62 1.76 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.495 1.918 . . . . 0.0 107.775 -172.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 72.31 160.8 0.23 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.542 1.937 . . . . 0.0 115.409 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.42 -32.58 67.02 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.31 170.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 p -65.76 -28.37 68.98 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.601 -1.312 . . . . 0.0 112.837 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 52.2 t -68.4 -46.17 70.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.028 1.285 . . . . 0.0 111.154 170.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.1 t -52.78 -55.42 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.143 0.429 . . . . 0.0 110.085 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -71.17 -17.41 62.54 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -176.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 m -74.58 -47.41 32.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.071 0.948 . . . . 0.0 111.492 167.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.8 -54.19 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.795 -1.191 . . . . 0.0 110.69 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -55.06 -30.68 60.12 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.82 2.048 . . . . 0.0 111.866 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.86 -51.17 8.07 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.874 1.702 . . . . 0.0 113.851 173.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 79.5 mmm -74.97 -53.87 8.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.5 1.52 . . . . 0.0 114.049 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.2 mm -71.24 -19.38 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.458 1.103 . . . . 0.0 112.437 -169.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 65.6 p -70.64 0.6 6.6 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 171.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -121.55 33.71 5.43 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.19 10.79 6.91 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.669 2.099 . . . . 0.0 116.669 -172.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 76.2 118.81 0.05 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.922 2.489 . . . . 0.0 113.968 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 97.12 21.74 19.52 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.106 -1.385 . . . . 0.0 114.398 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.34 94.94 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.181 2.192 . . . . 0.0 110.251 -178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -75.62 -56.53 4.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.032 0.933 . . . . 0.0 111.776 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -141.9 129.94 22.0 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.227 1.411 . . . . 0.0 109.007 -172.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -140.88 129.11 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.907 1.283 . . . . 0.0 110.517 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.2 t -142.23 129.65 21.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.21 1.004 . . . . 0.0 111.527 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.03 139.27 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.113 1.765 . . . . 0.0 110.522 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 74.5 p -143.3 146.3 33.46 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.5 mt -72.77 -24.27 60.92 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.63 -42.57 71.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.147 1.779 . . . . 0.0 113.535 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -111.09 -13.36 14.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.552 1.141 . . . . 0.0 110.409 168.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.57 49.7 7.08 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 125.453 1.501 . . . . 0.0 110.653 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.1 p -138.56 147.09 42.65 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -168.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -113.7 139.38 49.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.98 1.712 . . . . 0.0 112.297 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 7.5 t -112.25 125.62 54.35 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 166.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.59 134.74 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 122.153 -0.342 . . . . 0.0 110.852 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.93 113.77 25.53 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.768 2.427 . . . . 0.0 106.402 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -111.71 163.0 14.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.247 1.019 . . . . 0.0 112.95 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -97.11 98.1 4.37 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.417 1.887 . . . . 0.0 109.171 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.87 -12.13 33.66 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.137 1.891 . . . . 0.0 115.148 -169.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.36 -24.25 46.54 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.329 0.968 . . . . 0.0 112.447 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.8 t -95.7 -50.83 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.926 1.69 . . . . 0.0 111.046 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.33 149.5 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 122.095 0.95 . . . . 0.0 112.231 -170.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.5 t -97.68 143.43 26.2 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.673 1.589 . . . . 0.0 112.295 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.75 -16.12 51.93 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.62 2.214 . . . . 0.0 113.91 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -70.31 -27.36 64.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.696 1.134 . . . . 0.0 111.388 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -76.29 -20.29 57.47 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.764 2.026 . . . . 0.0 112.664 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 97.0 mt -67.37 -56.03 11.38 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.937 0.895 . . . . 0.0 111.32 -175.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -56.6 -38.33 71.87 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.788 -0.57 . . . . 0.0 112.406 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.86 -28.41 68.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.942 0.897 . . . . 0.0 112.974 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.37 69.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.462 1.028 . . . . 0.0 112.907 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.5 mp -72.48 -40.47 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.078 0.951 . . . . 0.0 110.867 171.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.14 -26.34 65.73 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.806 -0.559 . . . . 0.0 112.173 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.73 -26.75 62.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.503 1.521 . . . . 0.0 112.396 169.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 23.1 ttt -75.19 -38.32 60.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.225 1.01 . . . . 0.0 111.75 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.04 11.4 1.06 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.179 1.371 . . . . 0.0 116.338 172.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -111.11 -165.64 1.01 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.459 1.504 . . . . 0.0 110.049 -176.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -125.19 133.47 52.74 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.367 1.067 . . . . 0.0 111.364 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -136.43 143.8 44.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.991 1.316 . . . . 0.0 112.52 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -129.57 139.72 51.41 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.139 1.376 . . . . 0.0 109.036 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.2 p -87.89 111.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 125.491 1.517 . . . . 0.0 107.787 -173.39 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 120.658 0.266 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -95.71 151.82 19.02 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.424 1.489 . . . . 0.0 111.11 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -137.47 128.38 27.31 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 127.03 2.132 . . . . 0.0 109.012 -172.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -103.89 115.54 30.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.088 0.858 . . . . 0.0 112.01 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.83 142.08 44.78 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -109.14 107.36 17.63 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.709 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mm -80.0 152.25 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.966 1.706 . . . . 0.0 111.415 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -105.18 140.37 38.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.383 1.473 . . . . 0.0 110.283 168.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.65 -8.96 76.49 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.908 1.242 . . . . 0.0 114.142 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 ptm -66.26 -6.32 13.45 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.284 1.542 . . . . 0.0 115.153 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.13 -24.08 66.94 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.169 -0.957 . . . . 0.0 110.834 165.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -99.5 114.91 28.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.577 1.551 . . . . 0.0 107.466 167.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -59.09 -30.78 68.34 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.633 -1.292 . . . . 0.0 112.213 -173.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.4 m -51.31 -21.91 2.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.641 1.576 . . . . 0.0 114.227 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.7 t -58.59 -49.36 77.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.618 1.167 . . . . 0.0 112.804 170.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -73.85 -28.22 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.49 -47.96 83.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.491 1.116 . . . . 0.0 111.468 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -41.59 76.66 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.505 -0.747 . . . . 0.0 111.309 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.4 mt -65.6 -47.03 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 122.947 0.499 . . . . 0.0 109.912 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -65.9 -29.64 70.1 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.423 1.489 . . . . 0.0 113.32 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.56 -52.09 24.02 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.829 -0.544 . . . . 0.0 112.401 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -91.63 -7.95 48.57 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -166.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.6 mm -122.48 128.62 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.089 1.356 . . . . 0.0 108.504 172.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.76 -5.33 4.05 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.94 1.257 . . . . 0.0 115.397 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -114.98 -5.47 12.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.394 1.477 . . . . 0.0 112.976 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.34 152.14 44.47 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.916 1.287 . . . . 0.0 111.605 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -48.29 -30.7 5.08 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.86 7.72 27.6 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 116.548 -2.251 . . . . 0.0 115.67 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.87 116.67 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 121.466 2.633 . . . . 0.0 110.414 169.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -71.89 -51.28 23.05 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.631 0.372 . . . . 0.0 110.203 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 p -151.08 155.23 38.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.542 1.137 . . . . 0.0 113.149 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.7 tp -98.26 155.07 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.083 1.353 . . . . 0.0 109.199 169.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -138.26 144.63 40.62 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.53 1.059 . . . . 0.0 111.117 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.9 t -108.38 127.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.315 1.446 . . . . 0.0 108.842 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.9 m -133.82 54.28 1.96 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.512 0.672 . . . . 0.0 111.967 -172.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.3 mt -68.66 -25.99 65.09 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.413 -1.429 . . . . 0.0 113.35 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -74.17 -17.65 60.88 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 171.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -95.7 -8.17 35.38 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.101 1.361 . . . . 0.0 110.81 168.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 mptt 74.89 14.2 3.28 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.975 2.51 . . . . 0.0 113.004 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.7 p -124.16 175.23 7.15 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.285 2.234 . . . . 0.0 110.331 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.96 167.58 10.14 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.035 1.334 . . . . 0.0 107.981 165.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -140.62 143.35 35.15 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.717 0.407 . . . . 0.0 110.932 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 p -140.31 133.48 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.545 0.611 . . . . 0.0 111.511 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.39 81.44 2.53 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.993 1.717 . . . . 0.0 108.519 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -101.32 148.82 24.69 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.103 1.361 . . . . 0.0 111.825 -174.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.26 122.09 49.55 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.719 0.808 . . . . 0.0 110.482 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -60.28 0.47 0.7 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 124.659 3.573 . . . . 0.0 115.252 173.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.4 m -65.39 -35.0 79.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.527 1.531 . . . . 0.0 112.79 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 81.7 m -122.32 -23.06 5.36 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -170.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -143.07 -178.24 5.74 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.213 1.405 . . . . 0.0 111.181 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.9 t -163.17 143.39 7.07 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.429 1.892 . . . . 0.0 109.344 -171.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -40.57 -49.31 4.16 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 125.007 3.804 . . . . 0.0 117.263 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.6 m -70.0 -36.65 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.327 1.421 . . . . 0.0 113.362 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.34 -36.31 66.14 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.242 1.017 . . . . 0.0 110.839 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -67.61 -48.87 65.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.733 2.013 . . . . 0.0 110.787 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -53.25 -52.97 57.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.3 1.04 . . . . 0.0 110.836 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -57.84 -38.67 76.05 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.341 1.057 . . . . 0.0 112.493 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.1 -43.51 74.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.581 0.752 . . . . 0.0 112.776 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.2 pt -74.56 -37.42 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.91 -33.64 75.75 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -171.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.37 12.93 23.1 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.2 mt -53.61 -47.58 96.04 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.194 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.45 169.93 16.55 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.289 2.659 . . . . 0.0 112.566 171.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.88 64.2 7.62 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 124.893 3.729 . . . . 0.0 110.037 169.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.57 23.48 72.13 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.324 1.44 . . . . 0.0 114.602 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -94.46 -30.81 14.25 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -167.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -122.2 115.96 23.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.706 1.202 . . . . 0.0 108.893 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.79 157.09 16.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.082 0.953 . . . . 0.0 111.842 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.5 t -112.01 137.92 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.725 0.81 . . . . 0.0 110.478 167.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.4 m -113.29 129.61 56.48 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.113 0.565 . . . . 0.0 111.042 166.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 127.512 2.325 . . . . 0.0 112.398 -179.839 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.732 0.301 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 11.9 p 178.44 139.08 0.09 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.176 1.79 . . . . 0.0 113.269 -171.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 p -147.61 143.5 27.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.841 1.656 . . . . 0.0 111.515 168.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.78 147.26 24.57 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 120.058 1.299 . . . . 0.0 111.982 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.26 165.21 28.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.257 1.423 . . . . 0.0 113.127 173.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.17 135.36 46.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.683 1.993 . . . . 0.0 111.345 173.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.9 mm -120.34 136.12 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.716 1.206 . . . . 0.0 107.994 168.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.15 136.14 39.53 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.5 mt -130.07 142.21 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.707 -1.246 . . . . 0.0 110.884 -168.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.4 61.56 1.6 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.125 1.77 . . . . 0.0 112.939 -174.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.08 49.2 0.19 Allowed Glycine 0 N--CA 1.466 0.687 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.01 164.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 77.1 mtm -117.22 143.87 45.41 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.256 1.027 . . . . 0.0 111.505 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.0 t -159.82 127.45 4.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 127.185 2.194 . . . . 0.0 106.156 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 2.3 t 74.8 148.13 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.902 1.681 . . . . 0.0 113.034 -175.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.44 -29.6 49.94 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.453 -0.779 . . . . 0.0 112.29 171.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.9 p -61.93 -34.14 75.55 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.733 -1.23 . . . . 0.0 112.512 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 30.4 t -68.32 -37.56 80.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.305 1.411 . . . . 0.0 112.181 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 t -58.05 -56.52 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 118.883 -0.579 . . . . 0.0 109.888 169.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -62.95 -23.3 67.33 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.977 0.808 . . . . 0.0 112.798 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 m -70.33 -55.33 9.42 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.715 1.206 . . . . 0.0 111.966 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.86 -48.74 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 119.47 1.032 . . . . 0.0 110.837 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -60.42 -25.27 65.82 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.362 2.265 . . . . 0.0 111.844 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.5 -58.25 3.64 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 127.547 2.498 . . . . 0.0 114.094 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 21.5 mmt -71.73 -53.29 13.93 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.398 1.479 . . . . 0.0 113.204 -169.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.5 mm -66.0 -30.06 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.892 -0.505 . . . . 0.0 110.618 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.0 t -57.12 -19.71 21.52 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -96.69 17.38 16.61 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -167.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.89 169.59 9.74 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.476 1.51 . . . . 0.0 110.55 169.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -64.32 163.35 13.15 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.935 1.35 . . . . 0.0 114.501 -171.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.07 -32.21 1.31 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.62 1.581 . . . . 0.0 116.788 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.9 p -78.0 97.6 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 119.968 1.884 . . . . 0.0 112.935 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -76.66 -39.27 52.75 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.982 1.313 . . . . 0.0 112.84 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -144.58 140.75 28.97 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.33 1.052 . . . . 0.0 110.099 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -144.96 129.85 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 119.306 0.957 . . . . 0.0 111.571 172.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.19 124.6 20.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.699 1.2 . . . . 0.0 110.677 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.6 t -126.53 149.64 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 120.616 -1.302 . . . . 0.0 110.279 -169.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.7 t -142.94 145.47 33.05 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.185 0.993 . . . . 0.0 112.943 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.01 -18.33 61.97 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.525 1.93 . . . . 0.0 114.362 171.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.88 -48.24 67.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.227 1.411 . . . . 0.0 111.949 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -108.7 -17.47 13.94 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.27 1.828 . . . . 0.0 111.949 170.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.73 50.97 5.03 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.084 1.326 . . . . 0.0 111.622 -171.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 43.0 p -138.79 147.68 42.87 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.397 1.099 . . . . 0.0 113.677 -169.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -111.2 134.89 52.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.213 1.805 . . . . 0.0 111.402 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.1 t -109.07 118.37 36.59 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.5 138.21 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -167.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.8 118.73 33.88 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.079 2.152 . . . . 0.0 108.1 175.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -119.08 158.42 25.89 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.649 1.179 . . . . 0.0 112.45 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -95.69 115.06 65.22 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.066 1.346 . . . . 0.0 108.568 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.59 -6.7 17.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.41 2.74 . . . . 0.0 113.798 -170.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.06 -45.59 10.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.077 0.951 . . . . 0.0 112.007 169.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 72.2 t -83.38 -28.57 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.343 1.457 . . . . 0.0 112.52 -171.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 tt -147.27 144.87 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.517 1.127 . . . . 0.0 110.558 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.3 m -106.42 147.94 35.83 Favored Pre-proline 0 CA--C 1.551 1.002 0 O-C-N 121.244 -0.91 . . . . 0.0 111.319 173.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -53.53 -32.49 63.77 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.712 3.608 . . . . 0.0 116.177 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.53 -27.73 64.79 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.47 -32.99 66.68 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 112.241 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 65.6 mt -59.09 -50.47 73.93 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.616 1.166 . . . . 0.0 108.977 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -54.23 -48.35 71.19 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.95 1.3 . . . . 0.0 111.86 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.6 -30.48 71.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.71 -32.83 71.62 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.087 0.955 . . . . 0.0 112.938 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.6 mt -74.55 -32.9 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.195 0.998 . . . . 0.0 112.093 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -68.25 -34.13 75.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.899 0.772 . . . . 0.0 111.525 168.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.33 -30.01 70.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.429 1.091 . . . . 0.0 112.445 171.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.4 ttt -75.4 -28.73 59.57 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.351 -0.843 . . . . 0.0 112.491 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 116.82 30.56 1.95 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.648 1.594 . . . . 0.0 115.32 169.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -125.66 -156.88 0.76 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.466 1.507 . . . . 0.0 109.379 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -133.68 147.14 51.37 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.998 -1.064 . . . . 0.0 111.118 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.42 136.35 34.59 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.119 1.368 . . . . 0.0 112.592 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -114.45 125.91 54.36 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.344 1.858 . . . . 0.0 110.231 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.84 59.78 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.482 1.134 . . . . 0.0 109.759 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.014 0.925 . . . . 0.0 111.857 -169.782 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 122.084 0.945 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 m -109.21 135.1 50.87 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.846 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.288 0.1 OUTLIER -134.5 160.08 39.13 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.326 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -120.05 134.79 55.15 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.529 2.332 . . . . 0.0 108.563 -171.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 pp -146.49 160.52 42.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -102.04 155.64 18.05 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.67 1.188 . . . . 0.0 110.439 168.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.9 mt -135.16 141.29 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 126.658 1.983 . . . . 0.0 110.822 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -97.22 129.9 44.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.366 1.466 . . . . 0.0 109.195 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.24 -19.65 50.49 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.181 1.372 . . . . 0.0 113.627 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -14.01 56.46 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.426 1.613 . . . . 0.0 113.224 174.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -49.37 -37.45 24.98 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.766 1.627 . . . . 0.0 111.859 166.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 93.1 m -78.76 -1.11 33.13 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 71.25 -60.21 0.52 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 129.162 2.985 . . . . 0.0 112.19 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -53.03 -27.57 20.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.91 1.684 . . . . 0.0 114.551 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -46.68 -37.85 8.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.909 1.684 . . . . 0.0 112.985 169.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -19.07 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -69.67 -54.09 15.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 112.143 -171.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.2 -28.59 69.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.311 1.044 . . . . 0.0 111.894 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.3 mt -65.5 -56.08 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 118.895 0.77 . . . . 0.0 109.734 167.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -39.77 61.17 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.237 1.415 . . . . 0.0 112.506 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.28 -40.94 97.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.347 0.659 . . . . 0.0 112.554 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -90.82 -28.44 18.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.594 1.158 . . . . 0.0 113.209 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.3 mm -97.46 117.49 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.149 -0.969 . . . . 0.0 109.235 -173.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.64 -17.17 7.35 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.031 1.3 . . . . 0.0 115.648 -172.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -96.49 0.74 50.7 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.506 1.153 . . . . 0.0 113.228 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.4 mt -92.08 154.63 18.61 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.676 1.59 . . . . 0.0 113.081 -169.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -51.27 -34.18 31.73 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.59 4.87 31.06 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.715 -1.603 . . . . 0.0 115.845 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.3 t -134.32 119.62 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 120.905 2.353 . . . . 0.0 109.73 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 -26.81 13.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -169.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.3 p -149.11 173.18 13.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.69 1.196 . . . . 0.0 111.17 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 tp -138.78 145.95 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.054 0.942 . . . . 0.0 110.082 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -134.78 148.17 50.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.353 1.461 . . . . 0.0 108.394 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.92 150.62 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.624 -1.297 . . . . 0.0 110.762 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.2 t -141.45 58.36 1.51 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 122.881 1.324 . . . . 0.0 110.405 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.2 mt -69.83 -26.98 64.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.56 1.544 . . . . 0.0 113.641 -169.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.48 -24.02 63.72 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.34 1.456 . . . . 0.0 113.206 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -91.25 -25.11 19.64 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.751 1.62 . . . . 0.0 111.429 169.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 98.21 3.93 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.037 1 C-N-CA 132.577 4.351 . . . . 0.0 111.961 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.3 p -107.61 166.99 10.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.855 1.262 . . . . 0.0 112.578 -172.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.42 145.0 39.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.189 0.995 . . . . 0.0 108.534 167.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -124.82 106.31 9.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.806 1.242 . . . . 0.0 110.695 -169.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.3 143.53 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-O 121.188 0.518 . . . . 0.0 111.826 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -114.43 90.36 3.32 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.858 2.063 . . . . 0.0 107.235 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -115.62 154.42 29.49 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -166.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.22 117.51 65.57 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.848 2.059 . . . . 0.0 109.286 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.65 5.6 2.38 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.368 2.712 . . . . 0.0 114.672 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 p -84.81 -30.26 24.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.694 1.198 . . . . 0.0 113.585 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 64.1 m -113.43 -21.89 10.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.439 1.095 . . . . 0.0 113.63 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.9 t -144.41 179.81 7.02 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 122.067 0.937 . . . . 0.0 111.943 -169.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.8 p -166.03 164.7 11.21 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.878 2.071 . . . . 0.0 109.476 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.86 -49.25 16.53 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.334 2.689 . . . . 0.0 114.546 -174.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.33 -38.22 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.13 75.09 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.588 -0.695 . . . . 0.0 111.442 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.6 mt -58.8 -53.34 59.46 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.561 1.544 . . . . 0.0 110.408 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -50.8 -53.26 33.48 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.652 1.181 . . . . 0.0 110.758 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -25.76 64.58 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.6 -60.28 2.31 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.166 1.348 . . . . 0.0 111.349 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.9 pt -72.23 -32.22 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.84 -19.42 65.87 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.06 0.845 . . . . 0.0 112.92 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.37 10.42 39.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.1 mt -60.22 -50.56 85.45 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.76 165.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.05 172.79 12.58 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.084 2.522 . . . . 0.0 112.071 171.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.78 65.47 7.59 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 124.609 3.54 . . . . 0.0 110.627 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.7 33.15 81.36 Favored Glycine 0 N--CA 1.473 1.154 0 O-C-N 121.246 -0.909 . . . . 0.0 112.95 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -107.05 -19.49 13.6 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -166.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -130.47 105.85 8.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.293 1.437 . . . . 0.0 108.603 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -99.07 136.11 39.52 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.913 1.285 . . . . 0.0 112.372 -169.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 m -99.17 156.72 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.735 1.152 . . . . 0.0 112.737 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.6 m -134.72 116.93 15.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.44 1.096 . . . . 0.0 110.159 167.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 126.896 2.078 . . . . 0.0 110.594 -178.226 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 27.6 p -144.21 145.69 32.23 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -168.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.7 t -146.43 160.0 42.66 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.543 1.937 . . . . 0.0 109.407 167.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.55 138.12 54.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.289 0.636 . . . . 0.0 109.659 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.78 160.0 41.17 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.955 0.798 . . . . 0.0 112.778 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 tt -116.26 140.41 49.35 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.752 1.621 . . . . 0.0 110.248 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 mm -127.34 139.85 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 127.647 2.379 . . . . 0.0 108.777 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -104.57 133.58 49.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.913 1.285 . . . . 0.0 110.261 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.27 137.67 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 120.533 -1.354 . . . . 0.0 110.913 -173.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.45 58.55 1.13 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.314 1.845 . . . . 0.0 111.554 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.34 55.86 0.24 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 125.222 1.391 . . . . 0.0 111.183 168.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 64.7 mtm -131.94 111.57 11.67 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.738 1.215 . . . . 0.0 109.495 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.9 t -116.0 -12.17 11.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.241 1.816 . . . . 0.0 112.989 -169.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 52.7 m -156.04 161.5 40.43 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.773 2.429 . . . . 0.0 110.398 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.64 -31.06 65.9 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.864 -1.147 . . . . 0.0 113.947 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 17.0 p -53.65 -22.26 8.47 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.364 1.466 . . . . 0.0 114.626 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 75.4 m -56.15 -36.75 68.65 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.37 -0.831 . . . . 0.0 111.97 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.83 -53.43 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.793 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -69.14 -24.04 64.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.093 0.86 . . . . 0.0 111.55 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.1 m -72.54 -51.75 18.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.323 1.449 . . . . 0.0 111.598 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.5 mt -68.87 -55.45 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 121.008 -1.057 . . . . 0.0 111.296 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -55.13 -30.73 60.39 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.704 1.202 . . . . 0.0 111.059 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.17 -62.12 2.68 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.021 1.296 . . . . 0.0 114.505 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 94.2 mmm -71.31 -38.21 71.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -169.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.1 mm -72.53 -23.95 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.056 0.542 . . . . 0.0 111.353 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.6 t -67.22 1.69 1.99 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -106.23 -3.54 21.19 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -169.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.12 17.08 24.71 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.69 2.108 . . . . 0.0 116.69 -168.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 77.76 160.59 0.21 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 127.456 2.303 . . . . 0.0 112.663 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.73 -24.46 0.29 Allowed Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.48 -1.388 . . . . 0.0 115.811 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.85 96.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 127.79 2.436 . . . . 0.0 111.165 172.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -79.74 -47.43 15.29 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.779 0.832 . . . . 0.0 111.946 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -143.97 137.07 27.49 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.688 0.795 . . . . 0.0 110.414 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.36 134.39 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.849 -1.157 . . . . 0.0 110.933 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 30.0 t -139.24 141.39 37.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.881 1.672 . . . . 0.0 109.205 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.27 142.68 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.706 1.202 . . . . 0.0 112.015 -176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.0 t -140.58 139.23 34.91 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.441 1.096 . . . . 0.0 112.736 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.08 -17.18 62.01 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.266 1.826 . . . . 0.0 115.44 174.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.26 -42.54 77.55 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.021 1.328 . . . . 0.0 112.836 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -113.17 -8.39 13.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.749 1.619 . . . . 0.0 111.355 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 76.45 48.39 9.29 Favored Glycine 0 C--N 1.343 0.949 0 C-N-CA 125.289 1.423 . . . . 0.0 112.619 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 p -141.14 146.42 37.0 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -167.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -115.22 150.93 35.37 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.175 1.79 . . . . 0.0 111.844 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.7 t -125.11 130.03 51.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.479 1.512 . . . . 0.0 108.695 169.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.75 136.85 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.741 -0.599 . . . . 0.0 111.211 -169.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.57 112.96 24.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.876 2.471 . . . . 0.0 106.628 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -118.97 158.98 24.69 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.628 1.171 . . . . 0.0 112.506 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -93.46 112.94 58.72 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.773 1.229 . . . . 0.0 108.18 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.51 -11.17 18.85 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.218 2.612 . . . . 0.0 113.005 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.07 -45.97 31.46 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.851 1.205 . . . . 0.0 110.7 168.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 69.8 t -79.5 -42.43 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.369 1.467 . . . . 0.0 113.431 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.4 tt -140.35 150.44 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.211 0.914 . . . . 0.0 113.254 -169.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 60.0 m -112.76 150.71 43.19 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.285 1.434 . . . . 0.0 112.005 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.69 -41.16 38.35 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.424 3.416 . . . . 0.0 115.009 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.43 -20.27 65.42 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.36 -31.91 60.68 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.104 1.362 . . . . 0.0 113.735 170.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 73.5 mt -60.0 -50.73 72.59 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.033 0.933 . . . . 0.0 108.876 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -51.69 -51.01 59.28 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.195 0.998 . . . . 0.0 111.522 173.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.2 -31.67 65.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.14 -38.98 69.1 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.155 0.982 . . . . 0.0 113.265 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.1 mp -70.24 -35.53 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.55 -0.718 . . . . 0.0 110.498 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.0 -36.19 83.19 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.881 -0.512 . . . . 0.0 111.739 172.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -71.89 -29.5 64.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.155 1.782 . . . . 0.0 113.797 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 18.1 ttt -65.92 -30.17 70.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.322 1.049 . . . . 0.0 111.953 172.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 124.3 13.8 3.83 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.943 1.735 . . . . 0.0 115.362 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -119.75 -156.46 0.66 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.158 1.383 . . . . 0.0 109.568 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -136.06 137.47 41.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.928 1.291 . . . . 0.0 109.009 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -131.75 156.21 46.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.065 1.346 . . . . 0.0 111.627 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.1 t -141.96 140.57 32.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.27 1.828 . . . . 0.0 109.218 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.4 m -96.05 121.56 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.452 -0.78 . . . . 0.0 110.059 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 123.327 1.537 . . . . 0.0 110.829 -177.307 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.69 153.03 18.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.237 1.415 . . . . 0.0 110.53 171.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tt -145.64 135.5 23.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.733 1.613 . . . . 0.0 110.88 -172.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -98.27 123.54 42.41 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.793 -0.567 . . . . 0.0 111.596 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.47 138.67 27.81 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.334 1.054 . . . . 0.0 113.593 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -97.64 123.8 41.68 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.9 mt -95.37 138.63 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.417 1.487 . . . . 0.0 107.631 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -95.54 142.78 27.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.548 1.139 . . . . 0.0 110.598 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.94 -4.73 83.36 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.661 1.124 . . . . 0.0 113.953 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.7 ptp -68.44 0.09 4.37 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -63.94 -13.77 48.49 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.543 1.065 . . . . 0.0 113.213 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.9 t -105.33 125.33 50.86 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.239 1.381 . . . . 0.0 107.795 165.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.73 -31.16 47.27 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.838 1.255 . . . . 0.0 114.021 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.7 m -63.34 -21.87 66.53 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.042 -1.036 . . . . 0.0 113.079 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 63.5 m -71.86 -47.21 54.57 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.095 0.861 . . . . 0.0 111.881 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.4 -23.09 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.108 0.867 . . . . 0.0 112.427 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.8 -61.35 2.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.123 0.969 . . . . 0.0 111.854 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.03 -26.4 68.22 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.532 -0.73 . . . . 0.0 112.824 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mt -65.93 -53.07 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 120.506 -1.371 . . . . 0.0 110.521 169.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.86 -30.07 69.9 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.836 1.255 . . . . 0.0 112.305 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.0 -39.78 75.67 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.008 -1.057 . . . . 0.0 112.546 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -93.69 -19.92 20.64 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 mm -102.81 123.6 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 122.314 1.054 . . . . 0.0 111.55 -172.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.37 -10.09 2.97 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.105 1.812 . . . . 0.0 114.57 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -109.5 4.55 22.42 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.839 1.656 . . . . 0.0 113.101 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.13 176.39 8.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.394 1.078 . . . . 0.0 112.216 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.7 tp -38.24 -64.2 0.43 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.325 2.25 . . . . 0.0 114.058 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.7 -12.83 7.66 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 117.073 -1.959 . . . . 0.0 115.643 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.34 112.72 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-N 121.57 2.685 . . . . 0.0 109.438 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -95.32 -35.45 11.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.073 1.349 . . . . 0.0 112.099 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 t -145.18 169.57 17.92 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.853 0.835 . . . . 0.0 112.523 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.3 tp -138.16 144.83 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.115 1.766 . . . . 0.0 108.96 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -142.63 157.93 44.18 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.083 1.753 . . . . 0.0 108.784 -172.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 m -127.53 138.69 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 120.348 -1.47 . . . . 0.0 111.931 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.2 m -124.48 56.52 1.28 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.746 1.619 . . . . 0.0 107.855 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -65.36 -30.69 71.55 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.56 -16.91 62.33 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -95.1 -5.67 43.73 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.314 1.445 . . . . 0.0 111.726 169.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt 73.39 7.38 5.18 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.022 2.529 . . . . 0.0 112.214 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.9 p -110.94 167.07 10.52 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.022 2.129 . . . . 0.0 110.787 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.97 -179.7 4.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.067 165.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -143.86 133.22 23.27 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.175 -0.953 . . . . 0.0 109.594 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.94 137.36 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.38 0.991 . . . . 0.0 111.387 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -114.71 87.11 2.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.666 1.586 . . . . 0.0 108.37 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -119.65 155.12 32.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.768 1.227 . . . . 0.0 113.478 -171.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -96.57 113.27 62.33 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.617 1.967 . . . . 0.0 109.375 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.62 -6.89 20.1 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.353 2.702 . . . . 0.0 112.88 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 t -86.08 -5.98 59.11 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.268 1.027 . . . . 0.0 111.988 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 94.2 m -119.03 -42.4 2.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.257 1.423 . . . . 0.0 113.464 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -128.51 -176.31 3.79 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.672 1.589 . . . . 0.0 110.232 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.94 154.2 18.15 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.24 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.05 -56.88 2.4 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.069 3.179 . . . . 0.0 116.21 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.7 -36.05 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 121.059 1.754 . . . . 0.0 113.438 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.43 -41.12 61.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.222 1.009 . . . . 0.0 111.909 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -36.17 74.44 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.719 1.208 . . . . 0.0 110.886 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.416 HE21 ' HB ' ' A' ' 88' ' ' VAL . 66.0 tt0 -66.89 -47.69 71.04 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.365 -0.834 . . . . 0.0 111.327 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.6 mtt85 -59.65 -28.86 67.61 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.343 1.057 . . . . 0.0 112.937 172.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.71 -56.06 12.26 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.069 0.85 . . . . 0.0 111.51 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 pt -72.47 -33.47 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -68.77 -17.99 64.13 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.35 8.13 44.94 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 120.691 -1.256 . . . . 0.0 113.977 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.5 mt -59.36 -51.06 84.11 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.018 166.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.15 173.73 12.26 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.026 2.484 . . . . 0.0 111.1 168.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -75.18 52.1 3.03 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.418 3.412 . . . . 0.0 111.486 169.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.64 37.64 92.63 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 124.803 1.192 . . . . 0.0 112.09 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -102.26 -46.45 4.81 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -168.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -97.72 101.02 12.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.229 1.412 . . . . 0.0 107.402 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -99.72 144.4 28.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -167.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.416 ' HB ' HE21 ' A' ' 75' ' ' GLN . 3.5 t -103.0 138.56 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.722 0.809 . . . . 0.0 111.744 -172.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -133.55 121.1 21.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.549 1.14 . . . . 0.0 112.121 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.549 0.91 0 C-N-CA 126.223 1.809 . . . . 0.0 112.254 173.234 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 95.3 m -143.02 136.02 28.0 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.366 1.466 . . . . 0.0 112.541 -174.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.8 t -143.97 154.89 43.77 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.403 1.881 . . . . 0.0 109.229 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.4 m -114.53 141.16 48.09 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.634 0.652 . . . . 0.0 110.051 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.12 157.35 44.99 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.519 0.676 . . . . 0.0 112.415 168.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.32 136.36 41.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.357 1.863 . . . . 0.0 110.029 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.7 mt -127.92 133.68 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.717 1.607 . . . . 0.0 109.06 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.68 143.05 30.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.434 1.094 . . . . 0.0 109.842 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.04 131.8 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 119.395 0.998 . . . . 0.0 112.024 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.3 80.72 1.99 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.474 1.51 . . . . 0.0 111.998 173.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 178.49 55.01 0.07 OUTLIER Glycine 0 N--CA 1.467 0.766 0 C-N-CA 124.543 1.068 . . . . 0.0 113.996 165.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -137.41 145.47 43.24 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.4 t -151.72 -28.2 0.18 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.623 1.969 . . . . 0.0 112.387 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 77.4 m -125.76 136.73 53.49 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.968 1.707 . . . . 0.0 111.637 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.65 -27.38 6.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.517 1.527 . . . . 0.0 114.529 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.7 p -55.53 -31.64 62.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.14 1.376 . . . . 0.0 113.241 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 t -62.04 -19.44 62.89 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.95 -59.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.636 -0.665 . . . . 0.0 109.972 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -22.37 66.71 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 118.434 0.561 . . . . 0.0 112.155 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.0 m -72.24 -60.49 2.21 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.981 1.313 . . . . 0.0 112.893 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 94.4 mt -67.13 -54.48 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 120.362 1.437 . . . . 0.0 110.583 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.28 -29.96 67.95 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.792 1.237 . . . . 0.0 111.304 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.63 -62.57 2.66 Favored Glycine 0 C--N 1.343 0.948 0 C-N-CA 124.226 0.917 . . . . 0.0 113.998 173.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 82.1 mmm -70.03 -36.26 74.92 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -168.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.0 mm -68.02 -31.55 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 118.317 0.508 . . . . 0.0 110.659 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -66.11 -0.42 2.45 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -92.59 -7.38 47.27 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.389 -1.444 . . . . 0.0 113.915 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 pp -99.91 170.18 8.7 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.723 1.209 . . . . 0.0 112.046 171.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -79.05 166.34 22.42 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.76 -34.3 0.6 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.779 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.31 91.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 119.448 1.624 . . . . 0.0 110.601 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -72.71 -45.67 57.59 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.114 1.366 . . . . 0.0 111.819 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -143.3 143.49 31.72 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.455 0.702 . . . . 0.0 109.175 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -142.06 138.68 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 0.0 110.462 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 67.6 m -138.52 108.67 6.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.847 1.259 . . . . 0.0 109.701 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.71 133.9 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.728 -1.232 . . . . 0.0 110.519 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.2 t -119.71 93.33 4.03 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.142 2.177 . . . . 0.0 107.457 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.0 tt -66.83 -29.23 69.1 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.013 0.925 . . . . 0.0 110.597 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -49.6 -39.82 36.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.366 2.266 . . . . 0.0 113.629 167.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -100.26 -13.29 18.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.614 1.966 . . . . 0.0 112.123 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.76 26.93 73.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 127.735 2.588 . . . . 0.0 113.344 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.0 p -129.28 143.25 50.78 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.662 1.231 . . . . 0.0 114.27 -168.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.2 131.33 51.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.47 1.508 . . . . 0.0 109.505 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.9 t -113.55 124.09 51.55 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.66 139.83 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -165.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.25 111.22 23.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.68 2.392 . . . . 0.0 107.422 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -120.62 156.12 32.33 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.602 1.161 . . . . 0.0 112.685 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -98.6 109.8 54.43 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.695 1.198 . . . . 0.0 111.014 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.58 -13.43 30.02 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.206 2.604 . . . . 0.0 112.616 -172.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.36 -13.84 58.83 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.463 1.028 . . . . 0.0 113.719 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.3 t -118.63 -33.85 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.91 1.284 . . . . 0.0 112.481 -170.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.27 151.17 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.851 1.26 . . . . 0.0 110.504 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.5 t -104.7 144.17 28.19 Favored Pre-proline 0 N--CA 1.477 0.894 0 O-C-N 120.951 -1.093 . . . . 0.0 110.978 169.365 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.69 -27.86 27.77 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.698 2.932 . . . . 0.0 114.358 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -70.43 -41.73 72.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.534 0.606 . . . . 0.0 111.386 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.57 -28.05 58.83 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 170.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.49 -55.16 38.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.598 1.559 . . . . 0.0 110.4 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.08 -30.36 70.95 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.402 -0.811 . . . . 0.0 112.533 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.85 -16.12 63.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.08 62.16 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.361 0.982 . . . . 0.0 112.232 171.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.5 mp -71.84 -33.73 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.027 0.931 . . . . 0.0 110.461 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -66.37 -31.04 71.56 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.939 0.791 . . . . 0.0 112.084 170.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -70.86 -29.96 66.22 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 120.593 -1.317 . . . . 0.0 112.137 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 10.6 ttt -71.85 -27.44 62.89 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.679 1.192 . . . . 0.0 111.725 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 124.23 14.2 3.74 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.362 1.934 . . . . 0.0 116.886 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -128.03 147.09 50.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.828 1.314 . . . . 0.0 111.046 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -95.17 101.01 12.73 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 123.414 1.578 . . . . 0.0 110.525 -170.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -98.42 143.99 28.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 112.54 -2.118 . . . . 0.0 111.529 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.4 t -141.28 132.22 26.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.538 1.535 . . . . 0.0 111.812 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.8 m -86.04 72.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.329 1.052 . . . . 0.0 110.533 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.477 0.882 0 C-N-CA 124.2 1.0 . . . . 0.0 111.375 178.677 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 p -96.65 146.02 25.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.56 1.544 . . . . 0.0 112.192 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.95 126.44 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.935 1.694 . . . . 0.0 109.654 174.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.19 131.69 45.05 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.807 1.243 . . . . 0.0 110.192 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 155.48 43.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.977 169.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.91 129.66 46.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.704 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 mt -104.27 147.04 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.835 1.254 . . . . 0.0 110.923 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -96.18 140.33 31.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.956 2.102 . . . . 0.0 110.575 174.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.8 -8.13 73.8 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.641 1.115 . . . . 0.0 113.696 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 13.2 ptp -66.08 -13.25 59.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -54.23 -32.12 55.11 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.145 0.884 . . . . 0.0 111.85 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.61 -17.45 62.89 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm 76.31 -57.17 0.56 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.76 2.824 . . . . 0.0 112.394 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.4 p -53.79 -23.04 10.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.906 1.282 . . . . 0.0 113.822 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.5 t -47.17 -46.92 24.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.147 1.779 . . . . 0.0 111.949 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.17 -17.57 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.19 -56.25 10.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.464 1.106 . . . . 0.0 110.339 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -36.87 73.61 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.688 -0.632 . . . . 0.0 111.434 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mt -62.28 -48.19 89.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.525 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.17 -36.14 76.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.865 1.266 . . . . 0.0 112.849 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -64.95 -40.4 94.97 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.33 -0.856 . . . . 0.0 112.351 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -91.45 -35.58 14.26 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -172.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.5 mm -99.28 113.28 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.417 1.008 . . . . 0.0 110.686 -168.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.96 -21.68 0.89 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.477 1.037 . . . . 0.0 115.136 -170.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -108.92 -5.09 16.28 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.362 1.081 . . . . 0.0 113.34 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.72 153.12 43.82 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.992 1.717 . . . . 0.0 111.069 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.8 tp -11.12 -69.88 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 128.827 2.851 . . . . 0.0 114.642 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.48 9.76 22.01 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 115.734 -2.704 . . . . 0.0 117.469 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.42 130.62 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 123.117 3.459 . . . . 0.0 108.434 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -100.13 -43.69 6.24 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.174 0.59 . . . . 0.0 111.261 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 p -148.98 164.02 35.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.479 1.112 . . . . 0.0 113.028 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 tp -120.82 149.76 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.177 1.391 . . . . 0.0 111.625 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -142.64 154.4 44.33 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.259 1.824 . . . . 0.0 110.157 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.4 t -133.12 137.68 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 120.793 -1.192 . . . . 0.0 110.446 -171.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.461 ' HB3' ' HG1' ' A' ' 59' ' ' THR . 8.1 t -134.35 55.26 1.9 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.542 1.537 . . . . 0.0 109.435 175.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -33.36 74.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.91 1.684 . . . . 0.0 112.952 -169.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -47.89 -34.95 9.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.766 2.026 . . . . 0.0 112.504 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -116.53 23.22 12.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.023 1.329 . . . . 0.0 112.497 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.5 mttp 67.37 9.7 7.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.287 2.635 . . . . 0.0 115.481 169.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.461 ' HG1' ' HB3' ' A' ' 54' ' ' SER . 2.5 p -107.96 145.36 33.95 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.72 1.208 . . . . 0.0 112.44 -176.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.19 157.93 16.94 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.613 1.165 . . . . 0.0 108.764 167.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -139.81 118.46 12.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.487 0.315 . . . . 0.0 110.263 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.8 p -114.24 132.55 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.782 -0.574 . . . . 0.0 111.11 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.11 93.4 5.7 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.595 1.158 . . . . 0.0 109.008 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -118.19 152.44 35.66 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.353 1.061 . . . . 0.0 112.45 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -100.33 114.98 65.89 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.715 1.606 . . . . 0.0 109.829 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.67 5.69 3.21 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.359 3.372 . . . . 0.0 113.955 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 t -68.0 -34.79 77.19 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.026 0.93 . . . . 0.0 111.444 171.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 74.9 m -114.94 -25.42 8.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -168.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -144.4 -178.38 5.95 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.929 1.291 . . . . 0.0 111.839 -173.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.6 p -152.6 161.06 30.25 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.57 1.548 . . . . 0.0 111.919 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.72 -46.46 24.26 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.547 2.831 . . . . 0.0 115.137 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.3 m -70.21 -33.52 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.208 1.367 . . . . 0.0 113.262 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.86 -38.0 79.47 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.6 -0.688 . . . . 0.0 111.419 175.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.36 -44.09 79.85 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.335 1.054 . . . . 0.0 111.409 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -53.66 -55.66 24.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.303 1.041 . . . . 0.0 110.557 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -52.79 -48.34 66.94 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.52 0.728 . . . . 0.0 112.714 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.36 -58.44 8.59 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.608 0.763 . . . . 0.0 111.935 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.8 pt -74.31 -31.13 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.65 -39.12 67.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.483 1.113 . . . . 0.0 112.533 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.23 23.08 9.62 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.0 mt -60.16 -55.41 45.64 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.483 164.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.77 170.9 17.61 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.696 2.931 . . . . 0.0 112.163 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.59 35.79 0.33 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 125.03 3.82 . . . . 0.0 112.903 171.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.28 28.02 34.8 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.191 1.377 . . . . 0.0 113.115 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -104.02 -42.74 5.47 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -168.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -96.35 117.07 30.08 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 16.1 ttmm -102.16 135.51 43.62 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.363 1.865 . . . . 0.0 111.733 -173.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.66 150.25 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.868 1.213 . . . . 0.0 111.675 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.1 t -134.13 107.98 8.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.235 1.414 . . . . 0.0 110.067 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.549 0.905 0 CA-C-N 114.482 -1.235 . . . . 0.0 113.113 -174.744 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 29.1 p -155.75 142.48 18.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.502 1.121 . . . . 0.0 112.544 -175.609 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.8 t -142.9 160.17 40.84 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.948 1.699 . . . . 0.0 109.547 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 98.4 m -113.07 143.55 44.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.783 0.833 . . . . 0.0 109.484 171.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.71 165.29 27.89 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.687 0.795 . . . . 0.0 111.457 167.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -119.87 130.33 54.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.858 1.663 . . . . 0.0 110.048 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.47 140.88 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 126.292 1.837 . . . . 0.0 108.694 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.22 132.24 52.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.723 1.609 . . . . 0.0 109.952 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.86 136.79 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.214 1.006 . . . . 0.0 110.3 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.79 57.91 1.43 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.994 1.718 . . . . 0.0 112.715 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.58 52.23 0.31 Allowed Glycine 0 N--CA 1.467 0.739 0 C-N-CA 124.387 0.994 . . . . 0.0 112.533 168.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 68.0 mtm -131.71 150.86 52.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.471 1.108 . . . . 0.0 110.862 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.8 t -157.39 -30.46 0.08 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.039 1.336 . . . . 0.0 111.877 -168.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 64.7 m -128.28 140.7 51.74 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.036 1.734 . . . . 0.0 111.948 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -48.58 -33.86 10.51 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.162 1.785 . . . . 0.0 114.246 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.9 p -50.35 -32.29 16.92 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.422 1.089 . . . . 0.0 113.754 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 11.5 t -61.36 -21.87 64.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.3 t -59.5 -60.23 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 119.423 1.011 . . . . 0.0 109.54 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -62.48 -27.74 69.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.029 0.532 . . . . 0.0 111.772 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.7 m -71.71 -46.8 57.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.75 0.82 . . . . 0.0 113.139 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 79.3 mt -68.06 -54.37 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.986 1.266 . . . . 0.0 110.081 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -52.31 -31.8 34.75 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.624 1.57 . . . . 0.0 112.03 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.14 -61.87 2.57 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.632 1.587 . . . . 0.0 115.694 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 92.9 mmm -73.38 -35.1 65.87 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.5 mm -71.29 -29.07 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 121.778 -0.576 . . . . 0.0 111.272 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.6 t -56.57 -12.22 1.68 Allowed 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -84.42 -0.38 52.55 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 119.671 -1.893 . . . . 0.0 115.763 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 pp -116.54 8.46 13.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 -167.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 74.71 161.4 0.24 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.127 2.571 . . . . 0.0 115.707 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.25 -44.08 1.59 Allowed Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.345 -1.472 . . . . 0.0 113.22 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.11 97.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 127.295 2.238 . . . . 0.0 111.922 170.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.9 -61.58 1.79 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.472 1.109 . . . . 0.0 111.02 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -123.49 133.55 54.01 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.354 1.461 . . . . 0.0 108.495 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.5 tt -140.09 137.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.991 0.901 . . . . 0.0 110.799 -173.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.0 t -142.23 152.49 43.13 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.859 1.664 . . . . 0.0 109.991 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.58 139.07 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.439 1.096 . . . . 0.0 110.238 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 18.3 t -122.46 84.81 2.31 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.119 2.168 . . . . 0.0 108.708 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.7 -28.35 67.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.961 1.704 . . . . 0.0 111.519 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.2 -53.26 8.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.794 2.438 . . . . 0.0 112.887 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -95.16 -7.87 37.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.506 1.122 . . . . 0.0 111.707 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.55 42.13 64.21 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.059 1.79 . . . . 0.0 111.729 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.4 p -130.92 155.86 46.05 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.33 1.052 . . . . 0.0 111.51 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.29 129.93 38.25 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.525 1.13 . . . . 0.0 110.93 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.3 t -109.84 124.83 52.01 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.223 1.009 . . . . 0.0 108.962 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.76 138.58 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -169.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.43 114.49 26.16 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.897 2.479 . . . . 0.0 107.296 174.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -124.31 162.91 22.79 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.672 1.589 . . . . 0.0 112.022 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -96.79 112.62 60.96 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.259 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.13 -9.6 24.71 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.717 2.945 . . . . 0.0 115.456 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -88.36 -37.44 15.92 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.718 1.144 . . . . 0.0 112.084 169.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.65 -36.87 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.678 1.191 . . . . 0.0 112.209 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 tt -146.05 150.19 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 121.054 -1.029 . . . . 0.0 112.623 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.71 150.43 46.92 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.096 1.758 . . . . 0.0 110.535 -173.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.93 -37.56 67.21 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.398 2.732 . . . . 0.0 114.77 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.25 -27.68 68.14 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.56 -36.55 63.09 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.706 1.203 . . . . 0.0 112.149 172.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 91.0 mt -58.29 -52.93 63.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.775 0.83 . . . . 0.0 111.206 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -61.81 -38.74 89.24 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.13 -29.54 69.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.711 0.804 . . . . 0.0 112.469 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.44 -31.07 70.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.318 1.047 . . . . 0.0 113.045 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.26 -32.35 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.475 1.11 . . . . 0.0 111.362 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.06 -33.43 73.56 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.462 -0.774 . . . . 0.0 112.381 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -71.11 -30.42 66.5 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.842 0.746 . . . . 0.0 112.558 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 23.4 ttt -65.94 -43.3 88.44 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.123 0.969 . . . . 0.0 111.165 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 142.32 21.58 0.23 Allowed Glycine 0 CA--C 1.533 1.182 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 169.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -131.4 -155.16 0.67 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.111 1.365 . . . . 0.0 110.392 -171.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -129.44 140.57 51.27 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.426 1.491 . . . . 0.0 110.462 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.85 150.69 40.22 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.882 1.273 . . . . 0.0 114.404 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.7 t -141.8 146.95 36.51 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.252 1.421 . . . . 0.0 110.716 171.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.3 m -92.78 125.38 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.297 0.953 . . . . 0.0 109.665 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 124.384 2.04 . . . . 0.0 107.949 -177.305 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 121.47 0.652 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.9 m -99.01 164.4 12.19 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.782 1.633 . . . . 0.0 109.369 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.21 139.81 35.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.278 1.031 . . . . 0.0 110.315 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -98.51 123.85 42.9 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.753 0.787 . . . . 0.0 109.09 169.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.13 136.66 25.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.943 -1.48 . . . . 0.0 113.538 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -107.65 108.12 19.24 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.472 1.109 . . . . 0.0 110.053 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mt -92.99 145.74 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.678 1.591 . . . . 0.0 109.837 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.56 150.34 22.79 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.532 2.333 . . . . 0.0 111.29 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.98 -11.53 71.85 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.944 1.259 . . . . 0.0 114.348 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.7 ptp -70.29 -0.3 7.79 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.0 m170 -60.23 -23.96 64.48 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 120.315 1.416 . . . . 0.0 111.503 167.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.2 m -98.11 128.64 44.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.918 0.781 . . . . 0.0 110.377 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -56.49 -40.72 75.42 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.934 0.874 . . . . 0.0 112.392 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.8 p -59.39 -23.09 62.31 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.724 1.21 . . . . 0.0 113.907 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 74.8 m -72.97 -40.87 64.96 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.801 0.84 . . . . 0.0 112.149 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.2 p -74.59 -30.18 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -49.87 -60.74 2.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.266 1.426 . . . . 0.0 112.177 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.1 -24.15 66.02 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.304 -0.872 . . . . 0.0 113.266 -177.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 mt -70.5 -48.95 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.138 -0.976 . . . . 0.0 110.281 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -68.06 -26.43 65.85 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.345 1.058 . . . . 0.0 112.372 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.58 -39.26 88.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.764 1.225 . . . . 0.0 112.039 171.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -94.68 -23.92 17.38 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -172.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.3 mm -108.7 113.54 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.869 0.868 . . . . 0.0 109.981 -169.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.5 -14.76 4.47 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.076 1.322 . . . . 0.0 114.739 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -100.86 7.49 43.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.508 1.123 . . . . 0.0 113.326 174.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.0 mt -90.96 159.69 16.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.906 1.682 . . . . 0.0 112.932 -173.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.15 -23.7 62.4 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -171.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.99 3.79 6.39 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.181 -1.899 . . . . 0.0 115.067 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -113.68 117.47 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 121.105 2.452 . . . . 0.0 109.006 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -100.34 -29.72 12.26 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.7 m -147.59 158.61 44.07 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.681 -1.262 . . . . 0.0 112.955 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.1 tp -137.96 137.99 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.497 1.519 . . . . 0.0 109.707 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -141.02 159.58 41.9 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.883 2.073 . . . . 0.0 107.944 -171.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.19 152.34 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 120.627 -1.296 . . . . 0.0 110.79 168.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -125.54 56.22 1.38 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 168.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -28.14 68.59 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.386 1.875 . . . . 0.0 112.567 -168.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.16 -20.15 24.6 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 169.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -115.68 -2.89 12.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.349 2.26 . . . . 0.0 112.541 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt 73.27 15.67 4.31 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.144 2.178 . . . . 0.0 112.672 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.96 147.32 23.81 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.922 1.289 . . . . 0.0 109.1 170.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.04 158.08 16.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 166.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.73 116.86 15.38 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -168.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.91 133.58 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.836 -0.54 . . . . 0.0 110.883 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -107.61 96.21 6.23 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.02 2.128 . . . . 0.0 106.676 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -126.03 154.6 42.75 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.62 108.56 40.65 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 127.073 2.149 . . . . 0.0 107.192 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -71.26 1.73 5.12 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.672 2.914 . . . . 0.0 114.474 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 p -83.01 -23.82 33.11 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.927 1.291 . . . . 0.0 112.33 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 85.5 m -120.1 -18.38 8.11 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 t -147.88 -178.6 6.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.814 1.246 . . . . 0.0 111.422 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.8 m -168.35 161.47 8.97 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.923 1.689 . . . . 0.0 112.596 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.72 -52.9 7.95 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 124.199 3.266 . . . . 0.0 117.289 -168.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.19 -32.33 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 120.742 1.61 . . . . 0.0 113.083 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.53 -40.05 85.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.55 0.74 . . . . 0.0 111.381 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.83 -44.53 80.85 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.342 1.057 . . . . 0.0 111.875 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -55.36 -51.73 65.83 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.63 0.65 . . . . 0.0 110.019 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -67.78 -28.79 67.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.134 0.974 . . . . 0.0 113.299 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.37 -60.25 2.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.122 0.874 . . . . 0.0 111.308 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.2 pt -72.74 -32.92 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -169.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -66.12 -22.08 66.38 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.6 16.17 27.09 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.2 mt -62.31 -57.36 23.43 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.12 -1.419 . . . . 0.0 109.838 165.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.53 171.18 18.26 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.122 3.215 . . . . 0.0 111.963 172.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.96 45.72 2.07 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 124.045 3.163 . . . . 0.0 112.664 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.95 58.61 3.97 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -135.62 -25.07 1.31 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.09 98.0 5.87 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.279 1.399 . . . . 0.0 108.283 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -92.31 128.65 38.23 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.737 1.215 . . . . 0.0 110.94 -167.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.59 135.3 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.257 1.023 . . . . 0.0 112.063 -174.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.0 m -127.13 133.34 50.39 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.553 1.541 . . . . 0.0 111.347 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 124.736 1.214 . . . . 0.0 110.207 176.529 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 23.0 p -155.53 115.61 3.73 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -167.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.9 p -144.7 147.3 32.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.138 1.375 . . . . 0.0 111.209 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.2 m -98.79 141.49 31.52 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.493 -0.755 . . . . 0.0 110.204 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.31 164.12 31.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 112.04 169.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.44 133.95 54.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.715 2.006 . . . . 0.0 109.531 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.4 mm -119.82 133.26 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.297 1.039 . . . . 0.0 108.662 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.53 128.91 45.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.438 1.095 . . . . 0.0 109.001 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 89.9 mt -129.69 136.08 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.195 -0.941 . . . . 0.0 110.529 -169.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -119.68 56.89 0.93 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.752 1.621 . . . . 0.0 111.849 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.57 51.81 0.35 Allowed Glycine 0 N--CA 1.462 0.389 0 O-C-N 121.865 -0.522 . . . . 0.0 112.746 169.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 72.0 mtm -128.86 119.3 24.19 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.587 0.755 . . . . 0.0 109.189 171.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.92 -41.15 5.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.62 1.968 . . . . 0.0 110.34 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 86.7 m -134.32 157.66 45.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.308 1.843 . . . . 0.0 110.733 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.47 -28.49 65.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.99 -36.66 18.13 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.1 -1.0 . . . . 0.0 111.938 169.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 62.5 m -61.27 -42.66 99.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.485 1.114 . . . . 0.0 113.266 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.09 -54.98 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -66.98 -28.86 68.6 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.6 m -65.63 -52.62 50.45 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.077 1.351 . . . . 0.0 112.074 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.95 -51.08 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.03 -1.044 . . . . 0.0 110.547 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -52.81 -34.79 55.29 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.205 1.802 . . . . 0.0 110.86 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.31 -61.33 3.45 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.125 1.345 . . . . 0.0 113.306 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.7 mmt -63.51 -41.3 98.52 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.479 1.112 . . . . 0.0 112.799 -171.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.5 mm -70.86 -35.86 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 117.759 0.254 . . . . 0.0 110.901 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -63.18 -9.2 10.11 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -77.08 -18.84 57.73 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.224 -1.548 . . . . 0.0 114.086 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -99.63 164.98 11.83 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.144 1.338 . . . . 0.0 113.514 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -76.29 151.34 36.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.04 -25.72 6.66 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.838 1.208 . . . . 0.0 113.978 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.58 96.25 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.263 1.531 . . . . 0.0 109.955 169.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -74.47 -47.17 34.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.396 1.478 . . . . 0.0 111.806 -173.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -144.05 135.82 26.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.471 1.908 . . . . 0.0 108.669 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 tt -140.13 135.66 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.778 1.172 . . . . 0.0 111.34 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.3 t -140.61 126.09 18.91 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.018 1.327 . . . . 0.0 111.487 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 t -126.11 147.58 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 O-C-N 120.695 -1.253 . . . . 0.0 111.285 -169.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.4 t -140.77 144.31 35.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.954 0.883 . . . . 0.0 112.939 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.8 -20.22 62.61 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.798 1.639 . . . . 0.0 115.019 174.396 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.44 -35.6 52.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.395 1.478 . . . . 0.0 113.595 -172.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -125.25 -10.93 6.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.79 1.636 . . . . 0.0 112.382 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.33 47.97 6.63 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.235 1.398 . . . . 0.0 111.365 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.4 p -139.03 144.39 38.82 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -168.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.57 142.58 35.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.414 1.885 . . . . 0.0 111.361 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.0 t -116.94 124.87 50.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.84 142.1 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 122.955 0.502 . . . . 0.0 111.841 -168.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.35 109.42 21.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.65 1.98 . . . . 0.0 107.097 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -106.08 156.06 18.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.042 0.937 . . . . 0.0 111.969 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -95.33 109.63 46.16 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.271 1.028 . . . . 0.0 108.531 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.67 -12.69 18.28 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.763 2.308 . . . . 0.0 112.518 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.04 -36.49 40.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.165 0.986 . . . . 0.0 112.306 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.24 -34.11 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.682 1.193 . . . . 0.0 113.893 -170.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 18.2 tt -137.16 152.99 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.118 1.326 . . . . 0.0 112.19 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 m -99.84 141.09 22.14 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.358 1.463 . . . . 0.0 110.892 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -51.46 -35.72 56.27 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.445 2.764 . . . . 0.0 114.412 172.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -62.49 -28.45 69.84 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -71.93 -33.68 68.45 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.896 -1.127 . . . . 0.0 111.802 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 70.0 mt -59.94 -58.82 6.91 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.407 0.683 . . . . 0.0 109.899 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -61.35 -37.66 84.13 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.009 -0.432 . . . . 0.0 112.025 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.47 -30.14 71.04 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.83 -31.52 68.28 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.18 0.9 . . . . 0.0 112.376 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.7 mp -71.72 -39.82 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.267 1.027 . . . . 0.0 111.177 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.89 -35.37 79.83 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.007 0.523 . . . . 0.0 111.869 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.92 -23.38 61.46 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.486 1.514 . . . . 0.0 113.958 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 26.2 ttt -74.7 -46.82 35.19 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.313 -0.867 . . . . 0.0 110.946 176.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.96 42.99 0.09 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.064 1.316 . . . . 0.0 115.373 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -143.66 -159.16 0.95 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.867 1.667 . . . . 0.0 109.68 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.6 142.04 50.82 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.12 1.368 . . . . 0.0 110.163 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -140.67 147.5 39.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.5 1.92 . . . . 0.0 112.504 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.3 t -138.62 134.19 33.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.632 1.573 . . . . 0.0 111.966 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.4 m -83.92 78.26 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.116 0.96 . . . . 0.0 110.444 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.475 0.806 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.441 174.629 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.81 97.06 10.76 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 166.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.571 HD13 ' H ' ' A' ' 23' ' ' GLN . 4.5 tp -112.16 165.43 12.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.102 1.361 . . . . 0.0 107.902 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.571 ' H ' HD13 ' A' ' 22' ' ' LEU . 2.7 pt20 -147.0 161.97 39.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 119.774 -1.829 . . . . 0.0 114.078 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -140.72 150.41 43.41 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.941 1.697 . . . . 0.0 109.652 168.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -98.7 103.35 15.3 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 mm -76.37 146.77 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.475 1.51 . . . . 0.0 110.539 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -98.91 137.22 37.78 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.984 2.114 . . . . 0.0 110.968 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.44 -9.46 75.46 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.106 1.336 . . . . 0.0 113.697 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.94 -6.16 7.79 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -60.16 -27.11 66.83 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.945 1.248 . . . . 0.0 110.758 165.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.1 t -88.58 119.62 29.2 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 166.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -58.92 -33.48 70.61 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.352 -0.843 . . . . 0.0 111.685 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 m -54.89 -31.0 59.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.733 1.213 . . . . 0.0 112.822 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.6 m -72.2 -40.48 67.83 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.974 1.309 . . . . 0.0 112.774 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.7 p -76.31 -31.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.86 -55.14 36.04 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.585 1.154 . . . . 0.0 112.235 -175.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -59.97 -31.3 69.76 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.535 -0.728 . . . . 0.0 112.594 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mt -64.01 -47.76 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.403 -0.811 . . . . 0.0 109.995 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.99 -25.93 68.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.686 1.594 . . . . 0.0 113.795 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.64 -37.46 59.66 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.753 -1.217 . . . . 0.0 113.862 170.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -91.13 -35.11 14.76 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 39.5 mm -95.88 112.17 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 120.818 -1.176 . . . . 0.0 107.968 -170.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.59 -15.26 3.62 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.378 0.989 . . . . 0.0 115.285 -168.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -104.32 11.58 34.58 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.589 1.194 . . . . 0.0 113.029 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.9 mt -96.88 149.72 21.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.391 1.476 . . . . 0.0 113.143 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.2 tp -32.21 -58.73 0.31 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.16 2.184 . . . . 0.0 114.016 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.86 19.01 31.05 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.181 -1.9 . . . . 0.0 115.704 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -138.1 109.58 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.084 2.442 . . . . 0.0 108.873 168.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.66 -16.12 15.08 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.5 t -146.1 168.08 21.82 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.016 1.326 . . . . 0.0 110.875 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.0 tp -143.51 146.51 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.292 1.037 . . . . 0.0 111.64 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -144.16 157.92 44.02 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.5 1.52 . . . . 0.0 109.825 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.79 156.47 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 O-C-N 119.801 -1.812 . . . . 0.0 112.564 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 t -136.22 56.21 1.82 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.249 1.82 . . . . 0.0 108.04 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.03 -23.03 66.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.583 1.153 . . . . 0.0 112.908 -170.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -66.13 -14.79 62.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.942 1.297 . . . . 0.0 113.76 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -126.12 11.46 7.62 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.274 2.23 . . . . 0.0 112.5 169.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 71.16 7.33 6.12 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.765 2.026 . . . . 0.0 115.382 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.32 157.74 15.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.808 1.243 . . . . 0.0 110.412 172.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.83 144.11 47.52 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.987 1.315 . . . . 0.0 109.426 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -112.29 119.17 37.4 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -170.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.35 140.75 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 120.924 -1.11 . . . . 0.0 108.089 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -110.09 82.97 1.68 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.757 1.223 . . . . 0.0 107.752 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -106.0 152.1 23.78 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -169.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.81 103.02 16.84 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.708 2.003 . . . . 0.0 110.113 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.94 0.74 1.86 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.705 2.937 . . . . 0.0 114.944 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 98.5 p -74.91 -15.65 60.69 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.887 -1.133 . . . . 0.0 113.226 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.3 m -137.09 -24.44 1.1 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -171.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 t -144.53 178.16 8.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.355 1.462 . . . . 0.0 111.374 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.3 p -148.18 158.56 41.29 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.825 1.25 . . . . 0.0 113.008 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.7 -52.31 7.18 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.661 2.907 . . . . 0.0 114.648 -170.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.3 m -62.96 -30.16 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.879 1.218 . . . . 0.0 113.516 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.65 -46.48 58.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.474 0.71 . . . . 0.0 111.257 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.9 mt -58.2 -42.52 86.33 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.646 0.778 . . . . 0.0 111.482 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -57.57 -37.99 74.06 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.167 0.587 . . . . 0.0 111.638 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -72.2 -40.28 67.98 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.433 1.015 . . . . 0.0 112.626 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.51 -60.2 4.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.033 0.933 . . . . 0.0 112.411 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.1 pt -70.53 -28.59 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -168.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -69.98 -12.99 62.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.615 1.566 . . . . 0.0 113.326 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.0 6.43 29.06 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -55.7 -49.83 90.56 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 117.307 -1.33 . . . . 0.0 110.985 166.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.62 172.08 17.0 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.298 2.665 . . . . 0.0 111.311 168.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.47 44.35 1.22 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.323 3.349 . . . . 0.0 111.64 170.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.28 30.54 41.12 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.101 1.334 . . . . 0.0 113.746 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -95.1 -47.99 6.14 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.65 1.225 . . . . 0.0 112.22 -169.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -100.58 123.37 44.7 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.127 1.371 . . . . 0.0 109.025 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -101.46 165.48 11.23 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.051 0.94 . . . . 0.0 111.888 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.01 139.47 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.503 0.721 . . . . 0.0 111.802 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 m -110.92 134.88 52.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.656 1.183 . . . . 0.0 110.949 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.542 0.67 0 C-N-CA 126.862 2.065 . . . . 0.0 111.169 177.986 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 21.8 p -125.38 152.14 45.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.404 1.882 . . . . 0.0 113.148 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.0 t -140.6 149.95 42.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.791 2.036 . . . . 0.0 107.395 167.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m -99.88 142.05 31.87 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.15 0.5 . . . . 0.0 110.819 -170.234 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.25 145.25 31.92 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.596 0.758 . . . . 0.0 110.394 169.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tt -114.69 137.83 51.44 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.676 1.99 . . . . 0.0 108.346 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.9 mt -133.36 138.4 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.622 1.569 . . . . 0.0 109.768 -168.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.33 130.87 45.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.246 1.818 . . . . 0.0 109.296 172.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mp -126.38 122.43 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.274 -0.892 . . . . 0.0 111.855 -171.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.48 61.47 3.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.212 1.805 . . . . 0.0 111.24 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.59 54.96 0.27 Allowed Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.628 169.454 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 73.8 mtm -138.78 121.09 15.93 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.628 0.771 . . . . 0.0 110.57 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 t -125.25 -30.19 3.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.747 1.619 . . . . 0.0 112.513 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 11.8 m -147.74 163.49 36.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.682 1.993 . . . . 0.0 111.057 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.3 -30.51 70.54 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -172.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.2 m -57.53 -20.94 34.98 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.763 -1.21 . . . . 0.0 112.933 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 93.0 m -63.06 -44.1 96.75 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.931 -1.105 . . . . 0.0 112.286 168.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.66 -54.43 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -65.73 -24.5 66.98 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 117.998 0.363 . . . . 0.0 111.741 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 m -70.84 -53.11 16.44 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.747 -1.22 . . . . 0.0 111.792 170.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.1 -50.41 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.507 -1.371 . . . . 0.0 110.696 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.19 -33.01 68.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.808 2.043 . . . . 0.0 111.494 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.5 -61.89 2.85 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.856 1.217 . . . . 0.0 113.913 174.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -44.83 67.73 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.75 1.22 . . . . 0.0 112.844 -169.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.4 mm -70.74 -21.0 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.543 -0.723 . . . . 0.0 111.502 -173.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.4 -2.91 18.12 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 169.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -80.96 -13.77 58.59 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 119.591 -1.943 . . . . 0.0 115.403 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.25 -177.17 4.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.218 1.407 . . . . 0.0 113.445 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.99 137.18 32.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.134 0.974 . . . . 0.0 111.49 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.03 41.45 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 117.658 -1.634 . . . . 0.0 115.894 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.9 p -120.93 93.6 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.802 1.801 . . . . 0.0 110.863 -175.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -49.76 28.98 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.669 1.188 . . . . 0.0 110.122 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -147.31 142.72 27.45 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.751 1.221 . . . . 0.0 110.505 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 9.2 tt -135.83 140.51 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 119.426 1.012 . . . . 0.0 110.452 169.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 12.5 t -140.16 145.26 37.28 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.898 1.679 . . . . 0.0 109.667 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.3 t -141.01 146.4 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.659 1.118 . . . . 0.0 110.579 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 77.4 p -142.45 132.71 24.78 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.147 -0.971 . . . . 0.0 113.17 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -19.64 63.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.514 1.526 . . . . 0.0 112.614 171.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -48.88 -52.84 22.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.997 1.319 . . . . 0.0 111.64 170.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -96.23 -25.07 15.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.894 1.278 . . . . 0.0 112.321 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.76 25.53 55.99 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.791 1.186 . . . . 0.0 112.319 -170.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 p -136.02 147.12 47.81 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.526 1.163 . . . . 0.0 113.813 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -99.63 145.67 27.33 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.847 1.659 . . . . 0.0 110.366 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.9 t -127.95 129.36 46.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.647 0.779 . . . . 0.0 109.257 168.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.8 140.81 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 123.572 0.749 . . . . 0.0 111.181 -168.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.15 107.02 18.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.08 1.752 . . . . 0.0 106.947 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -101.79 157.04 17.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.423 0.689 . . . . 0.0 111.633 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -95.98 111.71 57.05 Favored Pre-proline 0 CA--C 1.542 0.673 0 O-C-N 121.242 -0.911 . . . . 0.0 110.285 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.95 -10.52 23.07 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.468 2.112 . . . . 0.0 112.823 -170.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.41 -8.64 59.76 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.143 0.977 . . . . 0.0 113.168 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 73.5 t -120.93 -42.25 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.994 1.318 . . . . 0.0 111.972 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.2 tt -143.39 165.09 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.212 1.005 . . . . 0.0 111.507 -170.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.46 154.01 72.45 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.0 1.72 . . . . 0.0 110.947 -175.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.19 -44.82 36.5 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.025 3.15 . . . . 0.0 114.962 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.53 -19.54 62.89 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.39 -0.819 . . . . 0.0 113.11 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -73.85 -29.14 61.95 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.844 -1.16 . . . . 0.0 111.944 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.75 -51.3 67.69 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.552 0.741 . . . . 0.0 109.296 170.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -50.64 -51.12 51.98 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.64 1.176 . . . . 0.0 111.686 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.45 -27.32 68.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.74 -34.9 64.96 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.824 0.85 . . . . 0.0 112.146 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.7 -38.59 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.877 0.871 . . . . 0.0 111.235 171.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -64.96 -35.87 82.57 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.986 0.812 . . . . 0.0 112.693 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.96 -35.28 79.63 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.197 -0.94 . . . . 0.0 111.72 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -43.48 80.15 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.758 0.823 . . . . 0.0 111.37 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 140.56 21.25 0.32 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 117.156 1.623 . . . . 0.0 117.156 169.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -114.95 -156.61 0.61 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.838 1.819 . . . . 0.0 110.272 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -131.54 140.7 49.55 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.992 1.317 . . . . 0.0 109.179 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -137.62 150.28 47.28 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.4 t -138.81 137.35 36.56 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.258 1.423 . . . . 0.0 109.577 169.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.77 135.05 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 121.513 -0.742 . . . . 0.0 110.308 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 124.095 1.903 . . . . 0.0 107.484 175.827 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 120.93 0.395 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.4 132.0 47.21 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.932 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.52 136.72 54.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.954 1.302 . . . . 0.0 109.657 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -97.09 128.66 44.23 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.852 1.661 . . . . 0.0 110.88 -169.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.74 141.16 33.25 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -109.55 116.33 31.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 mt -76.58 133.76 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 122.413 1.101 . . . . 0.0 110.136 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.88 104.97 15.26 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.625 2.37 . . . . 0.0 108.298 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.61 16.68 25.95 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.5 ptp -64.42 -36.21 83.41 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.659 1.73 . . . . 0.0 115.141 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 t60 67.53 -46.16 0.49 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 129.027 2.931 . . . . 0.0 113.83 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 96.0 m -153.63 163.78 39.39 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.949 2.5 . . . . 0.0 110.432 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -53.81 -31.32 48.66 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.223 -0.923 . . . . 0.0 112.884 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.1 p -49.0 -18.82 0.33 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.387 2.275 . . . . 0.0 115.48 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.3 t -57.6 -44.85 85.75 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.537 1.535 . . . . 0.0 112.466 167.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.63 -6.32 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.344 1.458 . . . . 0.0 114.075 -170.383 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.09 -59.19 4.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.987 0.915 . . . . 0.0 110.761 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -59.11 -36.16 74.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.617 -0.677 . . . . 0.0 110.901 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.11 -46.72 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 121.229 -0.92 . . . . 0.0 111.93 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.94 -31.52 72.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.677 1.191 . . . . 0.0 112.974 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -66.44 -34.52 78.13 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -94.64 -45.13 7.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.48 112.95 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 122.178 0.989 . . . . 0.0 109.995 -165.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.84 5.93 5.17 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.839 1.209 . . . . 0.0 114.383 -169.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.62 1.69 7.55 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.583 1.153 . . . . 0.0 113.609 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.76 171.2 8.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.087 1.355 . . . . 0.0 111.502 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -54.53 -37.84 65.88 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 171.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.2 11.95 7.63 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.445 -1.753 . . . . 0.0 115.918 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.87 120.27 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.005 2.402 . . . . 0.0 109.303 169.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 -21.15 12.36 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -142.78 166.72 23.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.882 1.219 . . . . 0.0 112.663 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.7 tp -140.88 138.65 34.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 126.591 1.956 . . . . 0.0 108.433 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -125.4 129.52 50.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.169 1.388 . . . . 0.0 109.51 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -99.4 112.4 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.315 1.446 . . . . 0.0 108.161 -170.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 m -125.8 49.58 1.93 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.829 0.823 . . . . 0.0 110.613 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.62 -15.18 60.8 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.255 1.822 . . . . 0.0 114.803 -170.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -43.7 -32.84 1.09 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.614 2.366 . . . . 0.0 115.538 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -125.33 23.39 7.59 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.666 1.186 . . . . 0.0 112.874 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 63.39 24.72 14.3 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.035 1.734 . . . . 0.0 112.263 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.28 164.4 13.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.075 1.75 . . . . 0.0 110.036 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.33 151.31 41.82 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 127.677 2.391 . . . . 0.0 106.8 170.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -124.71 134.53 52.81 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.415 -0.803 . . . . 0.0 111.292 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -102.52 139.74 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 117.847 0.294 . . . . 0.0 111.089 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -102.8 95.73 6.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.708 1.603 . . . . 0.0 108.857 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -120.8 152.48 38.3 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -170.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.34 112.0 59.83 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 127.85 2.46 . . . . 0.0 109.772 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -63.03 -2.74 3.97 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.838 3.025 . . . . 0.0 115.658 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.9 p -84.24 -16.66 42.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.71 1.204 . . . . 0.0 113.019 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 92.4 m -124.43 -28.4 3.63 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 t -142.18 179.2 7.05 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.684 1.129 . . . . 0.0 113.064 -169.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 97.6 p -165.61 162.53 13.27 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.7 1.6 . . . . 0.0 112.164 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -52.63 -49.33 17.85 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.728 2.952 . . . . 0.0 115.472 -172.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.32 -37.61 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 119.326 0.966 . . . . 0.0 112.459 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.47 87.93 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.299 1.039 . . . . 0.0 111.438 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.33 -47.4 70.61 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.863 0.865 . . . . 0.0 111.778 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -55.72 -47.96 75.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.087 0.858 . . . . 0.0 111.484 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -63.94 -29.64 70.8 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.25 -62.43 1.52 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.932 0.787 . . . . 0.0 112.277 170.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 pt -72.61 -17.3 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -73.81 -35.78 64.9 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 121.64 2.018 . . . . 0.0 113.156 168.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.41 13.7 26.94 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.944 -1.097 . . . . 0.0 112.261 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.2 tp -48.86 -54.39 28.29 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 129.331 3.052 . . . . 0.0 113.202 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -91.05 176.22 2.28 Favored 'Trans proline' 0 CA--C 1.55 1.285 0 C-N-CA 124.092 3.195 . . . . 0.0 111.879 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.35 53.01 3.75 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 124.663 3.575 . . . . 0.0 113.099 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.8 52.38 5.88 Favored Glycine 0 N--CA 1.471 1.011 0 O-C-N 120.689 -1.257 . . . . 0.0 111.823 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -127.74 -33.04 2.31 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.467 1.107 . . . . 0.0 113.875 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -135.01 113.94 11.97 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.126 1.77 . . . . 0.0 109.556 -173.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -98.43 173.92 6.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.36 1.464 . . . . 0.0 110.516 173.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.24 135.21 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.783 -1.198 . . . . 0.0 111.025 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -107.62 124.74 50.41 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.13 0.972 . . . . 0.0 109.831 167.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 124.239 1.016 . . . . 0.0 109.569 176.856 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.9 t 73.03 113.85 0.06 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.804 2.442 . . . . 0.0 114.835 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 60.9 m -145.37 148.6 33.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.109 2.163 . . . . 0.0 108.905 166.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.4 m -99.13 145.96 26.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.037 -1.039 . . . . 0.0 110.256 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.87 155.06 43.26 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.917 1.287 . . . . 0.0 110.978 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.0 tt -114.6 136.01 53.51 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.789 2.036 . . . . 0.0 110.745 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.6 mm -123.57 141.08 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 127.174 2.19 . . . . 0.0 109.697 -172.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.23 127.42 53.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.147 1.379 . . . . 0.0 110.706 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.23 143.72 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 120.801 -1.187 . . . . 0.0 111.566 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.85 56.46 1.31 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.195 1.798 . . . . 0.0 113.258 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.68 45.92 0.28 Allowed Glycine 0 N--CA 1.469 0.87 0 O-C-N 121.209 -0.932 . . . . 0.0 112.714 167.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 29.6 mtm -133.5 96.8 3.79 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.222 1.009 . . . . 0.0 110.024 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 t -98.99 -26.51 14.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.315 1.846 . . . . 0.0 112.939 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 95.7 m -125.62 150.43 47.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.188 1.395 . . . . 0.0 110.934 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.1 -23.79 67.46 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.918 -1.113 . . . . 0.0 113.312 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.1 p -53.55 -30.87 44.05 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.01 1.324 . . . . 0.0 113.429 169.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.8 m -57.17 -32.66 66.66 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.724 1.21 . . . . 0.0 112.3 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 41.5 t -57.07 -53.87 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.685 0.794 . . . . 0.0 109.988 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -66.31 -23.28 66.35 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.973 0.509 . . . . 0.0 112.21 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.5 m -71.19 -52.72 17.55 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.568 -0.707 . . . . 0.0 111.148 170.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 85.7 mt -70.37 -52.23 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 120.741 -1.225 . . . . 0.0 111.315 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -51.46 -42.08 61.32 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.82 1.248 . . . . 0.0 111.082 172.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.42 -62.42 2.9 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 123.558 0.599 . . . . 0.0 113.127 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -38.59 71.14 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.033 1.333 . . . . 0.0 113.026 -170.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.8 mm -71.04 -35.3 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.73 -0.606 . . . . 0.0 110.539 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -65.0 3.07 0.62 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -94.44 -11.28 30.07 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.686 1.194 . . . . 0.0 113.546 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -106.25 167.59 9.72 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.026 1.285 . . . . 0.0 112.87 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -68.38 161.38 27.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 123.213 1.482 . . . . 0.0 114.705 -174.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.82 -32.41 1.94 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.36 1.457 . . . . 0.0 114.911 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.51 98.61 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 119.106 1.453 . . . . 0.0 112.435 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -72.32 -45.89 58.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.196 0.998 . . . . 0.0 112.135 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -144.61 132.49 21.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.141 1.376 . . . . 0.0 109.783 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.71 142.3 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.745 1.157 . . . . 0.0 112.854 170.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 31.2 t -131.45 142.62 50.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.55 2.74 . . . . 0.0 109.224 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.27 146.97 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.89 1.223 . . . . 0.0 111.781 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 43.1 t -139.29 136.34 34.78 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -16.83 63.22 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.36 2.264 . . . . 0.0 113.514 171.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.74 97.05 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.783 1.233 . . . . 0.0 111.969 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -116.37 -16.05 10.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.7 1.6 . . . . 0.0 112.605 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.94 28.51 56.44 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.177 1.37 . . . . 0.0 112.855 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.1 p -128.89 151.54 49.52 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.077 0.939 . . . . 0.0 113.26 -169.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -113.32 146.71 38.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.25 1.42 . . . . 0.0 111.906 172.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.4 m -118.52 126.19 51.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.852 1.661 . . . . 0.0 107.342 168.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.77 137.33 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.321 0.649 . . . . 0.0 110.65 -171.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.25 109.69 21.78 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.75 2.02 . . . . 0.0 105.78 173.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -111.29 155.67 22.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.023 0.929 . . . . 0.0 111.993 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -97.4 107.05 36.57 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.725 1.21 . . . . 0.0 109.139 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -66.97 -15.86 48.06 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.8 1.667 . . . . 0.0 113.537 -174.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.85 -14.84 61.15 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.45 -31.67 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.165 1.786 . . . . 0.0 112.494 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.0 tt -151.77 152.31 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.865 -1.147 . . . . 0.0 112.964 -170.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 73.5 m -114.49 159.32 37.33 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.55 1.14 . . . . 0.0 112.858 171.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.8 -37.64 45.55 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.48 3.453 . . . . 0.0 115.103 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -57.82 -35.82 71.39 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.449 1.022 . . . . 0.0 113.066 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.28 -32.49 64.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.234 1.013 . . . . 0.0 111.564 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.64 -51.93 67.7 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.689 -0.632 . . . . 0.0 110.089 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -62.28 -41.82 98.81 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.733 -0.605 . . . . 0.0 111.617 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.25 73.18 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.8 -34.79 69.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.86 -38.97 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.705 0.802 . . . . 0.0 110.115 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -59.97 -46.73 88.48 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.331 0.653 . . . . 0.0 110.249 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.84 -22.49 65.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.4 1.48 . . . . 0.0 114.507 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -39.58 78.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.459 -0.775 . . . . 0.0 110.95 172.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 138.71 24.58 0.34 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.443 -1.198 . . . . 0.0 115.512 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -124.41 -153.36 0.56 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.162 1.481 . . . . 0.0 109.263 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.07 141.7 36.19 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.745 1.618 . . . . 0.0 108.018 168.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.97 154.88 47.3 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.9 t -138.88 143.53 38.77 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.024 2.13 . . . . 0.0 109.9 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.5 m -90.39 131.16 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.393 -0.817 . . . . 0.0 111.13 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 126.074 1.749 . . . . 0.0 109.903 -176.463 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.651 0.263 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.37 145.82 32.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.646 0.778 . . . . 0.0 110.945 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tt -121.4 136.44 54.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.377 1.071 . . . . 0.0 111.918 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.55 122.84 39.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 122.597 1.189 . . . . 0.0 110.295 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.82 143.04 26.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.323 -1.762 . . . . 0.0 113.203 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -113.49 118.02 33.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.618 1.167 . . . . 0.0 108.86 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 mm -83.11 147.69 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.818 1.247 . . . . 0.0 110.916 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.69 156.82 18.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.943 1.697 . . . . 0.0 112.014 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.27 -7.26 64.66 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.585 1.088 . . . . 0.0 113.957 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.0 mtm -65.7 0.37 1.73 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -58.96 -23.23 61.41 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 119.672 1.124 . . . . 0.0 112.412 167.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.9 -6.77 59.34 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.915 1.286 . . . . 0.0 113.814 171.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 tptm 59.54 -57.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 130.729 3.612 . . . . 0.0 116.123 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 m -56.32 -13.4 2.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.568 1.947 . . . . 0.0 113.589 -174.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 m -48.76 -39.67 25.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.837 2.455 . . . . 0.0 112.678 167.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.58 -20.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -172.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.63 -56.92 15.56 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.147 0.979 . . . . 0.0 112.039 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -61.91 -28.82 69.79 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.655 -0.653 . . . . 0.0 111.921 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.2 mt -61.86 -54.97 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.521 1.055 . . . . 0.0 110.005 168.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -61.82 -32.38 72.68 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.2 1.0 . . . . 0.0 113.081 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -67.75 -42.12 82.3 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.123 1.369 . . . . 0.0 112.252 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -92.75 -17.41 24.23 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 50.4 mm -117.25 128.51 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.342 1.057 . . . . 0.0 110.131 -176.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.16 -6.17 1.74 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.621 1.581 . . . . 0.0 115.703 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -119.0 -1.27 10.99 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.853 2.061 . . . . 0.0 112.71 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.89 160.26 9.95 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.316 1.446 . . . . 0.0 110.279 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -55.22 -39.74 70.03 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.51 -32.65 5.93 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 116.876 -2.069 . . . . 0.0 115.009 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.62 118.02 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 121.235 2.517 . . . . 0.0 110.529 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -105.55 -17.4 14.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.7 m -148.91 148.09 29.43 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.491 -1.38 . . . . 0.0 113.364 169.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.7 tp -110.21 131.98 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.956 0.902 . . . . 0.0 109.866 167.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -120.52 143.45 48.56 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.432 1.493 . . . . 0.0 109.148 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.1 t -120.09 120.58 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.658 1.183 . . . . 0.0 109.804 -169.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -119.66 55.32 0.97 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.432 1.493 . . . . 0.0 112.635 -168.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -68.47 -13.97 62.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -169.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -60.27 -33.4 72.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.286 1.034 . . . . 0.0 112.94 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -113.25 15.87 19.22 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.421 1.488 . . . . 0.0 111.725 171.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.0 mttt 66.89 11.54 8.38 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.217 2.207 . . . . 0.0 113.056 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.58 174.29 7.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.173 2.189 . . . . 0.0 110.29 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.04 164.67 24.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.756 1.623 . . . . 0.0 108.47 167.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -135.73 109.45 8.05 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.089 1.355 . . . . 0.0 108.048 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.9 p -98.64 133.59 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 121.856 -0.528 . . . . 0.0 110.069 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.03 96.11 7.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.382 1.473 . . . . 0.0 109.805 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -125.25 148.22 48.75 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -98.87 118.35 63.02 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.272 1.429 . . . . 0.0 109.43 171.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.57 2.16 4.26 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.836 3.024 . . . . 0.0 113.095 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 t -71.37 -28.05 63.77 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.103 -0.998 . . . . 0.0 112.289 171.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 82.6 m -113.0 -20.45 11.53 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -171.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.6 t -145.13 -176.25 5.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.853 1.661 . . . . 0.0 111.178 -171.07 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.8 p -158.38 155.39 25.51 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.635 1.574 . . . . 0.0 110.919 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -48.51 -46.35 23.96 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 124.132 3.221 . . . . 0.0 116.907 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.39 -32.16 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 120.472 1.487 . . . . 0.0 113.065 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.22 -30.09 67.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.93 0.892 . . . . 0.0 111.849 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.7 mt -71.9 -53.16 14.02 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.661 0.784 . . . . 0.0 111.125 169.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.426 HE21 HG21 ' A' ' 88' ' ' VAL . 14.5 tt0 -49.77 -57.32 7.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.944 1.298 . . . . 0.0 110.889 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -68.6 -27.15 65.78 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.25 -55.42 9.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.23 0.923 . . . . 0.0 111.356 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.7 pt -71.81 -31.85 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.86 -17.66 63.38 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.73 10.77 39.73 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.549 -1.344 . . . . 0.0 113.724 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.1 mt -59.17 -54.04 60.33 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.562 -1.209 . . . . 0.0 109.759 166.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.5 174.45 12.81 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.237 2.624 . . . . 0.0 110.849 168.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.74 54.49 3.53 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.142 3.228 . . . . 0.0 111.209 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.45 23.5 68.55 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.304 0.954 . . . . 0.0 112.999 -175.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -90.14 -30.37 17.68 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.554 0.677 . . . . 0.0 112.473 -169.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -109.49 116.0 30.99 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.282 1.433 . . . . 0.0 107.89 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.4 tptp -96.91 157.02 16.1 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.666 1.186 . . . . 0.0 110.592 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.426 HG21 HE21 ' A' ' 75' ' ' GLN . 3.9 m -124.2 133.81 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.756 1.616 . . . . 0.0 111.659 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.6 p -110.58 127.45 55.23 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.026 0.93 . . . . 0.0 110.528 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 125.355 1.462 . . . . 0.0 109.514 170.384 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.8 m 59.0 92.91 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.1 m -141.18 158.51 43.81 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.334 1.453 . . . . 0.0 110.804 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 52.9 m -99.22 142.51 30.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.734 0.814 . . . . 0.0 110.76 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.68 143.65 30.83 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.065 0.946 . . . . 0.0 111.312 170.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -102.68 135.72 43.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.277 1.431 . . . . 0.0 110.166 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 mm -113.83 136.04 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.552 1.941 . . . . 0.0 108.304 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -105.36 124.48 49.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.271 1.429 . . . . 0.0 109.306 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 88.3 mt -122.55 143.7 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 120.486 -1.384 . . . . 0.0 112.21 -166.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.62 56.39 1.48 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.298 1.439 . . . . 0.0 112.984 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.95 50.63 0.18 Allowed Glycine 0 N--CA 1.462 0.393 0 C-N-CA 125.17 1.367 . . . . 0.0 111.902 166.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 10.6 ptp -126.35 142.05 51.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.869 0.842 . . . . 0.0 110.637 168.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.0 t -155.72 143.03 19.33 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 128.152 2.581 . . . . 0.0 105.604 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 81.5 m 70.13 141.8 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.489 1.516 . . . . 0.0 113.422 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.41 -35.83 52.82 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.164 -0.96 . . . . 0.0 113.194 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.1 p -61.05 -25.22 66.77 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.109 -0.994 . . . . 0.0 113.373 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.3 t -65.91 -31.98 73.23 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.723 -0.611 . . . . 0.0 112.623 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.29 -60.5 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.305 0.642 . . . . 0.0 109.275 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -66.5 -20.01 65.93 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.5 t -71.08 -58.26 3.73 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.587 1.155 . . . . 0.0 111.764 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.5 mt -70.5 -49.41 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.002 1.321 . . . . 0.0 111.245 -176.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -53.16 -26.96 18.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.167 1.787 . . . . 0.0 111.775 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.62 -60.66 3.14 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.648 1.594 . . . . 0.0 113.321 167.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 70.1 mmm -54.29 -41.96 69.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.843 1.257 . . . . 0.0 114.001 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.79 -32.82 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.425 0.69 . . . . 0.0 111.97 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.0 t -64.9 1.11 0.97 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.256 1.423 . . . . 0.0 114.803 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -90.38 -30.31 17.49 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.357 -1.464 . . . . 0.0 114.031 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.86 176.77 8.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.216 1.006 . . . . 0.0 112.261 -174.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -86.84 154.45 20.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 122.489 1.138 . . . . 0.0 113.934 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.0 2.54 80.79 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 113.146 -1.843 . . . . 0.0 116.528 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.24 96.2 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 120.99 2.395 . . . . 0.0 112.231 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 2.7 mp0 -65.49 -50.28 65.91 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.88 0.872 . . . . 0.0 109.922 173.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.42 141.67 30.94 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.356 0.663 . . . . 0.0 111.427 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.48 138.98 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.961 0.886 . . . . 0.0 111.298 166.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.8 t -142.22 147.07 35.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 127.365 2.266 . . . . 0.0 109.05 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.3 t -134.75 136.44 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.314 0.961 . . . . 0.0 110.566 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.1 m -113.93 99.31 7.58 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.771 1.229 . . . . 0.0 111.149 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.6 -30.99 45.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.952 1.701 . . . . 0.0 110.973 169.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -49.57 -34.21 17.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.043 2.137 . . . . 0.0 114.597 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -130.59 -5.24 4.16 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.187 0.995 . . . . 0.0 113.065 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.44 30.85 57.82 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.46 1.027 . . . . 0.0 112.355 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 61.0 p -118.66 152.98 35.07 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 117.869 0.834 . . . . 0.0 110.676 -170.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -125.26 124.3 41.36 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.675 0.79 . . . . 0.0 109.488 171.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.4 t -106.66 132.56 52.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.969 0.508 . . . . 0.0 110.18 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.82 138.67 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.068 0.547 . . . . 0.0 111.375 -171.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.16 96.1 8.21 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -98.78 159.92 14.62 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.625 0.77 . . . . 0.0 111.964 -177.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -98.68 102.68 15.56 Favored Pre-proline 0 C--O 1.241 0.653 0 C-N-CA 124.935 1.294 . . . . 0.0 109.324 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.7 -16.93 55.37 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.612 1.541 . . . . 0.0 113.075 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.21 -12.94 60.4 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 173.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 76.4 t -119.78 -41.12 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.069 1.748 . . . . 0.0 111.858 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.4 tt -137.05 149.03 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.211 1.004 . . . . 0.0 112.05 -172.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 55.5 m -112.71 153.19 45.14 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 124.461 1.104 . . . . 0.0 111.991 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -52.28 -38.94 73.29 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.453 2.769 . . . . 0.0 114.559 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.34 -29.25 68.77 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -72.05 -31.44 66.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 112.532 172.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.39 -49.93 69.64 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.512 0.725 . . . . 0.0 109.351 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -52.7 -50.57 63.07 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.929 1.292 . . . . 0.0 111.834 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.94 69.41 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.78 65.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -74.34 -39.52 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.606 0.762 . . . . 0.0 110.91 170.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.61 -29.17 69.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.869 0.468 . . . . 0.0 111.746 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.07 -36.69 82.56 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.265 -1.522 . . . . 0.0 112.678 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 17.5 ttt -67.11 -28.66 68.34 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.86 0.864 . . . . 0.0 112.024 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 118.59 20.39 4.26 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.557 1.551 . . . . 0.0 115.747 169.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -106.46 -154.66 0.52 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.487 1.515 . . . . 0.0 109.69 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.58 138.13 42.67 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.119 1.367 . . . . 0.0 109.009 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -126.67 158.49 36.24 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.4 1.48 . . . . 0.0 111.545 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.2 t -140.51 136.11 32.59 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 126.947 2.099 . . . . 0.0 107.98 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.2 m -84.21 129.73 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.762 -0.586 . . . . 0.0 109.876 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 124.829 2.252 . . . . 0.0 107.151 171.095 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.59 144.01 50.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.951 0.9 . . . . 0.0 111.367 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.3 140.27 29.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.024 2.13 . . . . 0.0 109.205 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.544 ' NE2' HE22 ' A' ' 61' ' ' GLN . 2.3 pt20 -131.01 146.21 52.31 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 173.192 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.6 158.13 43.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.592 1.957 . . . . 0.0 110.707 174.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.12 101.57 13.33 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -77.1 133.8 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.253 1.021 . . . . 0.0 110.814 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -97.84 136.24 38.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.472 1.509 . . . . 0.0 111.256 172.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.45 57.51 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.252 1.406 . . . . 0.0 114.256 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.2 ptp -60.81 -17.89 52.25 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -63.35 -15.53 57.69 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 119.4 1.0 . . . . 0.0 113.499 172.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.55 -9.97 59.71 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 168.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? 71.09 -59.78 0.53 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 128.68 2.792 . . . . 0.0 111.482 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.9 p -45.27 -35.84 3.66 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.335 2.254 . . . . 0.0 114.055 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -45.68 -45.76 14.35 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.7 1.6 . . . . 0.0 112.492 174.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.69 -18.43 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -174.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.1 tp -63.49 -50.92 67.75 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.203 0.911 . . . . 0.0 111.087 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -39.84 63.02 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.65 0.738 . . . . 0.0 111.072 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.38 -52.54 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.452 1.101 . . . . 0.0 109.977 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.41 -34.63 70.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.646 1.579 . . . . 0.0 113.701 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.59 -41.1 89.01 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.637 1.108 . . . . 0.0 111.68 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -94.12 -36.55 12.03 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.2 mm -98.22 114.77 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 121.177 -0.952 . . . . 0.0 109.04 -170.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.45 -27.36 2.38 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.183 0.897 . . . . 0.0 114.84 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -106.02 3.68 28.51 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.5 mt -87.78 163.67 16.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.815 1.246 . . . . 0.0 112.784 -170.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 47.1 tp -29.5 -62.01 0.14 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.802 2.441 . . . . 0.0 114.902 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.83 -23.78 13.02 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.218 -1.323 . . . . 0.0 114.626 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.86 126.3 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 120.14 1.97 . . . . 0.0 110.601 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -97.52 -40.32 8.71 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.798 0.839 . . . . 0.0 111.733 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.8 t -149.95 -178.56 6.55 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.413 1.085 . . . . 0.0 113.706 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.9 tp -132.63 145.3 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 127.462 2.305 . . . . 0.0 109.097 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -132.98 118.69 19.15 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.635 1.207 . . . . 0.0 109.561 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.4 t -104.82 95.07 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.274 1.83 . . . . 0.0 109.385 -168.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -113.17 55.63 0.7 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.401 1.481 . . . . 0.0 111.345 -174.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.4 mt -58.6 -28.82 65.94 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -168.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.5 -25.42 25.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.232 1.413 . . . . 0.0 113.589 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -102.23 -0.36 33.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.056 1.343 . . . . 0.0 113.733 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 69.6 -15.86 0.28 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 127.746 2.418 . . . . 0.0 114.543 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.64 131.28 42.04 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.845 1.658 . . . . 0.0 108.702 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.37 145.29 27.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.594 1.158 . . . . 0.0 109.698 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.544 HE22 ' NE2' ' A' ' 23' ' ' GLN . 8.4 tp-100 -114.86 134.19 55.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.705 1.202 . . . . 0.0 109.246 -169.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 p -118.39 140.46 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 119.976 1.262 . . . . 0.0 111.045 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -113.51 101.4 9.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.234 1.813 . . . . 0.0 108.499 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 16.1 p90 -128.62 -179.37 5.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.842 1.657 . . . . 0.0 111.63 -168.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -120.23 138.12 26.79 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.803 1.241 . . . . 0.0 108.569 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.57 5.51 6.07 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.966 2.444 . . . . 0.0 113.556 -169.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.9 p -75.12 -29.1 60.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.413 1.085 . . . . 0.0 113.197 -172.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.63 -21.65 6.11 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -170.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -146.71 -179.21 6.62 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.956 1.702 . . . . 0.0 110.93 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.8 p -165.58 170.24 6.26 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.969 1.308 . . . . 0.0 111.882 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -45.61 -51.28 8.31 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 124.612 3.541 . . . . 0.0 116.122 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.3 m -70.16 -35.26 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 119.714 1.143 . . . . 0.0 112.879 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.1 77.46 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.471 0.708 . . . . 0.0 110.929 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.22 -48.33 78.76 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.336 1.054 . . . . 0.0 111.28 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -52.32 -54.65 28.81 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.191 0.905 . . . . 0.0 110.987 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -65.53 -36.13 82.9 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.305 1.042 . . . . 0.0 111.785 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.42 -53.98 39.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.472 0.709 . . . . 0.0 112.164 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.9 pt -72.4 -30.34 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -172.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -66.23 -27.39 67.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.139 0.881 . . . . 0.0 113.07 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.89 8.11 42.48 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.79 -51.52 80.28 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-O 117.688 -1.149 . . . . 0.0 112.4 168.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -71.75 167.47 26.46 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.221 1.947 . . . . 0.0 111.48 171.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.16 62.81 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.074 3.183 . . . . 0.0 110.019 169.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.56 53.8 38.81 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 124.943 1.258 . . . . 0.0 112.814 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -125.7 -50.79 1.6 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -171.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -97.52 118.92 35.1 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.13 149.76 22.72 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.244 1.018 . . . . 0.0 111.578 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.2 m -123.92 142.58 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -121.38 134.22 55.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.38 1.472 . . . . 0.0 111.561 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 126.865 2.066 . . . . 0.0 110.948 174.838 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.7 p -147.92 131.7 17.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -167.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.3 p -144.22 146.34 32.61 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.109 1.764 . . . . 0.0 111.504 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -99.31 147.53 25.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.502 1.121 . . . . 0.0 109.981 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.49 141.85 27.49 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.072 0.949 . . . . 0.0 110.497 168.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tt -108.74 144.55 36.4 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.07 1.348 . . . . 0.0 110.738 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mt -134.2 137.24 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.374 1.87 . . . . 0.0 110.39 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.83 133.73 42.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.308 1.443 . . . . 0.0 109.793 172.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 55.4 mt -140.33 130.53 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 119.462 1.028 . . . . 0.0 110.866 -171.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.19 53.43 0.72 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.344 1.058 . . . . 0.0 112.755 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.41 53.13 0.42 Allowed Glycine 0 N--CA 1.47 0.907 0 O-C-N 120.932 -1.105 . . . . 0.0 113.815 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -131.1 154.0 48.75 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.513 1.125 . . . . 0.0 109.903 170.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 t -157.33 -37.13 0.07 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.841 1.656 . . . . 0.0 111.217 -169.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 57.3 m -133.78 159.25 41.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.94 1.696 . . . . 0.0 111.577 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.85 -31.99 70.27 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -51.52 -26.3 8.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.898 1.279 . . . . 0.0 113.49 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 79.0 m -58.48 -26.42 63.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.519 1.128 . . . . 0.0 113.595 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.91 -47.33 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 118.892 0.769 . . . . 0.0 109.818 173.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -71.17 -13.89 62.09 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.4 m -70.98 -56.48 6.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.14 -54.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.846 1.258 . . . . 0.0 110.614 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -54.49 -32.82 58.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.22 1.008 . . . . 0.0 111.004 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.74 -49.53 63.39 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 124.171 0.891 . . . . 0.0 112.422 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 96.8 mmm -66.86 -46.99 73.32 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.689 1.244 . . . . 0.0 111.822 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.6 mm -73.19 -54.08 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.394 0.677 . . . . 0.0 112.707 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.5 t -62.46 -16.18 53.87 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -168.254 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -74.8 -30.84 61.55 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.978 1.311 . . . . 0.0 114.135 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 pp -89.28 -179.37 5.85 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.116 0.871 . . . . 0.0 111.407 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -87.39 -172.55 3.97 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.112 0.958 . . . . 0.0 111.6 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.63 -45.64 1.88 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.272 -1.517 . . . . 0.0 113.711 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.1 p -65.35 99.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.213 2.205 . . . . 0.0 112.096 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.23 -39.9 24.65 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.503 -0.748 . . . . 0.0 111.713 169.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -140.16 144.07 36.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.2 1.0 . . . . 0.0 110.461 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.45 138.32 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.997 0.903 . . . . 0.0 113.133 169.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.4 t -140.01 146.77 39.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.851 2.46 . . . . 0.0 110.691 -169.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.1 t -143.63 138.03 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.913 -1.117 . . . . 0.0 111.02 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 70.0 m -124.94 89.58 3.09 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.759 1.624 . . . . 0.0 111.126 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.53 -29.92 39.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.104 2.161 . . . . 0.0 113.242 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -47.7 -31.31 4.58 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.079 2.552 . . . . 0.0 115.259 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -130.18 -3.48 4.46 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.134 1.773 . . . . 0.0 112.237 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.29 36.32 63.48 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 117.852 -1.527 . . . . 0.0 112.882 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.8 p -124.1 153.74 41.0 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.126 1.463 . . . . 0.0 112.082 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -119.28 148.73 42.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.537 1.535 . . . . 0.0 109.722 169.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.9 t -138.39 133.55 33.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.585 0.754 . . . . 0.0 110.835 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.62 143.0 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.677 0.791 . . . . 0.0 111.451 -168.14 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.6 106.57 18.91 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.556 1.542 . . . . 0.0 107.371 169.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -108.38 158.09 17.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.957 1.303 . . . . 0.0 111.701 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -95.9 116.62 66.35 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 121.061 -1.024 . . . . 0.0 109.536 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.41 -10.22 20.48 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.326 2.017 . . . . 0.0 113.199 -170.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.15 -7.74 58.93 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.132 0.973 . . . . 0.0 113.418 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.97 -35.44 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.51 1.524 . . . . 0.0 112.348 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.0 tt -156.66 159.2 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.349 0.977 . . . . 0.0 112.205 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.76 150.72 43.2 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 126.213 1.805 . . . . 0.0 112.214 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.54 -43.87 37.39 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.3 3.334 . . . . 0.0 114.908 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -72.22 -15.94 61.94 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.68 -30.72 61.68 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.078 -1.014 . . . . 0.0 112.35 170.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 66.9 mt -59.04 -51.6 69.34 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.796 1.238 . . . . 0.0 110.406 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -49.73 -47.92 50.36 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.181 1.392 . . . . 0.0 112.512 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.02 -23.68 66.6 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.8 65.36 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.531 0.732 . . . . 0.0 112.207 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.3 mt -74.36 -41.36 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.75 1.22 . . . . 0.0 110.646 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -63.84 -28.27 69.74 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.011 0.924 . . . . 0.0 112.579 171.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -69.88 -35.46 74.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.177 0.991 . . . . 0.0 112.645 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 19.8 ttt -73.03 -34.06 66.1 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.871 0.868 . . . . 0.0 112.433 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 120.26 35.91 0.84 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.205 1.383 . . . . 0.0 114.741 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -134.48 147.56 50.39 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.82 1.648 . . . . 0.0 110.314 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -101.37 102.36 13.17 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.833 -1.167 . . . . 0.0 111.232 -167.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -99.98 147.34 25.69 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.284 2.234 . . . . 0.0 112.514 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.5 t -142.52 144.24 32.87 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.822 1.249 . . . . 0.0 109.999 168.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.2 m -71.71 136.39 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.702 -0.624 . . . . 0.0 110.675 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 125.766 1.626 . . . . 0.0 107.57 169.858 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.05 133.05 42.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.324 1.45 . . . . 0.0 109.373 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tt -126.53 128.83 47.5 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.307 2.243 . . . . 0.0 107.952 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -96.99 135.7 38.61 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.947 1.299 . . . . 0.0 110.344 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 pp -145.06 157.56 44.07 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.427 1.091 . . . . 0.0 113.736 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -116.06 125.39 52.36 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.02 1.328 . . . . 0.0 110.476 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.3 mt -100.86 150.23 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 126.169 1.788 . . . . 0.0 111.734 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.67 133.97 41.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.797 1.639 . . . . 0.0 110.923 173.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.43 1.25 81.35 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.853 1.216 . . . . 0.0 114.287 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.2 ptm -72.37 -6.78 45.83 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 116.196 1.925 . . . . 0.0 116.196 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -60.21 -18.87 51.49 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.425 1.011 . . . . 0.0 112.658 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.5 t -89.98 119.4 30.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 165.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -19.95 62.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.254 1.022 . . . . 0.0 113.397 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.3 m -63.59 -23.9 67.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.1 t -61.52 -52.38 64.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.902 1.683 . . . . 0.0 110.862 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.46 -15.77 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -69.65 -60.81 2.08 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.426 1.012 . . . . 0.0 111.264 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -26.07 68.65 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.34 -0.85 . . . . 0.0 112.117 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 92.3 mt -64.8 -50.94 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.913 -1.117 . . . . 0.0 111.048 167.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.0 -31.32 70.94 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.771 1.228 . . . . 0.0 113.658 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -56.03 -46.29 78.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.465 1.03 . . . . 0.0 110.541 173.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -90.29 -29.15 18.31 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.3 mm -110.09 113.43 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.34 1.056 . . . . 0.0 111.034 -169.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.27 -15.87 4.44 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 125.986 1.755 . . . . 0.0 114.45 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -101.77 5.66 41.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.79 1.236 . . . . 0.0 112.296 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.13 178.52 4.35 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.61 1.564 . . . . 0.0 112.142 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.9 -69.29 0.29 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.022 1.329 . . . . 0.0 111.333 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.69 -37.66 16.19 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.774 -1.57 . . . . 0.0 112.547 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.15 120.96 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 119.593 1.697 . . . . 0.0 110.126 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.29 -17.33 10.79 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.4 m -145.47 163.62 34.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.33 0.968 . . . . 0.0 111.324 169.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.5 tp -129.1 124.54 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.279 1.032 . . . . 0.0 109.045 168.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -114.13 142.14 46.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.408 1.483 . . . . 0.0 108.305 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.08 137.87 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.806 0.842 . . . . 0.0 109.687 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.0 t -136.12 55.53 1.85 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 123.967 1.842 . . . . 0.0 107.69 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.8 mt -68.9 -24.49 64.31 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.009 1.724 . . . . 0.0 114.516 -167.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.61 -52.42 63.85 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.317 1.047 . . . . 0.0 110.421 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -91.79 19.02 6.89 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.676 1.191 . . . . 0.0 111.942 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 65.12 28.01 12.32 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.569 1.948 . . . . 0.0 112.76 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.6 152.29 27.77 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.604 1.561 . . . . 0.0 111.447 -176.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.49 154.78 44.69 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -141.7 116.41 9.74 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -163.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 p -98.79 137.38 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 120.97 0.414 . . . . 0.0 111.236 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -108.3 97.65 7.3 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.812 2.045 . . . . 0.0 108.713 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -129.63 155.74 45.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.875 1.27 . . . . 0.0 113.921 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -99.17 118.53 62.42 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 125.564 1.545 . . . . 0.0 110.528 170.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.0 -2.13 2.05 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.203 3.935 . . . . 0.0 116.064 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.5 t -72.94 -22.65 60.68 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.136 1.374 . . . . 0.0 113.145 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 36.1 m -139.66 -8.62 1.24 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 t -147.91 -179.47 6.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.272 1.029 . . . . 0.0 110.833 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 p -160.81 156.29 21.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.057 0.943 . . . . 0.0 113.16 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.69 -55.68 3.88 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.747 3.631 . . . . 0.0 116.129 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 m -67.26 -34.17 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.097 1.317 . . . . 0.0 112.053 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.22 89.54 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.967 0.907 . . . . 0.0 111.661 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.7 mt -66.22 -43.81 85.59 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.849 0.86 . . . . 0.0 111.494 171.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -57.93 -44.76 87.09 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.237 0.926 . . . . 0.0 110.815 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -70.09 -31.2 68.65 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.368 1.067 . . . . 0.0 113.557 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.42 -51.77 27.09 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.952 0.901 . . . . 0.0 112.486 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.4 pt -74.29 -32.47 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -174.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.16 -30.01 69.02 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.59 7.08 40.99 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.08 -55.04 37.77 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.385 -1.293 . . . . 0.0 112.885 170.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.2 169.36 21.72 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.992 2.461 . . . . 0.0 111.492 174.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.12 51.95 3.32 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 125.245 3.964 . . . . 0.0 112.404 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.43 63.28 4.21 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -173.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -130.3 -58.1 1.06 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 20.4 m-85 -93.22 124.67 37.36 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -97.55 162.94 13.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.015 0.926 . . . . 0.0 110.452 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 p -140.82 137.25 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.0 m -118.85 139.39 51.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.142 2.177 . . . . 0.0 110.767 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 124.575 1.15 . . . . 0.0 111.584 175.268 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.26 5.7 t . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.459 0.171 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.4 m 49.8 93.16 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 166.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 p -133.92 141.44 47.33 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.476 -1.39 . . . . 0.0 111.211 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 44.2 m -97.46 134.42 40.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.664 1.12 . . . . 0.0 110.176 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.4 158.16 45.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.209 1.004 . . . . 0.0 113.067 175.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.22 136.51 45.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.323 2.249 . . . . 0.0 111.025 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.0 mm -128.58 134.4 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.963 1.705 . . . . 0.0 108.348 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.08 130.1 45.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.185 0.994 . . . . 0.0 109.486 172.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.35 147.53 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.47 -1.394 . . . . 0.0 110.921 -168.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -134.97 58.67 1.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.29 1.436 . . . . 0.0 113.221 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.1 48.74 0.3 Allowed Glycine 0 N--CA 1.469 0.846 0 O-C-N 120.889 -1.132 . . . . 0.0 113.696 166.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 74.3 mtm -102.14 -55.51 2.46 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 117.562 -1.209 . . . . 0.0 111.716 177.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.256 6.0 t 67.44 -38.64 0.35 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 129.647 3.179 . . . . 0.0 114.619 174.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 87.3 m -135.47 153.56 51.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.502 2.321 . . . . 0.0 111.529 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.56 76.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.353 1.061 . . . . 0.0 113.401 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.4 p -53.19 -35.29 59.69 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.813 0.733 . . . . 0.0 112.565 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.4 t -62.89 -25.8 68.48 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.2 t -58.94 -57.29 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.93 0.786 . . . . 0.0 109.076 169.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -65.54 -23.75 66.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.254 0.479 . . . . 0.0 112.16 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.1 m -69.9 -47.97 60.47 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.647 -0.658 . . . . 0.0 112.242 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.83 -53.68 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 119.725 1.148 . . . . 0.0 110.826 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -54.43 -31.01 54.37 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.673 1.989 . . . . 0.0 111.314 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.46 -61.74 2.71 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.3 1.429 . . . . 0.0 114.469 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 74.3 mmm -70.38 -41.81 72.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.844 1.258 . . . . 0.0 114.073 -168.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.8 mm -70.85 -27.57 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.714 -0.617 . . . . 0.0 110.66 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 2.7 t -65.73 0.39 1.73 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 177.092 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -99.48 -5.35 29.49 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -104.51 173.98 6.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.396 1.479 . . . . 0.0 111.821 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -79.14 142.87 36.0 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.079 -1.013 . . . . 0.0 111.712 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 94.09 11.47 57.49 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 117.133 -1.926 . . . . 0.0 116.947 175.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 10.1 p -111.85 -29.27 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.638 1.719 . . . . 0.0 114.775 -175.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 39.07 -71.3 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 129.988 3.315 . . . . 0.0 117.602 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -133.74 124.74 27.17 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.619 1.1 . . . . 0.0 110.373 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.7 tt -129.41 136.12 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.7 1.2 . . . . 0.0 111.24 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 24.5 t -136.38 126.56 26.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.218 1.807 . . . . 0.0 109.253 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.1 t -141.69 139.21 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.725 -1.234 . . . . 0.0 110.436 -168.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.1 m -145.39 140.17 27.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.211 0.604 . . . . 0.0 112.021 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.9 mt -65.63 -30.63 71.37 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.44 -56.36 5.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.754 2.021 . . . . 0.0 113.199 -170.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -101.39 -5.7 25.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.151 1.38 . . . . 0.0 111.198 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.27 35.53 77.08 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 125.248 1.404 . . . . 0.0 112.286 -175.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.4 p -116.7 139.17 50.85 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 124.697 1.199 . . . . 0.0 113.615 -167.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.65 138.72 41.37 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.664 1.586 . . . . 0.0 108.965 167.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.8 t -123.01 126.38 47.03 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 166.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.47 142.93 28.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 123.525 0.73 . . . . 0.0 111.313 -166.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -93.06 93.52 8.36 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.868 2.067 . . . . 0.0 106.601 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -94.62 158.12 15.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.96 0.886 . . . . 0.0 111.234 -174.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -95.77 106.98 30.98 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 121.701 -0.624 . . . . 0.0 109.975 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.15 -17.74 24.34 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.135 1.89 . . . . 0.0 112.856 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.71 41.0 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.457 1.103 . . . . 0.0 113.766 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.57 -27.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.097 1.759 . . . . 0.0 113.342 -171.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 21.3 tt -145.38 147.09 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 120.488 1.494 . . . . 0.0 112.457 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 35.3 m -98.5 144.71 28.61 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.279 1.032 . . . . 0.0 110.654 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.77 -33.51 32.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.315 3.344 . . . . 0.0 115.02 176.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -60.75 -28.59 68.82 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.5 -28.33 59.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.041 1.336 . . . . 0.0 113.07 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.23 -48.5 78.0 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.022 0.828 . . . . 0.0 109.104 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -52.66 -47.62 67.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.017 1.327 . . . . 0.0 111.068 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.46 -30.14 69.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.371 1.068 . . . . 0.0 113.712 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.38 -38.83 68.39 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.989 1.268 . . . . 0.0 113.001 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.63 -36.19 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.64 0.776 . . . . 0.0 110.391 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -69.66 -31.09 68.96 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.6 -0.688 . . . . 0.0 112.426 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.18 -28.76 65.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.663 1.985 . . . . 0.0 112.637 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.8 ttt -70.89 -36.69 72.87 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.34 1.056 . . . . 0.0 111.107 172.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 134.14 16.78 1.06 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.517 1.532 . . . . 0.0 116.117 169.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -113.08 -159.31 0.68 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.696 1.248 . . . . 0.0 110.216 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -128.27 140.63 51.78 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.525 1.13 . . . . 0.0 110.066 169.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -132.22 151.37 51.85 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.513 1.525 . . . . 0.0 111.875 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.2 t -133.41 132.49 41.22 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.394 1.478 . . . . 0.0 111.997 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.5 m -84.54 80.8 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.986 0.898 . . . . 0.0 110.722 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 126.654 1.982 . . . . 0.0 111.817 174.007 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.676 0.751 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -99.16 137.63 37.4 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.568 1.947 . . . . 0.0 110.002 -169.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tt -142.25 139.21 31.86 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.597 1.159 . . . . 0.0 110.62 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . 0.558 ' NE2' HE22 ' A' ' 61' ' ' GLN . 1.2 mp0 -98.35 133.94 42.05 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.692 1.997 . . . . 0.0 110.716 -176.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.11 134.07 24.01 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.794 170.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -100.05 113.64 26.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 mt -77.73 128.99 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 121.548 0.69 . . . . 0.0 109.577 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.2 107.85 19.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.235 2.214 . . . . 0.0 109.894 -171.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.09 10.52 34.2 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.676 1.131 . . . . 0.0 114.074 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.3 ptp -57.99 -35.58 71.41 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.155 1.478 . . . . 0.0 114.334 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 t60 68.06 -44.06 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 129.202 3.001 . . . . 0.0 113.294 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.8 p -166.74 166.88 15.58 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.647 2.379 . . . . 0.0 110.344 -173.104 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.55 -35.92 61.28 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.7 m -57.73 -23.09 50.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -172.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 t -49.39 -40.42 35.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.643 1.177 . . . . 0.0 112.004 168.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -12.34 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 117.83 -1.081 . . . . 0.0 113.565 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.87 -49.73 71.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.536 1.516 . . . . 0.0 111.884 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -40.94 68.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.144 0.884 . . . . 0.0 110.716 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mt -65.3 -52.31 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.311 1.444 . . . . 0.0 109.775 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -60.84 -33.32 72.86 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.936 2.495 . . . . 0.0 113.478 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -67.31 -45.05 77.64 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.517 1.127 . . . . 0.0 111.763 173.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -95.22 -29.43 14.52 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -170.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.3 mm -108.14 113.46 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.108 0.963 . . . . 0.0 109.577 -170.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.23 -22.55 7.06 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 125.857 1.694 . . . . 0.0 114.015 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -78.65 -10.68 59.84 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 118.188 0.994 . . . . 0.0 112.094 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.5 mt -67.81 -177.69 0.84 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.609 3.164 . . . . 0.0 112.404 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tt -82.12 -70.21 0.56 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.406 -0.809 . . . . 0.0 110.992 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.94 -44.44 78.67 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.118 -1.379 . . . . 0.0 112.483 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.14 117.82 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.65 1.725 . . . . 0.0 108.617 171.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -97.32 -41.47 8.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.153 0.981 . . . . 0.0 110.494 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 t -145.56 167.3 23.36 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.042 0.937 . . . . 0.0 112.666 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.6 tp -135.85 142.46 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.7 2.0 . . . . 0.0 108.437 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -141.48 153.93 45.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.01 1.724 . . . . 0.0 110.015 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 12.6 t -108.83 144.46 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.71 2.004 . . . . 0.0 109.926 -176.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.5 t -140.37 54.14 1.62 Allowed 'General case' 0 CA--C 1.555 1.159 0 CA-C-O 122.806 1.288 . . . . 0.0 109.939 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.11 -19.28 65.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.081 1.353 . . . . 0.0 113.973 -176.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.46 -24.21 44.1 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.1 19.36 8.33 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.875 1.67 . . . . 0.0 111.799 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.8 mttt 60.75 16.85 7.08 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.271 1.828 . . . . 0.0 113.788 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 p -96.92 159.71 14.76 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 123.517 1.627 . . . . 0.0 110.123 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.43 154.09 38.22 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.042 2.137 . . . . 0.0 106.813 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.558 HE22 ' NE2' ' A' ' 23' ' ' GLN . 3.0 tp60 -131.03 119.03 21.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.864 1.266 . . . . 0.0 108.587 -168.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 p -106.87 141.4 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.745 -0.597 . . . . 0.0 110.633 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.15 95.51 5.42 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.64 1.576 . . . . 0.0 108.97 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -123.31 150.64 43.33 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.362 1.065 . . . . 0.0 112.567 -173.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.4 123.11 57.68 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.544 1.137 . . . . 0.0 107.997 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.35 -12.79 6.23 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.067 3.178 . . . . 0.0 114.801 175.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.8 m -58.41 -28.32 65.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.032 1.733 . . . . 0.0 114.93 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 99.0 m -137.94 -12.17 1.48 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -148.2 177.14 9.65 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.869 1.267 . . . . 0.0 111.282 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.5 p -158.64 160.7 29.28 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.279 1.432 . . . . 0.0 111.893 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -53.99 -48.81 19.64 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.09 2.527 . . . . 0.0 115.398 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.2 m -69.31 -32.85 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 120.135 1.334 . . . . 0.0 112.938 177.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.55 -35.19 78.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.448 0.699 . . . . 0.0 111.643 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.96 -48.63 57.53 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.339 1.055 . . . . 0.0 111.213 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -54.59 -57.18 12.42 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.476 1.034 . . . . 0.0 111.555 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -60.51 -31.11 70.19 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.439 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.04 -61.94 1.61 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.009 0.924 . . . . 0.0 112.824 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.8 pt -70.48 -29.85 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -169.222 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -59.48 -35.07 73.41 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.996 0.919 . . . . 0.0 111.471 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.05 13.63 33.39 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mt -59.23 -55.99 40.63 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.909 166.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.56 171.27 18.09 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.524 2.816 . . . . 0.0 112.36 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.31 59.91 6.2 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.584 3.523 . . . . 0.0 110.975 171.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.32 35.58 92.14 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.999 1.285 . . . . 0.0 113.118 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -101.19 -41.17 6.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.685 0.742 . . . . 0.0 112.734 -169.093 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -115.78 117.02 29.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.611 1.164 . . . . 0.0 109.118 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -99.37 170.39 8.67 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.301 1.44 . . . . 0.0 111.337 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.7 m -135.26 130.28 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.064 -1.022 . . . . 0.0 110.902 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.9 m -103.75 117.78 35.16 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.146 0.978 . . . . 0.0 110.579 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.335 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 122.563 1.173 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 29.3 p -163.84 142.41 7.66 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.084 2.153 . . . . 0.0 110.958 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.2 t -144.98 158.41 43.82 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.311 -0.868 . . . . 0.0 111.094 172.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 98.6 m -98.53 140.52 32.64 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.86 149.64 40.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.514 1.126 . . . . 0.0 110.603 173.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 tt -115.25 136.79 52.73 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.986 1.714 . . . . 0.0 109.084 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.7 mm -119.66 138.07 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.737 2.015 . . . . 0.0 108.255 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.58 136.58 38.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.507 1.123 . . . . 0.0 108.91 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.26 139.2 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 120.729 -1.232 . . . . 0.0 110.134 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.39 57.86 1.0 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.359 2.264 . . . . 0.0 112.016 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.05 52.36 0.23 Allowed Glycine 0 N--CA 1.465 0.592 0 C-N-CA 124.435 1.017 . . . . 0.0 111.354 168.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.1 mtm -136.1 126.34 26.45 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.854 1.262 . . . . 0.0 108.788 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.2 t -144.7 -24.83 0.51 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.703 1.601 . . . . 0.0 111.457 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 96.6 m -116.01 142.54 46.66 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.552 1.941 . . . . 0.0 110.8 170.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -48.93 -32.81 9.66 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.112 1.365 . . . . 0.0 113.837 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.9 p -58.2 -22.54 52.24 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.6 t -61.87 -28.66 69.66 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.214 -0.928 . . . . 0.0 112.358 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.9 -51.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 121.627 -0.671 . . . . 0.0 110.722 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -70.13 -19.14 63.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.6 m -74.62 -56.09 5.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.376 1.07 . . . . 0.0 112.077 167.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.78 -57.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 121.123 -0.986 . . . . 0.0 111.153 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.43 -25.57 66.06 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.239 1.016 . . . . 0.0 110.912 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.49 -57.97 5.23 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.886 1.232 . . . . 0.0 113.611 174.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.2 -46.32 42.75 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.976 0.888 . . . . 0.0 113.337 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.0 mm -72.71 -24.09 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.635 0.774 . . . . 0.0 112.501 -172.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.9 p -65.6 -15.74 63.03 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.1 -10.87 43.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -168.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.99 -177.8 6.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.324 1.049 . . . . 0.0 113.253 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -93.63 127.11 39.16 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.256 1.022 . . . . 0.0 109.845 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 103.5 16.98 18.69 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 117.683 -1.621 . . . . 0.0 116.517 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.34 100.41 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 127.212 2.205 . . . . 0.0 112.475 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -78.12 -49.21 14.32 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.401 -0.812 . . . . 0.0 112.232 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -140.51 141.25 35.36 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.225 1.81 . . . . 0.0 108.669 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.5 tt -144.2 131.04 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.235 1.014 . . . . 0.0 111.545 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.38 122.65 13.88 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.691 0.797 . . . . 0.0 112.105 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.86 138.37 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.039 0.935 . . . . 0.0 111.854 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.5 t -141.55 134.56 29.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.28 1.432 . . . . 0.0 111.488 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.15 -17.96 61.32 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.81 63.61 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.338 1.455 . . . . 0.0 112.969 -173.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -113.41 -5.73 13.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.209 1.804 . . . . 0.0 111.566 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 72.08 49.76 20.45 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.554 1.55 . . . . 0.0 112.078 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.6 p -139.27 149.46 44.31 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -168.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.16 140.06 47.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.628 1.571 . . . . 0.0 110.741 169.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.8 t -116.9 127.71 54.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.58 141.42 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.544 0.738 . . . . 0.0 110.571 -171.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.96 108.74 21.52 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.242 1.817 . . . . 0.0 106.9 175.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -114.65 159.57 20.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.98 0.895 . . . . 0.0 112.767 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -97.84 113.4 63.62 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.101 0.96 . . . . 0.0 109.858 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.08 -7.1 17.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.961 2.441 . . . . 0.0 115.093 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.42 -37.17 20.11 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.717 1.144 . . . . 0.0 111.018 168.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 86.7 t -85.44 -32.46 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.461 1.104 . . . . 0.0 113.192 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.5 tt -148.96 151.72 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 120.268 1.394 . . . . 0.0 113.678 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.07 145.78 31.11 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.779 1.632 . . . . 0.0 112.456 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.67 -33.47 93.67 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.838 2.358 . . . . 0.0 115.286 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.74 -22.41 61.62 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.364 0.984 . . . . 0.0 113.135 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -72.62 -38.02 67.87 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.741 -1.224 . . . . 0.0 111.57 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 82.9 mt -55.44 -54.41 44.13 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.773 0.829 . . . . 0.0 109.908 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -51.22 -55.27 18.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.998 1.319 . . . . 0.0 111.299 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.5 -18.84 65.63 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.62 -33.33 68.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.942 1.247 . . . . 0.0 112.23 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.1 -39.72 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.396 1.078 . . . . 0.0 110.532 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.65 -31.77 72.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.241 0.616 . . . . 0.0 112.375 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.19 -5.11 39.93 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.539 1.936 . . . . 0.0 114.441 169.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.46 -47.98 5.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.126 1.37 . . . . 0.0 111.466 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 157.45 15.8 0.04 OUTLIER Glycine 0 N--CA 1.469 0.867 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -133.27 -163.46 1.35 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.987 1.394 . . . . 0.0 108.954 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.58 147.02 49.93 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.198 0.999 . . . . 0.0 109.357 169.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -138.97 160.18 40.38 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.0 t -138.36 141.67 39.68 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.485 1.914 . . . . 0.0 109.168 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.3 128.83 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.331 -0.856 . . . . 0.0 108.866 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 122.873 1.32 . . . . 0.0 108.733 -178.866 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.11 138.25 45.13 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.64 -0.663 . . . . 0.0 112.583 -173.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.56 163.72 25.38 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -109.71 133.25 53.34 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 127.819 2.448 . . . . 0.0 110.04 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -146.46 155.05 42.27 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.374 0.67 . . . . 0.0 112.327 171.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -116.98 107.51 14.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.557 0.694 . . . . 0.0 111.09 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.6 mt -88.62 143.42 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.795 2.038 . . . . 0.0 110.938 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -97.46 142.85 28.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.013 2.525 . . . . 0.0 110.137 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.95 -13.64 65.56 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.902 1.239 . . . . 0.0 114.506 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.5 ptp -62.12 -23.23 66.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.517 1.158 . . . . 0.0 113.925 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -69.51 -15.77 63.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.33 0.968 . . . . 0.0 113.599 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 87.7 m -75.49 -6.04 48.15 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 120.586 1.539 . . . . 0.0 112.18 166.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp 71.74 -52.24 0.69 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 130.415 3.486 . . . . 0.0 113.397 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -54.22 -23.28 14.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.564 1.146 . . . . 0.0 113.937 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.4 t -57.99 -47.41 83.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.359 1.864 . . . . 0.0 112.543 169.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -73.64 -24.63 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 118.555 0.616 . . . . 0.0 112.464 -173.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.6 tp -57.32 -53.9 52.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.021 0.928 . . . . 0.0 111.746 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -37.68 76.22 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.821 -0.549 . . . . 0.0 110.962 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.1 mt -66.11 -49.6 75.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.372 0.669 . . . . 0.0 110.579 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -60.25 -36.12 77.05 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.046 1.738 . . . . 0.0 112.914 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -68.31 -39.91 81.85 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.308 -0.87 . . . . 0.0 112.346 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -95.26 -37.52 10.97 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.9 mm -93.04 119.64 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 120.389 -1.445 . . . . 0.0 108.699 -168.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' H ' HD12 ' A' ' 45' ' ' LEU . . . 127.07 -17.83 6.24 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.019 1.771 . . . . 0.0 112.609 -167.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -87.72 -4.03 58.93 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.257 1.028 . . . . 0.0 112.443 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.434 HD12 ' H ' ' A' ' 43' ' ' GLY . 5.5 mp -80.67 178.26 8.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.593 1.957 . . . . 0.0 112.028 -170.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tp -59.52 -74.94 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.384 1.874 . . . . 0.0 112.31 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.58 52.42 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 117.483 -1.732 . . . . 0.0 115.671 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.5 t -87.51 113.56 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.589 2.194 . . . . 0.0 109.451 168.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -86.39 -43.37 12.9 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.485 1.114 . . . . 0.0 111.791 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.3 t -147.86 178.03 8.84 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.436 1.095 . . . . 0.0 111.649 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.6 tp -139.74 140.78 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.907 1.683 . . . . 0.0 108.611 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -129.36 120.53 25.74 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.213 1.405 . . . . 0.0 108.083 -173.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.87 86.97 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.394 1.478 . . . . 0.0 110.627 -166.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 p -98.67 54.29 1.03 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.569 1.948 . . . . 0.0 113.03 -170.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.9 mt -61.82 -26.3 68.03 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -172.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.32 -33.96 63.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.579 1.152 . . . . 0.0 113.148 173.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -94.81 -0.29 54.26 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.795 0.838 . . . . 0.0 112.572 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? 68.06 -0.34 2.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.883 2.473 . . . . 0.0 113.167 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.0 p -99.68 167.73 10.38 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 127.577 2.351 . . . . 0.0 109.881 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.53 149.21 41.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 168.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -116.0 125.92 53.13 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.245 1.418 . . . . 0.0 108.49 -172.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.73 135.0 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.001 -1.062 . . . . 0.0 111.0 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -99.26 95.82 7.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.048 1.739 . . . . 0.0 107.822 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -122.97 -179.32 4.22 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.075 1.75 . . . . 0.0 112.989 -168.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -129.22 136.12 28.66 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 125.612 1.565 . . . . 0.0 109.978 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -84.08 15.06 2.24 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.433 2.756 . . . . 0.0 113.317 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.1 t -111.33 -35.65 5.79 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.32 1.048 . . . . 0.0 111.082 173.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.1 m -90.58 -18.64 24.86 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . 0.252 2.8 t -148.49 -175.79 5.06 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.1 0.96 . . . . 0.0 112.163 175.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.1 p -153.72 167.59 13.33 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.046 1.739 . . . . 0.0 110.91 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.39 -44.09 24.69 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.593 2.196 . . . . 0.0 113.204 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.94 -37.87 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 118.92 0.782 . . . . 0.0 112.839 172.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.56 89.13 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.666 -0.646 . . . . 0.0 112.244 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.35 -55.77 30.51 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.111 1.765 . . . . 0.0 109.838 168.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -61.28 -39.82 91.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.87 0.868 . . . . 0.0 111.644 -173.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -70.8 -36.92 73.2 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.439 1.096 . . . . 0.0 112.804 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.66 -60.4 2.27 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.782 0.719 . . . . 0.0 112.681 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 pt -70.25 -26.78 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -167.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -70.81 -15.47 62.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.4 9.52 33.67 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.999 -1.063 . . . . 0.0 113.523 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.23 -47.95 97.26 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.145 165.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -77.56 171.57 17.31 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.646 2.231 . . . . 0.0 110.429 167.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -76.54 51.61 3.35 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 124.127 3.218 . . . . 0.0 110.978 170.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.16 28.51 68.14 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 120.996 -1.065 . . . . 0.0 113.756 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -97.32 -45.42 6.49 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.967 0.884 . . . . 0.0 112.459 -172.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -97.01 102.19 13.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.243 1.017 . . . . 0.0 108.73 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -96.52 141.42 29.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.265 1.026 . . . . 0.0 111.474 -170.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 p -130.27 134.66 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -172.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.3 m -118.95 144.41 46.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.461 1.504 . . . . 0.0 111.803 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 CA--C 1.539 0.549 0 C-N-CA 126.348 1.859 . . . . 0.0 112.21 -172.127 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.2 m -138.05 127.61 24.98 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.556 1.542 . . . . 0.0 111.81 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.0 m -146.34 152.63 39.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.925 1.29 . . . . 0.0 111.531 171.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 92.5 m -109.18 140.47 42.74 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.123 0.969 . . . . 0.0 109.58 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.22 158.54 43.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 168.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.89 127.46 48.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.488 2.315 . . . . 0.0 109.469 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.8 mm -113.28 136.37 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.438 1.095 . . . . 0.0 108.827 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -101.25 122.49 43.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.771 0.714 . . . . 0.0 109.33 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.66 135.2 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.065 0.946 . . . . 0.0 110.237 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -115.02 56.3 0.74 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.985 1.714 . . . . 0.0 112.09 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.02 54.86 0.32 Allowed Glycine 0 N--CA 1.465 0.6 0 C-N-CA 124.151 0.881 . . . . 0.0 112.076 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 39.6 mtm -148.35 138.25 22.38 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.033 0.933 . . . . 0.0 110.942 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.3 t -160.34 -32.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.122 1.369 . . . . 0.0 111.841 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 93.4 m -105.48 138.8 41.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.315 1.846 . . . . 0.0 109.937 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.07 -27.32 31.87 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.601 1.16 . . . . 0.0 113.751 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.6 t -56.34 -32.19 64.45 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.202 1.001 . . . . 0.0 112.969 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.5 t -60.65 -20.75 61.65 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.53 -59.62 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.005 168.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -63.31 -22.14 66.69 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.144 1.338 . . . . 0.0 112.815 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.6 m -70.65 -60.16 2.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.243 1.017 . . . . 0.0 112.153 170.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.0 mt -69.33 -51.28 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.581 -1.324 . . . . 0.0 110.897 -174.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -58.17 -30.98 66.84 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.136 1.374 . . . . 0.0 110.896 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.06 -62.34 2.64 Favored Glycine 0 C--N 1.343 0.967 0 C-N-CA 125.657 1.598 . . . . 0.0 114.615 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -44.98 62.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.483 1.113 . . . . 0.0 113.098 -172.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.2 mm -72.99 -29.51 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.09 0.556 . . . . 0.0 112.034 -172.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.5 p -64.86 0.99 0.98 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -106.9 -9.24 16.38 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -168.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.41 11.28 31.2 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -171.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 70.2 163.87 0.26 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.277 2.631 . . . . 0.0 114.191 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.98 -39.19 1.13 Allowed Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.486 -1.384 . . . . 0.0 112.977 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.52 98.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 127.462 2.305 . . . . 0.0 111.213 169.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -86.53 -54.72 4.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.853 0.861 . . . . 0.0 112.455 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -141.52 121.4 13.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.735 1.214 . . . . 0.0 109.045 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.0 tt -133.3 128.14 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.208 1.003 . . . . 0.0 110.92 -170.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.74 155.83 44.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.642 1.177 . . . . 0.0 109.9 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.69 142.31 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.433 1.015 . . . . 0.0 111.934 -171.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 45.0 m -115.28 86.98 2.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.832 2.453 . . . . 0.0 109.16 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.27 -27.55 69.09 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.376 -1.453 . . . . 0.0 111.451 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.8 -30.79 1.77 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.303 2.641 . . . . 0.0 114.824 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -118.07 -20.75 8.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.423 1.489 . . . . 0.0 111.772 173.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.37 36.56 8.72 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.592 1.567 . . . . 0.0 111.964 -174.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.6 p -128.28 140.6 51.8 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.803 1.301 . . . . 0.0 112.798 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.94 137.79 42.17 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.538 1.135 . . . . 0.0 110.736 169.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.9 t -111.49 121.95 46.53 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.24 140.91 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -169.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.03 115.93 28.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.122 2.169 . . . . 0.0 106.599 171.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -117.47 157.52 26.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.78 1.232 . . . . 0.0 111.71 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -99.75 105.79 36.49 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.716 1.206 . . . . 0.0 110.981 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -67.44 -13.33 38.86 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.253 2.635 . . . . 0.0 114.023 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.77 -10.73 58.75 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.282 0.946 . . . . 0.0 113.127 171.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.33 -34.04 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.556 1.543 . . . . 0.0 112.08 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.5 tt -159.93 147.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.886 1.221 . . . . 0.0 112.507 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.7 t -97.02 149.9 36.22 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.606 1.162 . . . . 0.0 112.528 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -49.99 -30.42 24.35 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.907 3.738 . . . . 0.0 114.19 168.351 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -67.02 -33.9 76.55 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.369 0.986 . . . . 0.0 112.39 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -75.29 -35.41 61.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.228 . . . . 0.0 110.404 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.04 -58.2 9.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.676 2.39 . . . . 0.0 111.48 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.54 -38.81 78.56 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.114 0.87 . . . . 0.0 112.35 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.98 -26.53 68.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.96 -30.42 63.83 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.461 1.028 . . . . 0.0 112.53 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.16 -34.52 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.306 1.042 . . . . 0.0 110.969 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -63.91 -39.34 93.94 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.674 0.67 . . . . 0.0 111.893 172.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.65 -31.44 72.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.52 1.928 . . . . 0.0 112.942 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 21.9 ttt -69.78 -37.18 76.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.156 0.982 . . . . 0.0 111.386 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 130.96 15.43 1.71 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.494 1.521 . . . . 0.0 116.306 169.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.92 -158.08 0.65 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.426 1.613 . . . . 0.0 108.923 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -133.52 142.7 48.33 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.032 0.933 . . . . 0.0 109.885 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -137.32 137.99 39.51 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.282 1.433 . . . . 0.0 112.975 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.2 t -123.07 131.35 53.66 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.834 1.654 . . . . 0.0 111.339 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 m -85.64 71.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.266 1.026 . . . . 0.0 110.661 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.582 -176.813 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 p -112.56 166.56 11.21 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.613 1.965 . . . . 0.0 112.049 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.56 137.42 31.96 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.837 1.255 . . . . 0.0 111.711 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -99.15 120.1 38.95 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.961 0.886 . . . . 0.0 109.679 168.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.25 139.21 30.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.512 -1.676 . . . . 0.0 112.825 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -101.49 143.22 31.76 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.932 1.293 . . . . 0.0 109.03 171.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mm -107.32 153.14 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.763 1.625 . . . . 0.0 109.807 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -106.1 140.27 39.34 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.654 1.582 . . . . 0.0 110.652 170.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.61 3.21 88.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.879 1.228 . . . . 0.0 114.033 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.5 ptm -70.53 -3.6 18.79 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -50.8 -26.18 5.36 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.806 1.242 . . . . 0.0 114.345 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.4 p -114.04 137.74 51.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.962 1.305 . . . . 0.0 111.033 169.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -65.07 -15.7 62.65 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -50.79 -31.95 18.46 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.992 -1.068 . . . . 0.0 113.21 169.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.1 t -67.99 -57.91 5.38 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.337 1.055 . . . . 0.0 111.678 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 p -62.79 -29.62 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.407 1.003 . . . . 0.0 112.056 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.72 -61.01 2.93 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.264 1.026 . . . . 0.0 112.289 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -65.46 -31.28 72.28 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.785 -0.572 . . . . 0.0 111.821 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.01 -52.42 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 118.795 0.725 . . . . 0.0 109.48 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -38.3 90.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.567 1.147 . . . . 0.0 113.184 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -65.76 -34.95 79.36 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.332 0.653 . . . . 0.0 111.982 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -92.91 -24.41 18.44 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.2 mm -105.75 122.85 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.385 0.993 . . . . 0.0 109.669 -171.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.25 -22.81 5.28 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 125.581 1.562 . . . . 0.0 113.956 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -84.65 -0.65 54.21 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.652 1.581 . . . . 0.0 113.165 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.43 -172.33 4.11 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.779 2.032 . . . . 0.0 113.959 -171.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 tp -68.87 -82.78 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.427 2.291 . . . . 0.0 111.974 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.32 -30.32 60.78 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 120.12 1.327 . . . . 0.0 114.241 -173.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 t -84.07 127.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.044 1.422 . . . . 0.0 110.339 169.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -114.51 -23.1 9.48 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.4 t -145.63 166.08 26.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.226 0.921 . . . . 0.0 111.069 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 tp -140.71 142.31 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.417 1.087 . . . . 0.0 110.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -142.92 156.32 44.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.656 1.183 . . . . 0.0 110.579 -171.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.28 133.02 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.312 1.445 . . . . 0.0 108.348 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.3 m -122.6 52.8 1.3 Allowed 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.488 1.137 . . . . 0.0 110.086 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -19.33 64.03 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -172.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -57.77 -36.6 72.36 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.769 1.168 . . . . 0.0 111.066 168.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -97.47 -8.02 30.25 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.036 2.134 . . . . 0.0 112.484 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 70.75 15.64 6.89 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.605 2.362 . . . . 0.0 112.28 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 p -98.78 163.7 12.52 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.68 1.592 . . . . 0.0 110.621 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.18 169.09 9.63 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -139.6 114.25 9.29 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 121.043 -1.036 . . . . 0.0 111.186 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.58 133.2 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 121.529 0.68 . . . . 0.0 111.847 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -109.74 99.17 8.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.267 1.427 . . . . 0.0 108.784 -169.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.3 p90 -131.45 -178.87 5.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.821 1.248 . . . . 0.0 112.25 -168.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.99 140.05 33.84 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.509 1.124 . . . . 0.0 108.258 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.06 11.41 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.029 2.486 . . . . 0.0 112.826 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.4 p -92.21 -19.04 22.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.889 1.276 . . . . 0.0 113.481 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 72.6 m -126.82 -20.43 4.26 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.703 1.601 . . . . 0.0 114.457 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.1 t -145.07 -177.86 5.75 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.16 1.784 . . . . 0.0 111.338 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -160.62 156.6 22.46 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.487 1.515 . . . . 0.0 112.95 174.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -43.64 -45.38 10.82 Favored 'Trans proline' 0 C--N 1.352 0.756 1 C-N-CA 126.425 4.75 . . . . 0.0 117.974 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.6 m -64.78 -37.67 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 119.825 1.193 . . . . 0.0 112.537 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.67 -40.28 69.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.705 0.802 . . . . 0.0 111.058 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.38 -47.64 84.91 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.758 1.223 . . . . 0.0 112.011 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.419 HE21 ' HB ' ' A' ' 88' ' ' VAL . 35.8 tt0 -53.05 -54.54 33.91 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.79 0.723 . . . . 0.0 109.775 175.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -61.89 -33.74 74.76 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.202 1.001 . . . . 0.0 113.349 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.02 -56.99 5.53 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.056 0.943 . . . . 0.0 111.847 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.1 pt -72.56 -27.09 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.86 -28.55 67.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.9 6.49 41.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.7 mt -53.92 -52.51 67.28 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 117.392 -1.29 . . . . 0.0 112.187 169.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.41 163.44 36.56 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.241 2.627 . . . . 0.0 112.717 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -81.42 50.99 3.71 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.852 3.702 . . . . 0.0 111.302 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.19 53.68 5.55 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.328 0.966 . . . . 0.0 112.103 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -132.82 -45.08 0.87 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -171.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -101.64 134.77 44.25 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.667 0.787 . . . . 0.0 109.32 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -111.74 152.32 27.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.786 1.634 . . . . 0.0 110.171 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.419 ' HB ' HE21 ' A' ' 75' ' ' GLN . 2.1 t -101.52 138.11 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.675 1.125 . . . . 0.0 109.608 168.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -110.2 113.12 25.55 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.224 1.01 . . . . 0.0 108.811 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 126.373 1.869 . . . . 0.0 109.939 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 8.5 p -137.9 126.13 23.08 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.446 1.898 . . . . 0.0 113.473 -169.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.7 t -141.02 154.83 46.19 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.877 1.671 . . . . 0.0 110.424 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.4 m -111.35 137.72 48.75 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.786 0.721 . . . . 0.0 110.397 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.5 163.53 30.92 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.391 1.076 . . . . 0.0 112.068 169.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -109.8 128.06 55.06 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.511 1.924 . . . . 0.0 110.366 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.2 mm -112.28 144.54 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.227 1.011 . . . . 0.0 109.694 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.63 122.82 47.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.709 1.604 . . . . 0.0 109.71 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.52 140.87 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.049 -1.657 . . . . 0.0 111.896 -167.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.34 66.63 1.45 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.32 1.448 . . . . 0.0 114.065 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -172.88 49.89 0.17 Allowed Glycine 0 N--CA 1.466 0.659 0 CA-C-O 118.921 -0.933 . . . . 0.0 114.09 166.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 74.0 mtm -110.86 -57.08 2.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 117.498 -1.239 . . . . 0.0 113.768 -171.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.0 t 55.32 -26.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 130.339 3.456 . . . . 0.0 118.273 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 36.0 t -131.73 139.94 49.12 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.543 1.537 . . . . 0.0 111.718 -170.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.01 -35.26 69.04 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.747 -0.596 . . . . 0.0 111.671 171.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.4 m -64.03 -31.79 73.1 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.789 -1.195 . . . . 0.0 112.105 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 26.2 t -70.59 -39.76 73.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.911 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.63 -54.52 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 119.63 1.105 . . . . 0.0 110.094 170.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -58.54 -34.71 71.3 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.029 0.377 . . . . 0.0 111.582 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.2 m -71.0 -43.35 68.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.048 0.939 . . . . 0.0 113.078 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 84.9 mt -64.49 -51.12 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.788 1.176 . . . . 0.0 109.714 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -53.14 -37.66 62.03 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.497 1.519 . . . . 0.0 111.164 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.1 -58.42 4.36 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.001 1.286 . . . . 0.0 113.467 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.0 mtp -67.91 -46.81 70.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.657 1.583 . . . . 0.0 113.677 -170.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 35.5 mm -66.58 -36.94 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 118.124 0.42 . . . . 0.0 110.066 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 t -56.67 -9.34 0.74 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -89.02 -8.49 53.93 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.475 -1.391 . . . . 0.0 113.755 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -107.82 177.3 4.86 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.276 1.398 . . . . 0.0 114.158 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -56.5 152.41 11.73 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.698 1.599 . . . . 0.0 115.314 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.21 -30.3 0.32 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.351 1.453 . . . . 0.0 116.676 169.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.3 p -78.91 92.86 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.463 1.632 . . . . 0.0 111.008 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -79.56 -40.02 30.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.872 1.669 . . . . 0.0 111.916 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -144.99 144.81 31.23 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.011 0.925 . . . . 0.0 109.478 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.5 tt -140.36 138.37 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 121.255 -0.903 . . . . 0.0 111.55 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t -139.18 136.31 34.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.78 1.632 . . . . 0.0 109.157 171.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.22 148.93 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.827 1.251 . . . . 0.0 111.396 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.8 t -142.62 148.52 37.6 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.43 -22.67 61.82 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.633 1.173 . . . . 0.0 113.707 172.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -50.86 -41.58 58.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.006 1.322 . . . . 0.0 112.372 -169.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -127.38 -1.96 6.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.007 1.323 . . . . 0.0 111.906 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.06 42.26 37.25 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 125.487 1.518 . . . . 0.0 111.981 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.5 p -130.93 146.07 52.22 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.404 1.102 . . . . 0.0 113.053 -168.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -118.84 119.69 35.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.757 1.623 . . . . 0.0 112.037 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 t -99.32 112.26 24.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.962 1.305 . . . . 0.0 107.8 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 139.11 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.588 0.755 . . . . 0.0 110.885 -168.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.95 107.96 20.29 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.97 2.108 . . . . 0.0 107.117 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -113.17 162.9 15.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.147 1.379 . . . . 0.0 111.762 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -94.79 112.16 57.03 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.846 0.859 . . . . 0.0 108.941 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.51 -10.54 17.32 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.035 2.49 . . . . 0.0 113.051 -173.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.4 -32.9 25.91 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.259 0.936 . . . . 0.0 112.618 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.68 -46.97 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.865 1.266 . . . . 0.0 113.448 -173.61 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.5 tt -124.75 149.41 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 120.384 1.447 . . . . 0.0 112.094 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.9 t -96.99 146.96 32.2 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.203 1.401 . . . . 0.0 112.833 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.33 -26.12 42.17 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.09 2.527 . . . . 0.0 113.49 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -68.23 -35.66 78.29 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.526 -0.734 . . . . 0.0 112.548 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.46 -31.83 67.62 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.148 0.979 . . . . 0.0 111.643 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.04 -57.65 11.61 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.198 0.999 . . . . 0.0 110.035 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -61.23 -41.67 97.28 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.779 -0.575 . . . . 0.0 112.307 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.44 -34.08 70.42 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.15 -34.73 71.27 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -73.56 -39.44 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.281 1.033 . . . . 0.0 111.579 171.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -62.92 -32.25 73.5 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.182 -0.949 . . . . 0.0 111.641 172.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.93 -13.9 60.97 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.713 2.405 . . . . 0.0 114.503 169.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 14.7 ttt -83.62 -20.95 32.77 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.986 -1.071 . . . . 0.0 112.148 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 111.82 19.03 7.53 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.949 1.737 . . . . 0.0 114.934 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -115.09 -159.06 0.69 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.215 1.406 . . . . 0.0 109.878 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.77 140.32 51.09 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 124.554 1.142 . . . . 0.0 109.555 170.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.01 147.71 42.47 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.126 1.37 . . . . 0.0 112.348 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.1 t -142.74 140.49 31.48 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.174 1.789 . . . . 0.0 109.011 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.2 p -90.49 130.56 39.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.327 0.584 . . . . 0.0 110.811 -171.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 166.743 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 121.058 0.456 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -109.26 134.86 51.24 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.195 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.02 133.04 43.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.152 1.381 . . . . 0.0 110.724 -174.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -96.19 137.59 35.04 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.148 1.779 . . . . 0.0 111.576 -171.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.73 152.18 39.99 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 173.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -100.11 113.91 26.88 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.498 1.119 . . . . 0.0 109.683 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 mt -88.46 140.81 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.714 1.205 . . . . 0.0 109.973 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -99.11 141.26 32.1 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.46 1.504 . . . . 0.0 111.341 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.14 -13.09 65.13 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.511 1.529 . . . . 0.0 113.809 -176.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.7 ptp -63.85 -14.63 54.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -60.06 -24.4 64.55 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.45 1.477 . . . . 0.0 112.384 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 59.2 m -78.4 -4.66 49.37 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.929 0.892 . . . . 0.0 113.372 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.55 -56.37 0.51 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.649 3.18 . . . . 0.0 113.224 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m -55.11 -25.16 29.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.64 1.176 . . . . 0.0 113.246 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.4 -50.12 70.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.003 1.721 . . . . 0.0 112.361 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -77.14 -30.71 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 5.0 tt -52.73 -57.19 10.93 Favored 'General case' 0 C--N 1.345 0.391 0 C-N-CA 124.309 1.043 . . . . 0.0 110.916 -179.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -60.02 -45.25 93.41 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 118.591 -0.719 . . . . 0.0 109.866 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.81 -36.68 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.919 1.236 . . . . 0.0 111.133 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.98 -22.26 64.11 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.978 0.911 . . . . 0.0 112.317 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -71.9 -52.96 14.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.78 1.232 . . . . 0.0 113.024 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -93.82 -17.39 23.14 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -167.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 23.9 mm -96.23 133.03 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 119.813 1.188 . . . . 0.0 108.042 173.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.08 -5.7 10.31 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 125.317 1.437 . . . . 0.0 114.749 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -126.68 17.02 7.49 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.2 1.8 . . . . 0.0 112.329 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.14 156.63 18.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.864 1.266 . . . . 0.0 109.971 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.4 tp -21.96 -64.56 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.534 2.734 . . . . 0.0 114.714 173.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.86 -15.92 20.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 116.527 -2.263 . . . . 0.0 116.011 175.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.6 t -82.64 124.0 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 122.588 3.194 . . . . 0.0 111.123 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.45 -31.9 11.41 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 172.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.6 t -148.62 163.58 36.83 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.063 -1.023 . . . . 0.0 112.705 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 tp -132.6 130.64 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.58 1.952 . . . . 0.0 106.445 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -129.91 161.73 30.18 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 172.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.47 164.62 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 120.954 -1.091 . . . . 0.0 112.84 -172.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 t -140.57 70.85 1.36 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 123.264 1.507 . . . . 0.0 109.37 170.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.9 mt -61.52 -21.57 64.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.642 1.177 . . . . 0.0 112.814 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.01 -30.82 48.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.694 1.197 . . . . 0.0 113.818 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -108.9 -7.95 15.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.469 1.908 . . . . 0.0 112.53 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mttm 77.05 15.96 1.8 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 127.576 2.351 . . . . 0.0 112.743 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.15 150.15 21.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.6 1.191 . . . . 0.0 110.806 177.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.82 151.06 40.08 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.415 1.886 . . . . 0.0 107.172 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -137.56 124.14 20.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.472 1.033 . . . . 0.0 113.446 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.8 p -97.12 136.12 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.52 1.128 . . . . 0.0 110.615 -170.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -110.67 102.4 10.96 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.625 1.57 . . . . 0.0 108.221 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -135.38 160.01 39.79 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -168.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -93.59 113.41 60.2 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 126.065 1.746 . . . . 0.0 108.218 173.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.33 -3.7 12.92 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.025 2.483 . . . . 0.0 112.761 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.4 p -81.75 -11.8 58.86 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.703 1.601 . . . . 0.0 112.388 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 37.3 m -121.74 -33.03 3.67 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.778 1.231 . . . . 0.0 113.044 -173.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.4 t -145.06 -179.36 6.57 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.886 1.675 . . . . 0.0 111.32 -174.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.9 p -160.8 155.19 19.71 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.457 1.103 . . . . 0.0 112.821 -170.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.9 -49.16 15.78 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.14 3.226 . . . . 0.0 116.668 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -70.22 -33.51 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 120.332 1.424 . . . . 0.0 112.638 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.66 81.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.481 0.712 . . . . 0.0 111.099 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.16 -46.89 75.81 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.321 1.448 . . . . 0.0 112.342 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.476 HE21 HG22 ' A' ' 88' ' ' VAL . 12.3 tt0 -53.58 -52.26 60.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.401 1.0 . . . . 0.0 109.778 175.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -65.65 -24.94 67.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.776 1.23 . . . . 0.0 113.676 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.39 -60.67 2.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.315 0.961 . . . . 0.0 112.581 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.0 pt -74.02 -29.71 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -167.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -71.28 -23.56 61.99 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.496 1.044 . . . . 0.0 113.705 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.16 17.8 9.05 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.001 -1.062 . . . . 0.0 113.675 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.75 -58.74 15.16 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 117.715 -1.136 . . . . 0.0 109.955 166.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -69.82 168.15 22.45 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.498 2.798 . . . . 0.0 112.337 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.4 42.16 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.459 3.439 . . . . 0.0 112.434 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.99 63.83 2.34 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -169.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -148.74 -16.71 0.31 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 -169.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -124.43 130.6 52.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 169.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -110.4 142.48 42.04 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.867 1.267 . . . . 0.0 111.766 -173.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.476 HG22 HE21 ' A' ' 75' ' ' GLN . 13.6 m -117.56 134.5 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 120.084 1.311 . . . . 0.0 111.178 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.0 m -128.97 120.93 26.94 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.916 0.865 . . . . 0.0 111.975 176.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.033 0 C-N-CA 127.727 2.411 . . . . 0.0 112.202 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 58.2 m 48.41 82.11 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.038 2.135 . . . . 0.0 115.715 168.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.3 p -133.13 143.8 49.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.596 1.959 . . . . 0.0 112.929 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.6 m -98.1 129.46 44.92 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.015 0.825 . . . . 0.0 111.18 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.63 164.6 21.68 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.608 0.763 . . . . 0.0 111.162 169.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.16 132.13 54.55 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.251 1.421 . . . . 0.0 109.982 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.0 mm -117.91 137.99 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.067 1.747 . . . . 0.0 109.014 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.6 125.46 49.33 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.527 1.531 . . . . 0.0 109.215 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.1 mt -126.21 127.15 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 120.393 -1.442 . . . . 0.0 111.241 -170.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.07 74.21 1.03 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.796 2.039 . . . . 0.0 112.609 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -179.12 52.89 0.09 OUTLIER Glycine 0 N--CA 1.466 0.677 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.938 165.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 65.4 mtm -137.54 91.85 2.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.47 0.708 . . . . 0.0 109.826 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.5 t -94.57 -29.19 15.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.672 1.189 . . . . 0.0 113.191 -173.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 91.6 m -125.11 154.56 41.23 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.514 1.526 . . . . 0.0 110.112 175.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.15 65.69 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.3 p -54.91 -24.32 22.99 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.079 -1.013 . . . . 0.0 113.615 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 95.2 m -57.13 -29.27 63.43 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.693 -1.254 . . . . 0.0 112.592 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.22 -49.88 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.612 0.765 . . . . 0.0 110.523 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.14 -21.05 66.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.255 0.934 . . . . 0.0 113.228 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 t -74.1 -62.11 1.62 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.453 0.701 . . . . 0.0 111.304 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 47.4 mt -70.78 -48.54 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.83 -1.169 . . . . 0.0 111.494 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.19 -26.15 68.67 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.223 0.609 . . . . 0.0 111.711 176.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.35 -59.77 4.05 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.531 1.062 . . . . 0.0 112.178 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 92.7 mmm -71.57 -39.5 70.57 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.923 1.689 . . . . 0.0 114.208 -172.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.3 mm -70.96 -32.45 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.366 -0.834 . . . . 0.0 111.084 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.7 t -65.36 0.55 1.42 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -96.35 -11.24 26.09 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.479 -1.388 . . . . 0.0 114.589 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 pp -93.07 166.04 12.55 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.485 1.514 . . . . 0.0 111.429 174.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.18 138.23 31.69 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.449 -0.782 . . . . 0.0 112.537 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 101.16 15.6 27.66 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.556 1.55 . . . . 0.0 115.029 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.8 94.43 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.705 2.002 . . . . 0.0 110.502 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -68.0 -56.98 6.94 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.165 0.986 . . . . 0.0 111.02 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -140.0 131.44 26.92 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.475 1.11 . . . . 0.0 109.147 -171.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -136.47 131.33 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.865 0.866 . . . . 0.0 110.452 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.1 t -138.25 138.77 38.79 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.239 1.816 . . . . 0.0 108.686 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.5 p -143.45 145.55 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.962 1.305 . . . . 0.0 111.73 -175.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 t -135.19 135.38 40.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -172.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.93 -18.91 64.7 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.058 2.143 . . . . 0.0 113.959 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.19 78.98 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.545 1.138 . . . . 0.0 113.114 -176.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -130.87 -8.05 3.97 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.419 1.488 . . . . 0.0 112.336 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.6 41.3 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.595 1.093 . . . . 0.0 111.502 -171.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 71.3 p -130.17 145.86 51.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.513 1.156 . . . . 0.0 113.559 -168.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -115.06 141.19 48.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.915 1.686 . . . . 0.0 112.459 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.1 t -110.39 124.19 51.26 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 167.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.27 136.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.828 -0.545 . . . . 0.0 111.366 -171.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.15 101.86 13.63 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.932 2.093 . . . . 0.0 106.485 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -104.18 164.2 11.88 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.597 1.159 . . . . 0.0 112.629 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -107.02 93.34 8.96 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.089 1.356 . . . . 0.0 110.849 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.19 -19.19 50.93 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.586 2.857 . . . . 0.0 112.26 -172.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.15 -15.87 63.01 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.77 -38.5 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 126.463 1.905 . . . . 0.0 113.422 -168.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.7 tt -141.93 151.71 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.878 1.271 . . . . 0.0 111.53 -171.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.9 t -101.07 143.38 26.48 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 170.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.37 -26.49 27.95 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.784 2.989 . . . . 0.0 113.935 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -70.49 -40.65 73.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.462 0.705 . . . . 0.0 111.551 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -78.23 -24.29 47.06 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 168.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.23 -50.8 72.61 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.955 1.302 . . . . 0.0 109.325 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -50.62 -46.63 58.29 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.371 1.468 . . . . 0.0 111.433 168.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.07 -21.35 66.49 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.58 65.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.449 1.022 . . . . 0.0 112.367 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.2 mp -74.27 -40.43 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.216 1.007 . . . . 0.0 111.158 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -65.71 -27.58 68.43 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.996 0.816 . . . . 0.0 112.846 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.24 -42.53 68.75 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.0 1.32 . . . . 0.0 112.362 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.1 tpt -61.23 -31.96 71.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.071 0.851 . . . . 0.0 111.434 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 109.0 44.16 1.13 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 126.584 2.04 . . . . 0.0 113.187 172.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -124.24 -159.73 0.89 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.92 149.6 47.43 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.692 -1.255 . . . . 0.0 109.212 168.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.55 155.0 44.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.502 1.144 . . . . 0.0 113.542 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.9 t -142.62 138.27 30.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.379 1.872 . . . . 0.0 108.99 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.3 m -88.11 128.68 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 121.47 -0.769 . . . . 0.0 109.108 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . 0.288 2.7 p . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 124.698 2.19 . . . . 0.0 107.675 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.41 150.95 22.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.317 2.247 . . . . 0.0 111.86 176.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 tt -146.24 143.65 29.35 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.264 2.226 . . . . 0.0 112.135 -169.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -95.2 121.76 37.18 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.387 1.089 . . . . 0.0 110.454 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -130.69 127.45 38.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.118 -1.401 . . . . 0.0 113.296 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -106.84 110.27 22.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.058 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 mm -77.15 157.37 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.236 1.014 . . . . 0.0 109.935 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -135.54 147.63 48.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.542 1.137 . . . . 0.0 110.959 168.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 11.24 84.72 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.63 1.109 . . . . 0.0 113.353 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.4 ptm -68.01 -33.07 73.92 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.993 1.396 . . . . 0.0 113.912 -169.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 69.08 -51.77 0.59 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.693 2.397 . . . . 0.0 112.474 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 31.0 p -173.37 -173.74 0.93 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.829 2.052 . . . . 0.0 112.388 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -46.44 -33.41 3.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.941 1.697 . . . . 0.0 113.503 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.5 m -53.25 -30.05 36.12 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.553 1.07 . . . . 0.0 113.703 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.5 t -64.46 -42.07 96.15 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.965 -1.084 . . . . 0.0 113.817 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.269 4.8 p -73.62 -6.31 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.34 -59.09 5.17 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.186 1.357 . . . . 0.0 111.712 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -61.33 -31.66 71.52 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.263 0.938 . . . . 0.0 111.989 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.1 mt -59.44 -56.5 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.33 -35.48 73.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.034 1.733 . . . . 0.0 114.424 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.01 -41.01 97.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.305 1.042 . . . . 0.0 111.534 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -96.35 -33.65 11.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.2 mm -107.09 111.92 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.616 1.166 . . . . 0.0 110.346 -167.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.08 -18.64 6.97 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.497 1.523 . . . . 0.0 113.877 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -85.53 -6.01 59.23 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.5 -1.0 . . . . 0.0 112.542 169.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.8 mt -79.49 -179.13 6.65 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.9 2.08 . . . . 0.0 113.538 -170.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.81 -77.97 0.06 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.306 2.243 . . . . 0.0 111.806 170.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.5 -36.47 58.96 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.589 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -92.51 118.59 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.246 1.523 . . . . 0.0 110.249 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -101.7 -24.62 14.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.742 0.817 . . . . 0.0 113.179 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.8 m -149.97 156.06 41.06 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.587 -1.32 . . . . 0.0 113.661 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 tp -125.94 147.06 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.011 1.324 . . . . 0.0 109.914 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -142.8 166.92 23.32 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.356 1.862 . . . . 0.0 108.471 -172.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -139.38 160.52 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 119.687 -1.883 . . . . 0.0 113.365 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.0 t -140.95 56.61 1.56 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.39 1.876 . . . . 0.0 108.244 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.7 mt -61.52 -33.99 74.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -168.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.17 -17.11 64.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.162 1.346 . . . . 0.0 113.388 172.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -104.02 -1.4 27.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.657 1.583 . . . . 0.0 111.807 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 70.12 9.57 7.09 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.27 2.628 . . . . 0.0 113.586 173.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.51 152.79 18.64 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.701 2.001 . . . . 0.0 109.325 176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.46 171.7 7.26 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.012 1.325 . . . . 0.0 107.551 165.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -141.92 137.79 31.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.915 0.486 . . . . 0.0 110.367 -169.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.35 132.65 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 118.795 0.725 . . . . 0.0 112.059 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -105.36 94.2 5.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.727 2.011 . . . . 0.0 107.702 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -131.23 162.73 29.34 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -168.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -97.57 114.12 64.43 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 128.106 2.562 . . . . 0.0 110.919 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.29 25.24 0.53 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.564 2.843 . . . . 0.0 113.617 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.8 t -117.82 -26.36 6.53 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.369 -1.457 . . . . 0.0 112.8 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.6 m -93.66 -29.01 15.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.128 0.971 . . . . 0.0 113.524 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -144.6 -179.07 6.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.97 1.708 . . . . 0.0 112.223 -171.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.6 p -157.81 163.0 26.09 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.133 1.373 . . . . 0.0 112.47 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -51.21 -50.68 13.14 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 124.771 3.647 . . . . 0.0 115.82 -171.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.28 -37.23 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 119.216 0.916 . . . . 0.0 112.59 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.57 79.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.257 0.623 . . . . 0.0 110.855 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.7 mt -64.37 -45.06 89.34 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.571 0.748 . . . . 0.0 112.142 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -52.06 -55.82 18.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.879 0.872 . . . . 0.0 110.545 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -70.21 -22.56 62.91 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.01 -56.47 6.09 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.316 0.962 . . . . 0.0 112.273 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 9.6 pt -71.54 -31.4 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -172.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -60.71 -30.23 69.83 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.29 13.79 26.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.6 mt -62.41 -49.27 84.54 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 117.305 -1.331 . . . . 0.0 112.662 167.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.61 172.07 16.43 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.707 2.938 . . . . 0.0 112.997 174.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.94 63.0 6.73 Favored 'Trans proline' 0 CA--C 1.541 0.847 1 C-N-CA 125.462 4.108 . . . . 0.0 111.109 173.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.87 32.5 82.15 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.011 1.291 . . . . 0.0 112.986 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -105.49 -48.17 3.74 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -166.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -95.6 128.53 42.54 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.01 157.56 15.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.51 1.524 . . . . 0.0 109.384 173.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.24 136.85 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 119.533 1.06 . . . . 0.0 111.636 170.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.3 m -124.36 140.37 53.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.686 1.595 . . . . 0.0 112.919 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.615 0 C-N-CA 126.462 1.905 . . . . 0.0 111.556 -163.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 5.7 m -144.03 138.8 28.61 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 p -142.35 154.82 44.98 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 127.44 2.296 . . . . 0.0 110.266 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 54.5 m -101.64 145.39 29.14 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.554 -0.716 . . . . 0.0 109.978 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.16 150.88 38.75 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.201 1.001 . . . . 0.0 111.058 172.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.76 137.96 50.3 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.583 1.553 . . . . 0.0 109.054 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.3 mm -119.12 137.29 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.554 1.942 . . . . 0.0 108.525 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -100.33 128.05 46.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.109 1.363 . . . . 0.0 109.288 170.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.02 136.21 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 120.702 -1.249 . . . . 0.0 110.909 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.68 61.7 1.23 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.965 1.706 . . . . 0.0 111.755 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.31 56.23 0.19 Allowed Glycine 0 N--CA 1.463 0.459 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.721 169.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.9 mtm -138.74 74.9 1.49 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.205 1.002 . . . . 0.0 110.499 -177.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.2 t -79.84 -19.99 47.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.72 1.208 . . . . 0.0 112.513 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 95.0 m -128.23 153.02 47.39 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.454 1.901 . . . . 0.0 111.06 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.77 -24.46 61.76 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.361 -0.837 . . . . 0.0 112.848 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.6 p -51.11 -37.36 45.49 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.987 -1.071 . . . . 0.0 111.97 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.4 m -54.15 -36.32 63.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.779 1.632 . . . . 0.0 113.336 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 t -59.85 -56.3 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -69.34 -17.61 63.72 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 m -72.52 -54.84 8.08 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.617 1.167 . . . . 0.0 111.788 167.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.81 -58.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.778 0.831 . . . . 0.0 110.198 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -57.32 -28.63 63.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.997 2.119 . . . . 0.0 112.014 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.62 -56.96 4.76 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 125.842 1.687 . . . . 0.0 114.239 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 13.1 mmt -71.29 -45.79 62.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.909 0.884 . . . . 0.0 112.093 -172.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.7 -39.68 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -169.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -2.25 2.7 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.96 -16.65 27.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.041 1.336 . . . . 0.0 113.814 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -95.75 162.55 13.55 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.908 1.231 . . . . 0.0 111.844 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -77.1 166.37 23.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.279 1.038 . . . . 0.0 113.596 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.9 -41.84 1.77 Allowed Glycine 0 CA--C 1.531 1.077 0 O-C-N 120.822 -1.174 . . . . 0.0 114.069 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 p -78.14 97.44 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.135 1.468 . . . . 0.0 111.394 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -68.87 -52.24 31.85 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.304 1.441 . . . . 0.0 111.545 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -143.52 144.68 32.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.868 0.867 . . . . 0.0 109.94 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.9 tt -135.93 140.17 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.14 0.976 . . . . 0.0 110.077 172.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 42.0 t -138.95 136.44 35.42 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.641 1.576 . . . . 0.0 109.946 175.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.5 p -143.79 147.39 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 119.665 1.12 . . . . 0.0 112.394 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.1 t -143.45 151.37 40.26 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.838 1.255 . . . . 0.0 112.658 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.6 mt -72.85 -29.3 63.1 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -46.21 -38.85 8.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.816 2.047 . . . . 0.0 115.303 -168.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -125.0 -1.14 7.82 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.194 1.798 . . . . 0.0 111.383 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 68.28 50.95 35.43 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 128.228 2.823 . . . . 0.0 112.019 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.8 p -141.66 145.12 34.56 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -114.99 144.87 42.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.043 1.737 . . . . 0.0 111.506 171.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.3 t -120.98 127.69 52.03 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.792 1.237 . . . . 0.0 108.208 168.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.26 140.18 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.024 0.93 . . . . 0.0 111.461 -167.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.34 116.25 30.17 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.431 2.292 . . . . 0.0 107.774 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -136.7 158.77 43.67 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -96.93 116.57 66.11 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.35 1.46 . . . . 0.0 110.606 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -82.25 -0.43 10.23 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.956 3.104 . . . . 0.0 114.121 -173.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.05 -37.48 12.14 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.678 1.191 . . . . 0.0 112.311 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 82.0 t -89.87 -31.69 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 126.668 1.987 . . . . 0.0 112.436 -176.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.459 ' CG1' ' H ' ' A' ' 172' ' ' SER . 14.6 tt -138.2 -178.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.522 1.129 . . . . 0.0 110.773 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' SER . . . . . 0.459 ' H ' ' CG1' ' A' ' 171' ' ' ILE . 21.6 t -140.6 148.2 52.2 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 126.497 1.919 . . . . 0.0 110.23 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.57 -27.12 31.49 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.684 2.256 . . . . 0.0 113.664 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.51 -31.53 69.83 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.982 0.81 . . . . 0.0 111.385 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.03 -36.52 64.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.971 1.709 . . . . 0.0 111.615 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.6 mt -58.04 -57.14 14.15 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.049 0.939 . . . . 0.0 109.743 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -38.9 93.0 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 177.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.91 -30.44 67.82 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.97 0.804 . . . . 0.0 113.034 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.57 -31.9 69.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.367 0.985 . . . . 0.0 112.45 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.07 -35.67 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.979 0.912 . . . . 0.0 111.256 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.38 -29.11 65.68 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.866 0.757 . . . . 0.0 112.895 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.51 -29.61 63.77 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.643 1.177 . . . . 0.0 113.078 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 53.4 ttm -69.63 -48.84 58.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.848 0.859 . . . . 0.0 110.257 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 134.76 43.46 0.12 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.051 1.31 . . . . 0.0 114.882 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -140.8 -155.67 0.61 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.467 1.507 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -133.07 143.83 49.59 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.511 1.124 . . . . 0.0 111.368 172.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -141.5 145.0 34.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.756 1.222 . . . . 0.0 112.337 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.4 t -133.23 141.2 47.92 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.41 1.484 . . . . 0.0 109.95 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.9 m -82.48 132.23 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 O-C-N 122.042 -0.411 . . . . 0.0 111.2 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . 0.264 5.0 p . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 124.673 2.177 . . . . 0.0 107.212 169.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.4 m -126.97 134.84 50.3 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 123.357 0.663 . . . . 0.0 110.909 -168.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.56 166.75 23.87 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 115.591 1.701 . . . . 0.0 115.591 175.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -120.45 128.17 52.91 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.088 2.155 . . . . 0.0 110.938 -169.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.05 138.35 29.87 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.74 109.91 22.58 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -177.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 mt -83.25 134.21 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.254 1.422 . . . . 0.0 109.293 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -101.69 127.45 48.43 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.371 1.468 . . . . 0.0 110.882 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.4 -5.76 38.47 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.192 1.377 . . . . 0.0 113.626 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.6 ptp -61.15 -10.41 6.4 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -53.35 -12.99 0.48 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.216 1.407 . . . . 0.0 113.623 167.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.2 t -119.41 127.88 53.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.409 1.884 . . . . 0.0 108.893 167.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -58.24 -31.68 67.62 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.941 -1.099 . . . . 0.0 113.343 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 m -50.32 -30.65 12.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.719 1.207 . . . . 0.0 113.617 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.0 t -63.48 -58.19 7.8 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.546 1.138 . . . . 0.0 111.759 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 p -70.01 -25.35 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.231 0.923 . . . . 0.0 111.82 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.33 -61.34 2.7 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.041 0.936 . . . . 0.0 111.885 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -62.88 -32.5 73.77 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.969 -0.457 . . . . 0.0 111.673 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.05 -50.37 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.751 0.705 . . . . 0.0 110.32 172.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.66 -31.84 73.14 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.949 1.3 . . . . 0.0 112.528 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -70.18 -46.94 63.6 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.256 -0.902 . . . . 0.0 112.067 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -91.46 -13.13 32.8 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -170.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.9 mm -105.16 121.79 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.924 1.238 . . . . 0.0 111.421 -178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.98 -19.77 7.74 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.899 1.714 . . . . 0.0 114.185 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -77.35 -3.19 38.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.767 1.227 . . . . 0.0 112.599 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.7 mt -84.52 -175.76 5.93 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.88 2.872 . . . . 0.0 111.966 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.9 tp -85.82 -79.85 0.24 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.066 1.746 . . . . 0.0 111.256 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.54 -30.98 65.9 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 117.857 -1.524 . . . . 0.0 113.576 -171.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.38 117.39 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 119.173 1.486 . . . . 0.0 107.734 167.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -108.09 -36.46 6.32 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -170.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -147.62 168.12 22.82 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.31 1.044 . . . . 0.0 111.229 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.5 tp -140.68 141.65 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.546 1.138 . . . . 0.0 110.085 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -137.24 155.4 49.54 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.954 2.102 . . . . 0.0 107.47 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.4 m -123.66 145.63 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.627 -1.921 . . . . 0.0 110.914 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m -128.15 54.45 1.73 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.574 1.15 . . . . 0.0 108.135 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.13 -30.04 71.13 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.685 1.594 . . . . 0.0 112.365 -171.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.68 -37.41 63.19 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.4 0.68 . . . . 0.0 111.994 170.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -102.51 2.53 36.44 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.608 1.563 . . . . 0.0 112.925 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? 68.18 12.38 8.74 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.149 2.579 . . . . 0.0 114.209 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.1 p -99.92 162.75 12.79 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.723 1.249 . . . . 0.0 110.273 169.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.1 161.93 14.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 165.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.3 tp60 -137.08 127.15 26.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -169.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.16 140.48 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.444 -1.41 . . . . 0.0 111.915 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.36 108.85 21.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.067 1.347 . . . . 0.0 108.601 173.184 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -131.09 178.64 6.54 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.132 1.373 . . . . 0.0 110.26 -175.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -124.44 134.49 25.58 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.53 1.132 . . . . 0.0 109.445 170.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.49 20.06 0.8 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.215 3.277 . . . . 0.0 114.307 -169.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 p -121.96 -51.76 2.0 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.813 2.045 . . . . 0.0 110.586 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 90.2 m -77.46 -25.32 50.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.562 1.545 . . . . 0.0 114.463 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 t -145.28 -177.36 5.51 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.42 1.888 . . . . 0.0 109.318 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.7 p -149.57 162.17 29.37 Favored Pre-proline 0 C--N 1.321 -0.674 0 C-N-CA 125.211 1.404 . . . . 0.0 110.155 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.19 -56.37 3.11 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.42 2.747 . . . . 0.0 113.05 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.25 -35.64 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.42 -52.68 12.86 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.378 0.671 . . . . 0.0 111.606 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -37.47 82.97 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.212 1.405 . . . . 0.0 111.071 -177.084 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.9 -57.86 10.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.523 1.129 . . . . 0.0 111.539 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -63.29 -32.16 73.5 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.49 -52.71 64.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.299 0.64 . . . . 0.0 110.659 174.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 pt -73.41 -31.37 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -70.17 -23.91 63.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.64 10.63 39.45 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 176.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 mt -56.71 -59.14 13.23 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.063 168.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.09 173.28 14.36 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.623 2.215 . . . . 0.0 111.001 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.89 67.5 5.82 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.731 2.954 . . . . 0.0 110.135 169.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 56.22 46.03 86.88 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 125.594 1.568 . . . . 0.0 112.741 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -115.39 -21.22 9.94 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -165.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -133.12 116.78 16.72 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.154 1.382 . . . . 0.0 110.75 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -99.19 139.42 34.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.21 1.404 . . . . 0.0 112.091 -173.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.5 140.43 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 120.5 1.5 . . . . 0.0 112.932 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.8 t -122.94 128.69 50.61 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.225 1.81 . . . . 0.0 110.89 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 125.79 1.636 . . . . 0.0 112.598 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 24.7 p -157.01 132.88 9.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.607 1.563 . . . . 0.0 113.56 -168.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.0 p -148.0 145.26 28.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.905 2.082 . . . . 0.0 110.041 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 90.2 m -105.26 135.58 46.37 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.471 1.032 . . . . 0.0 110.499 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.68 149.23 44.92 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.987 1.315 . . . . 0.0 110.974 172.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tt -96.46 141.21 30.03 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.095 2.158 . . . . 0.0 110.042 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mt -127.91 134.4 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.626 1.571 . . . . 0.0 109.246 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.2 130.76 44.39 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.27 1.028 . . . . 0.0 108.266 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 90.6 mt -132.94 136.09 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.48 -0.763 . . . . 0.0 111.144 -168.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.07 72.27 1.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.882 1.673 . . . . 0.0 111.882 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -177.49 52.13 0.1 Allowed Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.242 -0.89 . . . . 0.0 114.399 167.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -104.41 -58.08 1.94 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.274 5.6 t 54.84 -56.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 129.433 3.093 . . . . 0.0 115.757 -169.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 92.3 m -112.99 150.82 31.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.744 2.418 . . . . 0.0 111.095 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.6 73.43 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.865 1.266 . . . . 0.0 112.614 -177.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.5 p -43.49 -47.53 7.2 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.218 1.407 . . . . 0.0 112.385 169.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 5.6 t -71.5 -25.08 62.11 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.54 -53.39 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.43 -33.29 73.47 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.1 m -67.17 -51.72 50.28 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.708 0.803 . . . . 0.0 112.898 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 83.8 mt -62.01 -46.54 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-N 119.965 1.257 . . . . 0.0 110.665 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -58.74 -28.77 66.18 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.814 1.645 . . . . 0.0 112.164 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.48 -61.05 3.28 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.969 1.271 . . . . 0.0 113.281 170.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -47.74 69.74 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.319 1.448 . . . . 0.0 113.139 -169.246 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.0 mm -71.67 -34.67 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.157 -0.339 . . . . 0.0 111.735 -169.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.0 t -50.96 -21.99 2.04 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.487 1.915 . . . . 0.0 115.313 176.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -86.18 -19.82 29.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.122 1.769 . . . . 0.0 115.163 -167.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.1 pp -92.92 151.28 20.04 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.181 0.901 . . . . 0.0 112.403 -173.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -59.38 135.22 57.59 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.952 0.882 . . . . 0.0 112.49 -169.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.27 -27.56 9.21 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.064 -1.965 . . . . 0.0 115.343 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.97 94.05 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 121.214 2.507 . . . . 0.0 108.778 169.634 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -74.84 -44.07 51.11 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.345 1.058 . . . . 0.0 111.374 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -141.95 147.18 36.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.476 1.034 . . . . 0.0 109.96 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.46 148.54 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.109 0.956 . . . . 0.0 113.272 175.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 47.5 t -134.39 136.84 43.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 129.031 2.932 . . . . 0.0 108.513 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.77 143.9 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.616 1.553 . . . . 0.0 112.766 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 42.0 m -141.51 148.71 39.83 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.195 1.398 . . . . 0.0 113.233 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.43 -26.43 55.49 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.813 1.645 . . . . 0.0 114.133 172.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.25 -33.48 58.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.834 1.653 . . . . 0.0 113.894 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -123.83 -10.54 7.75 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.276 1.83 . . . . 0.0 111.087 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.72 44.61 19.8 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.406 1.003 . . . . 0.0 110.793 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 49.0 p -133.74 146.63 50.93 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.073 0.949 . . . . 0.0 111.863 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -121.82 161.2 23.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.77 1.628 . . . . 0.0 111.057 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.8 t -141.46 139.21 33.32 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 124.191 0.996 . . . . 0.0 109.173 168.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.63 142.86 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.226 -167.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.38 98.62 11.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 173.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -100.22 154.52 18.39 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.9 0.88 . . . . 0.0 111.67 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -98.81 109.11 52.31 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.161 0.984 . . . . 0.0 110.087 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.78 -10.88 23.64 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.438 2.092 . . . . 0.0 112.472 -170.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.26 -17.42 46.01 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 93.6 t -120.45 -29.12 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.911 1.284 . . . . 0.0 114.02 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.3 tt -141.1 147.25 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.186 0.903 . . . . 0.0 110.324 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.63 150.04 36.32 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.939 0.895 . . . . 0.0 111.004 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.43 -39.47 36.1 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.246 2.631 . . . . 0.0 113.924 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -65.01 -25.25 67.78 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.7 -27.79 55.64 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.614 1.165 . . . . 0.0 113.875 174.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.6 mt -59.77 -53.76 54.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -65.2 -34.68 78.95 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.18 -27.63 68.56 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.05 -36.44 72.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.89 0.768 . . . . 0.0 112.723 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.4 mp -72.41 -37.45 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.286 1.035 . . . . 0.0 110.837 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -63.43 -34.05 76.9 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.817 -0.552 . . . . 0.0 111.485 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -71.88 -24.4 61.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.008 1.323 . . . . 0.0 113.336 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 21.2 ttt -74.85 -29.46 61.05 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.673 1.189 . . . . 0.0 112.609 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 115.5 30.99 2.08 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 126.084 1.802 . . . . 0.0 114.875 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -133.76 -158.51 0.89 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.842 1.657 . . . . 0.0 109.18 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -137.57 143.17 41.41 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.287 1.035 . . . . 0.0 111.459 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -140.88 152.22 44.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.027 1.731 . . . . 0.0 112.065 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.5 t -141.36 130.99 24.02 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.006 1.323 . . . . 0.0 112.232 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.55 81.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.127 0.971 . . . . 0.0 111.412 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 125.025 1.33 . . . . 0.0 112.457 179.526 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -118.36 144.9 45.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.501 1.121 . . . . 0.0 111.399 -170.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.38 128.71 19.98 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.496 1.519 . . . . 0.0 109.85 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -96.3 135.69 37.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.355 1.462 . . . . 0.0 112.237 -176.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -142.87 146.91 34.54 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.92 109.62 19.85 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.449 1.499 . . . . 0.0 109.146 174.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.7 mt -85.41 147.21 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.199 1.799 . . . . 0.0 111.676 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -98.19 139.84 33.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.984 1.313 . . . . 0.0 111.07 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.27 -6.89 81.04 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.196 1.379 . . . . 0.0 114.101 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 ptp -64.19 -15.75 60.53 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -63.82 -13.5 44.99 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.62 1.554 . . . . 0.0 113.223 170.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.1 m -77.03 -14.72 59.79 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.15 -1.594 . . . . 0.0 114.155 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 70.8 -50.9 0.68 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 128.139 2.576 . . . . 0.0 111.955 -172.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 m -60.0 -17.97 42.49 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.766 -1.209 . . . . 0.0 113.583 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 t -64.38 -53.05 54.7 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.548 1.139 . . . . 0.0 111.565 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.72 -27.92 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 118.638 0.654 . . . . 0.0 112.281 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.1 tp -53.65 -49.54 67.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 112.376 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -39.18 88.51 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.478 0.581 . . . . 0.0 111.914 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.1 mt -65.51 -49.5 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.263 1.025 . . . . 0.0 109.264 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.69 -41.6 98.12 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.68 1.592 . . . . 0.0 111.938 -176.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.7 -39.22 87.97 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.031 -0.509 . . . . 0.0 111.49 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -91.6 -25.01 19.39 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -172.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 47.8 mm -102.91 118.64 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.874 0.87 . . . . 0.0 110.431 -173.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.23 -17.5 3.57 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.866 1.698 . . . . 0.0 115.215 -177.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -88.54 -5.33 58.27 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.091 1.356 . . . . 0.0 111.919 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -76.4 170.4 16.43 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.006 2.122 . . . . 0.0 111.247 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.57 -62.88 1.31 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.427 -0.795 . . . . 0.0 110.964 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.04 -43.13 17.85 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.853 -0.97 . . . . 0.0 113.237 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.26 123.92 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.221 1.511 . . . . 0.0 110.502 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -94.74 -46.22 7.0 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.186 0.994 . . . . 0.0 111.31 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.8 t -149.41 172.04 15.59 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.563 0.745 . . . . 0.0 112.481 -169.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 tp -142.39 125.2 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.561 1.944 . . . . 0.0 107.434 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -120.23 149.45 42.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.554 0.741 . . . . 0.0 109.65 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.8 m -106.62 155.87 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.201 -0.937 . . . . 0.0 111.03 -170.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.4 t -139.73 57.82 1.62 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 123.138 1.447 . . . . 0.0 108.182 175.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.86 -24.13 65.22 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.611 1.564 . . . . 0.0 112.714 -171.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.21 -11.88 35.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.003 1.321 . . . . 0.0 113.61 169.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -122.84 7.59 9.35 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.172 2.189 . . . . 0.0 111.649 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 mptt 62.2 14.17 6.46 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.383 2.273 . . . . 0.0 113.746 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.73 167.14 10.08 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.634 1.574 . . . . 0.0 111.76 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.67 152.79 45.64 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 127.157 2.183 . . . . 0.0 107.207 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.63 133.65 46.31 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 172.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 p -96.22 136.86 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.519 0.676 . . . . 0.0 109.732 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -107.19 87.89 2.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.59 1.956 . . . . 0.0 107.51 -172.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -116.33 -179.3 3.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.481 1.512 . . . . 0.0 110.42 -175.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.13 142.17 36.05 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 168.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.08 7.19 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.388 2.058 . . . . 0.0 114.308 -168.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -74.96 -51.38 13.85 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.28 -1.512 . . . . 0.0 112.369 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 90.0 m -95.46 -15.81 22.69 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -172.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.9 t -147.81 175.69 10.73 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.647 1.179 . . . . 0.0 112.448 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.4 p -155.46 161.54 29.23 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.606 1.162 . . . . 0.0 112.754 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.85 -45.71 38.98 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.131 2.554 . . . . 0.0 115.583 -170.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.91 -41.18 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 118.814 0.734 . . . . 0.0 111.945 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.48 86.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.954 0.901 . . . . 0.0 112.268 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.56 -40.56 92.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.989 0.916 . . . . 0.0 111.799 173.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 37.8 tt0 -58.69 -45.64 89.04 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.256 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -61.59 -36.79 81.66 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.542 1.065 . . . . 0.0 112.892 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.18 -60.33 2.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.23 1.012 . . . . 0.0 113.43 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 8.6 pt -73.2 -32.65 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -169.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -70.0 -19.62 63.32 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.84 0.856 . . . . 0.0 112.684 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.59 11.21 37.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.997 1.319 . . . . 0.0 113.934 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -60.61 -50.46 85.29 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.371 -1.3 . . . . 0.0 111.631 167.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.25 172.84 12.35 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.583 2.855 . . . . 0.0 112.22 170.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.56 43.25 1.18 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.217 3.278 . . . . 0.0 112.236 170.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.41 58.05 5.23 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 121.155 -0.966 . . . . 0.0 111.149 -174.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -133.8 -42.33 0.83 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -97.9 115.53 28.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -102.4 158.46 16.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.016 0.926 . . . . 0.0 111.772 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.86 139.25 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.364 0.984 . . . . 0.0 112.037 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.8 t -128.9 130.5 46.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.012 0.925 . . . . 0.0 111.945 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 CA--C 1.552 1.021 0 C-N-CA 125.355 1.462 . . . . 0.0 111.461 -175.887 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 87.1 m 58.53 92.63 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.237 1.815 . . . . 0.0 112.758 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 t -140.15 154.04 46.85 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.882 -1.136 . . . . 0.0 111.727 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.1 m -99.27 129.84 45.52 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -176.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.82 153.59 43.85 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.087 0.946 . . . . 0.0 110.126 168.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tt -102.55 130.5 49.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.705 2.002 . . . . 0.0 109.447 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.3 mm -115.12 138.55 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.174 1.789 . . . . 0.0 109.187 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -104.51 125.04 50.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.923 0.889 . . . . 0.0 110.044 169.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.9 mp -115.85 139.85 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.457 1.026 . . . . 0.0 112.369 -169.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.31 70.55 0.72 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.229 2.211 . . . . 0.0 111.539 171.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -176.2 54.09 0.11 Allowed Glycine 0 N--CA 1.466 0.659 0 C-N-CA 124.86 1.219 . . . . 0.0 112.753 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.9 mtm -134.98 157.78 46.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.514 1.526 . . . . 0.0 109.869 170.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.8 t -174.94 -45.34 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.593 1.557 . . . . 0.0 110.74 -171.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 67.0 m -104.68 146.05 29.48 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.863 1.265 . . . . 0.0 109.127 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.89 -27.69 68.34 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.622 -0.674 . . . . 0.0 112.605 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 79.9 p -56.06 -23.9 36.47 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.913 -1.117 . . . . 0.0 113.468 172.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 73.2 m -56.16 -27.82 55.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.372 1.069 . . . . 0.0 113.49 170.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.2 t -54.33 -52.58 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 118.91 0.777 . . . . 0.0 109.492 173.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -70.6 -14.8 62.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.232 1.013 . . . . 0.0 113.098 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.3 m -73.41 -56.14 5.44 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.064 -1.023 . . . . 0.0 109.65 167.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.5 mt -68.17 -59.23 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.695 1.198 . . . . 0.0 110.568 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -54.55 -29.52 51.21 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.646 1.578 . . . . 0.0 111.63 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.58 -62.65 3.15 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.373 0.987 . . . . 0.0 112.727 176.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 86.6 mmm -75.56 -42.49 52.09 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.771 1.396 . . . . 0.0 114.771 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 31.8 mm -72.32 -30.51 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.596 0.759 . . . . 0.0 111.829 -172.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.6 p -63.82 -9.37 14.44 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 175.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -107.92 22.95 15.22 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.028 1.331 . . . . 0.0 113.577 -171.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 pp -115.56 163.72 15.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.759 1.223 . . . . 0.0 111.544 169.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -65.57 135.8 55.56 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.12 16.57 74.17 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 117.891 -1.505 . . . . 0.0 115.89 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.75 -23.56 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 125.507 1.523 . . . . 0.0 114.292 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 42.65 -76.31 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 129.841 3.256 . . . . 0.0 117.37 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -128.28 127.91 43.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.55 1.523 . . . . 0.0 111.375 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.6 tt -134.6 137.66 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 121.188 -0.945 . . . . 0.0 111.164 -169.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 21.9 t -143.26 133.37 24.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.869 2.067 . . . . 0.0 108.248 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.58 143.62 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 119.785 1.175 . . . . 0.0 111.711 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -141.38 133.45 27.72 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -59.05 -22.08 60.16 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.041 2.137 . . . . 0.0 113.23 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.06 -31.17 62.93 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.792 1.237 . . . . 0.0 112.724 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -133.3 -16.7 2.4 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.185 1.394 . . . . 0.0 113.555 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.1 26.74 65.72 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.803 1.192 . . . . 0.0 112.112 -169.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.4 p -121.42 148.85 43.85 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.64 1.176 . . . . 0.0 111.693 -171.016 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.64 137.48 50.85 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.786 1.234 . . . . 0.0 110.771 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.0 t -112.66 121.13 43.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 167.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.59 141.28 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 121.906 -0.496 . . . . 0.0 110.614 -169.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.31 101.93 14.64 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.637 1.975 . . . . 0.0 105.887 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -97.65 157.8 15.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.293 1.044 . . . . 0.0 111.718 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -101.42 94.49 4.16 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.713 1.205 . . . . 0.0 110.267 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.55 -35.71 94.87 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.118 2.545 . . . . 0.0 111.372 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.57 -8.18 18.63 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.36 -28.98 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 126.181 1.792 . . . . 0.0 112.535 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.8 tt -155.91 158.02 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 119.943 1.247 . . . . 0.0 112.351 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.5 t -98.1 145.27 29.51 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.854 1.262 . . . . 0.0 113.104 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.42 -33.23 66.06 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.102 2.535 . . . . 0.0 112.546 167.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.42 -27.07 66.76 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.982 0.81 . . . . 0.0 112.432 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -76.38 -37.07 57.73 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.323 1.049 . . . . 0.0 111.953 168.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.43 -53.59 56.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.286 1.834 . . . . 0.0 110.641 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -59.83 -37.82 80.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.74 0.7 . . . . 0.0 112.809 173.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.63 -23.91 67.32 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.26 -35.63 71.47 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.111 1.323 . . . . 0.0 112.731 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.65 -38.18 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.574 1.149 . . . . 0.0 110.191 171.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -69.39 -26.76 64.8 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.41 1.084 . . . . 0.0 112.734 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.66 -44.51 64.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.182 1.393 . . . . 0.0 111.393 168.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 22.6 ttt -61.72 -27.67 68.88 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.654 1.582 . . . . 0.0 112.396 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 115.23 38.79 0.99 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.478 1.514 . . . . 0.0 114.024 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -130.7 -160.54 1.05 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.236 1.414 . . . . 0.0 108.266 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -131.51 146.86 52.44 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.904 -1.123 . . . . 0.0 110.335 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.93 141.53 31.49 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.8 t -124.36 135.5 53.36 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.5 1.12 . . . . 0.0 112.021 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 m -87.07 80.63 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.908 0.883 . . . . 0.0 110.768 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.476 0.839 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.603 -178.082 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -98.85 153.46 18.77 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.479 2.711 . . . . 0.0 112.927 -174.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.5 tt -143.96 139.31 29.02 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.221 1.409 . . . . 0.0 112.991 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -98.46 110.33 22.94 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 122.689 1.233 . . . . 0.0 111.928 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -138.17 133.73 33.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.472 -1.695 . . . . 0.0 112.667 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -98.6 119.38 37.22 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.7 mt -96.83 137.34 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.031 0.932 . . . . 0.0 109.146 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -96.64 117.8 31.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.904 0.882 . . . . 0.0 110.913 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.62 -12.36 12.13 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.306 1.432 . . . . 0.0 113.689 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 12.9 ptp -56.52 -22.17 31.1 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.939 1.87 . . . . 0.0 114.075 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -58.64 -25.97 63.28 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 169.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -80.42 -8.49 59.56 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.606 -1.309 . . . . 0.0 113.52 173.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.7 tptt 70.08 -56.0 0.59 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 129.025 2.93 . . . . 0.0 111.781 -170.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -48.86 -27.35 2.98 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.718 2.407 . . . . 0.0 114.567 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 t -53.59 -49.06 68.57 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.951 1.7 . . . . 0.0 113.265 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.9 -28.24 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -170.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.69 -51.86 45.5 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.215 1.406 . . . . 0.0 111.343 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.19 -54.12 49.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -60.69 -37.0 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.591 0.756 . . . . 0.0 111.34 -173.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -64.08 -28.65 69.93 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.402 -0.811 . . . . 0.0 112.399 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.24 -50.3 34.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.24 1.016 . . . . 0.0 112.085 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -92.57 -24.29 18.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.549 1.54 . . . . 0.0 115.076 -171.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.4 mm -98.86 125.84 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 120.345 1.429 . . . . 0.0 109.746 177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.403 ' H ' HD11 ' A' ' 45' ' ' LEU . . . 125.41 -14.24 7.32 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.039 1.78 . . . . 0.0 114.636 -174.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -96.65 -1.88 45.82 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.749 1.274 . . . . 0.0 113.092 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.403 HD11 ' H ' ' A' ' 43' ' ' GLY . 5.6 mp -71.03 178.59 3.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.567 1.947 . . . . 0.0 110.71 -178.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -58.6 4.31 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.854 -1.154 . . . . 0.0 111.569 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.74 -31.28 7.49 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.729 -1.595 . . . . 0.0 113.519 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.74 113.08 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.938 2.369 . . . . 0.0 109.46 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -98.4 -39.8 8.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.066 0.946 . . . . 0.0 111.894 -175.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.0 t -147.36 159.72 43.37 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.489 -0.757 . . . . 0.0 112.165 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -133.59 121.14 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.414 1.485 . . . . 0.0 109.214 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -110.14 177.43 4.71 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.248 1.419 . . . . 0.0 108.695 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.8 166.96 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 169.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 t -141.48 59.81 1.5 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.324 1.85 . . . . 0.0 110.378 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.31 -22.77 61.74 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.685 2.394 . . . . 0.0 115.664 -173.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -61.52 -35.76 78.62 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.691 1.132 . . . . 0.0 111.058 171.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -104.25 -2.27 25.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.252 1.421 . . . . 0.0 114.049 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.1 mttp 81.98 4.5 1.23 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.122 2.169 . . . . 0.0 112.37 173.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.26 155.16 16.99 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.902 2.081 . . . . 0.0 109.976 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.48 -179.71 4.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 165.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -145.52 105.11 3.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.444 -0.785 . . . . 0.0 111.686 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 p -101.7 132.14 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.432 0.634 . . . . 0.0 111.544 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.0 94.96 6.55 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.085 1.754 . . . . 0.0 109.832 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -120.16 148.98 42.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.007 0.923 . . . . 0.0 111.957 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -96.06 115.62 65.68 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.157 1.383 . . . . 0.0 108.832 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.97 -8.94 24.86 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.036 2.49 . . . . 0.0 113.186 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 t -77.86 -11.15 59.86 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.855 0.752 . . . . 0.0 112.23 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 66.0 m -130.27 -18.33 3.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.3 t -145.14 -177.68 5.67 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.899 1.227 . . . . 0.0 111.177 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 p -151.82 161.34 29.8 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 125.195 1.398 . . . . 0.0 109.352 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -50.09 -46.0 30.44 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.332 2.688 . . . . 0.0 114.228 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.0 p -67.84 -40.96 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 120.429 1.468 . . . . 0.0 111.763 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.23 90.2 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.917 0.887 . . . . 0.0 112.273 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.37 -47.0 58.98 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.976 0.51 . . . . 0.0 111.86 173.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -68.41 -41.52 80.3 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.37 -0.831 . . . . 0.0 112.549 -169.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -56.79 -30.71 63.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.466 0.706 . . . . 0.0 112.291 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.96 -55.59 7.19 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.107 0.867 . . . . 0.0 111.674 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 pt -64.93 -30.04 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -168.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -59.85 -34.48 73.17 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.88 13.0 30.23 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.1 mt -55.92 -56.03 34.89 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.937 168.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.423 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 86.5 Cg_endo -73.02 -179.98 4.83 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.872 3.048 . . . . 0.0 111.768 171.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.02 41.4 0.47 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.766 3.644 . . . . 0.0 111.989 168.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.47 27.13 64.06 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.849 1.214 . . . . 0.0 113.196 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -95.81 -40.62 9.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.272 1.036 . . . . 0.0 113.538 -168.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.423 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 24.7 m-85 -98.17 113.94 26.01 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.027 1.331 . . . . 0.0 108.182 173.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -97.38 164.02 12.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.19 0.596 . . . . 0.0 109.963 -174.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.99 141.56 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.123 0.969 . . . . 0.0 110.067 171.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.1 t -128.18 128.57 45.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.475 1.11 . . . . 0.0 112.59 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 127.69 2.396 . . . . 0.0 111.057 174.838 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 20.5 p -162.51 118.03 1.88 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.03 2.132 . . . . 0.0 110.92 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.0 p -141.91 142.56 33.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.577 1.951 . . . . 0.0 109.228 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.7 m -102.73 139.99 37.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.664 0.665 . . . . 0.0 109.454 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.43 161.85 35.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.397 0.679 . . . . 0.0 111.141 169.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 tt -114.03 132.38 56.02 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.316 1.847 . . . . 0.0 109.287 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mt -127.79 134.6 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.519 1.128 . . . . 0.0 110.083 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.75 127.71 43.9 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.109 1.363 . . . . 0.0 108.766 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.3 mt -129.43 145.88 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.248 -0.907 . . . . 0.0 112.101 -167.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -113.99 57.73 0.69 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.283 1.833 . . . . 0.0 112.277 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.73 53.27 0.44 Allowed Glycine 0 CA--C 1.524 0.642 0 O-C-N 121.553 -0.717 . . . . 0.0 113.842 168.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -138.2 98.97 3.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.417 1.487 . . . . 0.0 108.274 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.7 t -93.42 -31.37 14.64 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.228 1.411 . . . . 0.0 112.327 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 5.2 m -144.04 169.36 17.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.872 2.469 . . . . 0.0 110.594 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.94 71.46 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.231 -0.918 . . . . 0.0 112.512 172.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.0 p -50.44 -36.16 32.0 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.874 -1.141 . . . . 0.0 113.048 169.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.7 t -72.53 -34.96 67.93 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.257 1.423 . . . . 0.0 112.521 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.29 -52.58 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.915 0.886 . . . . 0.0 109.249 169.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -61.47 -23.27 65.76 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.1 t -70.69 -51.12 29.7 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.612 -0.68 . . . . 0.0 112.114 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 52.5 mt -63.4 -54.08 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 120.822 1.646 . . . . 0.0 111.055 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -59.26 -25.41 64.05 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.589 1.955 . . . . 0.0 110.918 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.8 -62.46 2.37 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.829 1.68 . . . . 0.0 114.056 168.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 89.8 mmm -70.56 -40.7 73.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.239 1.416 . . . . 0.0 113.817 -169.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.9 mm -70.67 -31.51 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.387 -0.821 . . . . 0.0 110.315 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.6 t -66.83 1.83 1.68 Allowed 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -87.13 -18.14 31.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.432 1.493 . . . . 0.0 114.09 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -102.6 165.85 10.85 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.972 1.26 . . . . 0.0 113.4 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -64.31 163.33 13.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.319 1.533 . . . . 0.0 113.779 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.87 -36.35 0.39 Allowed Glycine 0 CA--C 1.533 1.161 0 CA-C-O 117.847 -1.529 . . . . 0.0 115.283 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.0 p -70.42 93.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.493 1.647 . . . . 0.0 110.458 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -73.83 -45.55 50.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.98 1.712 . . . . 0.0 111.221 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -143.41 140.9 30.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.301 1.44 . . . . 0.0 108.299 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.9 tt -133.9 130.99 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.465 0.706 . . . . 0.0 110.822 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 43.2 m -131.88 104.2 6.74 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.825 1.25 . . . . 0.0 110.44 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.69 138.55 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.689 1.196 . . . . 0.0 111.737 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.0 m -133.85 142.74 47.94 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.747 1.261 . . . . 0.0 112.423 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.76 -15.67 59.69 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.613 1.965 . . . . 0.0 115.348 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.98 -46.03 71.56 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.312 1.445 . . . . 0.0 111.943 -174.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.7 -14.94 8.99 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.041 1.736 . . . . 0.0 110.897 172.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.17 39.67 7.82 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.881 1.229 . . . . 0.0 111.722 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.9 p -129.2 148.43 51.14 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.124 0.97 . . . . 0.0 113.015 -169.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -122.13 129.93 52.77 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.384 1.874 . . . . 0.0 111.777 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.2 t -103.72 122.76 45.74 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 167.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.99 137.5 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 122.018 -0.426 . . . . 0.0 110.748 -169.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.27 114.12 25.83 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.998 1.719 . . . . 0.0 107.935 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -114.4 155.98 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.882 0.873 . . . . 0.0 112.523 176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -96.48 110.42 52.73 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.883 0.873 . . . . 0.0 109.758 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.26 -14.23 20.65 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.941 2.427 . . . . 0.0 112.554 -171.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.47 -17.27 60.8 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.456 1.026 . . . . 0.0 112.951 170.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 99.1 t -117.49 -34.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.538 1.535 . . . . 0.0 113.078 -170.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.7 tt -145.71 154.04 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.446 1.021 . . . . 0.0 112.59 -174.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.8 t -101.65 151.79 37.95 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 125.829 1.652 . . . . 0.0 111.7 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.37 -32.47 42.23 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.232 2.621 . . . . 0.0 114.112 168.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -73.82 -24.21 59.76 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.778 0.717 . . . . 0.0 111.645 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.72 -38.02 58.92 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.941 1.296 . . . . 0.0 111.441 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.7 mt -56.36 -55.5 32.73 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -52.35 -51.53 58.33 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.625 1.57 . . . . 0.0 111.29 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.15 -25.14 68.21 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.52 68.14 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.713 1.597 . . . . 0.0 111.769 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.36 -38.2 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.443 1.097 . . . . 0.0 111.045 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.29 -40.12 95.3 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.696 0.68 . . . . 0.0 111.271 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.4 -23.53 62.78 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.163 2.185 . . . . 0.0 113.022 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 26.4 ttt -76.42 -40.83 49.63 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.733 1.213 . . . . 0.0 110.875 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 125.39 34.47 0.66 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.994 1.283 . . . . 0.0 115.661 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -129.02 -153.51 0.57 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.628 1.571 . . . . 0.0 108.68 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.52 148.29 49.11 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.356 -0.84 . . . . 0.0 112.118 169.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -136.07 151.52 49.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.038 1.335 . . . . 0.0 112.368 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.2 t -140.24 122.92 16.32 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.005 1.322 . . . . 0.0 111.357 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.4 m -84.39 78.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.651 1.215 . . . . 0.0 110.54 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 CA--C 1.547 0.843 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.751 172.991 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -98.0 142.13 30.1 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.683 1.593 . . . . 0.0 110.601 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tt -143.63 148.06 35.27 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.156 1.782 . . . . 0.0 111.886 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -96.51 130.74 43.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.452 1.12 . . . . 0.0 111.829 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.08 140.72 31.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 113.46 -1.7 . . . . 0.0 111.332 169.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -99.43 121.42 41.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.29 136.09 23.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 170.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.85 144.82 27.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.543 1.137 . . . . 0.0 109.094 171.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.1 -2.64 64.65 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.887 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.404 ' C ' ' H ' ' A' ' 31' ' ' CYS . 6.4 tmm? -73.32 -63.83 1.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.612 1.165 . . . . 0.0 109.825 174.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.7 m80 58.47 -12.75 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.781 2.433 . . . . 0.0 115.528 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.404 ' H ' ' C ' ' A' ' 29' ' ' MET . 32.0 p -164.39 155.62 15.54 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.837 1.255 . . . . 0.0 112.251 -169.067 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -32.38 23.23 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 175.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 m -60.16 -35.57 75.61 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.863 -1.148 . . . . 0.0 112.439 -174.557 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.8 m -74.75 -18.05 60.55 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.82 -8.61 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -56.89 -62.77 1.51 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.797 1.18 . . . . 0.0 112.387 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -53.84 -34.4 59.17 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.612 -0.68 . . . . 0.0 111.294 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.8 mt -63.39 -50.14 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 O-C-N 121.122 -0.986 . . . . 0.0 111.093 174.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -62.3 -32.48 73.23 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.289 0.95 . . . . 0.0 112.465 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -65.0 -54.59 28.04 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.541 1.064 . . . . 0.0 111.88 173.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -83.47 -33.75 25.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.185 1.394 . . . . 0.0 114.113 -170.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.1 mm -104.01 121.69 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 122.087 0.946 . . . . 0.0 110.47 -167.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.42 -28.55 5.0 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 125.807 1.67 . . . . 0.0 113.326 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -79.12 -0.55 32.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.619 -0.93 . . . . 0.0 112.692 174.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.39 -173.58 4.13 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.16 2.584 . . . . 0.0 112.756 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.02 -78.52 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.752 1.621 . . . . 0.0 111.932 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.61 -25.31 18.56 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.446 -1.752 . . . . 0.0 113.486 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -77.92 110.55 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 121.194 2.497 . . . . 0.0 107.819 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -104.41 -31.53 9.47 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.483 1.113 . . . . 0.0 112.137 -169.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 t -148.69 174.08 12.54 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 tp -144.79 136.78 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.83 1.652 . . . . 0.0 110.55 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -141.64 -178.08 5.48 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.675 1.19 . . . . 0.0 111.247 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.53 148.08 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 120.988 1.722 . . . . 0.0 114.581 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 m -130.36 57.88 1.7 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.657 1.583 . . . . 0.0 109.656 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.4 mt -64.93 -24.03 67.4 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.124 1.77 . . . . 0.0 115.333 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.77 -29.8 65.12 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.753 0.821 . . . . 0.0 111.963 170.31 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -120.7 13.05 11.54 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.817 1.647 . . . . 0.0 112.668 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 72.64 4.87 5.11 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.303 1.841 . . . . 0.0 115.298 168.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 p -96.47 152.74 18.33 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.604 1.192 . . . . 0.0 110.646 177.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.75 157.13 17.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 164.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.31 112.21 14.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.515 -0.741 . . . . 0.0 110.438 -168.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 p -96.74 136.15 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -117.83 82.9 1.9 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.535 1.534 . . . . 0.0 106.871 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -117.89 153.97 32.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.349 -170.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -97.1 109.42 49.26 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 127.332 2.253 . . . . 0.0 108.705 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.49 -3.15 10.47 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.339 2.693 . . . . 0.0 113.458 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.7 t -80.16 -18.77 48.82 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.39 0.995 . . . . 0.0 111.974 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 14.6 m -122.86 -16.03 7.23 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 t -146.3 -175.63 4.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.638 1.175 . . . . 0.0 111.409 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.7 m -153.87 156.34 32.0 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 126.567 1.947 . . . . 0.0 109.611 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -52.96 -56.9 2.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.26 2.64 . . . . 0.0 115.775 -169.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.16 -36.84 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 120.961 1.71 . . . . 0.0 112.711 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.84 -41.42 71.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.651 1.18 . . . . 0.0 112.256 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.94 -38.28 76.13 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.925 0.89 . . . . 0.0 111.279 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -69.78 -41.19 75.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.53 1.132 . . . . 0.0 111.848 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -50.18 -35.91 28.22 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.744 1.218 . . . . 0.0 113.13 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.17 -61.92 1.59 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.162 0.892 . . . . 0.0 112.198 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 30.4 pt -60.68 -21.22 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.937 1.695 . . . . 0.0 114.659 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.36 -25.39 65.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.345 1.458 . . . . 0.0 113.227 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -126.66 25.62 6.4 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.6 1.56 . . . . 0.0 113.397 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 11.3 tp -53.56 -55.62 33.18 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 127.248 2.219 . . . . 0.0 112.473 168.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_endo -84.45 -179.5 3.89 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.189 3.259 . . . . 0.0 111.163 172.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.76 56.72 2.4 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.681 3.587 . . . . 0.0 111.855 168.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.14 15.92 65.97 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.197 1.38 . . . . 0.0 114.183 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -83.92 -34.01 24.59 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.953 0.876 . . . . 0.0 112.387 -168.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.9 m-85 -121.56 129.77 53.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.04 2.136 . . . . 0.0 107.688 174.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -120.09 173.16 7.26 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.299 1.44 . . . . 0.0 110.309 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.06 131.48 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 119.964 1.256 . . . . 0.0 113.479 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -118.37 118.43 31.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.491 1.116 . . . . 0.0 110.617 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.958 1.303 . . . . 0.0 111.38 172.578 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 26.3 p -156.2 117.35 3.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.312 1.045 . . . . 0.0 113.358 -167.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.7 p -145.29 145.04 31.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.623 1.169 . . . . 0.0 111.381 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 88.3 m -96.98 140.91 30.8 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.41 149.98 36.95 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.418 1.087 . . . . 0.0 110.692 173.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tt -117.58 142.41 47.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.002 2.121 . . . . 0.0 110.331 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 mt -134.1 135.28 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.105 1.762 . . . . 0.0 110.754 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.88 128.57 45.96 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.769 1.628 . . . . 0.0 110.467 171.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.51 118.44 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 120.958 -1.089 . . . . 0.0 111.241 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.05 55.94 2.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.525 1.13 . . . . 0.0 110.917 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.54 53.29 0.32 Allowed Glycine 0 N--CA 1.462 0.415 0 C-N-CA 124.612 1.101 . . . . 0.0 111.139 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.8 mtm -145.36 145.6 31.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.676 0.79 . . . . 0.0 111.097 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.8 t -163.34 -43.94 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.425 0.69 . . . . 0.0 112.425 -168.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 83.5 m -114.26 152.03 31.95 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.393 1.477 . . . . 0.0 110.516 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.54 -25.53 68.09 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.872 -1.143 . . . . 0.0 113.14 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.7 p -59.18 -22.26 60.7 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.236 -1.54 . . . . 0.0 113.274 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 74.4 m -61.18 -30.22 70.28 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.754 -1.216 . . . . 0.0 112.052 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.73 -53.29 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.646 0.778 . . . . 0.0 109.914 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -65.27 -25.18 67.54 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.469 0.577 . . . . 0.0 111.847 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.5 m -70.58 -59.95 2.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.623 0.769 . . . . 0.0 111.943 170.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.1 mt -69.09 -42.28 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.056 1.342 . . . . 0.0 112.854 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -56.4 -34.28 66.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.358 0.663 . . . . 0.0 109.831 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.58 -34.31 67.45 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.037 -1.424 . . . . 0.0 114.088 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -47.42 72.52 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 121.244 2.522 . . . . 0.0 110.389 172.24 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 mm -75.52 -50.63 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.489 0.716 . . . . 0.0 112.192 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -71.32 -5.97 36.41 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.4 -1.438 . . . . 0.0 114.65 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -85.7 -21.7 28.19 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.24 -155.95 0.53 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -167.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -117.63 149.99 39.77 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.738 1.615 . . . . 0.0 111.816 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.56 18.91 59.34 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 117.638 -1.645 . . . . 0.0 114.584 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.0 p -112.03 97.22 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.844 2.058 . . . . 0.0 111.305 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.73 -47.56 8.15 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.195 -0.941 . . . . 0.0 112.53 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -142.48 145.58 33.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.607 1.163 . . . . 0.0 108.385 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.29 143.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 118.53 0.604 . . . . 0.0 111.036 167.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.5 t -140.37 149.75 43.07 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.049 2.14 . . . . 0.0 109.834 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.42 140.93 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.291 1.036 . . . . 0.0 111.329 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 67.2 m -121.87 77.69 1.39 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.116 2.167 . . . . 0.0 108.1 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.8 tt -53.59 -29.03 35.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.723 2.009 . . . . 0.0 112.383 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -41.48 -51.12 3.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.858 2.463 . . . . 0.0 112.882 167.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -90.43 -29.42 17.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.553 1.941 . . . . 0.0 111.125 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 93.09 27.93 12.77 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.143 1.83 . . . . 0.0 112.741 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.3 p -132.99 139.02 47.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.232 1.016 . . . . 0.0 112.457 -168.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.92 147.24 29.0 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.092 1.357 . . . . 0.0 111.113 173.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.2 t -131.29 133.89 45.83 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.509 1.124 . . . . 0.0 109.484 172.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.92 142.93 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.505 1.122 . . . . 0.0 110.927 -168.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.22 103.22 15.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.115 1.766 . . . . 0.0 106.773 169.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -108.9 156.66 19.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.002 0.921 . . . . 0.0 112.845 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -99.08 110.17 56.87 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.874 0.869 . . . . 0.0 111.148 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.08 -11.54 21.34 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.247 2.631 . . . . 0.0 113.761 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.89 -11.21 59.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.222 1.009 . . . . 0.0 113.356 171.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.3 t -120.09 -42.89 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.495 1.518 . . . . 0.0 111.895 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.1 tt -134.52 143.6 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 123.685 0.794 . . . . 0.0 111.596 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.9 t -97.11 151.49 37.73 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.404 1.082 . . . . 0.0 112.695 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.14 -28.96 53.74 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.729 2.286 . . . . 0.0 112.672 167.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -67.57 -30.82 70.54 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.414 -0.804 . . . . 0.0 112.857 173.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.08 -31.81 64.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.538 1.135 . . . . 0.0 112.044 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 63.0 mt -60.59 -53.39 58.09 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.082 0.953 . . . . 0.0 109.447 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -57.28 -49.21 76.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.857 0.863 . . . . 0.0 111.605 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.69 -27.59 66.56 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.63 -41.04 80.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.655 1.116 . . . . 0.0 112.073 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.69 -39.03 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.473 0.709 . . . . 0.0 110.835 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -65.3 -24.46 67.29 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.99 -21.55 59.95 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 172.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -50.06 9.21 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.185 0.594 . . . . 0.0 109.572 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 131.28 50.73 0.1 OUTLIER Glycine 0 N--CA 1.467 0.755 0 C-N-CA 124.658 1.123 . . . . 0.0 113.81 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -136.34 -167.18 2.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.326 1.85 . . . . 0.0 108.72 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -127.14 129.57 48.14 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 121.016 -1.053 . . . . 0.0 110.212 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -116.26 149.15 39.67 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.301 1.44 . . . . 0.0 109.472 172.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.3 t -140.66 133.67 29.3 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.34 1.056 . . . . 0.0 109.325 172.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 24.9 m -84.73 121.97 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.38 0.609 . . . . 0.0 109.432 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 126.171 1.788 . . . . 0.0 109.51 -172.627 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.0 m -120.46 151.36 39.44 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.475 1.11 . . . . 0.0 110.523 -171.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.96 176.42 8.95 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.182 0.993 . . . . 0.0 113.453 172.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -112.76 136.91 51.82 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.727 1.211 . . . . 0.0 113.093 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -147.17 142.43 27.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.636 168.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -104.77 111.98 24.92 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.914 1.286 . . . . 0.0 108.361 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 mt -85.12 139.43 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.657 0.783 . . . . 0.0 109.593 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.99 123.05 43.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.047 1.339 . . . . 0.0 111.304 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.14 -9.36 24.89 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.884 1.23 . . . . 0.0 114.886 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.2 ptp -57.35 -7.64 0.62 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -56.87 -24.65 53.13 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.828 -1.17 . . . . 0.0 112.839 168.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.8 m -97.38 119.18 35.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 167.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -58.04 -28.04 64.13 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.522 1.055 . . . . 0.0 113.454 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.6 p -53.13 -28.55 26.34 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 170.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.25 -51.52 68.59 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.877 0.762 . . . . 0.0 111.215 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -74.6 -27.64 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.54 -56.19 24.42 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.088 0.955 . . . . 0.0 111.847 -175.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -65.15 -33.94 77.2 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.732 -0.605 . . . . 0.0 112.285 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.3 mt -58.96 -47.95 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 118.885 0.766 . . . . 0.0 111.012 169.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -63.32 -33.8 76.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.578 1.151 . . . . 0.0 112.518 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -68.48 -41.37 80.22 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.34 -0.85 . . . . 0.0 112.295 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.62 -31.2 15.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -170.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.3 mm -96.35 119.14 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.78 1.173 . . . . 0.0 109.293 -171.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 132.54 -8.16 5.28 Favored Glycine 0 CA--C 1.541 1.719 0 C-N-CA 125.72 1.628 . . . . 0.0 113.626 -168.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -100.95 -13.88 18.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.502 1.921 . . . . 0.0 112.574 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.42 149.81 30.01 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.08 1.752 . . . . 0.0 111.539 -167.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.6 tp -17.46 -64.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.65 2.78 . . . . 0.0 114.411 170.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.29 19.1 13.4 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 116.333 -2.371 . . . . 0.0 115.868 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.3 t -115.47 118.19 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 121.683 2.742 . . . . 0.0 110.444 169.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -90.82 -40.54 11.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.777 0.831 . . . . 0.0 112.503 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.4 m -147.91 166.21 28.34 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.796 -1.19 . . . . 0.0 113.855 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.2 tp -126.82 145.67 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.996 1.318 . . . . 0.0 111.5 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -142.16 159.31 42.49 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.103 2.161 . . . . 0.0 109.774 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -140.71 144.29 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.338 -1.476 . . . . 0.0 112.206 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.0 m -138.77 58.32 1.66 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.184 1.394 . . . . 0.0 111.136 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.13 -30.14 69.09 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.817 2.047 . . . . 0.0 115.212 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -61.71 -20.36 63.4 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.654 1.116 . . . . 0.0 113.147 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -114.63 1.22 14.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.469 1.908 . . . . 0.0 112.303 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt 57.34 22.2 7.56 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.901 1.68 . . . . 0.0 112.876 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.77 153.13 18.06 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.343 1.068 . . . . 0.0 108.565 171.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.1 155.82 27.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 168.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.72 128.24 45.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -169.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -117.74 134.99 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 121.843 -0.535 . . . . 0.0 110.352 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -106.12 79.07 1.36 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -100.39 175.39 5.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.305 1.842 . . . . 0.0 109.53 -172.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.45 142.64 40.9 Favored Pre-proline 0 N--CA 1.477 0.89 0 CA-C-N 121.528 1.967 . . . . 0.0 111.501 168.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.89 5.67 6.28 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.972 2.448 . . . . 0.0 112.637 -172.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.2 t -87.39 -48.41 7.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.446 1.021 . . . . 0.0 110.168 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 85.1 m -101.3 -16.28 16.99 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.7 t -145.76 -178.35 6.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.381 1.072 . . . . 0.0 111.079 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 p -162.47 158.31 19.79 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.786 1.234 . . . . 0.0 111.83 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -46.79 -43.51 23.57 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.699 3.6 . . . . 0.0 116.368 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.8 m -70.64 -35.84 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.267 1.394 . . . . 0.0 112.388 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.42 85.45 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.153 0.981 . . . . 0.0 110.934 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.58 -48.2 73.16 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.257 1.023 . . . . 0.0 111.888 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -56.43 -52.06 66.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.121 0.873 . . . . 0.0 110.364 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -53.2 -42.95 66.79 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.649 1.18 . . . . 0.0 113.214 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.31 -59.24 2.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.602 1.161 . . . . 0.0 112.697 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 pt -71.94 -33.48 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -168.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -70.19 -12.01 61.29 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.26 0.624 . . . . 0.0 112.55 174.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.7 6.74 30.01 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.561 -1.337 . . . . 0.0 113.699 176.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt -56.42 -57.71 21.4 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.283 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.34 169.88 18.6 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.972 1.781 . . . . 0.0 110.459 168.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -76.21 55.65 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.269 3.313 . . . . 0.0 110.656 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.86 27.02 71.42 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.095 0.855 . . . . 0.0 113.898 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -100.46 -14.22 18.38 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 -167.018 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -135.26 114.03 11.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.051 1.34 . . . . 0.0 108.88 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -93.68 157.25 16.26 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.178 -0.951 . . . . 0.0 111.054 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.28 136.54 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 118.219 0.463 . . . . 0.0 111.859 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -111.38 121.54 45.49 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.195 0.998 . . . . 0.0 111.822 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.555 1.162 0 C-N-CA 128.241 2.617 . . . . 0.0 111.023 179.174 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.6 p -150.79 128.07 11.3 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.418 1.487 . . . . 0.0 113.609 -168.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.2 m -143.94 143.23 31.16 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.371 1.068 . . . . 0.0 111.649 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 84.8 m -100.2 144.31 29.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.546 0.738 . . . . 0.0 110.221 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.11 167.52 21.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.429 1.092 . . . . 0.0 110.903 166.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.04 133.45 55.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.457 1.903 . . . . 0.0 110.142 -176.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.7 mm -120.82 137.06 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.278 1.831 . . . . 0.0 109.306 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.03 125.44 48.72 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.957 1.303 . . . . 0.0 110.391 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.44 131.33 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.182 0.993 . . . . 0.0 111.52 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.44 53.68 0.87 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.815 1.646 . . . . 0.0 112.581 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.0 53.76 0.33 Allowed Glycine 0 N--CA 1.464 0.525 0 C-N-CA 124.926 1.251 . . . . 0.0 110.963 173.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.5 mtm -133.3 142.94 48.72 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.849 0.824 . . . . 0.0 112.01 -175.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 t -165.28 124.62 1.76 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.495 1.918 . . . . 0.0 107.775 -172.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 72.31 160.8 0.23 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.542 1.937 . . . . 0.0 115.409 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.42 -32.58 67.02 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.31 170.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 p -65.76 -28.37 68.98 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.601 -1.312 . . . . 0.0 112.837 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 52.2 t -68.4 -46.17 70.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.028 1.285 . . . . 0.0 111.154 170.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.1 t -52.78 -55.42 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.143 0.429 . . . . 0.0 110.085 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -71.17 -17.41 62.54 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -176.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 m -74.58 -47.41 32.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.071 0.948 . . . . 0.0 111.492 167.109 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.8 -54.19 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.795 -1.191 . . . . 0.0 110.69 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -55.06 -30.68 60.12 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.82 2.048 . . . . 0.0 111.866 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.86 -51.17 8.07 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.874 1.702 . . . . 0.0 113.851 173.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 79.5 mmm -74.97 -53.87 8.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.5 1.52 . . . . 0.0 114.049 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.2 mm -71.24 -19.38 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.458 1.103 . . . . 0.0 112.437 -169.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 65.6 p -70.64 0.6 6.6 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 171.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -121.55 33.71 5.43 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.19 10.79 6.91 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.669 2.099 . . . . 0.0 116.669 -172.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 76.2 118.81 0.05 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.922 2.489 . . . . 0.0 113.968 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 97.12 21.74 19.52 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.106 -1.385 . . . . 0.0 114.398 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.34 94.94 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.181 2.192 . . . . 0.0 110.251 -178.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -75.62 -56.53 4.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.032 0.933 . . . . 0.0 111.776 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -141.9 129.94 22.0 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.227 1.411 . . . . 0.0 109.007 -172.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -140.88 129.11 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.907 1.283 . . . . 0.0 110.517 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.2 t -142.23 129.65 21.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.21 1.004 . . . . 0.0 111.527 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.03 139.27 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.113 1.765 . . . . 0.0 110.522 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 74.5 p -143.3 146.3 33.46 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.5 mt -72.77 -24.27 60.92 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -176.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.63 -42.57 71.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.147 1.779 . . . . 0.0 113.535 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -111.09 -13.36 14.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.552 1.141 . . . . 0.0 110.409 168.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.57 49.7 7.08 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 125.453 1.501 . . . . 0.0 110.653 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.1 p -138.56 147.09 42.65 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -168.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -113.7 139.38 49.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.98 1.712 . . . . 0.0 112.297 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 7.5 t -112.25 125.62 54.35 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 166.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.59 134.74 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 122.153 -0.342 . . . . 0.0 110.852 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.93 113.77 25.53 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.768 2.427 . . . . 0.0 106.402 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -111.71 163.0 14.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.247 1.019 . . . . 0.0 112.95 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -97.11 98.1 4.37 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.417 1.887 . . . . 0.0 109.171 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.87 -12.13 33.66 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.137 1.891 . . . . 0.0 115.148 -169.254 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.36 -24.25 46.54 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.329 0.968 . . . . 0.0 112.447 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.8 t -95.7 -50.83 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.926 1.69 . . . . 0.0 111.046 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.33 149.5 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 122.095 0.95 . . . . 0.0 112.231 -170.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.5 t -97.68 143.43 26.2 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.673 1.589 . . . . 0.0 112.295 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.75 -16.12 51.93 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.62 2.214 . . . . 0.0 113.91 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -70.31 -27.36 64.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.696 1.134 . . . . 0.0 111.388 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -76.29 -20.29 57.47 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.764 2.026 . . . . 0.0 112.664 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 97.0 mt -67.37 -56.03 11.38 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.937 0.895 . . . . 0.0 111.32 -175.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -56.6 -38.33 71.87 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.788 -0.57 . . . . 0.0 112.406 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.86 -28.41 68.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.942 0.897 . . . . 0.0 112.974 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.37 69.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.462 1.028 . . . . 0.0 112.907 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.5 mp -72.48 -40.47 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.078 0.951 . . . . 0.0 110.867 171.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.14 -26.34 65.73 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.806 -0.559 . . . . 0.0 112.173 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.73 -26.75 62.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.503 1.521 . . . . 0.0 112.396 169.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 23.1 ttt -75.19 -38.32 60.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.225 1.01 . . . . 0.0 111.75 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.04 11.4 1.06 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.179 1.371 . . . . 0.0 116.338 172.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -111.11 -165.64 1.01 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.459 1.504 . . . . 0.0 110.049 -176.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -125.19 133.47 52.74 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.367 1.067 . . . . 0.0 111.364 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -136.43 143.8 44.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.991 1.316 . . . . 0.0 112.52 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -129.57 139.72 51.41 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.139 1.376 . . . . 0.0 109.036 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.2 p -87.89 111.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 125.491 1.517 . . . . 0.0 107.787 -173.39 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 120.658 0.266 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -95.71 151.82 19.02 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.424 1.489 . . . . 0.0 111.11 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -137.47 128.38 27.31 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 127.03 2.132 . . . . 0.0 109.012 -172.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -103.89 115.54 30.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.088 0.858 . . . . 0.0 112.01 -179.154 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -135.83 142.08 44.78 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -172.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -109.14 107.36 17.63 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.709 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mm -80.0 152.25 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.966 1.706 . . . . 0.0 111.415 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -105.18 140.37 38.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.383 1.473 . . . . 0.0 110.283 168.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.65 -8.96 76.49 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.908 1.242 . . . . 0.0 114.142 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 ptm -66.26 -6.32 13.45 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.284 1.542 . . . . 0.0 115.153 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.13 -24.08 66.94 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.169 -0.957 . . . . 0.0 110.834 165.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -99.5 114.91 28.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.577 1.551 . . . . 0.0 107.466 167.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -59.09 -30.78 68.34 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.633 -1.292 . . . . 0.0 112.213 -173.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.4 m -51.31 -21.91 2.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.641 1.576 . . . . 0.0 114.227 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.7 t -58.59 -49.36 77.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.618 1.167 . . . . 0.0 112.804 170.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -73.85 -28.22 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -169.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.49 -47.96 83.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.491 1.116 . . . . 0.0 111.468 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -41.59 76.66 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.505 -0.747 . . . . 0.0 111.309 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.4 mt -65.6 -47.03 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 122.947 0.499 . . . . 0.0 109.912 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.9 tm-20 -65.9 -29.64 70.1 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.423 1.489 . . . . 0.0 113.32 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.56 -52.09 24.02 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.829 -0.544 . . . . 0.0 112.401 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -91.63 -7.95 48.57 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -166.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 46.6 mm -122.48 128.62 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.089 1.356 . . . . 0.0 108.504 172.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.76 -5.33 4.05 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.94 1.257 . . . . 0.0 115.397 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -114.98 -5.47 12.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.394 1.477 . . . . 0.0 112.976 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.34 152.14 44.47 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.916 1.287 . . . . 0.0 111.605 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -48.29 -30.7 5.08 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.86 7.72 27.6 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 116.548 -2.251 . . . . 0.0 115.67 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.87 116.67 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 121.466 2.633 . . . . 0.0 110.414 169.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -71.89 -51.28 23.05 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.631 0.372 . . . . 0.0 110.203 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 p -151.08 155.23 38.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.542 1.137 . . . . 0.0 113.149 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.7 tp -98.26 155.07 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.083 1.353 . . . . 0.0 109.199 169.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -138.26 144.63 40.62 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.53 1.059 . . . . 0.0 111.117 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.9 t -108.38 127.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.315 1.446 . . . . 0.0 108.842 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.9 m -133.82 54.28 1.96 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.512 0.672 . . . . 0.0 111.967 -172.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.3 mt -68.66 -25.99 65.09 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.413 -1.429 . . . . 0.0 113.35 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -74.17 -17.65 60.88 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 171.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -95.7 -8.17 35.38 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.101 1.361 . . . . 0.0 110.81 168.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 mptt 74.89 14.2 3.28 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.975 2.51 . . . . 0.0 113.004 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 17.7 p -124.16 175.23 7.15 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.285 2.234 . . . . 0.0 110.331 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.96 167.58 10.14 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.035 1.334 . . . . 0.0 107.981 165.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -140.62 143.35 35.15 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.717 0.407 . . . . 0.0 110.932 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 p -140.31 133.48 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.545 0.611 . . . . 0.0 111.511 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.39 81.44 2.53 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.993 1.717 . . . . 0.0 108.519 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -101.32 148.82 24.69 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.103 1.361 . . . . 0.0 111.825 -174.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.26 122.09 49.55 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.719 0.808 . . . . 0.0 110.482 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -60.28 0.47 0.7 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 124.659 3.573 . . . . 0.0 115.252 173.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.4 m -65.39 -35.0 79.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.527 1.531 . . . . 0.0 112.79 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 81.7 m -122.32 -23.06 5.36 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -170.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -143.07 -178.24 5.74 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.213 1.405 . . . . 0.0 111.181 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.9 t -163.17 143.39 7.07 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.429 1.892 . . . . 0.0 109.344 -171.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -40.57 -49.31 4.16 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 125.007 3.804 . . . . 0.0 117.263 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.6 m -70.0 -36.65 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.327 1.421 . . . . 0.0 113.362 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.34 -36.31 66.14 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.242 1.017 . . . . 0.0 110.839 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -67.61 -48.87 65.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.733 2.013 . . . . 0.0 110.787 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -53.25 -52.97 57.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.3 1.04 . . . . 0.0 110.836 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -57.84 -38.67 76.05 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.341 1.057 . . . . 0.0 112.493 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.1 -43.51 74.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.581 0.752 . . . . 0.0 112.776 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.2 pt -74.56 -37.42 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 179.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.91 -33.64 75.75 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -171.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.37 12.93 23.1 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.2 mt -53.61 -47.58 96.04 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.194 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.45 169.93 16.55 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.289 2.659 . . . . 0.0 112.566 171.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.88 64.2 7.62 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 124.893 3.729 . . . . 0.0 110.037 169.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.57 23.48 72.13 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.324 1.44 . . . . 0.0 114.602 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -94.46 -30.81 14.25 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -167.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -122.2 115.96 23.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.706 1.202 . . . . 0.0 108.893 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.79 157.09 16.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.082 0.953 . . . . 0.0 111.842 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.5 t -112.01 137.92 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.725 0.81 . . . . 0.0 110.478 167.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.4 m -113.29 129.61 56.48 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.113 0.565 . . . . 0.0 111.042 166.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 14.4 mt . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 127.512 2.325 . . . . 0.0 112.398 -179.839 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.732 0.301 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 11.9 p 178.44 139.08 0.09 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.176 1.79 . . . . 0.0 113.269 -171.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 p -147.61 143.5 27.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.841 1.656 . . . . 0.0 111.515 168.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.78 147.26 24.57 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 120.058 1.299 . . . . 0.0 111.982 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.26 165.21 28.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.257 1.423 . . . . 0.0 113.127 173.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.17 135.36 46.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.683 1.993 . . . . 0.0 111.345 173.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.9 mm -120.34 136.12 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.716 1.206 . . . . 0.0 107.994 168.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.15 136.14 39.53 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.5 mt -130.07 142.21 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.707 -1.246 . . . . 0.0 110.884 -168.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.4 61.56 1.6 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.125 1.77 . . . . 0.0 112.939 -174.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.08 49.2 0.19 Allowed Glycine 0 N--CA 1.466 0.687 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.01 164.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 77.1 mtm -117.22 143.87 45.41 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.256 1.027 . . . . 0.0 111.505 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.0 t -159.82 127.45 4.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 127.185 2.194 . . . . 0.0 106.156 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 2.3 t 74.8 148.13 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.902 1.681 . . . . 0.0 113.034 -175.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.44 -29.6 49.94 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.453 -0.779 . . . . 0.0 112.29 171.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.9 p -61.93 -34.14 75.55 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.733 -1.23 . . . . 0.0 112.512 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 30.4 t -68.32 -37.56 80.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.305 1.411 . . . . 0.0 112.181 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 t -58.05 -56.52 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 118.883 -0.579 . . . . 0.0 109.888 169.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -62.95 -23.3 67.33 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.977 0.808 . . . . 0.0 112.798 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 m -70.33 -55.33 9.42 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.715 1.206 . . . . 0.0 111.966 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.86 -48.74 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 119.47 1.032 . . . . 0.0 110.837 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -60.42 -25.27 65.82 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.362 2.265 . . . . 0.0 111.844 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.5 -58.25 3.64 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 127.547 2.498 . . . . 0.0 114.094 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 21.5 mmt -71.73 -53.29 13.93 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.398 1.479 . . . . 0.0 113.204 -169.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.5 mm -66.0 -30.06 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.892 -0.505 . . . . 0.0 110.618 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.0 t -57.12 -19.71 21.52 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -96.69 17.38 16.61 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -167.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.89 169.59 9.74 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.476 1.51 . . . . 0.0 110.55 169.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -64.32 163.35 13.15 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.935 1.35 . . . . 0.0 114.501 -171.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.07 -32.21 1.31 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.62 1.581 . . . . 0.0 116.788 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.9 p -78.0 97.6 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 119.968 1.884 . . . . 0.0 112.935 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 26.8 tt0 -76.66 -39.27 52.75 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.982 1.313 . . . . 0.0 112.84 -178.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -144.58 140.75 28.97 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.33 1.052 . . . . 0.0 110.099 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -144.96 129.85 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 119.306 0.957 . . . . 0.0 111.571 172.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.19 124.6 20.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.699 1.2 . . . . 0.0 110.677 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.6 t -126.53 149.64 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 120.616 -1.302 . . . . 0.0 110.279 -169.69 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.7 t -142.94 145.47 33.05 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.185 0.993 . . . . 0.0 112.943 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.01 -18.33 61.97 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.525 1.93 . . . . 0.0 114.362 171.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.88 -48.24 67.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.227 1.411 . . . . 0.0 111.949 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -108.7 -17.47 13.94 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.27 1.828 . . . . 0.0 111.949 170.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.73 50.97 5.03 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.084 1.326 . . . . 0.0 111.622 -171.186 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 43.0 p -138.79 147.68 42.87 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.397 1.099 . . . . 0.0 113.677 -169.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -111.2 134.89 52.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.213 1.805 . . . . 0.0 111.402 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.1 t -109.07 118.37 36.59 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.5 138.21 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -167.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -96.8 118.73 33.88 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.079 2.152 . . . . 0.0 108.1 175.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -119.08 158.42 25.89 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.649 1.179 . . . . 0.0 112.45 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -95.69 115.06 65.22 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.066 1.346 . . . . 0.0 108.568 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.59 -6.7 17.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.41 2.74 . . . . 0.0 113.798 -170.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.06 -45.59 10.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.077 0.951 . . . . 0.0 112.007 169.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 72.2 t -83.38 -28.57 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.343 1.457 . . . . 0.0 112.52 -171.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 tt -147.27 144.87 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.517 1.127 . . . . 0.0 110.558 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.3 m -106.42 147.94 35.83 Favored Pre-proline 0 CA--C 1.551 1.002 0 O-C-N 121.244 -0.91 . . . . 0.0 111.319 173.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -53.53 -32.49 63.77 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.712 3.608 . . . . 0.0 116.177 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.53 -27.73 64.79 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.47 -32.99 66.68 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 112.241 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 65.6 mt -59.09 -50.47 73.93 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.616 1.166 . . . . 0.0 108.977 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -54.23 -48.35 71.19 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.95 1.3 . . . . 0.0 111.86 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.6 -30.48 71.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.71 -32.83 71.62 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.087 0.955 . . . . 0.0 112.938 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.6 mt -74.55 -32.9 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.195 0.998 . . . . 0.0 112.093 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -68.25 -34.13 75.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.899 0.772 . . . . 0.0 111.525 168.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.33 -30.01 70.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.429 1.091 . . . . 0.0 112.445 171.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.4 ttt -75.4 -28.73 59.57 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.351 -0.843 . . . . 0.0 112.491 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 116.82 30.56 1.95 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.648 1.594 . . . . 0.0 115.32 169.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -125.66 -156.88 0.76 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.466 1.507 . . . . 0.0 109.379 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -133.68 147.14 51.37 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.998 -1.064 . . . . 0.0 111.118 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.42 136.35 34.59 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.119 1.368 . . . . 0.0 112.592 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -114.45 125.91 54.36 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.344 1.858 . . . . 0.0 110.231 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.84 59.78 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.482 1.134 . . . . 0.0 109.759 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.014 0.925 . . . . 0.0 111.857 -169.782 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 122.084 0.945 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 m -109.21 135.1 50.87 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.846 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.288 0.1 OUTLIER -134.5 160.08 39.13 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.326 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -120.05 134.79 55.15 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.529 2.332 . . . . 0.0 108.563 -171.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 pp -146.49 160.52 42.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -102.04 155.64 18.05 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.67 1.188 . . . . 0.0 110.439 168.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.9 mt -135.16 141.29 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 126.658 1.983 . . . . 0.0 110.822 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -97.22 129.9 44.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.366 1.466 . . . . 0.0 109.195 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.24 -19.65 50.49 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.181 1.372 . . . . 0.0 113.627 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -14.01 56.46 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.426 1.613 . . . . 0.0 113.224 174.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -49.37 -37.45 24.98 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.766 1.627 . . . . 0.0 111.859 166.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 93.1 m -78.76 -1.11 33.13 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 71.25 -60.21 0.52 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 129.162 2.985 . . . . 0.0 112.19 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -53.03 -27.57 20.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.91 1.684 . . . . 0.0 114.551 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -46.68 -37.85 8.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.909 1.684 . . . . 0.0 112.985 169.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -19.07 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.421 HD13 ' C ' ' A' ' 36' ' ' LEU . 3.1 tm? -69.67 -54.09 15.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 112.143 -171.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.2 -28.59 69.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.311 1.044 . . . . 0.0 111.894 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.3 mt -65.5 -56.08 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 118.895 0.77 . . . . 0.0 109.734 167.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -39.77 61.17 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.237 1.415 . . . . 0.0 112.506 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.28 -40.94 97.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.347 0.659 . . . . 0.0 112.554 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -90.82 -28.44 18.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.594 1.158 . . . . 0.0 113.209 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.467 ' CD1' HG22 ' A' ' 78' ' ' ILE . 34.3 mm -97.46 117.49 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.149 -0.969 . . . . 0.0 109.235 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.64 -17.17 7.35 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.031 1.3 . . . . 0.0 115.648 -172.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -96.49 0.74 50.7 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.506 1.153 . . . . 0.0 113.228 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.4 mt -92.08 154.63 18.61 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.676 1.59 . . . . 0.0 113.081 -169.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -51.27 -34.18 31.73 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.59 4.87 31.06 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.715 -1.603 . . . . 0.0 115.845 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.3 t -134.32 119.62 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 120.905 2.353 . . . . 0.0 109.73 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 -26.81 13.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -169.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.3 p -149.11 173.18 13.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.69 1.196 . . . . 0.0 111.17 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 tp -138.78 145.95 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.054 0.942 . . . . 0.0 110.082 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -134.78 148.17 50.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.353 1.461 . . . . 0.0 108.394 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.92 150.62 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.624 -1.297 . . . . 0.0 110.762 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.2 t -141.45 58.36 1.51 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 122.881 1.324 . . . . 0.0 110.405 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.2 mt -69.83 -26.98 64.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.56 1.544 . . . . 0.0 113.641 -169.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.48 -24.02 63.72 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.34 1.456 . . . . 0.0 113.206 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -91.25 -25.11 19.64 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.751 1.62 . . . . 0.0 111.429 169.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 98.21 3.93 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.037 1 C-N-CA 132.577 4.351 . . . . 0.0 111.961 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.3 p -107.61 166.99 10.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.855 1.262 . . . . 0.0 112.578 -172.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.42 145.0 39.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.189 0.995 . . . . 0.0 108.534 167.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.407 HE21 ' HA ' ' A' ' 61' ' ' GLN . 2.9 tp60 -124.82 106.31 9.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.806 1.242 . . . . 0.0 110.695 -169.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.3 143.53 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-O 121.188 0.518 . . . . 0.0 111.826 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -114.43 90.36 3.32 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.858 2.063 . . . . 0.0 107.235 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -115.62 154.42 29.49 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -166.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.22 117.51 65.57 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.848 2.059 . . . . 0.0 109.286 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.65 5.6 2.38 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.368 2.712 . . . . 0.0 114.672 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 p -84.81 -30.26 24.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.694 1.198 . . . . 0.0 113.585 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 64.1 m -113.43 -21.89 10.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.439 1.095 . . . . 0.0 113.63 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.9 t -144.41 179.81 7.02 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 122.067 0.937 . . . . 0.0 111.943 -169.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.8 p -166.03 164.7 11.21 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.878 2.071 . . . . 0.0 109.476 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.86 -49.25 16.53 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.334 2.689 . . . . 0.0 114.546 -174.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.33 -38.22 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.13 75.09 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.588 -0.695 . . . . 0.0 111.442 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.6 mt -58.8 -53.34 59.46 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.561 1.544 . . . . 0.0 110.408 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.8 -53.26 33.48 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.652 1.181 . . . . 0.0 110.758 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -25.76 64.58 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.6 -60.28 2.31 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.166 1.348 . . . . 0.0 111.349 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.467 HG22 ' CD1' ' A' ' 42' ' ' ILE . 7.9 pt -72.23 -32.22 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.84 -19.42 65.87 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.06 0.845 . . . . 0.0 112.92 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.37 10.42 39.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.1 mt -60.22 -50.56 85.45 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.76 165.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.05 172.79 12.58 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.084 2.522 . . . . 0.0 112.071 171.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.78 65.47 7.59 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 124.609 3.54 . . . . 0.0 110.627 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.7 33.15 81.36 Favored Glycine 0 N--CA 1.473 1.154 0 O-C-N 121.246 -0.909 . . . . 0.0 112.95 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -107.05 -19.49 13.6 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -166.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -130.47 105.85 8.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.293 1.437 . . . . 0.0 108.603 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -99.07 136.11 39.52 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.913 1.285 . . . . 0.0 112.372 -169.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 m -99.17 156.72 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.735 1.152 . . . . 0.0 112.737 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.6 m -134.72 116.93 15.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.44 1.096 . . . . 0.0 110.159 167.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 126.896 2.078 . . . . 0.0 110.594 -178.226 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 27.6 p -144.21 145.69 32.23 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -168.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.7 t -146.43 160.0 42.66 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.543 1.937 . . . . 0.0 109.407 167.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.55 138.12 54.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.289 0.636 . . . . 0.0 109.659 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.78 160.0 41.17 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.955 0.798 . . . . 0.0 112.778 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 tt -116.26 140.41 49.35 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.752 1.621 . . . . 0.0 110.248 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 mm -127.34 139.85 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 127.647 2.379 . . . . 0.0 108.777 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -104.57 133.58 49.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.913 1.285 . . . . 0.0 110.261 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.27 137.67 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 120.533 -1.354 . . . . 0.0 110.913 -173.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.45 58.55 1.13 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.314 1.845 . . . . 0.0 111.554 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.34 55.86 0.24 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 125.222 1.391 . . . . 0.0 111.183 168.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 64.7 mtm -131.94 111.57 11.67 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.738 1.215 . . . . 0.0 109.495 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.9 t -116.0 -12.17 11.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.241 1.816 . . . . 0.0 112.989 -169.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 52.7 m -156.04 161.5 40.43 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.773 2.429 . . . . 0.0 110.398 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.64 -31.06 65.9 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.864 -1.147 . . . . 0.0 113.947 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 17.0 p -53.65 -22.26 8.47 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.364 1.466 . . . . 0.0 114.626 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 75.4 m -56.15 -36.75 68.65 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.37 -0.831 . . . . 0.0 111.97 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.83 -53.43 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.793 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -69.14 -24.04 64.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.093 0.86 . . . . 0.0 111.55 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.1 m -72.54 -51.75 18.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.323 1.449 . . . . 0.0 111.598 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.5 mt -68.87 -55.45 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 121.008 -1.057 . . . . 0.0 111.296 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -55.13 -30.73 60.39 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.704 1.202 . . . . 0.0 111.059 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.17 -62.12 2.68 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.021 1.296 . . . . 0.0 114.505 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 94.2 mmm -71.31 -38.21 71.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -169.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.1 mm -72.53 -23.95 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.056 0.542 . . . . 0.0 111.353 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.6 t -67.22 1.69 1.99 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -106.23 -3.54 21.19 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -169.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.12 17.08 24.71 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.69 2.108 . . . . 0.0 116.69 -168.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 77.76 160.59 0.21 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 127.456 2.303 . . . . 0.0 112.663 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.73 -24.46 0.29 Allowed Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.48 -1.388 . . . . 0.0 115.811 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.85 96.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 127.79 2.436 . . . . 0.0 111.165 172.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -79.74 -47.43 15.29 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.779 0.832 . . . . 0.0 111.946 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -143.97 137.07 27.49 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.688 0.795 . . . . 0.0 110.414 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.36 134.39 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.849 -1.157 . . . . 0.0 110.933 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 30.0 t -139.24 141.39 37.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.881 1.672 . . . . 0.0 109.205 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.27 142.68 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.706 1.202 . . . . 0.0 112.015 -176.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.0 t -140.58 139.23 34.91 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.441 1.096 . . . . 0.0 112.736 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.08 -17.18 62.01 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.266 1.826 . . . . 0.0 115.44 174.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.26 -42.54 77.55 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.021 1.328 . . . . 0.0 112.836 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -113.17 -8.39 13.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.749 1.619 . . . . 0.0 111.355 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 76.45 48.39 9.29 Favored Glycine 0 C--N 1.343 0.949 0 C-N-CA 125.289 1.423 . . . . 0.0 112.619 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 p -141.14 146.42 37.0 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -167.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -115.22 150.93 35.37 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.175 1.79 . . . . 0.0 111.844 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.7 t -125.11 130.03 51.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.479 1.512 . . . . 0.0 108.695 169.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.75 136.85 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.741 -0.599 . . . . 0.0 111.211 -169.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.57 112.96 24.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.876 2.471 . . . . 0.0 106.628 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -118.97 158.98 24.69 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.628 1.171 . . . . 0.0 112.506 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -93.46 112.94 58.72 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.773 1.229 . . . . 0.0 108.18 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.51 -11.17 18.85 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.218 2.612 . . . . 0.0 113.005 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.07 -45.97 31.46 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.851 1.205 . . . . 0.0 110.7 168.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 69.8 t -79.5 -42.43 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.369 1.467 . . . . 0.0 113.431 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.4 tt -140.35 150.44 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.211 0.914 . . . . 0.0 113.254 -169.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 60.0 m -112.76 150.71 43.19 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.285 1.434 . . . . 0.0 112.005 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.69 -41.16 38.35 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.424 3.416 . . . . 0.0 115.009 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.43 -20.27 65.42 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.36 -31.91 60.68 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.104 1.362 . . . . 0.0 113.735 170.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 73.5 mt -60.0 -50.73 72.59 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.033 0.933 . . . . 0.0 108.876 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -51.69 -51.01 59.28 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.195 0.998 . . . . 0.0 111.522 173.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.2 -31.67 65.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.14 -38.98 69.1 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.155 0.982 . . . . 0.0 113.265 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.1 mp -70.24 -35.53 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.55 -0.718 . . . . 0.0 110.498 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.0 -36.19 83.19 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.881 -0.512 . . . . 0.0 111.739 172.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -71.89 -29.5 64.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.155 1.782 . . . . 0.0 113.797 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 18.1 ttt -65.92 -30.17 70.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.322 1.049 . . . . 0.0 111.953 172.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 124.3 13.8 3.83 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.943 1.735 . . . . 0.0 115.362 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -119.75 -156.46 0.66 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.158 1.383 . . . . 0.0 109.568 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -136.06 137.47 41.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.928 1.291 . . . . 0.0 109.009 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -131.75 156.21 46.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.065 1.346 . . . . 0.0 111.627 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.1 t -141.96 140.57 32.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.27 1.828 . . . . 0.0 109.218 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.4 m -96.05 121.56 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.452 -0.78 . . . . 0.0 110.059 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 123.327 1.537 . . . . 0.0 110.829 -177.307 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.69 153.03 18.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.237 1.415 . . . . 0.0 110.53 171.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tt -145.64 135.5 23.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.733 1.613 . . . . 0.0 110.88 -172.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -98.27 123.54 42.41 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.793 -0.567 . . . . 0.0 111.596 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.47 138.67 27.81 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.334 1.054 . . . . 0.0 113.593 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -97.64 123.8 41.68 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.9 mt -95.37 138.63 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.417 1.487 . . . . 0.0 107.631 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -95.54 142.78 27.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.548 1.139 . . . . 0.0 110.598 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.94 -4.73 83.36 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.661 1.124 . . . . 0.0 113.953 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.7 ptp -68.44 0.09 4.37 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -63.94 -13.77 48.49 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.543 1.065 . . . . 0.0 113.213 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.9 t -105.33 125.33 50.86 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.239 1.381 . . . . 0.0 107.795 165.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.73 -31.16 47.27 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.838 1.255 . . . . 0.0 114.021 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.7 m -63.34 -21.87 66.53 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.042 -1.036 . . . . 0.0 113.079 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 63.5 m -71.86 -47.21 54.57 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.095 0.861 . . . . 0.0 111.881 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.4 -23.09 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.108 0.867 . . . . 0.0 112.427 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.8 -61.35 2.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.123 0.969 . . . . 0.0 111.854 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.03 -26.4 68.22 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.532 -0.73 . . . . 0.0 112.824 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mt -65.93 -53.07 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 120.506 -1.371 . . . . 0.0 110.521 169.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.86 -30.07 69.9 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.836 1.255 . . . . 0.0 112.305 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.0 -39.78 75.67 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.008 -1.057 . . . . 0.0 112.546 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -93.69 -19.92 20.64 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.587 HD12 HG22 ' A' ' 78' ' ' ILE . 38.5 mm -102.81 123.6 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 122.314 1.054 . . . . 0.0 111.55 -172.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.37 -10.09 2.97 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.105 1.812 . . . . 0.0 114.57 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -109.5 4.55 22.42 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.839 1.656 . . . . 0.0 113.101 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.13 176.39 8.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.394 1.078 . . . . 0.0 112.216 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.7 tp -38.24 -64.2 0.43 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.325 2.25 . . . . 0.0 114.058 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.7 -12.83 7.66 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 117.073 -1.959 . . . . 0.0 115.643 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.34 112.72 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-N 121.57 2.685 . . . . 0.0 109.438 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -95.32 -35.45 11.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.073 1.349 . . . . 0.0 112.099 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 t -145.18 169.57 17.92 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.853 0.835 . . . . 0.0 112.523 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.3 tp -138.16 144.83 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.115 1.766 . . . . 0.0 108.96 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -142.63 157.93 44.18 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.083 1.753 . . . . 0.0 108.784 -172.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 m -127.53 138.69 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 120.348 -1.47 . . . . 0.0 111.931 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.2 m -124.48 56.52 1.28 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.746 1.619 . . . . 0.0 107.855 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -65.36 -30.69 71.55 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.56 -16.91 62.33 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -95.1 -5.67 43.73 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.314 1.445 . . . . 0.0 111.726 169.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt 73.39 7.38 5.18 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.022 2.529 . . . . 0.0 112.214 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.9 p -110.94 167.07 10.52 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.022 2.129 . . . . 0.0 110.787 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.97 -179.7 4.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.067 165.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -143.86 133.22 23.27 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.175 -0.953 . . . . 0.0 109.594 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.94 137.36 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.38 0.991 . . . . 0.0 111.387 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -114.71 87.11 2.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.666 1.586 . . . . 0.0 108.37 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -119.65 155.12 32.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.768 1.227 . . . . 0.0 113.478 -171.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -96.57 113.27 62.33 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.617 1.967 . . . . 0.0 109.375 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.62 -6.89 20.1 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.353 2.702 . . . . 0.0 112.88 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 t -86.08 -5.98 59.11 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.268 1.027 . . . . 0.0 111.988 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 94.2 m -119.03 -42.4 2.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.257 1.423 . . . . 0.0 113.464 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -128.51 -176.31 3.79 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.672 1.589 . . . . 0.0 110.232 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.94 154.2 18.15 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.24 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.05 -56.88 2.4 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.069 3.179 . . . . 0.0 116.21 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.7 -36.05 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 121.059 1.754 . . . . 0.0 113.438 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.43 -41.12 61.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.222 1.009 . . . . 0.0 111.909 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -36.17 74.44 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.719 1.208 . . . . 0.0 110.886 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -66.89 -47.69 71.04 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.365 -0.834 . . . . 0.0 111.327 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.6 mtt85 -59.65 -28.86 67.61 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.343 1.057 . . . . 0.0 112.937 172.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.71 -56.06 12.26 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.069 0.85 . . . . 0.0 111.51 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.587 HG22 HD12 ' A' ' 42' ' ' ILE . 6.0 pt -72.47 -33.47 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -68.77 -17.99 64.13 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.35 8.13 44.94 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 120.691 -1.256 . . . . 0.0 113.977 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.5 mt -59.36 -51.06 84.11 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.018 166.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.15 173.73 12.26 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.026 2.484 . . . . 0.0 111.1 168.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -75.18 52.1 3.03 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.418 3.412 . . . . 0.0 111.486 169.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.64 37.64 92.63 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 124.803 1.192 . . . . 0.0 112.09 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -102.26 -46.45 4.81 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -168.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -97.72 101.02 12.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.229 1.412 . . . . 0.0 107.402 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -99.72 144.4 28.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -167.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.0 138.56 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.722 0.809 . . . . 0.0 111.744 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -133.55 121.1 21.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.549 1.14 . . . . 0.0 112.121 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.549 0.91 0 C-N-CA 126.223 1.809 . . . . 0.0 112.254 173.234 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 95.3 m -143.02 136.02 28.0 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.366 1.466 . . . . 0.0 112.541 -174.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.8 t -143.97 154.89 43.77 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.403 1.881 . . . . 0.0 109.229 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.4 m -114.53 141.16 48.09 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.634 0.652 . . . . 0.0 110.051 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.12 157.35 44.99 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.519 0.676 . . . . 0.0 112.415 168.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.32 136.36 41.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.357 1.863 . . . . 0.0 110.029 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.7 mt -127.92 133.68 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.717 1.607 . . . . 0.0 109.06 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.68 143.05 30.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.434 1.094 . . . . 0.0 109.842 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.04 131.8 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 119.395 0.998 . . . . 0.0 112.024 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.3 80.72 1.99 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.474 1.51 . . . . 0.0 111.998 173.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 178.49 55.01 0.07 OUTLIER Glycine 0 N--CA 1.467 0.766 0 C-N-CA 124.543 1.068 . . . . 0.0 113.996 165.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -137.41 145.47 43.24 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.4 t -151.72 -28.2 0.18 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.623 1.969 . . . . 0.0 112.387 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 77.4 m -125.76 136.73 53.49 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.968 1.707 . . . . 0.0 111.637 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.65 -27.38 6.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.517 1.527 . . . . 0.0 114.529 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.7 p -55.53 -31.64 62.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.14 1.376 . . . . 0.0 113.241 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 t -62.04 -19.44 62.89 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.95 -59.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.636 -0.665 . . . . 0.0 109.972 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -22.37 66.71 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 118.434 0.561 . . . . 0.0 112.155 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.0 m -72.24 -60.49 2.21 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.981 1.313 . . . . 0.0 112.893 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 94.4 mt -67.13 -54.48 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 120.362 1.437 . . . . 0.0 110.583 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.28 -29.96 67.95 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.792 1.237 . . . . 0.0 111.304 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.63 -62.57 2.66 Favored Glycine 0 C--N 1.343 0.948 0 C-N-CA 124.226 0.917 . . . . 0.0 113.998 173.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 82.1 mmm -70.03 -36.26 74.92 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -168.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.0 mm -68.02 -31.55 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 118.317 0.508 . . . . 0.0 110.659 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -66.11 -0.42 2.45 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -92.59 -7.38 47.27 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.389 -1.444 . . . . 0.0 113.915 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 pp -99.91 170.18 8.7 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.723 1.209 . . . . 0.0 112.046 171.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -79.05 166.34 22.42 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.76 -34.3 0.6 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.779 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.31 91.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 119.448 1.624 . . . . 0.0 110.601 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -72.71 -45.67 57.59 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.114 1.366 . . . . 0.0 111.819 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -143.3 143.49 31.72 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.455 0.702 . . . . 0.0 109.175 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -142.06 138.68 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 0.0 110.462 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 67.6 m -138.52 108.67 6.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.847 1.259 . . . . 0.0 109.701 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.71 133.9 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.728 -1.232 . . . . 0.0 110.519 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.2 t -119.71 93.33 4.03 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.142 2.177 . . . . 0.0 107.457 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.0 tt -66.83 -29.23 69.1 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.013 0.925 . . . . 0.0 110.597 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -49.6 -39.82 36.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.366 2.266 . . . . 0.0 113.629 167.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -100.26 -13.29 18.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.614 1.966 . . . . 0.0 112.123 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.76 26.93 73.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 127.735 2.588 . . . . 0.0 113.344 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.0 p -129.28 143.25 50.78 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.662 1.231 . . . . 0.0 114.27 -168.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.2 131.33 51.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.47 1.508 . . . . 0.0 109.505 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.9 t -113.55 124.09 51.55 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.66 139.83 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -165.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.25 111.22 23.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.68 2.392 . . . . 0.0 107.422 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -120.62 156.12 32.33 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.602 1.161 . . . . 0.0 112.685 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -98.6 109.8 54.43 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.695 1.198 . . . . 0.0 111.014 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.58 -13.43 30.02 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.206 2.604 . . . . 0.0 112.616 -172.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.36 -13.84 58.83 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.463 1.028 . . . . 0.0 113.719 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.3 t -118.63 -33.85 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.91 1.284 . . . . 0.0 112.481 -170.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.27 151.17 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.851 1.26 . . . . 0.0 110.504 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.5 t -104.7 144.17 28.19 Favored Pre-proline 0 N--CA 1.477 0.894 0 O-C-N 120.951 -1.093 . . . . 0.0 110.978 169.365 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.69 -27.86 27.77 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.698 2.932 . . . . 0.0 114.358 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -70.43 -41.73 72.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.534 0.606 . . . . 0.0 111.386 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.57 -28.05 58.83 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 170.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.49 -55.16 38.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.598 1.559 . . . . 0.0 110.4 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.08 -30.36 70.95 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.402 -0.811 . . . . 0.0 112.533 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.85 -16.12 63.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.08 62.16 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.361 0.982 . . . . 0.0 112.232 171.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.5 mp -71.84 -33.73 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.027 0.931 . . . . 0.0 110.461 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -66.37 -31.04 71.56 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.939 0.791 . . . . 0.0 112.084 170.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -70.86 -29.96 66.22 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 120.593 -1.317 . . . . 0.0 112.137 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 10.6 ttt -71.85 -27.44 62.89 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.679 1.192 . . . . 0.0 111.725 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 124.23 14.2 3.74 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.362 1.934 . . . . 0.0 116.886 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -128.03 147.09 50.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.828 1.314 . . . . 0.0 111.046 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -95.17 101.01 12.73 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 123.414 1.578 . . . . 0.0 110.525 -170.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -98.42 143.99 28.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 112.54 -2.118 . . . . 0.0 111.529 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.4 t -141.28 132.22 26.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.538 1.535 . . . . 0.0 111.812 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.8 m -86.04 72.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.329 1.052 . . . . 0.0 110.533 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.477 0.882 0 C-N-CA 124.2 1.0 . . . . 0.0 111.375 178.677 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 p -96.65 146.02 25.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.56 1.544 . . . . 0.0 112.192 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.95 126.44 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.935 1.694 . . . . 0.0 109.654 174.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.19 131.69 45.05 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.807 1.243 . . . . 0.0 110.192 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 155.48 43.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.977 169.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.91 129.66 46.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.704 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 mt -104.27 147.04 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.835 1.254 . . . . 0.0 110.923 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 87' ' ' LYS . 36.6 t70 -96.18 140.33 31.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.956 2.102 . . . . 0.0 110.575 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.8 -8.13 73.8 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.641 1.115 . . . . 0.0 113.696 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 13.2 ptp -66.08 -13.25 59.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -54.23 -32.12 55.11 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.145 0.884 . . . . 0.0 111.85 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.61 -17.45 62.89 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm 76.31 -57.17 0.56 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.76 2.824 . . . . 0.0 112.394 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.4 p -53.79 -23.04 10.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.906 1.282 . . . . 0.0 113.822 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.5 t -47.17 -46.92 24.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.147 1.779 . . . . 0.0 111.949 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.17 -17.57 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.19 -56.25 10.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.464 1.106 . . . . 0.0 110.339 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -36.87 73.61 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.688 -0.632 . . . . 0.0 111.434 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mt -62.28 -48.19 89.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.525 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.17 -36.14 76.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.865 1.266 . . . . 0.0 112.849 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -64.95 -40.4 94.97 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.33 -0.856 . . . . 0.0 112.351 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -91.45 -35.58 14.26 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -172.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.457 ' CD1' HG22 ' A' ' 78' ' ' ILE . 38.5 mm -99.28 113.28 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.417 1.008 . . . . 0.0 110.686 -168.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.96 -21.68 0.89 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.477 1.037 . . . . 0.0 115.136 -170.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -108.92 -5.09 16.28 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.362 1.081 . . . . 0.0 113.34 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.72 153.12 43.82 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.992 1.717 . . . . 0.0 111.069 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.8 tp -11.12 -69.88 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 128.827 2.851 . . . . 0.0 114.642 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.48 9.76 22.01 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 115.734 -2.704 . . . . 0.0 117.469 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.42 130.62 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 123.117 3.459 . . . . 0.0 108.434 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -100.13 -43.69 6.24 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.174 0.59 . . . . 0.0 111.261 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 p -148.98 164.02 35.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.479 1.112 . . . . 0.0 113.028 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 tp -120.82 149.76 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.177 1.391 . . . . 0.0 111.625 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -142.64 154.4 44.33 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.259 1.824 . . . . 0.0 110.157 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.4 t -133.12 137.68 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 120.793 -1.192 . . . . 0.0 110.446 -171.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t -134.35 55.26 1.9 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.542 1.537 . . . . 0.0 109.435 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -33.36 74.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.91 1.684 . . . . 0.0 112.952 -169.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -47.89 -34.95 9.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.766 2.026 . . . . 0.0 112.504 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -116.53 23.22 12.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.023 1.329 . . . . 0.0 112.497 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.5 mttp 67.37 9.7 7.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.287 2.635 . . . . 0.0 115.481 169.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 p -107.96 145.36 33.95 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.72 1.208 . . . . 0.0 112.44 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.19 157.93 16.94 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.613 1.165 . . . . 0.0 108.764 167.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -139.81 118.46 12.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.487 0.315 . . . . 0.0 110.263 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.8 p -114.24 132.55 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.782 -0.574 . . . . 0.0 111.11 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.11 93.4 5.7 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.595 1.158 . . . . 0.0 109.008 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -118.19 152.44 35.66 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.353 1.061 . . . . 0.0 112.45 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -100.33 114.98 65.89 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.715 1.606 . . . . 0.0 109.829 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.67 5.69 3.21 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.359 3.372 . . . . 0.0 113.955 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 t -68.0 -34.79 77.19 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.026 0.93 . . . . 0.0 111.444 171.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 74.9 m -114.94 -25.42 8.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -168.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -144.4 -178.38 5.95 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.929 1.291 . . . . 0.0 111.839 -173.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.6 p -152.6 161.06 30.25 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.57 1.548 . . . . 0.0 111.919 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.72 -46.46 24.26 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.547 2.831 . . . . 0.0 115.137 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.3 m -70.21 -33.52 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.208 1.367 . . . . 0.0 113.262 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.86 -38.0 79.47 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.6 -0.688 . . . . 0.0 111.419 175.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.36 -44.09 79.85 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.335 1.054 . . . . 0.0 111.409 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -53.66 -55.66 24.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.303 1.041 . . . . 0.0 110.557 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -52.79 -48.34 66.94 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.52 0.728 . . . . 0.0 112.714 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.36 -58.44 8.59 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.608 0.763 . . . . 0.0 111.935 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.457 HG22 ' CD1' ' A' ' 42' ' ' ILE . 5.8 pt -74.31 -31.13 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.65 -39.12 67.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.483 1.113 . . . . 0.0 112.533 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.23 23.08 9.62 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.0 mt -60.16 -55.41 45.64 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.483 164.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.77 170.9 17.61 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.696 2.931 . . . . 0.0 112.163 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.59 35.79 0.33 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 125.03 3.82 . . . . 0.0 112.903 171.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.28 28.02 34.8 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.191 1.377 . . . . 0.0 113.115 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -104.02 -42.74 5.47 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -168.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -96.35 117.07 30.08 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.434 ' H ' ' HB3' ' A' ' 27' ' ' ASP . 16.1 ttmm -102.16 135.51 43.62 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.363 1.865 . . . . 0.0 111.733 -173.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.66 150.25 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.868 1.213 . . . . 0.0 111.675 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.1 t -134.13 107.98 8.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.235 1.414 . . . . 0.0 110.067 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.549 0.905 0 CA-C-N 114.482 -1.235 . . . . 0.0 113.113 -174.744 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.512 ' HB2' HD11 ' A' ' 165' ' ' LEU . 29.1 p -155.75 142.48 18.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.502 1.121 . . . . 0.0 112.544 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.8 t -142.9 160.17 40.84 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.948 1.699 . . . . 0.0 109.547 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 98.4 m -113.07 143.55 44.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.783 0.833 . . . . 0.0 109.484 171.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.71 165.29 27.89 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.687 0.795 . . . . 0.0 111.457 167.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -119.87 130.33 54.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.858 1.663 . . . . 0.0 110.048 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.47 140.88 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 126.292 1.837 . . . . 0.0 108.694 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.22 132.24 52.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.723 1.609 . . . . 0.0 109.952 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.86 136.79 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.214 1.006 . . . . 0.0 110.3 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.79 57.91 1.43 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.994 1.718 . . . . 0.0 112.715 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.58 52.23 0.31 Allowed Glycine 0 N--CA 1.467 0.739 0 C-N-CA 124.387 0.994 . . . . 0.0 112.533 168.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 68.0 mtm -131.71 150.86 52.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.471 1.108 . . . . 0.0 110.862 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.8 t -157.39 -30.46 0.08 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.039 1.336 . . . . 0.0 111.877 -168.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 64.7 m -128.28 140.7 51.74 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.036 1.734 . . . . 0.0 111.948 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -48.58 -33.86 10.51 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.162 1.785 . . . . 0.0 114.246 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.9 p -50.35 -32.29 16.92 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.422 1.089 . . . . 0.0 113.754 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 11.5 t -61.36 -21.87 64.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.3 t -59.5 -60.23 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 119.423 1.011 . . . . 0.0 109.54 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -62.48 -27.74 69.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.029 0.532 . . . . 0.0 111.772 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.7 m -71.71 -46.8 57.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.75 0.82 . . . . 0.0 113.139 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 79.3 mt -68.06 -54.37 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.986 1.266 . . . . 0.0 110.081 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -52.31 -31.8 34.75 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.624 1.57 . . . . 0.0 112.03 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.14 -61.87 2.57 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.632 1.587 . . . . 0.0 115.694 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 92.9 mmm -73.38 -35.1 65.87 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.5 mm -71.29 -29.07 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 121.778 -0.576 . . . . 0.0 111.272 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.6 t -56.57 -12.22 1.68 Allowed 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -84.42 -0.38 52.55 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 119.671 -1.893 . . . . 0.0 115.763 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 pp -116.54 8.46 13.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 -167.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 74.71 161.4 0.24 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.127 2.571 . . . . 0.0 115.707 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.25 -44.08 1.59 Allowed Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.345 -1.472 . . . . 0.0 113.22 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.11 97.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 127.295 2.238 . . . . 0.0 111.922 170.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.9 -61.58 1.79 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.472 1.109 . . . . 0.0 111.02 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -123.49 133.55 54.01 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.354 1.461 . . . . 0.0 108.495 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.5 tt -140.09 137.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.991 0.901 . . . . 0.0 110.799 -173.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.0 t -142.23 152.49 43.13 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.859 1.664 . . . . 0.0 109.991 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.58 139.07 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.439 1.096 . . . . 0.0 110.238 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 18.3 t -122.46 84.81 2.31 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.119 2.168 . . . . 0.0 108.708 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.7 -28.35 67.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.961 1.704 . . . . 0.0 111.519 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.2 -53.26 8.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.794 2.438 . . . . 0.0 112.887 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -95.16 -7.87 37.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.506 1.122 . . . . 0.0 111.707 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.55 42.13 64.21 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.059 1.79 . . . . 0.0 111.729 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.4 p -130.92 155.86 46.05 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.33 1.052 . . . . 0.0 111.51 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.29 129.93 38.25 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.525 1.13 . . . . 0.0 110.93 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.3 t -109.84 124.83 52.01 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.223 1.009 . . . . 0.0 108.962 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.76 138.58 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -169.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 121' ' ' CYS . 0.7 OUTLIER -96.43 114.49 26.16 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.897 2.479 . . . . 0.0 107.296 174.508 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -124.31 162.91 22.79 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.672 1.589 . . . . 0.0 112.022 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -96.79 112.62 60.96 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.259 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.13 -9.6 24.71 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.717 2.945 . . . . 0.0 115.456 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -88.36 -37.44 15.92 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.718 1.144 . . . . 0.0 112.084 169.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.65 -36.87 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.678 1.191 . . . . 0.0 112.209 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 tt -146.05 150.19 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 121.054 -1.029 . . . . 0.0 112.623 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.71 150.43 46.92 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.096 1.758 . . . . 0.0 110.535 -173.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.93 -37.56 67.21 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.398 2.732 . . . . 0.0 114.77 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.25 -27.68 68.14 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.56 -36.55 63.09 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.706 1.203 . . . . 0.0 112.149 172.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 91.0 mt -58.29 -52.93 63.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.775 0.83 . . . . 0.0 111.206 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -61.81 -38.74 89.24 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.13 -29.54 69.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.711 0.804 . . . . 0.0 112.469 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.44 -31.07 70.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.318 1.047 . . . . 0.0 113.045 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.26 -32.35 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.475 1.11 . . . . 0.0 111.362 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.06 -33.43 73.56 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.462 -0.774 . . . . 0.0 112.381 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -71.11 -30.42 66.5 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.842 0.746 . . . . 0.0 112.558 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 23.4 ttt -65.94 -43.3 88.44 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.123 0.969 . . . . 0.0 111.165 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 142.32 21.58 0.23 Allowed Glycine 0 CA--C 1.533 1.182 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 169.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -131.4 -155.16 0.67 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.111 1.365 . . . . 0.0 110.392 -171.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -129.44 140.57 51.27 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.426 1.491 . . . . 0.0 110.462 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.85 150.69 40.22 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.882 1.273 . . . . 0.0 114.404 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.7 t -141.8 146.95 36.51 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.252 1.421 . . . . 0.0 110.716 171.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.3 m -92.78 125.38 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.297 0.953 . . . . 0.0 109.665 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 124.384 2.04 . . . . 0.0 107.949 -177.305 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 121.47 0.652 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.9 m -99.01 164.4 12.19 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.782 1.633 . . . . 0.0 109.369 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.21 139.81 35.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.278 1.031 . . . . 0.0 110.315 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -98.51 123.85 42.9 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.753 0.787 . . . . 0.0 109.09 169.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.13 136.66 25.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.943 -1.48 . . . . 0.0 113.538 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -107.65 108.12 19.24 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.472 1.109 . . . . 0.0 110.053 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mt -92.99 145.74 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.678 1.591 . . . . 0.0 109.837 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.56 150.34 22.79 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.532 2.333 . . . . 0.0 111.29 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.98 -11.53 71.85 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.944 1.259 . . . . 0.0 114.348 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.7 ptp -70.29 -0.3 7.79 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.0 m170 -60.23 -23.96 64.48 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 120.315 1.416 . . . . 0.0 111.503 167.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.2 m -98.11 128.64 44.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.918 0.781 . . . . 0.0 110.377 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -56.49 -40.72 75.42 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.934 0.874 . . . . 0.0 112.392 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.8 p -59.39 -23.09 62.31 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.724 1.21 . . . . 0.0 113.907 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 74.8 m -72.97 -40.87 64.96 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.801 0.84 . . . . 0.0 112.149 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.2 p -74.59 -30.18 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.436 ' C ' HD23 ' A' ' 36' ' ' LEU . 5.0 tt -49.87 -60.74 2.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.266 1.426 . . . . 0.0 112.177 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -61.1 -24.15 66.02 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.304 -0.872 . . . . 0.0 113.266 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 mt -70.5 -48.95 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.138 -0.976 . . . . 0.0 110.281 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -68.06 -26.43 65.85 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.345 1.058 . . . . 0.0 112.372 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.58 -39.26 88.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.764 1.225 . . . . 0.0 112.039 171.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -94.68 -23.92 17.38 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -172.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.48 ' CD1' HG22 ' A' ' 78' ' ' ILE . 44.3 mm -108.7 113.54 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.869 0.868 . . . . 0.0 109.981 -169.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.5 -14.76 4.47 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.076 1.322 . . . . 0.0 114.739 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -100.86 7.49 43.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.508 1.123 . . . . 0.0 113.326 174.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.0 mt -90.96 159.69 16.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.906 1.682 . . . . 0.0 112.932 -173.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.15 -23.7 62.4 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -171.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.99 3.79 6.39 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.181 -1.899 . . . . 0.0 115.067 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -113.68 117.47 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 121.105 2.452 . . . . 0.0 109.006 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -100.34 -29.72 12.26 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.7 m -147.59 158.61 44.07 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.681 -1.262 . . . . 0.0 112.955 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.1 tp -137.96 137.99 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.497 1.519 . . . . 0.0 109.707 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -141.02 159.58 41.9 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.883 2.073 . . . . 0.0 107.944 -171.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.19 152.34 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 120.627 -1.296 . . . . 0.0 110.79 168.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -125.54 56.22 1.38 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 168.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -28.14 68.59 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.386 1.875 . . . . 0.0 112.567 -168.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.16 -20.15 24.6 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 169.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -115.68 -2.89 12.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.349 2.26 . . . . 0.0 112.541 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt 73.27 15.67 4.31 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.144 2.178 . . . . 0.0 112.672 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.96 147.32 23.81 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.922 1.289 . . . . 0.0 109.1 170.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.04 158.08 16.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 166.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.73 116.86 15.38 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -168.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.91 133.58 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.836 -0.54 . . . . 0.0 110.883 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -107.61 96.21 6.23 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.02 2.128 . . . . 0.0 106.676 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -126.03 154.6 42.75 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.62 108.56 40.65 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 127.073 2.149 . . . . 0.0 107.192 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -71.26 1.73 5.12 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.672 2.914 . . . . 0.0 114.474 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 p -83.01 -23.82 33.11 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.927 1.291 . . . . 0.0 112.33 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 85.5 m -120.1 -18.38 8.11 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 t -147.88 -178.6 6.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.814 1.246 . . . . 0.0 111.422 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.8 m -168.35 161.47 8.97 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.923 1.689 . . . . 0.0 112.596 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.72 -52.9 7.95 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 124.199 3.266 . . . . 0.0 117.289 -168.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.19 -32.33 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 120.742 1.61 . . . . 0.0 113.083 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.53 -40.05 85.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.55 0.74 . . . . 0.0 111.381 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.83 -44.53 80.85 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.342 1.057 . . . . 0.0 111.875 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -55.36 -51.73 65.83 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.63 0.65 . . . . 0.0 110.019 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -67.78 -28.79 67.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.134 0.974 . . . . 0.0 113.299 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.37 -60.25 2.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.122 0.874 . . . . 0.0 111.308 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.48 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.2 pt -72.74 -32.92 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -169.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -66.12 -22.08 66.38 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.6 16.17 27.09 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.2 mt -62.31 -57.36 23.43 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.12 -1.419 . . . . 0.0 109.838 165.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.53 171.18 18.26 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.122 3.215 . . . . 0.0 111.963 172.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.96 45.72 2.07 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 124.045 3.163 . . . . 0.0 112.664 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.95 58.61 3.97 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -135.62 -25.07 1.31 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.09 98.0 5.87 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.279 1.399 . . . . 0.0 108.283 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -92.31 128.65 38.23 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.737 1.215 . . . . 0.0 110.94 -167.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.59 135.3 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.257 1.023 . . . . 0.0 112.063 -174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.0 m -127.13 133.34 50.39 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.553 1.541 . . . . 0.0 111.347 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 124.736 1.214 . . . . 0.0 110.207 176.529 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 23.0 p -155.53 115.61 3.73 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -167.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.9 p -144.7 147.3 32.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.138 1.375 . . . . 0.0 111.209 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.2 m -98.79 141.49 31.52 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.493 -0.755 . . . . 0.0 110.204 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.31 164.12 31.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 112.04 169.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.44 133.95 54.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.715 2.006 . . . . 0.0 109.531 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.4 mm -119.82 133.26 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.297 1.039 . . . . 0.0 108.662 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.53 128.91 45.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.438 1.095 . . . . 0.0 109.001 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 89.9 mt -129.69 136.08 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.195 -0.941 . . . . 0.0 110.529 -169.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -119.68 56.89 0.93 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.752 1.621 . . . . 0.0 111.849 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.57 51.81 0.35 Allowed Glycine 0 N--CA 1.462 0.389 0 O-C-N 121.865 -0.522 . . . . 0.0 112.746 169.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 72.0 mtm -128.86 119.3 24.19 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.587 0.755 . . . . 0.0 109.189 171.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.92 -41.15 5.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.62 1.968 . . . . 0.0 110.34 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 86.7 m -134.32 157.66 45.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.308 1.843 . . . . 0.0 110.733 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.47 -28.49 65.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.99 -36.66 18.13 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.1 -1.0 . . . . 0.0 111.938 169.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 62.5 m -61.27 -42.66 99.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.485 1.114 . . . . 0.0 113.266 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.09 -54.98 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -66.98 -28.86 68.6 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.6 m -65.63 -52.62 50.45 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.077 1.351 . . . . 0.0 112.074 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.95 -51.08 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.03 -1.044 . . . . 0.0 110.547 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -52.81 -34.79 55.29 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.205 1.802 . . . . 0.0 110.86 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.31 -61.33 3.45 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.125 1.345 . . . . 0.0 113.306 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.7 mmt -63.51 -41.3 98.52 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.479 1.112 . . . . 0.0 112.799 -171.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.5 mm -70.86 -35.86 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 117.759 0.254 . . . . 0.0 110.901 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -63.18 -9.2 10.11 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -77.08 -18.84 57.73 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.224 -1.548 . . . . 0.0 114.086 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -99.63 164.98 11.83 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.144 1.338 . . . . 0.0 113.514 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -76.29 151.34 36.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.04 -25.72 6.66 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.838 1.208 . . . . 0.0 113.978 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.58 96.25 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.263 1.531 . . . . 0.0 109.955 169.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -74.47 -47.17 34.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.396 1.478 . . . . 0.0 111.806 -173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -144.05 135.82 26.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.471 1.908 . . . . 0.0 108.669 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 tt -140.13 135.66 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.778 1.172 . . . . 0.0 111.34 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.3 t -140.61 126.09 18.91 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.018 1.327 . . . . 0.0 111.487 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 t -126.11 147.58 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 O-C-N 120.695 -1.253 . . . . 0.0 111.285 -169.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.4 t -140.77 144.31 35.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.954 0.883 . . . . 0.0 112.939 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.8 -20.22 62.61 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.798 1.639 . . . . 0.0 115.019 174.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.44 -35.6 52.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.395 1.478 . . . . 0.0 113.595 -172.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -125.25 -10.93 6.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.79 1.636 . . . . 0.0 112.382 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.33 47.97 6.63 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.235 1.398 . . . . 0.0 111.365 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.4 p -139.03 144.39 38.82 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -168.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.57 142.58 35.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.414 1.885 . . . . 0.0 111.361 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.0 t -116.94 124.87 50.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.84 142.1 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 122.955 0.502 . . . . 0.0 111.841 -168.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.35 109.42 21.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.65 1.98 . . . . 0.0 107.097 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -106.08 156.06 18.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.042 0.937 . . . . 0.0 111.969 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -95.33 109.63 46.16 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.271 1.028 . . . . 0.0 108.531 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.67 -12.69 18.28 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.763 2.308 . . . . 0.0 112.518 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.04 -36.49 40.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.165 0.986 . . . . 0.0 112.306 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.24 -34.11 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.682 1.193 . . . . 0.0 113.893 -170.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 18.2 tt -137.16 152.99 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.118 1.326 . . . . 0.0 112.19 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 m -99.84 141.09 22.14 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.358 1.463 . . . . 0.0 110.892 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -51.46 -35.72 56.27 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.445 2.764 . . . . 0.0 114.412 172.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -62.49 -28.45 69.84 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -71.93 -33.68 68.45 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.896 -1.127 . . . . 0.0 111.802 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 70.0 mt -59.94 -58.82 6.91 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.407 0.683 . . . . 0.0 109.899 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -61.35 -37.66 84.13 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.009 -0.432 . . . . 0.0 112.025 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.47 -30.14 71.04 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.83 -31.52 68.28 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.18 0.9 . . . . 0.0 112.376 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.7 mp -71.72 -39.82 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.267 1.027 . . . . 0.0 111.177 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.89 -35.37 79.83 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.007 0.523 . . . . 0.0 111.869 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.92 -23.38 61.46 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.486 1.514 . . . . 0.0 113.958 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 26.2 ttt -74.7 -46.82 35.19 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.313 -0.867 . . . . 0.0 110.946 176.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.96 42.99 0.09 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.064 1.316 . . . . 0.0 115.373 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -143.66 -159.16 0.95 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.867 1.667 . . . . 0.0 109.68 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.6 142.04 50.82 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.12 1.368 . . . . 0.0 110.163 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -140.67 147.5 39.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.5 1.92 . . . . 0.0 112.504 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.3 t -138.62 134.19 33.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.632 1.573 . . . . 0.0 111.966 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.4 m -83.92 78.26 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.116 0.96 . . . . 0.0 110.444 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.475 0.806 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.441 174.629 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.81 97.06 10.76 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 166.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.767 HD12 ' H ' ' A' ' 23' ' ' GLN . 4.5 tp -112.16 165.43 12.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.102 1.361 . . . . 0.0 107.902 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.767 ' H ' HD12 ' A' ' 22' ' ' LEU . 11.2 pt20 -147.0 161.97 39.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 119.774 -1.829 . . . . 0.0 114.078 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -140.72 150.41 43.41 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.941 1.697 . . . . 0.0 109.652 168.427 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -98.7 103.35 15.3 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 mm -76.37 146.77 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.475 1.51 . . . . 0.0 110.539 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -98.91 137.22 37.78 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.984 2.114 . . . . 0.0 110.968 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.44 -9.46 75.46 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.106 1.336 . . . . 0.0 113.697 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.94 -6.16 7.79 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -60.16 -27.11 66.83 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.945 1.248 . . . . 0.0 110.758 165.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.1 t -88.58 119.62 29.2 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 166.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -58.92 -33.48 70.61 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.352 -0.843 . . . . 0.0 111.685 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 m -54.89 -31.0 59.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.733 1.213 . . . . 0.0 112.822 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.6 m -72.2 -40.48 67.83 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.974 1.309 . . . . 0.0 112.774 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.7 p -76.31 -31.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.86 -55.14 36.04 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.585 1.154 . . . . 0.0 112.235 -175.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -59.97 -31.3 69.76 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.535 -0.728 . . . . 0.0 112.594 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mt -64.01 -47.76 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.403 -0.811 . . . . 0.0 109.995 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.99 -25.93 68.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.686 1.594 . . . . 0.0 113.795 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.64 -37.46 59.66 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.753 -1.217 . . . . 0.0 113.862 170.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -91.13 -35.11 14.76 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.492 ' CD1' HG22 ' A' ' 78' ' ' ILE . 39.5 mm -95.88 112.17 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 120.818 -1.176 . . . . 0.0 107.968 -170.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.59 -15.26 3.62 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.378 0.989 . . . . 0.0 115.285 -168.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -104.32 11.58 34.58 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.589 1.194 . . . . 0.0 113.029 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.9 mt -96.88 149.72 21.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.391 1.476 . . . . 0.0 113.143 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.2 tp -32.21 -58.73 0.31 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.16 2.184 . . . . 0.0 114.016 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.86 19.01 31.05 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.181 -1.9 . . . . 0.0 115.704 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -138.1 109.58 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.084 2.442 . . . . 0.0 108.873 168.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.66 -16.12 15.08 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.5 t -146.1 168.08 21.82 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.016 1.326 . . . . 0.0 110.875 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.0 tp -143.51 146.51 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.292 1.037 . . . . 0.0 111.64 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -144.16 157.92 44.02 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.5 1.52 . . . . 0.0 109.825 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.79 156.47 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 O-C-N 119.801 -1.812 . . . . 0.0 112.564 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 t -136.22 56.21 1.82 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.249 1.82 . . . . 0.0 108.04 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.03 -23.03 66.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.583 1.153 . . . . 0.0 112.908 -170.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -66.13 -14.79 62.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.942 1.297 . . . . 0.0 113.76 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -126.12 11.46 7.62 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.274 2.23 . . . . 0.0 112.5 169.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 71.16 7.33 6.12 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.765 2.026 . . . . 0.0 115.382 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.32 157.74 15.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.808 1.243 . . . . 0.0 110.412 172.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.83 144.11 47.52 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.987 1.315 . . . . 0.0 109.426 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -112.29 119.17 37.4 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -170.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.35 140.75 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 120.924 -1.11 . . . . 0.0 108.089 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -110.09 82.97 1.68 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.757 1.223 . . . . 0.0 107.752 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -106.0 152.1 23.78 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -169.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.81 103.02 16.84 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.708 2.003 . . . . 0.0 110.113 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.94 0.74 1.86 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.705 2.937 . . . . 0.0 114.944 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 98.5 p -74.91 -15.65 60.69 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.887 -1.133 . . . . 0.0 113.226 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.3 m -137.09 -24.44 1.1 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -171.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 t -144.53 178.16 8.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.355 1.462 . . . . 0.0 111.374 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.3 p -148.18 158.56 41.29 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.825 1.25 . . . . 0.0 113.008 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.7 -52.31 7.18 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.661 2.907 . . . . 0.0 114.648 -170.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.3 m -62.96 -30.16 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.879 1.218 . . . . 0.0 113.516 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.65 -46.48 58.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.474 0.71 . . . . 0.0 111.257 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.9 mt -58.2 -42.52 86.33 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.646 0.778 . . . . 0.0 111.482 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -57.57 -37.99 74.06 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.167 0.587 . . . . 0.0 111.638 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -72.2 -40.28 67.98 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.433 1.015 . . . . 0.0 112.626 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.51 -60.2 4.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.033 0.933 . . . . 0.0 112.411 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.492 HG22 ' CD1' ' A' ' 42' ' ' ILE . 9.1 pt -70.53 -28.59 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -168.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -69.98 -12.99 62.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.615 1.566 . . . . 0.0 113.326 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.0 6.43 29.06 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -55.7 -49.83 90.56 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 117.307 -1.33 . . . . 0.0 110.985 166.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.62 172.08 17.0 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.298 2.665 . . . . 0.0 111.311 168.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.47 44.35 1.22 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.323 3.349 . . . . 0.0 111.64 170.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.28 30.54 41.12 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.101 1.334 . . . . 0.0 113.746 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -95.1 -47.99 6.14 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.65 1.225 . . . . 0.0 112.22 -169.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -100.58 123.37 44.7 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.127 1.371 . . . . 0.0 109.025 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -101.46 165.48 11.23 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.051 0.94 . . . . 0.0 111.888 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.01 139.47 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.503 0.721 . . . . 0.0 111.802 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 m -110.92 134.88 52.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.656 1.183 . . . . 0.0 110.949 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.542 0.67 0 C-N-CA 126.862 2.065 . . . . 0.0 111.169 177.986 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 21.8 p -125.38 152.14 45.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.404 1.882 . . . . 0.0 113.148 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.0 t -140.6 149.95 42.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.791 2.036 . . . . 0.0 107.395 167.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m -99.88 142.05 31.87 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.15 0.5 . . . . 0.0 110.819 -170.234 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.25 145.25 31.92 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.596 0.758 . . . . 0.0 110.394 169.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tt -114.69 137.83 51.44 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.676 1.99 . . . . 0.0 108.346 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.9 mt -133.36 138.4 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.622 1.569 . . . . 0.0 109.768 -168.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.33 130.87 45.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.246 1.818 . . . . 0.0 109.296 172.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mp -126.38 122.43 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.274 -0.892 . . . . 0.0 111.855 -171.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.48 61.47 3.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.212 1.805 . . . . 0.0 111.24 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.59 54.96 0.27 Allowed Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.628 169.454 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 73.8 mtm -138.78 121.09 15.93 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.628 0.771 . . . . 0.0 110.57 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 t -125.25 -30.19 3.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.747 1.619 . . . . 0.0 112.513 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 11.8 m -147.74 163.49 36.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.682 1.993 . . . . 0.0 111.057 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.3 -30.51 70.54 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -172.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.2 m -57.53 -20.94 34.98 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.763 -1.21 . . . . 0.0 112.933 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 93.0 m -63.06 -44.1 96.75 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.931 -1.105 . . . . 0.0 112.286 168.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.66 -54.43 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -65.73 -24.5 66.98 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 117.998 0.363 . . . . 0.0 111.741 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 m -70.84 -53.11 16.44 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.747 -1.22 . . . . 0.0 111.792 170.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.1 -50.41 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.507 -1.371 . . . . 0.0 110.696 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.19 -33.01 68.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.808 2.043 . . . . 0.0 111.494 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.5 -61.89 2.85 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.856 1.217 . . . . 0.0 113.913 174.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -44.83 67.73 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.75 1.22 . . . . 0.0 112.844 -169.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.4 mm -70.74 -21.0 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.543 -0.723 . . . . 0.0 111.502 -173.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.4 -2.91 18.12 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 169.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -80.96 -13.77 58.59 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 119.591 -1.943 . . . . 0.0 115.403 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.25 -177.17 4.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.218 1.407 . . . . 0.0 113.445 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.99 137.18 32.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.134 0.974 . . . . 0.0 111.49 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.03 41.45 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 117.658 -1.634 . . . . 0.0 115.894 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.9 p -120.93 93.6 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.802 1.801 . . . . 0.0 110.863 -175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -49.76 28.98 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.669 1.188 . . . . 0.0 110.122 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -147.31 142.72 27.45 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.751 1.221 . . . . 0.0 110.505 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 9.2 tt -135.83 140.51 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 119.426 1.012 . . . . 0.0 110.452 169.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 12.5 t -140.16 145.26 37.28 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.898 1.679 . . . . 0.0 109.667 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.3 t -141.01 146.4 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.659 1.118 . . . . 0.0 110.579 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 77.4 p -142.45 132.71 24.78 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.147 -0.971 . . . . 0.0 113.17 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -19.64 63.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.514 1.526 . . . . 0.0 112.614 171.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -48.88 -52.84 22.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.997 1.319 . . . . 0.0 111.64 170.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -96.23 -25.07 15.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.894 1.278 . . . . 0.0 112.321 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.76 25.53 55.99 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.791 1.186 . . . . 0.0 112.319 -170.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 p -136.02 147.12 47.81 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.526 1.163 . . . . 0.0 113.813 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -99.63 145.67 27.33 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.847 1.659 . . . . 0.0 110.366 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.9 t -127.95 129.36 46.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.647 0.779 . . . . 0.0 109.257 168.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.8 140.81 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 123.572 0.749 . . . . 0.0 111.181 -168.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.15 107.02 18.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.08 1.752 . . . . 0.0 106.947 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -101.79 157.04 17.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.423 0.689 . . . . 0.0 111.633 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -95.98 111.71 57.05 Favored Pre-proline 0 CA--C 1.542 0.673 0 O-C-N 121.242 -0.911 . . . . 0.0 110.285 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.95 -10.52 23.07 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.468 2.112 . . . . 0.0 112.823 -170.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.41 -8.64 59.76 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.143 0.977 . . . . 0.0 113.168 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 73.5 t -120.93 -42.25 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.994 1.318 . . . . 0.0 111.972 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.2 tt -143.39 165.09 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.212 1.005 . . . . 0.0 111.507 -170.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.46 154.01 72.45 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.0 1.72 . . . . 0.0 110.947 -175.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.19 -44.82 36.5 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.025 3.15 . . . . 0.0 114.962 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.53 -19.54 62.89 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.39 -0.819 . . . . 0.0 113.11 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -73.85 -29.14 61.95 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.844 -1.16 . . . . 0.0 111.944 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.75 -51.3 67.69 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.552 0.741 . . . . 0.0 109.296 170.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -50.64 -51.12 51.98 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.64 1.176 . . . . 0.0 111.686 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.45 -27.32 68.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.74 -34.9 64.96 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.824 0.85 . . . . 0.0 112.146 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.7 -38.59 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.877 0.871 . . . . 0.0 111.235 171.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -64.96 -35.87 82.57 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.986 0.812 . . . . 0.0 112.693 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.96 -35.28 79.63 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.197 -0.94 . . . . 0.0 111.72 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -43.48 80.15 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.758 0.823 . . . . 0.0 111.37 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 140.56 21.25 0.32 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 117.156 1.623 . . . . 0.0 117.156 169.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -114.95 -156.61 0.61 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.838 1.819 . . . . 0.0 110.272 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -131.54 140.7 49.55 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.992 1.317 . . . . 0.0 109.179 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -137.62 150.28 47.28 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.4 t -138.81 137.35 36.56 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.258 1.423 . . . . 0.0 109.577 169.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.77 135.05 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 121.513 -0.742 . . . . 0.0 110.308 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 124.095 1.903 . . . . 0.0 107.484 175.827 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 120.93 0.395 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.4 132.0 47.21 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.932 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.52 136.72 54.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.954 1.302 . . . . 0.0 109.657 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -97.09 128.66 44.23 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.852 1.661 . . . . 0.0 110.88 -169.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.74 141.16 33.25 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -109.55 116.33 31.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 mt -76.58 133.76 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 122.413 1.101 . . . . 0.0 110.136 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.88 104.97 15.26 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.625 2.37 . . . . 0.0 108.298 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.61 16.68 25.95 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.5 ptp -64.42 -36.21 83.41 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.659 1.73 . . . . 0.0 115.141 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 t60 67.53 -46.16 0.49 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 129.027 2.931 . . . . 0.0 113.83 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 96.0 m -153.63 163.78 39.39 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.949 2.5 . . . . 0.0 110.432 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -53.81 -31.32 48.66 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.223 -0.923 . . . . 0.0 112.884 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.1 p -49.0 -18.82 0.33 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.387 2.275 . . . . 0.0 115.48 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.3 t -57.6 -44.85 85.75 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.537 1.535 . . . . 0.0 112.466 167.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.63 -6.32 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.344 1.458 . . . . 0.0 114.075 -170.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.09 -59.19 4.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.987 0.915 . . . . 0.0 110.761 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -59.11 -36.16 74.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.617 -0.677 . . . . 0.0 110.901 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.11 -46.72 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 121.229 -0.92 . . . . 0.0 111.93 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.94 -31.52 72.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.677 1.191 . . . . 0.0 112.974 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -66.44 -34.52 78.13 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -94.64 -45.13 7.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.48 112.95 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 122.178 0.989 . . . . 0.0 109.995 -165.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.84 5.93 5.17 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.839 1.209 . . . . 0.0 114.383 -169.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.62 1.69 7.55 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.583 1.153 . . . . 0.0 113.609 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.76 171.2 8.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.087 1.355 . . . . 0.0 111.502 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -54.53 -37.84 65.88 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 171.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.2 11.95 7.63 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.445 -1.753 . . . . 0.0 115.918 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.87 120.27 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.005 2.402 . . . . 0.0 109.303 169.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 -21.15 12.36 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -142.78 166.72 23.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.882 1.219 . . . . 0.0 112.663 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.7 tp -140.88 138.65 34.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 126.591 1.956 . . . . 0.0 108.433 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -125.4 129.52 50.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.169 1.388 . . . . 0.0 109.51 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -99.4 112.4 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.315 1.446 . . . . 0.0 108.161 -170.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 m -125.8 49.58 1.93 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.829 0.823 . . . . 0.0 110.613 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.62 -15.18 60.8 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.255 1.822 . . . . 0.0 114.803 -170.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -43.7 -32.84 1.09 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.614 2.366 . . . . 0.0 115.538 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -125.33 23.39 7.59 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.666 1.186 . . . . 0.0 112.874 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 63.39 24.72 14.3 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.035 1.734 . . . . 0.0 112.263 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.28 164.4 13.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.075 1.75 . . . . 0.0 110.036 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.33 151.31 41.82 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 127.677 2.391 . . . . 0.0 106.8 170.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -124.71 134.53 52.81 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.415 -0.803 . . . . 0.0 111.292 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -102.52 139.74 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 117.847 0.294 . . . . 0.0 111.089 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -102.8 95.73 6.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.708 1.603 . . . . 0.0 108.857 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -120.8 152.48 38.3 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -170.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.34 112.0 59.83 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 127.85 2.46 . . . . 0.0 109.772 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -63.03 -2.74 3.97 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.838 3.025 . . . . 0.0 115.658 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.9 p -84.24 -16.66 42.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.71 1.204 . . . . 0.0 113.019 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 92.4 m -124.43 -28.4 3.63 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 t -142.18 179.2 7.05 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.684 1.129 . . . . 0.0 113.064 -169.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 97.6 p -165.61 162.53 13.27 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.7 1.6 . . . . 0.0 112.164 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -52.63 -49.33 17.85 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.728 2.952 . . . . 0.0 115.472 -172.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.32 -37.61 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 119.326 0.966 . . . . 0.0 112.459 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.47 87.93 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.299 1.039 . . . . 0.0 111.438 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.33 -47.4 70.61 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.863 0.865 . . . . 0.0 111.778 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -55.72 -47.96 75.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.087 0.858 . . . . 0.0 111.484 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -63.94 -29.64 70.8 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.25 -62.43 1.52 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.932 0.787 . . . . 0.0 112.277 170.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 pt -72.61 -17.3 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -73.81 -35.78 64.9 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 121.64 2.018 . . . . 0.0 113.156 168.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.41 13.7 26.94 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.944 -1.097 . . . . 0.0 112.261 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.2 tp -48.86 -54.39 28.29 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 129.331 3.052 . . . . 0.0 113.202 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -91.05 176.22 2.28 Favored 'Trans proline' 0 CA--C 1.55 1.285 0 C-N-CA 124.092 3.195 . . . . 0.0 111.879 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.35 53.01 3.75 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 124.663 3.575 . . . . 0.0 113.099 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.8 52.38 5.88 Favored Glycine 0 N--CA 1.471 1.011 0 O-C-N 120.689 -1.257 . . . . 0.0 111.823 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -127.74 -33.04 2.31 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.467 1.107 . . . . 0.0 113.875 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -135.01 113.94 11.97 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.126 1.77 . . . . 0.0 109.556 -173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -98.43 173.92 6.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.36 1.464 . . . . 0.0 110.516 173.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.24 135.21 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.783 -1.198 . . . . 0.0 111.025 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -107.62 124.74 50.41 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.13 0.972 . . . . 0.0 109.831 167.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 124.239 1.016 . . . . 0.0 109.569 176.856 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.9 t 73.03 113.85 0.06 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.804 2.442 . . . . 0.0 114.835 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 60.9 m -145.37 148.6 33.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.109 2.163 . . . . 0.0 108.905 166.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.4 m -99.13 145.96 26.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.037 -1.039 . . . . 0.0 110.256 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.87 155.06 43.26 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.917 1.287 . . . . 0.0 110.978 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.0 tt -114.6 136.01 53.51 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.789 2.036 . . . . 0.0 110.745 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.6 mm -123.57 141.08 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 127.174 2.19 . . . . 0.0 109.697 -172.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.23 127.42 53.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.147 1.379 . . . . 0.0 110.706 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.23 143.72 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 120.801 -1.187 . . . . 0.0 111.566 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.85 56.46 1.31 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.195 1.798 . . . . 0.0 113.258 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.68 45.92 0.28 Allowed Glycine 0 N--CA 1.469 0.87 0 O-C-N 121.209 -0.932 . . . . 0.0 112.714 167.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 29.6 mtm -133.5 96.8 3.79 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.222 1.009 . . . . 0.0 110.024 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 t -98.99 -26.51 14.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.315 1.846 . . . . 0.0 112.939 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 95.7 m -125.62 150.43 47.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.188 1.395 . . . . 0.0 110.934 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.1 -23.79 67.46 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.918 -1.113 . . . . 0.0 113.312 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.1 p -53.55 -30.87 44.05 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.01 1.324 . . . . 0.0 113.429 169.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.8 m -57.17 -32.66 66.66 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.724 1.21 . . . . 0.0 112.3 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 41.5 t -57.07 -53.87 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.685 0.794 . . . . 0.0 109.988 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -66.31 -23.28 66.35 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.973 0.509 . . . . 0.0 112.21 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.5 m -71.19 -52.72 17.55 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.568 -0.707 . . . . 0.0 111.148 170.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 85.7 mt -70.37 -52.23 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 120.741 -1.225 . . . . 0.0 111.315 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -51.46 -42.08 61.32 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.82 1.248 . . . . 0.0 111.082 172.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.42 -62.42 2.9 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 123.558 0.599 . . . . 0.0 113.127 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -38.59 71.14 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.033 1.333 . . . . 0.0 113.026 -170.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.8 mm -71.04 -35.3 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.73 -0.606 . . . . 0.0 110.539 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -65.0 3.07 0.62 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -94.44 -11.28 30.07 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.686 1.194 . . . . 0.0 113.546 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -106.25 167.59 9.72 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.026 1.285 . . . . 0.0 112.87 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -68.38 161.38 27.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 123.213 1.482 . . . . 0.0 114.705 -174.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.82 -32.41 1.94 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.36 1.457 . . . . 0.0 114.911 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.51 98.61 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 119.106 1.453 . . . . 0.0 112.435 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -72.32 -45.89 58.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.196 0.998 . . . . 0.0 112.135 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -144.61 132.49 21.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.141 1.376 . . . . 0.0 109.783 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.71 142.3 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.745 1.157 . . . . 0.0 112.854 170.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 31.2 t -131.45 142.62 50.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.55 2.74 . . . . 0.0 109.224 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.27 146.97 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.89 1.223 . . . . 0.0 111.781 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 43.1 t -139.29 136.34 34.78 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -16.83 63.22 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.36 2.264 . . . . 0.0 113.514 171.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.74 97.05 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.783 1.233 . . . . 0.0 111.969 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -116.37 -16.05 10.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.7 1.6 . . . . 0.0 112.605 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.94 28.51 56.44 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.177 1.37 . . . . 0.0 112.855 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.1 p -128.89 151.54 49.52 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.077 0.939 . . . . 0.0 113.26 -169.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -113.32 146.71 38.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.25 1.42 . . . . 0.0 111.906 172.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.4 m -118.52 126.19 51.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.852 1.661 . . . . 0.0 107.342 168.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.77 137.33 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.321 0.649 . . . . 0.0 110.65 -171.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.25 109.69 21.78 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.75 2.02 . . . . 0.0 105.78 173.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -111.29 155.67 22.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.023 0.929 . . . . 0.0 111.993 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -97.4 107.05 36.57 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.725 1.21 . . . . 0.0 109.139 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -66.97 -15.86 48.06 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.8 1.667 . . . . 0.0 113.537 -174.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.85 -14.84 61.15 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.45 -31.67 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.165 1.786 . . . . 0.0 112.494 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.0 tt -151.77 152.31 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.865 -1.147 . . . . 0.0 112.964 -170.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 73.5 m -114.49 159.32 37.33 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.55 1.14 . . . . 0.0 112.858 171.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.8 -37.64 45.55 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.48 3.453 . . . . 0.0 115.103 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -57.82 -35.82 71.39 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.449 1.022 . . . . 0.0 113.066 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.28 -32.49 64.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.234 1.013 . . . . 0.0 111.564 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.64 -51.93 67.7 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.689 -0.632 . . . . 0.0 110.089 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -62.28 -41.82 98.81 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.733 -0.605 . . . . 0.0 111.617 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.25 73.18 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.8 -34.79 69.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.86 -38.97 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.705 0.802 . . . . 0.0 110.115 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -59.97 -46.73 88.48 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.331 0.653 . . . . 0.0 110.249 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.84 -22.49 65.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.4 1.48 . . . . 0.0 114.507 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -39.58 78.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.459 -0.775 . . . . 0.0 110.95 172.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 138.71 24.58 0.34 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.443 -1.198 . . . . 0.0 115.512 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -124.41 -153.36 0.56 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.162 1.481 . . . . 0.0 109.263 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.07 141.7 36.19 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.745 1.618 . . . . 0.0 108.018 168.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.97 154.88 47.3 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.9 t -138.88 143.53 38.77 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.024 2.13 . . . . 0.0 109.9 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.5 m -90.39 131.16 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.393 -0.817 . . . . 0.0 111.13 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 126.074 1.749 . . . . 0.0 109.903 -176.463 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.651 0.263 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.37 145.82 32.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.646 0.778 . . . . 0.0 110.945 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tt -121.4 136.44 54.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.377 1.071 . . . . 0.0 111.918 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.55 122.84 39.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 122.597 1.189 . . . . 0.0 110.295 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.82 143.04 26.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.323 -1.762 . . . . 0.0 113.203 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -113.49 118.02 33.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.618 1.167 . . . . 0.0 108.86 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 mm -83.11 147.69 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.818 1.247 . . . . 0.0 110.916 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.69 156.82 18.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.943 1.697 . . . . 0.0 112.014 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.27 -7.26 64.66 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.585 1.088 . . . . 0.0 113.957 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.0 mtm -65.7 0.37 1.73 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -58.96 -23.23 61.41 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 119.672 1.124 . . . . 0.0 112.412 167.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.9 -6.77 59.34 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.915 1.286 . . . . 0.0 113.814 171.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 tptm 59.54 -57.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 130.729 3.612 . . . . 0.0 116.123 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 m -56.32 -13.4 2.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.568 1.947 . . . . 0.0 113.589 -174.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 m -48.76 -39.67 25.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.837 2.455 . . . . 0.0 112.678 167.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.58 -20.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -172.034 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.63 -56.92 15.56 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.147 0.979 . . . . 0.0 112.039 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -61.91 -28.82 69.79 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.655 -0.653 . . . . 0.0 111.921 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.2 mt -61.86 -54.97 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.521 1.055 . . . . 0.0 110.005 168.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -61.82 -32.38 72.68 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.2 1.0 . . . . 0.0 113.081 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -67.75 -42.12 82.3 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.123 1.369 . . . . 0.0 112.252 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -92.75 -17.41 24.23 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.471 ' CD1' HG22 ' A' ' 78' ' ' ILE . 50.4 mm -117.25 128.51 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.342 1.057 . . . . 0.0 110.131 -176.019 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.16 -6.17 1.74 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.621 1.581 . . . . 0.0 115.703 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -119.0 -1.27 10.99 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.853 2.061 . . . . 0.0 112.71 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.89 160.26 9.95 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.316 1.446 . . . . 0.0 110.279 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.4 pt? -55.22 -39.74 70.03 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.51 -32.65 5.93 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 116.876 -2.069 . . . . 0.0 115.009 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.62 118.02 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 121.235 2.517 . . . . 0.0 110.529 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -105.55 -17.4 14.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.7 m -148.91 148.09 29.43 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.491 -1.38 . . . . 0.0 113.364 169.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.7 tp -110.21 131.98 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.956 0.902 . . . . 0.0 109.866 167.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -120.52 143.45 48.56 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.432 1.493 . . . . 0.0 109.148 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.403 ' CG1' HD23 ' A' ' 55' ' ' LEU . 95.1 t -120.09 120.58 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.658 1.183 . . . . 0.0 109.804 -169.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -119.66 55.32 0.97 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.432 1.493 . . . . 0.0 112.635 -168.216 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.403 HD23 ' CG1' ' A' ' 53' ' ' VAL . 1.2 mm? -68.47 -13.97 62.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -169.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -60.27 -33.4 72.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.286 1.034 . . . . 0.0 112.94 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -113.25 15.87 19.22 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.421 1.488 . . . . 0.0 111.725 171.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.0 mttt 66.89 11.54 8.38 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.217 2.207 . . . . 0.0 113.056 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.58 174.29 7.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.173 2.189 . . . . 0.0 110.29 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.04 164.67 24.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.756 1.623 . . . . 0.0 108.47 167.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -135.73 109.45 8.05 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.089 1.355 . . . . 0.0 108.048 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.9 p -98.64 133.59 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 121.856 -0.528 . . . . 0.0 110.069 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.03 96.11 7.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.382 1.473 . . . . 0.0 109.805 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -125.25 148.22 48.75 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -98.87 118.35 63.02 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.272 1.429 . . . . 0.0 109.43 171.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.57 2.16 4.26 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.836 3.024 . . . . 0.0 113.095 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 t -71.37 -28.05 63.77 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.103 -0.998 . . . . 0.0 112.289 171.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 82.6 m -113.0 -20.45 11.53 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -171.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.6 t -145.13 -176.25 5.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.853 1.661 . . . . 0.0 111.178 -171.07 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.8 p -158.38 155.39 25.51 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.635 1.574 . . . . 0.0 110.919 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -48.51 -46.35 23.96 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 124.132 3.221 . . . . 0.0 116.907 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.39 -32.16 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 120.472 1.487 . . . . 0.0 113.065 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.22 -30.09 67.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.93 0.892 . . . . 0.0 111.849 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.7 mt -71.9 -53.16 14.02 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.661 0.784 . . . . 0.0 111.125 169.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -49.77 -57.32 7.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.944 1.298 . . . . 0.0 110.889 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -68.6 -27.15 65.78 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.25 -55.42 9.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.23 0.923 . . . . 0.0 111.356 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.471 HG22 ' CD1' ' A' ' 42' ' ' ILE . 8.7 pt -71.81 -31.85 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.86 -17.66 63.38 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.73 10.77 39.73 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.549 -1.344 . . . . 0.0 113.724 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.1 mt -59.17 -54.04 60.33 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.562 -1.209 . . . . 0.0 109.759 166.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.5 174.45 12.81 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.237 2.624 . . . . 0.0 110.849 168.467 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.74 54.49 3.53 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.142 3.228 . . . . 0.0 111.209 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.45 23.5 68.55 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.304 0.954 . . . . 0.0 112.999 -175.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -90.14 -30.37 17.68 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.554 0.677 . . . . 0.0 112.473 -169.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -109.49 116.0 30.99 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.282 1.433 . . . . 0.0 107.89 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.4 tptp -96.91 157.02 16.1 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.666 1.186 . . . . 0.0 110.592 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 m -124.2 133.81 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.756 1.616 . . . . 0.0 111.659 170.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.6 p -110.58 127.45 55.23 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.026 0.93 . . . . 0.0 110.528 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 125.355 1.462 . . . . 0.0 109.514 170.384 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.8 m 59.0 92.91 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.1 m -141.18 158.51 43.81 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.334 1.453 . . . . 0.0 110.804 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 52.9 m -99.22 142.51 30.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.734 0.814 . . . . 0.0 110.76 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.68 143.65 30.83 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.065 0.946 . . . . 0.0 111.312 170.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -102.68 135.72 43.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.277 1.431 . . . . 0.0 110.166 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 mm -113.83 136.04 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.552 1.941 . . . . 0.0 108.304 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -105.36 124.48 49.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.271 1.429 . . . . 0.0 109.306 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 88.3 mt -122.55 143.7 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 120.486 -1.384 . . . . 0.0 112.21 -166.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.62 56.39 1.48 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.298 1.439 . . . . 0.0 112.984 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.95 50.63 0.18 Allowed Glycine 0 N--CA 1.462 0.393 0 C-N-CA 125.17 1.367 . . . . 0.0 111.902 166.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.499 ' SD ' HD22 ' A' ' 157' ' ' LEU . 10.6 ptp -126.35 142.05 51.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.869 0.842 . . . . 0.0 110.637 168.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.0 t -155.72 143.03 19.33 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 128.152 2.581 . . . . 0.0 105.604 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 81.5 m 70.13 141.8 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.489 1.516 . . . . 0.0 113.422 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.41 -35.83 52.82 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.164 -0.96 . . . . 0.0 113.194 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.1 p -61.05 -25.22 66.77 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.109 -0.994 . . . . 0.0 113.373 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.3 t -65.91 -31.98 73.23 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.723 -0.611 . . . . 0.0 112.623 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.29 -60.5 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.305 0.642 . . . . 0.0 109.275 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -66.5 -20.01 65.93 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.5 t -71.08 -58.26 3.73 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.587 1.155 . . . . 0.0 111.764 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.5 mt -70.5 -49.41 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.002 1.321 . . . . 0.0 111.245 -176.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -53.16 -26.96 18.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.167 1.787 . . . . 0.0 111.775 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.62 -60.66 3.14 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.648 1.594 . . . . 0.0 113.321 167.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 70.1 mmm -54.29 -41.96 69.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.843 1.257 . . . . 0.0 114.001 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.79 -32.82 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.425 0.69 . . . . 0.0 111.97 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.0 t -64.9 1.11 0.97 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.256 1.423 . . . . 0.0 114.803 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -90.38 -30.31 17.49 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.357 -1.464 . . . . 0.0 114.031 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.86 176.77 8.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.216 1.006 . . . . 0.0 112.261 -174.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -86.84 154.45 20.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 122.489 1.138 . . . . 0.0 113.934 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.0 2.54 80.79 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 113.146 -1.843 . . . . 0.0 116.528 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.24 96.2 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 120.99 2.395 . . . . 0.0 112.231 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.477 HE22 ' HB2' ' A' ' 167' ' ' ASN . 24.5 mp0 -65.49 -50.28 65.91 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.88 0.872 . . . . 0.0 109.922 173.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -143.42 141.67 30.94 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.356 0.663 . . . . 0.0 111.427 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.48 138.98 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.961 0.886 . . . . 0.0 111.298 166.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.8 t -142.22 147.07 35.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 127.365 2.266 . . . . 0.0 109.05 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.3 t -134.75 136.44 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.314 0.961 . . . . 0.0 110.566 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.1 m -113.93 99.31 7.58 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.771 1.229 . . . . 0.0 111.149 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' LEU . . . . . 0.499 HD22 ' SD ' ' A' ' 131' ' ' MET . 0.2 OUTLIER -53.6 -30.99 45.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.952 1.701 . . . . 0.0 110.973 169.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -49.57 -34.21 17.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.043 2.137 . . . . 0.0 114.597 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -130.59 -5.24 4.16 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.187 0.995 . . . . 0.0 113.065 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.44 30.85 57.82 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.46 1.027 . . . . 0.0 112.355 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 61.0 p -118.66 152.98 35.07 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 117.869 0.834 . . . . 0.0 110.676 -170.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -125.26 124.3 41.36 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.675 0.79 . . . . 0.0 109.488 171.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.4 t -106.66 132.56 52.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.969 0.508 . . . . 0.0 110.18 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.82 138.67 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.068 0.547 . . . . 0.0 111.375 -171.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.16 96.1 8.21 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -98.78 159.92 14.62 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.625 0.77 . . . . 0.0 111.964 -177.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.477 ' HB2' HE22 ' A' ' 151' ' ' GLN . 59.8 t-20 -98.68 102.68 15.56 Favored Pre-proline 0 C--O 1.241 0.653 0 C-N-CA 124.935 1.294 . . . . 0.0 109.324 173.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.7 -16.93 55.37 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.612 1.541 . . . . 0.0 113.075 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.21 -12.94 60.4 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 173.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 76.4 t -119.78 -41.12 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.069 1.748 . . . . 0.0 111.858 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.4 tt -137.05 149.03 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.211 1.004 . . . . 0.0 112.05 -172.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 55.5 m -112.71 153.19 45.14 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 124.461 1.104 . . . . 0.0 111.991 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -52.28 -38.94 73.29 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.453 2.769 . . . . 0.0 114.559 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.34 -29.25 68.77 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -72.05 -31.44 66.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 112.532 172.19 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.39 -49.93 69.64 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.512 0.725 . . . . 0.0 109.351 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -52.7 -50.57 63.07 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.929 1.292 . . . . 0.0 111.834 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.94 69.41 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.78 65.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -74.34 -39.52 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.606 0.762 . . . . 0.0 110.91 170.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.61 -29.17 69.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.869 0.468 . . . . 0.0 111.746 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.07 -36.69 82.56 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.265 -1.522 . . . . 0.0 112.678 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 17.5 ttt -67.11 -28.66 68.34 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.86 0.864 . . . . 0.0 112.024 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 118.59 20.39 4.26 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.557 1.551 . . . . 0.0 115.747 169.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -106.46 -154.66 0.52 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.487 1.515 . . . . 0.0 109.69 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.58 138.13 42.67 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.119 1.367 . . . . 0.0 109.009 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -126.67 158.49 36.24 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.4 1.48 . . . . 0.0 111.545 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.2 t -140.51 136.11 32.59 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 126.947 2.099 . . . . 0.0 107.98 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.2 m -84.21 129.73 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.762 -0.586 . . . . 0.0 109.876 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 124.829 2.252 . . . . 0.0 107.151 171.095 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.429 HG13 ' CE1' ' A' ' 64' ' ' TYR . 9.0 p . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.59 144.01 50.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.951 0.9 . . . . 0.0 111.367 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.3 140.27 29.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.024 2.13 . . . . 0.0 109.205 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.01 146.21 52.31 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' H ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -132.6 158.13 43.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.592 1.957 . . . . 0.0 110.707 174.058 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.12 101.57 13.33 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -77.1 133.8 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.253 1.021 . . . . 0.0 110.814 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -97.84 136.24 38.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.472 1.509 . . . . 0.0 111.256 172.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.45 57.51 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.252 1.406 . . . . 0.0 114.256 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.2 ptp -60.81 -17.89 52.25 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -63.35 -15.53 57.69 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 119.4 1.0 . . . . 0.0 113.499 172.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.55 -9.97 59.71 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 168.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? 71.09 -59.78 0.53 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 128.68 2.792 . . . . 0.0 111.482 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.9 p -45.27 -35.84 3.66 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.335 2.254 . . . . 0.0 114.055 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -45.68 -45.76 14.35 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.7 1.6 . . . . 0.0 112.492 174.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.69 -18.43 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -174.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.1 tp -63.49 -50.92 67.75 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.203 0.911 . . . . 0.0 111.087 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -39.84 63.02 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.65 0.738 . . . . 0.0 111.072 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.38 -52.54 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.452 1.101 . . . . 0.0 109.977 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.41 -34.63 70.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.646 1.579 . . . . 0.0 113.701 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.59 -41.1 89.01 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.637 1.108 . . . . 0.0 111.68 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -94.12 -36.55 12.03 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.458 ' CD1' HG22 ' A' ' 78' ' ' ILE . 33.2 mm -98.22 114.77 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 121.177 -0.952 . . . . 0.0 109.04 -170.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.45 -27.36 2.38 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.183 0.897 . . . . 0.0 114.84 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -106.02 3.68 28.51 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.5 mt -87.78 163.67 16.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.815 1.246 . . . . 0.0 112.784 -170.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 47.1 tp -29.5 -62.01 0.14 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.802 2.441 . . . . 0.0 114.902 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.83 -23.78 13.02 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.218 -1.323 . . . . 0.0 114.626 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.86 126.3 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 120.14 1.97 . . . . 0.0 110.601 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -97.52 -40.32 8.71 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.798 0.839 . . . . 0.0 111.733 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.8 t -149.95 -178.56 6.55 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.413 1.085 . . . . 0.0 113.706 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.9 tp -132.63 145.3 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 127.462 2.305 . . . . 0.0 109.097 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -132.98 118.69 19.15 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.635 1.207 . . . . 0.0 109.561 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.4 t -104.82 95.07 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.274 1.83 . . . . 0.0 109.385 -168.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -113.17 55.63 0.7 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.401 1.481 . . . . 0.0 111.345 -174.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.4 mt -58.6 -28.82 65.94 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -168.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.5 -25.42 25.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.232 1.413 . . . . 0.0 113.589 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -102.23 -0.36 33.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.056 1.343 . . . . 0.0 113.733 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 69.6 -15.86 0.28 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 127.746 2.418 . . . . 0.0 114.543 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.64 131.28 42.04 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.845 1.658 . . . . 0.0 108.702 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.37 145.29 27.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.594 1.158 . . . . 0.0 109.698 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -114.86 134.19 55.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.705 1.202 . . . . 0.0 109.246 -169.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 p -118.39 140.46 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 119.976 1.262 . . . . 0.0 111.045 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -113.51 101.4 9.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.234 1.813 . . . . 0.0 108.499 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.429 ' CE1' HG13 ' A' ' 20' ' ' VAL . 16.1 p90 -128.62 -179.37 5.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.842 1.657 . . . . 0.0 111.63 -168.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -120.23 138.12 26.79 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.803 1.241 . . . . 0.0 108.569 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.57 5.51 6.07 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.966 2.444 . . . . 0.0 113.556 -169.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.9 p -75.12 -29.1 60.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.413 1.085 . . . . 0.0 113.197 -172.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.63 -21.65 6.11 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -170.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -146.71 -179.21 6.62 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.956 1.702 . . . . 0.0 110.93 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.8 p -165.58 170.24 6.26 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.969 1.308 . . . . 0.0 111.882 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -45.61 -51.28 8.31 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 124.612 3.541 . . . . 0.0 116.122 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.3 m -70.16 -35.26 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 119.714 1.143 . . . . 0.0 112.879 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.1 77.46 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.471 0.708 . . . . 0.0 110.929 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.22 -48.33 78.76 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.336 1.054 . . . . 0.0 111.28 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -52.32 -54.65 28.81 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.191 0.905 . . . . 0.0 110.987 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -65.53 -36.13 82.9 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.305 1.042 . . . . 0.0 111.785 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.42 -53.98 39.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.472 0.709 . . . . 0.0 112.164 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.458 HG22 ' CD1' ' A' ' 42' ' ' ILE . 7.9 pt -72.4 -30.34 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -172.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -66.23 -27.39 67.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.139 0.881 . . . . 0.0 113.07 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.89 8.11 42.48 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.79 -51.52 80.28 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-O 117.688 -1.149 . . . . 0.0 112.4 168.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.408 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 76.6 Cg_endo -71.75 167.47 26.46 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.221 1.947 . . . . 0.0 111.48 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.16 62.81 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.074 3.183 . . . . 0.0 110.019 169.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.56 53.8 38.81 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 124.943 1.258 . . . . 0.0 112.814 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -125.7 -50.79 1.6 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -171.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.408 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 13.5 m-85 -97.52 118.92 35.1 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.13 149.76 22.72 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.244 1.018 . . . . 0.0 111.578 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.2 m -123.92 142.58 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -121.38 134.22 55.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.38 1.472 . . . . 0.0 111.561 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 126.865 2.066 . . . . 0.0 110.948 174.838 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.7 p -147.92 131.7 17.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -167.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.3 p -144.22 146.34 32.61 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.109 1.764 . . . . 0.0 111.504 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -99.31 147.53 25.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.502 1.121 . . . . 0.0 109.981 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.49 141.85 27.49 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.072 0.949 . . . . 0.0 110.497 168.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tt -108.74 144.55 36.4 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.07 1.348 . . . . 0.0 110.738 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mt -134.2 137.24 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.374 1.87 . . . . 0.0 110.39 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.83 133.73 42.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.308 1.443 . . . . 0.0 109.793 172.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 55.4 mt -140.33 130.53 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 119.462 1.028 . . . . 0.0 110.866 -171.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.19 53.43 0.72 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.344 1.058 . . . . 0.0 112.755 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.41 53.13 0.42 Allowed Glycine 0 N--CA 1.47 0.907 0 O-C-N 120.932 -1.105 . . . . 0.0 113.815 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -131.1 154.0 48.75 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.513 1.125 . . . . 0.0 109.903 170.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 t -157.33 -37.13 0.07 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.841 1.656 . . . . 0.0 111.217 -169.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 57.3 m -133.78 159.25 41.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.94 1.696 . . . . 0.0 111.577 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.85 -31.99 70.27 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -51.52 -26.3 8.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.898 1.279 . . . . 0.0 113.49 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 79.0 m -58.48 -26.42 63.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.519 1.128 . . . . 0.0 113.595 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.91 -47.33 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 118.892 0.769 . . . . 0.0 109.818 173.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -71.17 -13.89 62.09 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.4 m -70.98 -56.48 6.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.14 -54.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.846 1.258 . . . . 0.0 110.614 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -54.49 -32.82 58.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.22 1.008 . . . . 0.0 111.004 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.74 -49.53 63.39 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 124.171 0.891 . . . . 0.0 112.422 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 96.8 mmm -66.86 -46.99 73.32 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.689 1.244 . . . . 0.0 111.822 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.6 mm -73.19 -54.08 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.394 0.677 . . . . 0.0 112.707 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.5 t -62.46 -16.18 53.87 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -168.254 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -74.8 -30.84 61.55 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.978 1.311 . . . . 0.0 114.135 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 pp -89.28 -179.37 5.85 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.116 0.871 . . . . 0.0 111.407 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -87.39 -172.55 3.97 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.112 0.958 . . . . 0.0 111.6 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.63 -45.64 1.88 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.272 -1.517 . . . . 0.0 113.711 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.1 p -65.35 99.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.213 2.205 . . . . 0.0 112.096 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.23 -39.9 24.65 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.503 -0.748 . . . . 0.0 111.713 169.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -140.16 144.07 36.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.2 1.0 . . . . 0.0 110.461 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.45 138.32 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.997 0.903 . . . . 0.0 113.133 169.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.4 t -140.01 146.77 39.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.851 2.46 . . . . 0.0 110.691 -169.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.1 t -143.63 138.03 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.913 -1.117 . . . . 0.0 111.02 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 70.0 m -124.94 89.58 3.09 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.759 1.624 . . . . 0.0 111.126 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.53 -29.92 39.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.104 2.161 . . . . 0.0 113.242 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -47.7 -31.31 4.58 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.079 2.552 . . . . 0.0 115.259 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -130.18 -3.48 4.46 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.134 1.773 . . . . 0.0 112.237 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.29 36.32 63.48 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 117.852 -1.527 . . . . 0.0 112.882 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.8 p -124.1 153.74 41.0 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.126 1.463 . . . . 0.0 112.082 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -119.28 148.73 42.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.537 1.535 . . . . 0.0 109.722 169.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.9 t -138.39 133.55 33.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.585 0.754 . . . . 0.0 110.835 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.62 143.0 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.677 0.791 . . . . 0.0 111.451 -168.14 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.6 106.57 18.91 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.556 1.542 . . . . 0.0 107.371 169.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -108.38 158.09 17.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.957 1.303 . . . . 0.0 111.701 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -95.9 116.62 66.35 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 121.061 -1.024 . . . . 0.0 109.536 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.41 -10.22 20.48 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.326 2.017 . . . . 0.0 113.199 -170.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.15 -7.74 58.93 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.132 0.973 . . . . 0.0 113.418 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.97 -35.44 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.51 1.524 . . . . 0.0 112.348 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.0 tt -156.66 159.2 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.349 0.977 . . . . 0.0 112.205 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.76 150.72 43.2 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 126.213 1.805 . . . . 0.0 112.214 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.54 -43.87 37.39 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.3 3.334 . . . . 0.0 114.908 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -72.22 -15.94 61.94 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.68 -30.72 61.68 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.078 -1.014 . . . . 0.0 112.35 170.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 66.9 mt -59.04 -51.6 69.34 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.796 1.238 . . . . 0.0 110.406 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -49.73 -47.92 50.36 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.181 1.392 . . . . 0.0 112.512 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.02 -23.68 66.6 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.8 65.36 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.531 0.732 . . . . 0.0 112.207 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.3 mt -74.36 -41.36 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.75 1.22 . . . . 0.0 110.646 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -63.84 -28.27 69.74 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.011 0.924 . . . . 0.0 112.579 171.538 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -69.88 -35.46 74.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.177 0.991 . . . . 0.0 112.645 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 19.8 ttt -73.03 -34.06 66.1 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.871 0.868 . . . . 0.0 112.433 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 120.26 35.91 0.84 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.205 1.383 . . . . 0.0 114.741 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -134.48 147.56 50.39 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.82 1.648 . . . . 0.0 110.314 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -101.37 102.36 13.17 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.833 -1.167 . . . . 0.0 111.232 -167.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -99.98 147.34 25.69 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.284 2.234 . . . . 0.0 112.514 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.5 t -142.52 144.24 32.87 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.822 1.249 . . . . 0.0 109.999 168.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.2 m -71.71 136.39 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.702 -0.624 . . . . 0.0 110.675 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 125.766 1.626 . . . . 0.0 107.57 169.858 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.05 133.05 42.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.324 1.45 . . . . 0.0 109.373 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tt -126.53 128.83 47.5 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.307 2.243 . . . . 0.0 107.952 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -96.99 135.7 38.61 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.947 1.299 . . . . 0.0 110.344 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 pp -145.06 157.56 44.07 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.427 1.091 . . . . 0.0 113.736 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -116.06 125.39 52.36 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.02 1.328 . . . . 0.0 110.476 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.3 mt -100.86 150.23 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 126.169 1.788 . . . . 0.0 111.734 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.67 133.97 41.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.797 1.639 . . . . 0.0 110.923 173.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.43 1.25 81.35 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.853 1.216 . . . . 0.0 114.287 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.2 ptm -72.37 -6.78 45.83 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 116.196 1.925 . . . . 0.0 116.196 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -60.21 -18.87 51.49 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.425 1.011 . . . . 0.0 112.658 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.5 t -89.98 119.4 30.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 165.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -19.95 62.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.254 1.022 . . . . 0.0 113.397 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.3 m -63.59 -23.9 67.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.1 t -61.52 -52.38 64.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.902 1.683 . . . . 0.0 110.862 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.46 -15.77 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -69.65 -60.81 2.08 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.426 1.012 . . . . 0.0 111.264 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -26.07 68.65 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.34 -0.85 . . . . 0.0 112.117 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 92.3 mt -64.8 -50.94 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.913 -1.117 . . . . 0.0 111.048 167.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.0 -31.32 70.94 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.771 1.228 . . . . 0.0 113.658 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -56.03 -46.29 78.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.465 1.03 . . . . 0.0 110.541 173.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -90.29 -29.15 18.31 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.417 ' CD1' HG22 ' A' ' 78' ' ' ILE . 44.3 mm -110.09 113.43 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.34 1.056 . . . . 0.0 111.034 -169.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.27 -15.87 4.44 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 125.986 1.755 . . . . 0.0 114.45 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -101.77 5.66 41.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.79 1.236 . . . . 0.0 112.296 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.13 178.52 4.35 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.61 1.564 . . . . 0.0 112.142 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.9 -69.29 0.29 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.022 1.329 . . . . 0.0 111.333 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.69 -37.66 16.19 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.774 -1.57 . . . . 0.0 112.547 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.15 120.96 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 119.593 1.697 . . . . 0.0 110.126 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.29 -17.33 10.79 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.4 m -145.47 163.62 34.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.33 0.968 . . . . 0.0 111.324 169.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.5 tp -129.1 124.54 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.279 1.032 . . . . 0.0 109.045 168.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -114.13 142.14 46.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.408 1.483 . . . . 0.0 108.305 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.08 137.87 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.806 0.842 . . . . 0.0 109.687 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.0 t -136.12 55.53 1.85 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 123.967 1.842 . . . . 0.0 107.69 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.8 mt -68.9 -24.49 64.31 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.009 1.724 . . . . 0.0 114.516 -167.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.61 -52.42 63.85 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.317 1.047 . . . . 0.0 110.421 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.79 19.02 6.89 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.676 1.191 . . . . 0.0 111.942 174.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 65.12 28.01 12.32 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.569 1.948 . . . . 0.0 112.76 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.6 152.29 27.77 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.604 1.561 . . . . 0.0 111.447 -176.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.49 154.78 44.69 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -141.7 116.41 9.74 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -163.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 p -98.79 137.38 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 120.97 0.414 . . . . 0.0 111.236 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -108.3 97.65 7.3 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.812 2.045 . . . . 0.0 108.713 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -129.63 155.74 45.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.875 1.27 . . . . 0.0 113.921 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -99.17 118.53 62.42 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 125.564 1.545 . . . . 0.0 110.528 170.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.0 -2.13 2.05 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.203 3.935 . . . . 0.0 116.064 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.5 t -72.94 -22.65 60.68 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.136 1.374 . . . . 0.0 113.145 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 36.1 m -139.66 -8.62 1.24 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 t -147.91 -179.47 6.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.272 1.029 . . . . 0.0 110.833 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 p -160.81 156.29 21.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.057 0.943 . . . . 0.0 113.16 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.69 -55.68 3.88 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.747 3.631 . . . . 0.0 116.129 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 m -67.26 -34.17 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.097 1.317 . . . . 0.0 112.053 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.22 89.54 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.967 0.907 . . . . 0.0 111.661 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.7 mt -66.22 -43.81 85.59 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.849 0.86 . . . . 0.0 111.494 171.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -57.93 -44.76 87.09 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.237 0.926 . . . . 0.0 110.815 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -70.09 -31.2 68.65 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.368 1.067 . . . . 0.0 113.557 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.42 -51.77 27.09 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.952 0.901 . . . . 0.0 112.486 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.417 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.4 pt -74.29 -32.47 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -174.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.16 -30.01 69.02 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.59 7.08 40.99 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.08 -55.04 37.77 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.385 -1.293 . . . . 0.0 112.885 170.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 92.1 Cg_endo -72.2 169.36 21.72 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.992 2.461 . . . . 0.0 111.492 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.12 51.95 3.32 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 125.245 3.964 . . . . 0.0 112.404 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.43 63.28 4.21 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -173.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -130.3 -58.1 1.06 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.42 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 20.4 m-85 -93.22 124.67 37.36 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -97.55 162.94 13.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.015 0.926 . . . . 0.0 110.452 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 p -140.82 137.25 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.0 m -118.85 139.39 51.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.142 2.177 . . . . 0.0 110.767 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 124.575 1.15 . . . . 0.0 111.584 175.268 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.26 5.7 t . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.459 0.171 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.4 m 49.8 93.16 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 166.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 p -133.92 141.44 47.33 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.476 -1.39 . . . . 0.0 111.211 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 44.2 m -97.46 134.42 40.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.664 1.12 . . . . 0.0 110.176 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.4 158.16 45.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.209 1.004 . . . . 0.0 113.067 175.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.22 136.51 45.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.323 2.249 . . . . 0.0 111.025 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.0 mm -128.58 134.4 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.963 1.705 . . . . 0.0 108.348 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.08 130.1 45.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.185 0.994 . . . . 0.0 109.486 172.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.35 147.53 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.47 -1.394 . . . . 0.0 110.921 -168.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -134.97 58.67 1.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.29 1.436 . . . . 0.0 113.221 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.1 48.74 0.3 Allowed Glycine 0 N--CA 1.469 0.846 0 O-C-N 120.889 -1.132 . . . . 0.0 113.696 166.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' MET . . . . . 0.408 ' O ' HG22 ' A' ' 132' ' ' THR . 74.3 mtm -102.14 -55.51 2.46 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 117.562 -1.209 . . . . 0.0 111.716 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 131' ' ' MET 0.256 6.0 t 67.44 -38.64 0.35 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 129.647 3.179 . . . . 0.0 114.619 174.072 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 87.3 m -135.47 153.56 51.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.502 2.321 . . . . 0.0 111.529 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.56 76.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.353 1.061 . . . . 0.0 113.401 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.4 p -53.19 -35.29 59.69 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.813 0.733 . . . . 0.0 112.565 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.4 t -62.89 -25.8 68.48 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.2 t -58.94 -57.29 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.93 0.786 . . . . 0.0 109.076 169.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -65.54 -23.75 66.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.254 0.479 . . . . 0.0 112.16 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.1 m -69.9 -47.97 60.47 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.647 -0.658 . . . . 0.0 112.242 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.83 -53.68 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 119.725 1.148 . . . . 0.0 110.826 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -54.43 -31.01 54.37 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.673 1.989 . . . . 0.0 111.314 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.46 -61.74 2.71 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.3 1.429 . . . . 0.0 114.469 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 74.3 mmm -70.38 -41.81 72.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.844 1.258 . . . . 0.0 114.073 -168.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.8 mm -70.85 -27.57 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.714 -0.617 . . . . 0.0 110.66 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.411 ' HA ' HG11 ' A' ' 150' ' ' VAL . 2.7 t -65.73 0.39 1.73 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -99.48 -5.35 29.49 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -104.51 173.98 6.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.396 1.479 . . . . 0.0 111.821 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -79.14 142.87 36.0 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.079 -1.013 . . . . 0.0 111.712 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 94.09 11.47 57.49 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 117.133 -1.926 . . . . 0.0 116.947 175.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' A' ' 145' ' ' SER . 10.1 p -111.85 -29.27 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.638 1.719 . . . . 0.0 114.775 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 39.07 -71.3 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 129.988 3.315 . . . . 0.0 117.602 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -133.74 124.74 27.17 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.619 1.1 . . . . 0.0 110.373 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.7 tt -129.41 136.12 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.7 1.2 . . . . 0.0 111.24 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 24.5 t -136.38 126.56 26.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.218 1.807 . . . . 0.0 109.253 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.1 t -141.69 139.21 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.725 -1.234 . . . . 0.0 110.436 -168.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.1 m -145.39 140.17 27.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.211 0.604 . . . . 0.0 112.021 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.9 mt -65.63 -30.63 71.37 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.44 -56.36 5.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.754 2.021 . . . . 0.0 113.199 -170.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -101.39 -5.7 25.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.151 1.38 . . . . 0.0 111.198 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.27 35.53 77.08 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 125.248 1.404 . . . . 0.0 112.286 -175.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.4 p -116.7 139.17 50.85 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 124.697 1.199 . . . . 0.0 113.615 -167.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.65 138.72 41.37 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.664 1.586 . . . . 0.0 108.965 167.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.8 t -123.01 126.38 47.03 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 166.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.47 142.93 28.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 123.525 0.73 . . . . 0.0 111.313 -166.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -93.06 93.52 8.36 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.868 2.067 . . . . 0.0 106.601 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -94.62 158.12 15.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.96 0.886 . . . . 0.0 111.234 -174.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -95.77 106.98 30.98 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 121.701 -0.624 . . . . 0.0 109.975 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.15 -17.74 24.34 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.135 1.89 . . . . 0.0 112.856 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.71 41.0 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.457 1.103 . . . . 0.0 113.766 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.57 -27.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.097 1.759 . . . . 0.0 113.342 -171.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 21.3 tt -145.38 147.09 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 120.488 1.494 . . . . 0.0 112.457 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 35.3 m -98.5 144.71 28.61 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.279 1.032 . . . . 0.0 110.654 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.77 -33.51 32.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.315 3.344 . . . . 0.0 115.02 176.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -60.75 -28.59 68.82 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.5 -28.33 59.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.041 1.336 . . . . 0.0 113.07 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.23 -48.5 78.0 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.022 0.828 . . . . 0.0 109.104 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -52.66 -47.62 67.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.017 1.327 . . . . 0.0 111.068 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.46 -30.14 69.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.371 1.068 . . . . 0.0 113.712 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.38 -38.83 68.39 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.989 1.268 . . . . 0.0 113.001 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.63 -36.19 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.64 0.776 . . . . 0.0 110.391 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -69.66 -31.09 68.96 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.6 -0.688 . . . . 0.0 112.426 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.18 -28.76 65.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.663 1.985 . . . . 0.0 112.637 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.8 ttt -70.89 -36.69 72.87 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.34 1.056 . . . . 0.0 111.107 172.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 134.14 16.78 1.06 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.517 1.532 . . . . 0.0 116.117 169.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -113.08 -159.31 0.68 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.696 1.248 . . . . 0.0 110.216 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -128.27 140.63 51.78 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.525 1.13 . . . . 0.0 110.066 169.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -132.22 151.37 51.85 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.513 1.525 . . . . 0.0 111.875 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.2 t -133.41 132.49 41.22 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.394 1.478 . . . . 0.0 111.997 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.5 m -84.54 80.8 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.986 0.898 . . . . 0.0 110.722 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 126.654 1.982 . . . . 0.0 111.817 174.007 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.676 0.751 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -99.16 137.63 37.4 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.568 1.947 . . . . 0.0 110.002 -169.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tt -142.25 139.21 31.86 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.597 1.159 . . . . 0.0 110.62 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.35 133.94 42.05 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.692 1.997 . . . . 0.0 110.716 -176.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.11 134.07 24.01 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.794 170.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -100.05 113.64 26.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 mt -77.73 128.99 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 121.548 0.69 . . . . 0.0 109.577 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.2 107.85 19.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.235 2.214 . . . . 0.0 109.894 -171.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.09 10.52 34.2 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.676 1.131 . . . . 0.0 114.074 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.3 ptp -57.99 -35.58 71.41 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.155 1.478 . . . . 0.0 114.334 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 t60 68.06 -44.06 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 129.202 3.001 . . . . 0.0 113.294 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.8 p -166.74 166.88 15.58 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.647 2.379 . . . . 0.0 110.344 -173.104 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.55 -35.92 61.28 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.7 m -57.73 -23.09 50.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 t -49.39 -40.42 35.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.643 1.177 . . . . 0.0 112.004 168.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -12.34 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 117.83 -1.081 . . . . 0.0 113.565 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.87 -49.73 71.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.536 1.516 . . . . 0.0 111.884 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -40.94 68.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.144 0.884 . . . . 0.0 110.716 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mt -65.3 -52.31 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.311 1.444 . . . . 0.0 109.775 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -60.84 -33.32 72.86 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.936 2.495 . . . . 0.0 113.478 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -67.31 -45.05 77.64 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.517 1.127 . . . . 0.0 111.763 173.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -95.22 -29.43 14.52 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -170.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.415 ' CD1' HG22 ' A' ' 78' ' ' ILE . 47.3 mm -108.14 113.46 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.108 0.963 . . . . 0.0 109.577 -170.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.23 -22.55 7.06 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 125.857 1.694 . . . . 0.0 114.015 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -78.65 -10.68 59.84 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 118.188 0.994 . . . . 0.0 112.094 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.5 mt -67.81 -177.69 0.84 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.609 3.164 . . . . 0.0 112.404 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tt -82.12 -70.21 0.56 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.406 -0.809 . . . . 0.0 110.992 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.94 -44.44 78.67 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.118 -1.379 . . . . 0.0 112.483 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.14 117.82 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.65 1.725 . . . . 0.0 108.617 171.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -97.32 -41.47 8.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.153 0.981 . . . . 0.0 110.494 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 t -145.56 167.3 23.36 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.042 0.937 . . . . 0.0 112.666 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.6 tp -135.85 142.46 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.7 2.0 . . . . 0.0 108.437 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -141.48 153.93 45.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.01 1.724 . . . . 0.0 110.015 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.445 HG13 HD13 ' A' ' 55' ' ' LEU . 12.6 t -108.83 144.46 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.71 2.004 . . . . 0.0 109.926 -176.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.5 t -140.37 54.14 1.62 Allowed 'General case' 0 CA--C 1.555 1.159 0 CA-C-O 122.806 1.288 . . . . 0.0 109.939 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.445 HD13 HG13 ' A' ' 53' ' ' VAL . 1.7 mp -64.11 -19.28 65.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.081 1.353 . . . . 0.0 113.973 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.46 -24.21 44.1 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.1 19.36 8.33 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.875 1.67 . . . . 0.0 111.799 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.8 mttt 60.75 16.85 7.08 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.271 1.828 . . . . 0.0 113.788 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 p -96.92 159.71 14.76 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 123.517 1.627 . . . . 0.0 110.123 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.43 154.09 38.22 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.042 2.137 . . . . 0.0 106.813 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -131.03 119.03 21.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.864 1.266 . . . . 0.0 108.587 -168.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 p -106.87 141.4 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.745 -0.597 . . . . 0.0 110.633 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.15 95.51 5.42 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.64 1.576 . . . . 0.0 108.97 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -123.31 150.64 43.33 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.362 1.065 . . . . 0.0 112.567 -173.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.4 123.11 57.68 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.544 1.137 . . . . 0.0 107.997 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.35 -12.79 6.23 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.067 3.178 . . . . 0.0 114.801 175.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.8 m -58.41 -28.32 65.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.032 1.733 . . . . 0.0 114.93 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 99.0 m -137.94 -12.17 1.48 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -148.2 177.14 9.65 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.869 1.267 . . . . 0.0 111.282 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.5 p -158.64 160.7 29.28 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.279 1.432 . . . . 0.0 111.893 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -53.99 -48.81 19.64 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.09 2.527 . . . . 0.0 115.398 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.2 m -69.31 -32.85 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 120.135 1.334 . . . . 0.0 112.938 177.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.55 -35.19 78.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.448 0.699 . . . . 0.0 111.643 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.96 -48.63 57.53 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.339 1.055 . . . . 0.0 111.213 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -54.59 -57.18 12.42 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.476 1.034 . . . . 0.0 111.555 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -60.51 -31.11 70.19 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.439 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.04 -61.94 1.61 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.009 0.924 . . . . 0.0 112.824 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.415 HG22 ' CD1' ' A' ' 42' ' ' ILE . 8.8 pt -70.48 -29.85 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -169.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -59.48 -35.07 73.41 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.996 0.919 . . . . 0.0 111.471 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.05 13.63 33.39 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mt -59.23 -55.99 40.63 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.909 166.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.56 171.27 18.09 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.524 2.816 . . . . 0.0 112.36 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.31 59.91 6.2 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.584 3.523 . . . . 0.0 110.975 171.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.32 35.58 92.14 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.999 1.285 . . . . 0.0 113.118 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -101.19 -41.17 6.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.685 0.742 . . . . 0.0 112.734 -169.093 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -115.78 117.02 29.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.611 1.164 . . . . 0.0 109.118 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -99.37 170.39 8.67 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.301 1.44 . . . . 0.0 111.337 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.7 m -135.26 130.28 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.064 -1.022 . . . . 0.0 110.902 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.9 m -103.75 117.78 35.16 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.146 0.978 . . . . 0.0 110.579 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.335 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 122.563 1.173 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 29.3 p -163.84 142.41 7.66 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.084 2.153 . . . . 0.0 110.958 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.2 t -144.98 158.41 43.82 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.311 -0.868 . . . . 0.0 111.094 172.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 98.6 m -98.53 140.52 32.64 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.86 149.64 40.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.514 1.126 . . . . 0.0 110.603 173.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 tt -115.25 136.79 52.73 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.986 1.714 . . . . 0.0 109.084 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.7 mm -119.66 138.07 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.737 2.015 . . . . 0.0 108.255 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.58 136.58 38.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.507 1.123 . . . . 0.0 108.91 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.26 139.2 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 120.729 -1.232 . . . . 0.0 110.134 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.39 57.86 1.0 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.359 2.264 . . . . 0.0 112.016 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.05 52.36 0.23 Allowed Glycine 0 N--CA 1.465 0.592 0 C-N-CA 124.435 1.017 . . . . 0.0 111.354 168.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.1 mtm -136.1 126.34 26.45 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.854 1.262 . . . . 0.0 108.788 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.2 t -144.7 -24.83 0.51 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.703 1.601 . . . . 0.0 111.457 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 96.6 m -116.01 142.54 46.66 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.552 1.941 . . . . 0.0 110.8 170.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -48.93 -32.81 9.66 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.112 1.365 . . . . 0.0 113.837 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.9 p -58.2 -22.54 52.24 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.6 t -61.87 -28.66 69.66 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.214 -0.928 . . . . 0.0 112.358 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.9 -51.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 121.627 -0.671 . . . . 0.0 110.722 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -70.13 -19.14 63.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.6 m -74.62 -56.09 5.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.376 1.07 . . . . 0.0 112.077 167.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.78 -57.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 121.123 -0.986 . . . . 0.0 111.153 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.43 -25.57 66.06 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.239 1.016 . . . . 0.0 110.912 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.49 -57.97 5.23 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.886 1.232 . . . . 0.0 113.611 174.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.2 -46.32 42.75 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.976 0.888 . . . . 0.0 113.337 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.0 mm -72.71 -24.09 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.635 0.774 . . . . 0.0 112.501 -172.058 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.9 p -65.6 -15.74 63.03 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.1 -10.87 43.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -168.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.99 -177.8 6.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.324 1.049 . . . . 0.0 113.253 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -93.63 127.11 39.16 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.256 1.022 . . . . 0.0 109.845 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 103.5 16.98 18.69 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 117.683 -1.621 . . . . 0.0 116.517 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.34 100.41 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 127.212 2.205 . . . . 0.0 112.475 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -78.12 -49.21 14.32 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.401 -0.812 . . . . 0.0 112.232 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -140.51 141.25 35.36 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.225 1.81 . . . . 0.0 108.669 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.5 tt -144.2 131.04 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.235 1.014 . . . . 0.0 111.545 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.38 122.65 13.88 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.691 0.797 . . . . 0.0 112.105 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.86 138.37 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.039 0.935 . . . . 0.0 111.854 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.5 t -141.55 134.56 29.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.28 1.432 . . . . 0.0 111.488 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.15 -17.96 61.32 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.81 63.61 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.338 1.455 . . . . 0.0 112.969 -173.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -113.41 -5.73 13.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.209 1.804 . . . . 0.0 111.566 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 72.08 49.76 20.45 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.554 1.55 . . . . 0.0 112.078 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.6 p -139.27 149.46 44.31 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -168.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.16 140.06 47.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.628 1.571 . . . . 0.0 110.741 169.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.8 t -116.9 127.71 54.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.58 141.42 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.544 0.738 . . . . 0.0 110.571 -171.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.96 108.74 21.52 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.242 1.817 . . . . 0.0 106.9 175.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -114.65 159.57 20.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.98 0.895 . . . . 0.0 112.767 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -97.84 113.4 63.62 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.101 0.96 . . . . 0.0 109.858 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.08 -7.1 17.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.961 2.441 . . . . 0.0 115.093 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.42 -37.17 20.11 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.717 1.144 . . . . 0.0 111.018 168.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 86.7 t -85.44 -32.46 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.461 1.104 . . . . 0.0 113.192 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.5 tt -148.96 151.72 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 120.268 1.394 . . . . 0.0 113.678 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.07 145.78 31.11 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.779 1.632 . . . . 0.0 112.456 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.67 -33.47 93.67 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.838 2.358 . . . . 0.0 115.286 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.74 -22.41 61.62 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.364 0.984 . . . . 0.0 113.135 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -72.62 -38.02 67.87 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.741 -1.224 . . . . 0.0 111.57 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 82.9 mt -55.44 -54.41 44.13 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.773 0.829 . . . . 0.0 109.908 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -51.22 -55.27 18.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.998 1.319 . . . . 0.0 111.299 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.5 -18.84 65.63 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.62 -33.33 68.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.942 1.247 . . . . 0.0 112.23 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.1 -39.72 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.396 1.078 . . . . 0.0 110.532 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.65 -31.77 72.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.241 0.616 . . . . 0.0 112.375 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.19 -5.11 39.93 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.539 1.936 . . . . 0.0 114.441 169.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.46 -47.98 5.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.126 1.37 . . . . 0.0 111.466 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 157.45 15.8 0.04 OUTLIER Glycine 0 N--CA 1.469 0.867 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -133.27 -163.46 1.35 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.987 1.394 . . . . 0.0 108.954 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.58 147.02 49.93 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.198 0.999 . . . . 0.0 109.357 169.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -138.97 160.18 40.38 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.0 t -138.36 141.67 39.68 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.485 1.914 . . . . 0.0 109.168 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.3 128.83 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.331 -0.856 . . . . 0.0 108.866 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 122.873 1.32 . . . . 0.0 108.733 -178.866 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.11 138.25 45.13 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.64 -0.663 . . . . 0.0 112.583 -173.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.56 163.72 25.38 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -109.71 133.25 53.34 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 127.819 2.448 . . . . 0.0 110.04 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -146.46 155.05 42.27 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.374 0.67 . . . . 0.0 112.327 171.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -116.98 107.51 14.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.557 0.694 . . . . 0.0 111.09 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.6 mt -88.62 143.42 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.795 2.038 . . . . 0.0 110.938 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -97.46 142.85 28.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.013 2.525 . . . . 0.0 110.137 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.95 -13.64 65.56 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.902 1.239 . . . . 0.0 114.506 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.5 ptp -62.12 -23.23 66.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.517 1.158 . . . . 0.0 113.925 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -69.51 -15.77 63.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.33 0.968 . . . . 0.0 113.599 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 87.7 m -75.49 -6.04 48.15 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 120.586 1.539 . . . . 0.0 112.18 166.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp 71.74 -52.24 0.69 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 130.415 3.486 . . . . 0.0 113.397 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -54.22 -23.28 14.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.564 1.146 . . . . 0.0 113.937 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.4 t -57.99 -47.41 83.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.359 1.864 . . . . 0.0 112.543 169.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -73.64 -24.63 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 118.555 0.616 . . . . 0.0 112.464 -173.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.6 tp -57.32 -53.9 52.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.021 0.928 . . . . 0.0 111.746 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -37.68 76.22 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.821 -0.549 . . . . 0.0 110.962 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.1 mt -66.11 -49.6 75.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.372 0.669 . . . . 0.0 110.579 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -60.25 -36.12 77.05 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.046 1.738 . . . . 0.0 112.914 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -68.31 -39.91 81.85 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.308 -0.87 . . . . 0.0 112.346 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -95.26 -37.52 10.97 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.9 mm -93.04 119.64 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 120.389 -1.445 . . . . 0.0 108.699 -168.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.07 -17.83 6.24 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.019 1.771 . . . . 0.0 112.609 -167.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -87.72 -4.03 58.93 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.257 1.028 . . . . 0.0 112.443 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.67 178.26 8.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.593 1.957 . . . . 0.0 112.028 -170.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tp -59.52 -74.94 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.384 1.874 . . . . 0.0 112.31 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.58 52.42 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 117.483 -1.732 . . . . 0.0 115.671 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.5 t -87.51 113.56 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.589 2.194 . . . . 0.0 109.451 168.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -86.39 -43.37 12.9 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.485 1.114 . . . . 0.0 111.791 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.3 t -147.86 178.03 8.84 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.436 1.095 . . . . 0.0 111.649 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.6 tp -139.74 140.78 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.907 1.683 . . . . 0.0 108.611 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -129.36 120.53 25.74 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.213 1.405 . . . . 0.0 108.083 -173.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.87 86.97 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.394 1.478 . . . . 0.0 110.627 -166.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 p -98.67 54.29 1.03 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.569 1.948 . . . . 0.0 113.03 -170.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.9 mt -61.82 -26.3 68.03 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -172.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.32 -33.96 63.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.579 1.152 . . . . 0.0 113.148 173.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -94.81 -0.29 54.26 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.795 0.838 . . . . 0.0 112.572 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? 68.06 -0.34 2.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.883 2.473 . . . . 0.0 113.167 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.0 p -99.68 167.73 10.38 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 127.577 2.351 . . . . 0.0 109.881 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.53 149.21 41.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 168.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -116.0 125.92 53.13 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.245 1.418 . . . . 0.0 108.49 -172.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.73 135.0 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.001 -1.062 . . . . 0.0 111.0 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -99.26 95.82 7.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.048 1.739 . . . . 0.0 107.822 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -122.97 -179.32 4.22 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.075 1.75 . . . . 0.0 112.989 -168.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -129.22 136.12 28.66 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 125.612 1.565 . . . . 0.0 109.978 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -84.08 15.06 2.24 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.433 2.756 . . . . 0.0 113.317 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.1 t -111.33 -35.65 5.79 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.32 1.048 . . . . 0.0 111.082 173.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.1 m -90.58 -18.64 24.86 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . 0.252 2.8 t -148.49 -175.79 5.06 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.1 0.96 . . . . 0.0 112.163 175.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.1 p -153.72 167.59 13.33 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.046 1.739 . . . . 0.0 110.91 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.39 -44.09 24.69 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.593 2.196 . . . . 0.0 113.204 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.94 -37.87 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 118.92 0.782 . . . . 0.0 112.839 172.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.56 89.13 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.666 -0.646 . . . . 0.0 112.244 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.35 -55.77 30.51 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.111 1.765 . . . . 0.0 109.838 168.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -61.28 -39.82 91.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.87 0.868 . . . . 0.0 111.644 -173.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -70.8 -36.92 73.2 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.439 1.096 . . . . 0.0 112.804 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.66 -60.4 2.27 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.782 0.719 . . . . 0.0 112.681 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 pt -70.25 -26.78 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -167.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -70.81 -15.47 62.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.4 9.52 33.67 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.999 -1.063 . . . . 0.0 113.523 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.23 -47.95 97.26 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.145 165.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -77.56 171.57 17.31 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.646 2.231 . . . . 0.0 110.429 167.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -76.54 51.61 3.35 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 124.127 3.218 . . . . 0.0 110.978 170.064 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.16 28.51 68.14 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 120.996 -1.065 . . . . 0.0 113.756 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -97.32 -45.42 6.49 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.967 0.884 . . . . 0.0 112.459 -172.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -97.01 102.19 13.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.243 1.017 . . . . 0.0 108.73 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -96.52 141.42 29.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.265 1.026 . . . . 0.0 111.474 -170.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 p -130.27 134.66 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -172.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.3 m -118.95 144.41 46.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.461 1.504 . . . . 0.0 111.803 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 CA--C 1.539 0.549 0 C-N-CA 126.348 1.859 . . . . 0.0 112.21 -172.127 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.2 m -138.05 127.61 24.98 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.556 1.542 . . . . 0.0 111.81 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.0 m -146.34 152.63 39.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.925 1.29 . . . . 0.0 111.531 171.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 92.5 m -109.18 140.47 42.74 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.123 0.969 . . . . 0.0 109.58 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.22 158.54 43.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 168.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.89 127.46 48.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.488 2.315 . . . . 0.0 109.469 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.8 mm -113.28 136.37 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.438 1.095 . . . . 0.0 108.827 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -101.25 122.49 43.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.771 0.714 . . . . 0.0 109.33 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.66 135.2 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.065 0.946 . . . . 0.0 110.237 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -115.02 56.3 0.74 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.985 1.714 . . . . 0.0 112.09 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.02 54.86 0.32 Allowed Glycine 0 N--CA 1.465 0.6 0 C-N-CA 124.151 0.881 . . . . 0.0 112.076 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 39.6 mtm -148.35 138.25 22.38 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.033 0.933 . . . . 0.0 110.942 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.3 t -160.34 -32.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.122 1.369 . . . . 0.0 111.841 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 93.4 m -105.48 138.8 41.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.315 1.846 . . . . 0.0 109.937 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.07 -27.32 31.87 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.601 1.16 . . . . 0.0 113.751 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.6 t -56.34 -32.19 64.45 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.202 1.001 . . . . 0.0 112.969 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.5 t -60.65 -20.75 61.65 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.53 -59.62 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.005 168.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -63.31 -22.14 66.69 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.144 1.338 . . . . 0.0 112.815 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.6 m -70.65 -60.16 2.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.243 1.017 . . . . 0.0 112.153 170.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.0 mt -69.33 -51.28 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.581 -1.324 . . . . 0.0 110.897 -174.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -58.17 -30.98 66.84 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.136 1.374 . . . . 0.0 110.896 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.06 -62.34 2.64 Favored Glycine 0 C--N 1.343 0.967 0 C-N-CA 125.657 1.598 . . . . 0.0 114.615 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -44.98 62.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.483 1.113 . . . . 0.0 113.098 -172.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.2 mm -72.99 -29.51 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.09 0.556 . . . . 0.0 112.034 -172.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.5 p -64.86 0.99 0.98 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -106.9 -9.24 16.38 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -168.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.41 11.28 31.2 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -171.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 70.2 163.87 0.26 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.277 2.631 . . . . 0.0 114.191 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.98 -39.19 1.13 Allowed Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.486 -1.384 . . . . 0.0 112.977 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.52 98.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 127.462 2.305 . . . . 0.0 111.213 169.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -86.53 -54.72 4.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.853 0.861 . . . . 0.0 112.455 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -141.52 121.4 13.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.735 1.214 . . . . 0.0 109.045 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.0 tt -133.3 128.14 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.208 1.003 . . . . 0.0 110.92 -170.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.74 155.83 44.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.642 1.177 . . . . 0.0 109.9 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.69 142.31 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.433 1.015 . . . . 0.0 111.934 -171.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 45.0 m -115.28 86.98 2.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.832 2.453 . . . . 0.0 109.16 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.27 -27.55 69.09 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.376 -1.453 . . . . 0.0 111.451 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.8 -30.79 1.77 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.303 2.641 . . . . 0.0 114.824 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -118.07 -20.75 8.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.423 1.489 . . . . 0.0 111.772 173.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.37 36.56 8.72 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.592 1.567 . . . . 0.0 111.964 -174.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.6 p -128.28 140.6 51.8 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.803 1.301 . . . . 0.0 112.798 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.94 137.79 42.17 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.538 1.135 . . . . 0.0 110.736 169.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.9 t -111.49 121.95 46.53 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.24 140.91 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -169.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.03 115.93 28.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.122 2.169 . . . . 0.0 106.599 171.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -117.47 157.52 26.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.78 1.232 . . . . 0.0 111.71 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -99.75 105.79 36.49 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.716 1.206 . . . . 0.0 110.981 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -67.44 -13.33 38.86 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.253 2.635 . . . . 0.0 114.023 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.77 -10.73 58.75 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.282 0.946 . . . . 0.0 113.127 171.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.33 -34.04 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.556 1.543 . . . . 0.0 112.08 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.5 tt -159.93 147.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.886 1.221 . . . . 0.0 112.507 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.7 t -97.02 149.9 36.22 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.606 1.162 . . . . 0.0 112.528 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -49.99 -30.42 24.35 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.907 3.738 . . . . 0.0 114.19 168.351 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -67.02 -33.9 76.55 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.369 0.986 . . . . 0.0 112.39 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -75.29 -35.41 61.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.228 . . . . 0.0 110.404 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.04 -58.2 9.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.676 2.39 . . . . 0.0 111.48 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.54 -38.81 78.56 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.114 0.87 . . . . 0.0 112.35 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.98 -26.53 68.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.96 -30.42 63.83 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.461 1.028 . . . . 0.0 112.53 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.16 -34.52 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.306 1.042 . . . . 0.0 110.969 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -63.91 -39.34 93.94 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.674 0.67 . . . . 0.0 111.893 172.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.65 -31.44 72.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.52 1.928 . . . . 0.0 112.942 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 21.9 ttt -69.78 -37.18 76.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.156 0.982 . . . . 0.0 111.386 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 130.96 15.43 1.71 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.494 1.521 . . . . 0.0 116.306 169.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.92 -158.08 0.65 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.426 1.613 . . . . 0.0 108.923 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -133.52 142.7 48.33 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.032 0.933 . . . . 0.0 109.885 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -137.32 137.99 39.51 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.282 1.433 . . . . 0.0 112.975 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.2 t -123.07 131.35 53.66 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.834 1.654 . . . . 0.0 111.339 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 m -85.64 71.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.266 1.026 . . . . 0.0 110.661 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.582 -176.813 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.422 HG13 ' CE1' ' A' ' 64' ' ' TYR . 11.0 p . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 p -112.56 166.56 11.21 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.613 1.965 . . . . 0.0 112.049 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.56 137.42 31.96 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.837 1.255 . . . . 0.0 111.711 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -99.15 120.1 38.95 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.961 0.886 . . . . 0.0 109.679 168.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.25 139.21 30.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.512 -1.676 . . . . 0.0 112.825 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -101.49 143.22 31.76 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.932 1.293 . . . . 0.0 109.03 171.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mm -107.32 153.14 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.763 1.625 . . . . 0.0 109.807 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -106.1 140.27 39.34 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.654 1.582 . . . . 0.0 110.652 170.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.61 3.21 88.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.879 1.228 . . . . 0.0 114.033 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.5 ptm -70.53 -3.6 18.79 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -50.8 -26.18 5.36 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.806 1.242 . . . . 0.0 114.345 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.4 p -114.04 137.74 51.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.962 1.305 . . . . 0.0 111.033 169.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -65.07 -15.7 62.65 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -50.79 -31.95 18.46 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.992 -1.068 . . . . 0.0 113.21 169.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.1 t -67.99 -57.91 5.38 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.337 1.055 . . . . 0.0 111.678 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 p -62.79 -29.62 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.407 1.003 . . . . 0.0 112.056 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.72 -61.01 2.93 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.264 1.026 . . . . 0.0 112.289 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -65.46 -31.28 72.28 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.785 -0.572 . . . . 0.0 111.821 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.01 -52.42 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 118.795 0.725 . . . . 0.0 109.48 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -38.3 90.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.567 1.147 . . . . 0.0 113.184 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -65.76 -34.95 79.36 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.332 0.653 . . . . 0.0 111.982 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -92.91 -24.41 18.44 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.435 ' CD1' HG22 ' A' ' 78' ' ' ILE . 47.2 mm -105.75 122.85 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.385 0.993 . . . . 0.0 109.669 -171.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.25 -22.81 5.28 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 125.581 1.562 . . . . 0.0 113.956 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -84.65 -0.65 54.21 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.652 1.581 . . . . 0.0 113.165 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.43 -172.33 4.11 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.779 2.032 . . . . 0.0 113.959 -171.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 tp -68.87 -82.78 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.427 2.291 . . . . 0.0 111.974 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.32 -30.32 60.78 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 120.12 1.327 . . . . 0.0 114.241 -173.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 t -84.07 127.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.044 1.422 . . . . 0.0 110.339 169.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -114.51 -23.1 9.48 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.4 t -145.63 166.08 26.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.226 0.921 . . . . 0.0 111.069 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 tp -140.71 142.31 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.417 1.087 . . . . 0.0 110.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -142.92 156.32 44.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.656 1.183 . . . . 0.0 110.579 -171.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.28 133.02 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.312 1.445 . . . . 0.0 108.348 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.3 m -122.6 52.8 1.3 Allowed 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.488 1.137 . . . . 0.0 110.086 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -19.33 64.03 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -172.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -57.77 -36.6 72.36 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.769 1.168 . . . . 0.0 111.066 168.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -97.47 -8.02 30.25 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.036 2.134 . . . . 0.0 112.484 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 70.75 15.64 6.89 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.605 2.362 . . . . 0.0 112.28 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 p -98.78 163.7 12.52 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.68 1.592 . . . . 0.0 110.621 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.18 169.09 9.63 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -139.6 114.25 9.29 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 121.043 -1.036 . . . . 0.0 111.186 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.58 133.2 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 121.529 0.68 . . . . 0.0 111.847 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -109.74 99.17 8.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.267 1.427 . . . . 0.0 108.784 -169.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.422 ' CE1' HG13 ' A' ' 20' ' ' VAL . 17.3 p90 -131.45 -178.87 5.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.821 1.248 . . . . 0.0 112.25 -168.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.99 140.05 33.84 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.509 1.124 . . . . 0.0 108.258 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.06 11.41 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.029 2.486 . . . . 0.0 112.826 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.4 p -92.21 -19.04 22.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.889 1.276 . . . . 0.0 113.481 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 72.6 m -126.82 -20.43 4.26 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.703 1.601 . . . . 0.0 114.457 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.1 t -145.07 -177.86 5.75 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.16 1.784 . . . . 0.0 111.338 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -160.62 156.6 22.46 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.487 1.515 . . . . 0.0 112.95 174.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -43.64 -45.38 10.82 Favored 'Trans proline' 0 C--N 1.352 0.756 1 C-N-CA 126.425 4.75 . . . . 0.0 117.974 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.6 m -64.78 -37.67 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 119.825 1.193 . . . . 0.0 112.537 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.67 -40.28 69.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.705 0.802 . . . . 0.0 111.058 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.38 -47.64 84.91 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.758 1.223 . . . . 0.0 112.011 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -53.05 -54.54 33.91 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.79 0.723 . . . . 0.0 109.775 175.24 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -61.89 -33.74 74.76 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.202 1.001 . . . . 0.0 113.349 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.02 -56.99 5.53 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.056 0.943 . . . . 0.0 111.847 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.435 HG22 ' CD1' ' A' ' 42' ' ' ILE . 10.1 pt -72.56 -27.09 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.86 -28.55 67.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.9 6.49 41.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.7 mt -53.92 -52.51 67.28 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 117.392 -1.29 . . . . 0.0 112.187 169.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.41 163.44 36.56 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.241 2.627 . . . . 0.0 112.717 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -81.42 50.99 3.71 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.852 3.702 . . . . 0.0 111.302 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.19 53.68 5.55 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.328 0.966 . . . . 0.0 112.103 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -132.82 -45.08 0.87 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -171.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -101.64 134.77 44.25 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.667 0.787 . . . . 0.0 109.32 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -111.74 152.32 27.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.786 1.634 . . . . 0.0 110.171 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.52 138.11 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.675 1.125 . . . . 0.0 109.608 168.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -110.2 113.12 25.55 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.224 1.01 . . . . 0.0 108.811 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 126.373 1.869 . . . . 0.0 109.939 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 8.5 p -137.9 126.13 23.08 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.446 1.898 . . . . 0.0 113.473 -169.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.7 t -141.02 154.83 46.19 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.877 1.671 . . . . 0.0 110.424 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.4 m -111.35 137.72 48.75 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.786 0.721 . . . . 0.0 110.397 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.5 163.53 30.92 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.391 1.076 . . . . 0.0 112.068 169.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -109.8 128.06 55.06 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.511 1.924 . . . . 0.0 110.366 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.2 mm -112.28 144.54 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.227 1.011 . . . . 0.0 109.694 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.63 122.82 47.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.709 1.604 . . . . 0.0 109.71 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.52 140.87 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.049 -1.657 . . . . 0.0 111.896 -167.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.34 66.63 1.45 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.32 1.448 . . . . 0.0 114.065 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -172.88 49.89 0.17 Allowed Glycine 0 N--CA 1.466 0.659 0 CA-C-O 118.921 -0.933 . . . . 0.0 114.09 166.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 74.0 mtm -110.86 -57.08 2.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 117.498 -1.239 . . . . 0.0 113.768 -171.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.0 t 55.32 -26.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 130.339 3.456 . . . . 0.0 118.273 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 36.0 t -131.73 139.94 49.12 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.543 1.537 . . . . 0.0 111.718 -170.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.01 -35.26 69.04 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.747 -0.596 . . . . 0.0 111.671 171.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.4 m -64.03 -31.79 73.1 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.789 -1.195 . . . . 0.0 112.105 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 26.2 t -70.59 -39.76 73.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.911 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.63 -54.52 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 119.63 1.105 . . . . 0.0 110.094 170.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -58.54 -34.71 71.3 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.029 0.377 . . . . 0.0 111.582 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.2 m -71.0 -43.35 68.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.048 0.939 . . . . 0.0 113.078 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 84.9 mt -64.49 -51.12 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.788 1.176 . . . . 0.0 109.714 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -53.14 -37.66 62.03 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.497 1.519 . . . . 0.0 111.164 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.1 -58.42 4.36 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.001 1.286 . . . . 0.0 113.467 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.0 mtp -67.91 -46.81 70.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.657 1.583 . . . . 0.0 113.677 -170.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 35.5 mm -66.58 -36.94 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 118.124 0.42 . . . . 0.0 110.066 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 t -56.67 -9.34 0.74 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -89.02 -8.49 53.93 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.475 -1.391 . . . . 0.0 113.755 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -107.82 177.3 4.86 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.276 1.398 . . . . 0.0 114.158 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -56.5 152.41 11.73 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.698 1.599 . . . . 0.0 115.314 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.21 -30.3 0.32 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.351 1.453 . . . . 0.0 116.676 169.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.3 p -78.91 92.86 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.463 1.632 . . . . 0.0 111.008 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -79.56 -40.02 30.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.872 1.669 . . . . 0.0 111.916 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -144.99 144.81 31.23 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.011 0.925 . . . . 0.0 109.478 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.5 tt -140.36 138.37 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 121.255 -0.903 . . . . 0.0 111.55 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t -139.18 136.31 34.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.78 1.632 . . . . 0.0 109.157 171.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.22 148.93 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.827 1.251 . . . . 0.0 111.396 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.8 t -142.62 148.52 37.6 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.43 -22.67 61.82 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.633 1.173 . . . . 0.0 113.707 172.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -50.86 -41.58 58.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.006 1.322 . . . . 0.0 112.372 -169.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -127.38 -1.96 6.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.007 1.323 . . . . 0.0 111.906 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.06 42.26 37.25 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 125.487 1.518 . . . . 0.0 111.981 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.5 p -130.93 146.07 52.22 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.404 1.102 . . . . 0.0 113.053 -168.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -118.84 119.69 35.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.757 1.623 . . . . 0.0 112.037 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 t -99.32 112.26 24.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.962 1.305 . . . . 0.0 107.8 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 139.11 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.588 0.755 . . . . 0.0 110.885 -168.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.95 107.96 20.29 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.97 2.108 . . . . 0.0 107.117 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -113.17 162.9 15.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.147 1.379 . . . . 0.0 111.762 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -94.79 112.16 57.03 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.846 0.859 . . . . 0.0 108.941 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.51 -10.54 17.32 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.035 2.49 . . . . 0.0 113.051 -173.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.4 -32.9 25.91 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.259 0.936 . . . . 0.0 112.618 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.68 -46.97 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.865 1.266 . . . . 0.0 113.448 -173.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.5 tt -124.75 149.41 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 120.384 1.447 . . . . 0.0 112.094 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.9 t -96.99 146.96 32.2 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.203 1.401 . . . . 0.0 112.833 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.33 -26.12 42.17 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.09 2.527 . . . . 0.0 113.49 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -68.23 -35.66 78.29 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.526 -0.734 . . . . 0.0 112.548 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.46 -31.83 67.62 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.148 0.979 . . . . 0.0 111.643 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.04 -57.65 11.61 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.198 0.999 . . . . 0.0 110.035 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -61.23 -41.67 97.28 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.779 -0.575 . . . . 0.0 112.307 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.44 -34.08 70.42 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.15 -34.73 71.27 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -73.56 -39.44 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.281 1.033 . . . . 0.0 111.579 171.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -62.92 -32.25 73.5 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.182 -0.949 . . . . 0.0 111.641 172.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.93 -13.9 60.97 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.713 2.405 . . . . 0.0 114.503 169.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 14.7 ttt -83.62 -20.95 32.77 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.986 -1.071 . . . . 0.0 112.148 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 111.82 19.03 7.53 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.949 1.737 . . . . 0.0 114.934 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -115.09 -159.06 0.69 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.215 1.406 . . . . 0.0 109.878 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.77 140.32 51.09 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 124.554 1.142 . . . . 0.0 109.555 170.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.01 147.71 42.47 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.126 1.37 . . . . 0.0 112.348 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.1 t -142.74 140.49 31.48 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.174 1.789 . . . . 0.0 109.011 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.2 p -90.49 130.56 39.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.327 0.584 . . . . 0.0 110.811 -171.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 166.743 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 121.058 0.456 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -109.26 134.86 51.24 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.195 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.02 133.04 43.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.152 1.381 . . . . 0.0 110.724 -174.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -96.19 137.59 35.04 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.148 1.779 . . . . 0.0 111.576 -171.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.73 152.18 39.99 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 173.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -100.11 113.91 26.88 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.498 1.119 . . . . 0.0 109.683 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 mt -88.46 140.81 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.714 1.205 . . . . 0.0 109.973 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -99.11 141.26 32.1 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.46 1.504 . . . . 0.0 111.341 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.14 -13.09 65.13 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.511 1.529 . . . . 0.0 113.809 -176.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.7 ptp -63.85 -14.63 54.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -60.06 -24.4 64.55 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.45 1.477 . . . . 0.0 112.384 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 59.2 m -78.4 -4.66 49.37 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.929 0.892 . . . . 0.0 113.372 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.55 -56.37 0.51 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.649 3.18 . . . . 0.0 113.224 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m -55.11 -25.16 29.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.64 1.176 . . . . 0.0 113.246 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.4 -50.12 70.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.003 1.721 . . . . 0.0 112.361 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -77.14 -30.71 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 36' ' ' LEU . 5.0 tt -52.73 -57.19 10.93 Favored 'General case' 0 C--N 1.345 0.391 0 C-N-CA 124.309 1.043 . . . . 0.0 110.916 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -60.02 -45.25 93.41 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 118.591 -0.719 . . . . 0.0 109.866 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.81 -36.68 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.919 1.236 . . . . 0.0 111.133 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.98 -22.26 64.11 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.978 0.911 . . . . 0.0 112.317 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -71.9 -52.96 14.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.78 1.232 . . . . 0.0 113.024 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -93.82 -17.39 23.14 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -167.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.49 ' CD1' HG22 ' A' ' 78' ' ' ILE . 23.9 mm -96.23 133.03 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 119.813 1.188 . . . . 0.0 108.042 173.451 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.08 -5.7 10.31 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 125.317 1.437 . . . . 0.0 114.749 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -126.68 17.02 7.49 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.2 1.8 . . . . 0.0 112.329 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.14 156.63 18.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.864 1.266 . . . . 0.0 109.971 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.4 tp -21.96 -64.56 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.534 2.734 . . . . 0.0 114.714 173.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.86 -15.92 20.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 116.527 -2.263 . . . . 0.0 116.011 175.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.6 t -82.64 124.0 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 122.588 3.194 . . . . 0.0 111.123 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.45 -31.9 11.41 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 172.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.6 t -148.62 163.58 36.83 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.063 -1.023 . . . . 0.0 112.705 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 tp -132.6 130.64 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.58 1.952 . . . . 0.0 106.445 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -129.91 161.73 30.18 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 172.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.47 164.62 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 120.954 -1.091 . . . . 0.0 112.84 -172.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 t -140.57 70.85 1.36 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 123.264 1.507 . . . . 0.0 109.37 170.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.9 mt -61.52 -21.57 64.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.642 1.177 . . . . 0.0 112.814 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.01 -30.82 48.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.694 1.197 . . . . 0.0 113.818 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -108.9 -7.95 15.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.469 1.908 . . . . 0.0 112.53 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mttm 77.05 15.96 1.8 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 127.576 2.351 . . . . 0.0 112.743 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.15 150.15 21.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.6 1.191 . . . . 0.0 110.806 177.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.82 151.06 40.08 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.415 1.886 . . . . 0.0 107.172 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -137.56 124.14 20.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.472 1.033 . . . . 0.0 113.446 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.8 p -97.12 136.12 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.52 1.128 . . . . 0.0 110.615 -170.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -110.67 102.4 10.96 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.625 1.57 . . . . 0.0 108.221 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -135.38 160.01 39.79 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -168.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -93.59 113.41 60.2 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 126.065 1.746 . . . . 0.0 108.218 173.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.33 -3.7 12.92 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.025 2.483 . . . . 0.0 112.761 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.4 p -81.75 -11.8 58.86 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.703 1.601 . . . . 0.0 112.388 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 37.3 m -121.74 -33.03 3.67 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.778 1.231 . . . . 0.0 113.044 -173.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.4 t -145.06 -179.36 6.57 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.886 1.675 . . . . 0.0 111.32 -174.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.9 p -160.8 155.19 19.71 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.457 1.103 . . . . 0.0 112.821 -170.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.9 -49.16 15.78 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.14 3.226 . . . . 0.0 116.668 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -70.22 -33.51 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 120.332 1.424 . . . . 0.0 112.638 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.66 81.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.481 0.712 . . . . 0.0 111.099 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.16 -46.89 75.81 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.321 1.448 . . . . 0.0 112.342 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -53.58 -52.26 60.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.401 1.0 . . . . 0.0 109.778 175.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -65.65 -24.94 67.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.776 1.23 . . . . 0.0 113.676 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.39 -60.67 2.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.315 0.961 . . . . 0.0 112.581 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.49 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.0 pt -74.02 -29.71 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -167.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -71.28 -23.56 61.99 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.496 1.044 . . . . 0.0 113.705 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.16 17.8 9.05 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.001 -1.062 . . . . 0.0 113.675 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.75 -58.74 15.16 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 117.715 -1.136 . . . . 0.0 109.955 166.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -69.82 168.15 22.45 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.498 2.798 . . . . 0.0 112.337 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.4 42.16 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.459 3.439 . . . . 0.0 112.434 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.99 63.83 2.34 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -169.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -148.74 -16.71 0.31 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 -169.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -124.43 130.6 52.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 169.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -110.4 142.48 42.04 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.867 1.267 . . . . 0.0 111.766 -173.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 m -117.56 134.5 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 120.084 1.311 . . . . 0.0 111.178 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.0 m -128.97 120.93 26.94 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.916 0.865 . . . . 0.0 111.975 176.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.033 0 C-N-CA 127.727 2.411 . . . . 0.0 112.202 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 58.2 m 48.41 82.11 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.038 2.135 . . . . 0.0 115.715 168.558 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.3 p -133.13 143.8 49.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.596 1.959 . . . . 0.0 112.929 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.6 m -98.1 129.46 44.92 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.015 0.825 . . . . 0.0 111.18 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.63 164.6 21.68 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.608 0.763 . . . . 0.0 111.162 169.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.16 132.13 54.55 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.251 1.421 . . . . 0.0 109.982 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.0 mm -117.91 137.99 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.067 1.747 . . . . 0.0 109.014 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.6 125.46 49.33 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.527 1.531 . . . . 0.0 109.215 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.1 mt -126.21 127.15 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 120.393 -1.442 . . . . 0.0 111.241 -170.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.07 74.21 1.03 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.796 2.039 . . . . 0.0 112.609 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -179.12 52.89 0.09 OUTLIER Glycine 0 N--CA 1.466 0.677 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.938 165.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 65.4 mtm -137.54 91.85 2.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.47 0.708 . . . . 0.0 109.826 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.5 t -94.57 -29.19 15.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.672 1.189 . . . . 0.0 113.191 -173.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 91.6 m -125.11 154.56 41.23 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.514 1.526 . . . . 0.0 110.112 175.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.15 65.69 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.3 p -54.91 -24.32 22.99 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.079 -1.013 . . . . 0.0 113.615 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 95.2 m -57.13 -29.27 63.43 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.693 -1.254 . . . . 0.0 112.592 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.22 -49.88 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.612 0.765 . . . . 0.0 110.523 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.14 -21.05 66.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.255 0.934 . . . . 0.0 113.228 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 t -74.1 -62.11 1.62 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.453 0.701 . . . . 0.0 111.304 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 47.4 mt -70.78 -48.54 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.83 -1.169 . . . . 0.0 111.494 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.19 -26.15 68.67 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.223 0.609 . . . . 0.0 111.711 176.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.35 -59.77 4.05 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.531 1.062 . . . . 0.0 112.178 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 92.7 mmm -71.57 -39.5 70.57 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.923 1.689 . . . . 0.0 114.208 -172.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.3 mm -70.96 -32.45 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.366 -0.834 . . . . 0.0 111.084 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.7 t -65.36 0.55 1.42 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -96.35 -11.24 26.09 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.479 -1.388 . . . . 0.0 114.589 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 pp -93.07 166.04 12.55 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.485 1.514 . . . . 0.0 111.429 174.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.18 138.23 31.69 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.449 -0.782 . . . . 0.0 112.537 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 101.16 15.6 27.66 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.556 1.55 . . . . 0.0 115.029 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.8 94.43 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.705 2.002 . . . . 0.0 110.502 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -68.0 -56.98 6.94 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.165 0.986 . . . . 0.0 111.02 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -140.0 131.44 26.92 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.475 1.11 . . . . 0.0 109.147 -171.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -136.47 131.33 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.865 0.866 . . . . 0.0 110.452 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.1 t -138.25 138.77 38.79 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.239 1.816 . . . . 0.0 108.686 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.5 p -143.45 145.55 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.962 1.305 . . . . 0.0 111.73 -175.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 t -135.19 135.38 40.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -172.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.93 -18.91 64.7 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.058 2.143 . . . . 0.0 113.959 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.19 78.98 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.545 1.138 . . . . 0.0 113.114 -176.622 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -130.87 -8.05 3.97 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.419 1.488 . . . . 0.0 112.336 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.6 41.3 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.595 1.093 . . . . 0.0 111.502 -171.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 71.3 p -130.17 145.86 51.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.513 1.156 . . . . 0.0 113.559 -168.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -115.06 141.19 48.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.915 1.686 . . . . 0.0 112.459 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.1 t -110.39 124.19 51.26 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 167.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.27 136.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.828 -0.545 . . . . 0.0 111.366 -171.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.15 101.86 13.63 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.932 2.093 . . . . 0.0 106.485 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -104.18 164.2 11.88 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.597 1.159 . . . . 0.0 112.629 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -107.02 93.34 8.96 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.089 1.356 . . . . 0.0 110.849 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.19 -19.19 50.93 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.586 2.857 . . . . 0.0 112.26 -172.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.15 -15.87 63.01 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.77 -38.5 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 126.463 1.905 . . . . 0.0 113.422 -168.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.7 tt -141.93 151.71 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.878 1.271 . . . . 0.0 111.53 -171.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.9 t -101.07 143.38 26.48 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 170.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.37 -26.49 27.95 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.784 2.989 . . . . 0.0 113.935 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -70.49 -40.65 73.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.462 0.705 . . . . 0.0 111.551 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -78.23 -24.29 47.06 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 168.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.23 -50.8 72.61 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.955 1.302 . . . . 0.0 109.325 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -50.62 -46.63 58.29 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.371 1.468 . . . . 0.0 111.433 168.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.07 -21.35 66.49 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.58 65.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.449 1.022 . . . . 0.0 112.367 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.2 mp -74.27 -40.43 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.216 1.007 . . . . 0.0 111.158 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -65.71 -27.58 68.43 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.996 0.816 . . . . 0.0 112.846 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.24 -42.53 68.75 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.0 1.32 . . . . 0.0 112.362 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.1 tpt -61.23 -31.96 71.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.071 0.851 . . . . 0.0 111.434 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 109.0 44.16 1.13 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 126.584 2.04 . . . . 0.0 113.187 172.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -124.24 -159.73 0.89 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.92 149.6 47.43 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.692 -1.255 . . . . 0.0 109.212 168.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.55 155.0 44.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.502 1.144 . . . . 0.0 113.542 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.9 t -142.62 138.27 30.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.379 1.872 . . . . 0.0 108.99 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.3 m -88.11 128.68 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 121.47 -0.769 . . . . 0.0 109.108 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . 0.288 2.7 p . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 124.698 2.19 . . . . 0.0 107.675 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.41 150.95 22.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.317 2.247 . . . . 0.0 111.86 176.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 tt -146.24 143.65 29.35 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.264 2.226 . . . . 0.0 112.135 -169.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -95.2 121.76 37.18 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.387 1.089 . . . . 0.0 110.454 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -130.69 127.45 38.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.118 -1.401 . . . . 0.0 113.296 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -106.84 110.27 22.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.058 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 mm -77.15 157.37 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.236 1.014 . . . . 0.0 109.935 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -135.54 147.63 48.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.542 1.137 . . . . 0.0 110.959 168.525 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 11.24 84.72 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.63 1.109 . . . . 0.0 113.353 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.4 ptm -68.01 -33.07 73.92 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.993 1.396 . . . . 0.0 113.912 -169.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 69.08 -51.77 0.59 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.693 2.397 . . . . 0.0 112.474 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 31.0 p -173.37 -173.74 0.93 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.829 2.052 . . . . 0.0 112.388 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -46.44 -33.41 3.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.941 1.697 . . . . 0.0 113.503 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.5 m -53.25 -30.05 36.12 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.553 1.07 . . . . 0.0 113.703 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.5 t -64.46 -42.07 96.15 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.965 -1.084 . . . . 0.0 113.817 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.269 4.8 p -73.62 -6.31 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.34 -59.09 5.17 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.186 1.357 . . . . 0.0 111.712 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -61.33 -31.66 71.52 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.263 0.938 . . . . 0.0 111.989 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.1 mt -59.44 -56.5 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.33 -35.48 73.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.034 1.733 . . . . 0.0 114.424 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.01 -41.01 97.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.305 1.042 . . . . 0.0 111.534 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -96.35 -33.65 11.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.441 ' CD1' HG22 ' A' ' 78' ' ' ILE . 38.2 mm -107.09 111.92 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.616 1.166 . . . . 0.0 110.346 -167.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.08 -18.64 6.97 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.497 1.523 . . . . 0.0 113.877 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -85.53 -6.01 59.23 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.5 -1.0 . . . . 0.0 112.542 169.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.8 mt -79.49 -179.13 6.65 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.9 2.08 . . . . 0.0 113.538 -170.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.81 -77.97 0.06 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.306 2.243 . . . . 0.0 111.806 170.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.5 -36.47 58.96 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.589 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -92.51 118.59 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.246 1.523 . . . . 0.0 110.249 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -101.7 -24.62 14.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.742 0.817 . . . . 0.0 113.179 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.8 m -149.97 156.06 41.06 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.587 -1.32 . . . . 0.0 113.661 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 tp -125.94 147.06 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.011 1.324 . . . . 0.0 109.914 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -142.8 166.92 23.32 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.356 1.862 . . . . 0.0 108.471 -172.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -139.38 160.52 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 119.687 -1.883 . . . . 0.0 113.365 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.0 t -140.95 56.61 1.56 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.39 1.876 . . . . 0.0 108.244 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.7 mt -61.52 -33.99 74.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -168.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.17 -17.11 64.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.162 1.346 . . . . 0.0 113.388 172.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -104.02 -1.4 27.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.657 1.583 . . . . 0.0 111.807 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 70.12 9.57 7.09 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.27 2.628 . . . . 0.0 113.586 173.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.51 152.79 18.64 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.701 2.001 . . . . 0.0 109.325 176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.46 171.7 7.26 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.012 1.325 . . . . 0.0 107.551 165.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -141.92 137.79 31.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.915 0.486 . . . . 0.0 110.367 -169.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.35 132.65 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 118.795 0.725 . . . . 0.0 112.059 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -105.36 94.2 5.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.727 2.011 . . . . 0.0 107.702 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -131.23 162.73 29.34 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -168.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -97.57 114.12 64.43 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 128.106 2.562 . . . . 0.0 110.919 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.29 25.24 0.53 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.564 2.843 . . . . 0.0 113.617 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.8 t -117.82 -26.36 6.53 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.369 -1.457 . . . . 0.0 112.8 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.6 m -93.66 -29.01 15.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.128 0.971 . . . . 0.0 113.524 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -144.6 -179.07 6.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.97 1.708 . . . . 0.0 112.223 -171.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.6 p -157.81 163.0 26.09 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.133 1.373 . . . . 0.0 112.47 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -51.21 -50.68 13.14 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 124.771 3.647 . . . . 0.0 115.82 -171.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.28 -37.23 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 119.216 0.916 . . . . 0.0 112.59 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.57 79.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.257 0.623 . . . . 0.0 110.855 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.7 mt -64.37 -45.06 89.34 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.571 0.748 . . . . 0.0 112.142 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -52.06 -55.82 18.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.879 0.872 . . . . 0.0 110.545 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -70.21 -22.56 62.91 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.01 -56.47 6.09 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.316 0.962 . . . . 0.0 112.273 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.441 HG22 ' CD1' ' A' ' 42' ' ' ILE . 9.6 pt -71.54 -31.4 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -172.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -60.71 -30.23 69.83 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.29 13.79 26.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.6 mt -62.41 -49.27 84.54 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 117.305 -1.331 . . . . 0.0 112.662 167.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.61 172.07 16.43 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.707 2.938 . . . . 0.0 112.997 174.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.94 63.0 6.73 Favored 'Trans proline' 0 CA--C 1.541 0.847 1 C-N-CA 125.462 4.108 . . . . 0.0 111.109 173.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.87 32.5 82.15 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.011 1.291 . . . . 0.0 112.986 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -105.49 -48.17 3.74 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -166.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -95.6 128.53 42.54 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.01 157.56 15.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.51 1.524 . . . . 0.0 109.384 173.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.24 136.85 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 119.533 1.06 . . . . 0.0 111.636 170.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.3 m -124.36 140.37 53.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.686 1.595 . . . . 0.0 112.919 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.615 0 C-N-CA 126.462 1.905 . . . . 0.0 111.556 -163.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 5.7 m -144.03 138.8 28.61 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 p -142.35 154.82 44.98 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 127.44 2.296 . . . . 0.0 110.266 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 54.5 m -101.64 145.39 29.14 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.554 -0.716 . . . . 0.0 109.978 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.16 150.88 38.75 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.201 1.001 . . . . 0.0 111.058 172.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.76 137.96 50.3 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.583 1.553 . . . . 0.0 109.054 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.3 mm -119.12 137.29 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.554 1.942 . . . . 0.0 108.525 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -100.33 128.05 46.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.109 1.363 . . . . 0.0 109.288 170.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.02 136.21 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 120.702 -1.249 . . . . 0.0 110.909 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.68 61.7 1.23 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.965 1.706 . . . . 0.0 111.755 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.31 56.23 0.19 Allowed Glycine 0 N--CA 1.463 0.459 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.721 169.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.9 mtm -138.74 74.9 1.49 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.205 1.002 . . . . 0.0 110.499 -177.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.2 t -79.84 -19.99 47.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.72 1.208 . . . . 0.0 112.513 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 95.0 m -128.23 153.02 47.39 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.454 1.901 . . . . 0.0 111.06 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.77 -24.46 61.76 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.361 -0.837 . . . . 0.0 112.848 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.6 p -51.11 -37.36 45.49 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.987 -1.071 . . . . 0.0 111.97 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.4 m -54.15 -36.32 63.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.779 1.632 . . . . 0.0 113.336 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 t -59.85 -56.3 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -69.34 -17.61 63.72 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 m -72.52 -54.84 8.08 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.617 1.167 . . . . 0.0 111.788 167.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.81 -58.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.778 0.831 . . . . 0.0 110.198 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -57.32 -28.63 63.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.997 2.119 . . . . 0.0 112.014 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.62 -56.96 4.76 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 125.842 1.687 . . . . 0.0 114.239 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 13.1 mmt -71.29 -45.79 62.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.909 0.884 . . . . 0.0 112.093 -172.653 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.7 -39.68 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -169.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -2.25 2.7 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.96 -16.65 27.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.041 1.336 . . . . 0.0 113.814 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -95.75 162.55 13.55 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.908 1.231 . . . . 0.0 111.844 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -77.1 166.37 23.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.279 1.038 . . . . 0.0 113.596 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.9 -41.84 1.77 Allowed Glycine 0 CA--C 1.531 1.077 0 O-C-N 120.822 -1.174 . . . . 0.0 114.069 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 p -78.14 97.44 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.135 1.468 . . . . 0.0 111.394 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -68.87 -52.24 31.85 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.304 1.441 . . . . 0.0 111.545 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -143.52 144.68 32.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.868 0.867 . . . . 0.0 109.94 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.9 tt -135.93 140.17 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.14 0.976 . . . . 0.0 110.077 172.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 42.0 t -138.95 136.44 35.42 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.641 1.576 . . . . 0.0 109.946 175.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.5 p -143.79 147.39 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 119.665 1.12 . . . . 0.0 112.394 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.1 t -143.45 151.37 40.26 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.838 1.255 . . . . 0.0 112.658 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.6 mt -72.85 -29.3 63.1 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -46.21 -38.85 8.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.816 2.047 . . . . 0.0 115.303 -168.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -125.0 -1.14 7.82 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.194 1.798 . . . . 0.0 111.383 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 68.28 50.95 35.43 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 128.228 2.823 . . . . 0.0 112.019 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.8 p -141.66 145.12 34.56 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -114.99 144.87 42.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.043 1.737 . . . . 0.0 111.506 171.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.3 t -120.98 127.69 52.03 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.792 1.237 . . . . 0.0 108.208 168.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.26 140.18 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.024 0.93 . . . . 0.0 111.461 -167.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.34 116.25 30.17 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.431 2.292 . . . . 0.0 107.774 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -136.7 158.77 43.67 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -96.93 116.57 66.11 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.35 1.46 . . . . 0.0 110.606 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -82.25 -0.43 10.23 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.956 3.104 . . . . 0.0 114.121 -173.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.05 -37.48 12.14 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.678 1.191 . . . . 0.0 112.311 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 82.0 t -89.87 -31.69 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 126.668 1.987 . . . . 0.0 112.436 -176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.426 ' CG1' ' H ' ' A' ' 172' ' ' SER . 14.6 tt -138.2 -178.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.522 1.129 . . . . 0.0 110.773 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' SER . . . . . 0.426 ' H ' ' CG1' ' A' ' 171' ' ' ILE . 21.6 t -140.6 148.2 52.2 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 126.497 1.919 . . . . 0.0 110.23 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.57 -27.12 31.49 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.684 2.256 . . . . 0.0 113.664 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.51 -31.53 69.83 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.982 0.81 . . . . 0.0 111.385 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.03 -36.52 64.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.971 1.709 . . . . 0.0 111.615 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.6 mt -58.04 -57.14 14.15 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.049 0.939 . . . . 0.0 109.743 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -38.9 93.0 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 177.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.91 -30.44 67.82 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.97 0.804 . . . . 0.0 113.034 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.57 -31.9 69.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.367 0.985 . . . . 0.0 112.45 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.07 -35.67 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.979 0.912 . . . . 0.0 111.256 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.38 -29.11 65.68 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.866 0.757 . . . . 0.0 112.895 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.51 -29.61 63.77 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.643 1.177 . . . . 0.0 113.078 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 53.4 ttm -69.63 -48.84 58.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.848 0.859 . . . . 0.0 110.257 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 134.76 43.46 0.12 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.051 1.31 . . . . 0.0 114.882 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -140.8 -155.67 0.61 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.467 1.507 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -133.07 143.83 49.59 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.511 1.124 . . . . 0.0 111.368 172.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -141.5 145.0 34.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.756 1.222 . . . . 0.0 112.337 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.4 t -133.23 141.2 47.92 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.41 1.484 . . . . 0.0 109.95 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.9 m -82.48 132.23 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 O-C-N 122.042 -0.411 . . . . 0.0 111.2 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . 0.264 5.0 p . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 124.673 2.177 . . . . 0.0 107.212 169.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.4 m -126.97 134.84 50.3 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 123.357 0.663 . . . . 0.0 110.909 -168.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.56 166.75 23.87 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 115.591 1.701 . . . . 0.0 115.591 175.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -120.45 128.17 52.91 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.088 2.155 . . . . 0.0 110.938 -169.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.05 138.35 29.87 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.74 109.91 22.58 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -177.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 mt -83.25 134.21 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.254 1.422 . . . . 0.0 109.293 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -101.69 127.45 48.43 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.371 1.468 . . . . 0.0 110.882 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.4 -5.76 38.47 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.192 1.377 . . . . 0.0 113.626 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.6 ptp -61.15 -10.41 6.4 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -53.35 -12.99 0.48 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.216 1.407 . . . . 0.0 113.623 167.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.2 t -119.41 127.88 53.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.409 1.884 . . . . 0.0 108.893 167.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -58.24 -31.68 67.62 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.941 -1.099 . . . . 0.0 113.343 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 m -50.32 -30.65 12.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.719 1.207 . . . . 0.0 113.617 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.0 t -63.48 -58.19 7.8 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.546 1.138 . . . . 0.0 111.759 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 p -70.01 -25.35 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.231 0.923 . . . . 0.0 111.82 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.33 -61.34 2.7 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.041 0.936 . . . . 0.0 111.885 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -62.88 -32.5 73.77 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.969 -0.457 . . . . 0.0 111.673 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.05 -50.37 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.751 0.705 . . . . 0.0 110.32 172.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.66 -31.84 73.14 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.949 1.3 . . . . 0.0 112.528 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -70.18 -46.94 63.6 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.256 -0.902 . . . . 0.0 112.067 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -91.46 -13.13 32.8 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -170.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.564 ' CD1' HG22 ' A' ' 78' ' ' ILE . 44.9 mm -105.16 121.79 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.924 1.238 . . . . 0.0 111.421 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.98 -19.77 7.74 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.899 1.714 . . . . 0.0 114.185 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -77.35 -3.19 38.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.767 1.227 . . . . 0.0 112.599 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.7 mt -84.52 -175.76 5.93 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.88 2.872 . . . . 0.0 111.966 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.9 tp -85.82 -79.85 0.24 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.066 1.746 . . . . 0.0 111.256 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.54 -30.98 65.9 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 117.857 -1.524 . . . . 0.0 113.576 -171.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.38 117.39 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 119.173 1.486 . . . . 0.0 107.734 167.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -108.09 -36.46 6.32 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -170.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -147.62 168.12 22.82 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.31 1.044 . . . . 0.0 111.229 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.5 tp -140.68 141.65 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.546 1.138 . . . . 0.0 110.085 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -137.24 155.4 49.54 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.954 2.102 . . . . 0.0 107.47 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.4 m -123.66 145.63 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.627 -1.921 . . . . 0.0 110.914 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m -128.15 54.45 1.73 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.574 1.15 . . . . 0.0 108.135 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.13 -30.04 71.13 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.685 1.594 . . . . 0.0 112.365 -171.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.68 -37.41 63.19 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.4 0.68 . . . . 0.0 111.994 170.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -102.51 2.53 36.44 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.608 1.563 . . . . 0.0 112.925 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? 68.18 12.38 8.74 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.149 2.579 . . . . 0.0 114.209 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.1 p -99.92 162.75 12.79 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.723 1.249 . . . . 0.0 110.273 169.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.1 161.93 14.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 165.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.458 HE21 ' HA ' ' A' ' 61' ' ' GLN . 2.3 tp60 -137.08 127.15 26.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -169.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.16 140.48 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.444 -1.41 . . . . 0.0 111.915 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.36 108.85 21.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.067 1.347 . . . . 0.0 108.601 173.184 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -131.09 178.64 6.54 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.132 1.373 . . . . 0.0 110.26 -175.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -124.44 134.49 25.58 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.53 1.132 . . . . 0.0 109.445 170.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.49 20.06 0.8 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.215 3.277 . . . . 0.0 114.307 -169.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 p -121.96 -51.76 2.0 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.813 2.045 . . . . 0.0 110.586 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 90.2 m -77.46 -25.32 50.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.562 1.545 . . . . 0.0 114.463 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 t -145.28 -177.36 5.51 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.42 1.888 . . . . 0.0 109.318 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.7 p -149.57 162.17 29.37 Favored Pre-proline 0 C--N 1.321 -0.674 0 C-N-CA 125.211 1.404 . . . . 0.0 110.155 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.19 -56.37 3.11 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.42 2.747 . . . . 0.0 113.05 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.25 -35.64 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.42 -52.68 12.86 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.378 0.671 . . . . 0.0 111.606 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -37.47 82.97 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.212 1.405 . . . . 0.0 111.071 -177.084 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.9 -57.86 10.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.523 1.129 . . . . 0.0 111.539 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -63.29 -32.16 73.5 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.49 -52.71 64.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.299 0.64 . . . . 0.0 110.659 174.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.564 HG22 ' CD1' ' A' ' 42' ' ' ILE . 4.8 pt -73.41 -31.37 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -70.17 -23.91 63.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.64 10.63 39.45 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 176.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 mt -56.71 -59.14 13.23 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.063 168.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.09 173.28 14.36 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.623 2.215 . . . . 0.0 111.001 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.89 67.5 5.82 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.731 2.954 . . . . 0.0 110.135 169.534 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 56.22 46.03 86.88 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 125.594 1.568 . . . . 0.0 112.741 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -115.39 -21.22 9.94 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -165.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -133.12 116.78 16.72 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.154 1.382 . . . . 0.0 110.75 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -99.19 139.42 34.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.21 1.404 . . . . 0.0 112.091 -173.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.5 140.43 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 120.5 1.5 . . . . 0.0 112.932 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.8 t -122.94 128.69 50.61 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.225 1.81 . . . . 0.0 110.89 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 125.79 1.636 . . . . 0.0 112.598 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 24.7 p -157.01 132.88 9.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.607 1.563 . . . . 0.0 113.56 -168.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.0 p -148.0 145.26 28.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.905 2.082 . . . . 0.0 110.041 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 90.2 m -105.26 135.58 46.37 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.471 1.032 . . . . 0.0 110.499 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.68 149.23 44.92 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.987 1.315 . . . . 0.0 110.974 172.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tt -96.46 141.21 30.03 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.095 2.158 . . . . 0.0 110.042 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mt -127.91 134.4 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.626 1.571 . . . . 0.0 109.246 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.2 130.76 44.39 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.27 1.028 . . . . 0.0 108.266 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 90.6 mt -132.94 136.09 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.48 -0.763 . . . . 0.0 111.144 -168.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.07 72.27 1.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.882 1.673 . . . . 0.0 111.882 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -177.49 52.13 0.1 Allowed Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.242 -0.89 . . . . 0.0 114.399 167.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -104.41 -58.08 1.94 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.274 5.6 t 54.84 -56.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 129.433 3.093 . . . . 0.0 115.757 -169.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 92.3 m -112.99 150.82 31.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.744 2.418 . . . . 0.0 111.095 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.6 73.43 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.865 1.266 . . . . 0.0 112.614 -177.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.5 p -43.49 -47.53 7.2 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.218 1.407 . . . . 0.0 112.385 169.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 5.6 t -71.5 -25.08 62.11 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.54 -53.39 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.43 -33.29 73.47 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.1 m -67.17 -51.72 50.28 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.708 0.803 . . . . 0.0 112.898 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 83.8 mt -62.01 -46.54 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-N 119.965 1.257 . . . . 0.0 110.665 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -58.74 -28.77 66.18 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.814 1.645 . . . . 0.0 112.164 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.48 -61.05 3.28 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.969 1.271 . . . . 0.0 113.281 170.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -47.74 69.74 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.319 1.448 . . . . 0.0 113.139 -169.246 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.0 mm -71.67 -34.67 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.157 -0.339 . . . . 0.0 111.735 -169.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.0 t -50.96 -21.99 2.04 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.487 1.915 . . . . 0.0 115.313 176.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -86.18 -19.82 29.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.122 1.769 . . . . 0.0 115.163 -167.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.1 pp -92.92 151.28 20.04 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.181 0.901 . . . . 0.0 112.403 -173.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -59.38 135.22 57.59 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.952 0.882 . . . . 0.0 112.49 -169.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.27 -27.56 9.21 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.064 -1.965 . . . . 0.0 115.343 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.97 94.05 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 121.214 2.507 . . . . 0.0 108.778 169.634 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -74.84 -44.07 51.11 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.345 1.058 . . . . 0.0 111.374 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -141.95 147.18 36.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.476 1.034 . . . . 0.0 109.96 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.46 148.54 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.109 0.956 . . . . 0.0 113.272 175.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 47.5 t -134.39 136.84 43.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 129.031 2.932 . . . . 0.0 108.513 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.77 143.9 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.616 1.553 . . . . 0.0 112.766 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 42.0 m -141.51 148.71 39.83 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.195 1.398 . . . . 0.0 113.233 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.43 -26.43 55.49 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.813 1.645 . . . . 0.0 114.133 172.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.25 -33.48 58.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.834 1.653 . . . . 0.0 113.894 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -123.83 -10.54 7.75 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.276 1.83 . . . . 0.0 111.087 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.72 44.61 19.8 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.406 1.003 . . . . 0.0 110.793 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 49.0 p -133.74 146.63 50.93 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.073 0.949 . . . . 0.0 111.863 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -121.82 161.2 23.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.77 1.628 . . . . 0.0 111.057 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.8 t -141.46 139.21 33.32 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 124.191 0.996 . . . . 0.0 109.173 168.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.63 142.86 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.226 -167.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.38 98.62 11.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 173.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -100.22 154.52 18.39 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.9 0.88 . . . . 0.0 111.67 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -98.81 109.11 52.31 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.161 0.984 . . . . 0.0 110.087 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.78 -10.88 23.64 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.438 2.092 . . . . 0.0 112.472 -170.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.26 -17.42 46.01 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 93.6 t -120.45 -29.12 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.911 1.284 . . . . 0.0 114.02 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.3 tt -141.1 147.25 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.186 0.903 . . . . 0.0 110.324 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.63 150.04 36.32 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.939 0.895 . . . . 0.0 111.004 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.43 -39.47 36.1 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.246 2.631 . . . . 0.0 113.924 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -65.01 -25.25 67.78 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.7 -27.79 55.64 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.614 1.165 . . . . 0.0 113.875 174.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.6 mt -59.77 -53.76 54.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -65.2 -34.68 78.95 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.18 -27.63 68.56 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.05 -36.44 72.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.89 0.768 . . . . 0.0 112.723 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.4 mp -72.41 -37.45 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.286 1.035 . . . . 0.0 110.837 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -63.43 -34.05 76.9 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.817 -0.552 . . . . 0.0 111.485 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -71.88 -24.4 61.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.008 1.323 . . . . 0.0 113.336 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 21.2 ttt -74.85 -29.46 61.05 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.673 1.189 . . . . 0.0 112.609 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 115.5 30.99 2.08 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 126.084 1.802 . . . . 0.0 114.875 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -133.76 -158.51 0.89 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.842 1.657 . . . . 0.0 109.18 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -137.57 143.17 41.41 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.287 1.035 . . . . 0.0 111.459 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -140.88 152.22 44.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.027 1.731 . . . . 0.0 112.065 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.5 t -141.36 130.99 24.02 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.006 1.323 . . . . 0.0 112.232 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.55 81.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.127 0.971 . . . . 0.0 111.412 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 125.025 1.33 . . . . 0.0 112.457 179.526 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.484 HG13 ' CE1' ' A' ' 64' ' ' TYR . 9.9 p . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -118.36 144.9 45.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.501 1.121 . . . . 0.0 111.399 -170.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.38 128.71 19.98 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.496 1.519 . . . . 0.0 109.85 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -96.3 135.69 37.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.355 1.462 . . . . 0.0 112.237 -176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -142.87 146.91 34.54 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.92 109.62 19.85 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.449 1.499 . . . . 0.0 109.146 174.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.7 mt -85.41 147.21 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.199 1.799 . . . . 0.0 111.676 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -98.19 139.84 33.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.984 1.313 . . . . 0.0 111.07 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.27 -6.89 81.04 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.196 1.379 . . . . 0.0 114.101 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 ptp -64.19 -15.75 60.53 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -63.82 -13.5 44.99 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.62 1.554 . . . . 0.0 113.223 170.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.1 m -77.03 -14.72 59.79 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.15 -1.594 . . . . 0.0 114.155 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 70.8 -50.9 0.68 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 128.139 2.576 . . . . 0.0 111.955 -172.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 m -60.0 -17.97 42.49 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.766 -1.209 . . . . 0.0 113.583 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 t -64.38 -53.05 54.7 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.548 1.139 . . . . 0.0 111.565 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.72 -27.92 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 118.638 0.654 . . . . 0.0 112.281 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.1 tp -53.65 -49.54 67.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 112.376 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -39.18 88.51 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.478 0.581 . . . . 0.0 111.914 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.1 mt -65.51 -49.5 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.263 1.025 . . . . 0.0 109.264 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.69 -41.6 98.12 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.68 1.592 . . . . 0.0 111.938 -176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.7 -39.22 87.97 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.031 -0.509 . . . . 0.0 111.49 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -91.6 -25.01 19.39 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -172.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.426 ' CD1' HG22 ' A' ' 78' ' ' ILE . 47.8 mm -102.91 118.64 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.874 0.87 . . . . 0.0 110.431 -173.246 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.23 -17.5 3.57 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.866 1.698 . . . . 0.0 115.215 -177.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -88.54 -5.33 58.27 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.091 1.356 . . . . 0.0 111.919 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -76.4 170.4 16.43 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.006 2.122 . . . . 0.0 111.247 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.57 -62.88 1.31 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.427 -0.795 . . . . 0.0 110.964 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.04 -43.13 17.85 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.853 -0.97 . . . . 0.0 113.237 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.26 123.92 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.221 1.511 . . . . 0.0 110.502 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -94.74 -46.22 7.0 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.186 0.994 . . . . 0.0 111.31 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.8 t -149.41 172.04 15.59 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.563 0.745 . . . . 0.0 112.481 -169.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 tp -142.39 125.2 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.561 1.944 . . . . 0.0 107.434 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -120.23 149.45 42.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.554 0.741 . . . . 0.0 109.65 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.8 m -106.62 155.87 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.201 -0.937 . . . . 0.0 111.03 -170.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.4 t -139.73 57.82 1.62 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 123.138 1.447 . . . . 0.0 108.182 175.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.86 -24.13 65.22 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.611 1.564 . . . . 0.0 112.714 -171.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.21 -11.88 35.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.003 1.321 . . . . 0.0 113.61 169.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -122.84 7.59 9.35 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.172 2.189 . . . . 0.0 111.649 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 mptt 62.2 14.17 6.46 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.383 2.273 . . . . 0.0 113.746 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.73 167.14 10.08 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.634 1.574 . . . . 0.0 111.76 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.67 152.79 45.64 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 127.157 2.183 . . . . 0.0 107.207 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -130.63 133.65 46.31 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 172.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 p -96.22 136.86 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.519 0.676 . . . . 0.0 109.732 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -107.19 87.89 2.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.59 1.956 . . . . 0.0 107.51 -172.435 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.484 ' CE1' HG13 ' A' ' 20' ' ' VAL . 8.8 p90 -116.33 -179.3 3.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.481 1.512 . . . . 0.0 110.42 -175.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.13 142.17 36.05 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 168.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.08 7.19 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.388 2.058 . . . . 0.0 114.308 -168.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -74.96 -51.38 13.85 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.28 -1.512 . . . . 0.0 112.369 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 90.0 m -95.46 -15.81 22.69 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -172.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.9 t -147.81 175.69 10.73 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.647 1.179 . . . . 0.0 112.448 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.4 p -155.46 161.54 29.23 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.606 1.162 . . . . 0.0 112.754 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.85 -45.71 38.98 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.131 2.554 . . . . 0.0 115.583 -170.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.91 -41.18 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 118.814 0.734 . . . . 0.0 111.945 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.48 86.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.954 0.901 . . . . 0.0 112.268 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.56 -40.56 92.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.989 0.916 . . . . 0.0 111.799 173.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -58.69 -45.64 89.04 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.256 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -61.59 -36.79 81.66 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.542 1.065 . . . . 0.0 112.892 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.18 -60.33 2.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.23 1.012 . . . . 0.0 113.43 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.426 HG22 ' CD1' ' A' ' 42' ' ' ILE . 8.6 pt -73.2 -32.65 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -169.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -70.0 -19.62 63.32 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.84 0.856 . . . . 0.0 112.684 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.59 11.21 37.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.997 1.319 . . . . 0.0 113.934 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -60.61 -50.46 85.29 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.371 -1.3 . . . . 0.0 111.631 167.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 73.4 Cg_endo -70.25 172.84 12.35 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.583 2.855 . . . . 0.0 112.22 170.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.56 43.25 1.18 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.217 3.278 . . . . 0.0 112.236 170.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.41 58.05 5.23 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 121.155 -0.966 . . . . 0.0 111.149 -174.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -133.8 -42.33 0.83 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.41 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 14.9 m-85 -97.9 115.53 28.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -102.4 158.46 16.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.016 0.926 . . . . 0.0 111.772 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.86 139.25 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.364 0.984 . . . . 0.0 112.037 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.8 t -128.9 130.5 46.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.012 0.925 . . . . 0.0 111.945 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 CA--C 1.552 1.021 0 C-N-CA 125.355 1.462 . . . . 0.0 111.461 -175.887 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 87.1 m 58.53 92.63 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.237 1.815 . . . . 0.0 112.758 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 t -140.15 154.04 46.85 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.882 -1.136 . . . . 0.0 111.727 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.1 m -99.27 129.84 45.52 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -176.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.82 153.59 43.85 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.087 0.946 . . . . 0.0 110.126 168.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tt -102.55 130.5 49.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.705 2.002 . . . . 0.0 109.447 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.3 mm -115.12 138.55 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.174 1.789 . . . . 0.0 109.187 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -104.51 125.04 50.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.923 0.889 . . . . 0.0 110.044 169.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.9 mp -115.85 139.85 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.457 1.026 . . . . 0.0 112.369 -169.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.31 70.55 0.72 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.229 2.211 . . . . 0.0 111.539 171.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -176.2 54.09 0.11 Allowed Glycine 0 N--CA 1.466 0.659 0 C-N-CA 124.86 1.219 . . . . 0.0 112.753 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.9 mtm -134.98 157.78 46.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.514 1.526 . . . . 0.0 109.869 170.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.8 t -174.94 -45.34 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.593 1.557 . . . . 0.0 110.74 -171.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 67.0 m -104.68 146.05 29.48 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.863 1.265 . . . . 0.0 109.127 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.89 -27.69 68.34 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.622 -0.674 . . . . 0.0 112.605 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 79.9 p -56.06 -23.9 36.47 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.913 -1.117 . . . . 0.0 113.468 172.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 73.2 m -56.16 -27.82 55.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.372 1.069 . . . . 0.0 113.49 170.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.2 t -54.33 -52.58 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 118.91 0.777 . . . . 0.0 109.492 173.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -70.6 -14.8 62.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.232 1.013 . . . . 0.0 113.098 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.3 m -73.41 -56.14 5.44 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.064 -1.023 . . . . 0.0 109.65 167.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.5 mt -68.17 -59.23 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.695 1.198 . . . . 0.0 110.568 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -54.55 -29.52 51.21 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.646 1.578 . . . . 0.0 111.63 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.58 -62.65 3.15 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.373 0.987 . . . . 0.0 112.727 176.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 86.6 mmm -75.56 -42.49 52.09 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.771 1.396 . . . . 0.0 114.771 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 31.8 mm -72.32 -30.51 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.596 0.759 . . . . 0.0 111.829 -172.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.6 p -63.82 -9.37 14.44 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 175.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -107.92 22.95 15.22 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.028 1.331 . . . . 0.0 113.577 -171.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 pp -115.56 163.72 15.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.759 1.223 . . . . 0.0 111.544 169.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -65.57 135.8 55.56 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.12 16.57 74.17 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 117.891 -1.505 . . . . 0.0 115.89 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.75 -23.56 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 125.507 1.523 . . . . 0.0 114.292 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 42.65 -76.31 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 129.841 3.256 . . . . 0.0 117.37 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -128.28 127.91 43.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.55 1.523 . . . . 0.0 111.375 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.6 tt -134.6 137.66 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 121.188 -0.945 . . . . 0.0 111.164 -169.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 21.9 t -143.26 133.37 24.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.869 2.067 . . . . 0.0 108.248 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.58 143.62 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 119.785 1.175 . . . . 0.0 111.711 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -141.38 133.45 27.72 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -59.05 -22.08 60.16 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.041 2.137 . . . . 0.0 113.23 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.06 -31.17 62.93 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.792 1.237 . . . . 0.0 112.724 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -133.3 -16.7 2.4 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.185 1.394 . . . . 0.0 113.555 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.1 26.74 65.72 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.803 1.192 . . . . 0.0 112.112 -169.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.4 p -121.42 148.85 43.85 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.64 1.176 . . . . 0.0 111.693 -171.016 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.64 137.48 50.85 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.786 1.234 . . . . 0.0 110.771 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.0 t -112.66 121.13 43.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 167.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.59 141.28 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 121.906 -0.496 . . . . 0.0 110.614 -169.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.31 101.93 14.64 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.637 1.975 . . . . 0.0 105.887 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -97.65 157.8 15.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.293 1.044 . . . . 0.0 111.718 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -101.42 94.49 4.16 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.713 1.205 . . . . 0.0 110.267 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.55 -35.71 94.87 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.118 2.545 . . . . 0.0 111.372 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.57 -8.18 18.63 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.36 -28.98 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 126.181 1.792 . . . . 0.0 112.535 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.8 tt -155.91 158.02 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 119.943 1.247 . . . . 0.0 112.351 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.5 t -98.1 145.27 29.51 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.854 1.262 . . . . 0.0 113.104 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.42 -33.23 66.06 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.102 2.535 . . . . 0.0 112.546 167.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.42 -27.07 66.76 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.982 0.81 . . . . 0.0 112.432 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -76.38 -37.07 57.73 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.323 1.049 . . . . 0.0 111.953 168.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.43 -53.59 56.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.286 1.834 . . . . 0.0 110.641 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -59.83 -37.82 80.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.74 0.7 . . . . 0.0 112.809 173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.63 -23.91 67.32 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.26 -35.63 71.47 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.111 1.323 . . . . 0.0 112.731 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.65 -38.18 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.574 1.149 . . . . 0.0 110.191 171.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -69.39 -26.76 64.8 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.41 1.084 . . . . 0.0 112.734 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.66 -44.51 64.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.182 1.393 . . . . 0.0 111.393 168.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 22.6 ttt -61.72 -27.67 68.88 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.654 1.582 . . . . 0.0 112.396 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 115.23 38.79 0.99 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.478 1.514 . . . . 0.0 114.024 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -130.7 -160.54 1.05 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.236 1.414 . . . . 0.0 108.266 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -131.51 146.86 52.44 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.904 -1.123 . . . . 0.0 110.335 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.93 141.53 31.49 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.8 t -124.36 135.5 53.36 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.5 1.12 . . . . 0.0 112.021 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 m -87.07 80.63 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.908 0.883 . . . . 0.0 110.768 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.476 0.839 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.603 -178.082 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -98.85 153.46 18.77 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.479 2.711 . . . . 0.0 112.927 -174.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.5 tt -143.96 139.31 29.02 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.221 1.409 . . . . 0.0 112.991 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -98.46 110.33 22.94 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 122.689 1.233 . . . . 0.0 111.928 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -138.17 133.73 33.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.472 -1.695 . . . . 0.0 112.667 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -98.6 119.38 37.22 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.7 mt -96.83 137.34 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.031 0.932 . . . . 0.0 109.146 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -96.64 117.8 31.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.904 0.882 . . . . 0.0 110.913 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.62 -12.36 12.13 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.306 1.432 . . . . 0.0 113.689 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 12.9 ptp -56.52 -22.17 31.1 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.939 1.87 . . . . 0.0 114.075 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -58.64 -25.97 63.28 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 169.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -80.42 -8.49 59.56 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.606 -1.309 . . . . 0.0 113.52 173.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.7 tptt 70.08 -56.0 0.59 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 129.025 2.93 . . . . 0.0 111.781 -170.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -48.86 -27.35 2.98 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.718 2.407 . . . . 0.0 114.567 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 t -53.59 -49.06 68.57 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.951 1.7 . . . . 0.0 113.265 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.9 -28.24 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -170.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.69 -51.86 45.5 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.215 1.406 . . . . 0.0 111.343 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.19 -54.12 49.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -60.69 -37.0 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.591 0.756 . . . . 0.0 111.34 -173.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -64.08 -28.65 69.93 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.402 -0.811 . . . . 0.0 112.399 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.24 -50.3 34.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.24 1.016 . . . . 0.0 112.085 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -92.57 -24.29 18.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.549 1.54 . . . . 0.0 115.076 -171.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.424 ' CD1' HG22 ' A' ' 78' ' ' ILE . 33.4 mm -98.86 125.84 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 120.345 1.429 . . . . 0.0 109.746 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.41 -14.24 7.32 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.039 1.78 . . . . 0.0 114.636 -174.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -96.65 -1.88 45.82 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.749 1.274 . . . . 0.0 113.092 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 mp -71.03 178.59 3.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.567 1.947 . . . . 0.0 110.71 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -58.6 4.31 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.854 -1.154 . . . . 0.0 111.569 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.74 -31.28 7.49 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.729 -1.595 . . . . 0.0 113.519 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.74 113.08 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.938 2.369 . . . . 0.0 109.46 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -98.4 -39.8 8.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.066 0.946 . . . . 0.0 111.894 -175.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.0 t -147.36 159.72 43.37 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.489 -0.757 . . . . 0.0 112.165 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -133.59 121.14 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.414 1.485 . . . . 0.0 109.214 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -110.14 177.43 4.71 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.248 1.419 . . . . 0.0 108.695 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.8 166.96 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 169.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 t -141.48 59.81 1.5 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.324 1.85 . . . . 0.0 110.378 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.31 -22.77 61.74 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.685 2.394 . . . . 0.0 115.664 -173.459 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -61.52 -35.76 78.62 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.691 1.132 . . . . 0.0 111.058 171.021 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -104.25 -2.27 25.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.252 1.421 . . . . 0.0 114.049 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.1 mttp 81.98 4.5 1.23 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.122 2.169 . . . . 0.0 112.37 173.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.26 155.16 16.99 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.902 2.081 . . . . 0.0 109.976 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.48 -179.71 4.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 165.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -145.52 105.11 3.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.444 -0.785 . . . . 0.0 111.686 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 p -101.7 132.14 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.432 0.634 . . . . 0.0 111.544 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.0 94.96 6.55 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.085 1.754 . . . . 0.0 109.832 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -120.16 148.98 42.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.007 0.923 . . . . 0.0 111.957 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -96.06 115.62 65.68 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.157 1.383 . . . . 0.0 108.832 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.97 -8.94 24.86 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.036 2.49 . . . . 0.0 113.186 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 t -77.86 -11.15 59.86 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.855 0.752 . . . . 0.0 112.23 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 66.0 m -130.27 -18.33 3.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.3 t -145.14 -177.68 5.67 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.899 1.227 . . . . 0.0 111.177 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 p -151.82 161.34 29.8 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 125.195 1.398 . . . . 0.0 109.352 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -50.09 -46.0 30.44 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.332 2.688 . . . . 0.0 114.228 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.0 p -67.84 -40.96 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 120.429 1.468 . . . . 0.0 111.763 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.23 90.2 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.917 0.887 . . . . 0.0 112.273 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.37 -47.0 58.98 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.976 0.51 . . . . 0.0 111.86 173.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -68.41 -41.52 80.3 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.37 -0.831 . . . . 0.0 112.549 -169.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -56.79 -30.71 63.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.466 0.706 . . . . 0.0 112.291 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.96 -55.59 7.19 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.107 0.867 . . . . 0.0 111.674 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.424 HG22 ' CD1' ' A' ' 42' ' ' ILE . 1.9 pt -64.93 -30.04 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -168.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -59.85 -34.48 73.17 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.88 13.0 30.23 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.1 mt -55.92 -56.03 34.89 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.937 168.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.505 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 86.5 Cg_endo -73.02 -179.98 4.83 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.872 3.048 . . . . 0.0 111.768 171.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.02 41.4 0.47 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.766 3.644 . . . . 0.0 111.989 168.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.47 27.13 64.06 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.849 1.214 . . . . 0.0 113.196 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -95.81 -40.62 9.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.272 1.036 . . . . 0.0 113.538 -168.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.505 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 24.7 m-85 -98.17 113.94 26.01 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.027 1.331 . . . . 0.0 108.182 173.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -97.38 164.02 12.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.19 0.596 . . . . 0.0 109.963 -174.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.99 141.56 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.123 0.969 . . . . 0.0 110.067 171.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.1 t -128.18 128.57 45.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.475 1.11 . . . . 0.0 112.59 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 127.69 2.396 . . . . 0.0 111.057 174.838 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 20.5 p -162.51 118.03 1.88 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.03 2.132 . . . . 0.0 110.92 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.0 p -141.91 142.56 33.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.577 1.951 . . . . 0.0 109.228 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.7 m -102.73 139.99 37.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.664 0.665 . . . . 0.0 109.454 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.43 161.85 35.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.397 0.679 . . . . 0.0 111.141 169.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 tt -114.03 132.38 56.02 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.316 1.847 . . . . 0.0 109.287 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mt -127.79 134.6 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.519 1.128 . . . . 0.0 110.083 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.75 127.71 43.9 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.109 1.363 . . . . 0.0 108.766 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.3 mt -129.43 145.88 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.248 -0.907 . . . . 0.0 112.101 -167.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -113.99 57.73 0.69 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.283 1.833 . . . . 0.0 112.277 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.73 53.27 0.44 Allowed Glycine 0 CA--C 1.524 0.642 0 O-C-N 121.553 -0.717 . . . . 0.0 113.842 168.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -138.2 98.97 3.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.417 1.487 . . . . 0.0 108.274 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.7 t -93.42 -31.37 14.64 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.228 1.411 . . . . 0.0 112.327 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 5.2 m -144.04 169.36 17.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.872 2.469 . . . . 0.0 110.594 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.94 71.46 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.231 -0.918 . . . . 0.0 112.512 172.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.0 p -50.44 -36.16 32.0 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.874 -1.141 . . . . 0.0 113.048 169.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.7 t -72.53 -34.96 67.93 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.257 1.423 . . . . 0.0 112.521 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.29 -52.58 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.915 0.886 . . . . 0.0 109.249 169.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -61.47 -23.27 65.76 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.1 t -70.69 -51.12 29.7 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.612 -0.68 . . . . 0.0 112.114 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 52.5 mt -63.4 -54.08 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 120.822 1.646 . . . . 0.0 111.055 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -59.26 -25.41 64.05 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.589 1.955 . . . . 0.0 110.918 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.8 -62.46 2.37 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.829 1.68 . . . . 0.0 114.056 168.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 89.8 mmm -70.56 -40.7 73.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.239 1.416 . . . . 0.0 113.817 -169.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.9 mm -70.67 -31.51 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.387 -0.821 . . . . 0.0 110.315 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.6 t -66.83 1.83 1.68 Allowed 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -87.13 -18.14 31.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.432 1.493 . . . . 0.0 114.09 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -102.6 165.85 10.85 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.972 1.26 . . . . 0.0 113.4 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -64.31 163.33 13.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.319 1.533 . . . . 0.0 113.779 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.87 -36.35 0.39 Allowed Glycine 0 CA--C 1.533 1.161 0 CA-C-O 117.847 -1.529 . . . . 0.0 115.283 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.0 p -70.42 93.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.493 1.647 . . . . 0.0 110.458 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -73.83 -45.55 50.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.98 1.712 . . . . 0.0 111.221 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -143.41 140.9 30.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.301 1.44 . . . . 0.0 108.299 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.9 tt -133.9 130.99 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.465 0.706 . . . . 0.0 110.822 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 43.2 m -131.88 104.2 6.74 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.825 1.25 . . . . 0.0 110.44 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.69 138.55 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.689 1.196 . . . . 0.0 111.737 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.0 m -133.85 142.74 47.94 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.747 1.261 . . . . 0.0 112.423 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.76 -15.67 59.69 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.613 1.965 . . . . 0.0 115.348 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.98 -46.03 71.56 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.312 1.445 . . . . 0.0 111.943 -174.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.7 -14.94 8.99 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.041 1.736 . . . . 0.0 110.897 172.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.17 39.67 7.82 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.881 1.229 . . . . 0.0 111.722 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.9 p -129.2 148.43 51.14 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.124 0.97 . . . . 0.0 113.015 -169.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -122.13 129.93 52.77 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.384 1.874 . . . . 0.0 111.777 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.2 t -103.72 122.76 45.74 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 167.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.99 137.5 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 122.018 -0.426 . . . . 0.0 110.748 -169.639 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.27 114.12 25.83 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.998 1.719 . . . . 0.0 107.935 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -114.4 155.98 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.882 0.873 . . . . 0.0 112.523 176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -96.48 110.42 52.73 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.883 0.873 . . . . 0.0 109.758 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.26 -14.23 20.65 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.941 2.427 . . . . 0.0 112.554 -171.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.47 -17.27 60.8 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.456 1.026 . . . . 0.0 112.951 170.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 99.1 t -117.49 -34.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.538 1.535 . . . . 0.0 113.078 -170.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.7 tt -145.71 154.04 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.446 1.021 . . . . 0.0 112.59 -174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.8 t -101.65 151.79 37.95 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 125.829 1.652 . . . . 0.0 111.7 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.37 -32.47 42.23 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.232 2.621 . . . . 0.0 114.112 168.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -73.82 -24.21 59.76 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.778 0.717 . . . . 0.0 111.645 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.72 -38.02 58.92 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.941 1.296 . . . . 0.0 111.441 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.7 mt -56.36 -55.5 32.73 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -52.35 -51.53 58.33 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.625 1.57 . . . . 0.0 111.29 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.15 -25.14 68.21 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.52 68.14 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.713 1.597 . . . . 0.0 111.769 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.36 -38.2 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.443 1.097 . . . . 0.0 111.045 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.29 -40.12 95.3 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.696 0.68 . . . . 0.0 111.271 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.4 -23.53 62.78 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.163 2.185 . . . . 0.0 113.022 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 26.4 ttt -76.42 -40.83 49.63 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.733 1.213 . . . . 0.0 110.875 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 125.39 34.47 0.66 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.994 1.283 . . . . 0.0 115.661 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -129.02 -153.51 0.57 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.628 1.571 . . . . 0.0 108.68 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.52 148.29 49.11 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.356 -0.84 . . . . 0.0 112.118 169.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -136.07 151.52 49.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.038 1.335 . . . . 0.0 112.368 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.2 t -140.24 122.92 16.32 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.005 1.322 . . . . 0.0 111.357 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.4 m -84.39 78.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.651 1.215 . . . . 0.0 110.54 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 CA--C 1.547 0.843 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.751 172.991 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -98.0 142.13 30.1 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.683 1.593 . . . . 0.0 110.601 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tt -143.63 148.06 35.27 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.156 1.782 . . . . 0.0 111.886 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -96.51 130.74 43.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.452 1.12 . . . . 0.0 111.829 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.08 140.72 31.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 113.46 -1.7 . . . . 0.0 111.332 169.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -99.43 121.42 41.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.29 136.09 23.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 170.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.85 144.82 27.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.543 1.137 . . . . 0.0 109.094 171.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.1 -2.64 64.65 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.887 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -73.32 -63.83 1.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.612 1.165 . . . . 0.0 109.825 174.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.7 m80 58.47 -12.75 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.781 2.433 . . . . 0.0 115.528 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 32.0 p -164.39 155.62 15.54 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.837 1.255 . . . . 0.0 112.251 -169.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -32.38 23.23 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 175.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 m -60.16 -35.57 75.61 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.863 -1.148 . . . . 0.0 112.439 -174.557 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.8 m -74.75 -18.05 60.55 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.82 -8.61 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -56.89 -62.77 1.51 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.797 1.18 . . . . 0.0 112.387 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -53.84 -34.4 59.17 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.612 -0.68 . . . . 0.0 111.294 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.414 ' HA ' HD21 ' A' ' 81' ' ' LEU . 1.8 mt -63.39 -50.14 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 O-C-N 121.122 -0.986 . . . . 0.0 111.093 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -62.3 -32.48 73.23 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.289 0.95 . . . . 0.0 112.465 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -65.0 -54.59 28.04 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.541 1.064 . . . . 0.0 111.88 173.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -83.47 -33.75 25.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.185 1.394 . . . . 0.0 114.113 -170.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.1 mm -104.01 121.69 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 122.087 0.946 . . . . 0.0 110.47 -167.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.42 -28.55 5.0 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 125.807 1.67 . . . . 0.0 113.326 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -79.12 -0.55 32.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.619 -0.93 . . . . 0.0 112.692 174.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.39 -173.58 4.13 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.16 2.584 . . . . 0.0 112.756 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.02 -78.52 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.752 1.621 . . . . 0.0 111.932 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.61 -25.31 18.56 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.446 -1.752 . . . . 0.0 113.486 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -77.92 110.55 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 121.194 2.497 . . . . 0.0 107.819 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -104.41 -31.53 9.47 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.483 1.113 . . . . 0.0 112.137 -169.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 t -148.69 174.08 12.54 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 tp -144.79 136.78 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.83 1.652 . . . . 0.0 110.55 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -141.64 -178.08 5.48 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.675 1.19 . . . . 0.0 111.247 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.53 148.08 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 120.988 1.722 . . . . 0.0 114.581 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 m -130.36 57.88 1.7 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.657 1.583 . . . . 0.0 109.656 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.4 mt -64.93 -24.03 67.4 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.124 1.77 . . . . 0.0 115.333 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.77 -29.8 65.12 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.753 0.821 . . . . 0.0 111.963 170.31 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -120.7 13.05 11.54 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.817 1.647 . . . . 0.0 112.668 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 72.64 4.87 5.11 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.303 1.841 . . . . 0.0 115.298 168.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 p -96.47 152.74 18.33 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.604 1.192 . . . . 0.0 110.646 177.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.75 157.13 17.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 164.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.31 112.21 14.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.515 -0.741 . . . . 0.0 110.438 -168.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 p -96.74 136.15 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -117.83 82.9 1.9 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.535 1.534 . . . . 0.0 106.871 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -117.89 153.97 32.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.349 -170.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -97.1 109.42 49.26 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 127.332 2.253 . . . . 0.0 108.705 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.49 -3.15 10.47 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.339 2.693 . . . . 0.0 113.458 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.7 t -80.16 -18.77 48.82 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.39 0.995 . . . . 0.0 111.974 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 14.6 m -122.86 -16.03 7.23 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 t -146.3 -175.63 4.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.638 1.175 . . . . 0.0 111.409 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.7 m -153.87 156.34 32.0 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 126.567 1.947 . . . . 0.0 109.611 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -52.96 -56.9 2.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.26 2.64 . . . . 0.0 115.775 -169.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.16 -36.84 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 120.961 1.71 . . . . 0.0 112.711 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.84 -41.42 71.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.651 1.18 . . . . 0.0 112.256 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.94 -38.28 76.13 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.925 0.89 . . . . 0.0 111.279 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -69.78 -41.19 75.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.53 1.132 . . . . 0.0 111.848 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -50.18 -35.91 28.22 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.744 1.218 . . . . 0.0 113.13 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.17 -61.92 1.59 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.162 0.892 . . . . 0.0 112.198 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.411 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 30.4 pt -60.68 -21.22 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.937 1.695 . . . . 0.0 114.659 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.36 -25.39 65.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.345 1.458 . . . . 0.0 113.227 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -126.66 25.62 6.4 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.6 1.56 . . . . 0.0 113.397 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.414 HD21 ' HA ' ' A' ' 38' ' ' ILE . 11.3 tp -53.56 -55.62 33.18 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 127.248 2.219 . . . . 0.0 112.473 168.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 32.3 Cg_endo -84.45 -179.5 3.89 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.189 3.259 . . . . 0.0 111.163 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.76 56.72 2.4 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.681 3.587 . . . . 0.0 111.855 168.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.14 15.92 65.97 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.197 1.38 . . . . 0.0 114.183 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -83.92 -34.01 24.59 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.953 0.876 . . . . 0.0 112.387 -168.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.48 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 8.9 m-85 -121.56 129.77 53.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.04 2.136 . . . . 0.0 107.688 174.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -120.09 173.16 7.26 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.299 1.44 . . . . 0.0 110.309 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.06 131.48 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 119.964 1.256 . . . . 0.0 113.479 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -118.37 118.43 31.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.491 1.116 . . . . 0.0 110.617 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.958 1.303 . . . . 0.0 111.38 172.578 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 26.3 p -156.2 117.35 3.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.312 1.045 . . . . 0.0 113.358 -167.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.7 p -145.29 145.04 31.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.623 1.169 . . . . 0.0 111.381 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 88.3 m -96.98 140.91 30.8 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.41 149.98 36.95 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.418 1.087 . . . . 0.0 110.692 173.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tt -117.58 142.41 47.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.002 2.121 . . . . 0.0 110.331 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 mt -134.1 135.28 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.105 1.762 . . . . 0.0 110.754 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.88 128.57 45.96 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.769 1.628 . . . . 0.0 110.467 171.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.51 118.44 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 120.958 -1.089 . . . . 0.0 111.241 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.05 55.94 2.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.525 1.13 . . . . 0.0 110.917 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.54 53.29 0.32 Allowed Glycine 0 N--CA 1.462 0.415 0 C-N-CA 124.612 1.101 . . . . 0.0 111.139 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.8 mtm -145.36 145.6 31.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.676 0.79 . . . . 0.0 111.097 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.8 t -163.34 -43.94 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.425 0.69 . . . . 0.0 112.425 -168.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 83.5 m -114.26 152.03 31.95 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.393 1.477 . . . . 0.0 110.516 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.54 -25.53 68.09 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.872 -1.143 . . . . 0.0 113.14 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.7 p -59.18 -22.26 60.7 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.236 -1.54 . . . . 0.0 113.274 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 74.4 m -61.18 -30.22 70.28 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.754 -1.216 . . . . 0.0 112.052 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.73 -53.29 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.646 0.778 . . . . 0.0 109.914 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -65.27 -25.18 67.54 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.469 0.577 . . . . 0.0 111.847 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.5 m -70.58 -59.95 2.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.623 0.769 . . . . 0.0 111.943 170.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.1 mt -69.09 -42.28 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.056 1.342 . . . . 0.0 112.854 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -56.4 -34.28 66.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.358 0.663 . . . . 0.0 109.831 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.58 -34.31 67.45 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.037 -1.424 . . . . 0.0 114.088 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -47.42 72.52 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 121.244 2.522 . . . . 0.0 110.389 172.24 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 mm -75.52 -50.63 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.489 0.716 . . . . 0.0 112.192 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -71.32 -5.97 36.41 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.4 -1.438 . . . . 0.0 114.65 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -85.7 -21.7 28.19 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.24 -155.95 0.53 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -167.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -117.63 149.99 39.77 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.738 1.615 . . . . 0.0 111.816 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.56 18.91 59.34 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 117.638 -1.645 . . . . 0.0 114.584 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.0 p -112.03 97.22 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.844 2.058 . . . . 0.0 111.305 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.73 -47.56 8.15 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.195 -0.941 . . . . 0.0 112.53 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -142.48 145.58 33.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.607 1.163 . . . . 0.0 108.385 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.29 143.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 118.53 0.604 . . . . 0.0 111.036 167.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.5 t -140.37 149.75 43.07 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.049 2.14 . . . . 0.0 109.834 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.42 140.93 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.291 1.036 . . . . 0.0 111.329 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 67.2 m -121.87 77.69 1.39 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.116 2.167 . . . . 0.0 108.1 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.8 tt -53.59 -29.03 35.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.723 2.009 . . . . 0.0 112.383 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -41.48 -51.12 3.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.858 2.463 . . . . 0.0 112.882 167.168 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -90.43 -29.42 17.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.553 1.941 . . . . 0.0 111.125 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 93.09 27.93 12.77 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.143 1.83 . . . . 0.0 112.741 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.3 p -132.99 139.02 47.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.232 1.016 . . . . 0.0 112.457 -168.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.92 147.24 29.0 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.092 1.357 . . . . 0.0 111.113 173.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.2 t -131.29 133.89 45.83 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.509 1.124 . . . . 0.0 109.484 172.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.92 142.93 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.505 1.122 . . . . 0.0 110.927 -168.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.22 103.22 15.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.115 1.766 . . . . 0.0 106.773 169.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -108.9 156.66 19.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.002 0.921 . . . . 0.0 112.845 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -99.08 110.17 56.87 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.874 0.869 . . . . 0.0 111.148 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.08 -11.54 21.34 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.247 2.631 . . . . 0.0 113.761 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.89 -11.21 59.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.222 1.009 . . . . 0.0 113.356 171.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.3 t -120.09 -42.89 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.495 1.518 . . . . 0.0 111.895 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.1 tt -134.52 143.6 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 123.685 0.794 . . . . 0.0 111.596 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.9 t -97.11 151.49 37.73 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.404 1.082 . . . . 0.0 112.695 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.14 -28.96 53.74 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.729 2.286 . . . . 0.0 112.672 167.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -67.57 -30.82 70.54 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.414 -0.804 . . . . 0.0 112.857 173.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.08 -31.81 64.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.538 1.135 . . . . 0.0 112.044 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 63.0 mt -60.59 -53.39 58.09 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.082 0.953 . . . . 0.0 109.447 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -57.28 -49.21 76.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.857 0.863 . . . . 0.0 111.605 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.69 -27.59 66.56 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.63 -41.04 80.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.655 1.116 . . . . 0.0 112.073 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.69 -39.03 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.473 0.709 . . . . 0.0 110.835 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -65.3 -24.46 67.29 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.99 -21.55 59.95 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 172.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -50.06 9.21 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.185 0.594 . . . . 0.0 109.572 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 131.28 50.73 0.1 OUTLIER Glycine 0 N--CA 1.467 0.755 0 C-N-CA 124.658 1.123 . . . . 0.0 113.81 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -136.34 -167.18 2.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.326 1.85 . . . . 0.0 108.72 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -127.14 129.57 48.14 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 121.016 -1.053 . . . . 0.0 110.212 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -116.26 149.15 39.67 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.301 1.44 . . . . 0.0 109.472 172.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.3 t -140.66 133.67 29.3 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.34 1.056 . . . . 0.0 109.325 172.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 24.9 m -84.73 121.97 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.38 0.609 . . . . 0.0 109.432 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 126.171 1.788 . . . . 0.0 109.51 -172.627 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.0 m -120.46 151.36 39.44 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.475 1.11 . . . . 0.0 110.523 -171.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.96 176.42 8.95 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.182 0.993 . . . . 0.0 113.453 172.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -112.76 136.91 51.82 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.727 1.211 . . . . 0.0 113.093 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -147.17 142.43 27.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.636 168.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -104.77 111.98 24.92 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.914 1.286 . . . . 0.0 108.361 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 mt -85.12 139.43 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.657 0.783 . . . . 0.0 109.593 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.99 123.05 43.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.047 1.339 . . . . 0.0 111.304 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.14 -9.36 24.89 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.884 1.23 . . . . 0.0 114.886 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.2 ptp -57.35 -7.64 0.62 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -56.87 -24.65 53.13 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.828 -1.17 . . . . 0.0 112.839 168.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.8 m -97.38 119.18 35.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 167.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -58.04 -28.04 64.13 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.522 1.055 . . . . 0.0 113.454 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.6 p -53.13 -28.55 26.34 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 170.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.25 -51.52 68.59 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.877 0.762 . . . . 0.0 111.215 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -74.6 -27.64 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.54 -56.19 24.42 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.088 0.955 . . . . 0.0 111.847 -175.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -65.15 -33.94 77.2 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.732 -0.605 . . . . 0.0 112.285 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.3 mt -58.96 -47.95 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 118.885 0.766 . . . . 0.0 111.012 169.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -63.32 -33.8 76.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.578 1.151 . . . . 0.0 112.518 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -68.48 -41.37 80.22 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.34 -0.85 . . . . 0.0 112.295 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.62 -31.2 15.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -170.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.465 ' CD1' HG22 ' A' ' 78' ' ' ILE . 35.3 mm -96.35 119.14 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.78 1.173 . . . . 0.0 109.293 -171.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 132.54 -8.16 5.28 Favored Glycine 0 CA--C 1.541 1.719 0 C-N-CA 125.72 1.628 . . . . 0.0 113.626 -168.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -100.95 -13.88 18.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.502 1.921 . . . . 0.0 112.574 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.42 149.81 30.01 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.08 1.752 . . . . 0.0 111.539 -167.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.6 tp -17.46 -64.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.65 2.78 . . . . 0.0 114.411 170.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.29 19.1 13.4 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 116.333 -2.371 . . . . 0.0 115.868 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.3 t -115.47 118.19 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 121.683 2.742 . . . . 0.0 110.444 169.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -90.82 -40.54 11.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.777 0.831 . . . . 0.0 112.503 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.4 m -147.91 166.21 28.34 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.796 -1.19 . . . . 0.0 113.855 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.2 tp -126.82 145.67 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.996 1.318 . . . . 0.0 111.5 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -142.16 159.31 42.49 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.103 2.161 . . . . 0.0 109.774 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -140.71 144.29 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.338 -1.476 . . . . 0.0 112.206 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.0 m -138.77 58.32 1.66 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.184 1.394 . . . . 0.0 111.136 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.13 -30.14 69.09 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.817 2.047 . . . . 0.0 115.212 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -61.71 -20.36 63.4 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.654 1.116 . . . . 0.0 113.147 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -114.63 1.22 14.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.469 1.908 . . . . 0.0 112.303 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt 57.34 22.2 7.56 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.901 1.68 . . . . 0.0 112.876 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.77 153.13 18.06 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.343 1.068 . . . . 0.0 108.565 171.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.1 155.82 27.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 168.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.72 128.24 45.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -169.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -117.74 134.99 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 121.843 -0.535 . . . . 0.0 110.352 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -106.12 79.07 1.36 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -100.39 175.39 5.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.305 1.842 . . . . 0.0 109.53 -172.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.45 142.64 40.9 Favored Pre-proline 0 N--CA 1.477 0.89 0 CA-C-N 121.528 1.967 . . . . 0.0 111.501 168.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.89 5.67 6.28 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.972 2.448 . . . . 0.0 112.637 -172.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.2 t -87.39 -48.41 7.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.446 1.021 . . . . 0.0 110.168 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 85.1 m -101.3 -16.28 16.99 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.7 t -145.76 -178.35 6.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.381 1.072 . . . . 0.0 111.079 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 p -162.47 158.31 19.79 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.786 1.234 . . . . 0.0 111.83 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -46.79 -43.51 23.57 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.699 3.6 . . . . 0.0 116.368 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.8 m -70.64 -35.84 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.267 1.394 . . . . 0.0 112.388 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.42 85.45 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.153 0.981 . . . . 0.0 110.934 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.58 -48.2 73.16 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.257 1.023 . . . . 0.0 111.888 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -56.43 -52.06 66.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.121 0.873 . . . . 0.0 110.364 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -53.2 -42.95 66.79 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.649 1.18 . . . . 0.0 113.214 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.31 -59.24 2.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.602 1.161 . . . . 0.0 112.697 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.465 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.7 pt -71.94 -33.48 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -168.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -70.19 -12.01 61.29 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.26 0.624 . . . . 0.0 112.55 174.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.7 6.74 30.01 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.561 -1.337 . . . . 0.0 113.699 176.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt -56.42 -57.71 21.4 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.283 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.34 169.88 18.6 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.972 1.781 . . . . 0.0 110.459 168.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -76.21 55.65 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.269 3.313 . . . . 0.0 110.656 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.86 27.02 71.42 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.095 0.855 . . . . 0.0 113.898 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -100.46 -14.22 18.38 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 -167.018 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -135.26 114.03 11.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.051 1.34 . . . . 0.0 108.88 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -93.68 157.25 16.26 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.178 -0.951 . . . . 0.0 111.054 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.28 136.54 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 118.219 0.463 . . . . 0.0 111.859 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -111.38 121.54 45.49 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.195 0.998 . . . . 0.0 111.822 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.555 1.162 0 C-N-CA 128.241 2.617 . . . . 0.0 111.023 179.174 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.6 p -150.79 128.07 11.3 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.418 1.487 . . . . 0.0 113.609 -168.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.2 m -143.94 143.23 31.16 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.371 1.068 . . . . 0.0 111.649 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 84.8 m -100.2 144.31 29.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.546 0.738 . . . . 0.0 110.221 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.11 167.52 21.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.429 1.092 . . . . 0.0 110.903 166.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.04 133.45 55.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.457 1.903 . . . . 0.0 110.142 -176.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.7 mm -120.82 137.06 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.278 1.831 . . . . 0.0 109.306 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.03 125.44 48.72 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.957 1.303 . . . . 0.0 110.391 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.44 131.33 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.182 0.993 . . . . 0.0 111.52 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.44 53.68 0.87 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.815 1.646 . . . . 0.0 112.581 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.0 53.76 0.33 Allowed Glycine 0 N--CA 1.464 0.525 0 C-N-CA 124.926 1.251 . . . . 0.0 110.963 173.196 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.5 mtm -133.3 142.94 48.72 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.849 0.824 . . . . 0.0 112.01 -175.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 t -165.28 124.62 1.76 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.495 1.918 . . . . 0.0 107.775 -172.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 72.31 160.8 0.23 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.542 1.937 . . . . 0.0 115.409 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.42 -32.58 67.02 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.31 170.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 p -65.76 -28.37 68.98 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.601 -1.312 . . . . 0.0 112.837 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 52.2 t -68.4 -46.17 70.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.028 1.285 . . . . 0.0 111.154 170.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.1 t -52.78 -55.42 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.143 0.429 . . . . 0.0 110.085 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -71.17 -17.41 62.54 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -176.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 m -74.58 -47.41 32.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.071 0.948 . . . . 0.0 111.492 167.109 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.8 -54.19 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.795 -1.191 . . . . 0.0 110.69 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -55.06 -30.68 60.12 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.82 2.048 . . . . 0.0 111.866 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.86 -51.17 8.07 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.874 1.702 . . . . 0.0 113.851 173.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 79.5 mmm -74.97 -53.87 8.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.5 1.52 . . . . 0.0 114.049 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.2 mm -71.24 -19.38 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.458 1.103 . . . . 0.0 112.437 -169.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 65.6 p -70.64 0.6 6.6 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 171.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -121.55 33.71 5.43 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.19 10.79 6.91 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.669 2.099 . . . . 0.0 116.669 -172.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 76.2 118.81 0.05 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.922 2.489 . . . . 0.0 113.968 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 97.12 21.74 19.52 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.106 -1.385 . . . . 0.0 114.398 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.34 94.94 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.181 2.192 . . . . 0.0 110.251 -178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -75.62 -56.53 4.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.032 0.933 . . . . 0.0 111.776 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -141.9 129.94 22.0 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.227 1.411 . . . . 0.0 109.007 -172.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -140.88 129.11 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.907 1.283 . . . . 0.0 110.517 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.2 t -142.23 129.65 21.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.21 1.004 . . . . 0.0 111.527 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.03 139.27 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.113 1.765 . . . . 0.0 110.522 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 74.5 p -143.3 146.3 33.46 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.5 mt -72.77 -24.27 60.92 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.63 -42.57 71.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.147 1.779 . . . . 0.0 113.535 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -111.09 -13.36 14.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.552 1.141 . . . . 0.0 110.409 168.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.57 49.7 7.08 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 125.453 1.501 . . . . 0.0 110.653 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.1 p -138.56 147.09 42.65 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -168.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -113.7 139.38 49.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.98 1.712 . . . . 0.0 112.297 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 7.5 t -112.25 125.62 54.35 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 166.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.59 134.74 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 122.153 -0.342 . . . . 0.0 110.852 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.93 113.77 25.53 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.768 2.427 . . . . 0.0 106.402 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -111.71 163.0 14.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.247 1.019 . . . . 0.0 112.95 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -97.11 98.1 4.37 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.417 1.887 . . . . 0.0 109.171 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.87 -12.13 33.66 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.137 1.891 . . . . 0.0 115.148 -169.254 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.36 -24.25 46.54 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.329 0.968 . . . . 0.0 112.447 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.8 t -95.7 -50.83 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.926 1.69 . . . . 0.0 111.046 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.33 149.5 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 122.095 0.95 . . . . 0.0 112.231 -170.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.5 t -97.68 143.43 26.2 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.673 1.589 . . . . 0.0 112.295 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.75 -16.12 51.93 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.62 2.214 . . . . 0.0 113.91 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -70.31 -27.36 64.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.696 1.134 . . . . 0.0 111.388 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -76.29 -20.29 57.47 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.764 2.026 . . . . 0.0 112.664 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 97.0 mt -67.37 -56.03 11.38 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.937 0.895 . . . . 0.0 111.32 -175.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -56.6 -38.33 71.87 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.788 -0.57 . . . . 0.0 112.406 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.86 -28.41 68.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.942 0.897 . . . . 0.0 112.974 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.37 69.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.462 1.028 . . . . 0.0 112.907 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.5 mp -72.48 -40.47 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.078 0.951 . . . . 0.0 110.867 171.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.14 -26.34 65.73 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.806 -0.559 . . . . 0.0 112.173 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.73 -26.75 62.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.503 1.521 . . . . 0.0 112.396 169.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 23.1 ttt -75.19 -38.32 60.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.225 1.01 . . . . 0.0 111.75 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.04 11.4 1.06 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.179 1.371 . . . . 0.0 116.338 172.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -111.11 -165.64 1.01 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.459 1.504 . . . . 0.0 110.049 -176.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -125.19 133.47 52.74 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.367 1.067 . . . . 0.0 111.364 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -136.43 143.8 44.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.991 1.316 . . . . 0.0 112.52 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -129.57 139.72 51.41 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.139 1.376 . . . . 0.0 109.036 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.2 p -87.89 111.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 125.491 1.517 . . . . 0.0 107.787 -173.39 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 120.658 0.266 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -95.71 151.82 19.02 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.424 1.489 . . . . 0.0 111.11 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -137.47 128.38 27.31 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 127.03 2.132 . . . . 0.0 109.012 -172.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLN . . . . . 0.522 ' HG3' HG21 ' A' ' 59' ' ' THR . 3.5 tp-100 -103.89 115.54 30.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.088 0.858 . . . . 0.0 112.01 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.454 ' HB3' HD21 ' A' ' 90' ' ' LEU . 1.7 pt? -135.83 142.08 44.78 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -172.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -109.14 107.36 17.63 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.709 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mm -80.0 152.25 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.966 1.706 . . . . 0.0 111.415 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -105.18 140.37 38.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.383 1.473 . . . . 0.0 110.283 168.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.65 -8.96 76.49 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.908 1.242 . . . . 0.0 114.142 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 ptm -66.26 -6.32 13.45 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.284 1.542 . . . . 0.0 115.153 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.13 -24.08 66.94 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.169 -0.957 . . . . 0.0 110.834 165.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -99.5 114.91 28.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.577 1.551 . . . . 0.0 107.466 167.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -59.09 -30.78 68.34 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.633 -1.292 . . . . 0.0 112.213 -173.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.4 m -51.31 -21.91 2.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.641 1.576 . . . . 0.0 114.227 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.7 t -58.59 -49.36 77.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.618 1.167 . . . . 0.0 112.804 170.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -73.85 -28.22 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.49 -47.96 83.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.491 1.116 . . . . 0.0 111.468 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -41.59 76.66 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.505 -0.747 . . . . 0.0 111.309 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.4 mt -65.6 -47.03 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 122.947 0.499 . . . . 0.0 109.912 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HA ' HG21 ' A' ' 51' ' ' ILE . 14.9 tm-20 -65.9 -29.64 70.1 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.423 1.489 . . . . 0.0 113.32 -175.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.56 -52.09 24.02 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.829 -0.544 . . . . 0.0 112.401 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -91.63 -7.95 48.57 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -166.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.466 ' CD1' HG22 ' A' ' 78' ' ' ILE . 46.6 mm -122.48 128.62 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.089 1.356 . . . . 0.0 108.504 172.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.76 -5.33 4.05 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.94 1.257 . . . . 0.0 115.397 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -114.98 -5.47 12.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.394 1.477 . . . . 0.0 112.976 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.34 152.14 44.47 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.916 1.287 . . . . 0.0 111.605 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -48.29 -30.7 5.08 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.86 7.72 27.6 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 116.548 -2.251 . . . . 0.0 115.67 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.87 116.67 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 121.466 2.633 . . . . 0.0 110.414 169.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -71.89 -51.28 23.05 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.631 0.372 . . . . 0.0 110.203 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 p -151.08 155.23 38.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.542 1.137 . . . . 0.0 113.149 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.489 HG21 ' HA ' ' A' ' 39' ' ' GLU . 10.7 tp -98.26 155.07 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.083 1.353 . . . . 0.0 109.199 169.018 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -138.26 144.63 40.62 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.53 1.059 . . . . 0.0 111.117 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.9 t -108.38 127.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.315 1.446 . . . . 0.0 108.842 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.9 m -133.82 54.28 1.96 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.512 0.672 . . . . 0.0 111.967 -172.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.3 mt -68.66 -25.99 65.09 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.413 -1.429 . . . . 0.0 113.35 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -74.17 -17.65 60.88 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 171.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -95.7 -8.17 35.38 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.101 1.361 . . . . 0.0 110.81 168.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 mptt 74.89 14.2 3.28 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.975 2.51 . . . . 0.0 113.004 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.522 HG21 ' HG3' ' A' ' 23' ' ' GLN . 17.7 p -124.16 175.23 7.15 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.285 2.234 . . . . 0.0 110.331 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.96 167.58 10.14 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.035 1.334 . . . . 0.0 107.981 165.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -140.62 143.35 35.15 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.717 0.407 . . . . 0.0 110.932 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 p -140.31 133.48 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.545 0.611 . . . . 0.0 111.511 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.39 81.44 2.53 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.993 1.717 . . . . 0.0 108.519 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -101.32 148.82 24.69 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.103 1.361 . . . . 0.0 111.825 -174.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.26 122.09 49.55 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.719 0.808 . . . . 0.0 110.482 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -60.28 0.47 0.7 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 124.659 3.573 . . . . 0.0 115.252 173.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.4 m -65.39 -35.0 79.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.527 1.531 . . . . 0.0 112.79 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 81.7 m -122.32 -23.06 5.36 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -170.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -143.07 -178.24 5.74 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.213 1.405 . . . . 0.0 111.181 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.9 t -163.17 143.39 7.07 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.429 1.892 . . . . 0.0 109.344 -171.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -40.57 -49.31 4.16 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 125.007 3.804 . . . . 0.0 117.263 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.6 m -70.0 -36.65 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.327 1.421 . . . . 0.0 113.362 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.34 -36.31 66.14 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.242 1.017 . . . . 0.0 110.839 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -67.61 -48.87 65.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.733 2.013 . . . . 0.0 110.787 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -53.25 -52.97 57.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.3 1.04 . . . . 0.0 110.836 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -57.84 -38.67 76.05 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.341 1.057 . . . . 0.0 112.493 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.1 -43.51 74.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.581 0.752 . . . . 0.0 112.776 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.466 HG22 ' CD1' ' A' ' 42' ' ' ILE . 7.2 pt -74.56 -37.42 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.91 -33.64 75.75 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -171.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.37 12.93 23.1 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.2 mt -53.61 -47.58 96.04 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.194 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.45 169.93 16.55 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.289 2.659 . . . . 0.0 112.566 171.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.88 64.2 7.62 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 124.893 3.729 . . . . 0.0 110.037 169.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.57 23.48 72.13 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.324 1.44 . . . . 0.0 114.602 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -94.46 -30.81 14.25 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -167.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -122.2 115.96 23.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.706 1.202 . . . . 0.0 108.893 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.79 157.09 16.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.082 0.953 . . . . 0.0 111.842 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.5 t -112.01 137.92 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.725 0.81 . . . . 0.0 110.478 167.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.4 m -113.29 129.61 56.48 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.113 0.565 . . . . 0.0 111.042 166.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.454 HD21 ' HB3' ' A' ' 24' ' ' LEU . 14.4 mt . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 127.512 2.325 . . . . 0.0 112.398 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.732 0.301 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 121' ' ' CYS . . . . . 0.548 ' HB2' HD11 ' A' ' 165' ' ' LEU . 11.9 p 178.44 139.08 0.09 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.176 1.79 . . . . 0.0 113.269 -171.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 p -147.61 143.5 27.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.841 1.656 . . . . 0.0 111.515 168.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.78 147.26 24.57 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 120.058 1.299 . . . . 0.0 111.982 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.26 165.21 28.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.257 1.423 . . . . 0.0 113.127 173.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.17 135.36 46.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.683 1.993 . . . . 0.0 111.345 173.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.9 mm -120.34 136.12 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.716 1.206 . . . . 0.0 107.994 168.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.15 136.14 39.53 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.5 mt -130.07 142.21 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.707 -1.246 . . . . 0.0 110.884 -168.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.4 61.56 1.6 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.125 1.77 . . . . 0.0 112.939 -174.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.08 49.2 0.19 Allowed Glycine 0 N--CA 1.466 0.687 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.01 164.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 77.1 mtm -117.22 143.87 45.41 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.256 1.027 . . . . 0.0 111.505 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.0 t -159.82 127.45 4.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 127.185 2.194 . . . . 0.0 106.156 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 2.3 t 74.8 148.13 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.902 1.681 . . . . 0.0 113.034 -175.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.44 -29.6 49.94 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.453 -0.779 . . . . 0.0 112.29 171.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.9 p -61.93 -34.14 75.55 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.733 -1.23 . . . . 0.0 112.512 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 30.4 t -68.32 -37.56 80.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.305 1.411 . . . . 0.0 112.181 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 t -58.05 -56.52 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 118.883 -0.579 . . . . 0.0 109.888 169.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -62.95 -23.3 67.33 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.977 0.808 . . . . 0.0 112.798 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 m -70.33 -55.33 9.42 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.715 1.206 . . . . 0.0 111.966 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.86 -48.74 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 119.47 1.032 . . . . 0.0 110.837 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -60.42 -25.27 65.82 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.362 2.265 . . . . 0.0 111.844 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.5 -58.25 3.64 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 127.547 2.498 . . . . 0.0 114.094 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 21.5 mmt -71.73 -53.29 13.93 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.398 1.479 . . . . 0.0 113.204 -169.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.5 mm -66.0 -30.06 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.892 -0.505 . . . . 0.0 110.618 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.0 t -57.12 -19.71 21.52 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -96.69 17.38 16.61 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -167.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.89 169.59 9.74 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.476 1.51 . . . . 0.0 110.55 169.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -64.32 163.35 13.15 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.935 1.35 . . . . 0.0 114.501 -171.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.07 -32.21 1.31 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.62 1.581 . . . . 0.0 116.788 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.9 p -78.0 97.6 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 119.968 1.884 . . . . 0.0 112.935 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLN . . . . . 0.517 ' HB3' HD12 ' A' ' 165' ' ' LEU . 26.8 tt0 -76.66 -39.27 52.75 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.982 1.313 . . . . 0.0 112.84 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -144.58 140.75 28.97 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.33 1.052 . . . . 0.0 110.099 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -144.96 129.85 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 119.306 0.957 . . . . 0.0 111.571 172.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.19 124.6 20.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.699 1.2 . . . . 0.0 110.677 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.6 t -126.53 149.64 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 120.616 -1.302 . . . . 0.0 110.279 -169.69 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.7 t -142.94 145.47 33.05 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.185 0.993 . . . . 0.0 112.943 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.01 -18.33 61.97 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.525 1.93 . . . . 0.0 114.362 171.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.88 -48.24 67.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.227 1.411 . . . . 0.0 111.949 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -108.7 -17.47 13.94 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.27 1.828 . . . . 0.0 111.949 170.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.73 50.97 5.03 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.084 1.326 . . . . 0.0 111.622 -171.186 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 43.0 p -138.79 147.68 42.87 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.397 1.099 . . . . 0.0 113.677 -169.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -111.2 134.89 52.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.213 1.805 . . . . 0.0 111.402 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.1 t -109.07 118.37 36.59 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.5 138.21 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -167.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 121' ' ' CYS . 0.4 OUTLIER -96.8 118.73 33.88 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.079 2.152 . . . . 0.0 108.1 175.675 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -119.08 158.42 25.89 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.649 1.179 . . . . 0.0 112.45 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -95.69 115.06 65.22 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.066 1.346 . . . . 0.0 108.568 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.59 -6.7 17.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.41 2.74 . . . . 0.0 113.798 -170.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.06 -45.59 10.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.077 0.951 . . . . 0.0 112.007 169.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 72.2 t -83.38 -28.57 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.343 1.457 . . . . 0.0 112.52 -171.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 tt -147.27 144.87 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.517 1.127 . . . . 0.0 110.558 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.3 m -106.42 147.94 35.83 Favored Pre-proline 0 CA--C 1.551 1.002 0 O-C-N 121.244 -0.91 . . . . 0.0 111.319 173.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -53.53 -32.49 63.77 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.712 3.608 . . . . 0.0 116.177 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.53 -27.73 64.79 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.47 -32.99 66.68 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 112.241 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 65.6 mt -59.09 -50.47 73.93 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.616 1.166 . . . . 0.0 108.977 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -54.23 -48.35 71.19 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.95 1.3 . . . . 0.0 111.86 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.6 -30.48 71.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.71 -32.83 71.62 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.087 0.955 . . . . 0.0 112.938 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.6 mt -74.55 -32.9 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.195 0.998 . . . . 0.0 112.093 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -68.25 -34.13 75.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.899 0.772 . . . . 0.0 111.525 168.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.33 -30.01 70.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.429 1.091 . . . . 0.0 112.445 171.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.4 ttt -75.4 -28.73 59.57 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.351 -0.843 . . . . 0.0 112.491 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 116.82 30.56 1.95 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.648 1.594 . . . . 0.0 115.32 169.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -125.66 -156.88 0.76 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.466 1.507 . . . . 0.0 109.379 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -133.68 147.14 51.37 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.998 -1.064 . . . . 0.0 111.118 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.42 136.35 34.59 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.119 1.368 . . . . 0.0 112.592 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -114.45 125.91 54.36 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.344 1.858 . . . . 0.0 110.231 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.84 59.78 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.482 1.134 . . . . 0.0 109.759 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.014 0.925 . . . . 0.0 111.857 -169.782 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 122.084 0.945 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 m -109.21 135.1 50.87 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.846 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.288 0.1 OUTLIER -134.5 160.08 39.13 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.326 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -120.05 134.79 55.15 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.529 2.332 . . . . 0.0 108.563 -171.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 pp -146.49 160.52 42.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -102.04 155.64 18.05 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.67 1.188 . . . . 0.0 110.439 168.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.9 mt -135.16 141.29 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 126.658 1.983 . . . . 0.0 110.822 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -97.22 129.9 44.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.366 1.466 . . . . 0.0 109.195 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.24 -19.65 50.49 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.181 1.372 . . . . 0.0 113.627 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -14.01 56.46 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.426 1.613 . . . . 0.0 113.224 174.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -49.37 -37.45 24.98 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.766 1.627 . . . . 0.0 111.859 166.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 93.1 m -78.76 -1.11 33.13 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 71.25 -60.21 0.52 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 129.162 2.985 . . . . 0.0 112.19 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -53.03 -27.57 20.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.91 1.684 . . . . 0.0 114.551 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -46.68 -37.85 8.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.909 1.684 . . . . 0.0 112.985 169.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -19.07 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.421 HD13 ' C ' ' A' ' 36' ' ' LEU . 3.1 tm? -69.67 -54.09 15.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 112.143 -171.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.2 -28.59 69.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.311 1.044 . . . . 0.0 111.894 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.3 mt -65.5 -56.08 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 118.895 0.77 . . . . 0.0 109.734 167.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -39.77 61.17 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.237 1.415 . . . . 0.0 112.506 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.28 -40.94 97.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.347 0.659 . . . . 0.0 112.554 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -90.82 -28.44 18.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.594 1.158 . . . . 0.0 113.209 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.467 ' CD1' HG22 ' A' ' 78' ' ' ILE . 34.3 mm -97.46 117.49 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.149 -0.969 . . . . 0.0 109.235 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.64 -17.17 7.35 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.031 1.3 . . . . 0.0 115.648 -172.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -96.49 0.74 50.7 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.506 1.153 . . . . 0.0 113.228 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.4 mt -92.08 154.63 18.61 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.676 1.59 . . . . 0.0 113.081 -169.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -51.27 -34.18 31.73 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.59 4.87 31.06 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.715 -1.603 . . . . 0.0 115.845 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.3 t -134.32 119.62 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 120.905 2.353 . . . . 0.0 109.73 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 -26.81 13.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -169.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.3 p -149.11 173.18 13.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.69 1.196 . . . . 0.0 111.17 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 tp -138.78 145.95 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.054 0.942 . . . . 0.0 110.082 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -134.78 148.17 50.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.353 1.461 . . . . 0.0 108.394 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.92 150.62 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.624 -1.297 . . . . 0.0 110.762 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.2 t -141.45 58.36 1.51 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 122.881 1.324 . . . . 0.0 110.405 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.2 mt -69.83 -26.98 64.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.56 1.544 . . . . 0.0 113.641 -169.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.48 -24.02 63.72 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.34 1.456 . . . . 0.0 113.206 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -91.25 -25.11 19.64 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.751 1.62 . . . . 0.0 111.429 169.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 98.21 3.93 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.037 1 C-N-CA 132.577 4.351 . . . . 0.0 111.961 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.3 p -107.61 166.99 10.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.855 1.262 . . . . 0.0 112.578 -172.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.42 145.0 39.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.189 0.995 . . . . 0.0 108.534 167.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.407 HE21 ' HA ' ' A' ' 61' ' ' GLN . 2.9 tp60 -124.82 106.31 9.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.806 1.242 . . . . 0.0 110.695 -169.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.3 143.53 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-O 121.188 0.518 . . . . 0.0 111.826 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -114.43 90.36 3.32 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.858 2.063 . . . . 0.0 107.235 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -115.62 154.42 29.49 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -166.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.22 117.51 65.57 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.848 2.059 . . . . 0.0 109.286 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.65 5.6 2.38 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.368 2.712 . . . . 0.0 114.672 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 p -84.81 -30.26 24.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.694 1.198 . . . . 0.0 113.585 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 64.1 m -113.43 -21.89 10.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.439 1.095 . . . . 0.0 113.63 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.9 t -144.41 179.81 7.02 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 122.067 0.937 . . . . 0.0 111.943 -169.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.8 p -166.03 164.7 11.21 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.878 2.071 . . . . 0.0 109.476 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.86 -49.25 16.53 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.334 2.689 . . . . 0.0 114.546 -174.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.33 -38.22 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.13 75.09 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.588 -0.695 . . . . 0.0 111.442 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.6 mt -58.8 -53.34 59.46 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.561 1.544 . . . . 0.0 110.408 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 4.0 tt0 -50.8 -53.26 33.48 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.652 1.181 . . . . 0.0 110.758 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -25.76 64.58 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.6 -60.28 2.31 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.166 1.348 . . . . 0.0 111.349 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.467 HG22 ' CD1' ' A' ' 42' ' ' ILE . 7.9 pt -72.23 -32.22 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.84 -19.42 65.87 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.06 0.845 . . . . 0.0 112.92 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.37 10.42 39.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.1 mt -60.22 -50.56 85.45 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.76 165.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.05 172.79 12.58 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.084 2.522 . . . . 0.0 112.071 171.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.78 65.47 7.59 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 124.609 3.54 . . . . 0.0 110.627 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.7 33.15 81.36 Favored Glycine 0 N--CA 1.473 1.154 0 O-C-N 121.246 -0.909 . . . . 0.0 112.95 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -107.05 -19.49 13.6 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -166.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -130.47 105.85 8.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.293 1.437 . . . . 0.0 108.603 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -99.07 136.11 39.52 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.913 1.285 . . . . 0.0 112.372 -169.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 m -99.17 156.72 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.735 1.152 . . . . 0.0 112.737 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.6 m -134.72 116.93 15.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.44 1.096 . . . . 0.0 110.159 167.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 126.896 2.078 . . . . 0.0 110.594 -178.226 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 27.6 p -144.21 145.69 32.23 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -168.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.7 t -146.43 160.0 42.66 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.543 1.937 . . . . 0.0 109.407 167.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.55 138.12 54.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.289 0.636 . . . . 0.0 109.659 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.78 160.0 41.17 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.955 0.798 . . . . 0.0 112.778 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 tt -116.26 140.41 49.35 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.752 1.621 . . . . 0.0 110.248 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 mm -127.34 139.85 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 127.647 2.379 . . . . 0.0 108.777 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -104.57 133.58 49.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.913 1.285 . . . . 0.0 110.261 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.27 137.67 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 120.533 -1.354 . . . . 0.0 110.913 -173.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.45 58.55 1.13 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.314 1.845 . . . . 0.0 111.554 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.34 55.86 0.24 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 125.222 1.391 . . . . 0.0 111.183 168.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 64.7 mtm -131.94 111.57 11.67 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.738 1.215 . . . . 0.0 109.495 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.9 t -116.0 -12.17 11.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.241 1.816 . . . . 0.0 112.989 -169.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 52.7 m -156.04 161.5 40.43 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.773 2.429 . . . . 0.0 110.398 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.64 -31.06 65.9 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.864 -1.147 . . . . 0.0 113.947 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 17.0 p -53.65 -22.26 8.47 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.364 1.466 . . . . 0.0 114.626 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 75.4 m -56.15 -36.75 68.65 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.37 -0.831 . . . . 0.0 111.97 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.83 -53.43 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.793 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -69.14 -24.04 64.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.093 0.86 . . . . 0.0 111.55 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.1 m -72.54 -51.75 18.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.323 1.449 . . . . 0.0 111.598 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.5 mt -68.87 -55.45 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 121.008 -1.057 . . . . 0.0 111.296 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -55.13 -30.73 60.39 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.704 1.202 . . . . 0.0 111.059 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.17 -62.12 2.68 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.021 1.296 . . . . 0.0 114.505 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 94.2 mmm -71.31 -38.21 71.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -169.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.1 mm -72.53 -23.95 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.056 0.542 . . . . 0.0 111.353 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.6 t -67.22 1.69 1.99 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -106.23 -3.54 21.19 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -169.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.12 17.08 24.71 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.69 2.108 . . . . 0.0 116.69 -168.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 77.76 160.59 0.21 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 127.456 2.303 . . . . 0.0 112.663 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.73 -24.46 0.29 Allowed Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.48 -1.388 . . . . 0.0 115.811 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.85 96.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 127.79 2.436 . . . . 0.0 111.165 172.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -79.74 -47.43 15.29 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.779 0.832 . . . . 0.0 111.946 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -143.97 137.07 27.49 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.688 0.795 . . . . 0.0 110.414 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.36 134.39 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.849 -1.157 . . . . 0.0 110.933 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 30.0 t -139.24 141.39 37.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.881 1.672 . . . . 0.0 109.205 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.27 142.68 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.706 1.202 . . . . 0.0 112.015 -176.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.0 t -140.58 139.23 34.91 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.441 1.096 . . . . 0.0 112.736 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.08 -17.18 62.01 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.266 1.826 . . . . 0.0 115.44 174.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.26 -42.54 77.55 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.021 1.328 . . . . 0.0 112.836 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -113.17 -8.39 13.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.749 1.619 . . . . 0.0 111.355 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 76.45 48.39 9.29 Favored Glycine 0 C--N 1.343 0.949 0 C-N-CA 125.289 1.423 . . . . 0.0 112.619 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 p -141.14 146.42 37.0 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -167.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -115.22 150.93 35.37 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.175 1.79 . . . . 0.0 111.844 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.7 t -125.11 130.03 51.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.479 1.512 . . . . 0.0 108.695 169.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.75 136.85 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.741 -0.599 . . . . 0.0 111.211 -169.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.57 112.96 24.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.876 2.471 . . . . 0.0 106.628 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -118.97 158.98 24.69 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.628 1.171 . . . . 0.0 112.506 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -93.46 112.94 58.72 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.773 1.229 . . . . 0.0 108.18 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.51 -11.17 18.85 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.218 2.612 . . . . 0.0 113.005 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.07 -45.97 31.46 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.851 1.205 . . . . 0.0 110.7 168.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 69.8 t -79.5 -42.43 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.369 1.467 . . . . 0.0 113.431 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.4 tt -140.35 150.44 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.211 0.914 . . . . 0.0 113.254 -169.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 60.0 m -112.76 150.71 43.19 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.285 1.434 . . . . 0.0 112.005 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.69 -41.16 38.35 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.424 3.416 . . . . 0.0 115.009 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.43 -20.27 65.42 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.36 -31.91 60.68 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.104 1.362 . . . . 0.0 113.735 170.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 73.5 mt -60.0 -50.73 72.59 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.033 0.933 . . . . 0.0 108.876 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -51.69 -51.01 59.28 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.195 0.998 . . . . 0.0 111.522 173.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.2 -31.67 65.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.14 -38.98 69.1 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.155 0.982 . . . . 0.0 113.265 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.1 mp -70.24 -35.53 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.55 -0.718 . . . . 0.0 110.498 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.0 -36.19 83.19 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.881 -0.512 . . . . 0.0 111.739 172.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -71.89 -29.5 64.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.155 1.782 . . . . 0.0 113.797 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 18.1 ttt -65.92 -30.17 70.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.322 1.049 . . . . 0.0 111.953 172.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 124.3 13.8 3.83 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.943 1.735 . . . . 0.0 115.362 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -119.75 -156.46 0.66 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.158 1.383 . . . . 0.0 109.568 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -136.06 137.47 41.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.928 1.291 . . . . 0.0 109.009 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -131.75 156.21 46.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.065 1.346 . . . . 0.0 111.627 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.1 t -141.96 140.57 32.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.27 1.828 . . . . 0.0 109.218 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.4 m -96.05 121.56 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.452 -0.78 . . . . 0.0 110.059 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 123.327 1.537 . . . . 0.0 110.829 -177.307 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.69 153.03 18.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.237 1.415 . . . . 0.0 110.53 171.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tt -145.64 135.5 23.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.733 1.613 . . . . 0.0 110.88 -172.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -98.27 123.54 42.41 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.793 -0.567 . . . . 0.0 111.596 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.47 138.67 27.81 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.334 1.054 . . . . 0.0 113.593 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -97.64 123.8 41.68 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.9 mt -95.37 138.63 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.417 1.487 . . . . 0.0 107.631 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -95.54 142.78 27.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.548 1.139 . . . . 0.0 110.598 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.94 -4.73 83.36 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.661 1.124 . . . . 0.0 113.953 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.7 ptp -68.44 0.09 4.37 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -63.94 -13.77 48.49 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.543 1.065 . . . . 0.0 113.213 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.9 t -105.33 125.33 50.86 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.239 1.381 . . . . 0.0 107.795 165.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.73 -31.16 47.27 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.838 1.255 . . . . 0.0 114.021 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.7 m -63.34 -21.87 66.53 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.042 -1.036 . . . . 0.0 113.079 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 63.5 m -71.86 -47.21 54.57 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.095 0.861 . . . . 0.0 111.881 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.4 -23.09 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.108 0.867 . . . . 0.0 112.427 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.8 -61.35 2.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.123 0.969 . . . . 0.0 111.854 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.03 -26.4 68.22 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.532 -0.73 . . . . 0.0 112.824 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mt -65.93 -53.07 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 120.506 -1.371 . . . . 0.0 110.521 169.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.86 -30.07 69.9 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.836 1.255 . . . . 0.0 112.305 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.0 -39.78 75.67 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.008 -1.057 . . . . 0.0 112.546 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -93.69 -19.92 20.64 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.587 HD12 HG22 ' A' ' 78' ' ' ILE . 38.5 mm -102.81 123.6 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 122.314 1.054 . . . . 0.0 111.55 -172.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.37 -10.09 2.97 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.105 1.812 . . . . 0.0 114.57 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -109.5 4.55 22.42 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.839 1.656 . . . . 0.0 113.101 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.13 176.39 8.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.394 1.078 . . . . 0.0 112.216 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.7 tp -38.24 -64.2 0.43 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.325 2.25 . . . . 0.0 114.058 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.7 -12.83 7.66 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 117.073 -1.959 . . . . 0.0 115.643 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.34 112.72 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-N 121.57 2.685 . . . . 0.0 109.438 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -95.32 -35.45 11.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.073 1.349 . . . . 0.0 112.099 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 t -145.18 169.57 17.92 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.853 0.835 . . . . 0.0 112.523 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.3 tp -138.16 144.83 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.115 1.766 . . . . 0.0 108.96 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -142.63 157.93 44.18 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.083 1.753 . . . . 0.0 108.784 -172.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 m -127.53 138.69 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 120.348 -1.47 . . . . 0.0 111.931 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.2 m -124.48 56.52 1.28 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.746 1.619 . . . . 0.0 107.855 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -65.36 -30.69 71.55 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.56 -16.91 62.33 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -95.1 -5.67 43.73 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.314 1.445 . . . . 0.0 111.726 169.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt 73.39 7.38 5.18 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.022 2.529 . . . . 0.0 112.214 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.9 p -110.94 167.07 10.52 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.022 2.129 . . . . 0.0 110.787 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.97 -179.7 4.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.067 165.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -143.86 133.22 23.27 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.175 -0.953 . . . . 0.0 109.594 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.94 137.36 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.38 0.991 . . . . 0.0 111.387 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -114.71 87.11 2.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.666 1.586 . . . . 0.0 108.37 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -119.65 155.12 32.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.768 1.227 . . . . 0.0 113.478 -171.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -96.57 113.27 62.33 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.617 1.967 . . . . 0.0 109.375 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.62 -6.89 20.1 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.353 2.702 . . . . 0.0 112.88 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 t -86.08 -5.98 59.11 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.268 1.027 . . . . 0.0 111.988 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 94.2 m -119.03 -42.4 2.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.257 1.423 . . . . 0.0 113.464 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -128.51 -176.31 3.79 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.672 1.589 . . . . 0.0 110.232 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.94 154.2 18.15 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.24 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.05 -56.88 2.4 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.069 3.179 . . . . 0.0 116.21 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.7 -36.05 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 121.059 1.754 . . . . 0.0 113.438 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.43 -41.12 61.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.222 1.009 . . . . 0.0 111.909 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -36.17 74.44 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.719 1.208 . . . . 0.0 110.886 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -66.89 -47.69 71.04 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.365 -0.834 . . . . 0.0 111.327 175.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.6 mtt85 -59.65 -28.86 67.61 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.343 1.057 . . . . 0.0 112.937 172.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.71 -56.06 12.26 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.069 0.85 . . . . 0.0 111.51 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.587 HG22 HD12 ' A' ' 42' ' ' ILE . 6.0 pt -72.47 -33.47 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -68.77 -17.99 64.13 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.35 8.13 44.94 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 120.691 -1.256 . . . . 0.0 113.977 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.5 mt -59.36 -51.06 84.11 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.018 166.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.15 173.73 12.26 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.026 2.484 . . . . 0.0 111.1 168.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -75.18 52.1 3.03 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.418 3.412 . . . . 0.0 111.486 169.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.64 37.64 92.63 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 124.803 1.192 . . . . 0.0 112.09 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -102.26 -46.45 4.81 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -168.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -97.72 101.02 12.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.229 1.412 . . . . 0.0 107.402 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -99.72 144.4 28.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -167.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.0 138.56 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.722 0.809 . . . . 0.0 111.744 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -133.55 121.1 21.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.549 1.14 . . . . 0.0 112.121 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.549 0.91 0 C-N-CA 126.223 1.809 . . . . 0.0 112.254 173.234 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 95.3 m -143.02 136.02 28.0 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.366 1.466 . . . . 0.0 112.541 -174.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.8 t -143.97 154.89 43.77 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.403 1.881 . . . . 0.0 109.229 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.4 m -114.53 141.16 48.09 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.634 0.652 . . . . 0.0 110.051 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.12 157.35 44.99 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.519 0.676 . . . . 0.0 112.415 168.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.32 136.36 41.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.357 1.863 . . . . 0.0 110.029 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.7 mt -127.92 133.68 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.717 1.607 . . . . 0.0 109.06 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.68 143.05 30.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.434 1.094 . . . . 0.0 109.842 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.04 131.8 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 119.395 0.998 . . . . 0.0 112.024 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.3 80.72 1.99 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.474 1.51 . . . . 0.0 111.998 173.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 178.49 55.01 0.07 OUTLIER Glycine 0 N--CA 1.467 0.766 0 C-N-CA 124.543 1.068 . . . . 0.0 113.996 165.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -137.41 145.47 43.24 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.4 t -151.72 -28.2 0.18 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.623 1.969 . . . . 0.0 112.387 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 77.4 m -125.76 136.73 53.49 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.968 1.707 . . . . 0.0 111.637 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.65 -27.38 6.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.517 1.527 . . . . 0.0 114.529 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.7 p -55.53 -31.64 62.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.14 1.376 . . . . 0.0 113.241 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 t -62.04 -19.44 62.89 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.95 -59.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.636 -0.665 . . . . 0.0 109.972 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -22.37 66.71 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 118.434 0.561 . . . . 0.0 112.155 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.0 m -72.24 -60.49 2.21 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.981 1.313 . . . . 0.0 112.893 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 94.4 mt -67.13 -54.48 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 120.362 1.437 . . . . 0.0 110.583 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.28 -29.96 67.95 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.792 1.237 . . . . 0.0 111.304 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.63 -62.57 2.66 Favored Glycine 0 C--N 1.343 0.948 0 C-N-CA 124.226 0.917 . . . . 0.0 113.998 173.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 82.1 mmm -70.03 -36.26 74.92 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -168.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.0 mm -68.02 -31.55 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 118.317 0.508 . . . . 0.0 110.659 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -66.11 -0.42 2.45 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -92.59 -7.38 47.27 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.389 -1.444 . . . . 0.0 113.915 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 pp -99.91 170.18 8.7 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.723 1.209 . . . . 0.0 112.046 171.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -79.05 166.34 22.42 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.76 -34.3 0.6 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.779 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.31 91.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 119.448 1.624 . . . . 0.0 110.601 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -72.71 -45.67 57.59 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.114 1.366 . . . . 0.0 111.819 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -143.3 143.49 31.72 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.455 0.702 . . . . 0.0 109.175 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -142.06 138.68 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 0.0 110.462 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 67.6 m -138.52 108.67 6.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.847 1.259 . . . . 0.0 109.701 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.71 133.9 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.728 -1.232 . . . . 0.0 110.519 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.2 t -119.71 93.33 4.03 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.142 2.177 . . . . 0.0 107.457 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.0 tt -66.83 -29.23 69.1 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.013 0.925 . . . . 0.0 110.597 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -49.6 -39.82 36.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.366 2.266 . . . . 0.0 113.629 167.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -100.26 -13.29 18.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.614 1.966 . . . . 0.0 112.123 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.76 26.93 73.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 127.735 2.588 . . . . 0.0 113.344 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.0 p -129.28 143.25 50.78 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.662 1.231 . . . . 0.0 114.27 -168.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.2 131.33 51.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.47 1.508 . . . . 0.0 109.505 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.9 t -113.55 124.09 51.55 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.66 139.83 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -165.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.25 111.22 23.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.68 2.392 . . . . 0.0 107.422 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -120.62 156.12 32.33 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.602 1.161 . . . . 0.0 112.685 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -98.6 109.8 54.43 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.695 1.198 . . . . 0.0 111.014 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.58 -13.43 30.02 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.206 2.604 . . . . 0.0 112.616 -172.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.36 -13.84 58.83 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.463 1.028 . . . . 0.0 113.719 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.3 t -118.63 -33.85 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.91 1.284 . . . . 0.0 112.481 -170.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.27 151.17 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.851 1.26 . . . . 0.0 110.504 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.5 t -104.7 144.17 28.19 Favored Pre-proline 0 N--CA 1.477 0.894 0 O-C-N 120.951 -1.093 . . . . 0.0 110.978 169.365 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.69 -27.86 27.77 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.698 2.932 . . . . 0.0 114.358 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -70.43 -41.73 72.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.534 0.606 . . . . 0.0 111.386 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.57 -28.05 58.83 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 170.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.49 -55.16 38.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.598 1.559 . . . . 0.0 110.4 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.08 -30.36 70.95 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.402 -0.811 . . . . 0.0 112.533 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.85 -16.12 63.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.08 62.16 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.361 0.982 . . . . 0.0 112.232 171.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.5 mp -71.84 -33.73 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.027 0.931 . . . . 0.0 110.461 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -66.37 -31.04 71.56 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.939 0.791 . . . . 0.0 112.084 170.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -70.86 -29.96 66.22 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 120.593 -1.317 . . . . 0.0 112.137 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 10.6 ttt -71.85 -27.44 62.89 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.679 1.192 . . . . 0.0 111.725 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 124.23 14.2 3.74 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.362 1.934 . . . . 0.0 116.886 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -128.03 147.09 50.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.828 1.314 . . . . 0.0 111.046 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -95.17 101.01 12.73 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 123.414 1.578 . . . . 0.0 110.525 -170.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -98.42 143.99 28.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 112.54 -2.118 . . . . 0.0 111.529 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.4 t -141.28 132.22 26.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.538 1.535 . . . . 0.0 111.812 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.8 m -86.04 72.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.329 1.052 . . . . 0.0 110.533 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.477 0.882 0 C-N-CA 124.2 1.0 . . . . 0.0 111.375 178.677 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 p -96.65 146.02 25.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.56 1.544 . . . . 0.0 112.192 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.95 126.44 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.935 1.694 . . . . 0.0 109.654 174.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.19 131.69 45.05 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.807 1.243 . . . . 0.0 110.192 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 155.48 43.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.977 169.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.91 129.66 46.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.704 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 mt -104.27 147.04 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.835 1.254 . . . . 0.0 110.923 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 87' ' ' LYS . 36.6 t70 -96.18 140.33 31.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.956 2.102 . . . . 0.0 110.575 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.8 -8.13 73.8 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.641 1.115 . . . . 0.0 113.696 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 13.2 ptp -66.08 -13.25 59.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -54.23 -32.12 55.11 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.145 0.884 . . . . 0.0 111.85 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.61 -17.45 62.89 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm 76.31 -57.17 0.56 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.76 2.824 . . . . 0.0 112.394 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.4 p -53.79 -23.04 10.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.906 1.282 . . . . 0.0 113.822 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.5 t -47.17 -46.92 24.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.147 1.779 . . . . 0.0 111.949 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.17 -17.57 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.19 -56.25 10.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.464 1.106 . . . . 0.0 110.339 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -36.87 73.61 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.688 -0.632 . . . . 0.0 111.434 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mt -62.28 -48.19 89.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.525 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.17 -36.14 76.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.865 1.266 . . . . 0.0 112.849 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -64.95 -40.4 94.97 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.33 -0.856 . . . . 0.0 112.351 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -91.45 -35.58 14.26 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -172.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.457 ' CD1' HG22 ' A' ' 78' ' ' ILE . 38.5 mm -99.28 113.28 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.417 1.008 . . . . 0.0 110.686 -168.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.96 -21.68 0.89 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.477 1.037 . . . . 0.0 115.136 -170.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -108.92 -5.09 16.28 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.362 1.081 . . . . 0.0 113.34 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.72 153.12 43.82 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.992 1.717 . . . . 0.0 111.069 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.8 tp -11.12 -69.88 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 128.827 2.851 . . . . 0.0 114.642 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.48 9.76 22.01 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 115.734 -2.704 . . . . 0.0 117.469 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.42 130.62 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 123.117 3.459 . . . . 0.0 108.434 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -100.13 -43.69 6.24 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.174 0.59 . . . . 0.0 111.261 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 p -148.98 164.02 35.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.479 1.112 . . . . 0.0 113.028 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 tp -120.82 149.76 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.177 1.391 . . . . 0.0 111.625 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -142.64 154.4 44.33 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.259 1.824 . . . . 0.0 110.157 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.4 t -133.12 137.68 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 120.793 -1.192 . . . . 0.0 110.446 -171.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t -134.35 55.26 1.9 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.542 1.537 . . . . 0.0 109.435 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -33.36 74.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.91 1.684 . . . . 0.0 112.952 -169.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -47.89 -34.95 9.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.766 2.026 . . . . 0.0 112.504 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -116.53 23.22 12.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.023 1.329 . . . . 0.0 112.497 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.5 mttp 67.37 9.7 7.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.287 2.635 . . . . 0.0 115.481 169.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 p -107.96 145.36 33.95 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.72 1.208 . . . . 0.0 112.44 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.19 157.93 16.94 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.613 1.165 . . . . 0.0 108.764 167.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -139.81 118.46 12.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.487 0.315 . . . . 0.0 110.263 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.8 p -114.24 132.55 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.782 -0.574 . . . . 0.0 111.11 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.11 93.4 5.7 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.595 1.158 . . . . 0.0 109.008 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -118.19 152.44 35.66 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.353 1.061 . . . . 0.0 112.45 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -100.33 114.98 65.89 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.715 1.606 . . . . 0.0 109.829 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.67 5.69 3.21 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.359 3.372 . . . . 0.0 113.955 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 t -68.0 -34.79 77.19 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.026 0.93 . . . . 0.0 111.444 171.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 74.9 m -114.94 -25.42 8.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -168.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -144.4 -178.38 5.95 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.929 1.291 . . . . 0.0 111.839 -173.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.6 p -152.6 161.06 30.25 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.57 1.548 . . . . 0.0 111.919 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.72 -46.46 24.26 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.547 2.831 . . . . 0.0 115.137 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.3 m -70.21 -33.52 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.208 1.367 . . . . 0.0 113.262 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.86 -38.0 79.47 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.6 -0.688 . . . . 0.0 111.419 175.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.36 -44.09 79.85 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.335 1.054 . . . . 0.0 111.409 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.9 tt0 -53.66 -55.66 24.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.303 1.041 . . . . 0.0 110.557 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -52.79 -48.34 66.94 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.52 0.728 . . . . 0.0 112.714 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.36 -58.44 8.59 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.608 0.763 . . . . 0.0 111.935 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.457 HG22 ' CD1' ' A' ' 42' ' ' ILE . 5.8 pt -74.31 -31.13 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.65 -39.12 67.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.483 1.113 . . . . 0.0 112.533 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.23 23.08 9.62 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.0 mt -60.16 -55.41 45.64 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.483 164.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.77 170.9 17.61 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.696 2.931 . . . . 0.0 112.163 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.59 35.79 0.33 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 125.03 3.82 . . . . 0.0 112.903 171.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.28 28.02 34.8 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.191 1.377 . . . . 0.0 113.115 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -104.02 -42.74 5.47 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -168.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -96.35 117.07 30.08 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.434 ' H ' ' HB3' ' A' ' 27' ' ' ASP . 16.1 ttmm -102.16 135.51 43.62 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.363 1.865 . . . . 0.0 111.733 -173.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.66 150.25 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.868 1.213 . . . . 0.0 111.675 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.1 t -134.13 107.98 8.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.235 1.414 . . . . 0.0 110.067 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.549 0.905 0 CA-C-N 114.482 -1.235 . . . . 0.0 113.113 -174.744 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.512 ' HB2' HD11 ' A' ' 165' ' ' LEU . 29.1 p -155.75 142.48 18.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.502 1.121 . . . . 0.0 112.544 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.8 t -142.9 160.17 40.84 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.948 1.699 . . . . 0.0 109.547 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 98.4 m -113.07 143.55 44.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.783 0.833 . . . . 0.0 109.484 171.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.71 165.29 27.89 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.687 0.795 . . . . 0.0 111.457 167.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -119.87 130.33 54.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.858 1.663 . . . . 0.0 110.048 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.47 140.88 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 126.292 1.837 . . . . 0.0 108.694 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.22 132.24 52.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.723 1.609 . . . . 0.0 109.952 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.86 136.79 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.214 1.006 . . . . 0.0 110.3 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.79 57.91 1.43 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.994 1.718 . . . . 0.0 112.715 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.58 52.23 0.31 Allowed Glycine 0 N--CA 1.467 0.739 0 C-N-CA 124.387 0.994 . . . . 0.0 112.533 168.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 68.0 mtm -131.71 150.86 52.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.471 1.108 . . . . 0.0 110.862 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.8 t -157.39 -30.46 0.08 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.039 1.336 . . . . 0.0 111.877 -168.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 64.7 m -128.28 140.7 51.74 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.036 1.734 . . . . 0.0 111.948 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -48.58 -33.86 10.51 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.162 1.785 . . . . 0.0 114.246 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.9 p -50.35 -32.29 16.92 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.422 1.089 . . . . 0.0 113.754 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 11.5 t -61.36 -21.87 64.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.3 t -59.5 -60.23 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 119.423 1.011 . . . . 0.0 109.54 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -62.48 -27.74 69.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.029 0.532 . . . . 0.0 111.772 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.7 m -71.71 -46.8 57.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.75 0.82 . . . . 0.0 113.139 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 79.3 mt -68.06 -54.37 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.986 1.266 . . . . 0.0 110.081 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -52.31 -31.8 34.75 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.624 1.57 . . . . 0.0 112.03 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.14 -61.87 2.57 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.632 1.587 . . . . 0.0 115.694 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 92.9 mmm -73.38 -35.1 65.87 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.5 mm -71.29 -29.07 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 121.778 -0.576 . . . . 0.0 111.272 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.6 t -56.57 -12.22 1.68 Allowed 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -84.42 -0.38 52.55 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 119.671 -1.893 . . . . 0.0 115.763 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 pp -116.54 8.46 13.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 -167.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 74.71 161.4 0.24 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.127 2.571 . . . . 0.0 115.707 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.25 -44.08 1.59 Allowed Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.345 -1.472 . . . . 0.0 113.22 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.11 97.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 127.295 2.238 . . . . 0.0 111.922 170.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.9 -61.58 1.79 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.472 1.109 . . . . 0.0 111.02 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -123.49 133.55 54.01 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.354 1.461 . . . . 0.0 108.495 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.5 tt -140.09 137.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.991 0.901 . . . . 0.0 110.799 -173.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.0 t -142.23 152.49 43.13 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.859 1.664 . . . . 0.0 109.991 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.58 139.07 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.439 1.096 . . . . 0.0 110.238 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 18.3 t -122.46 84.81 2.31 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.119 2.168 . . . . 0.0 108.708 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.7 -28.35 67.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.961 1.704 . . . . 0.0 111.519 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.2 -53.26 8.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.794 2.438 . . . . 0.0 112.887 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -95.16 -7.87 37.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.506 1.122 . . . . 0.0 111.707 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.55 42.13 64.21 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.059 1.79 . . . . 0.0 111.729 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.4 p -130.92 155.86 46.05 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.33 1.052 . . . . 0.0 111.51 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.29 129.93 38.25 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.525 1.13 . . . . 0.0 110.93 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.3 t -109.84 124.83 52.01 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.223 1.009 . . . . 0.0 108.962 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.76 138.58 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -169.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 121' ' ' CYS . 0.7 OUTLIER -96.43 114.49 26.16 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.897 2.479 . . . . 0.0 107.296 174.508 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -124.31 162.91 22.79 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.672 1.589 . . . . 0.0 112.022 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -96.79 112.62 60.96 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.259 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.13 -9.6 24.71 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.717 2.945 . . . . 0.0 115.456 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -88.36 -37.44 15.92 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.718 1.144 . . . . 0.0 112.084 169.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.65 -36.87 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.678 1.191 . . . . 0.0 112.209 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 tt -146.05 150.19 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 121.054 -1.029 . . . . 0.0 112.623 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.71 150.43 46.92 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.096 1.758 . . . . 0.0 110.535 -173.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.93 -37.56 67.21 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.398 2.732 . . . . 0.0 114.77 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.25 -27.68 68.14 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.56 -36.55 63.09 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.706 1.203 . . . . 0.0 112.149 172.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 91.0 mt -58.29 -52.93 63.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.775 0.83 . . . . 0.0 111.206 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -61.81 -38.74 89.24 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.13 -29.54 69.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.711 0.804 . . . . 0.0 112.469 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.44 -31.07 70.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.318 1.047 . . . . 0.0 113.045 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.26 -32.35 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.475 1.11 . . . . 0.0 111.362 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.06 -33.43 73.56 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.462 -0.774 . . . . 0.0 112.381 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -71.11 -30.42 66.5 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.842 0.746 . . . . 0.0 112.558 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 23.4 ttt -65.94 -43.3 88.44 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.123 0.969 . . . . 0.0 111.165 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 142.32 21.58 0.23 Allowed Glycine 0 CA--C 1.533 1.182 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 169.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -131.4 -155.16 0.67 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.111 1.365 . . . . 0.0 110.392 -171.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -129.44 140.57 51.27 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.426 1.491 . . . . 0.0 110.462 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.85 150.69 40.22 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.882 1.273 . . . . 0.0 114.404 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.7 t -141.8 146.95 36.51 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.252 1.421 . . . . 0.0 110.716 171.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.3 m -92.78 125.38 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.297 0.953 . . . . 0.0 109.665 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 124.384 2.04 . . . . 0.0 107.949 -177.305 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 121.47 0.652 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.9 m -99.01 164.4 12.19 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.782 1.633 . . . . 0.0 109.369 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.21 139.81 35.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.278 1.031 . . . . 0.0 110.315 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -98.51 123.85 42.9 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.753 0.787 . . . . 0.0 109.09 169.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.13 136.66 25.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.943 -1.48 . . . . 0.0 113.538 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -107.65 108.12 19.24 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.472 1.109 . . . . 0.0 110.053 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mt -92.99 145.74 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.678 1.591 . . . . 0.0 109.837 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.56 150.34 22.79 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.532 2.333 . . . . 0.0 111.29 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.98 -11.53 71.85 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.944 1.259 . . . . 0.0 114.348 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.7 ptp -70.29 -0.3 7.79 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.0 m170 -60.23 -23.96 64.48 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 120.315 1.416 . . . . 0.0 111.503 167.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.2 m -98.11 128.64 44.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.918 0.781 . . . . 0.0 110.377 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -56.49 -40.72 75.42 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.934 0.874 . . . . 0.0 112.392 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.8 p -59.39 -23.09 62.31 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.724 1.21 . . . . 0.0 113.907 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 74.8 m -72.97 -40.87 64.96 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.801 0.84 . . . . 0.0 112.149 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.2 p -74.59 -30.18 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.436 ' C ' HD23 ' A' ' 36' ' ' LEU . 5.0 tt -49.87 -60.74 2.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.266 1.426 . . . . 0.0 112.177 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -61.1 -24.15 66.02 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.304 -0.872 . . . . 0.0 113.266 -177.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 mt -70.5 -48.95 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.138 -0.976 . . . . 0.0 110.281 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -68.06 -26.43 65.85 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.345 1.058 . . . . 0.0 112.372 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.58 -39.26 88.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.764 1.225 . . . . 0.0 112.039 171.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -94.68 -23.92 17.38 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -172.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.48 ' CD1' HG22 ' A' ' 78' ' ' ILE . 44.3 mm -108.7 113.54 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.869 0.868 . . . . 0.0 109.981 -169.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.5 -14.76 4.47 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.076 1.322 . . . . 0.0 114.739 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -100.86 7.49 43.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.508 1.123 . . . . 0.0 113.326 174.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.0 mt -90.96 159.69 16.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.906 1.682 . . . . 0.0 112.932 -173.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.15 -23.7 62.4 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -171.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.99 3.79 6.39 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.181 -1.899 . . . . 0.0 115.067 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -113.68 117.47 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 121.105 2.452 . . . . 0.0 109.006 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -100.34 -29.72 12.26 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.7 m -147.59 158.61 44.07 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.681 -1.262 . . . . 0.0 112.955 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.1 tp -137.96 137.99 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.497 1.519 . . . . 0.0 109.707 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -141.02 159.58 41.9 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.883 2.073 . . . . 0.0 107.944 -171.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.19 152.34 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 120.627 -1.296 . . . . 0.0 110.79 168.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -125.54 56.22 1.38 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 168.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -28.14 68.59 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.386 1.875 . . . . 0.0 112.567 -168.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.16 -20.15 24.6 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 169.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -115.68 -2.89 12.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.349 2.26 . . . . 0.0 112.541 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt 73.27 15.67 4.31 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.144 2.178 . . . . 0.0 112.672 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.96 147.32 23.81 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.922 1.289 . . . . 0.0 109.1 170.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.04 158.08 16.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 166.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.73 116.86 15.38 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -168.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.91 133.58 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.836 -0.54 . . . . 0.0 110.883 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -107.61 96.21 6.23 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.02 2.128 . . . . 0.0 106.676 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -126.03 154.6 42.75 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.62 108.56 40.65 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 127.073 2.149 . . . . 0.0 107.192 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -71.26 1.73 5.12 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.672 2.914 . . . . 0.0 114.474 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 p -83.01 -23.82 33.11 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.927 1.291 . . . . 0.0 112.33 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 85.5 m -120.1 -18.38 8.11 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 t -147.88 -178.6 6.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.814 1.246 . . . . 0.0 111.422 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.8 m -168.35 161.47 8.97 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.923 1.689 . . . . 0.0 112.596 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.72 -52.9 7.95 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 124.199 3.266 . . . . 0.0 117.289 -168.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.19 -32.33 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 120.742 1.61 . . . . 0.0 113.083 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.53 -40.05 85.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.55 0.74 . . . . 0.0 111.381 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.83 -44.53 80.85 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.342 1.057 . . . . 0.0 111.875 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -55.36 -51.73 65.83 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.63 0.65 . . . . 0.0 110.019 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -67.78 -28.79 67.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.134 0.974 . . . . 0.0 113.299 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.37 -60.25 2.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.122 0.874 . . . . 0.0 111.308 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.48 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.2 pt -72.74 -32.92 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -169.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -66.12 -22.08 66.38 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.6 16.17 27.09 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.2 mt -62.31 -57.36 23.43 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.12 -1.419 . . . . 0.0 109.838 165.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.53 171.18 18.26 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.122 3.215 . . . . 0.0 111.963 172.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.96 45.72 2.07 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 124.045 3.163 . . . . 0.0 112.664 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.95 58.61 3.97 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -135.62 -25.07 1.31 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.09 98.0 5.87 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.279 1.399 . . . . 0.0 108.283 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -92.31 128.65 38.23 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.737 1.215 . . . . 0.0 110.94 -167.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.59 135.3 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.257 1.023 . . . . 0.0 112.063 -174.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.0 m -127.13 133.34 50.39 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.553 1.541 . . . . 0.0 111.347 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 124.736 1.214 . . . . 0.0 110.207 176.529 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 23.0 p -155.53 115.61 3.73 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -167.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.9 p -144.7 147.3 32.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.138 1.375 . . . . 0.0 111.209 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.2 m -98.79 141.49 31.52 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.493 -0.755 . . . . 0.0 110.204 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.31 164.12 31.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 112.04 169.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.44 133.95 54.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.715 2.006 . . . . 0.0 109.531 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.4 mm -119.82 133.26 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.297 1.039 . . . . 0.0 108.662 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.53 128.91 45.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.438 1.095 . . . . 0.0 109.001 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 89.9 mt -129.69 136.08 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.195 -0.941 . . . . 0.0 110.529 -169.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -119.68 56.89 0.93 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.752 1.621 . . . . 0.0 111.849 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.57 51.81 0.35 Allowed Glycine 0 N--CA 1.462 0.389 0 O-C-N 121.865 -0.522 . . . . 0.0 112.746 169.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 72.0 mtm -128.86 119.3 24.19 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.587 0.755 . . . . 0.0 109.189 171.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.92 -41.15 5.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.62 1.968 . . . . 0.0 110.34 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 86.7 m -134.32 157.66 45.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.308 1.843 . . . . 0.0 110.733 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.47 -28.49 65.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.99 -36.66 18.13 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.1 -1.0 . . . . 0.0 111.938 169.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 62.5 m -61.27 -42.66 99.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.485 1.114 . . . . 0.0 113.266 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.09 -54.98 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -66.98 -28.86 68.6 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.6 m -65.63 -52.62 50.45 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.077 1.351 . . . . 0.0 112.074 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.95 -51.08 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.03 -1.044 . . . . 0.0 110.547 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -52.81 -34.79 55.29 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.205 1.802 . . . . 0.0 110.86 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.31 -61.33 3.45 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.125 1.345 . . . . 0.0 113.306 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.7 mmt -63.51 -41.3 98.52 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.479 1.112 . . . . 0.0 112.799 -171.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.5 mm -70.86 -35.86 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 117.759 0.254 . . . . 0.0 110.901 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -63.18 -9.2 10.11 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -77.08 -18.84 57.73 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.224 -1.548 . . . . 0.0 114.086 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -99.63 164.98 11.83 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.144 1.338 . . . . 0.0 113.514 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -76.29 151.34 36.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.04 -25.72 6.66 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.838 1.208 . . . . 0.0 113.978 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.58 96.25 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.263 1.531 . . . . 0.0 109.955 169.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -74.47 -47.17 34.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.396 1.478 . . . . 0.0 111.806 -173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -144.05 135.82 26.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.471 1.908 . . . . 0.0 108.669 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 tt -140.13 135.66 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.778 1.172 . . . . 0.0 111.34 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.3 t -140.61 126.09 18.91 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.018 1.327 . . . . 0.0 111.487 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 t -126.11 147.58 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 O-C-N 120.695 -1.253 . . . . 0.0 111.285 -169.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.4 t -140.77 144.31 35.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.954 0.883 . . . . 0.0 112.939 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.8 -20.22 62.61 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.798 1.639 . . . . 0.0 115.019 174.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.44 -35.6 52.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.395 1.478 . . . . 0.0 113.595 -172.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -125.25 -10.93 6.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.79 1.636 . . . . 0.0 112.382 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.33 47.97 6.63 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.235 1.398 . . . . 0.0 111.365 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.4 p -139.03 144.39 38.82 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -168.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.57 142.58 35.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.414 1.885 . . . . 0.0 111.361 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.0 t -116.94 124.87 50.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.84 142.1 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 122.955 0.502 . . . . 0.0 111.841 -168.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.35 109.42 21.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.65 1.98 . . . . 0.0 107.097 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -106.08 156.06 18.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.042 0.937 . . . . 0.0 111.969 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -95.33 109.63 46.16 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.271 1.028 . . . . 0.0 108.531 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.67 -12.69 18.28 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.763 2.308 . . . . 0.0 112.518 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.04 -36.49 40.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.165 0.986 . . . . 0.0 112.306 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.24 -34.11 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.682 1.193 . . . . 0.0 113.893 -170.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 18.2 tt -137.16 152.99 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.118 1.326 . . . . 0.0 112.19 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 m -99.84 141.09 22.14 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.358 1.463 . . . . 0.0 110.892 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -51.46 -35.72 56.27 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.445 2.764 . . . . 0.0 114.412 172.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -62.49 -28.45 69.84 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -71.93 -33.68 68.45 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.896 -1.127 . . . . 0.0 111.802 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 70.0 mt -59.94 -58.82 6.91 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.407 0.683 . . . . 0.0 109.899 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -61.35 -37.66 84.13 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.009 -0.432 . . . . 0.0 112.025 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.47 -30.14 71.04 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.83 -31.52 68.28 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.18 0.9 . . . . 0.0 112.376 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.7 mp -71.72 -39.82 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.267 1.027 . . . . 0.0 111.177 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.89 -35.37 79.83 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.007 0.523 . . . . 0.0 111.869 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.92 -23.38 61.46 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.486 1.514 . . . . 0.0 113.958 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 26.2 ttt -74.7 -46.82 35.19 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.313 -0.867 . . . . 0.0 110.946 176.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.96 42.99 0.09 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.064 1.316 . . . . 0.0 115.373 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -143.66 -159.16 0.95 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.867 1.667 . . . . 0.0 109.68 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.6 142.04 50.82 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.12 1.368 . . . . 0.0 110.163 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -140.67 147.5 39.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.5 1.92 . . . . 0.0 112.504 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.3 t -138.62 134.19 33.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.632 1.573 . . . . 0.0 111.966 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.4 m -83.92 78.26 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.116 0.96 . . . . 0.0 110.444 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.475 0.806 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.441 174.629 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.81 97.06 10.76 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 166.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.767 HD12 ' H ' ' A' ' 23' ' ' GLN . 4.5 tp -112.16 165.43 12.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.102 1.361 . . . . 0.0 107.902 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.767 ' H ' HD12 ' A' ' 22' ' ' LEU . 11.2 pt20 -147.0 161.97 39.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 119.774 -1.829 . . . . 0.0 114.078 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -140.72 150.41 43.41 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.941 1.697 . . . . 0.0 109.652 168.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -98.7 103.35 15.3 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 mm -76.37 146.77 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.475 1.51 . . . . 0.0 110.539 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -98.91 137.22 37.78 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.984 2.114 . . . . 0.0 110.968 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.44 -9.46 75.46 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.106 1.336 . . . . 0.0 113.697 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.94 -6.16 7.79 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -60.16 -27.11 66.83 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.945 1.248 . . . . 0.0 110.758 165.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.1 t -88.58 119.62 29.2 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 166.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -58.92 -33.48 70.61 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.352 -0.843 . . . . 0.0 111.685 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 m -54.89 -31.0 59.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.733 1.213 . . . . 0.0 112.822 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.6 m -72.2 -40.48 67.83 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.974 1.309 . . . . 0.0 112.774 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.7 p -76.31 -31.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.86 -55.14 36.04 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.585 1.154 . . . . 0.0 112.235 -175.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -59.97 -31.3 69.76 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.535 -0.728 . . . . 0.0 112.594 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mt -64.01 -47.76 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.403 -0.811 . . . . 0.0 109.995 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.99 -25.93 68.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.686 1.594 . . . . 0.0 113.795 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.64 -37.46 59.66 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.753 -1.217 . . . . 0.0 113.862 170.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -91.13 -35.11 14.76 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.492 ' CD1' HG22 ' A' ' 78' ' ' ILE . 39.5 mm -95.88 112.17 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 120.818 -1.176 . . . . 0.0 107.968 -170.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.59 -15.26 3.62 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.378 0.989 . . . . 0.0 115.285 -168.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -104.32 11.58 34.58 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.589 1.194 . . . . 0.0 113.029 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.9 mt -96.88 149.72 21.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.391 1.476 . . . . 0.0 113.143 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.2 tp -32.21 -58.73 0.31 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.16 2.184 . . . . 0.0 114.016 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.86 19.01 31.05 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.181 -1.9 . . . . 0.0 115.704 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -138.1 109.58 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.084 2.442 . . . . 0.0 108.873 168.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.66 -16.12 15.08 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.5 t -146.1 168.08 21.82 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.016 1.326 . . . . 0.0 110.875 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.0 tp -143.51 146.51 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.292 1.037 . . . . 0.0 111.64 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -144.16 157.92 44.02 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.5 1.52 . . . . 0.0 109.825 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.79 156.47 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 O-C-N 119.801 -1.812 . . . . 0.0 112.564 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 t -136.22 56.21 1.82 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.249 1.82 . . . . 0.0 108.04 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.03 -23.03 66.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.583 1.153 . . . . 0.0 112.908 -170.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -66.13 -14.79 62.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.942 1.297 . . . . 0.0 113.76 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -126.12 11.46 7.62 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.274 2.23 . . . . 0.0 112.5 169.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 71.16 7.33 6.12 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.765 2.026 . . . . 0.0 115.382 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.32 157.74 15.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.808 1.243 . . . . 0.0 110.412 172.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.83 144.11 47.52 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.987 1.315 . . . . 0.0 109.426 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.2 tp60 -112.29 119.17 37.4 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -170.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.35 140.75 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 120.924 -1.11 . . . . 0.0 108.089 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -110.09 82.97 1.68 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.757 1.223 . . . . 0.0 107.752 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -106.0 152.1 23.78 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -169.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.81 103.02 16.84 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.708 2.003 . . . . 0.0 110.113 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.94 0.74 1.86 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.705 2.937 . . . . 0.0 114.944 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 98.5 p -74.91 -15.65 60.69 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.887 -1.133 . . . . 0.0 113.226 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.3 m -137.09 -24.44 1.1 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -171.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 t -144.53 178.16 8.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.355 1.462 . . . . 0.0 111.374 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.3 p -148.18 158.56 41.29 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.825 1.25 . . . . 0.0 113.008 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.7 -52.31 7.18 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.661 2.907 . . . . 0.0 114.648 -170.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.3 m -62.96 -30.16 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.879 1.218 . . . . 0.0 113.516 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.65 -46.48 58.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.474 0.71 . . . . 0.0 111.257 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.9 mt -58.2 -42.52 86.33 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.646 0.778 . . . . 0.0 111.482 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -57.57 -37.99 74.06 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.167 0.587 . . . . 0.0 111.638 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -72.2 -40.28 67.98 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.433 1.015 . . . . 0.0 112.626 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.51 -60.2 4.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.033 0.933 . . . . 0.0 112.411 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.492 HG22 ' CD1' ' A' ' 42' ' ' ILE . 9.1 pt -70.53 -28.59 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -168.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -69.98 -12.99 62.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.615 1.566 . . . . 0.0 113.326 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.0 6.43 29.06 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -55.7 -49.83 90.56 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 117.307 -1.33 . . . . 0.0 110.985 166.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.62 172.08 17.0 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.298 2.665 . . . . 0.0 111.311 168.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.47 44.35 1.22 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.323 3.349 . . . . 0.0 111.64 170.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.28 30.54 41.12 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.101 1.334 . . . . 0.0 113.746 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -95.1 -47.99 6.14 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.65 1.225 . . . . 0.0 112.22 -169.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -100.58 123.37 44.7 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.127 1.371 . . . . 0.0 109.025 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -101.46 165.48 11.23 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.051 0.94 . . . . 0.0 111.888 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.01 139.47 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.503 0.721 . . . . 0.0 111.802 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 m -110.92 134.88 52.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.656 1.183 . . . . 0.0 110.949 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.542 0.67 0 C-N-CA 126.862 2.065 . . . . 0.0 111.169 177.986 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 21.8 p -125.38 152.14 45.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.404 1.882 . . . . 0.0 113.148 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.0 t -140.6 149.95 42.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.791 2.036 . . . . 0.0 107.395 167.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m -99.88 142.05 31.87 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.15 0.5 . . . . 0.0 110.819 -170.234 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.25 145.25 31.92 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.596 0.758 . . . . 0.0 110.394 169.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tt -114.69 137.83 51.44 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.676 1.99 . . . . 0.0 108.346 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.9 mt -133.36 138.4 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.622 1.569 . . . . 0.0 109.768 -168.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.33 130.87 45.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.246 1.818 . . . . 0.0 109.296 172.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mp -126.38 122.43 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.274 -0.892 . . . . 0.0 111.855 -171.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.48 61.47 3.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.212 1.805 . . . . 0.0 111.24 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.59 54.96 0.27 Allowed Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.628 169.454 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 73.8 mtm -138.78 121.09 15.93 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.628 0.771 . . . . 0.0 110.57 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 t -125.25 -30.19 3.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.747 1.619 . . . . 0.0 112.513 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 11.8 m -147.74 163.49 36.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.682 1.993 . . . . 0.0 111.057 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.3 -30.51 70.54 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -172.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.2 m -57.53 -20.94 34.98 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.763 -1.21 . . . . 0.0 112.933 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 93.0 m -63.06 -44.1 96.75 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.931 -1.105 . . . . 0.0 112.286 168.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.66 -54.43 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -65.73 -24.5 66.98 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 117.998 0.363 . . . . 0.0 111.741 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 m -70.84 -53.11 16.44 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.747 -1.22 . . . . 0.0 111.792 170.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.1 -50.41 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.507 -1.371 . . . . 0.0 110.696 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.19 -33.01 68.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.808 2.043 . . . . 0.0 111.494 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.5 -61.89 2.85 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.856 1.217 . . . . 0.0 113.913 174.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -44.83 67.73 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.75 1.22 . . . . 0.0 112.844 -169.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.4 mm -70.74 -21.0 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.543 -0.723 . . . . 0.0 111.502 -173.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.4 -2.91 18.12 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 169.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -80.96 -13.77 58.59 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 119.591 -1.943 . . . . 0.0 115.403 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.25 -177.17 4.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.218 1.407 . . . . 0.0 113.445 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.99 137.18 32.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.134 0.974 . . . . 0.0 111.49 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.03 41.45 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 117.658 -1.634 . . . . 0.0 115.894 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.9 p -120.93 93.6 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.802 1.801 . . . . 0.0 110.863 -175.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -49.76 28.98 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.669 1.188 . . . . 0.0 110.122 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -147.31 142.72 27.45 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.751 1.221 . . . . 0.0 110.505 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 9.2 tt -135.83 140.51 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 119.426 1.012 . . . . 0.0 110.452 169.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 12.5 t -140.16 145.26 37.28 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.898 1.679 . . . . 0.0 109.667 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.3 t -141.01 146.4 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.659 1.118 . . . . 0.0 110.579 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 77.4 p -142.45 132.71 24.78 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.147 -0.971 . . . . 0.0 113.17 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -19.64 63.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.514 1.526 . . . . 0.0 112.614 171.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -48.88 -52.84 22.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.997 1.319 . . . . 0.0 111.64 170.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -96.23 -25.07 15.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.894 1.278 . . . . 0.0 112.321 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.76 25.53 55.99 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.791 1.186 . . . . 0.0 112.319 -170.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 p -136.02 147.12 47.81 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.526 1.163 . . . . 0.0 113.813 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -99.63 145.67 27.33 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.847 1.659 . . . . 0.0 110.366 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.9 t -127.95 129.36 46.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.647 0.779 . . . . 0.0 109.257 168.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.8 140.81 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 123.572 0.749 . . . . 0.0 111.181 -168.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.15 107.02 18.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.08 1.752 . . . . 0.0 106.947 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -101.79 157.04 17.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.423 0.689 . . . . 0.0 111.633 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -95.98 111.71 57.05 Favored Pre-proline 0 CA--C 1.542 0.673 0 O-C-N 121.242 -0.911 . . . . 0.0 110.285 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.95 -10.52 23.07 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.468 2.112 . . . . 0.0 112.823 -170.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.41 -8.64 59.76 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.143 0.977 . . . . 0.0 113.168 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 73.5 t -120.93 -42.25 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.994 1.318 . . . . 0.0 111.972 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.2 tt -143.39 165.09 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.212 1.005 . . . . 0.0 111.507 -170.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.46 154.01 72.45 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.0 1.72 . . . . 0.0 110.947 -175.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.19 -44.82 36.5 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.025 3.15 . . . . 0.0 114.962 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.53 -19.54 62.89 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.39 -0.819 . . . . 0.0 113.11 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -73.85 -29.14 61.95 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.844 -1.16 . . . . 0.0 111.944 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.75 -51.3 67.69 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.552 0.741 . . . . 0.0 109.296 170.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -50.64 -51.12 51.98 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.64 1.176 . . . . 0.0 111.686 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.45 -27.32 68.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.74 -34.9 64.96 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.824 0.85 . . . . 0.0 112.146 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.7 -38.59 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.877 0.871 . . . . 0.0 111.235 171.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -64.96 -35.87 82.57 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.986 0.812 . . . . 0.0 112.693 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.96 -35.28 79.63 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.197 -0.94 . . . . 0.0 111.72 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -43.48 80.15 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.758 0.823 . . . . 0.0 111.37 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 140.56 21.25 0.32 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 117.156 1.623 . . . . 0.0 117.156 169.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -114.95 -156.61 0.61 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.838 1.819 . . . . 0.0 110.272 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -131.54 140.7 49.55 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.992 1.317 . . . . 0.0 109.179 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -137.62 150.28 47.28 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.4 t -138.81 137.35 36.56 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.258 1.423 . . . . 0.0 109.577 169.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.77 135.05 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 121.513 -0.742 . . . . 0.0 110.308 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 124.095 1.903 . . . . 0.0 107.484 175.827 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 120.93 0.395 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.4 132.0 47.21 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.932 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.52 136.72 54.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.954 1.302 . . . . 0.0 109.657 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -97.09 128.66 44.23 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.852 1.661 . . . . 0.0 110.88 -169.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.74 141.16 33.25 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -109.55 116.33 31.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 mt -76.58 133.76 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 122.413 1.101 . . . . 0.0 110.136 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.88 104.97 15.26 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.625 2.37 . . . . 0.0 108.298 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.61 16.68 25.95 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.5 ptp -64.42 -36.21 83.41 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.659 1.73 . . . . 0.0 115.141 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 t60 67.53 -46.16 0.49 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 129.027 2.931 . . . . 0.0 113.83 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 96.0 m -153.63 163.78 39.39 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.949 2.5 . . . . 0.0 110.432 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -53.81 -31.32 48.66 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.223 -0.923 . . . . 0.0 112.884 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.1 p -49.0 -18.82 0.33 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.387 2.275 . . . . 0.0 115.48 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.3 t -57.6 -44.85 85.75 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.537 1.535 . . . . 0.0 112.466 167.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.63 -6.32 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.344 1.458 . . . . 0.0 114.075 -170.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.09 -59.19 4.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.987 0.915 . . . . 0.0 110.761 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -59.11 -36.16 74.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.617 -0.677 . . . . 0.0 110.901 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.11 -46.72 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 121.229 -0.92 . . . . 0.0 111.93 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.94 -31.52 72.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.677 1.191 . . . . 0.0 112.974 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -66.44 -34.52 78.13 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -94.64 -45.13 7.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.48 112.95 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 122.178 0.989 . . . . 0.0 109.995 -165.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.84 5.93 5.17 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.839 1.209 . . . . 0.0 114.383 -169.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.62 1.69 7.55 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.583 1.153 . . . . 0.0 113.609 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.76 171.2 8.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.087 1.355 . . . . 0.0 111.502 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -54.53 -37.84 65.88 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 171.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.2 11.95 7.63 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.445 -1.753 . . . . 0.0 115.918 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.87 120.27 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.005 2.402 . . . . 0.0 109.303 169.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 -21.15 12.36 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -142.78 166.72 23.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.882 1.219 . . . . 0.0 112.663 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.7 tp -140.88 138.65 34.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 126.591 1.956 . . . . 0.0 108.433 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -125.4 129.52 50.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.169 1.388 . . . . 0.0 109.51 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -99.4 112.4 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.315 1.446 . . . . 0.0 108.161 -170.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 m -125.8 49.58 1.93 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.829 0.823 . . . . 0.0 110.613 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.62 -15.18 60.8 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.255 1.822 . . . . 0.0 114.803 -170.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -43.7 -32.84 1.09 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.614 2.366 . . . . 0.0 115.538 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -125.33 23.39 7.59 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.666 1.186 . . . . 0.0 112.874 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 63.39 24.72 14.3 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.035 1.734 . . . . 0.0 112.263 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.28 164.4 13.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.075 1.75 . . . . 0.0 110.036 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.33 151.31 41.82 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 127.677 2.391 . . . . 0.0 106.8 170.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -124.71 134.53 52.81 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.415 -0.803 . . . . 0.0 111.292 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -102.52 139.74 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 117.847 0.294 . . . . 0.0 111.089 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -102.8 95.73 6.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.708 1.603 . . . . 0.0 108.857 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -120.8 152.48 38.3 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -170.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.34 112.0 59.83 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 127.85 2.46 . . . . 0.0 109.772 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -63.03 -2.74 3.97 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.838 3.025 . . . . 0.0 115.658 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.9 p -84.24 -16.66 42.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.71 1.204 . . . . 0.0 113.019 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 92.4 m -124.43 -28.4 3.63 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 t -142.18 179.2 7.05 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.684 1.129 . . . . 0.0 113.064 -169.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 97.6 p -165.61 162.53 13.27 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.7 1.6 . . . . 0.0 112.164 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -52.63 -49.33 17.85 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.728 2.952 . . . . 0.0 115.472 -172.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.32 -37.61 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 119.326 0.966 . . . . 0.0 112.459 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.47 87.93 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.299 1.039 . . . . 0.0 111.438 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.33 -47.4 70.61 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.863 0.865 . . . . 0.0 111.778 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -55.72 -47.96 75.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.087 0.858 . . . . 0.0 111.484 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -63.94 -29.64 70.8 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.25 -62.43 1.52 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.932 0.787 . . . . 0.0 112.277 170.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 pt -72.61 -17.3 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -73.81 -35.78 64.9 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 121.64 2.018 . . . . 0.0 113.156 168.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.41 13.7 26.94 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.944 -1.097 . . . . 0.0 112.261 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.2 tp -48.86 -54.39 28.29 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 129.331 3.052 . . . . 0.0 113.202 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -91.05 176.22 2.28 Favored 'Trans proline' 0 CA--C 1.55 1.285 0 C-N-CA 124.092 3.195 . . . . 0.0 111.879 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.35 53.01 3.75 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 124.663 3.575 . . . . 0.0 113.099 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.8 52.38 5.88 Favored Glycine 0 N--CA 1.471 1.011 0 O-C-N 120.689 -1.257 . . . . 0.0 111.823 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -127.74 -33.04 2.31 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.467 1.107 . . . . 0.0 113.875 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -135.01 113.94 11.97 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.126 1.77 . . . . 0.0 109.556 -173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -98.43 173.92 6.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.36 1.464 . . . . 0.0 110.516 173.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.24 135.21 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.783 -1.198 . . . . 0.0 111.025 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -107.62 124.74 50.41 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.13 0.972 . . . . 0.0 109.831 167.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 124.239 1.016 . . . . 0.0 109.569 176.856 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.9 t 73.03 113.85 0.06 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.804 2.442 . . . . 0.0 114.835 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 60.9 m -145.37 148.6 33.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.109 2.163 . . . . 0.0 108.905 166.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.4 m -99.13 145.96 26.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.037 -1.039 . . . . 0.0 110.256 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.87 155.06 43.26 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.917 1.287 . . . . 0.0 110.978 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.0 tt -114.6 136.01 53.51 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.789 2.036 . . . . 0.0 110.745 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.6 mm -123.57 141.08 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 127.174 2.19 . . . . 0.0 109.697 -172.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.23 127.42 53.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.147 1.379 . . . . 0.0 110.706 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.23 143.72 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 120.801 -1.187 . . . . 0.0 111.566 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.85 56.46 1.31 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.195 1.798 . . . . 0.0 113.258 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.68 45.92 0.28 Allowed Glycine 0 N--CA 1.469 0.87 0 O-C-N 121.209 -0.932 . . . . 0.0 112.714 167.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 29.6 mtm -133.5 96.8 3.79 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.222 1.009 . . . . 0.0 110.024 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 t -98.99 -26.51 14.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.315 1.846 . . . . 0.0 112.939 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 95.7 m -125.62 150.43 47.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.188 1.395 . . . . 0.0 110.934 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.1 -23.79 67.46 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.918 -1.113 . . . . 0.0 113.312 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.1 p -53.55 -30.87 44.05 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.01 1.324 . . . . 0.0 113.429 169.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.8 m -57.17 -32.66 66.66 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.724 1.21 . . . . 0.0 112.3 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 41.5 t -57.07 -53.87 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.685 0.794 . . . . 0.0 109.988 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -66.31 -23.28 66.35 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.973 0.509 . . . . 0.0 112.21 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.5 m -71.19 -52.72 17.55 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.568 -0.707 . . . . 0.0 111.148 170.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 85.7 mt -70.37 -52.23 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 120.741 -1.225 . . . . 0.0 111.315 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -51.46 -42.08 61.32 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.82 1.248 . . . . 0.0 111.082 172.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.42 -62.42 2.9 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 123.558 0.599 . . . . 0.0 113.127 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -38.59 71.14 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.033 1.333 . . . . 0.0 113.026 -170.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.8 mm -71.04 -35.3 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.73 -0.606 . . . . 0.0 110.539 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -65.0 3.07 0.62 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -94.44 -11.28 30.07 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.686 1.194 . . . . 0.0 113.546 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -106.25 167.59 9.72 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.026 1.285 . . . . 0.0 112.87 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -68.38 161.38 27.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 123.213 1.482 . . . . 0.0 114.705 -174.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.82 -32.41 1.94 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.36 1.457 . . . . 0.0 114.911 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.51 98.61 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 119.106 1.453 . . . . 0.0 112.435 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -72.32 -45.89 58.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.196 0.998 . . . . 0.0 112.135 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -144.61 132.49 21.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.141 1.376 . . . . 0.0 109.783 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.71 142.3 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.745 1.157 . . . . 0.0 112.854 170.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 31.2 t -131.45 142.62 50.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.55 2.74 . . . . 0.0 109.224 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.27 146.97 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.89 1.223 . . . . 0.0 111.781 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 43.1 t -139.29 136.34 34.78 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -16.83 63.22 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.36 2.264 . . . . 0.0 113.514 171.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.74 97.05 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.783 1.233 . . . . 0.0 111.969 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -116.37 -16.05 10.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.7 1.6 . . . . 0.0 112.605 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.94 28.51 56.44 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.177 1.37 . . . . 0.0 112.855 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.1 p -128.89 151.54 49.52 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.077 0.939 . . . . 0.0 113.26 -169.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -113.32 146.71 38.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.25 1.42 . . . . 0.0 111.906 172.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.4 m -118.52 126.19 51.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.852 1.661 . . . . 0.0 107.342 168.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.77 137.33 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.321 0.649 . . . . 0.0 110.65 -171.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.25 109.69 21.78 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.75 2.02 . . . . 0.0 105.78 173.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -111.29 155.67 22.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.023 0.929 . . . . 0.0 111.993 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -97.4 107.05 36.57 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.725 1.21 . . . . 0.0 109.139 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -66.97 -15.86 48.06 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.8 1.667 . . . . 0.0 113.537 -174.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.85 -14.84 61.15 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.45 -31.67 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.165 1.786 . . . . 0.0 112.494 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.0 tt -151.77 152.31 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.865 -1.147 . . . . 0.0 112.964 -170.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 73.5 m -114.49 159.32 37.33 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.55 1.14 . . . . 0.0 112.858 171.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.8 -37.64 45.55 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.48 3.453 . . . . 0.0 115.103 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -57.82 -35.82 71.39 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.449 1.022 . . . . 0.0 113.066 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.28 -32.49 64.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.234 1.013 . . . . 0.0 111.564 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.64 -51.93 67.7 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.689 -0.632 . . . . 0.0 110.089 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -62.28 -41.82 98.81 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.733 -0.605 . . . . 0.0 111.617 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.25 73.18 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.8 -34.79 69.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.86 -38.97 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.705 0.802 . . . . 0.0 110.115 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -59.97 -46.73 88.48 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.331 0.653 . . . . 0.0 110.249 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.84 -22.49 65.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.4 1.48 . . . . 0.0 114.507 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -39.58 78.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.459 -0.775 . . . . 0.0 110.95 172.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 138.71 24.58 0.34 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.443 -1.198 . . . . 0.0 115.512 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -124.41 -153.36 0.56 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.162 1.481 . . . . 0.0 109.263 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.07 141.7 36.19 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.745 1.618 . . . . 0.0 108.018 168.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.97 154.88 47.3 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.9 t -138.88 143.53 38.77 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.024 2.13 . . . . 0.0 109.9 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.5 m -90.39 131.16 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.393 -0.817 . . . . 0.0 111.13 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 126.074 1.749 . . . . 0.0 109.903 -176.463 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.651 0.263 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.37 145.82 32.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.646 0.778 . . . . 0.0 110.945 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tt -121.4 136.44 54.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.377 1.071 . . . . 0.0 111.918 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.55 122.84 39.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 122.597 1.189 . . . . 0.0 110.295 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.82 143.04 26.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.323 -1.762 . . . . 0.0 113.203 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -113.49 118.02 33.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.618 1.167 . . . . 0.0 108.86 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 mm -83.11 147.69 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.818 1.247 . . . . 0.0 110.916 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.69 156.82 18.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.943 1.697 . . . . 0.0 112.014 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.27 -7.26 64.66 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.585 1.088 . . . . 0.0 113.957 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.0 mtm -65.7 0.37 1.73 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -58.96 -23.23 61.41 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 119.672 1.124 . . . . 0.0 112.412 167.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.9 -6.77 59.34 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.915 1.286 . . . . 0.0 113.814 171.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 tptm 59.54 -57.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 130.729 3.612 . . . . 0.0 116.123 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 m -56.32 -13.4 2.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.568 1.947 . . . . 0.0 113.589 -174.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 m -48.76 -39.67 25.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.837 2.455 . . . . 0.0 112.678 167.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.58 -20.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -172.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.63 -56.92 15.56 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.147 0.979 . . . . 0.0 112.039 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -61.91 -28.82 69.79 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.655 -0.653 . . . . 0.0 111.921 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.2 mt -61.86 -54.97 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.521 1.055 . . . . 0.0 110.005 168.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -61.82 -32.38 72.68 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.2 1.0 . . . . 0.0 113.081 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -67.75 -42.12 82.3 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.123 1.369 . . . . 0.0 112.252 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -92.75 -17.41 24.23 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.471 ' CD1' HG22 ' A' ' 78' ' ' ILE . 50.4 mm -117.25 128.51 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.342 1.057 . . . . 0.0 110.131 -176.019 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.16 -6.17 1.74 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.621 1.581 . . . . 0.0 115.703 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -119.0 -1.27 10.99 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.853 2.061 . . . . 0.0 112.71 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.89 160.26 9.95 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.316 1.446 . . . . 0.0 110.279 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.4 pt? -55.22 -39.74 70.03 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.51 -32.65 5.93 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 116.876 -2.069 . . . . 0.0 115.009 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.62 118.02 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 121.235 2.517 . . . . 0.0 110.529 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -105.55 -17.4 14.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.7 m -148.91 148.09 29.43 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.491 -1.38 . . . . 0.0 113.364 169.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.7 tp -110.21 131.98 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.956 0.902 . . . . 0.0 109.866 167.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -120.52 143.45 48.56 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.432 1.493 . . . . 0.0 109.148 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.403 ' CG1' HD23 ' A' ' 55' ' ' LEU . 95.1 t -120.09 120.58 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.658 1.183 . . . . 0.0 109.804 -169.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -119.66 55.32 0.97 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.432 1.493 . . . . 0.0 112.635 -168.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.403 HD23 ' CG1' ' A' ' 53' ' ' VAL . 1.2 mm? -68.47 -13.97 62.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -169.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -60.27 -33.4 72.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.286 1.034 . . . . 0.0 112.94 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -113.25 15.87 19.22 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.421 1.488 . . . . 0.0 111.725 171.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.0 mttt 66.89 11.54 8.38 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.217 2.207 . . . . 0.0 113.056 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.58 174.29 7.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.173 2.189 . . . . 0.0 110.29 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.04 164.67 24.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.756 1.623 . . . . 0.0 108.47 167.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -135.73 109.45 8.05 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.089 1.355 . . . . 0.0 108.048 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.9 p -98.64 133.59 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 121.856 -0.528 . . . . 0.0 110.069 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.03 96.11 7.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.382 1.473 . . . . 0.0 109.805 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -125.25 148.22 48.75 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -98.87 118.35 63.02 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.272 1.429 . . . . 0.0 109.43 171.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.57 2.16 4.26 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.836 3.024 . . . . 0.0 113.095 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 t -71.37 -28.05 63.77 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.103 -0.998 . . . . 0.0 112.289 171.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 82.6 m -113.0 -20.45 11.53 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -171.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.6 t -145.13 -176.25 5.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.853 1.661 . . . . 0.0 111.178 -171.07 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.8 p -158.38 155.39 25.51 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.635 1.574 . . . . 0.0 110.919 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -48.51 -46.35 23.96 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 124.132 3.221 . . . . 0.0 116.907 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.39 -32.16 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 120.472 1.487 . . . . 0.0 113.065 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.22 -30.09 67.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.93 0.892 . . . . 0.0 111.849 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.7 mt -71.9 -53.16 14.02 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.661 0.784 . . . . 0.0 111.125 169.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -49.77 -57.32 7.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.944 1.298 . . . . 0.0 110.889 -178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -68.6 -27.15 65.78 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.25 -55.42 9.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.23 0.923 . . . . 0.0 111.356 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.471 HG22 ' CD1' ' A' ' 42' ' ' ILE . 8.7 pt -71.81 -31.85 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.86 -17.66 63.38 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.73 10.77 39.73 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.549 -1.344 . . . . 0.0 113.724 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.1 mt -59.17 -54.04 60.33 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.562 -1.209 . . . . 0.0 109.759 166.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.5 174.45 12.81 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.237 2.624 . . . . 0.0 110.849 168.467 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.74 54.49 3.53 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.142 3.228 . . . . 0.0 111.209 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.45 23.5 68.55 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.304 0.954 . . . . 0.0 112.999 -175.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -90.14 -30.37 17.68 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.554 0.677 . . . . 0.0 112.473 -169.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -109.49 116.0 30.99 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.282 1.433 . . . . 0.0 107.89 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.4 tptp -96.91 157.02 16.1 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.666 1.186 . . . . 0.0 110.592 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 3.9 m -124.2 133.81 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.756 1.616 . . . . 0.0 111.659 170.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.6 p -110.58 127.45 55.23 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.026 0.93 . . . . 0.0 110.528 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 125.355 1.462 . . . . 0.0 109.514 170.384 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.8 m 59.0 92.91 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.1 m -141.18 158.51 43.81 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.334 1.453 . . . . 0.0 110.804 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 52.9 m -99.22 142.51 30.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.734 0.814 . . . . 0.0 110.76 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.68 143.65 30.83 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.065 0.946 . . . . 0.0 111.312 170.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -102.68 135.72 43.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.277 1.431 . . . . 0.0 110.166 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 mm -113.83 136.04 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.552 1.941 . . . . 0.0 108.304 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -105.36 124.48 49.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.271 1.429 . . . . 0.0 109.306 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 88.3 mt -122.55 143.7 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 120.486 -1.384 . . . . 0.0 112.21 -166.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.62 56.39 1.48 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.298 1.439 . . . . 0.0 112.984 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.95 50.63 0.18 Allowed Glycine 0 N--CA 1.462 0.393 0 C-N-CA 125.17 1.367 . . . . 0.0 111.902 166.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.499 ' SD ' HD22 ' A' ' 157' ' ' LEU . 10.6 ptp -126.35 142.05 51.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.869 0.842 . . . . 0.0 110.637 168.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.0 t -155.72 143.03 19.33 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 128.152 2.581 . . . . 0.0 105.604 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 81.5 m 70.13 141.8 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.489 1.516 . . . . 0.0 113.422 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.41 -35.83 52.82 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.164 -0.96 . . . . 0.0 113.194 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.1 p -61.05 -25.22 66.77 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.109 -0.994 . . . . 0.0 113.373 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.3 t -65.91 -31.98 73.23 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.723 -0.611 . . . . 0.0 112.623 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.29 -60.5 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.305 0.642 . . . . 0.0 109.275 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -66.5 -20.01 65.93 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.5 t -71.08 -58.26 3.73 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.587 1.155 . . . . 0.0 111.764 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.5 mt -70.5 -49.41 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.002 1.321 . . . . 0.0 111.245 -176.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -53.16 -26.96 18.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.167 1.787 . . . . 0.0 111.775 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.62 -60.66 3.14 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.648 1.594 . . . . 0.0 113.321 167.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 70.1 mmm -54.29 -41.96 69.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.843 1.257 . . . . 0.0 114.001 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.79 -32.82 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.425 0.69 . . . . 0.0 111.97 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.0 t -64.9 1.11 0.97 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.256 1.423 . . . . 0.0 114.803 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -90.38 -30.31 17.49 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.357 -1.464 . . . . 0.0 114.031 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.86 176.77 8.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.216 1.006 . . . . 0.0 112.261 -174.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -86.84 154.45 20.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 122.489 1.138 . . . . 0.0 113.934 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.0 2.54 80.79 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 113.146 -1.843 . . . . 0.0 116.528 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.24 96.2 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 120.99 2.395 . . . . 0.0 112.231 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.477 HE22 ' HB2' ' A' ' 167' ' ' ASN . 24.5 mp0 -65.49 -50.28 65.91 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.88 0.872 . . . . 0.0 109.922 173.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -143.42 141.67 30.94 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.356 0.663 . . . . 0.0 111.427 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.48 138.98 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.961 0.886 . . . . 0.0 111.298 166.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.8 t -142.22 147.07 35.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 127.365 2.266 . . . . 0.0 109.05 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.3 t -134.75 136.44 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.314 0.961 . . . . 0.0 110.566 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.1 m -113.93 99.31 7.58 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.771 1.229 . . . . 0.0 111.149 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' LEU . . . . . 0.499 HD22 ' SD ' ' A' ' 131' ' ' MET . 0.2 OUTLIER -53.6 -30.99 45.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.952 1.701 . . . . 0.0 110.973 169.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -49.57 -34.21 17.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.043 2.137 . . . . 0.0 114.597 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -130.59 -5.24 4.16 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.187 0.995 . . . . 0.0 113.065 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.44 30.85 57.82 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.46 1.027 . . . . 0.0 112.355 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 61.0 p -118.66 152.98 35.07 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 117.869 0.834 . . . . 0.0 110.676 -170.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -125.26 124.3 41.36 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.675 0.79 . . . . 0.0 109.488 171.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.4 t -106.66 132.56 52.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.969 0.508 . . . . 0.0 110.18 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.82 138.67 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.068 0.547 . . . . 0.0 111.375 -171.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.16 96.1 8.21 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -98.78 159.92 14.62 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.625 0.77 . . . . 0.0 111.964 -177.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.477 ' HB2' HE22 ' A' ' 151' ' ' GLN . 59.8 t-20 -98.68 102.68 15.56 Favored Pre-proline 0 C--O 1.241 0.653 0 C-N-CA 124.935 1.294 . . . . 0.0 109.324 173.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.7 -16.93 55.37 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.612 1.541 . . . . 0.0 113.075 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.21 -12.94 60.4 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 173.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 76.4 t -119.78 -41.12 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.069 1.748 . . . . 0.0 111.858 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.4 tt -137.05 149.03 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.211 1.004 . . . . 0.0 112.05 -172.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 55.5 m -112.71 153.19 45.14 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 124.461 1.104 . . . . 0.0 111.991 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -52.28 -38.94 73.29 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.453 2.769 . . . . 0.0 114.559 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.34 -29.25 68.77 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -72.05 -31.44 66.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 112.532 172.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.39 -49.93 69.64 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.512 0.725 . . . . 0.0 109.351 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -52.7 -50.57 63.07 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.929 1.292 . . . . 0.0 111.834 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.94 69.41 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.78 65.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -74.34 -39.52 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.606 0.762 . . . . 0.0 110.91 170.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.61 -29.17 69.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.869 0.468 . . . . 0.0 111.746 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.07 -36.69 82.56 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.265 -1.522 . . . . 0.0 112.678 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 17.5 ttt -67.11 -28.66 68.34 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.86 0.864 . . . . 0.0 112.024 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 118.59 20.39 4.26 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.557 1.551 . . . . 0.0 115.747 169.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -106.46 -154.66 0.52 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.487 1.515 . . . . 0.0 109.69 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.58 138.13 42.67 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.119 1.367 . . . . 0.0 109.009 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -126.67 158.49 36.24 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.4 1.48 . . . . 0.0 111.545 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.2 t -140.51 136.11 32.59 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 126.947 2.099 . . . . 0.0 107.98 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.2 m -84.21 129.73 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.762 -0.586 . . . . 0.0 109.876 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 124.829 2.252 . . . . 0.0 107.151 171.095 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.429 HG13 ' CE1' ' A' ' 64' ' ' TYR . 9.0 p . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.59 144.01 50.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.951 0.9 . . . . 0.0 111.367 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.3 140.27 29.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.024 2.13 . . . . 0.0 109.205 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -131.01 146.21 52.31 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' H ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -132.6 158.13 43.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.592 1.957 . . . . 0.0 110.707 174.058 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.12 101.57 13.33 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -77.1 133.8 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.253 1.021 . . . . 0.0 110.814 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -97.84 136.24 38.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.472 1.509 . . . . 0.0 111.256 172.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.45 57.51 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.252 1.406 . . . . 0.0 114.256 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.2 ptp -60.81 -17.89 52.25 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -63.35 -15.53 57.69 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 119.4 1.0 . . . . 0.0 113.499 172.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.55 -9.97 59.71 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 168.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? 71.09 -59.78 0.53 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 128.68 2.792 . . . . 0.0 111.482 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.9 p -45.27 -35.84 3.66 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.335 2.254 . . . . 0.0 114.055 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -45.68 -45.76 14.35 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.7 1.6 . . . . 0.0 112.492 174.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.69 -18.43 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -174.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.1 tp -63.49 -50.92 67.75 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.203 0.911 . . . . 0.0 111.087 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -39.84 63.02 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.65 0.738 . . . . 0.0 111.072 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.38 -52.54 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.452 1.101 . . . . 0.0 109.977 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.41 -34.63 70.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.646 1.579 . . . . 0.0 113.701 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.59 -41.1 89.01 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.637 1.108 . . . . 0.0 111.68 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -94.12 -36.55 12.03 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.458 ' CD1' HG22 ' A' ' 78' ' ' ILE . 33.2 mm -98.22 114.77 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 121.177 -0.952 . . . . 0.0 109.04 -170.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.45 -27.36 2.38 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.183 0.897 . . . . 0.0 114.84 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -106.02 3.68 28.51 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.5 mt -87.78 163.67 16.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.815 1.246 . . . . 0.0 112.784 -170.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 47.1 tp -29.5 -62.01 0.14 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.802 2.441 . . . . 0.0 114.902 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.83 -23.78 13.02 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.218 -1.323 . . . . 0.0 114.626 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.86 126.3 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 120.14 1.97 . . . . 0.0 110.601 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -97.52 -40.32 8.71 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.798 0.839 . . . . 0.0 111.733 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.8 t -149.95 -178.56 6.55 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.413 1.085 . . . . 0.0 113.706 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.9 tp -132.63 145.3 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 127.462 2.305 . . . . 0.0 109.097 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -132.98 118.69 19.15 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.635 1.207 . . . . 0.0 109.561 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.4 t -104.82 95.07 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.274 1.83 . . . . 0.0 109.385 -168.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -113.17 55.63 0.7 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.401 1.481 . . . . 0.0 111.345 -174.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.4 mt -58.6 -28.82 65.94 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -168.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.5 -25.42 25.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.232 1.413 . . . . 0.0 113.589 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.7 m-80 -102.23 -0.36 33.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.056 1.343 . . . . 0.0 113.733 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 69.6 -15.86 0.28 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 127.746 2.418 . . . . 0.0 114.543 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.64 131.28 42.04 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.845 1.658 . . . . 0.0 108.702 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.37 145.29 27.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.594 1.158 . . . . 0.0 109.698 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.4 tp-100 -114.86 134.19 55.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.705 1.202 . . . . 0.0 109.246 -169.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 p -118.39 140.46 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 119.976 1.262 . . . . 0.0 111.045 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -113.51 101.4 9.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.234 1.813 . . . . 0.0 108.499 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.429 ' CE1' HG13 ' A' ' 20' ' ' VAL . 16.1 p90 -128.62 -179.37 5.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.842 1.657 . . . . 0.0 111.63 -168.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -120.23 138.12 26.79 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.803 1.241 . . . . 0.0 108.569 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.57 5.51 6.07 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.966 2.444 . . . . 0.0 113.556 -169.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.9 p -75.12 -29.1 60.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.413 1.085 . . . . 0.0 113.197 -172.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.63 -21.65 6.11 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -170.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -146.71 -179.21 6.62 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.956 1.702 . . . . 0.0 110.93 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.8 p -165.58 170.24 6.26 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.969 1.308 . . . . 0.0 111.882 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -45.61 -51.28 8.31 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 124.612 3.541 . . . . 0.0 116.122 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.3 m -70.16 -35.26 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 119.714 1.143 . . . . 0.0 112.879 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.1 77.46 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.471 0.708 . . . . 0.0 110.929 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.22 -48.33 78.76 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.336 1.054 . . . . 0.0 111.28 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -52.32 -54.65 28.81 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.191 0.905 . . . . 0.0 110.987 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -65.53 -36.13 82.9 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.305 1.042 . . . . 0.0 111.785 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.42 -53.98 39.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.472 0.709 . . . . 0.0 112.164 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.458 HG22 ' CD1' ' A' ' 42' ' ' ILE . 7.9 pt -72.4 -30.34 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -172.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -66.23 -27.39 67.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.139 0.881 . . . . 0.0 113.07 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.89 8.11 42.48 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.79 -51.52 80.28 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-O 117.688 -1.149 . . . . 0.0 112.4 168.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.408 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 76.6 Cg_endo -71.75 167.47 26.46 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.221 1.947 . . . . 0.0 111.48 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.16 62.81 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.074 3.183 . . . . 0.0 110.019 169.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.56 53.8 38.81 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 124.943 1.258 . . . . 0.0 112.814 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -125.7 -50.79 1.6 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -171.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.408 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 13.5 m-85 -97.52 118.92 35.1 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.13 149.76 22.72 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.244 1.018 . . . . 0.0 111.578 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.2 m -123.92 142.58 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -121.38 134.22 55.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.38 1.472 . . . . 0.0 111.561 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 126.865 2.066 . . . . 0.0 110.948 174.838 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.7 p -147.92 131.7 17.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -167.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.3 p -144.22 146.34 32.61 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.109 1.764 . . . . 0.0 111.504 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -99.31 147.53 25.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.502 1.121 . . . . 0.0 109.981 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.49 141.85 27.49 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.072 0.949 . . . . 0.0 110.497 168.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tt -108.74 144.55 36.4 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.07 1.348 . . . . 0.0 110.738 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mt -134.2 137.24 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.374 1.87 . . . . 0.0 110.39 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.83 133.73 42.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.308 1.443 . . . . 0.0 109.793 172.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 55.4 mt -140.33 130.53 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 119.462 1.028 . . . . 0.0 110.866 -171.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.19 53.43 0.72 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.344 1.058 . . . . 0.0 112.755 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.41 53.13 0.42 Allowed Glycine 0 N--CA 1.47 0.907 0 O-C-N 120.932 -1.105 . . . . 0.0 113.815 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -131.1 154.0 48.75 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.513 1.125 . . . . 0.0 109.903 170.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 t -157.33 -37.13 0.07 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.841 1.656 . . . . 0.0 111.217 -169.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 57.3 m -133.78 159.25 41.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.94 1.696 . . . . 0.0 111.577 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.85 -31.99 70.27 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -51.52 -26.3 8.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.898 1.279 . . . . 0.0 113.49 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 79.0 m -58.48 -26.42 63.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.519 1.128 . . . . 0.0 113.595 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.91 -47.33 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 118.892 0.769 . . . . 0.0 109.818 173.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -71.17 -13.89 62.09 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.4 m -70.98 -56.48 6.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.14 -54.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.846 1.258 . . . . 0.0 110.614 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -54.49 -32.82 58.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.22 1.008 . . . . 0.0 111.004 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.74 -49.53 63.39 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 124.171 0.891 . . . . 0.0 112.422 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 96.8 mmm -66.86 -46.99 73.32 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.689 1.244 . . . . 0.0 111.822 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.6 mm -73.19 -54.08 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.394 0.677 . . . . 0.0 112.707 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.5 t -62.46 -16.18 53.87 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -168.254 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -74.8 -30.84 61.55 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.978 1.311 . . . . 0.0 114.135 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 pp -89.28 -179.37 5.85 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.116 0.871 . . . . 0.0 111.407 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -87.39 -172.55 3.97 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.112 0.958 . . . . 0.0 111.6 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.63 -45.64 1.88 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.272 -1.517 . . . . 0.0 113.711 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.1 p -65.35 99.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.213 2.205 . . . . 0.0 112.096 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.23 -39.9 24.65 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.503 -0.748 . . . . 0.0 111.713 169.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -140.16 144.07 36.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.2 1.0 . . . . 0.0 110.461 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.45 138.32 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.997 0.903 . . . . 0.0 113.133 169.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.4 t -140.01 146.77 39.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.851 2.46 . . . . 0.0 110.691 -169.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.1 t -143.63 138.03 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.913 -1.117 . . . . 0.0 111.02 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 70.0 m -124.94 89.58 3.09 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.759 1.624 . . . . 0.0 111.126 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.53 -29.92 39.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.104 2.161 . . . . 0.0 113.242 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -47.7 -31.31 4.58 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.079 2.552 . . . . 0.0 115.259 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -130.18 -3.48 4.46 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.134 1.773 . . . . 0.0 112.237 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.29 36.32 63.48 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 117.852 -1.527 . . . . 0.0 112.882 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.8 p -124.1 153.74 41.0 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.126 1.463 . . . . 0.0 112.082 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -119.28 148.73 42.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.537 1.535 . . . . 0.0 109.722 169.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.9 t -138.39 133.55 33.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.585 0.754 . . . . 0.0 110.835 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.62 143.0 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.677 0.791 . . . . 0.0 111.451 -168.14 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.6 106.57 18.91 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.556 1.542 . . . . 0.0 107.371 169.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -108.38 158.09 17.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.957 1.303 . . . . 0.0 111.701 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -95.9 116.62 66.35 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 121.061 -1.024 . . . . 0.0 109.536 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.41 -10.22 20.48 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.326 2.017 . . . . 0.0 113.199 -170.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.15 -7.74 58.93 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.132 0.973 . . . . 0.0 113.418 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.97 -35.44 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.51 1.524 . . . . 0.0 112.348 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.0 tt -156.66 159.2 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.349 0.977 . . . . 0.0 112.205 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.76 150.72 43.2 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 126.213 1.805 . . . . 0.0 112.214 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.54 -43.87 37.39 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.3 3.334 . . . . 0.0 114.908 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -72.22 -15.94 61.94 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.68 -30.72 61.68 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.078 -1.014 . . . . 0.0 112.35 170.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 66.9 mt -59.04 -51.6 69.34 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.796 1.238 . . . . 0.0 110.406 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -49.73 -47.92 50.36 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.181 1.392 . . . . 0.0 112.512 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.02 -23.68 66.6 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.8 65.36 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.531 0.732 . . . . 0.0 112.207 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.3 mt -74.36 -41.36 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.75 1.22 . . . . 0.0 110.646 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -63.84 -28.27 69.74 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.011 0.924 . . . . 0.0 112.579 171.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -69.88 -35.46 74.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.177 0.991 . . . . 0.0 112.645 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 19.8 ttt -73.03 -34.06 66.1 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.871 0.868 . . . . 0.0 112.433 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 120.26 35.91 0.84 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.205 1.383 . . . . 0.0 114.741 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -134.48 147.56 50.39 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.82 1.648 . . . . 0.0 110.314 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -101.37 102.36 13.17 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.833 -1.167 . . . . 0.0 111.232 -167.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -99.98 147.34 25.69 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.284 2.234 . . . . 0.0 112.514 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.5 t -142.52 144.24 32.87 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.822 1.249 . . . . 0.0 109.999 168.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.2 m -71.71 136.39 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.702 -0.624 . . . . 0.0 110.675 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 125.766 1.626 . . . . 0.0 107.57 169.858 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.05 133.05 42.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.324 1.45 . . . . 0.0 109.373 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tt -126.53 128.83 47.5 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.307 2.243 . . . . 0.0 107.952 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -96.99 135.7 38.61 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.947 1.299 . . . . 0.0 110.344 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 pp -145.06 157.56 44.07 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.427 1.091 . . . . 0.0 113.736 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -116.06 125.39 52.36 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.02 1.328 . . . . 0.0 110.476 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.3 mt -100.86 150.23 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 126.169 1.788 . . . . 0.0 111.734 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.67 133.97 41.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.797 1.639 . . . . 0.0 110.923 173.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.43 1.25 81.35 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.853 1.216 . . . . 0.0 114.287 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.2 ptm -72.37 -6.78 45.83 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 116.196 1.925 . . . . 0.0 116.196 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -60.21 -18.87 51.49 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.425 1.011 . . . . 0.0 112.658 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.5 t -89.98 119.4 30.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 165.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -19.95 62.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.254 1.022 . . . . 0.0 113.397 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.3 m -63.59 -23.9 67.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.1 t -61.52 -52.38 64.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.902 1.683 . . . . 0.0 110.862 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.46 -15.77 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -69.65 -60.81 2.08 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.426 1.012 . . . . 0.0 111.264 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -26.07 68.65 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.34 -0.85 . . . . 0.0 112.117 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 92.3 mt -64.8 -50.94 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.913 -1.117 . . . . 0.0 111.048 167.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.0 -31.32 70.94 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.771 1.228 . . . . 0.0 113.658 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -56.03 -46.29 78.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.465 1.03 . . . . 0.0 110.541 173.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -90.29 -29.15 18.31 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.417 ' CD1' HG22 ' A' ' 78' ' ' ILE . 44.3 mm -110.09 113.43 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.34 1.056 . . . . 0.0 111.034 -169.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.27 -15.87 4.44 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 125.986 1.755 . . . . 0.0 114.45 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -101.77 5.66 41.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.79 1.236 . . . . 0.0 112.296 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.13 178.52 4.35 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.61 1.564 . . . . 0.0 112.142 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.9 -69.29 0.29 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.022 1.329 . . . . 0.0 111.333 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.69 -37.66 16.19 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.774 -1.57 . . . . 0.0 112.547 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.15 120.96 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 119.593 1.697 . . . . 0.0 110.126 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.29 -17.33 10.79 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.4 m -145.47 163.62 34.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.33 0.968 . . . . 0.0 111.324 169.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.5 tp -129.1 124.54 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.279 1.032 . . . . 0.0 109.045 168.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -114.13 142.14 46.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.408 1.483 . . . . 0.0 108.305 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.08 137.87 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.806 0.842 . . . . 0.0 109.687 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.0 t -136.12 55.53 1.85 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 123.967 1.842 . . . . 0.0 107.69 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.8 mt -68.9 -24.49 64.31 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.009 1.724 . . . . 0.0 114.516 -167.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.61 -52.42 63.85 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.317 1.047 . . . . 0.0 110.421 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.79 19.02 6.89 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.676 1.191 . . . . 0.0 111.942 174.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 65.12 28.01 12.32 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.569 1.948 . . . . 0.0 112.76 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.6 152.29 27.77 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.604 1.561 . . . . 0.0 111.447 -176.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.49 154.78 44.69 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -141.7 116.41 9.74 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -163.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 p -98.79 137.38 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 120.97 0.414 . . . . 0.0 111.236 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -108.3 97.65 7.3 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.812 2.045 . . . . 0.0 108.713 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -129.63 155.74 45.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.875 1.27 . . . . 0.0 113.921 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -99.17 118.53 62.42 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 125.564 1.545 . . . . 0.0 110.528 170.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.0 -2.13 2.05 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.203 3.935 . . . . 0.0 116.064 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.5 t -72.94 -22.65 60.68 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.136 1.374 . . . . 0.0 113.145 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 36.1 m -139.66 -8.62 1.24 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 t -147.91 -179.47 6.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.272 1.029 . . . . 0.0 110.833 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 p -160.81 156.29 21.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.057 0.943 . . . . 0.0 113.16 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.69 -55.68 3.88 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.747 3.631 . . . . 0.0 116.129 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 m -67.26 -34.17 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.097 1.317 . . . . 0.0 112.053 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.22 89.54 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.967 0.907 . . . . 0.0 111.661 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.7 mt -66.22 -43.81 85.59 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.849 0.86 . . . . 0.0 111.494 171.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -57.93 -44.76 87.09 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.237 0.926 . . . . 0.0 110.815 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -70.09 -31.2 68.65 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.368 1.067 . . . . 0.0 113.557 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.42 -51.77 27.09 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.952 0.901 . . . . 0.0 112.486 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.417 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.4 pt -74.29 -32.47 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -174.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.16 -30.01 69.02 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.59 7.08 40.99 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.08 -55.04 37.77 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.385 -1.293 . . . . 0.0 112.885 170.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 92.1 Cg_endo -72.2 169.36 21.72 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.992 2.461 . . . . 0.0 111.492 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.12 51.95 3.32 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 125.245 3.964 . . . . 0.0 112.404 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.43 63.28 4.21 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -173.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.2 t30 -130.3 -58.1 1.06 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.42 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 20.4 m-85 -93.22 124.67 37.36 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -97.55 162.94 13.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.015 0.926 . . . . 0.0 110.452 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 p -140.82 137.25 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.0 m -118.85 139.39 51.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.142 2.177 . . . . 0.0 110.767 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 124.575 1.15 . . . . 0.0 111.584 175.268 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.26 5.7 t . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.459 0.171 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.4 m 49.8 93.16 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 166.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 p -133.92 141.44 47.33 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.476 -1.39 . . . . 0.0 111.211 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 44.2 m -97.46 134.42 40.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.664 1.12 . . . . 0.0 110.176 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.4 158.16 45.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.209 1.004 . . . . 0.0 113.067 175.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.22 136.51 45.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.323 2.249 . . . . 0.0 111.025 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.0 mm -128.58 134.4 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.963 1.705 . . . . 0.0 108.348 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.08 130.1 45.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.185 0.994 . . . . 0.0 109.486 172.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.35 147.53 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.47 -1.394 . . . . 0.0 110.921 -168.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -134.97 58.67 1.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.29 1.436 . . . . 0.0 113.221 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.1 48.74 0.3 Allowed Glycine 0 N--CA 1.469 0.846 0 O-C-N 120.889 -1.132 . . . . 0.0 113.696 166.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' MET . . . . . 0.408 ' O ' HG22 ' A' ' 132' ' ' THR . 74.3 mtm -102.14 -55.51 2.46 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 117.562 -1.209 . . . . 0.0 111.716 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 131' ' ' MET 0.256 6.0 t 67.44 -38.64 0.35 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 129.647 3.179 . . . . 0.0 114.619 174.072 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 87.3 m -135.47 153.56 51.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.502 2.321 . . . . 0.0 111.529 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.56 76.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.353 1.061 . . . . 0.0 113.401 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.4 p -53.19 -35.29 59.69 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.813 0.733 . . . . 0.0 112.565 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.4 t -62.89 -25.8 68.48 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.2 t -58.94 -57.29 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.93 0.786 . . . . 0.0 109.076 169.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -65.54 -23.75 66.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.254 0.479 . . . . 0.0 112.16 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.1 m -69.9 -47.97 60.47 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.647 -0.658 . . . . 0.0 112.242 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.83 -53.68 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 119.725 1.148 . . . . 0.0 110.826 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -54.43 -31.01 54.37 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.673 1.989 . . . . 0.0 111.314 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.46 -61.74 2.71 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.3 1.429 . . . . 0.0 114.469 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 74.3 mmm -70.38 -41.81 72.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.844 1.258 . . . . 0.0 114.073 -168.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.8 mm -70.85 -27.57 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.714 -0.617 . . . . 0.0 110.66 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.411 ' HA ' HG11 ' A' ' 150' ' ' VAL . 2.7 t -65.73 0.39 1.73 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -99.48 -5.35 29.49 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -104.51 173.98 6.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.396 1.479 . . . . 0.0 111.821 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -79.14 142.87 36.0 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.079 -1.013 . . . . 0.0 111.712 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 94.09 11.47 57.49 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 117.133 -1.926 . . . . 0.0 116.947 175.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' A' ' 145' ' ' SER . 10.1 p -111.85 -29.27 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.638 1.719 . . . . 0.0 114.775 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 39.07 -71.3 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 129.988 3.315 . . . . 0.0 117.602 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -133.74 124.74 27.17 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.619 1.1 . . . . 0.0 110.373 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.7 tt -129.41 136.12 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.7 1.2 . . . . 0.0 111.24 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 24.5 t -136.38 126.56 26.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.218 1.807 . . . . 0.0 109.253 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.1 t -141.69 139.21 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.725 -1.234 . . . . 0.0 110.436 -168.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.1 m -145.39 140.17 27.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.211 0.604 . . . . 0.0 112.021 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.9 mt -65.63 -30.63 71.37 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.44 -56.36 5.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.754 2.021 . . . . 0.0 113.199 -170.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -101.39 -5.7 25.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.151 1.38 . . . . 0.0 111.198 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.27 35.53 77.08 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 125.248 1.404 . . . . 0.0 112.286 -175.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.4 p -116.7 139.17 50.85 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 124.697 1.199 . . . . 0.0 113.615 -167.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.65 138.72 41.37 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.664 1.586 . . . . 0.0 108.965 167.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.8 t -123.01 126.38 47.03 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 166.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.47 142.93 28.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 123.525 0.73 . . . . 0.0 111.313 -166.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -93.06 93.52 8.36 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.868 2.067 . . . . 0.0 106.601 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -94.62 158.12 15.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.96 0.886 . . . . 0.0 111.234 -174.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -95.77 106.98 30.98 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 121.701 -0.624 . . . . 0.0 109.975 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.15 -17.74 24.34 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.135 1.89 . . . . 0.0 112.856 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.71 41.0 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.457 1.103 . . . . 0.0 113.766 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.57 -27.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.097 1.759 . . . . 0.0 113.342 -171.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 21.3 tt -145.38 147.09 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 120.488 1.494 . . . . 0.0 112.457 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 35.3 m -98.5 144.71 28.61 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.279 1.032 . . . . 0.0 110.654 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.77 -33.51 32.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.315 3.344 . . . . 0.0 115.02 176.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -60.75 -28.59 68.82 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.5 -28.33 59.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.041 1.336 . . . . 0.0 113.07 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.23 -48.5 78.0 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.022 0.828 . . . . 0.0 109.104 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -52.66 -47.62 67.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.017 1.327 . . . . 0.0 111.068 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.46 -30.14 69.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.371 1.068 . . . . 0.0 113.712 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.38 -38.83 68.39 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.989 1.268 . . . . 0.0 113.001 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.63 -36.19 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.64 0.776 . . . . 0.0 110.391 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -69.66 -31.09 68.96 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.6 -0.688 . . . . 0.0 112.426 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.18 -28.76 65.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.663 1.985 . . . . 0.0 112.637 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.8 ttt -70.89 -36.69 72.87 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.34 1.056 . . . . 0.0 111.107 172.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 134.14 16.78 1.06 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.517 1.532 . . . . 0.0 116.117 169.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -113.08 -159.31 0.68 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.696 1.248 . . . . 0.0 110.216 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -128.27 140.63 51.78 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.525 1.13 . . . . 0.0 110.066 169.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -132.22 151.37 51.85 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.513 1.525 . . . . 0.0 111.875 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.2 t -133.41 132.49 41.22 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.394 1.478 . . . . 0.0 111.997 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.5 m -84.54 80.8 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.986 0.898 . . . . 0.0 110.722 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 126.654 1.982 . . . . 0.0 111.817 174.007 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.676 0.751 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -99.16 137.63 37.4 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.568 1.947 . . . . 0.0 110.002 -169.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tt -142.25 139.21 31.86 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.597 1.159 . . . . 0.0 110.62 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -98.35 133.94 42.05 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.692 1.997 . . . . 0.0 110.716 -176.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.11 134.07 24.01 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.794 170.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -100.05 113.64 26.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 mt -77.73 128.99 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 121.548 0.69 . . . . 0.0 109.577 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.2 107.85 19.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.235 2.214 . . . . 0.0 109.894 -171.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.09 10.52 34.2 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.676 1.131 . . . . 0.0 114.074 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.3 ptp -57.99 -35.58 71.41 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.155 1.478 . . . . 0.0 114.334 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 t60 68.06 -44.06 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 129.202 3.001 . . . . 0.0 113.294 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.8 p -166.74 166.88 15.58 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.647 2.379 . . . . 0.0 110.344 -173.104 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.55 -35.92 61.28 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.7 m -57.73 -23.09 50.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 t -49.39 -40.42 35.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.643 1.177 . . . . 0.0 112.004 168.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -12.34 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 117.83 -1.081 . . . . 0.0 113.565 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.87 -49.73 71.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.536 1.516 . . . . 0.0 111.884 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -40.94 68.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.144 0.884 . . . . 0.0 110.716 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mt -65.3 -52.31 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.311 1.444 . . . . 0.0 109.775 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -60.84 -33.32 72.86 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.936 2.495 . . . . 0.0 113.478 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -67.31 -45.05 77.64 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.517 1.127 . . . . 0.0 111.763 173.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -95.22 -29.43 14.52 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -170.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.415 ' CD1' HG22 ' A' ' 78' ' ' ILE . 47.3 mm -108.14 113.46 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.108 0.963 . . . . 0.0 109.577 -170.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.23 -22.55 7.06 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 125.857 1.694 . . . . 0.0 114.015 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -78.65 -10.68 59.84 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 118.188 0.994 . . . . 0.0 112.094 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.5 mt -67.81 -177.69 0.84 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.609 3.164 . . . . 0.0 112.404 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tt -82.12 -70.21 0.56 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.406 -0.809 . . . . 0.0 110.992 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.94 -44.44 78.67 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.118 -1.379 . . . . 0.0 112.483 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.14 117.82 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.65 1.725 . . . . 0.0 108.617 171.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -97.32 -41.47 8.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.153 0.981 . . . . 0.0 110.494 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 t -145.56 167.3 23.36 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.042 0.937 . . . . 0.0 112.666 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.6 tp -135.85 142.46 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.7 2.0 . . . . 0.0 108.437 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -141.48 153.93 45.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.01 1.724 . . . . 0.0 110.015 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.445 HG13 HD13 ' A' ' 55' ' ' LEU . 12.6 t -108.83 144.46 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.71 2.004 . . . . 0.0 109.926 -176.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.5 t -140.37 54.14 1.62 Allowed 'General case' 0 CA--C 1.555 1.159 0 CA-C-O 122.806 1.288 . . . . 0.0 109.939 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.445 HD13 HG13 ' A' ' 53' ' ' VAL . 1.7 mp -64.11 -19.28 65.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.081 1.353 . . . . 0.0 113.973 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.46 -24.21 44.1 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.1 19.36 8.33 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.875 1.67 . . . . 0.0 111.799 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.8 mttt 60.75 16.85 7.08 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.271 1.828 . . . . 0.0 113.788 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 p -96.92 159.71 14.76 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 123.517 1.627 . . . . 0.0 110.123 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.43 154.09 38.22 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.042 2.137 . . . . 0.0 106.813 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 tp-100 -131.03 119.03 21.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.864 1.266 . . . . 0.0 108.587 -168.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 p -106.87 141.4 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.745 -0.597 . . . . 0.0 110.633 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.15 95.51 5.42 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.64 1.576 . . . . 0.0 108.97 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -123.31 150.64 43.33 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.362 1.065 . . . . 0.0 112.567 -173.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.4 123.11 57.68 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.544 1.137 . . . . 0.0 107.997 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.35 -12.79 6.23 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.067 3.178 . . . . 0.0 114.801 175.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.8 m -58.41 -28.32 65.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.032 1.733 . . . . 0.0 114.93 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 99.0 m -137.94 -12.17 1.48 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -148.2 177.14 9.65 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.869 1.267 . . . . 0.0 111.282 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.5 p -158.64 160.7 29.28 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.279 1.432 . . . . 0.0 111.893 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -53.99 -48.81 19.64 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.09 2.527 . . . . 0.0 115.398 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.2 m -69.31 -32.85 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 120.135 1.334 . . . . 0.0 112.938 177.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.55 -35.19 78.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.448 0.699 . . . . 0.0 111.643 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.96 -48.63 57.53 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.339 1.055 . . . . 0.0 111.213 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.0 tt0 -54.59 -57.18 12.42 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.476 1.034 . . . . 0.0 111.555 -178.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -60.51 -31.11 70.19 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.439 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.04 -61.94 1.61 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.009 0.924 . . . . 0.0 112.824 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.415 HG22 ' CD1' ' A' ' 42' ' ' ILE . 8.8 pt -70.48 -29.85 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -169.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -59.48 -35.07 73.41 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.996 0.919 . . . . 0.0 111.471 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.05 13.63 33.39 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mt -59.23 -55.99 40.63 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.909 166.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.56 171.27 18.09 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.524 2.816 . . . . 0.0 112.36 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.31 59.91 6.2 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.584 3.523 . . . . 0.0 110.975 171.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.32 35.58 92.14 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.999 1.285 . . . . 0.0 113.118 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -101.19 -41.17 6.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.685 0.742 . . . . 0.0 112.734 -169.093 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -115.78 117.02 29.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.611 1.164 . . . . 0.0 109.118 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -99.37 170.39 8.67 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.301 1.44 . . . . 0.0 111.337 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 32.7 m -135.26 130.28 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.064 -1.022 . . . . 0.0 110.902 173.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.9 m -103.75 117.78 35.16 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.146 0.978 . . . . 0.0 110.579 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.335 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 122.563 1.173 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 29.3 p -163.84 142.41 7.66 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.084 2.153 . . . . 0.0 110.958 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.2 t -144.98 158.41 43.82 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.311 -0.868 . . . . 0.0 111.094 172.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 98.6 m -98.53 140.52 32.64 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.86 149.64 40.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.514 1.126 . . . . 0.0 110.603 173.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 tt -115.25 136.79 52.73 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.986 1.714 . . . . 0.0 109.084 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.7 mm -119.66 138.07 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.737 2.015 . . . . 0.0 108.255 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.58 136.58 38.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.507 1.123 . . . . 0.0 108.91 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.26 139.2 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 120.729 -1.232 . . . . 0.0 110.134 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.39 57.86 1.0 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.359 2.264 . . . . 0.0 112.016 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.05 52.36 0.23 Allowed Glycine 0 N--CA 1.465 0.592 0 C-N-CA 124.435 1.017 . . . . 0.0 111.354 168.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.1 mtm -136.1 126.34 26.45 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.854 1.262 . . . . 0.0 108.788 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.2 t -144.7 -24.83 0.51 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.703 1.601 . . . . 0.0 111.457 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 96.6 m -116.01 142.54 46.66 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.552 1.941 . . . . 0.0 110.8 170.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -48.93 -32.81 9.66 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.112 1.365 . . . . 0.0 113.837 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.9 p -58.2 -22.54 52.24 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.6 t -61.87 -28.66 69.66 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.214 -0.928 . . . . 0.0 112.358 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.9 -51.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 121.627 -0.671 . . . . 0.0 110.722 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -70.13 -19.14 63.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.6 m -74.62 -56.09 5.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.376 1.07 . . . . 0.0 112.077 167.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.78 -57.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 121.123 -0.986 . . . . 0.0 111.153 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.43 -25.57 66.06 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.239 1.016 . . . . 0.0 110.912 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.49 -57.97 5.23 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.886 1.232 . . . . 0.0 113.611 174.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.2 -46.32 42.75 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.976 0.888 . . . . 0.0 113.337 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.0 mm -72.71 -24.09 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.635 0.774 . . . . 0.0 112.501 -172.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.9 p -65.6 -15.74 63.03 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.1 -10.87 43.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -168.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.99 -177.8 6.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.324 1.049 . . . . 0.0 113.253 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -93.63 127.11 39.16 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.256 1.022 . . . . 0.0 109.845 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 103.5 16.98 18.69 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 117.683 -1.621 . . . . 0.0 116.517 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.34 100.41 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 127.212 2.205 . . . . 0.0 112.475 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -78.12 -49.21 14.32 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.401 -0.812 . . . . 0.0 112.232 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -140.51 141.25 35.36 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.225 1.81 . . . . 0.0 108.669 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.5 tt -144.2 131.04 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.235 1.014 . . . . 0.0 111.545 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.38 122.65 13.88 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.691 0.797 . . . . 0.0 112.105 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.86 138.37 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.039 0.935 . . . . 0.0 111.854 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.5 t -141.55 134.56 29.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.28 1.432 . . . . 0.0 111.488 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.15 -17.96 61.32 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.81 63.61 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.338 1.455 . . . . 0.0 112.969 -173.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -113.41 -5.73 13.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.209 1.804 . . . . 0.0 111.566 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 72.08 49.76 20.45 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.554 1.55 . . . . 0.0 112.078 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.6 p -139.27 149.46 44.31 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -168.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.16 140.06 47.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.628 1.571 . . . . 0.0 110.741 169.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.8 t -116.9 127.71 54.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.58 141.42 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.544 0.738 . . . . 0.0 110.571 -171.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.96 108.74 21.52 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.242 1.817 . . . . 0.0 106.9 175.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -114.65 159.57 20.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.98 0.895 . . . . 0.0 112.767 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -97.84 113.4 63.62 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.101 0.96 . . . . 0.0 109.858 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.08 -7.1 17.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.961 2.441 . . . . 0.0 115.093 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.42 -37.17 20.11 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.717 1.144 . . . . 0.0 111.018 168.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 86.7 t -85.44 -32.46 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.461 1.104 . . . . 0.0 113.192 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.5 tt -148.96 151.72 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 120.268 1.394 . . . . 0.0 113.678 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.07 145.78 31.11 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.779 1.632 . . . . 0.0 112.456 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.67 -33.47 93.67 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.838 2.358 . . . . 0.0 115.286 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.74 -22.41 61.62 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.364 0.984 . . . . 0.0 113.135 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -72.62 -38.02 67.87 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.741 -1.224 . . . . 0.0 111.57 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 82.9 mt -55.44 -54.41 44.13 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.773 0.829 . . . . 0.0 109.908 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -51.22 -55.27 18.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.998 1.319 . . . . 0.0 111.299 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.5 -18.84 65.63 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.62 -33.33 68.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.942 1.247 . . . . 0.0 112.23 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.1 -39.72 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.396 1.078 . . . . 0.0 110.532 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.65 -31.77 72.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.241 0.616 . . . . 0.0 112.375 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.19 -5.11 39.93 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.539 1.936 . . . . 0.0 114.441 169.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.46 -47.98 5.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.126 1.37 . . . . 0.0 111.466 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 157.45 15.8 0.04 OUTLIER Glycine 0 N--CA 1.469 0.867 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -133.27 -163.46 1.35 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.987 1.394 . . . . 0.0 108.954 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.58 147.02 49.93 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.198 0.999 . . . . 0.0 109.357 169.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -138.97 160.18 40.38 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.0 t -138.36 141.67 39.68 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.485 1.914 . . . . 0.0 109.168 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.3 128.83 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.331 -0.856 . . . . 0.0 108.866 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 122.873 1.32 . . . . 0.0 108.733 -178.866 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.11 138.25 45.13 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.64 -0.663 . . . . 0.0 112.583 -173.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.56 163.72 25.38 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -109.71 133.25 53.34 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 127.819 2.448 . . . . 0.0 110.04 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -146.46 155.05 42.27 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.374 0.67 . . . . 0.0 112.327 171.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -116.98 107.51 14.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.557 0.694 . . . . 0.0 111.09 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.6 mt -88.62 143.42 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.795 2.038 . . . . 0.0 110.938 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -97.46 142.85 28.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.013 2.525 . . . . 0.0 110.137 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.95 -13.64 65.56 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.902 1.239 . . . . 0.0 114.506 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.5 ptp -62.12 -23.23 66.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.517 1.158 . . . . 0.0 113.925 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -69.51 -15.77 63.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.33 0.968 . . . . 0.0 113.599 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 87.7 m -75.49 -6.04 48.15 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 120.586 1.539 . . . . 0.0 112.18 166.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp 71.74 -52.24 0.69 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 130.415 3.486 . . . . 0.0 113.397 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -54.22 -23.28 14.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.564 1.146 . . . . 0.0 113.937 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.4 t -57.99 -47.41 83.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.359 1.864 . . . . 0.0 112.543 169.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -73.64 -24.63 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 118.555 0.616 . . . . 0.0 112.464 -173.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.6 tp -57.32 -53.9 52.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.021 0.928 . . . . 0.0 111.746 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -37.68 76.22 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.821 -0.549 . . . . 0.0 110.962 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.1 mt -66.11 -49.6 75.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.372 0.669 . . . . 0.0 110.579 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -60.25 -36.12 77.05 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.046 1.738 . . . . 0.0 112.914 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -68.31 -39.91 81.85 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.308 -0.87 . . . . 0.0 112.346 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -95.26 -37.52 10.97 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.9 mm -93.04 119.64 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 120.389 -1.445 . . . . 0.0 108.699 -168.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.07 -17.83 6.24 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.019 1.771 . . . . 0.0 112.609 -167.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -87.72 -4.03 58.93 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.257 1.028 . . . . 0.0 112.443 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.67 178.26 8.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.593 1.957 . . . . 0.0 112.028 -170.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tp -59.52 -74.94 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.384 1.874 . . . . 0.0 112.31 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.58 52.42 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 117.483 -1.732 . . . . 0.0 115.671 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.5 t -87.51 113.56 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.589 2.194 . . . . 0.0 109.451 168.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -86.39 -43.37 12.9 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.485 1.114 . . . . 0.0 111.791 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.3 t -147.86 178.03 8.84 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.436 1.095 . . . . 0.0 111.649 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.6 tp -139.74 140.78 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.907 1.683 . . . . 0.0 108.611 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -129.36 120.53 25.74 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.213 1.405 . . . . 0.0 108.083 -173.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.87 86.97 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.394 1.478 . . . . 0.0 110.627 -166.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 p -98.67 54.29 1.03 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.569 1.948 . . . . 0.0 113.03 -170.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.9 mt -61.82 -26.3 68.03 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -172.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.32 -33.96 63.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.579 1.152 . . . . 0.0 113.148 173.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -94.81 -0.29 54.26 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.795 0.838 . . . . 0.0 112.572 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? 68.06 -0.34 2.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.883 2.473 . . . . 0.0 113.167 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.0 p -99.68 167.73 10.38 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 127.577 2.351 . . . . 0.0 109.881 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.53 149.21 41.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 168.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.1 tp60 -116.0 125.92 53.13 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.245 1.418 . . . . 0.0 108.49 -172.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.73 135.0 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.001 -1.062 . . . . 0.0 111.0 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -99.26 95.82 7.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.048 1.739 . . . . 0.0 107.822 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -122.97 -179.32 4.22 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.075 1.75 . . . . 0.0 112.989 -168.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -129.22 136.12 28.66 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 125.612 1.565 . . . . 0.0 109.978 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -84.08 15.06 2.24 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.433 2.756 . . . . 0.0 113.317 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.1 t -111.33 -35.65 5.79 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.32 1.048 . . . . 0.0 111.082 173.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.1 m -90.58 -18.64 24.86 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . 0.252 2.8 t -148.49 -175.79 5.06 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.1 0.96 . . . . 0.0 112.163 175.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.1 p -153.72 167.59 13.33 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.046 1.739 . . . . 0.0 110.91 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.39 -44.09 24.69 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.593 2.196 . . . . 0.0 113.204 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.94 -37.87 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 118.92 0.782 . . . . 0.0 112.839 172.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.56 89.13 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.666 -0.646 . . . . 0.0 112.244 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.35 -55.77 30.51 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.111 1.765 . . . . 0.0 109.838 168.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -61.28 -39.82 91.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.87 0.868 . . . . 0.0 111.644 -173.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -70.8 -36.92 73.2 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.439 1.096 . . . . 0.0 112.804 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.66 -60.4 2.27 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.782 0.719 . . . . 0.0 112.681 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 pt -70.25 -26.78 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -167.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -70.81 -15.47 62.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.4 9.52 33.67 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.999 -1.063 . . . . 0.0 113.523 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.23 -47.95 97.26 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.145 165.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -77.56 171.57 17.31 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.646 2.231 . . . . 0.0 110.429 167.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -76.54 51.61 3.35 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 124.127 3.218 . . . . 0.0 110.978 170.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.16 28.51 68.14 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 120.996 -1.065 . . . . 0.0 113.756 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -97.32 -45.42 6.49 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.967 0.884 . . . . 0.0 112.459 -172.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -97.01 102.19 13.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.243 1.017 . . . . 0.0 108.73 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -96.52 141.42 29.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.265 1.026 . . . . 0.0 111.474 -170.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 p -130.27 134.66 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -172.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.3 m -118.95 144.41 46.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.461 1.504 . . . . 0.0 111.803 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 CA--C 1.539 0.549 0 C-N-CA 126.348 1.859 . . . . 0.0 112.21 -172.127 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.2 m -138.05 127.61 24.98 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.556 1.542 . . . . 0.0 111.81 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.0 m -146.34 152.63 39.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.925 1.29 . . . . 0.0 111.531 171.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 92.5 m -109.18 140.47 42.74 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.123 0.969 . . . . 0.0 109.58 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.22 158.54 43.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 168.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.89 127.46 48.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.488 2.315 . . . . 0.0 109.469 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.8 mm -113.28 136.37 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.438 1.095 . . . . 0.0 108.827 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -101.25 122.49 43.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.771 0.714 . . . . 0.0 109.33 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.66 135.2 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.065 0.946 . . . . 0.0 110.237 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -115.02 56.3 0.74 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.985 1.714 . . . . 0.0 112.09 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.02 54.86 0.32 Allowed Glycine 0 N--CA 1.465 0.6 0 C-N-CA 124.151 0.881 . . . . 0.0 112.076 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 39.6 mtm -148.35 138.25 22.38 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.033 0.933 . . . . 0.0 110.942 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.3 t -160.34 -32.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.122 1.369 . . . . 0.0 111.841 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 93.4 m -105.48 138.8 41.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.315 1.846 . . . . 0.0 109.937 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.07 -27.32 31.87 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.601 1.16 . . . . 0.0 113.751 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.6 t -56.34 -32.19 64.45 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.202 1.001 . . . . 0.0 112.969 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.5 t -60.65 -20.75 61.65 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.53 -59.62 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.005 168.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -63.31 -22.14 66.69 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.144 1.338 . . . . 0.0 112.815 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.6 m -70.65 -60.16 2.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.243 1.017 . . . . 0.0 112.153 170.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.0 mt -69.33 -51.28 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.581 -1.324 . . . . 0.0 110.897 -174.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -58.17 -30.98 66.84 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.136 1.374 . . . . 0.0 110.896 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.06 -62.34 2.64 Favored Glycine 0 C--N 1.343 0.967 0 C-N-CA 125.657 1.598 . . . . 0.0 114.615 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -44.98 62.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.483 1.113 . . . . 0.0 113.098 -172.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.2 mm -72.99 -29.51 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.09 0.556 . . . . 0.0 112.034 -172.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.5 p -64.86 0.99 0.98 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -106.9 -9.24 16.38 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -168.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.41 11.28 31.2 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -171.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 70.2 163.87 0.26 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.277 2.631 . . . . 0.0 114.191 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.98 -39.19 1.13 Allowed Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.486 -1.384 . . . . 0.0 112.977 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.52 98.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 127.462 2.305 . . . . 0.0 111.213 169.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -86.53 -54.72 4.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.853 0.861 . . . . 0.0 112.455 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -141.52 121.4 13.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.735 1.214 . . . . 0.0 109.045 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.0 tt -133.3 128.14 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.208 1.003 . . . . 0.0 110.92 -170.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.74 155.83 44.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.642 1.177 . . . . 0.0 109.9 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.69 142.31 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.433 1.015 . . . . 0.0 111.934 -171.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 45.0 m -115.28 86.98 2.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.832 2.453 . . . . 0.0 109.16 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.27 -27.55 69.09 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.376 -1.453 . . . . 0.0 111.451 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.8 -30.79 1.77 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.303 2.641 . . . . 0.0 114.824 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -118.07 -20.75 8.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.423 1.489 . . . . 0.0 111.772 173.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.37 36.56 8.72 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.592 1.567 . . . . 0.0 111.964 -174.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.6 p -128.28 140.6 51.8 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.803 1.301 . . . . 0.0 112.798 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.94 137.79 42.17 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.538 1.135 . . . . 0.0 110.736 169.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.9 t -111.49 121.95 46.53 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.24 140.91 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -169.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.03 115.93 28.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.122 2.169 . . . . 0.0 106.599 171.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -117.47 157.52 26.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.78 1.232 . . . . 0.0 111.71 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -99.75 105.79 36.49 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.716 1.206 . . . . 0.0 110.981 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -67.44 -13.33 38.86 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.253 2.635 . . . . 0.0 114.023 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.77 -10.73 58.75 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.282 0.946 . . . . 0.0 113.127 171.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.33 -34.04 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.556 1.543 . . . . 0.0 112.08 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.5 tt -159.93 147.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.886 1.221 . . . . 0.0 112.507 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.7 t -97.02 149.9 36.22 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.606 1.162 . . . . 0.0 112.528 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -49.99 -30.42 24.35 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.907 3.738 . . . . 0.0 114.19 168.351 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -67.02 -33.9 76.55 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.369 0.986 . . . . 0.0 112.39 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -75.29 -35.41 61.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.228 . . . . 0.0 110.404 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.04 -58.2 9.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.676 2.39 . . . . 0.0 111.48 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.54 -38.81 78.56 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.114 0.87 . . . . 0.0 112.35 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.98 -26.53 68.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.96 -30.42 63.83 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.461 1.028 . . . . 0.0 112.53 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.16 -34.52 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.306 1.042 . . . . 0.0 110.969 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -63.91 -39.34 93.94 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.674 0.67 . . . . 0.0 111.893 172.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.65 -31.44 72.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.52 1.928 . . . . 0.0 112.942 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 21.9 ttt -69.78 -37.18 76.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.156 0.982 . . . . 0.0 111.386 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 130.96 15.43 1.71 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.494 1.521 . . . . 0.0 116.306 169.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.92 -158.08 0.65 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.426 1.613 . . . . 0.0 108.923 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -133.52 142.7 48.33 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.032 0.933 . . . . 0.0 109.885 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -137.32 137.99 39.51 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.282 1.433 . . . . 0.0 112.975 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.2 t -123.07 131.35 53.66 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.834 1.654 . . . . 0.0 111.339 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 m -85.64 71.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.266 1.026 . . . . 0.0 110.661 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.582 -176.813 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.422 HG13 ' CE1' ' A' ' 64' ' ' TYR . 11.0 p . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 p -112.56 166.56 11.21 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.613 1.965 . . . . 0.0 112.049 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.56 137.42 31.96 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.837 1.255 . . . . 0.0 111.711 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -99.15 120.1 38.95 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.961 0.886 . . . . 0.0 109.679 168.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.25 139.21 30.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.512 -1.676 . . . . 0.0 112.825 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -101.49 143.22 31.76 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.932 1.293 . . . . 0.0 109.03 171.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mm -107.32 153.14 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.763 1.625 . . . . 0.0 109.807 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -106.1 140.27 39.34 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.654 1.582 . . . . 0.0 110.652 170.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.61 3.21 88.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.879 1.228 . . . . 0.0 114.033 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.5 ptm -70.53 -3.6 18.79 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -50.8 -26.18 5.36 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.806 1.242 . . . . 0.0 114.345 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.4 p -114.04 137.74 51.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.962 1.305 . . . . 0.0 111.033 169.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -65.07 -15.7 62.65 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -50.79 -31.95 18.46 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.992 -1.068 . . . . 0.0 113.21 169.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.1 t -67.99 -57.91 5.38 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.337 1.055 . . . . 0.0 111.678 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 p -62.79 -29.62 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.407 1.003 . . . . 0.0 112.056 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.72 -61.01 2.93 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.264 1.026 . . . . 0.0 112.289 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -65.46 -31.28 72.28 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.785 -0.572 . . . . 0.0 111.821 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.01 -52.42 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 118.795 0.725 . . . . 0.0 109.48 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -38.3 90.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.567 1.147 . . . . 0.0 113.184 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -65.76 -34.95 79.36 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.332 0.653 . . . . 0.0 111.982 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -92.91 -24.41 18.44 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.435 ' CD1' HG22 ' A' ' 78' ' ' ILE . 47.2 mm -105.75 122.85 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.385 0.993 . . . . 0.0 109.669 -171.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.25 -22.81 5.28 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 125.581 1.562 . . . . 0.0 113.956 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -84.65 -0.65 54.21 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.652 1.581 . . . . 0.0 113.165 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.43 -172.33 4.11 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.779 2.032 . . . . 0.0 113.959 -171.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 tp -68.87 -82.78 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.427 2.291 . . . . 0.0 111.974 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.32 -30.32 60.78 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 120.12 1.327 . . . . 0.0 114.241 -173.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 t -84.07 127.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.044 1.422 . . . . 0.0 110.339 169.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -114.51 -23.1 9.48 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.4 t -145.63 166.08 26.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.226 0.921 . . . . 0.0 111.069 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 tp -140.71 142.31 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.417 1.087 . . . . 0.0 110.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -142.92 156.32 44.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.656 1.183 . . . . 0.0 110.579 -171.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.28 133.02 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.312 1.445 . . . . 0.0 108.348 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.3 m -122.6 52.8 1.3 Allowed 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.488 1.137 . . . . 0.0 110.086 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -19.33 64.03 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -172.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -57.77 -36.6 72.36 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.769 1.168 . . . . 0.0 111.066 168.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -97.47 -8.02 30.25 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.036 2.134 . . . . 0.0 112.484 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 70.75 15.64 6.89 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.605 2.362 . . . . 0.0 112.28 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 p -98.78 163.7 12.52 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.68 1.592 . . . . 0.0 110.621 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.18 169.09 9.63 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -139.6 114.25 9.29 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 121.043 -1.036 . . . . 0.0 111.186 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.58 133.2 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 121.529 0.68 . . . . 0.0 111.847 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -109.74 99.17 8.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.267 1.427 . . . . 0.0 108.784 -169.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.422 ' CE1' HG13 ' A' ' 20' ' ' VAL . 17.3 p90 -131.45 -178.87 5.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.821 1.248 . . . . 0.0 112.25 -168.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.99 140.05 33.84 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.509 1.124 . . . . 0.0 108.258 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.06 11.41 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.029 2.486 . . . . 0.0 112.826 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.4 p -92.21 -19.04 22.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.889 1.276 . . . . 0.0 113.481 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 72.6 m -126.82 -20.43 4.26 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.703 1.601 . . . . 0.0 114.457 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.1 t -145.07 -177.86 5.75 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.16 1.784 . . . . 0.0 111.338 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -160.62 156.6 22.46 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.487 1.515 . . . . 0.0 112.95 174.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -43.64 -45.38 10.82 Favored 'Trans proline' 0 C--N 1.352 0.756 1 C-N-CA 126.425 4.75 . . . . 0.0 117.974 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.6 m -64.78 -37.67 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 119.825 1.193 . . . . 0.0 112.537 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.67 -40.28 69.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.705 0.802 . . . . 0.0 111.058 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.38 -47.64 84.91 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.758 1.223 . . . . 0.0 112.011 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 -53.05 -54.54 33.91 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.79 0.723 . . . . 0.0 109.775 175.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -61.89 -33.74 74.76 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.202 1.001 . . . . 0.0 113.349 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.02 -56.99 5.53 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.056 0.943 . . . . 0.0 111.847 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.435 HG22 ' CD1' ' A' ' 42' ' ' ILE . 10.1 pt -72.56 -27.09 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.86 -28.55 67.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.9 6.49 41.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.7 mt -53.92 -52.51 67.28 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 117.392 -1.29 . . . . 0.0 112.187 169.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.41 163.44 36.56 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.241 2.627 . . . . 0.0 112.717 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -81.42 50.99 3.71 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.852 3.702 . . . . 0.0 111.302 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.19 53.68 5.55 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.328 0.966 . . . . 0.0 112.103 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -132.82 -45.08 0.87 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -171.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -101.64 134.77 44.25 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.667 0.787 . . . . 0.0 109.32 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -111.74 152.32 27.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.786 1.634 . . . . 0.0 110.171 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.1 t -101.52 138.11 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.675 1.125 . . . . 0.0 109.608 168.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -110.2 113.12 25.55 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.224 1.01 . . . . 0.0 108.811 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 126.373 1.869 . . . . 0.0 109.939 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 8.5 p -137.9 126.13 23.08 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.446 1.898 . . . . 0.0 113.473 -169.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.7 t -141.02 154.83 46.19 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.877 1.671 . . . . 0.0 110.424 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.4 m -111.35 137.72 48.75 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.786 0.721 . . . . 0.0 110.397 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.5 163.53 30.92 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.391 1.076 . . . . 0.0 112.068 169.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -109.8 128.06 55.06 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.511 1.924 . . . . 0.0 110.366 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.2 mm -112.28 144.54 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.227 1.011 . . . . 0.0 109.694 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.63 122.82 47.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.709 1.604 . . . . 0.0 109.71 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.52 140.87 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.049 -1.657 . . . . 0.0 111.896 -167.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.34 66.63 1.45 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.32 1.448 . . . . 0.0 114.065 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -172.88 49.89 0.17 Allowed Glycine 0 N--CA 1.466 0.659 0 CA-C-O 118.921 -0.933 . . . . 0.0 114.09 166.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 74.0 mtm -110.86 -57.08 2.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 117.498 -1.239 . . . . 0.0 113.768 -171.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.0 t 55.32 -26.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 130.339 3.456 . . . . 0.0 118.273 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 36.0 t -131.73 139.94 49.12 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.543 1.537 . . . . 0.0 111.718 -170.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.01 -35.26 69.04 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.747 -0.596 . . . . 0.0 111.671 171.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.4 m -64.03 -31.79 73.1 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.789 -1.195 . . . . 0.0 112.105 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 26.2 t -70.59 -39.76 73.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.911 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.63 -54.52 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 119.63 1.105 . . . . 0.0 110.094 170.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -58.54 -34.71 71.3 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.029 0.377 . . . . 0.0 111.582 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.2 m -71.0 -43.35 68.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.048 0.939 . . . . 0.0 113.078 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 84.9 mt -64.49 -51.12 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.788 1.176 . . . . 0.0 109.714 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -53.14 -37.66 62.03 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.497 1.519 . . . . 0.0 111.164 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.1 -58.42 4.36 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.001 1.286 . . . . 0.0 113.467 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.0 mtp -67.91 -46.81 70.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.657 1.583 . . . . 0.0 113.677 -170.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 35.5 mm -66.58 -36.94 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 118.124 0.42 . . . . 0.0 110.066 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 t -56.67 -9.34 0.74 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -89.02 -8.49 53.93 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.475 -1.391 . . . . 0.0 113.755 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -107.82 177.3 4.86 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.276 1.398 . . . . 0.0 114.158 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -56.5 152.41 11.73 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.698 1.599 . . . . 0.0 115.314 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.21 -30.3 0.32 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.351 1.453 . . . . 0.0 116.676 169.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.3 p -78.91 92.86 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.463 1.632 . . . . 0.0 111.008 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -79.56 -40.02 30.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.872 1.669 . . . . 0.0 111.916 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -144.99 144.81 31.23 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.011 0.925 . . . . 0.0 109.478 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.5 tt -140.36 138.37 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 121.255 -0.903 . . . . 0.0 111.55 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t -139.18 136.31 34.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.78 1.632 . . . . 0.0 109.157 171.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.22 148.93 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.827 1.251 . . . . 0.0 111.396 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.8 t -142.62 148.52 37.6 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.43 -22.67 61.82 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.633 1.173 . . . . 0.0 113.707 172.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -50.86 -41.58 58.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.006 1.322 . . . . 0.0 112.372 -169.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -127.38 -1.96 6.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.007 1.323 . . . . 0.0 111.906 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.06 42.26 37.25 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 125.487 1.518 . . . . 0.0 111.981 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.5 p -130.93 146.07 52.22 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.404 1.102 . . . . 0.0 113.053 -168.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -118.84 119.69 35.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.757 1.623 . . . . 0.0 112.037 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 t -99.32 112.26 24.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.962 1.305 . . . . 0.0 107.8 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 139.11 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.588 0.755 . . . . 0.0 110.885 -168.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.95 107.96 20.29 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.97 2.108 . . . . 0.0 107.117 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -113.17 162.9 15.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.147 1.379 . . . . 0.0 111.762 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -94.79 112.16 57.03 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.846 0.859 . . . . 0.0 108.941 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.51 -10.54 17.32 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.035 2.49 . . . . 0.0 113.051 -173.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.4 -32.9 25.91 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.259 0.936 . . . . 0.0 112.618 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.68 -46.97 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.865 1.266 . . . . 0.0 113.448 -173.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.5 tt -124.75 149.41 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 120.384 1.447 . . . . 0.0 112.094 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.9 t -96.99 146.96 32.2 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.203 1.401 . . . . 0.0 112.833 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.33 -26.12 42.17 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.09 2.527 . . . . 0.0 113.49 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -68.23 -35.66 78.29 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.526 -0.734 . . . . 0.0 112.548 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.46 -31.83 67.62 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.148 0.979 . . . . 0.0 111.643 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.04 -57.65 11.61 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.198 0.999 . . . . 0.0 110.035 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -61.23 -41.67 97.28 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.779 -0.575 . . . . 0.0 112.307 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.44 -34.08 70.42 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.15 -34.73 71.27 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -73.56 -39.44 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.281 1.033 . . . . 0.0 111.579 171.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -62.92 -32.25 73.5 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.182 -0.949 . . . . 0.0 111.641 172.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.93 -13.9 60.97 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.713 2.405 . . . . 0.0 114.503 169.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 14.7 ttt -83.62 -20.95 32.77 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.986 -1.071 . . . . 0.0 112.148 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 111.82 19.03 7.53 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.949 1.737 . . . . 0.0 114.934 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -115.09 -159.06 0.69 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.215 1.406 . . . . 0.0 109.878 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.77 140.32 51.09 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 124.554 1.142 . . . . 0.0 109.555 170.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.01 147.71 42.47 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.126 1.37 . . . . 0.0 112.348 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.1 t -142.74 140.49 31.48 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.174 1.789 . . . . 0.0 109.011 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.2 p -90.49 130.56 39.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.327 0.584 . . . . 0.0 110.811 -171.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 166.743 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 121.058 0.456 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -109.26 134.86 51.24 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.195 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.02 133.04 43.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.152 1.381 . . . . 0.0 110.724 -174.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -96.19 137.59 35.04 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.148 1.779 . . . . 0.0 111.576 -171.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.73 152.18 39.99 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 173.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -100.11 113.91 26.88 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.498 1.119 . . . . 0.0 109.683 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 mt -88.46 140.81 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.714 1.205 . . . . 0.0 109.973 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -99.11 141.26 32.1 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.46 1.504 . . . . 0.0 111.341 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.14 -13.09 65.13 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.511 1.529 . . . . 0.0 113.809 -176.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.7 ptp -63.85 -14.63 54.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -60.06 -24.4 64.55 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.45 1.477 . . . . 0.0 112.384 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 59.2 m -78.4 -4.66 49.37 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.929 0.892 . . . . 0.0 113.372 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.55 -56.37 0.51 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.649 3.18 . . . . 0.0 113.224 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m -55.11 -25.16 29.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.64 1.176 . . . . 0.0 113.246 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.4 -50.12 70.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.003 1.721 . . . . 0.0 112.361 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -77.14 -30.71 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 36' ' ' LEU . 5.0 tt -52.73 -57.19 10.93 Favored 'General case' 0 C--N 1.345 0.391 0 C-N-CA 124.309 1.043 . . . . 0.0 110.916 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -60.02 -45.25 93.41 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 118.591 -0.719 . . . . 0.0 109.866 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.81 -36.68 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.919 1.236 . . . . 0.0 111.133 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.98 -22.26 64.11 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.978 0.911 . . . . 0.0 112.317 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -71.9 -52.96 14.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.78 1.232 . . . . 0.0 113.024 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -93.82 -17.39 23.14 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -167.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.49 ' CD1' HG22 ' A' ' 78' ' ' ILE . 23.9 mm -96.23 133.03 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 119.813 1.188 . . . . 0.0 108.042 173.451 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.08 -5.7 10.31 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 125.317 1.437 . . . . 0.0 114.749 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -126.68 17.02 7.49 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.2 1.8 . . . . 0.0 112.329 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.14 156.63 18.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.864 1.266 . . . . 0.0 109.971 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.4 tp -21.96 -64.56 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.534 2.734 . . . . 0.0 114.714 173.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.86 -15.92 20.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 116.527 -2.263 . . . . 0.0 116.011 175.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.6 t -82.64 124.0 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 122.588 3.194 . . . . 0.0 111.123 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.45 -31.9 11.41 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 172.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.6 t -148.62 163.58 36.83 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.063 -1.023 . . . . 0.0 112.705 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 tp -132.6 130.64 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.58 1.952 . . . . 0.0 106.445 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -129.91 161.73 30.18 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 172.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.47 164.62 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 120.954 -1.091 . . . . 0.0 112.84 -172.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 t -140.57 70.85 1.36 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 123.264 1.507 . . . . 0.0 109.37 170.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.9 mt -61.52 -21.57 64.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.642 1.177 . . . . 0.0 112.814 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.01 -30.82 48.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.694 1.197 . . . . 0.0 113.818 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -108.9 -7.95 15.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.469 1.908 . . . . 0.0 112.53 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mttm 77.05 15.96 1.8 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 127.576 2.351 . . . . 0.0 112.743 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.15 150.15 21.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.6 1.191 . . . . 0.0 110.806 177.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.82 151.06 40.08 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.415 1.886 . . . . 0.0 107.172 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -137.56 124.14 20.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.472 1.033 . . . . 0.0 113.446 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.8 p -97.12 136.12 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.52 1.128 . . . . 0.0 110.615 -170.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -110.67 102.4 10.96 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.625 1.57 . . . . 0.0 108.221 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -135.38 160.01 39.79 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -168.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -93.59 113.41 60.2 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 126.065 1.746 . . . . 0.0 108.218 173.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.33 -3.7 12.92 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.025 2.483 . . . . 0.0 112.761 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.4 p -81.75 -11.8 58.86 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.703 1.601 . . . . 0.0 112.388 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 37.3 m -121.74 -33.03 3.67 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.778 1.231 . . . . 0.0 113.044 -173.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.4 t -145.06 -179.36 6.57 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.886 1.675 . . . . 0.0 111.32 -174.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.9 p -160.8 155.19 19.71 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.457 1.103 . . . . 0.0 112.821 -170.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.9 -49.16 15.78 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.14 3.226 . . . . 0.0 116.668 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -70.22 -33.51 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 120.332 1.424 . . . . 0.0 112.638 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.66 81.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.481 0.712 . . . . 0.0 111.099 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.16 -46.89 75.81 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.321 1.448 . . . . 0.0 112.342 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 13.2 tt0 -53.58 -52.26 60.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.401 1.0 . . . . 0.0 109.778 175.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -65.65 -24.94 67.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.776 1.23 . . . . 0.0 113.676 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.39 -60.67 2.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.315 0.961 . . . . 0.0 112.581 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.49 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.0 pt -74.02 -29.71 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -167.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -71.28 -23.56 61.99 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.496 1.044 . . . . 0.0 113.705 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.16 17.8 9.05 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.001 -1.062 . . . . 0.0 113.675 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.75 -58.74 15.16 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 117.715 -1.136 . . . . 0.0 109.955 166.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -69.82 168.15 22.45 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.498 2.798 . . . . 0.0 112.337 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.4 42.16 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.459 3.439 . . . . 0.0 112.434 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.99 63.83 2.34 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -169.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -148.74 -16.71 0.31 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 -169.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -124.43 130.6 52.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 169.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -110.4 142.48 42.04 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.867 1.267 . . . . 0.0 111.766 -173.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 13.6 m -117.56 134.5 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 120.084 1.311 . . . . 0.0 111.178 179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.0 m -128.97 120.93 26.94 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.916 0.865 . . . . 0.0 111.975 176.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.033 0 C-N-CA 127.727 2.411 . . . . 0.0 112.202 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 58.2 m 48.41 82.11 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.038 2.135 . . . . 0.0 115.715 168.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.3 p -133.13 143.8 49.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.596 1.959 . . . . 0.0 112.929 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.6 m -98.1 129.46 44.92 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.015 0.825 . . . . 0.0 111.18 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.63 164.6 21.68 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.608 0.763 . . . . 0.0 111.162 169.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.16 132.13 54.55 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.251 1.421 . . . . 0.0 109.982 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.0 mm -117.91 137.99 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.067 1.747 . . . . 0.0 109.014 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.6 125.46 49.33 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.527 1.531 . . . . 0.0 109.215 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.1 mt -126.21 127.15 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 120.393 -1.442 . . . . 0.0 111.241 -170.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.07 74.21 1.03 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.796 2.039 . . . . 0.0 112.609 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -179.12 52.89 0.09 OUTLIER Glycine 0 N--CA 1.466 0.677 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.938 165.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 65.4 mtm -137.54 91.85 2.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.47 0.708 . . . . 0.0 109.826 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.5 t -94.57 -29.19 15.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.672 1.189 . . . . 0.0 113.191 -173.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 91.6 m -125.11 154.56 41.23 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.514 1.526 . . . . 0.0 110.112 175.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.15 65.69 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.3 p -54.91 -24.32 22.99 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.079 -1.013 . . . . 0.0 113.615 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 95.2 m -57.13 -29.27 63.43 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.693 -1.254 . . . . 0.0 112.592 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.22 -49.88 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.612 0.765 . . . . 0.0 110.523 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.14 -21.05 66.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.255 0.934 . . . . 0.0 113.228 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 t -74.1 -62.11 1.62 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.453 0.701 . . . . 0.0 111.304 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 47.4 mt -70.78 -48.54 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.83 -1.169 . . . . 0.0 111.494 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.19 -26.15 68.67 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.223 0.609 . . . . 0.0 111.711 176.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.35 -59.77 4.05 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.531 1.062 . . . . 0.0 112.178 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 92.7 mmm -71.57 -39.5 70.57 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.923 1.689 . . . . 0.0 114.208 -172.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.3 mm -70.96 -32.45 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.366 -0.834 . . . . 0.0 111.084 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.7 t -65.36 0.55 1.42 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -96.35 -11.24 26.09 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.479 -1.388 . . . . 0.0 114.589 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 pp -93.07 166.04 12.55 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.485 1.514 . . . . 0.0 111.429 174.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.18 138.23 31.69 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.449 -0.782 . . . . 0.0 112.537 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 101.16 15.6 27.66 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.556 1.55 . . . . 0.0 115.029 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.8 94.43 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.705 2.002 . . . . 0.0 110.502 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -68.0 -56.98 6.94 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.165 0.986 . . . . 0.0 111.02 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -140.0 131.44 26.92 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.475 1.11 . . . . 0.0 109.147 -171.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -136.47 131.33 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.865 0.866 . . . . 0.0 110.452 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.1 t -138.25 138.77 38.79 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.239 1.816 . . . . 0.0 108.686 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.5 p -143.45 145.55 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.962 1.305 . . . . 0.0 111.73 -175.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 t -135.19 135.38 40.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -172.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.93 -18.91 64.7 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.058 2.143 . . . . 0.0 113.959 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.19 78.98 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.545 1.138 . . . . 0.0 113.114 -176.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -130.87 -8.05 3.97 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.419 1.488 . . . . 0.0 112.336 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.6 41.3 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.595 1.093 . . . . 0.0 111.502 -171.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 71.3 p -130.17 145.86 51.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.513 1.156 . . . . 0.0 113.559 -168.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -115.06 141.19 48.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.915 1.686 . . . . 0.0 112.459 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.1 t -110.39 124.19 51.26 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 167.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.27 136.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.828 -0.545 . . . . 0.0 111.366 -171.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.15 101.86 13.63 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.932 2.093 . . . . 0.0 106.485 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -104.18 164.2 11.88 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.597 1.159 . . . . 0.0 112.629 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -107.02 93.34 8.96 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.089 1.356 . . . . 0.0 110.849 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.19 -19.19 50.93 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.586 2.857 . . . . 0.0 112.26 -172.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.15 -15.87 63.01 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.77 -38.5 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 126.463 1.905 . . . . 0.0 113.422 -168.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.7 tt -141.93 151.71 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.878 1.271 . . . . 0.0 111.53 -171.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.9 t -101.07 143.38 26.48 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 170.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.37 -26.49 27.95 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.784 2.989 . . . . 0.0 113.935 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -70.49 -40.65 73.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.462 0.705 . . . . 0.0 111.551 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -78.23 -24.29 47.06 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 168.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.23 -50.8 72.61 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.955 1.302 . . . . 0.0 109.325 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -50.62 -46.63 58.29 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.371 1.468 . . . . 0.0 111.433 168.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.07 -21.35 66.49 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.58 65.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.449 1.022 . . . . 0.0 112.367 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.2 mp -74.27 -40.43 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.216 1.007 . . . . 0.0 111.158 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -65.71 -27.58 68.43 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.996 0.816 . . . . 0.0 112.846 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.24 -42.53 68.75 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.0 1.32 . . . . 0.0 112.362 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.1 tpt -61.23 -31.96 71.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.071 0.851 . . . . 0.0 111.434 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 109.0 44.16 1.13 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 126.584 2.04 . . . . 0.0 113.187 172.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -124.24 -159.73 0.89 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.92 149.6 47.43 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.692 -1.255 . . . . 0.0 109.212 168.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.55 155.0 44.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.502 1.144 . . . . 0.0 113.542 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.9 t -142.62 138.27 30.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.379 1.872 . . . . 0.0 108.99 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.3 m -88.11 128.68 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 121.47 -0.769 . . . . 0.0 109.108 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . 0.288 2.7 p . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 124.698 2.19 . . . . 0.0 107.675 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.41 150.95 22.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.317 2.247 . . . . 0.0 111.86 176.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 tt -146.24 143.65 29.35 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.264 2.226 . . . . 0.0 112.135 -169.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 18.3 mm100 -95.2 121.76 37.18 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.387 1.089 . . . . 0.0 110.454 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -130.69 127.45 38.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.118 -1.401 . . . . 0.0 113.296 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -106.84 110.27 22.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.058 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 mm -77.15 157.37 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.236 1.014 . . . . 0.0 109.935 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -135.54 147.63 48.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.542 1.137 . . . . 0.0 110.959 168.525 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 11.24 84.72 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.63 1.109 . . . . 0.0 113.353 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.4 ptm -68.01 -33.07 73.92 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.993 1.396 . . . . 0.0 113.912 -169.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 69.08 -51.77 0.59 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.693 2.397 . . . . 0.0 112.474 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 31.0 p -173.37 -173.74 0.93 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.829 2.052 . . . . 0.0 112.388 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -46.44 -33.41 3.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.941 1.697 . . . . 0.0 113.503 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.5 m -53.25 -30.05 36.12 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.553 1.07 . . . . 0.0 113.703 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.5 t -64.46 -42.07 96.15 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.965 -1.084 . . . . 0.0 113.817 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.269 4.8 p -73.62 -6.31 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.34 -59.09 5.17 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.186 1.357 . . . . 0.0 111.712 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -61.33 -31.66 71.52 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.263 0.938 . . . . 0.0 111.989 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.1 mt -59.44 -56.5 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.33 -35.48 73.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.034 1.733 . . . . 0.0 114.424 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.01 -41.01 97.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.305 1.042 . . . . 0.0 111.534 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -96.35 -33.65 11.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.441 ' CD1' HG22 ' A' ' 78' ' ' ILE . 38.2 mm -107.09 111.92 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.616 1.166 . . . . 0.0 110.346 -167.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.08 -18.64 6.97 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.497 1.523 . . . . 0.0 113.877 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -85.53 -6.01 59.23 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.5 -1.0 . . . . 0.0 112.542 169.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.8 mt -79.49 -179.13 6.65 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.9 2.08 . . . . 0.0 113.538 -170.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.81 -77.97 0.06 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.306 2.243 . . . . 0.0 111.806 170.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.5 -36.47 58.96 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.589 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -92.51 118.59 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.246 1.523 . . . . 0.0 110.249 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -101.7 -24.62 14.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.742 0.817 . . . . 0.0 113.179 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.8 m -149.97 156.06 41.06 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.587 -1.32 . . . . 0.0 113.661 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 tp -125.94 147.06 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.011 1.324 . . . . 0.0 109.914 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -142.8 166.92 23.32 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.356 1.862 . . . . 0.0 108.471 -172.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -139.38 160.52 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 119.687 -1.883 . . . . 0.0 113.365 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.0 t -140.95 56.61 1.56 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.39 1.876 . . . . 0.0 108.244 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.7 mt -61.52 -33.99 74.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -168.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.17 -17.11 64.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.162 1.346 . . . . 0.0 113.388 172.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -104.02 -1.4 27.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.657 1.583 . . . . 0.0 111.807 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 70.12 9.57 7.09 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.27 2.628 . . . . 0.0 113.586 173.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.51 152.79 18.64 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.701 2.001 . . . . 0.0 109.325 176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.46 171.7 7.26 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.012 1.325 . . . . 0.0 107.551 165.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -141.92 137.79 31.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.915 0.486 . . . . 0.0 110.367 -169.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.35 132.65 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 118.795 0.725 . . . . 0.0 112.059 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -105.36 94.2 5.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.727 2.011 . . . . 0.0 107.702 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -131.23 162.73 29.34 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -168.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -97.57 114.12 64.43 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 128.106 2.562 . . . . 0.0 110.919 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.29 25.24 0.53 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.564 2.843 . . . . 0.0 113.617 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.8 t -117.82 -26.36 6.53 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.369 -1.457 . . . . 0.0 112.8 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.6 m -93.66 -29.01 15.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.128 0.971 . . . . 0.0 113.524 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -144.6 -179.07 6.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.97 1.708 . . . . 0.0 112.223 -171.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.6 p -157.81 163.0 26.09 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.133 1.373 . . . . 0.0 112.47 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -51.21 -50.68 13.14 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 124.771 3.647 . . . . 0.0 115.82 -171.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.28 -37.23 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 119.216 0.916 . . . . 0.0 112.59 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.57 79.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.257 0.623 . . . . 0.0 110.855 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.7 mt -64.37 -45.06 89.34 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.571 0.748 . . . . 0.0 112.142 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -52.06 -55.82 18.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.879 0.872 . . . . 0.0 110.545 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -70.21 -22.56 62.91 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.01 -56.47 6.09 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.316 0.962 . . . . 0.0 112.273 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.441 HG22 ' CD1' ' A' ' 42' ' ' ILE . 9.6 pt -71.54 -31.4 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -172.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -60.71 -30.23 69.83 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.29 13.79 26.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.6 mt -62.41 -49.27 84.54 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 117.305 -1.331 . . . . 0.0 112.662 167.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.61 172.07 16.43 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.707 2.938 . . . . 0.0 112.997 174.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.94 63.0 6.73 Favored 'Trans proline' 0 CA--C 1.541 0.847 1 C-N-CA 125.462 4.108 . . . . 0.0 111.109 173.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.87 32.5 82.15 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.011 1.291 . . . . 0.0 112.986 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -105.49 -48.17 3.74 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -166.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -95.6 128.53 42.54 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.01 157.56 15.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.51 1.524 . . . . 0.0 109.384 173.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.24 136.85 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 119.533 1.06 . . . . 0.0 111.636 170.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.3 m -124.36 140.37 53.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.686 1.595 . . . . 0.0 112.919 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.615 0 C-N-CA 126.462 1.905 . . . . 0.0 111.556 -163.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 5.7 m -144.03 138.8 28.61 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 p -142.35 154.82 44.98 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 127.44 2.296 . . . . 0.0 110.266 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 54.5 m -101.64 145.39 29.14 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.554 -0.716 . . . . 0.0 109.978 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.16 150.88 38.75 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.201 1.001 . . . . 0.0 111.058 172.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.76 137.96 50.3 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.583 1.553 . . . . 0.0 109.054 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.3 mm -119.12 137.29 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.554 1.942 . . . . 0.0 108.525 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -100.33 128.05 46.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.109 1.363 . . . . 0.0 109.288 170.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.02 136.21 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 120.702 -1.249 . . . . 0.0 110.909 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.68 61.7 1.23 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.965 1.706 . . . . 0.0 111.755 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.31 56.23 0.19 Allowed Glycine 0 N--CA 1.463 0.459 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.721 169.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.9 mtm -138.74 74.9 1.49 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.205 1.002 . . . . 0.0 110.499 -177.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.2 t -79.84 -19.99 47.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.72 1.208 . . . . 0.0 112.513 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 95.0 m -128.23 153.02 47.39 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.454 1.901 . . . . 0.0 111.06 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.77 -24.46 61.76 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.361 -0.837 . . . . 0.0 112.848 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.6 p -51.11 -37.36 45.49 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.987 -1.071 . . . . 0.0 111.97 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.4 m -54.15 -36.32 63.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.779 1.632 . . . . 0.0 113.336 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 t -59.85 -56.3 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -69.34 -17.61 63.72 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 m -72.52 -54.84 8.08 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.617 1.167 . . . . 0.0 111.788 167.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.81 -58.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.778 0.831 . . . . 0.0 110.198 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -57.32 -28.63 63.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.997 2.119 . . . . 0.0 112.014 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.62 -56.96 4.76 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 125.842 1.687 . . . . 0.0 114.239 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 13.1 mmt -71.29 -45.79 62.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.909 0.884 . . . . 0.0 112.093 -172.653 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.7 -39.68 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -169.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -2.25 2.7 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.96 -16.65 27.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.041 1.336 . . . . 0.0 113.814 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -95.75 162.55 13.55 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.908 1.231 . . . . 0.0 111.844 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -77.1 166.37 23.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.279 1.038 . . . . 0.0 113.596 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.9 -41.84 1.77 Allowed Glycine 0 CA--C 1.531 1.077 0 O-C-N 120.822 -1.174 . . . . 0.0 114.069 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 p -78.14 97.44 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.135 1.468 . . . . 0.0 111.394 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -68.87 -52.24 31.85 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.304 1.441 . . . . 0.0 111.545 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -143.52 144.68 32.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.868 0.867 . . . . 0.0 109.94 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.9 tt -135.93 140.17 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.14 0.976 . . . . 0.0 110.077 172.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 42.0 t -138.95 136.44 35.42 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.641 1.576 . . . . 0.0 109.946 175.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.5 p -143.79 147.39 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 119.665 1.12 . . . . 0.0 112.394 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.1 t -143.45 151.37 40.26 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.838 1.255 . . . . 0.0 112.658 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.6 mt -72.85 -29.3 63.1 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -46.21 -38.85 8.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.816 2.047 . . . . 0.0 115.303 -168.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -125.0 -1.14 7.82 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.194 1.798 . . . . 0.0 111.383 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 68.28 50.95 35.43 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 128.228 2.823 . . . . 0.0 112.019 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.8 p -141.66 145.12 34.56 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -114.99 144.87 42.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.043 1.737 . . . . 0.0 111.506 171.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.3 t -120.98 127.69 52.03 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.792 1.237 . . . . 0.0 108.208 168.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.26 140.18 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.024 0.93 . . . . 0.0 111.461 -167.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.34 116.25 30.17 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.431 2.292 . . . . 0.0 107.774 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -136.7 158.77 43.67 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -96.93 116.57 66.11 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.35 1.46 . . . . 0.0 110.606 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -82.25 -0.43 10.23 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.956 3.104 . . . . 0.0 114.121 -173.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.05 -37.48 12.14 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.678 1.191 . . . . 0.0 112.311 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 82.0 t -89.87 -31.69 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 126.668 1.987 . . . . 0.0 112.436 -176.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.426 ' CG1' ' H ' ' A' ' 172' ' ' SER . 14.6 tt -138.2 -178.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.522 1.129 . . . . 0.0 110.773 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' SER . . . . . 0.426 ' H ' ' CG1' ' A' ' 171' ' ' ILE . 21.6 t -140.6 148.2 52.2 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 126.497 1.919 . . . . 0.0 110.23 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.57 -27.12 31.49 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.684 2.256 . . . . 0.0 113.664 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.51 -31.53 69.83 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.982 0.81 . . . . 0.0 111.385 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.03 -36.52 64.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.971 1.709 . . . . 0.0 111.615 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.6 mt -58.04 -57.14 14.15 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.049 0.939 . . . . 0.0 109.743 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -38.9 93.0 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 177.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.91 -30.44 67.82 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.97 0.804 . . . . 0.0 113.034 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.57 -31.9 69.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.367 0.985 . . . . 0.0 112.45 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.07 -35.67 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.979 0.912 . . . . 0.0 111.256 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.38 -29.11 65.68 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.866 0.757 . . . . 0.0 112.895 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.51 -29.61 63.77 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.643 1.177 . . . . 0.0 113.078 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 53.4 ttm -69.63 -48.84 58.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.848 0.859 . . . . 0.0 110.257 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 134.76 43.46 0.12 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.051 1.31 . . . . 0.0 114.882 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -140.8 -155.67 0.61 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.467 1.507 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -133.07 143.83 49.59 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.511 1.124 . . . . 0.0 111.368 172.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -141.5 145.0 34.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.756 1.222 . . . . 0.0 112.337 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.4 t -133.23 141.2 47.92 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.41 1.484 . . . . 0.0 109.95 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.9 m -82.48 132.23 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 O-C-N 122.042 -0.411 . . . . 0.0 111.2 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . 0.264 5.0 p . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 124.673 2.177 . . . . 0.0 107.212 169.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.4 m -126.97 134.84 50.3 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 123.357 0.663 . . . . 0.0 110.909 -168.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.56 166.75 23.87 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 115.591 1.701 . . . . 0.0 115.591 175.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -120.45 128.17 52.91 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.088 2.155 . . . . 0.0 110.938 -169.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.05 138.35 29.87 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.74 109.91 22.58 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -177.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 mt -83.25 134.21 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.254 1.422 . . . . 0.0 109.293 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -101.69 127.45 48.43 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.371 1.468 . . . . 0.0 110.882 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.4 -5.76 38.47 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.192 1.377 . . . . 0.0 113.626 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.6 ptp -61.15 -10.41 6.4 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -53.35 -12.99 0.48 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.216 1.407 . . . . 0.0 113.623 167.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.2 t -119.41 127.88 53.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.409 1.884 . . . . 0.0 108.893 167.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -58.24 -31.68 67.62 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.941 -1.099 . . . . 0.0 113.343 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 m -50.32 -30.65 12.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.719 1.207 . . . . 0.0 113.617 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.0 t -63.48 -58.19 7.8 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.546 1.138 . . . . 0.0 111.759 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 p -70.01 -25.35 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.231 0.923 . . . . 0.0 111.82 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.33 -61.34 2.7 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.041 0.936 . . . . 0.0 111.885 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -62.88 -32.5 73.77 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.969 -0.457 . . . . 0.0 111.673 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.05 -50.37 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.751 0.705 . . . . 0.0 110.32 172.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.66 -31.84 73.14 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.949 1.3 . . . . 0.0 112.528 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -70.18 -46.94 63.6 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.256 -0.902 . . . . 0.0 112.067 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -91.46 -13.13 32.8 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -170.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.564 ' CD1' HG22 ' A' ' 78' ' ' ILE . 44.9 mm -105.16 121.79 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.924 1.238 . . . . 0.0 111.421 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.98 -19.77 7.74 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.899 1.714 . . . . 0.0 114.185 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -77.35 -3.19 38.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.767 1.227 . . . . 0.0 112.599 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.7 mt -84.52 -175.76 5.93 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.88 2.872 . . . . 0.0 111.966 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.9 tp -85.82 -79.85 0.24 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.066 1.746 . . . . 0.0 111.256 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.54 -30.98 65.9 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 117.857 -1.524 . . . . 0.0 113.576 -171.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.38 117.39 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 119.173 1.486 . . . . 0.0 107.734 167.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -108.09 -36.46 6.32 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -170.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -147.62 168.12 22.82 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.31 1.044 . . . . 0.0 111.229 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.5 tp -140.68 141.65 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.546 1.138 . . . . 0.0 110.085 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -137.24 155.4 49.54 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.954 2.102 . . . . 0.0 107.47 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.4 m -123.66 145.63 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.627 -1.921 . . . . 0.0 110.914 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m -128.15 54.45 1.73 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.574 1.15 . . . . 0.0 108.135 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.13 -30.04 71.13 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.685 1.594 . . . . 0.0 112.365 -171.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.68 -37.41 63.19 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.4 0.68 . . . . 0.0 111.994 170.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -102.51 2.53 36.44 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.608 1.563 . . . . 0.0 112.925 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? 68.18 12.38 8.74 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.149 2.579 . . . . 0.0 114.209 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.1 p -99.92 162.75 12.79 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.723 1.249 . . . . 0.0 110.273 169.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.1 161.93 14.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 165.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.458 HE21 ' HA ' ' A' ' 61' ' ' GLN . 2.3 tp60 -137.08 127.15 26.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -169.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.16 140.48 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.444 -1.41 . . . . 0.0 111.915 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.36 108.85 21.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.067 1.347 . . . . 0.0 108.601 173.184 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -131.09 178.64 6.54 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.132 1.373 . . . . 0.0 110.26 -175.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -124.44 134.49 25.58 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.53 1.132 . . . . 0.0 109.445 170.117 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.49 20.06 0.8 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.215 3.277 . . . . 0.0 114.307 -169.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 p -121.96 -51.76 2.0 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.813 2.045 . . . . 0.0 110.586 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 90.2 m -77.46 -25.32 50.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.562 1.545 . . . . 0.0 114.463 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 t -145.28 -177.36 5.51 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.42 1.888 . . . . 0.0 109.318 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.7 p -149.57 162.17 29.37 Favored Pre-proline 0 C--N 1.321 -0.674 0 C-N-CA 125.211 1.404 . . . . 0.0 110.155 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.19 -56.37 3.11 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.42 2.747 . . . . 0.0 113.05 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.25 -35.64 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.42 -52.68 12.86 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.378 0.671 . . . . 0.0 111.606 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -37.47 82.97 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.212 1.405 . . . . 0.0 111.071 -177.084 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.9 -57.86 10.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.523 1.129 . . . . 0.0 111.539 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -63.29 -32.16 73.5 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.49 -52.71 64.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.299 0.64 . . . . 0.0 110.659 174.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.564 HG22 ' CD1' ' A' ' 42' ' ' ILE . 4.8 pt -73.41 -31.37 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -70.17 -23.91 63.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.64 10.63 39.45 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 176.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 mt -56.71 -59.14 13.23 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.063 168.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.09 173.28 14.36 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.623 2.215 . . . . 0.0 111.001 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.89 67.5 5.82 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.731 2.954 . . . . 0.0 110.135 169.534 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 56.22 46.03 86.88 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 125.594 1.568 . . . . 0.0 112.741 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -115.39 -21.22 9.94 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -165.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -133.12 116.78 16.72 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.154 1.382 . . . . 0.0 110.75 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -99.19 139.42 34.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.21 1.404 . . . . 0.0 112.091 -173.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.5 140.43 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 120.5 1.5 . . . . 0.0 112.932 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.8 t -122.94 128.69 50.61 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.225 1.81 . . . . 0.0 110.89 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 125.79 1.636 . . . . 0.0 112.598 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 24.7 p -157.01 132.88 9.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.607 1.563 . . . . 0.0 113.56 -168.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.0 p -148.0 145.26 28.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.905 2.082 . . . . 0.0 110.041 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 90.2 m -105.26 135.58 46.37 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.471 1.032 . . . . 0.0 110.499 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.68 149.23 44.92 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.987 1.315 . . . . 0.0 110.974 172.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tt -96.46 141.21 30.03 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.095 2.158 . . . . 0.0 110.042 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mt -127.91 134.4 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.626 1.571 . . . . 0.0 109.246 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.2 130.76 44.39 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.27 1.028 . . . . 0.0 108.266 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 90.6 mt -132.94 136.09 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.48 -0.763 . . . . 0.0 111.144 -168.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.07 72.27 1.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.882 1.673 . . . . 0.0 111.882 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -177.49 52.13 0.1 Allowed Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.242 -0.89 . . . . 0.0 114.399 167.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -104.41 -58.08 1.94 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.274 5.6 t 54.84 -56.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 129.433 3.093 . . . . 0.0 115.757 -169.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 92.3 m -112.99 150.82 31.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.744 2.418 . . . . 0.0 111.095 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.6 73.43 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.865 1.266 . . . . 0.0 112.614 -177.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.5 p -43.49 -47.53 7.2 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.218 1.407 . . . . 0.0 112.385 169.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 5.6 t -71.5 -25.08 62.11 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.54 -53.39 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.43 -33.29 73.47 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.1 m -67.17 -51.72 50.28 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.708 0.803 . . . . 0.0 112.898 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 83.8 mt -62.01 -46.54 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-N 119.965 1.257 . . . . 0.0 110.665 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -58.74 -28.77 66.18 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.814 1.645 . . . . 0.0 112.164 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.48 -61.05 3.28 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.969 1.271 . . . . 0.0 113.281 170.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -47.74 69.74 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.319 1.448 . . . . 0.0 113.139 -169.246 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.0 mm -71.67 -34.67 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.157 -0.339 . . . . 0.0 111.735 -169.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.0 t -50.96 -21.99 2.04 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.487 1.915 . . . . 0.0 115.313 176.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -86.18 -19.82 29.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.122 1.769 . . . . 0.0 115.163 -167.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.1 pp -92.92 151.28 20.04 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.181 0.901 . . . . 0.0 112.403 -173.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -59.38 135.22 57.59 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.952 0.882 . . . . 0.0 112.49 -169.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.27 -27.56 9.21 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.064 -1.965 . . . . 0.0 115.343 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.97 94.05 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 121.214 2.507 . . . . 0.0 108.778 169.634 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -74.84 -44.07 51.11 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.345 1.058 . . . . 0.0 111.374 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -141.95 147.18 36.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.476 1.034 . . . . 0.0 109.96 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.46 148.54 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.109 0.956 . . . . 0.0 113.272 175.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 47.5 t -134.39 136.84 43.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 129.031 2.932 . . . . 0.0 108.513 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.77 143.9 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.616 1.553 . . . . 0.0 112.766 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 42.0 m -141.51 148.71 39.83 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.195 1.398 . . . . 0.0 113.233 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.43 -26.43 55.49 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.813 1.645 . . . . 0.0 114.133 172.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.25 -33.48 58.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.834 1.653 . . . . 0.0 113.894 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -123.83 -10.54 7.75 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.276 1.83 . . . . 0.0 111.087 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.72 44.61 19.8 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.406 1.003 . . . . 0.0 110.793 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 49.0 p -133.74 146.63 50.93 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.073 0.949 . . . . 0.0 111.863 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -121.82 161.2 23.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.77 1.628 . . . . 0.0 111.057 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.8 t -141.46 139.21 33.32 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 124.191 0.996 . . . . 0.0 109.173 168.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.63 142.86 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.226 -167.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.38 98.62 11.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 173.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -100.22 154.52 18.39 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.9 0.88 . . . . 0.0 111.67 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -98.81 109.11 52.31 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.161 0.984 . . . . 0.0 110.087 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.78 -10.88 23.64 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.438 2.092 . . . . 0.0 112.472 -170.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.26 -17.42 46.01 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 93.6 t -120.45 -29.12 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.911 1.284 . . . . 0.0 114.02 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.3 tt -141.1 147.25 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.186 0.903 . . . . 0.0 110.324 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.63 150.04 36.32 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.939 0.895 . . . . 0.0 111.004 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.43 -39.47 36.1 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.246 2.631 . . . . 0.0 113.924 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -65.01 -25.25 67.78 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.7 -27.79 55.64 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.614 1.165 . . . . 0.0 113.875 174.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.6 mt -59.77 -53.76 54.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -65.2 -34.68 78.95 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.18 -27.63 68.56 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.05 -36.44 72.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.89 0.768 . . . . 0.0 112.723 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.4 mp -72.41 -37.45 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.286 1.035 . . . . 0.0 110.837 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -63.43 -34.05 76.9 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.817 -0.552 . . . . 0.0 111.485 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -71.88 -24.4 61.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.008 1.323 . . . . 0.0 113.336 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 21.2 ttt -74.85 -29.46 61.05 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.673 1.189 . . . . 0.0 112.609 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 115.5 30.99 2.08 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 126.084 1.802 . . . . 0.0 114.875 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -133.76 -158.51 0.89 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.842 1.657 . . . . 0.0 109.18 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -137.57 143.17 41.41 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.287 1.035 . . . . 0.0 111.459 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -140.88 152.22 44.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.027 1.731 . . . . 0.0 112.065 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.5 t -141.36 130.99 24.02 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.006 1.323 . . . . 0.0 112.232 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.55 81.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.127 0.971 . . . . 0.0 111.412 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 125.025 1.33 . . . . 0.0 112.457 179.526 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.484 HG13 ' CE1' ' A' ' 64' ' ' TYR . 9.9 p . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -118.36 144.9 45.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.501 1.121 . . . . 0.0 111.399 -170.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.38 128.71 19.98 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.496 1.519 . . . . 0.0 109.85 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 22.5 tp60 -96.3 135.69 37.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.355 1.462 . . . . 0.0 112.237 -176.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -142.87 146.91 34.54 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.92 109.62 19.85 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.449 1.499 . . . . 0.0 109.146 174.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.7 mt -85.41 147.21 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.199 1.799 . . . . 0.0 111.676 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -98.19 139.84 33.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.984 1.313 . . . . 0.0 111.07 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.27 -6.89 81.04 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.196 1.379 . . . . 0.0 114.101 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 ptp -64.19 -15.75 60.53 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -63.82 -13.5 44.99 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.62 1.554 . . . . 0.0 113.223 170.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.1 m -77.03 -14.72 59.79 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.15 -1.594 . . . . 0.0 114.155 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 70.8 -50.9 0.68 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 128.139 2.576 . . . . 0.0 111.955 -172.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 m -60.0 -17.97 42.49 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.766 -1.209 . . . . 0.0 113.583 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 t -64.38 -53.05 54.7 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.548 1.139 . . . . 0.0 111.565 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.72 -27.92 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 118.638 0.654 . . . . 0.0 112.281 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.1 tp -53.65 -49.54 67.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 112.376 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -39.18 88.51 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.478 0.581 . . . . 0.0 111.914 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.1 mt -65.51 -49.5 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.263 1.025 . . . . 0.0 109.264 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.69 -41.6 98.12 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.68 1.592 . . . . 0.0 111.938 -176.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.7 -39.22 87.97 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.031 -0.509 . . . . 0.0 111.49 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -91.6 -25.01 19.39 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -172.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.426 ' CD1' HG22 ' A' ' 78' ' ' ILE . 47.8 mm -102.91 118.64 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.874 0.87 . . . . 0.0 110.431 -173.246 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.23 -17.5 3.57 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.866 1.698 . . . . 0.0 115.215 -177.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -88.54 -5.33 58.27 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.091 1.356 . . . . 0.0 111.919 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -76.4 170.4 16.43 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.006 2.122 . . . . 0.0 111.247 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.57 -62.88 1.31 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.427 -0.795 . . . . 0.0 110.964 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.04 -43.13 17.85 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.853 -0.97 . . . . 0.0 113.237 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.26 123.92 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.221 1.511 . . . . 0.0 110.502 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -94.74 -46.22 7.0 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.186 0.994 . . . . 0.0 111.31 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.8 t -149.41 172.04 15.59 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.563 0.745 . . . . 0.0 112.481 -169.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 tp -142.39 125.2 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.561 1.944 . . . . 0.0 107.434 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -120.23 149.45 42.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.554 0.741 . . . . 0.0 109.65 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.8 m -106.62 155.87 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.201 -0.937 . . . . 0.0 111.03 -170.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.4 t -139.73 57.82 1.62 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 123.138 1.447 . . . . 0.0 108.182 175.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.86 -24.13 65.22 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.611 1.564 . . . . 0.0 112.714 -171.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.21 -11.88 35.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.003 1.321 . . . . 0.0 113.61 169.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -122.84 7.59 9.35 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.172 2.189 . . . . 0.0 111.649 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 mptt 62.2 14.17 6.46 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.383 2.273 . . . . 0.0 113.746 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.73 167.14 10.08 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.634 1.574 . . . . 0.0 111.76 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.67 152.79 45.64 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 127.157 2.183 . . . . 0.0 107.207 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -130.63 133.65 46.31 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 172.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 p -96.22 136.86 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.519 0.676 . . . . 0.0 109.732 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -107.19 87.89 2.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.59 1.956 . . . . 0.0 107.51 -172.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.484 ' CE1' HG13 ' A' ' 20' ' ' VAL . 8.8 p90 -116.33 -179.3 3.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.481 1.512 . . . . 0.0 110.42 -175.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.13 142.17 36.05 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 168.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.08 7.19 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.388 2.058 . . . . 0.0 114.308 -168.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -74.96 -51.38 13.85 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.28 -1.512 . . . . 0.0 112.369 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 90.0 m -95.46 -15.81 22.69 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -172.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.9 t -147.81 175.69 10.73 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.647 1.179 . . . . 0.0 112.448 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.4 p -155.46 161.54 29.23 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.606 1.162 . . . . 0.0 112.754 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.85 -45.71 38.98 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.131 2.554 . . . . 0.0 115.583 -170.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.91 -41.18 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 118.814 0.734 . . . . 0.0 111.945 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.48 86.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.954 0.901 . . . . 0.0 112.268 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.56 -40.56 92.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.989 0.916 . . . . 0.0 111.799 173.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 -58.69 -45.64 89.04 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.256 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -61.59 -36.79 81.66 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.542 1.065 . . . . 0.0 112.892 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.18 -60.33 2.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.23 1.012 . . . . 0.0 113.43 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.426 HG22 ' CD1' ' A' ' 42' ' ' ILE . 8.6 pt -73.2 -32.65 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -169.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -70.0 -19.62 63.32 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.84 0.856 . . . . 0.0 112.684 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.59 11.21 37.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.997 1.319 . . . . 0.0 113.934 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -60.61 -50.46 85.29 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.371 -1.3 . . . . 0.0 111.631 167.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 73.4 Cg_endo -70.25 172.84 12.35 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.583 2.855 . . . . 0.0 112.22 170.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.56 43.25 1.18 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.217 3.278 . . . . 0.0 112.236 170.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.41 58.05 5.23 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 121.155 -0.966 . . . . 0.0 111.149 -174.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -133.8 -42.33 0.83 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.41 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 14.9 m-85 -97.9 115.53 28.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -102.4 158.46 16.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.016 0.926 . . . . 0.0 111.772 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 m -126.86 139.25 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.364 0.984 . . . . 0.0 112.037 175.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.8 t -128.9 130.5 46.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.012 0.925 . . . . 0.0 111.945 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 CA--C 1.552 1.021 0 C-N-CA 125.355 1.462 . . . . 0.0 111.461 -175.887 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 87.1 m 58.53 92.63 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.237 1.815 . . . . 0.0 112.758 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 t -140.15 154.04 46.85 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.882 -1.136 . . . . 0.0 111.727 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.1 m -99.27 129.84 45.52 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -176.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.82 153.59 43.85 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.087 0.946 . . . . 0.0 110.126 168.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tt -102.55 130.5 49.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.705 2.002 . . . . 0.0 109.447 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.3 mm -115.12 138.55 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.174 1.789 . . . . 0.0 109.187 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -104.51 125.04 50.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.923 0.889 . . . . 0.0 110.044 169.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.9 mp -115.85 139.85 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.457 1.026 . . . . 0.0 112.369 -169.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.31 70.55 0.72 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.229 2.211 . . . . 0.0 111.539 171.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -176.2 54.09 0.11 Allowed Glycine 0 N--CA 1.466 0.659 0 C-N-CA 124.86 1.219 . . . . 0.0 112.753 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.9 mtm -134.98 157.78 46.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.514 1.526 . . . . 0.0 109.869 170.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.8 t -174.94 -45.34 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.593 1.557 . . . . 0.0 110.74 -171.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 67.0 m -104.68 146.05 29.48 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.863 1.265 . . . . 0.0 109.127 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.89 -27.69 68.34 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.622 -0.674 . . . . 0.0 112.605 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 79.9 p -56.06 -23.9 36.47 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.913 -1.117 . . . . 0.0 113.468 172.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 73.2 m -56.16 -27.82 55.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.372 1.069 . . . . 0.0 113.49 170.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.2 t -54.33 -52.58 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 118.91 0.777 . . . . 0.0 109.492 173.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -70.6 -14.8 62.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.232 1.013 . . . . 0.0 113.098 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.3 m -73.41 -56.14 5.44 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.064 -1.023 . . . . 0.0 109.65 167.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.5 mt -68.17 -59.23 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.695 1.198 . . . . 0.0 110.568 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -54.55 -29.52 51.21 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.646 1.578 . . . . 0.0 111.63 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.58 -62.65 3.15 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.373 0.987 . . . . 0.0 112.727 176.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 86.6 mmm -75.56 -42.49 52.09 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.771 1.396 . . . . 0.0 114.771 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 31.8 mm -72.32 -30.51 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.596 0.759 . . . . 0.0 111.829 -172.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.6 p -63.82 -9.37 14.44 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 175.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -107.92 22.95 15.22 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.028 1.331 . . . . 0.0 113.577 -171.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 pp -115.56 163.72 15.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.759 1.223 . . . . 0.0 111.544 169.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -65.57 135.8 55.56 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.12 16.57 74.17 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 117.891 -1.505 . . . . 0.0 115.89 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.75 -23.56 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 125.507 1.523 . . . . 0.0 114.292 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 42.65 -76.31 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 129.841 3.256 . . . . 0.0 117.37 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -128.28 127.91 43.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.55 1.523 . . . . 0.0 111.375 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.6 tt -134.6 137.66 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 121.188 -0.945 . . . . 0.0 111.164 -169.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 21.9 t -143.26 133.37 24.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.869 2.067 . . . . 0.0 108.248 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.58 143.62 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 119.785 1.175 . . . . 0.0 111.711 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -141.38 133.45 27.72 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -59.05 -22.08 60.16 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.041 2.137 . . . . 0.0 113.23 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.06 -31.17 62.93 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.792 1.237 . . . . 0.0 112.724 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -133.3 -16.7 2.4 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.185 1.394 . . . . 0.0 113.555 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.1 26.74 65.72 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.803 1.192 . . . . 0.0 112.112 -169.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.4 p -121.42 148.85 43.85 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.64 1.176 . . . . 0.0 111.693 -171.016 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.64 137.48 50.85 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.786 1.234 . . . . 0.0 110.771 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.0 t -112.66 121.13 43.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 167.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.59 141.28 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 121.906 -0.496 . . . . 0.0 110.614 -169.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.31 101.93 14.64 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.637 1.975 . . . . 0.0 105.887 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -97.65 157.8 15.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.293 1.044 . . . . 0.0 111.718 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -101.42 94.49 4.16 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.713 1.205 . . . . 0.0 110.267 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.55 -35.71 94.87 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.118 2.545 . . . . 0.0 111.372 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.57 -8.18 18.63 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.36 -28.98 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 126.181 1.792 . . . . 0.0 112.535 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.8 tt -155.91 158.02 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 119.943 1.247 . . . . 0.0 112.351 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.5 t -98.1 145.27 29.51 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.854 1.262 . . . . 0.0 113.104 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.42 -33.23 66.06 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.102 2.535 . . . . 0.0 112.546 167.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.42 -27.07 66.76 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.982 0.81 . . . . 0.0 112.432 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -76.38 -37.07 57.73 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.323 1.049 . . . . 0.0 111.953 168.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.43 -53.59 56.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.286 1.834 . . . . 0.0 110.641 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -59.83 -37.82 80.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.74 0.7 . . . . 0.0 112.809 173.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.63 -23.91 67.32 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.26 -35.63 71.47 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.111 1.323 . . . . 0.0 112.731 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.65 -38.18 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.574 1.149 . . . . 0.0 110.191 171.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -69.39 -26.76 64.8 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.41 1.084 . . . . 0.0 112.734 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.66 -44.51 64.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.182 1.393 . . . . 0.0 111.393 168.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 22.6 ttt -61.72 -27.67 68.88 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.654 1.582 . . . . 0.0 112.396 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 115.23 38.79 0.99 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.478 1.514 . . . . 0.0 114.024 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -130.7 -160.54 1.05 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.236 1.414 . . . . 0.0 108.266 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -131.51 146.86 52.44 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.904 -1.123 . . . . 0.0 110.335 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.93 141.53 31.49 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.8 t -124.36 135.5 53.36 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.5 1.12 . . . . 0.0 112.021 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 m -87.07 80.63 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.908 0.883 . . . . 0.0 110.768 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.476 0.839 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.603 -178.082 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -98.85 153.46 18.77 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.479 2.711 . . . . 0.0 112.927 -174.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.5 tt -143.96 139.31 29.02 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.221 1.409 . . . . 0.0 112.991 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -98.46 110.33 22.94 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 122.689 1.233 . . . . 0.0 111.928 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -138.17 133.73 33.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.472 -1.695 . . . . 0.0 112.667 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -98.6 119.38 37.22 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.7 mt -96.83 137.34 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.031 0.932 . . . . 0.0 109.146 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -96.64 117.8 31.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.904 0.882 . . . . 0.0 110.913 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.62 -12.36 12.13 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.306 1.432 . . . . 0.0 113.689 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 12.9 ptp -56.52 -22.17 31.1 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.939 1.87 . . . . 0.0 114.075 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -58.64 -25.97 63.28 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 169.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -80.42 -8.49 59.56 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.606 -1.309 . . . . 0.0 113.52 173.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.7 tptt 70.08 -56.0 0.59 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 129.025 2.93 . . . . 0.0 111.781 -170.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -48.86 -27.35 2.98 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.718 2.407 . . . . 0.0 114.567 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 t -53.59 -49.06 68.57 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.951 1.7 . . . . 0.0 113.265 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.9 -28.24 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -170.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.69 -51.86 45.5 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.215 1.406 . . . . 0.0 111.343 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.19 -54.12 49.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -60.69 -37.0 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.591 0.756 . . . . 0.0 111.34 -173.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -64.08 -28.65 69.93 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.402 -0.811 . . . . 0.0 112.399 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.24 -50.3 34.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.24 1.016 . . . . 0.0 112.085 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -92.57 -24.29 18.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.549 1.54 . . . . 0.0 115.076 -171.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.424 ' CD1' HG22 ' A' ' 78' ' ' ILE . 33.4 mm -98.86 125.84 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 120.345 1.429 . . . . 0.0 109.746 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.41 -14.24 7.32 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.039 1.78 . . . . 0.0 114.636 -174.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -96.65 -1.88 45.82 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.749 1.274 . . . . 0.0 113.092 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 mp -71.03 178.59 3.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.567 1.947 . . . . 0.0 110.71 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -58.6 4.31 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.854 -1.154 . . . . 0.0 111.569 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.74 -31.28 7.49 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.729 -1.595 . . . . 0.0 113.519 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.74 113.08 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.938 2.369 . . . . 0.0 109.46 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -98.4 -39.8 8.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.066 0.946 . . . . 0.0 111.894 -175.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.0 t -147.36 159.72 43.37 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.489 -0.757 . . . . 0.0 112.165 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -133.59 121.14 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.414 1.485 . . . . 0.0 109.214 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -110.14 177.43 4.71 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.248 1.419 . . . . 0.0 108.695 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.8 166.96 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 169.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 t -141.48 59.81 1.5 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.324 1.85 . . . . 0.0 110.378 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.31 -22.77 61.74 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.685 2.394 . . . . 0.0 115.664 -173.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -61.52 -35.76 78.62 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.691 1.132 . . . . 0.0 111.058 171.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -104.25 -2.27 25.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.252 1.421 . . . . 0.0 114.049 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.1 mttp 81.98 4.5 1.23 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.122 2.169 . . . . 0.0 112.37 173.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.26 155.16 16.99 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.902 2.081 . . . . 0.0 109.976 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.48 -179.71 4.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 165.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -145.52 105.11 3.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.444 -0.785 . . . . 0.0 111.686 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 p -101.7 132.14 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.432 0.634 . . . . 0.0 111.544 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.0 94.96 6.55 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.085 1.754 . . . . 0.0 109.832 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -120.16 148.98 42.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.007 0.923 . . . . 0.0 111.957 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -96.06 115.62 65.68 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.157 1.383 . . . . 0.0 108.832 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.97 -8.94 24.86 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.036 2.49 . . . . 0.0 113.186 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 t -77.86 -11.15 59.86 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.855 0.752 . . . . 0.0 112.23 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 66.0 m -130.27 -18.33 3.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.3 t -145.14 -177.68 5.67 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.899 1.227 . . . . 0.0 111.177 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 p -151.82 161.34 29.8 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 125.195 1.398 . . . . 0.0 109.352 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -50.09 -46.0 30.44 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.332 2.688 . . . . 0.0 114.228 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.0 p -67.84 -40.96 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 120.429 1.468 . . . . 0.0 111.763 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.23 90.2 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.917 0.887 . . . . 0.0 112.273 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.37 -47.0 58.98 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.976 0.51 . . . . 0.0 111.86 173.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -68.41 -41.52 80.3 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.37 -0.831 . . . . 0.0 112.549 -169.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -56.79 -30.71 63.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.466 0.706 . . . . 0.0 112.291 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.96 -55.59 7.19 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.107 0.867 . . . . 0.0 111.674 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.424 HG22 ' CD1' ' A' ' 42' ' ' ILE . 1.9 pt -64.93 -30.04 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -168.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -59.85 -34.48 73.17 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.88 13.0 30.23 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.1 mt -55.92 -56.03 34.89 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.937 168.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.505 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 86.5 Cg_endo -73.02 -179.98 4.83 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.872 3.048 . . . . 0.0 111.768 171.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.02 41.4 0.47 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.766 3.644 . . . . 0.0 111.989 168.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.47 27.13 64.06 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.849 1.214 . . . . 0.0 113.196 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -95.81 -40.62 9.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.272 1.036 . . . . 0.0 113.538 -168.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.505 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 24.7 m-85 -98.17 113.94 26.01 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.027 1.331 . . . . 0.0 108.182 173.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -97.38 164.02 12.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.19 0.596 . . . . 0.0 109.963 -174.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.99 141.56 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.123 0.969 . . . . 0.0 110.067 171.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.1 t -128.18 128.57 45.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.475 1.11 . . . . 0.0 112.59 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 127.69 2.396 . . . . 0.0 111.057 174.838 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 20.5 p -162.51 118.03 1.88 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.03 2.132 . . . . 0.0 110.92 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.0 p -141.91 142.56 33.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.577 1.951 . . . . 0.0 109.228 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.7 m -102.73 139.99 37.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.664 0.665 . . . . 0.0 109.454 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.43 161.85 35.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.397 0.679 . . . . 0.0 111.141 169.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 tt -114.03 132.38 56.02 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.316 1.847 . . . . 0.0 109.287 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mt -127.79 134.6 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.519 1.128 . . . . 0.0 110.083 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.75 127.71 43.9 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.109 1.363 . . . . 0.0 108.766 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.3 mt -129.43 145.88 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.248 -0.907 . . . . 0.0 112.101 -167.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -113.99 57.73 0.69 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.283 1.833 . . . . 0.0 112.277 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.73 53.27 0.44 Allowed Glycine 0 CA--C 1.524 0.642 0 O-C-N 121.553 -0.717 . . . . 0.0 113.842 168.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -138.2 98.97 3.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.417 1.487 . . . . 0.0 108.274 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.7 t -93.42 -31.37 14.64 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.228 1.411 . . . . 0.0 112.327 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 5.2 m -144.04 169.36 17.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.872 2.469 . . . . 0.0 110.594 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.94 71.46 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.231 -0.918 . . . . 0.0 112.512 172.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.0 p -50.44 -36.16 32.0 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.874 -1.141 . . . . 0.0 113.048 169.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.7 t -72.53 -34.96 67.93 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.257 1.423 . . . . 0.0 112.521 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.29 -52.58 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.915 0.886 . . . . 0.0 109.249 169.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -61.47 -23.27 65.76 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.1 t -70.69 -51.12 29.7 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.612 -0.68 . . . . 0.0 112.114 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 52.5 mt -63.4 -54.08 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 120.822 1.646 . . . . 0.0 111.055 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -59.26 -25.41 64.05 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.589 1.955 . . . . 0.0 110.918 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.8 -62.46 2.37 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.829 1.68 . . . . 0.0 114.056 168.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 89.8 mmm -70.56 -40.7 73.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.239 1.416 . . . . 0.0 113.817 -169.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.9 mm -70.67 -31.51 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.387 -0.821 . . . . 0.0 110.315 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.6 t -66.83 1.83 1.68 Allowed 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -87.13 -18.14 31.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.432 1.493 . . . . 0.0 114.09 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -102.6 165.85 10.85 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.972 1.26 . . . . 0.0 113.4 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -64.31 163.33 13.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.319 1.533 . . . . 0.0 113.779 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.87 -36.35 0.39 Allowed Glycine 0 CA--C 1.533 1.161 0 CA-C-O 117.847 -1.529 . . . . 0.0 115.283 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.0 p -70.42 93.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.493 1.647 . . . . 0.0 110.458 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -73.83 -45.55 50.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.98 1.712 . . . . 0.0 111.221 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -143.41 140.9 30.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.301 1.44 . . . . 0.0 108.299 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.9 tt -133.9 130.99 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.465 0.706 . . . . 0.0 110.822 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 43.2 m -131.88 104.2 6.74 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.825 1.25 . . . . 0.0 110.44 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.69 138.55 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.689 1.196 . . . . 0.0 111.737 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.0 m -133.85 142.74 47.94 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.747 1.261 . . . . 0.0 112.423 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.76 -15.67 59.69 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.613 1.965 . . . . 0.0 115.348 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.98 -46.03 71.56 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.312 1.445 . . . . 0.0 111.943 -174.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.7 -14.94 8.99 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.041 1.736 . . . . 0.0 110.897 172.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.17 39.67 7.82 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.881 1.229 . . . . 0.0 111.722 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.9 p -129.2 148.43 51.14 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.124 0.97 . . . . 0.0 113.015 -169.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -122.13 129.93 52.77 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.384 1.874 . . . . 0.0 111.777 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.2 t -103.72 122.76 45.74 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 167.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.99 137.5 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 122.018 -0.426 . . . . 0.0 110.748 -169.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.27 114.12 25.83 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.998 1.719 . . . . 0.0 107.935 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -114.4 155.98 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.882 0.873 . . . . 0.0 112.523 176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -96.48 110.42 52.73 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.883 0.873 . . . . 0.0 109.758 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.26 -14.23 20.65 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.941 2.427 . . . . 0.0 112.554 -171.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.47 -17.27 60.8 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.456 1.026 . . . . 0.0 112.951 170.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 99.1 t -117.49 -34.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.538 1.535 . . . . 0.0 113.078 -170.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.7 tt -145.71 154.04 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.446 1.021 . . . . 0.0 112.59 -174.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.8 t -101.65 151.79 37.95 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 125.829 1.652 . . . . 0.0 111.7 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.37 -32.47 42.23 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.232 2.621 . . . . 0.0 114.112 168.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -73.82 -24.21 59.76 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.778 0.717 . . . . 0.0 111.645 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.72 -38.02 58.92 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.941 1.296 . . . . 0.0 111.441 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.7 mt -56.36 -55.5 32.73 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -52.35 -51.53 58.33 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.625 1.57 . . . . 0.0 111.29 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.15 -25.14 68.21 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.52 68.14 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.713 1.597 . . . . 0.0 111.769 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.36 -38.2 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.443 1.097 . . . . 0.0 111.045 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.29 -40.12 95.3 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.696 0.68 . . . . 0.0 111.271 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.4 -23.53 62.78 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.163 2.185 . . . . 0.0 113.022 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 26.4 ttt -76.42 -40.83 49.63 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.733 1.213 . . . . 0.0 110.875 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 125.39 34.47 0.66 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.994 1.283 . . . . 0.0 115.661 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -129.02 -153.51 0.57 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.628 1.571 . . . . 0.0 108.68 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.52 148.29 49.11 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.356 -0.84 . . . . 0.0 112.118 169.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -136.07 151.52 49.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.038 1.335 . . . . 0.0 112.368 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.2 t -140.24 122.92 16.32 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.005 1.322 . . . . 0.0 111.357 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.4 m -84.39 78.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.651 1.215 . . . . 0.0 110.54 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 CA--C 1.547 0.843 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.751 172.991 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -98.0 142.13 30.1 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.683 1.593 . . . . 0.0 110.601 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tt -143.63 148.06 35.27 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.156 1.782 . . . . 0.0 111.886 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -96.51 130.74 43.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.452 1.12 . . . . 0.0 111.829 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.08 140.72 31.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 113.46 -1.7 . . . . 0.0 111.332 169.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -99.43 121.42 41.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.29 136.09 23.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 170.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.85 144.82 27.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.543 1.137 . . . . 0.0 109.094 171.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.1 -2.64 64.65 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.887 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -73.32 -63.83 1.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.612 1.165 . . . . 0.0 109.825 174.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.7 m80 58.47 -12.75 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.781 2.433 . . . . 0.0 115.528 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 32.0 p -164.39 155.62 15.54 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.837 1.255 . . . . 0.0 112.251 -169.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -32.38 23.23 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 175.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 m -60.16 -35.57 75.61 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.863 -1.148 . . . . 0.0 112.439 -174.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.8 m -74.75 -18.05 60.55 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.82 -8.61 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -56.89 -62.77 1.51 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.797 1.18 . . . . 0.0 112.387 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -53.84 -34.4 59.17 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.612 -0.68 . . . . 0.0 111.294 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.414 ' HA ' HD21 ' A' ' 81' ' ' LEU . 1.8 mt -63.39 -50.14 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 O-C-N 121.122 -0.986 . . . . 0.0 111.093 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -62.3 -32.48 73.23 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.289 0.95 . . . . 0.0 112.465 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -65.0 -54.59 28.04 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.541 1.064 . . . . 0.0 111.88 173.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -83.47 -33.75 25.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.185 1.394 . . . . 0.0 114.113 -170.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.1 mm -104.01 121.69 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 122.087 0.946 . . . . 0.0 110.47 -167.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.42 -28.55 5.0 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 125.807 1.67 . . . . 0.0 113.326 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -79.12 -0.55 32.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.619 -0.93 . . . . 0.0 112.692 174.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.39 -173.58 4.13 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.16 2.584 . . . . 0.0 112.756 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.02 -78.52 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.752 1.621 . . . . 0.0 111.932 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.61 -25.31 18.56 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.446 -1.752 . . . . 0.0 113.486 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -77.92 110.55 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 121.194 2.497 . . . . 0.0 107.819 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -104.41 -31.53 9.47 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.483 1.113 . . . . 0.0 112.137 -169.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 t -148.69 174.08 12.54 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 tp -144.79 136.78 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.83 1.652 . . . . 0.0 110.55 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -141.64 -178.08 5.48 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.675 1.19 . . . . 0.0 111.247 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.53 148.08 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 120.988 1.722 . . . . 0.0 114.581 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 m -130.36 57.88 1.7 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.657 1.583 . . . . 0.0 109.656 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.4 mt -64.93 -24.03 67.4 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.124 1.77 . . . . 0.0 115.333 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.77 -29.8 65.12 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.753 0.821 . . . . 0.0 111.963 170.31 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -120.7 13.05 11.54 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.817 1.647 . . . . 0.0 112.668 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 72.64 4.87 5.11 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.303 1.841 . . . . 0.0 115.298 168.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 p -96.47 152.74 18.33 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.604 1.192 . . . . 0.0 110.646 177.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.75 157.13 17.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 164.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.31 112.21 14.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.515 -0.741 . . . . 0.0 110.438 -168.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 p -96.74 136.15 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -117.83 82.9 1.9 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.535 1.534 . . . . 0.0 106.871 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -117.89 153.97 32.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.349 -170.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -97.1 109.42 49.26 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 127.332 2.253 . . . . 0.0 108.705 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.49 -3.15 10.47 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.339 2.693 . . . . 0.0 113.458 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.7 t -80.16 -18.77 48.82 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.39 0.995 . . . . 0.0 111.974 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 14.6 m -122.86 -16.03 7.23 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 t -146.3 -175.63 4.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.638 1.175 . . . . 0.0 111.409 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.7 m -153.87 156.34 32.0 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 126.567 1.947 . . . . 0.0 109.611 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -52.96 -56.9 2.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.26 2.64 . . . . 0.0 115.775 -169.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.16 -36.84 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 120.961 1.71 . . . . 0.0 112.711 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.84 -41.42 71.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.651 1.18 . . . . 0.0 112.256 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.94 -38.28 76.13 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.925 0.89 . . . . 0.0 111.279 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -69.78 -41.19 75.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.53 1.132 . . . . 0.0 111.848 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -50.18 -35.91 28.22 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.744 1.218 . . . . 0.0 113.13 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.17 -61.92 1.59 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.162 0.892 . . . . 0.0 112.198 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.411 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 30.4 pt -60.68 -21.22 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.937 1.695 . . . . 0.0 114.659 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.36 -25.39 65.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.345 1.458 . . . . 0.0 113.227 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -126.66 25.62 6.4 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.6 1.56 . . . . 0.0 113.397 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD21 ' HA ' ' A' ' 38' ' ' ILE . 11.3 tp -53.56 -55.62 33.18 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 127.248 2.219 . . . . 0.0 112.473 168.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 32.3 Cg_endo -84.45 -179.5 3.89 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.189 3.259 . . . . 0.0 111.163 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.76 56.72 2.4 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.681 3.587 . . . . 0.0 111.855 168.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.14 15.92 65.97 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.197 1.38 . . . . 0.0 114.183 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -83.92 -34.01 24.59 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.953 0.876 . . . . 0.0 112.387 -168.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.48 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 8.9 m-85 -121.56 129.77 53.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.04 2.136 . . . . 0.0 107.688 174.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -120.09 173.16 7.26 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.299 1.44 . . . . 0.0 110.309 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.06 131.48 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 119.964 1.256 . . . . 0.0 113.479 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -118.37 118.43 31.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.491 1.116 . . . . 0.0 110.617 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.958 1.303 . . . . 0.0 111.38 172.578 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 26.3 p -156.2 117.35 3.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.312 1.045 . . . . 0.0 113.358 -167.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.7 p -145.29 145.04 31.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.623 1.169 . . . . 0.0 111.381 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 88.3 m -96.98 140.91 30.8 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.41 149.98 36.95 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.418 1.087 . . . . 0.0 110.692 173.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tt -117.58 142.41 47.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.002 2.121 . . . . 0.0 110.331 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 mt -134.1 135.28 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.105 1.762 . . . . 0.0 110.754 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.88 128.57 45.96 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.769 1.628 . . . . 0.0 110.467 171.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.51 118.44 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 120.958 -1.089 . . . . 0.0 111.241 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.05 55.94 2.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.525 1.13 . . . . 0.0 110.917 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.54 53.29 0.32 Allowed Glycine 0 N--CA 1.462 0.415 0 C-N-CA 124.612 1.101 . . . . 0.0 111.139 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.8 mtm -145.36 145.6 31.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.676 0.79 . . . . 0.0 111.097 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.8 t -163.34 -43.94 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.425 0.69 . . . . 0.0 112.425 -168.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 83.5 m -114.26 152.03 31.95 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.393 1.477 . . . . 0.0 110.516 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.54 -25.53 68.09 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.872 -1.143 . . . . 0.0 113.14 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.7 p -59.18 -22.26 60.7 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.236 -1.54 . . . . 0.0 113.274 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 74.4 m -61.18 -30.22 70.28 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.754 -1.216 . . . . 0.0 112.052 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.73 -53.29 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.646 0.778 . . . . 0.0 109.914 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -65.27 -25.18 67.54 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.469 0.577 . . . . 0.0 111.847 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.5 m -70.58 -59.95 2.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.623 0.769 . . . . 0.0 111.943 170.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.1 mt -69.09 -42.28 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.056 1.342 . . . . 0.0 112.854 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -56.4 -34.28 66.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.358 0.663 . . . . 0.0 109.831 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.58 -34.31 67.45 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.037 -1.424 . . . . 0.0 114.088 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -47.42 72.52 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 121.244 2.522 . . . . 0.0 110.389 172.24 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 mm -75.52 -50.63 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.489 0.716 . . . . 0.0 112.192 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -71.32 -5.97 36.41 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.4 -1.438 . . . . 0.0 114.65 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -85.7 -21.7 28.19 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.24 -155.95 0.53 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -167.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -117.63 149.99 39.77 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.738 1.615 . . . . 0.0 111.816 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.56 18.91 59.34 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 117.638 -1.645 . . . . 0.0 114.584 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.0 p -112.03 97.22 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.844 2.058 . . . . 0.0 111.305 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.73 -47.56 8.15 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.195 -0.941 . . . . 0.0 112.53 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -142.48 145.58 33.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.607 1.163 . . . . 0.0 108.385 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.29 143.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 118.53 0.604 . . . . 0.0 111.036 167.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.5 t -140.37 149.75 43.07 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.049 2.14 . . . . 0.0 109.834 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.42 140.93 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.291 1.036 . . . . 0.0 111.329 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 67.2 m -121.87 77.69 1.39 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.116 2.167 . . . . 0.0 108.1 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.8 tt -53.59 -29.03 35.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.723 2.009 . . . . 0.0 112.383 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -41.48 -51.12 3.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.858 2.463 . . . . 0.0 112.882 167.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -90.43 -29.42 17.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.553 1.941 . . . . 0.0 111.125 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 93.09 27.93 12.77 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.143 1.83 . . . . 0.0 112.741 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.3 p -132.99 139.02 47.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.232 1.016 . . . . 0.0 112.457 -168.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.92 147.24 29.0 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.092 1.357 . . . . 0.0 111.113 173.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.2 t -131.29 133.89 45.83 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.509 1.124 . . . . 0.0 109.484 172.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.92 142.93 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.505 1.122 . . . . 0.0 110.927 -168.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.22 103.22 15.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.115 1.766 . . . . 0.0 106.773 169.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -108.9 156.66 19.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.002 0.921 . . . . 0.0 112.845 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -99.08 110.17 56.87 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.874 0.869 . . . . 0.0 111.148 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.08 -11.54 21.34 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.247 2.631 . . . . 0.0 113.761 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.89 -11.21 59.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.222 1.009 . . . . 0.0 113.356 171.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.3 t -120.09 -42.89 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.495 1.518 . . . . 0.0 111.895 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.1 tt -134.52 143.6 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 123.685 0.794 . . . . 0.0 111.596 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.9 t -97.11 151.49 37.73 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.404 1.082 . . . . 0.0 112.695 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.14 -28.96 53.74 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.729 2.286 . . . . 0.0 112.672 167.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -67.57 -30.82 70.54 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.414 -0.804 . . . . 0.0 112.857 173.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.08 -31.81 64.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.538 1.135 . . . . 0.0 112.044 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 63.0 mt -60.59 -53.39 58.09 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.082 0.953 . . . . 0.0 109.447 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -57.28 -49.21 76.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.857 0.863 . . . . 0.0 111.605 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.69 -27.59 66.56 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.63 -41.04 80.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.655 1.116 . . . . 0.0 112.073 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.69 -39.03 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.473 0.709 . . . . 0.0 110.835 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -65.3 -24.46 67.29 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.99 -21.55 59.95 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 172.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -50.06 9.21 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.185 0.594 . . . . 0.0 109.572 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 131.28 50.73 0.1 OUTLIER Glycine 0 N--CA 1.467 0.755 0 C-N-CA 124.658 1.123 . . . . 0.0 113.81 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -136.34 -167.18 2.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.326 1.85 . . . . 0.0 108.72 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -127.14 129.57 48.14 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 121.016 -1.053 . . . . 0.0 110.212 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -116.26 149.15 39.67 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.301 1.44 . . . . 0.0 109.472 172.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.3 t -140.66 133.67 29.3 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.34 1.056 . . . . 0.0 109.325 172.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 24.9 m -84.73 121.97 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.38 0.609 . . . . 0.0 109.432 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 126.171 1.788 . . . . 0.0 109.51 -172.627 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.0 m -120.46 151.36 39.44 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.475 1.11 . . . . 0.0 110.523 -171.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.96 176.42 8.95 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.182 0.993 . . . . 0.0 113.453 172.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -112.76 136.91 51.82 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.727 1.211 . . . . 0.0 113.093 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -147.17 142.43 27.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.636 168.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -104.77 111.98 24.92 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.914 1.286 . . . . 0.0 108.361 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 mt -85.12 139.43 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.657 0.783 . . . . 0.0 109.593 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.99 123.05 43.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.047 1.339 . . . . 0.0 111.304 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.14 -9.36 24.89 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.884 1.23 . . . . 0.0 114.886 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.2 ptp -57.35 -7.64 0.62 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -56.87 -24.65 53.13 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.828 -1.17 . . . . 0.0 112.839 168.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.8 m -97.38 119.18 35.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 167.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -58.04 -28.04 64.13 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.522 1.055 . . . . 0.0 113.454 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.6 p -53.13 -28.55 26.34 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 170.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.25 -51.52 68.59 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.877 0.762 . . . . 0.0 111.215 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -74.6 -27.64 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.54 -56.19 24.42 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.088 0.955 . . . . 0.0 111.847 -175.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -65.15 -33.94 77.2 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.732 -0.605 . . . . 0.0 112.285 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.3 mt -58.96 -47.95 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 118.885 0.766 . . . . 0.0 111.012 169.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -63.32 -33.8 76.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.578 1.151 . . . . 0.0 112.518 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -68.48 -41.37 80.22 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.34 -0.85 . . . . 0.0 112.295 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.62 -31.2 15.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -170.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.465 ' CD1' HG22 ' A' ' 78' ' ' ILE . 35.3 mm -96.35 119.14 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.78 1.173 . . . . 0.0 109.293 -171.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 132.54 -8.16 5.28 Favored Glycine 0 CA--C 1.541 1.719 0 C-N-CA 125.72 1.628 . . . . 0.0 113.626 -168.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -100.95 -13.88 18.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.502 1.921 . . . . 0.0 112.574 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.42 149.81 30.01 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.08 1.752 . . . . 0.0 111.539 -167.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.6 tp -17.46 -64.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.65 2.78 . . . . 0.0 114.411 170.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.29 19.1 13.4 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 116.333 -2.371 . . . . 0.0 115.868 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.3 t -115.47 118.19 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 121.683 2.742 . . . . 0.0 110.444 169.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -90.82 -40.54 11.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.777 0.831 . . . . 0.0 112.503 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.4 m -147.91 166.21 28.34 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.796 -1.19 . . . . 0.0 113.855 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.2 tp -126.82 145.67 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.996 1.318 . . . . 0.0 111.5 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -142.16 159.31 42.49 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.103 2.161 . . . . 0.0 109.774 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -140.71 144.29 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.338 -1.476 . . . . 0.0 112.206 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.0 m -138.77 58.32 1.66 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.184 1.394 . . . . 0.0 111.136 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.13 -30.14 69.09 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.817 2.047 . . . . 0.0 115.212 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -61.71 -20.36 63.4 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.654 1.116 . . . . 0.0 113.147 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -114.63 1.22 14.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.469 1.908 . . . . 0.0 112.303 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt 57.34 22.2 7.56 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.901 1.68 . . . . 0.0 112.876 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.77 153.13 18.06 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.343 1.068 . . . . 0.0 108.565 171.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.1 155.82 27.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 168.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.72 128.24 45.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -169.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -117.74 134.99 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 121.843 -0.535 . . . . 0.0 110.352 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -106.12 79.07 1.36 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -100.39 175.39 5.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.305 1.842 . . . . 0.0 109.53 -172.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.45 142.64 40.9 Favored Pre-proline 0 N--CA 1.477 0.89 0 CA-C-N 121.528 1.967 . . . . 0.0 111.501 168.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.89 5.67 6.28 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.972 2.448 . . . . 0.0 112.637 -172.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.2 t -87.39 -48.41 7.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.446 1.021 . . . . 0.0 110.168 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 85.1 m -101.3 -16.28 16.99 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.7 t -145.76 -178.35 6.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.381 1.072 . . . . 0.0 111.079 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 p -162.47 158.31 19.79 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.786 1.234 . . . . 0.0 111.83 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -46.79 -43.51 23.57 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.699 3.6 . . . . 0.0 116.368 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.8 m -70.64 -35.84 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.267 1.394 . . . . 0.0 112.388 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.42 85.45 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.153 0.981 . . . . 0.0 110.934 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.58 -48.2 73.16 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.257 1.023 . . . . 0.0 111.888 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -56.43 -52.06 66.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.121 0.873 . . . . 0.0 110.364 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -53.2 -42.95 66.79 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.649 1.18 . . . . 0.0 113.214 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.31 -59.24 2.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.602 1.161 . . . . 0.0 112.697 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.465 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.7 pt -71.94 -33.48 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -168.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -70.19 -12.01 61.29 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.26 0.624 . . . . 0.0 112.55 174.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.7 6.74 30.01 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.561 -1.337 . . . . 0.0 113.699 176.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt -56.42 -57.71 21.4 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.283 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.34 169.88 18.6 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.972 1.781 . . . . 0.0 110.459 168.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -76.21 55.65 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.269 3.313 . . . . 0.0 110.656 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.86 27.02 71.42 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.095 0.855 . . . . 0.0 113.898 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -100.46 -14.22 18.38 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 -167.018 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -135.26 114.03 11.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.051 1.34 . . . . 0.0 108.88 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -93.68 157.25 16.26 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.178 -0.951 . . . . 0.0 111.054 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.28 136.54 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 118.219 0.463 . . . . 0.0 111.859 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -111.38 121.54 45.49 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.195 0.998 . . . . 0.0 111.822 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.555 1.162 0 C-N-CA 128.241 2.617 . . . . 0.0 111.023 179.174 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.6 p -150.79 128.07 11.3 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.418 1.487 . . . . 0.0 113.609 -168.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.2 m -143.94 143.23 31.16 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.371 1.068 . . . . 0.0 111.649 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 84.8 m -100.2 144.31 29.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.546 0.738 . . . . 0.0 110.221 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.11 167.52 21.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.429 1.092 . . . . 0.0 110.903 166.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.04 133.45 55.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.457 1.903 . . . . 0.0 110.142 -176.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.7 mm -120.82 137.06 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.278 1.831 . . . . 0.0 109.306 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.03 125.44 48.72 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.957 1.303 . . . . 0.0 110.391 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.44 131.33 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.182 0.993 . . . . 0.0 111.52 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.44 53.68 0.87 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.815 1.646 . . . . 0.0 112.581 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.0 53.76 0.33 Allowed Glycine 0 N--CA 1.464 0.525 0 C-N-CA 124.926 1.251 . . . . 0.0 110.963 173.196 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.5 mtm -133.3 142.94 48.72 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.849 0.824 . . . . 0.0 112.01 -175.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 t -165.28 124.62 1.76 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.495 1.918 . . . . 0.0 107.775 -172.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 72.31 160.8 0.23 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.542 1.937 . . . . 0.0 115.409 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.42 -32.58 67.02 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.31 170.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 p -65.76 -28.37 68.98 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.601 -1.312 . . . . 0.0 112.837 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 52.2 t -68.4 -46.17 70.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.028 1.285 . . . . 0.0 111.154 170.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.1 t -52.78 -55.42 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.143 0.429 . . . . 0.0 110.085 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -71.17 -17.41 62.54 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -176.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 m -74.58 -47.41 32.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.071 0.948 . . . . 0.0 111.492 167.109 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.8 -54.19 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.795 -1.191 . . . . 0.0 110.69 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -55.06 -30.68 60.12 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.82 2.048 . . . . 0.0 111.866 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.86 -51.17 8.07 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.874 1.702 . . . . 0.0 113.851 173.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 79.5 mmm -74.97 -53.87 8.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.5 1.52 . . . . 0.0 114.049 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.2 mm -71.24 -19.38 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.458 1.103 . . . . 0.0 112.437 -169.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 65.6 p -70.64 0.6 6.6 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 171.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -121.55 33.71 5.43 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.19 10.79 6.91 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.669 2.099 . . . . 0.0 116.669 -172.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 76.2 118.81 0.05 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.922 2.489 . . . . 0.0 113.968 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 97.12 21.74 19.52 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.106 -1.385 . . . . 0.0 114.398 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.34 94.94 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.181 2.192 . . . . 0.0 110.251 -178.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -75.62 -56.53 4.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.032 0.933 . . . . 0.0 111.776 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -141.9 129.94 22.0 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.227 1.411 . . . . 0.0 109.007 -172.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -140.88 129.11 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.907 1.283 . . . . 0.0 110.517 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.2 t -142.23 129.65 21.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.21 1.004 . . . . 0.0 111.527 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.03 139.27 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.113 1.765 . . . . 0.0 110.522 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 74.5 p -143.3 146.3 33.46 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.5 mt -72.77 -24.27 60.92 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -176.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.63 -42.57 71.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.147 1.779 . . . . 0.0 113.535 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -111.09 -13.36 14.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.552 1.141 . . . . 0.0 110.409 168.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.57 49.7 7.08 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 125.453 1.501 . . . . 0.0 110.653 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.1 p -138.56 147.09 42.65 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -168.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -113.7 139.38 49.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.98 1.712 . . . . 0.0 112.297 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 7.5 t -112.25 125.62 54.35 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 166.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.59 134.74 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 122.153 -0.342 . . . . 0.0 110.852 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.93 113.77 25.53 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.768 2.427 . . . . 0.0 106.402 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -111.71 163.0 14.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.247 1.019 . . . . 0.0 112.95 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -97.11 98.1 4.37 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.417 1.887 . . . . 0.0 109.171 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.87 -12.13 33.66 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.137 1.891 . . . . 0.0 115.148 -169.254 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.36 -24.25 46.54 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.329 0.968 . . . . 0.0 112.447 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.8 t -95.7 -50.83 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.926 1.69 . . . . 0.0 111.046 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.33 149.5 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 122.095 0.95 . . . . 0.0 112.231 -170.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.5 t -97.68 143.43 26.2 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.673 1.589 . . . . 0.0 112.295 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.75 -16.12 51.93 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.62 2.214 . . . . 0.0 113.91 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -70.31 -27.36 64.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.696 1.134 . . . . 0.0 111.388 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -76.29 -20.29 57.47 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.764 2.026 . . . . 0.0 112.664 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 97.0 mt -67.37 -56.03 11.38 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.937 0.895 . . . . 0.0 111.32 -175.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -56.6 -38.33 71.87 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.788 -0.57 . . . . 0.0 112.406 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.86 -28.41 68.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.942 0.897 . . . . 0.0 112.974 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.37 69.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.462 1.028 . . . . 0.0 112.907 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.5 mp -72.48 -40.47 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.078 0.951 . . . . 0.0 110.867 171.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.14 -26.34 65.73 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.806 -0.559 . . . . 0.0 112.173 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.73 -26.75 62.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.503 1.521 . . . . 0.0 112.396 169.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 23.1 ttt -75.19 -38.32 60.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.225 1.01 . . . . 0.0 111.75 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.04 11.4 1.06 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.179 1.371 . . . . 0.0 116.338 172.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -111.11 -165.64 1.01 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.459 1.504 . . . . 0.0 110.049 -176.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -125.19 133.47 52.74 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.367 1.067 . . . . 0.0 111.364 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -136.43 143.8 44.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.991 1.316 . . . . 0.0 112.52 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -129.57 139.72 51.41 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.139 1.376 . . . . 0.0 109.036 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.2 p -87.89 111.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 125.491 1.517 . . . . 0.0 107.787 -173.39 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 120.658 0.266 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -95.71 151.82 19.02 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.424 1.489 . . . . 0.0 111.11 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -137.47 128.38 27.31 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 127.03 2.132 . . . . 0.0 109.012 -172.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLN . . . . . 0.522 ' HG3' HG21 ' A' ' 59' ' ' THR . 3.5 tp-100 -103.89 115.54 30.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.088 0.858 . . . . 0.0 112.01 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.454 ' HB3' HD21 ' A' ' 90' ' ' LEU . 1.7 pt? -135.83 142.08 44.78 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -172.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -109.14 107.36 17.63 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.709 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mm -80.0 152.25 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.966 1.706 . . . . 0.0 111.415 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -105.18 140.37 38.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.383 1.473 . . . . 0.0 110.283 168.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.65 -8.96 76.49 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.908 1.242 . . . . 0.0 114.142 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 ptm -66.26 -6.32 13.45 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.284 1.542 . . . . 0.0 115.153 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.13 -24.08 66.94 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.169 -0.957 . . . . 0.0 110.834 165.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -99.5 114.91 28.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.577 1.551 . . . . 0.0 107.466 167.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -59.09 -30.78 68.34 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.633 -1.292 . . . . 0.0 112.213 -173.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.4 m -51.31 -21.91 2.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.641 1.576 . . . . 0.0 114.227 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.7 t -58.59 -49.36 77.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.618 1.167 . . . . 0.0 112.804 170.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -73.85 -28.22 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -169.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.49 -47.96 83.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.491 1.116 . . . . 0.0 111.468 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -41.59 76.66 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.505 -0.747 . . . . 0.0 111.309 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.4 mt -65.6 -47.03 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 122.947 0.499 . . . . 0.0 109.912 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HA ' HG21 ' A' ' 51' ' ' ILE . 14.9 tm-20 -65.9 -29.64 70.1 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.423 1.489 . . . . 0.0 113.32 -175.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.56 -52.09 24.02 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.829 -0.544 . . . . 0.0 112.401 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -91.63 -7.95 48.57 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -166.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.466 ' CD1' HG22 ' A' ' 78' ' ' ILE . 46.6 mm -122.48 128.62 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.089 1.356 . . . . 0.0 108.504 172.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.76 -5.33 4.05 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.94 1.257 . . . . 0.0 115.397 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -114.98 -5.47 12.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.394 1.477 . . . . 0.0 112.976 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.34 152.14 44.47 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.916 1.287 . . . . 0.0 111.605 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -48.29 -30.7 5.08 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.86 7.72 27.6 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 116.548 -2.251 . . . . 0.0 115.67 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.87 116.67 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 121.466 2.633 . . . . 0.0 110.414 169.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -71.89 -51.28 23.05 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.631 0.372 . . . . 0.0 110.203 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 p -151.08 155.23 38.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.542 1.137 . . . . 0.0 113.149 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.489 HG21 ' HA ' ' A' ' 39' ' ' GLU . 10.7 tp -98.26 155.07 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.083 1.353 . . . . 0.0 109.199 169.018 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -138.26 144.63 40.62 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.53 1.059 . . . . 0.0 111.117 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.9 t -108.38 127.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.315 1.446 . . . . 0.0 108.842 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.9 m -133.82 54.28 1.96 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.512 0.672 . . . . 0.0 111.967 -172.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.3 mt -68.66 -25.99 65.09 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.413 -1.429 . . . . 0.0 113.35 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -74.17 -17.65 60.88 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 171.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -95.7 -8.17 35.38 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.101 1.361 . . . . 0.0 110.81 168.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 mptt 74.89 14.2 3.28 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.975 2.51 . . . . 0.0 113.004 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.522 HG21 ' HG3' ' A' ' 23' ' ' GLN . 17.7 p -124.16 175.23 7.15 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.285 2.234 . . . . 0.0 110.331 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.96 167.58 10.14 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.035 1.334 . . . . 0.0 107.981 165.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -140.62 143.35 35.15 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.717 0.407 . . . . 0.0 110.932 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 p -140.31 133.48 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.545 0.611 . . . . 0.0 111.511 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.39 81.44 2.53 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.993 1.717 . . . . 0.0 108.519 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -101.32 148.82 24.69 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.103 1.361 . . . . 0.0 111.825 -174.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.26 122.09 49.55 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.719 0.808 . . . . 0.0 110.482 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -60.28 0.47 0.7 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 124.659 3.573 . . . . 0.0 115.252 173.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.4 m -65.39 -35.0 79.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.527 1.531 . . . . 0.0 112.79 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 81.7 m -122.32 -23.06 5.36 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -170.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -143.07 -178.24 5.74 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.213 1.405 . . . . 0.0 111.181 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.9 t -163.17 143.39 7.07 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.429 1.892 . . . . 0.0 109.344 -171.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -40.57 -49.31 4.16 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 125.007 3.804 . . . . 0.0 117.263 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.6 m -70.0 -36.65 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.327 1.421 . . . . 0.0 113.362 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.34 -36.31 66.14 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.242 1.017 . . . . 0.0 110.839 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -67.61 -48.87 65.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.733 2.013 . . . . 0.0 110.787 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -53.25 -52.97 57.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.3 1.04 . . . . 0.0 110.836 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -57.84 -38.67 76.05 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.341 1.057 . . . . 0.0 112.493 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.1 -43.51 74.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.581 0.752 . . . . 0.0 112.776 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.466 HG22 ' CD1' ' A' ' 42' ' ' ILE . 7.2 pt -74.56 -37.42 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.91 -33.64 75.75 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -171.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.37 12.93 23.1 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.2 mt -53.61 -47.58 96.04 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.194 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.45 169.93 16.55 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.289 2.659 . . . . 0.0 112.566 171.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.88 64.2 7.62 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 124.893 3.729 . . . . 0.0 110.037 169.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.57 23.48 72.13 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.324 1.44 . . . . 0.0 114.602 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -94.46 -30.81 14.25 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -167.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -122.2 115.96 23.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.706 1.202 . . . . 0.0 108.893 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.79 157.09 16.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.082 0.953 . . . . 0.0 111.842 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.5 t -112.01 137.92 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.725 0.81 . . . . 0.0 110.478 167.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.4 m -113.29 129.61 56.48 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.113 0.565 . . . . 0.0 111.042 166.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.454 HD21 ' HB3' ' A' ' 24' ' ' LEU . 14.4 mt . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 127.512 2.325 . . . . 0.0 112.398 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.732 0.301 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 121' ' ' CYS . . . . . 0.548 ' HB2' HD11 ' A' ' 165' ' ' LEU . 11.9 p 178.44 139.08 0.09 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.176 1.79 . . . . 0.0 113.269 -171.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 p -147.61 143.5 27.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.841 1.656 . . . . 0.0 111.515 168.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.78 147.26 24.57 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 120.058 1.299 . . . . 0.0 111.982 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.26 165.21 28.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.257 1.423 . . . . 0.0 113.127 173.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.17 135.36 46.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.683 1.993 . . . . 0.0 111.345 173.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.9 mm -120.34 136.12 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.716 1.206 . . . . 0.0 107.994 168.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.15 136.14 39.53 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.5 mt -130.07 142.21 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.707 -1.246 . . . . 0.0 110.884 -168.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.4 61.56 1.6 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.125 1.77 . . . . 0.0 112.939 -174.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.08 49.2 0.19 Allowed Glycine 0 N--CA 1.466 0.687 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.01 164.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 77.1 mtm -117.22 143.87 45.41 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.256 1.027 . . . . 0.0 111.505 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.0 t -159.82 127.45 4.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 127.185 2.194 . . . . 0.0 106.156 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 2.3 t 74.8 148.13 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.902 1.681 . . . . 0.0 113.034 -175.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.44 -29.6 49.94 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.453 -0.779 . . . . 0.0 112.29 171.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.9 p -61.93 -34.14 75.55 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.733 -1.23 . . . . 0.0 112.512 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 30.4 t -68.32 -37.56 80.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.305 1.411 . . . . 0.0 112.181 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 t -58.05 -56.52 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 118.883 -0.579 . . . . 0.0 109.888 169.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -62.95 -23.3 67.33 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.977 0.808 . . . . 0.0 112.798 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 m -70.33 -55.33 9.42 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.715 1.206 . . . . 0.0 111.966 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.86 -48.74 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 119.47 1.032 . . . . 0.0 110.837 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -60.42 -25.27 65.82 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.362 2.265 . . . . 0.0 111.844 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.5 -58.25 3.64 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 127.547 2.498 . . . . 0.0 114.094 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 21.5 mmt -71.73 -53.29 13.93 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.398 1.479 . . . . 0.0 113.204 -169.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.5 mm -66.0 -30.06 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.892 -0.505 . . . . 0.0 110.618 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.0 t -57.12 -19.71 21.52 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -96.69 17.38 16.61 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -167.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.89 169.59 9.74 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.476 1.51 . . . . 0.0 110.55 169.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -64.32 163.35 13.15 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.935 1.35 . . . . 0.0 114.501 -171.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.07 -32.21 1.31 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.62 1.581 . . . . 0.0 116.788 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.9 p -78.0 97.6 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 119.968 1.884 . . . . 0.0 112.935 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.517 ' HB3' HD12 ' A' ' 165' ' ' LEU . 26.8 tt0 -76.66 -39.27 52.75 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.982 1.313 . . . . 0.0 112.84 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -144.58 140.75 28.97 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.33 1.052 . . . . 0.0 110.099 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -144.96 129.85 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 119.306 0.957 . . . . 0.0 111.571 172.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.19 124.6 20.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.699 1.2 . . . . 0.0 110.677 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.6 t -126.53 149.64 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 120.616 -1.302 . . . . 0.0 110.279 -169.69 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.7 t -142.94 145.47 33.05 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.185 0.993 . . . . 0.0 112.943 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.01 -18.33 61.97 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.525 1.93 . . . . 0.0 114.362 171.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.88 -48.24 67.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.227 1.411 . . . . 0.0 111.949 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -108.7 -17.47 13.94 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.27 1.828 . . . . 0.0 111.949 170.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.73 50.97 5.03 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.084 1.326 . . . . 0.0 111.622 -171.186 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 43.0 p -138.79 147.68 42.87 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.397 1.099 . . . . 0.0 113.677 -169.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -111.2 134.89 52.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.213 1.805 . . . . 0.0 111.402 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.1 t -109.07 118.37 36.59 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.5 138.21 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -167.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 121' ' ' CYS . 0.4 OUTLIER -96.8 118.73 33.88 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.079 2.152 . . . . 0.0 108.1 175.675 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -119.08 158.42 25.89 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.649 1.179 . . . . 0.0 112.45 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -95.69 115.06 65.22 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.066 1.346 . . . . 0.0 108.568 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.59 -6.7 17.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.41 2.74 . . . . 0.0 113.798 -170.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.06 -45.59 10.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.077 0.951 . . . . 0.0 112.007 169.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 72.2 t -83.38 -28.57 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.343 1.457 . . . . 0.0 112.52 -171.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 tt -147.27 144.87 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.517 1.127 . . . . 0.0 110.558 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.3 m -106.42 147.94 35.83 Favored Pre-proline 0 CA--C 1.551 1.002 0 O-C-N 121.244 -0.91 . . . . 0.0 111.319 173.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -53.53 -32.49 63.77 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.712 3.608 . . . . 0.0 116.177 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.53 -27.73 64.79 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.47 -32.99 66.68 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 112.241 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 65.6 mt -59.09 -50.47 73.93 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.616 1.166 . . . . 0.0 108.977 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -54.23 -48.35 71.19 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.95 1.3 . . . . 0.0 111.86 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.6 -30.48 71.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.71 -32.83 71.62 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.087 0.955 . . . . 0.0 112.938 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.6 mt -74.55 -32.9 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.195 0.998 . . . . 0.0 112.093 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -68.25 -34.13 75.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.899 0.772 . . . . 0.0 111.525 168.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.33 -30.01 70.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.429 1.091 . . . . 0.0 112.445 171.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.4 ttt -75.4 -28.73 59.57 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.351 -0.843 . . . . 0.0 112.491 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 116.82 30.56 1.95 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.648 1.594 . . . . 0.0 115.32 169.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -125.66 -156.88 0.76 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.466 1.507 . . . . 0.0 109.379 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -133.68 147.14 51.37 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.998 -1.064 . . . . 0.0 111.118 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.42 136.35 34.59 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.119 1.368 . . . . 0.0 112.592 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -114.45 125.91 54.36 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.344 1.858 . . . . 0.0 110.231 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.84 59.78 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.482 1.134 . . . . 0.0 109.759 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.014 0.925 . . . . 0.0 111.857 -169.782 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 122.084 0.945 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 m -109.21 135.1 50.87 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.846 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.288 0.1 OUTLIER -134.5 160.08 39.13 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -120.05 134.79 55.15 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.529 2.332 . . . . 0.0 108.563 -171.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 pp -146.49 160.52 42.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -102.04 155.64 18.05 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.67 1.188 . . . . 0.0 110.439 168.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.9 mt -135.16 141.29 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 126.658 1.983 . . . . 0.0 110.822 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -97.22 129.9 44.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.366 1.466 . . . . 0.0 109.195 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.24 -19.65 50.49 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.181 1.372 . . . . 0.0 113.627 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -14.01 56.46 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.426 1.613 . . . . 0.0 113.224 174.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -49.37 -37.45 24.98 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.766 1.627 . . . . 0.0 111.859 166.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 93.1 m -78.76 -1.11 33.13 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 71.25 -60.21 0.52 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 129.162 2.985 . . . . 0.0 112.19 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -53.03 -27.57 20.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.91 1.684 . . . . 0.0 114.551 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -46.68 -37.85 8.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.909 1.684 . . . . 0.0 112.985 169.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -19.07 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.421 HD13 ' C ' ' A' ' 36' ' ' LEU . 3.1 tm? -69.67 -54.09 15.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 112.143 -171.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.2 -28.59 69.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.311 1.044 . . . . 0.0 111.894 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.3 mt -65.5 -56.08 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 118.895 0.77 . . . . 0.0 109.734 167.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -39.77 61.17 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.237 1.415 . . . . 0.0 112.506 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.28 -40.94 97.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.347 0.659 . . . . 0.0 112.554 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -90.82 -28.44 18.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.594 1.158 . . . . 0.0 113.209 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.467 ' CD1' HG22 ' A' ' 78' ' ' ILE . 34.3 mm -97.46 117.49 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.149 -0.969 . . . . 0.0 109.235 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.64 -17.17 7.35 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.031 1.3 . . . . 0.0 115.648 -172.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -96.49 0.74 50.7 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.506 1.153 . . . . 0.0 113.228 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.4 mt -92.08 154.63 18.61 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.676 1.59 . . . . 0.0 113.081 -169.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -51.27 -34.18 31.73 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.59 4.87 31.06 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.715 -1.603 . . . . 0.0 115.845 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.3 t -134.32 119.62 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 120.905 2.353 . . . . 0.0 109.73 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 -26.81 13.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -169.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.3 p -149.11 173.18 13.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.69 1.196 . . . . 0.0 111.17 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 tp -138.78 145.95 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.054 0.942 . . . . 0.0 110.082 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -134.78 148.17 50.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.353 1.461 . . . . 0.0 108.394 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.92 150.62 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.624 -1.297 . . . . 0.0 110.762 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.2 t -141.45 58.36 1.51 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 122.881 1.324 . . . . 0.0 110.405 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.2 mt -69.83 -26.98 64.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.56 1.544 . . . . 0.0 113.641 -169.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.48 -24.02 63.72 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.34 1.456 . . . . 0.0 113.206 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -91.25 -25.11 19.64 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.751 1.62 . . . . 0.0 111.429 169.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 98.21 3.93 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.037 1 C-N-CA 132.577 4.351 . . . . 0.0 111.961 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.3 p -107.61 166.99 10.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.855 1.262 . . . . 0.0 112.578 -172.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.42 145.0 39.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.189 0.995 . . . . 0.0 108.534 167.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.407 HE21 ' HA ' ' A' ' 61' ' ' GLN . 2.9 tp60 -124.82 106.31 9.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.806 1.242 . . . . 0.0 110.695 -169.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.3 143.53 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-O 121.188 0.518 . . . . 0.0 111.826 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -114.43 90.36 3.32 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.858 2.063 . . . . 0.0 107.235 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -115.62 154.42 29.49 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -166.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.22 117.51 65.57 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.848 2.059 . . . . 0.0 109.286 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.65 5.6 2.38 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.368 2.712 . . . . 0.0 114.672 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 p -84.81 -30.26 24.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.694 1.198 . . . . 0.0 113.585 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 64.1 m -113.43 -21.89 10.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.439 1.095 . . . . 0.0 113.63 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.9 t -144.41 179.81 7.02 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 122.067 0.937 . . . . 0.0 111.943 -169.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.8 p -166.03 164.7 11.21 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.878 2.071 . . . . 0.0 109.476 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.86 -49.25 16.53 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.334 2.689 . . . . 0.0 114.546 -174.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.33 -38.22 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.13 75.09 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.588 -0.695 . . . . 0.0 111.442 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.6 mt -58.8 -53.34 59.46 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.561 1.544 . . . . 0.0 110.408 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -50.8 -53.26 33.48 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.652 1.181 . . . . 0.0 110.758 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -25.76 64.58 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.6 -60.28 2.31 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.166 1.348 . . . . 0.0 111.349 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.467 HG22 ' CD1' ' A' ' 42' ' ' ILE . 7.9 pt -72.23 -32.22 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.84 -19.42 65.87 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.06 0.845 . . . . 0.0 112.92 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.37 10.42 39.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.1 mt -60.22 -50.56 85.45 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.76 165.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.05 172.79 12.58 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.084 2.522 . . . . 0.0 112.071 171.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.78 65.47 7.59 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 124.609 3.54 . . . . 0.0 110.627 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.7 33.15 81.36 Favored Glycine 0 N--CA 1.473 1.154 0 O-C-N 121.246 -0.909 . . . . 0.0 112.95 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -107.05 -19.49 13.6 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -166.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -130.47 105.85 8.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.293 1.437 . . . . 0.0 108.603 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -99.07 136.11 39.52 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.913 1.285 . . . . 0.0 112.372 -169.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 m -99.17 156.72 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.735 1.152 . . . . 0.0 112.737 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.6 m -134.72 116.93 15.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.44 1.096 . . . . 0.0 110.159 167.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 126.896 2.078 . . . . 0.0 110.594 -178.226 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 27.6 p -144.21 145.69 32.23 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -168.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.7 t -146.43 160.0 42.66 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.543 1.937 . . . . 0.0 109.407 167.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.55 138.12 54.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.289 0.636 . . . . 0.0 109.659 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.78 160.0 41.17 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.955 0.798 . . . . 0.0 112.778 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 tt -116.26 140.41 49.35 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.752 1.621 . . . . 0.0 110.248 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 mm -127.34 139.85 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 127.647 2.379 . . . . 0.0 108.777 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -104.57 133.58 49.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.913 1.285 . . . . 0.0 110.261 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.27 137.67 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 120.533 -1.354 . . . . 0.0 110.913 -173.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.45 58.55 1.13 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.314 1.845 . . . . 0.0 111.554 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.34 55.86 0.24 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 125.222 1.391 . . . . 0.0 111.183 168.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 64.7 mtm -131.94 111.57 11.67 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.738 1.215 . . . . 0.0 109.495 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.9 t -116.0 -12.17 11.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.241 1.816 . . . . 0.0 112.989 -169.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 52.7 m -156.04 161.5 40.43 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.773 2.429 . . . . 0.0 110.398 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.64 -31.06 65.9 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.864 -1.147 . . . . 0.0 113.947 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 17.0 p -53.65 -22.26 8.47 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.364 1.466 . . . . 0.0 114.626 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 75.4 m -56.15 -36.75 68.65 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.37 -0.831 . . . . 0.0 111.97 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.83 -53.43 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.793 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -69.14 -24.04 64.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.093 0.86 . . . . 0.0 111.55 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.1 m -72.54 -51.75 18.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.323 1.449 . . . . 0.0 111.598 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.5 mt -68.87 -55.45 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 121.008 -1.057 . . . . 0.0 111.296 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -55.13 -30.73 60.39 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.704 1.202 . . . . 0.0 111.059 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.17 -62.12 2.68 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.021 1.296 . . . . 0.0 114.505 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 94.2 mmm -71.31 -38.21 71.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -169.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.1 mm -72.53 -23.95 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.056 0.542 . . . . 0.0 111.353 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.6 t -67.22 1.69 1.99 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -106.23 -3.54 21.19 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -169.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.12 17.08 24.71 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.69 2.108 . . . . 0.0 116.69 -168.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 77.76 160.59 0.21 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 127.456 2.303 . . . . 0.0 112.663 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.73 -24.46 0.29 Allowed Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.48 -1.388 . . . . 0.0 115.811 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.85 96.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 127.79 2.436 . . . . 0.0 111.165 172.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -79.74 -47.43 15.29 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.779 0.832 . . . . 0.0 111.946 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -143.97 137.07 27.49 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.688 0.795 . . . . 0.0 110.414 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.36 134.39 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.849 -1.157 . . . . 0.0 110.933 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 30.0 t -139.24 141.39 37.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.881 1.672 . . . . 0.0 109.205 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.27 142.68 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.706 1.202 . . . . 0.0 112.015 -176.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.0 t -140.58 139.23 34.91 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.441 1.096 . . . . 0.0 112.736 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.08 -17.18 62.01 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.266 1.826 . . . . 0.0 115.44 174.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.26 -42.54 77.55 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.021 1.328 . . . . 0.0 112.836 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -113.17 -8.39 13.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.749 1.619 . . . . 0.0 111.355 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 76.45 48.39 9.29 Favored Glycine 0 C--N 1.343 0.949 0 C-N-CA 125.289 1.423 . . . . 0.0 112.619 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 p -141.14 146.42 37.0 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -167.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -115.22 150.93 35.37 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.175 1.79 . . . . 0.0 111.844 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.7 t -125.11 130.03 51.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.479 1.512 . . . . 0.0 108.695 169.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.75 136.85 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.741 -0.599 . . . . 0.0 111.211 -169.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.57 112.96 24.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.876 2.471 . . . . 0.0 106.628 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -118.97 158.98 24.69 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.628 1.171 . . . . 0.0 112.506 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -93.46 112.94 58.72 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.773 1.229 . . . . 0.0 108.18 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.51 -11.17 18.85 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.218 2.612 . . . . 0.0 113.005 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.07 -45.97 31.46 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.851 1.205 . . . . 0.0 110.7 168.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 69.8 t -79.5 -42.43 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.369 1.467 . . . . 0.0 113.431 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.4 tt -140.35 150.44 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.211 0.914 . . . . 0.0 113.254 -169.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 60.0 m -112.76 150.71 43.19 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.285 1.434 . . . . 0.0 112.005 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.69 -41.16 38.35 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.424 3.416 . . . . 0.0 115.009 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.43 -20.27 65.42 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.36 -31.91 60.68 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.104 1.362 . . . . 0.0 113.735 170.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 73.5 mt -60.0 -50.73 72.59 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.033 0.933 . . . . 0.0 108.876 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -51.69 -51.01 59.28 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.195 0.998 . . . . 0.0 111.522 173.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.2 -31.67 65.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.14 -38.98 69.1 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.155 0.982 . . . . 0.0 113.265 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.1 mp -70.24 -35.53 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.55 -0.718 . . . . 0.0 110.498 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.0 -36.19 83.19 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.881 -0.512 . . . . 0.0 111.739 172.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -71.89 -29.5 64.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.155 1.782 . . . . 0.0 113.797 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 18.1 ttt -65.92 -30.17 70.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.322 1.049 . . . . 0.0 111.953 172.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 124.3 13.8 3.83 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.943 1.735 . . . . 0.0 115.362 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -119.75 -156.46 0.66 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.158 1.383 . . . . 0.0 109.568 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -136.06 137.47 41.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.928 1.291 . . . . 0.0 109.009 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -131.75 156.21 46.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.065 1.346 . . . . 0.0 111.627 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.1 t -141.96 140.57 32.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.27 1.828 . . . . 0.0 109.218 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.4 m -96.05 121.56 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.452 -0.78 . . . . 0.0 110.059 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 123.327 1.537 . . . . 0.0 110.829 -177.307 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.69 153.03 18.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.237 1.415 . . . . 0.0 110.53 171.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tt -145.64 135.5 23.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.733 1.613 . . . . 0.0 110.88 -172.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -98.27 123.54 42.41 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.793 -0.567 . . . . 0.0 111.596 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.47 138.67 27.81 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.334 1.054 . . . . 0.0 113.593 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -97.64 123.8 41.68 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.9 mt -95.37 138.63 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.417 1.487 . . . . 0.0 107.631 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -95.54 142.78 27.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.548 1.139 . . . . 0.0 110.598 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.94 -4.73 83.36 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.661 1.124 . . . . 0.0 113.953 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.7 ptp -68.44 0.09 4.37 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -63.94 -13.77 48.49 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.543 1.065 . . . . 0.0 113.213 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.9 t -105.33 125.33 50.86 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.239 1.381 . . . . 0.0 107.795 165.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.73 -31.16 47.27 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.838 1.255 . . . . 0.0 114.021 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.7 m -63.34 -21.87 66.53 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.042 -1.036 . . . . 0.0 113.079 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 63.5 m -71.86 -47.21 54.57 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.095 0.861 . . . . 0.0 111.881 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.4 -23.09 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.108 0.867 . . . . 0.0 112.427 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.8 -61.35 2.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.123 0.969 . . . . 0.0 111.854 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.03 -26.4 68.22 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.532 -0.73 . . . . 0.0 112.824 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mt -65.93 -53.07 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 120.506 -1.371 . . . . 0.0 110.521 169.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.86 -30.07 69.9 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.836 1.255 . . . . 0.0 112.305 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.0 -39.78 75.67 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.008 -1.057 . . . . 0.0 112.546 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -93.69 -19.92 20.64 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.587 HD12 HG22 ' A' ' 78' ' ' ILE . 38.5 mm -102.81 123.6 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 122.314 1.054 . . . . 0.0 111.55 -172.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.37 -10.09 2.97 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.105 1.812 . . . . 0.0 114.57 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -109.5 4.55 22.42 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.839 1.656 . . . . 0.0 113.101 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.13 176.39 8.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.394 1.078 . . . . 0.0 112.216 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.7 tp -38.24 -64.2 0.43 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.325 2.25 . . . . 0.0 114.058 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.7 -12.83 7.66 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 117.073 -1.959 . . . . 0.0 115.643 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.34 112.72 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-N 121.57 2.685 . . . . 0.0 109.438 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -95.32 -35.45 11.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.073 1.349 . . . . 0.0 112.099 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 t -145.18 169.57 17.92 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.853 0.835 . . . . 0.0 112.523 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.3 tp -138.16 144.83 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.115 1.766 . . . . 0.0 108.96 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -142.63 157.93 44.18 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.083 1.753 . . . . 0.0 108.784 -172.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 m -127.53 138.69 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 120.348 -1.47 . . . . 0.0 111.931 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.2 m -124.48 56.52 1.28 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.746 1.619 . . . . 0.0 107.855 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -65.36 -30.69 71.55 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.56 -16.91 62.33 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -95.1 -5.67 43.73 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.314 1.445 . . . . 0.0 111.726 169.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt 73.39 7.38 5.18 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.022 2.529 . . . . 0.0 112.214 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.9 p -110.94 167.07 10.52 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.022 2.129 . . . . 0.0 110.787 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.97 -179.7 4.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.067 165.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -143.86 133.22 23.27 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.175 -0.953 . . . . 0.0 109.594 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.94 137.36 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.38 0.991 . . . . 0.0 111.387 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -114.71 87.11 2.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.666 1.586 . . . . 0.0 108.37 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -119.65 155.12 32.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.768 1.227 . . . . 0.0 113.478 -171.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -96.57 113.27 62.33 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.617 1.967 . . . . 0.0 109.375 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.62 -6.89 20.1 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.353 2.702 . . . . 0.0 112.88 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 t -86.08 -5.98 59.11 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.268 1.027 . . . . 0.0 111.988 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 94.2 m -119.03 -42.4 2.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.257 1.423 . . . . 0.0 113.464 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -128.51 -176.31 3.79 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.672 1.589 . . . . 0.0 110.232 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.94 154.2 18.15 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.24 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.05 -56.88 2.4 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.069 3.179 . . . . 0.0 116.21 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.7 -36.05 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 121.059 1.754 . . . . 0.0 113.438 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.43 -41.12 61.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.222 1.009 . . . . 0.0 111.909 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -36.17 74.44 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.719 1.208 . . . . 0.0 110.886 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.436 HE21 ' HB ' ' A' ' 88' ' ' VAL . 66.0 tt0 -66.89 -47.69 71.04 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.365 -0.834 . . . . 0.0 111.327 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.6 mtt85 -59.65 -28.86 67.61 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.343 1.057 . . . . 0.0 112.937 172.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.71 -56.06 12.26 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.069 0.85 . . . . 0.0 111.51 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.587 HG22 HD12 ' A' ' 42' ' ' ILE . 6.0 pt -72.47 -33.47 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -68.77 -17.99 64.13 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.35 8.13 44.94 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 120.691 -1.256 . . . . 0.0 113.977 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.5 mt -59.36 -51.06 84.11 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.018 166.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.15 173.73 12.26 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.026 2.484 . . . . 0.0 111.1 168.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -75.18 52.1 3.03 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.418 3.412 . . . . 0.0 111.486 169.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.64 37.64 92.63 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 124.803 1.192 . . . . 0.0 112.09 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -102.26 -46.45 4.81 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -168.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -97.72 101.02 12.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.229 1.412 . . . . 0.0 107.402 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -99.72 144.4 28.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -167.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.436 ' HB ' HE21 ' A' ' 75' ' ' GLN . 3.5 t -103.0 138.56 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.722 0.809 . . . . 0.0 111.744 -172.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -133.55 121.1 21.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.549 1.14 . . . . 0.0 112.121 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.549 0.91 0 C-N-CA 126.223 1.809 . . . . 0.0 112.254 173.234 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 95.3 m -143.02 136.02 28.0 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.366 1.466 . . . . 0.0 112.541 -174.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.8 t -143.97 154.89 43.77 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.403 1.881 . . . . 0.0 109.229 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.4 m -114.53 141.16 48.09 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.634 0.652 . . . . 0.0 110.051 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.12 157.35 44.99 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.519 0.676 . . . . 0.0 112.415 168.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.32 136.36 41.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.357 1.863 . . . . 0.0 110.029 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.7 mt -127.92 133.68 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.717 1.607 . . . . 0.0 109.06 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.68 143.05 30.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.434 1.094 . . . . 0.0 109.842 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.04 131.8 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 119.395 0.998 . . . . 0.0 112.024 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.3 80.72 1.99 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.474 1.51 . . . . 0.0 111.998 173.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 178.49 55.01 0.07 OUTLIER Glycine 0 N--CA 1.467 0.766 0 C-N-CA 124.543 1.068 . . . . 0.0 113.996 165.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -137.41 145.47 43.24 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.4 t -151.72 -28.2 0.18 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.623 1.969 . . . . 0.0 112.387 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 77.4 m -125.76 136.73 53.49 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.968 1.707 . . . . 0.0 111.637 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.65 -27.38 6.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.517 1.527 . . . . 0.0 114.529 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.7 p -55.53 -31.64 62.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.14 1.376 . . . . 0.0 113.241 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 t -62.04 -19.44 62.89 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.95 -59.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.636 -0.665 . . . . 0.0 109.972 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -22.37 66.71 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 118.434 0.561 . . . . 0.0 112.155 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.0 m -72.24 -60.49 2.21 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.981 1.313 . . . . 0.0 112.893 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 94.4 mt -67.13 -54.48 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 120.362 1.437 . . . . 0.0 110.583 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.28 -29.96 67.95 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.792 1.237 . . . . 0.0 111.304 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.63 -62.57 2.66 Favored Glycine 0 C--N 1.343 0.948 0 C-N-CA 124.226 0.917 . . . . 0.0 113.998 173.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 82.1 mmm -70.03 -36.26 74.92 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -168.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.0 mm -68.02 -31.55 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 118.317 0.508 . . . . 0.0 110.659 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -66.11 -0.42 2.45 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -92.59 -7.38 47.27 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.389 -1.444 . . . . 0.0 113.915 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 pp -99.91 170.18 8.7 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.723 1.209 . . . . 0.0 112.046 171.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -79.05 166.34 22.42 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.76 -34.3 0.6 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.779 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.31 91.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 119.448 1.624 . . . . 0.0 110.601 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -72.71 -45.67 57.59 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.114 1.366 . . . . 0.0 111.819 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -143.3 143.49 31.72 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.455 0.702 . . . . 0.0 109.175 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -142.06 138.68 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 0.0 110.462 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 67.6 m -138.52 108.67 6.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.847 1.259 . . . . 0.0 109.701 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.71 133.9 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.728 -1.232 . . . . 0.0 110.519 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.2 t -119.71 93.33 4.03 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.142 2.177 . . . . 0.0 107.457 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.0 tt -66.83 -29.23 69.1 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.013 0.925 . . . . 0.0 110.597 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -49.6 -39.82 36.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.366 2.266 . . . . 0.0 113.629 167.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -100.26 -13.29 18.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.614 1.966 . . . . 0.0 112.123 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.76 26.93 73.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 127.735 2.588 . . . . 0.0 113.344 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.0 p -129.28 143.25 50.78 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.662 1.231 . . . . 0.0 114.27 -168.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.2 131.33 51.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.47 1.508 . . . . 0.0 109.505 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.9 t -113.55 124.09 51.55 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.66 139.83 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -165.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.25 111.22 23.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.68 2.392 . . . . 0.0 107.422 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -120.62 156.12 32.33 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.602 1.161 . . . . 0.0 112.685 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -98.6 109.8 54.43 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.695 1.198 . . . . 0.0 111.014 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.58 -13.43 30.02 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.206 2.604 . . . . 0.0 112.616 -172.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.36 -13.84 58.83 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.463 1.028 . . . . 0.0 113.719 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.3 t -118.63 -33.85 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.91 1.284 . . . . 0.0 112.481 -170.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.27 151.17 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.851 1.26 . . . . 0.0 110.504 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.5 t -104.7 144.17 28.19 Favored Pre-proline 0 N--CA 1.477 0.894 0 O-C-N 120.951 -1.093 . . . . 0.0 110.978 169.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.69 -27.86 27.77 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.698 2.932 . . . . 0.0 114.358 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -70.43 -41.73 72.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.534 0.606 . . . . 0.0 111.386 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.57 -28.05 58.83 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 170.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.49 -55.16 38.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.598 1.559 . . . . 0.0 110.4 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.08 -30.36 70.95 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.402 -0.811 . . . . 0.0 112.533 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.85 -16.12 63.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.08 62.16 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.361 0.982 . . . . 0.0 112.232 171.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.5 mp -71.84 -33.73 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.027 0.931 . . . . 0.0 110.461 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -66.37 -31.04 71.56 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.939 0.791 . . . . 0.0 112.084 170.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -70.86 -29.96 66.22 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 120.593 -1.317 . . . . 0.0 112.137 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 10.6 ttt -71.85 -27.44 62.89 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.679 1.192 . . . . 0.0 111.725 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 124.23 14.2 3.74 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.362 1.934 . . . . 0.0 116.886 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -128.03 147.09 50.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.828 1.314 . . . . 0.0 111.046 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -95.17 101.01 12.73 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 123.414 1.578 . . . . 0.0 110.525 -170.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -98.42 143.99 28.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 112.54 -2.118 . . . . 0.0 111.529 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.4 t -141.28 132.22 26.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.538 1.535 . . . . 0.0 111.812 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.8 m -86.04 72.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.329 1.052 . . . . 0.0 110.533 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.477 0.882 0 C-N-CA 124.2 1.0 . . . . 0.0 111.375 178.677 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 p -96.65 146.02 25.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.56 1.544 . . . . 0.0 112.192 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.95 126.44 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.935 1.694 . . . . 0.0 109.654 174.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.19 131.69 45.05 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.807 1.243 . . . . 0.0 110.192 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 155.48 43.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.977 169.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.91 129.66 46.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.704 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 mt -104.27 147.04 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.835 1.254 . . . . 0.0 110.923 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 87' ' ' LYS . 36.6 t70 -96.18 140.33 31.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.956 2.102 . . . . 0.0 110.575 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.8 -8.13 73.8 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.641 1.115 . . . . 0.0 113.696 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 13.2 ptp -66.08 -13.25 59.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -54.23 -32.12 55.11 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.145 0.884 . . . . 0.0 111.85 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.61 -17.45 62.89 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm 76.31 -57.17 0.56 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.76 2.824 . . . . 0.0 112.394 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.4 p -53.79 -23.04 10.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.906 1.282 . . . . 0.0 113.822 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.5 t -47.17 -46.92 24.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.147 1.779 . . . . 0.0 111.949 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.17 -17.57 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.19 -56.25 10.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.464 1.106 . . . . 0.0 110.339 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -36.87 73.61 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.688 -0.632 . . . . 0.0 111.434 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mt -62.28 -48.19 89.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.525 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.17 -36.14 76.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.865 1.266 . . . . 0.0 112.849 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -64.95 -40.4 94.97 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.33 -0.856 . . . . 0.0 112.351 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -91.45 -35.58 14.26 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -172.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.457 ' CD1' HG22 ' A' ' 78' ' ' ILE . 38.5 mm -99.28 113.28 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.417 1.008 . . . . 0.0 110.686 -168.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.96 -21.68 0.89 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.477 1.037 . . . . 0.0 115.136 -170.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -108.92 -5.09 16.28 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.362 1.081 . . . . 0.0 113.34 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.72 153.12 43.82 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.992 1.717 . . . . 0.0 111.069 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.8 tp -11.12 -69.88 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 128.827 2.851 . . . . 0.0 114.642 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.48 9.76 22.01 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 115.734 -2.704 . . . . 0.0 117.469 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.42 130.62 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 123.117 3.459 . . . . 0.0 108.434 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -100.13 -43.69 6.24 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.174 0.59 . . . . 0.0 111.261 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 p -148.98 164.02 35.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.479 1.112 . . . . 0.0 113.028 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 tp -120.82 149.76 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.177 1.391 . . . . 0.0 111.625 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -142.64 154.4 44.33 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.259 1.824 . . . . 0.0 110.157 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.4 t -133.12 137.68 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 120.793 -1.192 . . . . 0.0 110.446 -171.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t -134.35 55.26 1.9 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.542 1.537 . . . . 0.0 109.435 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -33.36 74.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.91 1.684 . . . . 0.0 112.952 -169.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -47.89 -34.95 9.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.766 2.026 . . . . 0.0 112.504 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -116.53 23.22 12.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.023 1.329 . . . . 0.0 112.497 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.5 mttp 67.37 9.7 7.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.287 2.635 . . . . 0.0 115.481 169.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 p -107.96 145.36 33.95 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.72 1.208 . . . . 0.0 112.44 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.19 157.93 16.94 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.613 1.165 . . . . 0.0 108.764 167.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -139.81 118.46 12.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.487 0.315 . . . . 0.0 110.263 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.8 p -114.24 132.55 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.782 -0.574 . . . . 0.0 111.11 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.11 93.4 5.7 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.595 1.158 . . . . 0.0 109.008 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -118.19 152.44 35.66 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.353 1.061 . . . . 0.0 112.45 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -100.33 114.98 65.89 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.715 1.606 . . . . 0.0 109.829 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.67 5.69 3.21 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.359 3.372 . . . . 0.0 113.955 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 t -68.0 -34.79 77.19 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.026 0.93 . . . . 0.0 111.444 171.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 74.9 m -114.94 -25.42 8.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -168.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -144.4 -178.38 5.95 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.929 1.291 . . . . 0.0 111.839 -173.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.6 p -152.6 161.06 30.25 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.57 1.548 . . . . 0.0 111.919 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.72 -46.46 24.26 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.547 2.831 . . . . 0.0 115.137 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.3 m -70.21 -33.52 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.208 1.367 . . . . 0.0 113.262 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.86 -38.0 79.47 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.6 -0.688 . . . . 0.0 111.419 175.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.36 -44.09 79.85 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.335 1.054 . . . . 0.0 111.409 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -53.66 -55.66 24.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.303 1.041 . . . . 0.0 110.557 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -52.79 -48.34 66.94 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.52 0.728 . . . . 0.0 112.714 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.36 -58.44 8.59 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.608 0.763 . . . . 0.0 111.935 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.457 HG22 ' CD1' ' A' ' 42' ' ' ILE . 5.8 pt -74.31 -31.13 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.65 -39.12 67.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.483 1.113 . . . . 0.0 112.533 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.23 23.08 9.62 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.0 mt -60.16 -55.41 45.64 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.483 164.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.77 170.9 17.61 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.696 2.931 . . . . 0.0 112.163 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.59 35.79 0.33 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 125.03 3.82 . . . . 0.0 112.903 171.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.28 28.02 34.8 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.191 1.377 . . . . 0.0 113.115 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -104.02 -42.74 5.47 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -168.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -96.35 117.07 30.08 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.434 ' H ' ' HB3' ' A' ' 27' ' ' ASP . 16.1 ttmm -102.16 135.51 43.62 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.363 1.865 . . . . 0.0 111.733 -173.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.66 150.25 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.868 1.213 . . . . 0.0 111.675 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.1 t -134.13 107.98 8.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.235 1.414 . . . . 0.0 110.067 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.549 0.905 0 CA-C-N 114.482 -1.235 . . . . 0.0 113.113 -174.744 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.512 ' HB2' HD11 ' A' ' 165' ' ' LEU . 29.1 p -155.75 142.48 18.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.502 1.121 . . . . 0.0 112.544 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.8 t -142.9 160.17 40.84 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.948 1.699 . . . . 0.0 109.547 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 98.4 m -113.07 143.55 44.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.783 0.833 . . . . 0.0 109.484 171.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.71 165.29 27.89 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.687 0.795 . . . . 0.0 111.457 167.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -119.87 130.33 54.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.858 1.663 . . . . 0.0 110.048 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.47 140.88 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 126.292 1.837 . . . . 0.0 108.694 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.22 132.24 52.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.723 1.609 . . . . 0.0 109.952 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.86 136.79 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.214 1.006 . . . . 0.0 110.3 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.79 57.91 1.43 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.994 1.718 . . . . 0.0 112.715 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.58 52.23 0.31 Allowed Glycine 0 N--CA 1.467 0.739 0 C-N-CA 124.387 0.994 . . . . 0.0 112.533 168.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 68.0 mtm -131.71 150.86 52.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.471 1.108 . . . . 0.0 110.862 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.8 t -157.39 -30.46 0.08 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.039 1.336 . . . . 0.0 111.877 -168.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 64.7 m -128.28 140.7 51.74 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.036 1.734 . . . . 0.0 111.948 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -48.58 -33.86 10.51 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.162 1.785 . . . . 0.0 114.246 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.9 p -50.35 -32.29 16.92 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.422 1.089 . . . . 0.0 113.754 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 11.5 t -61.36 -21.87 64.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.3 t -59.5 -60.23 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 119.423 1.011 . . . . 0.0 109.54 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -62.48 -27.74 69.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.029 0.532 . . . . 0.0 111.772 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.7 m -71.71 -46.8 57.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.75 0.82 . . . . 0.0 113.139 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 79.3 mt -68.06 -54.37 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.986 1.266 . . . . 0.0 110.081 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -52.31 -31.8 34.75 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.624 1.57 . . . . 0.0 112.03 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.14 -61.87 2.57 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.632 1.587 . . . . 0.0 115.694 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 92.9 mmm -73.38 -35.1 65.87 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.5 mm -71.29 -29.07 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 121.778 -0.576 . . . . 0.0 111.272 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.6 t -56.57 -12.22 1.68 Allowed 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -84.42 -0.38 52.55 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 119.671 -1.893 . . . . 0.0 115.763 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 pp -116.54 8.46 13.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 -167.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 74.71 161.4 0.24 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.127 2.571 . . . . 0.0 115.707 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.25 -44.08 1.59 Allowed Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.345 -1.472 . . . . 0.0 113.22 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.11 97.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 127.295 2.238 . . . . 0.0 111.922 170.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.9 -61.58 1.79 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.472 1.109 . . . . 0.0 111.02 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -123.49 133.55 54.01 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.354 1.461 . . . . 0.0 108.495 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.5 tt -140.09 137.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.991 0.901 . . . . 0.0 110.799 -173.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.0 t -142.23 152.49 43.13 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.859 1.664 . . . . 0.0 109.991 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.58 139.07 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.439 1.096 . . . . 0.0 110.238 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 18.3 t -122.46 84.81 2.31 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.119 2.168 . . . . 0.0 108.708 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.7 -28.35 67.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.961 1.704 . . . . 0.0 111.519 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.2 -53.26 8.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.794 2.438 . . . . 0.0 112.887 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -95.16 -7.87 37.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.506 1.122 . . . . 0.0 111.707 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.55 42.13 64.21 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.059 1.79 . . . . 0.0 111.729 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.4 p -130.92 155.86 46.05 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.33 1.052 . . . . 0.0 111.51 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.29 129.93 38.25 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.525 1.13 . . . . 0.0 110.93 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.3 t -109.84 124.83 52.01 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.223 1.009 . . . . 0.0 108.962 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.76 138.58 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -169.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 121' ' ' CYS . 0.7 OUTLIER -96.43 114.49 26.16 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.897 2.479 . . . . 0.0 107.296 174.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -124.31 162.91 22.79 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.672 1.589 . . . . 0.0 112.022 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -96.79 112.62 60.96 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.259 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.13 -9.6 24.71 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.717 2.945 . . . . 0.0 115.456 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -88.36 -37.44 15.92 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.718 1.144 . . . . 0.0 112.084 169.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.65 -36.87 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.678 1.191 . . . . 0.0 112.209 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 tt -146.05 150.19 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 121.054 -1.029 . . . . 0.0 112.623 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.71 150.43 46.92 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.096 1.758 . . . . 0.0 110.535 -173.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.93 -37.56 67.21 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.398 2.732 . . . . 0.0 114.77 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.25 -27.68 68.14 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.56 -36.55 63.09 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.706 1.203 . . . . 0.0 112.149 172.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 91.0 mt -58.29 -52.93 63.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.775 0.83 . . . . 0.0 111.206 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -61.81 -38.74 89.24 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.13 -29.54 69.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.711 0.804 . . . . 0.0 112.469 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.44 -31.07 70.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.318 1.047 . . . . 0.0 113.045 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.26 -32.35 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.475 1.11 . . . . 0.0 111.362 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.06 -33.43 73.56 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.462 -0.774 . . . . 0.0 112.381 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -71.11 -30.42 66.5 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.842 0.746 . . . . 0.0 112.558 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 23.4 ttt -65.94 -43.3 88.44 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.123 0.969 . . . . 0.0 111.165 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 142.32 21.58 0.23 Allowed Glycine 0 CA--C 1.533 1.182 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 169.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -131.4 -155.16 0.67 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.111 1.365 . . . . 0.0 110.392 -171.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -129.44 140.57 51.27 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.426 1.491 . . . . 0.0 110.462 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.85 150.69 40.22 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.882 1.273 . . . . 0.0 114.404 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.7 t -141.8 146.95 36.51 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.252 1.421 . . . . 0.0 110.716 171.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.3 m -92.78 125.38 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.297 0.953 . . . . 0.0 109.665 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 124.384 2.04 . . . . 0.0 107.949 -177.305 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 121.47 0.652 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.9 m -99.01 164.4 12.19 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.782 1.633 . . . . 0.0 109.369 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.21 139.81 35.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.278 1.031 . . . . 0.0 110.315 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -98.51 123.85 42.9 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.753 0.787 . . . . 0.0 109.09 169.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.13 136.66 25.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.943 -1.48 . . . . 0.0 113.538 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -107.65 108.12 19.24 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.472 1.109 . . . . 0.0 110.053 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mt -92.99 145.74 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.678 1.591 . . . . 0.0 109.837 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.56 150.34 22.79 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.532 2.333 . . . . 0.0 111.29 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.98 -11.53 71.85 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.944 1.259 . . . . 0.0 114.348 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.7 ptp -70.29 -0.3 7.79 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.0 m170 -60.23 -23.96 64.48 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 120.315 1.416 . . . . 0.0 111.503 167.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.2 m -98.11 128.64 44.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.918 0.781 . . . . 0.0 110.377 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -56.49 -40.72 75.42 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.934 0.874 . . . . 0.0 112.392 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.8 p -59.39 -23.09 62.31 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.724 1.21 . . . . 0.0 113.907 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 74.8 m -72.97 -40.87 64.96 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.801 0.84 . . . . 0.0 112.149 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.2 p -74.59 -30.18 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.436 ' C ' HD23 ' A' ' 36' ' ' LEU . 5.0 tt -49.87 -60.74 2.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.266 1.426 . . . . 0.0 112.177 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.1 -24.15 66.02 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.304 -0.872 . . . . 0.0 113.266 -177.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 mt -70.5 -48.95 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.138 -0.976 . . . . 0.0 110.281 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -68.06 -26.43 65.85 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.345 1.058 . . . . 0.0 112.372 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.58 -39.26 88.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.764 1.225 . . . . 0.0 112.039 171.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -94.68 -23.92 17.38 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -172.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.48 ' CD1' HG22 ' A' ' 78' ' ' ILE . 44.3 mm -108.7 113.54 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.869 0.868 . . . . 0.0 109.981 -169.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.5 -14.76 4.47 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.076 1.322 . . . . 0.0 114.739 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -100.86 7.49 43.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.508 1.123 . . . . 0.0 113.326 174.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.0 mt -90.96 159.69 16.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.906 1.682 . . . . 0.0 112.932 -173.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.15 -23.7 62.4 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -171.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.99 3.79 6.39 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.181 -1.899 . . . . 0.0 115.067 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -113.68 117.47 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 121.105 2.452 . . . . 0.0 109.006 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -100.34 -29.72 12.26 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.7 m -147.59 158.61 44.07 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.681 -1.262 . . . . 0.0 112.955 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.1 tp -137.96 137.99 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.497 1.519 . . . . 0.0 109.707 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -141.02 159.58 41.9 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.883 2.073 . . . . 0.0 107.944 -171.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.19 152.34 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 120.627 -1.296 . . . . 0.0 110.79 168.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -125.54 56.22 1.38 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 168.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -28.14 68.59 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.386 1.875 . . . . 0.0 112.567 -168.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.16 -20.15 24.6 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 169.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -115.68 -2.89 12.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.349 2.26 . . . . 0.0 112.541 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt 73.27 15.67 4.31 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.144 2.178 . . . . 0.0 112.672 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.96 147.32 23.81 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.922 1.289 . . . . 0.0 109.1 170.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.04 158.08 16.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 166.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.73 116.86 15.38 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -168.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.91 133.58 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.836 -0.54 . . . . 0.0 110.883 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -107.61 96.21 6.23 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.02 2.128 . . . . 0.0 106.676 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -126.03 154.6 42.75 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.62 108.56 40.65 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 127.073 2.149 . . . . 0.0 107.192 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -71.26 1.73 5.12 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.672 2.914 . . . . 0.0 114.474 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 p -83.01 -23.82 33.11 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.927 1.291 . . . . 0.0 112.33 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 85.5 m -120.1 -18.38 8.11 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 t -147.88 -178.6 6.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.814 1.246 . . . . 0.0 111.422 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.8 m -168.35 161.47 8.97 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.923 1.689 . . . . 0.0 112.596 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.72 -52.9 7.95 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 124.199 3.266 . . . . 0.0 117.289 -168.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.19 -32.33 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 120.742 1.61 . . . . 0.0 113.083 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.53 -40.05 85.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.55 0.74 . . . . 0.0 111.381 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.83 -44.53 80.85 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.342 1.057 . . . . 0.0 111.875 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -55.36 -51.73 65.83 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.63 0.65 . . . . 0.0 110.019 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -67.78 -28.79 67.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.134 0.974 . . . . 0.0 113.299 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.37 -60.25 2.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.122 0.874 . . . . 0.0 111.308 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.48 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.2 pt -72.74 -32.92 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -169.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -66.12 -22.08 66.38 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.6 16.17 27.09 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.2 mt -62.31 -57.36 23.43 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.12 -1.419 . . . . 0.0 109.838 165.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.53 171.18 18.26 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.122 3.215 . . . . 0.0 111.963 172.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.96 45.72 2.07 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 124.045 3.163 . . . . 0.0 112.664 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.95 58.61 3.97 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -135.62 -25.07 1.31 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.09 98.0 5.87 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.279 1.399 . . . . 0.0 108.283 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -92.31 128.65 38.23 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.737 1.215 . . . . 0.0 110.94 -167.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.59 135.3 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.257 1.023 . . . . 0.0 112.063 -174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.0 m -127.13 133.34 50.39 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.553 1.541 . . . . 0.0 111.347 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 124.736 1.214 . . . . 0.0 110.207 176.529 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 23.0 p -155.53 115.61 3.73 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -167.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.9 p -144.7 147.3 32.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.138 1.375 . . . . 0.0 111.209 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.2 m -98.79 141.49 31.52 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.493 -0.755 . . . . 0.0 110.204 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.31 164.12 31.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 112.04 169.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.44 133.95 54.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.715 2.006 . . . . 0.0 109.531 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.4 mm -119.82 133.26 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.297 1.039 . . . . 0.0 108.662 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.53 128.91 45.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.438 1.095 . . . . 0.0 109.001 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 89.9 mt -129.69 136.08 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.195 -0.941 . . . . 0.0 110.529 -169.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -119.68 56.89 0.93 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.752 1.621 . . . . 0.0 111.849 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.57 51.81 0.35 Allowed Glycine 0 N--CA 1.462 0.389 0 O-C-N 121.865 -0.522 . . . . 0.0 112.746 169.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 72.0 mtm -128.86 119.3 24.19 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.587 0.755 . . . . 0.0 109.189 171.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.92 -41.15 5.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.62 1.968 . . . . 0.0 110.34 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 86.7 m -134.32 157.66 45.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.308 1.843 . . . . 0.0 110.733 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.47 -28.49 65.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.99 -36.66 18.13 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.1 -1.0 . . . . 0.0 111.938 169.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 62.5 m -61.27 -42.66 99.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.485 1.114 . . . . 0.0 113.266 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.09 -54.98 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -66.98 -28.86 68.6 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.6 m -65.63 -52.62 50.45 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.077 1.351 . . . . 0.0 112.074 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.95 -51.08 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.03 -1.044 . . . . 0.0 110.547 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -52.81 -34.79 55.29 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.205 1.802 . . . . 0.0 110.86 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.31 -61.33 3.45 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.125 1.345 . . . . 0.0 113.306 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.7 mmt -63.51 -41.3 98.52 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.479 1.112 . . . . 0.0 112.799 -171.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.5 mm -70.86 -35.86 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 117.759 0.254 . . . . 0.0 110.901 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -63.18 -9.2 10.11 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -77.08 -18.84 57.73 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.224 -1.548 . . . . 0.0 114.086 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -99.63 164.98 11.83 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.144 1.338 . . . . 0.0 113.514 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -76.29 151.34 36.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.04 -25.72 6.66 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.838 1.208 . . . . 0.0 113.978 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.58 96.25 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.263 1.531 . . . . 0.0 109.955 169.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -74.47 -47.17 34.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.396 1.478 . . . . 0.0 111.806 -173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -144.05 135.82 26.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.471 1.908 . . . . 0.0 108.669 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 tt -140.13 135.66 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.778 1.172 . . . . 0.0 111.34 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.3 t -140.61 126.09 18.91 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.018 1.327 . . . . 0.0 111.487 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 t -126.11 147.58 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 O-C-N 120.695 -1.253 . . . . 0.0 111.285 -169.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.4 t -140.77 144.31 35.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.954 0.883 . . . . 0.0 112.939 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.8 -20.22 62.61 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.798 1.639 . . . . 0.0 115.019 174.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.44 -35.6 52.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.395 1.478 . . . . 0.0 113.595 -172.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -125.25 -10.93 6.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.79 1.636 . . . . 0.0 112.382 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.33 47.97 6.63 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.235 1.398 . . . . 0.0 111.365 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.4 p -139.03 144.39 38.82 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -168.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.57 142.58 35.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.414 1.885 . . . . 0.0 111.361 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.0 t -116.94 124.87 50.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.84 142.1 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 122.955 0.502 . . . . 0.0 111.841 -168.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.35 109.42 21.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.65 1.98 . . . . 0.0 107.097 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -106.08 156.06 18.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.042 0.937 . . . . 0.0 111.969 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -95.33 109.63 46.16 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.271 1.028 . . . . 0.0 108.531 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.67 -12.69 18.28 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.763 2.308 . . . . 0.0 112.518 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.04 -36.49 40.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.165 0.986 . . . . 0.0 112.306 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.24 -34.11 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.682 1.193 . . . . 0.0 113.893 -170.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 18.2 tt -137.16 152.99 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.118 1.326 . . . . 0.0 112.19 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 m -99.84 141.09 22.14 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.358 1.463 . . . . 0.0 110.892 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -51.46 -35.72 56.27 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.445 2.764 . . . . 0.0 114.412 172.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -62.49 -28.45 69.84 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -71.93 -33.68 68.45 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.896 -1.127 . . . . 0.0 111.802 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 70.0 mt -59.94 -58.82 6.91 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.407 0.683 . . . . 0.0 109.899 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -61.35 -37.66 84.13 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.009 -0.432 . . . . 0.0 112.025 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.47 -30.14 71.04 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.83 -31.52 68.28 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.18 0.9 . . . . 0.0 112.376 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.7 mp -71.72 -39.82 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.267 1.027 . . . . 0.0 111.177 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.89 -35.37 79.83 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.007 0.523 . . . . 0.0 111.869 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.92 -23.38 61.46 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.486 1.514 . . . . 0.0 113.958 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 26.2 ttt -74.7 -46.82 35.19 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.313 -0.867 . . . . 0.0 110.946 176.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.96 42.99 0.09 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.064 1.316 . . . . 0.0 115.373 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -143.66 -159.16 0.95 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.867 1.667 . . . . 0.0 109.68 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.6 142.04 50.82 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.12 1.368 . . . . 0.0 110.163 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -140.67 147.5 39.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.5 1.92 . . . . 0.0 112.504 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.3 t -138.62 134.19 33.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.632 1.573 . . . . 0.0 111.966 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.4 m -83.92 78.26 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.116 0.96 . . . . 0.0 110.444 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.475 0.806 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.441 174.629 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.81 97.06 10.76 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 166.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.767 HD12 ' H ' ' A' ' 23' ' ' GLN . 4.5 tp -112.16 165.43 12.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.102 1.361 . . . . 0.0 107.902 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.767 ' H ' HD12 ' A' ' 22' ' ' LEU . 2.7 pt20 -147.0 161.97 39.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 119.774 -1.829 . . . . 0.0 114.078 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -140.72 150.41 43.41 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.941 1.697 . . . . 0.0 109.652 168.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -98.7 103.35 15.3 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 mm -76.37 146.77 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.475 1.51 . . . . 0.0 110.539 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -98.91 137.22 37.78 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.984 2.114 . . . . 0.0 110.968 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.44 -9.46 75.46 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.106 1.336 . . . . 0.0 113.697 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.94 -6.16 7.79 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -60.16 -27.11 66.83 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.945 1.248 . . . . 0.0 110.758 165.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.1 t -88.58 119.62 29.2 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 166.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -58.92 -33.48 70.61 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.352 -0.843 . . . . 0.0 111.685 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 m -54.89 -31.0 59.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.733 1.213 . . . . 0.0 112.822 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.6 m -72.2 -40.48 67.83 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.974 1.309 . . . . 0.0 112.774 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.7 p -76.31 -31.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.86 -55.14 36.04 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.585 1.154 . . . . 0.0 112.235 -175.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -59.97 -31.3 69.76 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.535 -0.728 . . . . 0.0 112.594 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mt -64.01 -47.76 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.403 -0.811 . . . . 0.0 109.995 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.99 -25.93 68.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.686 1.594 . . . . 0.0 113.795 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.64 -37.46 59.66 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.753 -1.217 . . . . 0.0 113.862 170.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -91.13 -35.11 14.76 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.492 ' CD1' HG22 ' A' ' 78' ' ' ILE . 39.5 mm -95.88 112.17 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 120.818 -1.176 . . . . 0.0 107.968 -170.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.59 -15.26 3.62 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.378 0.989 . . . . 0.0 115.285 -168.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -104.32 11.58 34.58 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.589 1.194 . . . . 0.0 113.029 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.9 mt -96.88 149.72 21.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.391 1.476 . . . . 0.0 113.143 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.2 tp -32.21 -58.73 0.31 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.16 2.184 . . . . 0.0 114.016 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.86 19.01 31.05 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.181 -1.9 . . . . 0.0 115.704 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -138.1 109.58 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.084 2.442 . . . . 0.0 108.873 168.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.66 -16.12 15.08 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.5 t -146.1 168.08 21.82 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.016 1.326 . . . . 0.0 110.875 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.0 tp -143.51 146.51 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.292 1.037 . . . . 0.0 111.64 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -144.16 157.92 44.02 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.5 1.52 . . . . 0.0 109.825 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.79 156.47 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 O-C-N 119.801 -1.812 . . . . 0.0 112.564 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 t -136.22 56.21 1.82 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.249 1.82 . . . . 0.0 108.04 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.03 -23.03 66.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.583 1.153 . . . . 0.0 112.908 -170.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -66.13 -14.79 62.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.942 1.297 . . . . 0.0 113.76 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -126.12 11.46 7.62 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.274 2.23 . . . . 0.0 112.5 169.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 71.16 7.33 6.12 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.765 2.026 . . . . 0.0 115.382 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.32 157.74 15.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.808 1.243 . . . . 0.0 110.412 172.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.83 144.11 47.52 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.987 1.315 . . . . 0.0 109.426 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -112.29 119.17 37.4 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -170.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.35 140.75 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 120.924 -1.11 . . . . 0.0 108.089 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -110.09 82.97 1.68 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.757 1.223 . . . . 0.0 107.752 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -106.0 152.1 23.78 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -169.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.81 103.02 16.84 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.708 2.003 . . . . 0.0 110.113 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.94 0.74 1.86 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.705 2.937 . . . . 0.0 114.944 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 98.5 p -74.91 -15.65 60.69 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.887 -1.133 . . . . 0.0 113.226 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.3 m -137.09 -24.44 1.1 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -171.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 t -144.53 178.16 8.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.355 1.462 . . . . 0.0 111.374 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.3 p -148.18 158.56 41.29 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.825 1.25 . . . . 0.0 113.008 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.7 -52.31 7.18 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.661 2.907 . . . . 0.0 114.648 -170.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.3 m -62.96 -30.16 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.879 1.218 . . . . 0.0 113.516 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.65 -46.48 58.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.474 0.71 . . . . 0.0 111.257 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.9 mt -58.2 -42.52 86.33 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.646 0.778 . . . . 0.0 111.482 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -57.57 -37.99 74.06 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.167 0.587 . . . . 0.0 111.638 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -72.2 -40.28 67.98 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.433 1.015 . . . . 0.0 112.626 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.51 -60.2 4.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.033 0.933 . . . . 0.0 112.411 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.492 HG22 ' CD1' ' A' ' 42' ' ' ILE . 9.1 pt -70.53 -28.59 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -168.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -69.98 -12.99 62.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.615 1.566 . . . . 0.0 113.326 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.0 6.43 29.06 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -55.7 -49.83 90.56 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 117.307 -1.33 . . . . 0.0 110.985 166.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.62 172.08 17.0 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.298 2.665 . . . . 0.0 111.311 168.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.47 44.35 1.22 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.323 3.349 . . . . 0.0 111.64 170.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.28 30.54 41.12 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.101 1.334 . . . . 0.0 113.746 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -95.1 -47.99 6.14 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.65 1.225 . . . . 0.0 112.22 -169.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -100.58 123.37 44.7 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.127 1.371 . . . . 0.0 109.025 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -101.46 165.48 11.23 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.051 0.94 . . . . 0.0 111.888 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.01 139.47 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.503 0.721 . . . . 0.0 111.802 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 m -110.92 134.88 52.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.656 1.183 . . . . 0.0 110.949 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.542 0.67 0 C-N-CA 126.862 2.065 . . . . 0.0 111.169 177.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 21.8 p -125.38 152.14 45.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.404 1.882 . . . . 0.0 113.148 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.0 t -140.6 149.95 42.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.791 2.036 . . . . 0.0 107.395 167.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m -99.88 142.05 31.87 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.15 0.5 . . . . 0.0 110.819 -170.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.25 145.25 31.92 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.596 0.758 . . . . 0.0 110.394 169.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tt -114.69 137.83 51.44 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.676 1.99 . . . . 0.0 108.346 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.9 mt -133.36 138.4 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.622 1.569 . . . . 0.0 109.768 -168.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.33 130.87 45.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.246 1.818 . . . . 0.0 109.296 172.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mp -126.38 122.43 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.274 -0.892 . . . . 0.0 111.855 -171.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.48 61.47 3.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.212 1.805 . . . . 0.0 111.24 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.59 54.96 0.27 Allowed Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.628 169.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 73.8 mtm -138.78 121.09 15.93 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.628 0.771 . . . . 0.0 110.57 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 t -125.25 -30.19 3.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.747 1.619 . . . . 0.0 112.513 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 11.8 m -147.74 163.49 36.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.682 1.993 . . . . 0.0 111.057 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.3 -30.51 70.54 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -172.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.2 m -57.53 -20.94 34.98 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.763 -1.21 . . . . 0.0 112.933 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 93.0 m -63.06 -44.1 96.75 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.931 -1.105 . . . . 0.0 112.286 168.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.66 -54.43 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -65.73 -24.5 66.98 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 117.998 0.363 . . . . 0.0 111.741 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 m -70.84 -53.11 16.44 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.747 -1.22 . . . . 0.0 111.792 170.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.1 -50.41 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.507 -1.371 . . . . 0.0 110.696 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.19 -33.01 68.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.808 2.043 . . . . 0.0 111.494 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.5 -61.89 2.85 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.856 1.217 . . . . 0.0 113.913 174.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -44.83 67.73 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.75 1.22 . . . . 0.0 112.844 -169.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.4 mm -70.74 -21.0 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.543 -0.723 . . . . 0.0 111.502 -173.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.4 -2.91 18.12 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 169.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -80.96 -13.77 58.59 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 119.591 -1.943 . . . . 0.0 115.403 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.25 -177.17 4.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.218 1.407 . . . . 0.0 113.445 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.99 137.18 32.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.134 0.974 . . . . 0.0 111.49 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.03 41.45 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 117.658 -1.634 . . . . 0.0 115.894 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.9 p -120.93 93.6 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.802 1.801 . . . . 0.0 110.863 -175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -49.76 28.98 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.669 1.188 . . . . 0.0 110.122 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -147.31 142.72 27.45 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.751 1.221 . . . . 0.0 110.505 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 9.2 tt -135.83 140.51 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 119.426 1.012 . . . . 0.0 110.452 169.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 12.5 t -140.16 145.26 37.28 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.898 1.679 . . . . 0.0 109.667 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.3 t -141.01 146.4 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.659 1.118 . . . . 0.0 110.579 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 77.4 p -142.45 132.71 24.78 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.147 -0.971 . . . . 0.0 113.17 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -19.64 63.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.514 1.526 . . . . 0.0 112.614 171.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -48.88 -52.84 22.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.997 1.319 . . . . 0.0 111.64 170.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -96.23 -25.07 15.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.894 1.278 . . . . 0.0 112.321 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.76 25.53 55.99 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.791 1.186 . . . . 0.0 112.319 -170.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 p -136.02 147.12 47.81 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.526 1.163 . . . . 0.0 113.813 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -99.63 145.67 27.33 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.847 1.659 . . . . 0.0 110.366 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.9 t -127.95 129.36 46.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.647 0.779 . . . . 0.0 109.257 168.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.8 140.81 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 123.572 0.749 . . . . 0.0 111.181 -168.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.15 107.02 18.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.08 1.752 . . . . 0.0 106.947 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -101.79 157.04 17.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.423 0.689 . . . . 0.0 111.633 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -95.98 111.71 57.05 Favored Pre-proline 0 CA--C 1.542 0.673 0 O-C-N 121.242 -0.911 . . . . 0.0 110.285 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.95 -10.52 23.07 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.468 2.112 . . . . 0.0 112.823 -170.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.41 -8.64 59.76 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.143 0.977 . . . . 0.0 113.168 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 73.5 t -120.93 -42.25 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.994 1.318 . . . . 0.0 111.972 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.2 tt -143.39 165.09 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.212 1.005 . . . . 0.0 111.507 -170.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.46 154.01 72.45 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.0 1.72 . . . . 0.0 110.947 -175.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.19 -44.82 36.5 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.025 3.15 . . . . 0.0 114.962 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.53 -19.54 62.89 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.39 -0.819 . . . . 0.0 113.11 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -73.85 -29.14 61.95 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.844 -1.16 . . . . 0.0 111.944 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.75 -51.3 67.69 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.552 0.741 . . . . 0.0 109.296 170.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -50.64 -51.12 51.98 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.64 1.176 . . . . 0.0 111.686 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.45 -27.32 68.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.74 -34.9 64.96 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.824 0.85 . . . . 0.0 112.146 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.7 -38.59 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.877 0.871 . . . . 0.0 111.235 171.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -64.96 -35.87 82.57 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.986 0.812 . . . . 0.0 112.693 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.96 -35.28 79.63 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.197 -0.94 . . . . 0.0 111.72 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -43.48 80.15 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.758 0.823 . . . . 0.0 111.37 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 140.56 21.25 0.32 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 117.156 1.623 . . . . 0.0 117.156 169.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -114.95 -156.61 0.61 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.838 1.819 . . . . 0.0 110.272 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -131.54 140.7 49.55 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.992 1.317 . . . . 0.0 109.179 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -137.62 150.28 47.28 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.4 t -138.81 137.35 36.56 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.258 1.423 . . . . 0.0 109.577 169.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.77 135.05 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 121.513 -0.742 . . . . 0.0 110.308 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 124.095 1.903 . . . . 0.0 107.484 175.827 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 120.93 0.395 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.4 132.0 47.21 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.932 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.52 136.72 54.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.954 1.302 . . . . 0.0 109.657 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -97.09 128.66 44.23 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.852 1.661 . . . . 0.0 110.88 -169.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.74 141.16 33.25 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -109.55 116.33 31.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 mt -76.58 133.76 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 122.413 1.101 . . . . 0.0 110.136 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.88 104.97 15.26 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.625 2.37 . . . . 0.0 108.298 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.61 16.68 25.95 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.5 ptp -64.42 -36.21 83.41 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.659 1.73 . . . . 0.0 115.141 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 t60 67.53 -46.16 0.49 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 129.027 2.931 . . . . 0.0 113.83 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 96.0 m -153.63 163.78 39.39 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.949 2.5 . . . . 0.0 110.432 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -53.81 -31.32 48.66 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.223 -0.923 . . . . 0.0 112.884 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.1 p -49.0 -18.82 0.33 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.387 2.275 . . . . 0.0 115.48 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.3 t -57.6 -44.85 85.75 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.537 1.535 . . . . 0.0 112.466 167.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.63 -6.32 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.344 1.458 . . . . 0.0 114.075 -170.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.09 -59.19 4.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.987 0.915 . . . . 0.0 110.761 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -59.11 -36.16 74.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.617 -0.677 . . . . 0.0 110.901 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.11 -46.72 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 121.229 -0.92 . . . . 0.0 111.93 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.94 -31.52 72.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.677 1.191 . . . . 0.0 112.974 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -66.44 -34.52 78.13 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -94.64 -45.13 7.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.48 112.95 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 122.178 0.989 . . . . 0.0 109.995 -165.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.84 5.93 5.17 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.839 1.209 . . . . 0.0 114.383 -169.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.62 1.69 7.55 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.583 1.153 . . . . 0.0 113.609 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.76 171.2 8.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.087 1.355 . . . . 0.0 111.502 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -54.53 -37.84 65.88 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 171.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.2 11.95 7.63 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.445 -1.753 . . . . 0.0 115.918 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.87 120.27 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.005 2.402 . . . . 0.0 109.303 169.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 -21.15 12.36 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -142.78 166.72 23.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.882 1.219 . . . . 0.0 112.663 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.7 tp -140.88 138.65 34.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 126.591 1.956 . . . . 0.0 108.433 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -125.4 129.52 50.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.169 1.388 . . . . 0.0 109.51 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -99.4 112.4 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.315 1.446 . . . . 0.0 108.161 -170.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 m -125.8 49.58 1.93 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.829 0.823 . . . . 0.0 110.613 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.62 -15.18 60.8 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.255 1.822 . . . . 0.0 114.803 -170.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -43.7 -32.84 1.09 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.614 2.366 . . . . 0.0 115.538 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -125.33 23.39 7.59 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.666 1.186 . . . . 0.0 112.874 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 63.39 24.72 14.3 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.035 1.734 . . . . 0.0 112.263 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.28 164.4 13.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.075 1.75 . . . . 0.0 110.036 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.33 151.31 41.82 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 127.677 2.391 . . . . 0.0 106.8 170.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -124.71 134.53 52.81 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.415 -0.803 . . . . 0.0 111.292 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -102.52 139.74 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 117.847 0.294 . . . . 0.0 111.089 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -102.8 95.73 6.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.708 1.603 . . . . 0.0 108.857 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -120.8 152.48 38.3 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -170.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.34 112.0 59.83 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 127.85 2.46 . . . . 0.0 109.772 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -63.03 -2.74 3.97 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.838 3.025 . . . . 0.0 115.658 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.9 p -84.24 -16.66 42.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.71 1.204 . . . . 0.0 113.019 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 92.4 m -124.43 -28.4 3.63 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 t -142.18 179.2 7.05 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.684 1.129 . . . . 0.0 113.064 -169.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 97.6 p -165.61 162.53 13.27 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.7 1.6 . . . . 0.0 112.164 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -52.63 -49.33 17.85 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.728 2.952 . . . . 0.0 115.472 -172.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.32 -37.61 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 119.326 0.966 . . . . 0.0 112.459 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.47 87.93 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.299 1.039 . . . . 0.0 111.438 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.33 -47.4 70.61 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.863 0.865 . . . . 0.0 111.778 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -55.72 -47.96 75.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.087 0.858 . . . . 0.0 111.484 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -63.94 -29.64 70.8 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.25 -62.43 1.52 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.932 0.787 . . . . 0.0 112.277 170.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 pt -72.61 -17.3 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -73.81 -35.78 64.9 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 121.64 2.018 . . . . 0.0 113.156 168.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.41 13.7 26.94 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.944 -1.097 . . . . 0.0 112.261 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.2 tp -48.86 -54.39 28.29 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 129.331 3.052 . . . . 0.0 113.202 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -91.05 176.22 2.28 Favored 'Trans proline' 0 CA--C 1.55 1.285 0 C-N-CA 124.092 3.195 . . . . 0.0 111.879 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.35 53.01 3.75 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 124.663 3.575 . . . . 0.0 113.099 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.8 52.38 5.88 Favored Glycine 0 N--CA 1.471 1.011 0 O-C-N 120.689 -1.257 . . . . 0.0 111.823 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -127.74 -33.04 2.31 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.467 1.107 . . . . 0.0 113.875 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -135.01 113.94 11.97 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.126 1.77 . . . . 0.0 109.556 -173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -98.43 173.92 6.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.36 1.464 . . . . 0.0 110.516 173.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.24 135.21 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.783 -1.198 . . . . 0.0 111.025 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -107.62 124.74 50.41 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.13 0.972 . . . . 0.0 109.831 167.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 124.239 1.016 . . . . 0.0 109.569 176.856 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.9 t 73.03 113.85 0.06 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.804 2.442 . . . . 0.0 114.835 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 60.9 m -145.37 148.6 33.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.109 2.163 . . . . 0.0 108.905 166.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.4 m -99.13 145.96 26.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.037 -1.039 . . . . 0.0 110.256 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.87 155.06 43.26 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.917 1.287 . . . . 0.0 110.978 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.0 tt -114.6 136.01 53.51 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.789 2.036 . . . . 0.0 110.745 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.6 mm -123.57 141.08 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 127.174 2.19 . . . . 0.0 109.697 -172.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.23 127.42 53.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.147 1.379 . . . . 0.0 110.706 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.23 143.72 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 120.801 -1.187 . . . . 0.0 111.566 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.85 56.46 1.31 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.195 1.798 . . . . 0.0 113.258 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.68 45.92 0.28 Allowed Glycine 0 N--CA 1.469 0.87 0 O-C-N 121.209 -0.932 . . . . 0.0 112.714 167.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 29.6 mtm -133.5 96.8 3.79 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.222 1.009 . . . . 0.0 110.024 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 t -98.99 -26.51 14.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.315 1.846 . . . . 0.0 112.939 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 95.7 m -125.62 150.43 47.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.188 1.395 . . . . 0.0 110.934 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.1 -23.79 67.46 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.918 -1.113 . . . . 0.0 113.312 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.1 p -53.55 -30.87 44.05 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.01 1.324 . . . . 0.0 113.429 169.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.8 m -57.17 -32.66 66.66 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.724 1.21 . . . . 0.0 112.3 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 41.5 t -57.07 -53.87 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.685 0.794 . . . . 0.0 109.988 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -66.31 -23.28 66.35 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.973 0.509 . . . . 0.0 112.21 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.5 m -71.19 -52.72 17.55 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.568 -0.707 . . . . 0.0 111.148 170.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 85.7 mt -70.37 -52.23 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 120.741 -1.225 . . . . 0.0 111.315 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -51.46 -42.08 61.32 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.82 1.248 . . . . 0.0 111.082 172.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.42 -62.42 2.9 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 123.558 0.599 . . . . 0.0 113.127 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -38.59 71.14 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.033 1.333 . . . . 0.0 113.026 -170.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.8 mm -71.04 -35.3 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.73 -0.606 . . . . 0.0 110.539 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -65.0 3.07 0.62 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -94.44 -11.28 30.07 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.686 1.194 . . . . 0.0 113.546 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -106.25 167.59 9.72 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.026 1.285 . . . . 0.0 112.87 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -68.38 161.38 27.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 123.213 1.482 . . . . 0.0 114.705 -174.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.82 -32.41 1.94 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.36 1.457 . . . . 0.0 114.911 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.51 98.61 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 119.106 1.453 . . . . 0.0 112.435 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -72.32 -45.89 58.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.196 0.998 . . . . 0.0 112.135 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -144.61 132.49 21.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.141 1.376 . . . . 0.0 109.783 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.71 142.3 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.745 1.157 . . . . 0.0 112.854 170.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 31.2 t -131.45 142.62 50.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.55 2.74 . . . . 0.0 109.224 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.27 146.97 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.89 1.223 . . . . 0.0 111.781 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 43.1 t -139.29 136.34 34.78 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -16.83 63.22 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.36 2.264 . . . . 0.0 113.514 171.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.74 97.05 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.783 1.233 . . . . 0.0 111.969 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -116.37 -16.05 10.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.7 1.6 . . . . 0.0 112.605 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.94 28.51 56.44 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.177 1.37 . . . . 0.0 112.855 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.1 p -128.89 151.54 49.52 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.077 0.939 . . . . 0.0 113.26 -169.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -113.32 146.71 38.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.25 1.42 . . . . 0.0 111.906 172.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.4 m -118.52 126.19 51.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.852 1.661 . . . . 0.0 107.342 168.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.77 137.33 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.321 0.649 . . . . 0.0 110.65 -171.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.25 109.69 21.78 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.75 2.02 . . . . 0.0 105.78 173.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -111.29 155.67 22.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.023 0.929 . . . . 0.0 111.993 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -97.4 107.05 36.57 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.725 1.21 . . . . 0.0 109.139 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -66.97 -15.86 48.06 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.8 1.667 . . . . 0.0 113.537 -174.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.85 -14.84 61.15 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.45 -31.67 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.165 1.786 . . . . 0.0 112.494 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.0 tt -151.77 152.31 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.865 -1.147 . . . . 0.0 112.964 -170.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 73.5 m -114.49 159.32 37.33 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.55 1.14 . . . . 0.0 112.858 171.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.8 -37.64 45.55 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.48 3.453 . . . . 0.0 115.103 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -57.82 -35.82 71.39 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.449 1.022 . . . . 0.0 113.066 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.28 -32.49 64.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.234 1.013 . . . . 0.0 111.564 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.64 -51.93 67.7 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.689 -0.632 . . . . 0.0 110.089 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -62.28 -41.82 98.81 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.733 -0.605 . . . . 0.0 111.617 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.25 73.18 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.8 -34.79 69.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.86 -38.97 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.705 0.802 . . . . 0.0 110.115 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -59.97 -46.73 88.48 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.331 0.653 . . . . 0.0 110.249 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.84 -22.49 65.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.4 1.48 . . . . 0.0 114.507 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -39.58 78.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.459 -0.775 . . . . 0.0 110.95 172.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 138.71 24.58 0.34 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.443 -1.198 . . . . 0.0 115.512 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -124.41 -153.36 0.56 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.162 1.481 . . . . 0.0 109.263 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.07 141.7 36.19 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.745 1.618 . . . . 0.0 108.018 168.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.97 154.88 47.3 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.9 t -138.88 143.53 38.77 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.024 2.13 . . . . 0.0 109.9 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.5 m -90.39 131.16 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.393 -0.817 . . . . 0.0 111.13 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 126.074 1.749 . . . . 0.0 109.903 -176.463 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.651 0.263 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.37 145.82 32.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.646 0.778 . . . . 0.0 110.945 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tt -121.4 136.44 54.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.377 1.071 . . . . 0.0 111.918 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.55 122.84 39.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 122.597 1.189 . . . . 0.0 110.295 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.82 143.04 26.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.323 -1.762 . . . . 0.0 113.203 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -113.49 118.02 33.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.618 1.167 . . . . 0.0 108.86 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 mm -83.11 147.69 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.818 1.247 . . . . 0.0 110.916 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.69 156.82 18.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.943 1.697 . . . . 0.0 112.014 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.27 -7.26 64.66 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.585 1.088 . . . . 0.0 113.957 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.0 mtm -65.7 0.37 1.73 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -58.96 -23.23 61.41 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 119.672 1.124 . . . . 0.0 112.412 167.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.9 -6.77 59.34 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.915 1.286 . . . . 0.0 113.814 171.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 tptm 59.54 -57.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 130.729 3.612 . . . . 0.0 116.123 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 m -56.32 -13.4 2.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.568 1.947 . . . . 0.0 113.589 -174.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 m -48.76 -39.67 25.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.837 2.455 . . . . 0.0 112.678 167.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.58 -20.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -172.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.63 -56.92 15.56 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.147 0.979 . . . . 0.0 112.039 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -61.91 -28.82 69.79 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.655 -0.653 . . . . 0.0 111.921 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.2 mt -61.86 -54.97 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.521 1.055 . . . . 0.0 110.005 168.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -61.82 -32.38 72.68 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.2 1.0 . . . . 0.0 113.081 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -67.75 -42.12 82.3 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.123 1.369 . . . . 0.0 112.252 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -92.75 -17.41 24.23 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.471 ' CD1' HG22 ' A' ' 78' ' ' ILE . 50.4 mm -117.25 128.51 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.342 1.057 . . . . 0.0 110.131 -176.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.16 -6.17 1.74 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.621 1.581 . . . . 0.0 115.703 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -119.0 -1.27 10.99 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.853 2.061 . . . . 0.0 112.71 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.89 160.26 9.95 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.316 1.446 . . . . 0.0 110.279 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.4 pt? -55.22 -39.74 70.03 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.51 -32.65 5.93 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 116.876 -2.069 . . . . 0.0 115.009 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.62 118.02 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 121.235 2.517 . . . . 0.0 110.529 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -105.55 -17.4 14.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.7 m -148.91 148.09 29.43 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.491 -1.38 . . . . 0.0 113.364 169.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.7 tp -110.21 131.98 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.956 0.902 . . . . 0.0 109.866 167.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -120.52 143.45 48.56 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.432 1.493 . . . . 0.0 109.148 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.403 ' CG1' HD23 ' A' ' 55' ' ' LEU . 95.1 t -120.09 120.58 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.658 1.183 . . . . 0.0 109.804 -169.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -119.66 55.32 0.97 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.432 1.493 . . . . 0.0 112.635 -168.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.403 HD23 ' CG1' ' A' ' 53' ' ' VAL . 1.2 mm? -68.47 -13.97 62.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -169.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -60.27 -33.4 72.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.286 1.034 . . . . 0.0 112.94 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -113.25 15.87 19.22 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.421 1.488 . . . . 0.0 111.725 171.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.0 mttt 66.89 11.54 8.38 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.217 2.207 . . . . 0.0 113.056 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.58 174.29 7.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.173 2.189 . . . . 0.0 110.29 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.04 164.67 24.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.756 1.623 . . . . 0.0 108.47 167.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -135.73 109.45 8.05 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.089 1.355 . . . . 0.0 108.048 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.9 p -98.64 133.59 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 121.856 -0.528 . . . . 0.0 110.069 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.03 96.11 7.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.382 1.473 . . . . 0.0 109.805 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -125.25 148.22 48.75 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -98.87 118.35 63.02 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.272 1.429 . . . . 0.0 109.43 171.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.57 2.16 4.26 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.836 3.024 . . . . 0.0 113.095 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 t -71.37 -28.05 63.77 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.103 -0.998 . . . . 0.0 112.289 171.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 82.6 m -113.0 -20.45 11.53 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -171.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.6 t -145.13 -176.25 5.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.853 1.661 . . . . 0.0 111.178 -171.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.8 p -158.38 155.39 25.51 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.635 1.574 . . . . 0.0 110.919 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -48.51 -46.35 23.96 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 124.132 3.221 . . . . 0.0 116.907 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.39 -32.16 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 120.472 1.487 . . . . 0.0 113.065 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.22 -30.09 67.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.93 0.892 . . . . 0.0 111.849 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.7 mt -71.9 -53.16 14.02 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.661 0.784 . . . . 0.0 111.125 169.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.546 HE21 HG23 ' A' ' 88' ' ' VAL . 14.5 tt0 -49.77 -57.32 7.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.944 1.298 . . . . 0.0 110.889 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -68.6 -27.15 65.78 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.25 -55.42 9.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.23 0.923 . . . . 0.0 111.356 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.471 HG22 ' CD1' ' A' ' 42' ' ' ILE . 8.7 pt -71.81 -31.85 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.86 -17.66 63.38 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.73 10.77 39.73 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.549 -1.344 . . . . 0.0 113.724 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.1 mt -59.17 -54.04 60.33 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.562 -1.209 . . . . 0.0 109.759 166.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.5 174.45 12.81 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.237 2.624 . . . . 0.0 110.849 168.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.74 54.49 3.53 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.142 3.228 . . . . 0.0 111.209 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.45 23.5 68.55 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.304 0.954 . . . . 0.0 112.999 -175.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -90.14 -30.37 17.68 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.554 0.677 . . . . 0.0 112.473 -169.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -109.49 116.0 30.99 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.282 1.433 . . . . 0.0 107.89 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.4 tptp -96.91 157.02 16.1 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.666 1.186 . . . . 0.0 110.592 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.546 HG23 HE21 ' A' ' 75' ' ' GLN . 3.9 m -124.2 133.81 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.756 1.616 . . . . 0.0 111.659 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.6 p -110.58 127.45 55.23 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.026 0.93 . . . . 0.0 110.528 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 125.355 1.462 . . . . 0.0 109.514 170.384 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.8 m 59.0 92.91 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.1 m -141.18 158.51 43.81 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.334 1.453 . . . . 0.0 110.804 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 52.9 m -99.22 142.51 30.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.734 0.814 . . . . 0.0 110.76 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.68 143.65 30.83 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.065 0.946 . . . . 0.0 111.312 170.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -102.68 135.72 43.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.277 1.431 . . . . 0.0 110.166 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 mm -113.83 136.04 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.552 1.941 . . . . 0.0 108.304 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -105.36 124.48 49.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.271 1.429 . . . . 0.0 109.306 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 88.3 mt -122.55 143.7 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 120.486 -1.384 . . . . 0.0 112.21 -166.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.62 56.39 1.48 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.298 1.439 . . . . 0.0 112.984 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.95 50.63 0.18 Allowed Glycine 0 N--CA 1.462 0.393 0 C-N-CA 125.17 1.367 . . . . 0.0 111.902 166.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.499 ' SD ' HD22 ' A' ' 157' ' ' LEU . 10.6 ptp -126.35 142.05 51.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.869 0.842 . . . . 0.0 110.637 168.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.0 t -155.72 143.03 19.33 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 128.152 2.581 . . . . 0.0 105.604 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 81.5 m 70.13 141.8 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.489 1.516 . . . . 0.0 113.422 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.41 -35.83 52.82 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.164 -0.96 . . . . 0.0 113.194 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.1 p -61.05 -25.22 66.77 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.109 -0.994 . . . . 0.0 113.373 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.3 t -65.91 -31.98 73.23 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.723 -0.611 . . . . 0.0 112.623 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.29 -60.5 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.305 0.642 . . . . 0.0 109.275 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -66.5 -20.01 65.93 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.5 t -71.08 -58.26 3.73 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.587 1.155 . . . . 0.0 111.764 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.5 mt -70.5 -49.41 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.002 1.321 . . . . 0.0 111.245 -176.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -53.16 -26.96 18.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.167 1.787 . . . . 0.0 111.775 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.62 -60.66 3.14 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.648 1.594 . . . . 0.0 113.321 167.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 70.1 mmm -54.29 -41.96 69.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.843 1.257 . . . . 0.0 114.001 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.79 -32.82 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.425 0.69 . . . . 0.0 111.97 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.0 t -64.9 1.11 0.97 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.256 1.423 . . . . 0.0 114.803 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -90.38 -30.31 17.49 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.357 -1.464 . . . . 0.0 114.031 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.86 176.77 8.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.216 1.006 . . . . 0.0 112.261 -174.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -86.84 154.45 20.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 122.489 1.138 . . . . 0.0 113.934 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.0 2.54 80.79 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 113.146 -1.843 . . . . 0.0 116.528 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.24 96.2 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 120.99 2.395 . . . . 0.0 112.231 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.514 ' NE2' ' H ' ' A' ' 151' ' ' GLN . 2.7 mp0 -65.49 -50.28 65.91 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.88 0.872 . . . . 0.0 109.922 173.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.42 141.67 30.94 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.356 0.663 . . . . 0.0 111.427 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.48 138.98 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.961 0.886 . . . . 0.0 111.298 166.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.8 t -142.22 147.07 35.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 127.365 2.266 . . . . 0.0 109.05 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.3 t -134.75 136.44 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.314 0.961 . . . . 0.0 110.566 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.1 m -113.93 99.31 7.58 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.771 1.229 . . . . 0.0 111.149 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . 0.499 HD22 ' SD ' ' A' ' 131' ' ' MET . 0.2 OUTLIER -53.6 -30.99 45.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.952 1.701 . . . . 0.0 110.973 169.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -49.57 -34.21 17.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.043 2.137 . . . . 0.0 114.597 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -130.59 -5.24 4.16 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.187 0.995 . . . . 0.0 113.065 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.44 30.85 57.82 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.46 1.027 . . . . 0.0 112.355 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 61.0 p -118.66 152.98 35.07 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 117.869 0.834 . . . . 0.0 110.676 -170.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -125.26 124.3 41.36 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.675 0.79 . . . . 0.0 109.488 171.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.4 t -106.66 132.56 52.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.969 0.508 . . . . 0.0 110.18 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.82 138.67 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.068 0.547 . . . . 0.0 111.375 -171.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.16 96.1 8.21 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -98.78 159.92 14.62 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.625 0.77 . . . . 0.0 111.964 -177.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -98.68 102.68 15.56 Favored Pre-proline 0 C--O 1.241 0.653 0 C-N-CA 124.935 1.294 . . . . 0.0 109.324 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.7 -16.93 55.37 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.612 1.541 . . . . 0.0 113.075 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.21 -12.94 60.4 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 173.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 76.4 t -119.78 -41.12 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.069 1.748 . . . . 0.0 111.858 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.4 tt -137.05 149.03 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.211 1.004 . . . . 0.0 112.05 -172.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 55.5 m -112.71 153.19 45.14 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 124.461 1.104 . . . . 0.0 111.991 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -52.28 -38.94 73.29 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.453 2.769 . . . . 0.0 114.559 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.34 -29.25 68.77 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -72.05 -31.44 66.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 112.532 172.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.39 -49.93 69.64 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.512 0.725 . . . . 0.0 109.351 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -52.7 -50.57 63.07 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.929 1.292 . . . . 0.0 111.834 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.94 69.41 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.78 65.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -74.34 -39.52 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.606 0.762 . . . . 0.0 110.91 170.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.61 -29.17 69.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.869 0.468 . . . . 0.0 111.746 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.07 -36.69 82.56 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.265 -1.522 . . . . 0.0 112.678 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 17.5 ttt -67.11 -28.66 68.34 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.86 0.864 . . . . 0.0 112.024 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 118.59 20.39 4.26 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.557 1.551 . . . . 0.0 115.747 169.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -106.46 -154.66 0.52 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.487 1.515 . . . . 0.0 109.69 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.58 138.13 42.67 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.119 1.367 . . . . 0.0 109.009 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -126.67 158.49 36.24 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.4 1.48 . . . . 0.0 111.545 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.2 t -140.51 136.11 32.59 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 126.947 2.099 . . . . 0.0 107.98 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.2 m -84.21 129.73 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.762 -0.586 . . . . 0.0 109.876 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 124.829 2.252 . . . . 0.0 107.151 171.095 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.429 HG13 ' CE1' ' A' ' 64' ' ' TYR . 9.0 p . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.59 144.01 50.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.951 0.9 . . . . 0.0 111.367 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.3 140.27 29.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.024 2.13 . . . . 0.0 109.205 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.528 ' NE2' HE22 ' A' ' 61' ' ' GLN . 2.3 pt20 -131.01 146.21 52.31 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 173.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.404 ' H ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -132.6 158.13 43.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.592 1.957 . . . . 0.0 110.707 174.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.12 101.57 13.33 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -77.1 133.8 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.253 1.021 . . . . 0.0 110.814 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -97.84 136.24 38.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.472 1.509 . . . . 0.0 111.256 172.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.45 57.51 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.252 1.406 . . . . 0.0 114.256 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.2 ptp -60.81 -17.89 52.25 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -63.35 -15.53 57.69 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 119.4 1.0 . . . . 0.0 113.499 172.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.55 -9.97 59.71 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 168.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? 71.09 -59.78 0.53 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 128.68 2.792 . . . . 0.0 111.482 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.9 p -45.27 -35.84 3.66 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.335 2.254 . . . . 0.0 114.055 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -45.68 -45.76 14.35 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.7 1.6 . . . . 0.0 112.492 174.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.69 -18.43 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -174.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.1 tp -63.49 -50.92 67.75 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.203 0.911 . . . . 0.0 111.087 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -39.84 63.02 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.65 0.738 . . . . 0.0 111.072 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.38 -52.54 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.452 1.101 . . . . 0.0 109.977 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.41 -34.63 70.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.646 1.579 . . . . 0.0 113.701 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.59 -41.1 89.01 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.637 1.108 . . . . 0.0 111.68 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -94.12 -36.55 12.03 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.458 ' CD1' HG22 ' A' ' 78' ' ' ILE . 33.2 mm -98.22 114.77 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 121.177 -0.952 . . . . 0.0 109.04 -170.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.45 -27.36 2.38 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.183 0.897 . . . . 0.0 114.84 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -106.02 3.68 28.51 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.5 mt -87.78 163.67 16.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.815 1.246 . . . . 0.0 112.784 -170.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 47.1 tp -29.5 -62.01 0.14 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.802 2.441 . . . . 0.0 114.902 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.83 -23.78 13.02 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.218 -1.323 . . . . 0.0 114.626 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.86 126.3 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 120.14 1.97 . . . . 0.0 110.601 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -97.52 -40.32 8.71 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.798 0.839 . . . . 0.0 111.733 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.8 t -149.95 -178.56 6.55 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.413 1.085 . . . . 0.0 113.706 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.9 tp -132.63 145.3 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 127.462 2.305 . . . . 0.0 109.097 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -132.98 118.69 19.15 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.635 1.207 . . . . 0.0 109.561 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.4 t -104.82 95.07 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.274 1.83 . . . . 0.0 109.385 -168.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -113.17 55.63 0.7 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.401 1.481 . . . . 0.0 111.345 -174.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.4 mt -58.6 -28.82 65.94 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -168.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.5 -25.42 25.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.232 1.413 . . . . 0.0 113.589 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -102.23 -0.36 33.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.056 1.343 . . . . 0.0 113.733 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 69.6 -15.86 0.28 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 127.746 2.418 . . . . 0.0 114.543 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.64 131.28 42.04 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.845 1.658 . . . . 0.0 108.702 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.37 145.29 27.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.594 1.158 . . . . 0.0 109.698 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.528 HE22 ' NE2' ' A' ' 23' ' ' GLN . 8.4 tp-100 -114.86 134.19 55.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.705 1.202 . . . . 0.0 109.246 -169.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 p -118.39 140.46 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 119.976 1.262 . . . . 0.0 111.045 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -113.51 101.4 9.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.234 1.813 . . . . 0.0 108.499 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.429 ' CE1' HG13 ' A' ' 20' ' ' VAL . 16.1 p90 -128.62 -179.37 5.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.842 1.657 . . . . 0.0 111.63 -168.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -120.23 138.12 26.79 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.803 1.241 . . . . 0.0 108.569 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.57 5.51 6.07 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.966 2.444 . . . . 0.0 113.556 -169.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.9 p -75.12 -29.1 60.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.413 1.085 . . . . 0.0 113.197 -172.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.63 -21.65 6.11 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -170.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -146.71 -179.21 6.62 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.956 1.702 . . . . 0.0 110.93 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.8 p -165.58 170.24 6.26 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.969 1.308 . . . . 0.0 111.882 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -45.61 -51.28 8.31 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 124.612 3.541 . . . . 0.0 116.122 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.3 m -70.16 -35.26 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 119.714 1.143 . . . . 0.0 112.879 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.1 77.46 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.471 0.708 . . . . 0.0 110.929 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.22 -48.33 78.76 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.336 1.054 . . . . 0.0 111.28 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -52.32 -54.65 28.81 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.191 0.905 . . . . 0.0 110.987 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -65.53 -36.13 82.9 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.305 1.042 . . . . 0.0 111.785 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.42 -53.98 39.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.472 0.709 . . . . 0.0 112.164 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.458 HG22 ' CD1' ' A' ' 42' ' ' ILE . 7.9 pt -72.4 -30.34 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -172.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -66.23 -27.39 67.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.139 0.881 . . . . 0.0 113.07 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.89 8.11 42.48 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.79 -51.52 80.28 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-O 117.688 -1.149 . . . . 0.0 112.4 168.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.408 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 76.6 Cg_endo -71.75 167.47 26.46 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.221 1.947 . . . . 0.0 111.48 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.16 62.81 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.074 3.183 . . . . 0.0 110.019 169.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.56 53.8 38.81 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 124.943 1.258 . . . . 0.0 112.814 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -125.7 -50.79 1.6 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -171.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.408 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 13.5 m-85 -97.52 118.92 35.1 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.13 149.76 22.72 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.244 1.018 . . . . 0.0 111.578 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.2 m -123.92 142.58 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -121.38 134.22 55.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.38 1.472 . . . . 0.0 111.561 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 126.865 2.066 . . . . 0.0 110.948 174.838 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.7 p -147.92 131.7 17.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -167.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.3 p -144.22 146.34 32.61 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.109 1.764 . . . . 0.0 111.504 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -99.31 147.53 25.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.502 1.121 . . . . 0.0 109.981 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.49 141.85 27.49 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.072 0.949 . . . . 0.0 110.497 168.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tt -108.74 144.55 36.4 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.07 1.348 . . . . 0.0 110.738 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mt -134.2 137.24 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.374 1.87 . . . . 0.0 110.39 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.83 133.73 42.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.308 1.443 . . . . 0.0 109.793 172.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 55.4 mt -140.33 130.53 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 119.462 1.028 . . . . 0.0 110.866 -171.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.19 53.43 0.72 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.344 1.058 . . . . 0.0 112.755 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.41 53.13 0.42 Allowed Glycine 0 N--CA 1.47 0.907 0 O-C-N 120.932 -1.105 . . . . 0.0 113.815 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -131.1 154.0 48.75 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.513 1.125 . . . . 0.0 109.903 170.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 t -157.33 -37.13 0.07 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.841 1.656 . . . . 0.0 111.217 -169.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 57.3 m -133.78 159.25 41.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.94 1.696 . . . . 0.0 111.577 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.85 -31.99 70.27 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -51.52 -26.3 8.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.898 1.279 . . . . 0.0 113.49 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 79.0 m -58.48 -26.42 63.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.519 1.128 . . . . 0.0 113.595 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.91 -47.33 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 118.892 0.769 . . . . 0.0 109.818 173.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -71.17 -13.89 62.09 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.4 m -70.98 -56.48 6.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.14 -54.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.846 1.258 . . . . 0.0 110.614 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -54.49 -32.82 58.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.22 1.008 . . . . 0.0 111.004 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.74 -49.53 63.39 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 124.171 0.891 . . . . 0.0 112.422 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 96.8 mmm -66.86 -46.99 73.32 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.689 1.244 . . . . 0.0 111.822 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.6 mm -73.19 -54.08 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.394 0.677 . . . . 0.0 112.707 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.5 t -62.46 -16.18 53.87 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -168.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -74.8 -30.84 61.55 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.978 1.311 . . . . 0.0 114.135 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 pp -89.28 -179.37 5.85 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.116 0.871 . . . . 0.0 111.407 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -87.39 -172.55 3.97 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.112 0.958 . . . . 0.0 111.6 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.63 -45.64 1.88 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.272 -1.517 . . . . 0.0 113.711 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.1 p -65.35 99.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.213 2.205 . . . . 0.0 112.096 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.23 -39.9 24.65 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.503 -0.748 . . . . 0.0 111.713 169.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -140.16 144.07 36.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.2 1.0 . . . . 0.0 110.461 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.45 138.32 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.997 0.903 . . . . 0.0 113.133 169.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.4 t -140.01 146.77 39.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.851 2.46 . . . . 0.0 110.691 -169.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.1 t -143.63 138.03 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.913 -1.117 . . . . 0.0 111.02 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 70.0 m -124.94 89.58 3.09 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.759 1.624 . . . . 0.0 111.126 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.53 -29.92 39.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.104 2.161 . . . . 0.0 113.242 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -47.7 -31.31 4.58 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.079 2.552 . . . . 0.0 115.259 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -130.18 -3.48 4.46 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.134 1.773 . . . . 0.0 112.237 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.29 36.32 63.48 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 117.852 -1.527 . . . . 0.0 112.882 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.8 p -124.1 153.74 41.0 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.126 1.463 . . . . 0.0 112.082 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -119.28 148.73 42.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.537 1.535 . . . . 0.0 109.722 169.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.9 t -138.39 133.55 33.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.585 0.754 . . . . 0.0 110.835 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.62 143.0 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.677 0.791 . . . . 0.0 111.451 -168.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.6 106.57 18.91 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.556 1.542 . . . . 0.0 107.371 169.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -108.38 158.09 17.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.957 1.303 . . . . 0.0 111.701 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -95.9 116.62 66.35 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 121.061 -1.024 . . . . 0.0 109.536 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.41 -10.22 20.48 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.326 2.017 . . . . 0.0 113.199 -170.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.15 -7.74 58.93 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.132 0.973 . . . . 0.0 113.418 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.97 -35.44 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.51 1.524 . . . . 0.0 112.348 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.0 tt -156.66 159.2 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.349 0.977 . . . . 0.0 112.205 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.76 150.72 43.2 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 126.213 1.805 . . . . 0.0 112.214 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.54 -43.87 37.39 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.3 3.334 . . . . 0.0 114.908 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -72.22 -15.94 61.94 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.68 -30.72 61.68 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.078 -1.014 . . . . 0.0 112.35 170.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 66.9 mt -59.04 -51.6 69.34 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.796 1.238 . . . . 0.0 110.406 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -49.73 -47.92 50.36 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.181 1.392 . . . . 0.0 112.512 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.02 -23.68 66.6 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.8 65.36 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.531 0.732 . . . . 0.0 112.207 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.3 mt -74.36 -41.36 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.75 1.22 . . . . 0.0 110.646 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -63.84 -28.27 69.74 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.011 0.924 . . . . 0.0 112.579 171.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -69.88 -35.46 74.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.177 0.991 . . . . 0.0 112.645 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 19.8 ttt -73.03 -34.06 66.1 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.871 0.868 . . . . 0.0 112.433 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 120.26 35.91 0.84 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.205 1.383 . . . . 0.0 114.741 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -134.48 147.56 50.39 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.82 1.648 . . . . 0.0 110.314 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -101.37 102.36 13.17 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.833 -1.167 . . . . 0.0 111.232 -167.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -99.98 147.34 25.69 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.284 2.234 . . . . 0.0 112.514 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.5 t -142.52 144.24 32.87 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.822 1.249 . . . . 0.0 109.999 168.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.2 m -71.71 136.39 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.702 -0.624 . . . . 0.0 110.675 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 125.766 1.626 . . . . 0.0 107.57 169.858 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.05 133.05 42.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.324 1.45 . . . . 0.0 109.373 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tt -126.53 128.83 47.5 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.307 2.243 . . . . 0.0 107.952 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -96.99 135.7 38.61 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.947 1.299 . . . . 0.0 110.344 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 pp -145.06 157.56 44.07 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.427 1.091 . . . . 0.0 113.736 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -116.06 125.39 52.36 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.02 1.328 . . . . 0.0 110.476 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.3 mt -100.86 150.23 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 126.169 1.788 . . . . 0.0 111.734 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.67 133.97 41.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.797 1.639 . . . . 0.0 110.923 173.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.43 1.25 81.35 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.853 1.216 . . . . 0.0 114.287 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.2 ptm -72.37 -6.78 45.83 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 116.196 1.925 . . . . 0.0 116.196 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -60.21 -18.87 51.49 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.425 1.011 . . . . 0.0 112.658 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.5 t -89.98 119.4 30.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 165.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -19.95 62.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.254 1.022 . . . . 0.0 113.397 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.3 m -63.59 -23.9 67.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.1 t -61.52 -52.38 64.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.902 1.683 . . . . 0.0 110.862 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.46 -15.77 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -69.65 -60.81 2.08 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.426 1.012 . . . . 0.0 111.264 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -26.07 68.65 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.34 -0.85 . . . . 0.0 112.117 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 92.3 mt -64.8 -50.94 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.913 -1.117 . . . . 0.0 111.048 167.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.0 -31.32 70.94 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.771 1.228 . . . . 0.0 113.658 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -56.03 -46.29 78.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.465 1.03 . . . . 0.0 110.541 173.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -90.29 -29.15 18.31 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.417 ' CD1' HG22 ' A' ' 78' ' ' ILE . 44.3 mm -110.09 113.43 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.34 1.056 . . . . 0.0 111.034 -169.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.27 -15.87 4.44 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 125.986 1.755 . . . . 0.0 114.45 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -101.77 5.66 41.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.79 1.236 . . . . 0.0 112.296 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.13 178.52 4.35 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.61 1.564 . . . . 0.0 112.142 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.9 -69.29 0.29 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.022 1.329 . . . . 0.0 111.333 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.69 -37.66 16.19 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.774 -1.57 . . . . 0.0 112.547 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.15 120.96 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 119.593 1.697 . . . . 0.0 110.126 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.29 -17.33 10.79 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.4 m -145.47 163.62 34.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.33 0.968 . . . . 0.0 111.324 169.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.5 tp -129.1 124.54 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.279 1.032 . . . . 0.0 109.045 168.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -114.13 142.14 46.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.408 1.483 . . . . 0.0 108.305 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.08 137.87 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.806 0.842 . . . . 0.0 109.687 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.0 t -136.12 55.53 1.85 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 123.967 1.842 . . . . 0.0 107.69 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.8 mt -68.9 -24.49 64.31 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.009 1.724 . . . . 0.0 114.516 -167.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.61 -52.42 63.85 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.317 1.047 . . . . 0.0 110.421 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -91.79 19.02 6.89 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.676 1.191 . . . . 0.0 111.942 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 65.12 28.01 12.32 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.569 1.948 . . . . 0.0 112.76 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.6 152.29 27.77 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.604 1.561 . . . . 0.0 111.447 -176.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.49 154.78 44.69 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -141.7 116.41 9.74 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -163.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 p -98.79 137.38 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 120.97 0.414 . . . . 0.0 111.236 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -108.3 97.65 7.3 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.812 2.045 . . . . 0.0 108.713 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -129.63 155.74 45.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.875 1.27 . . . . 0.0 113.921 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -99.17 118.53 62.42 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 125.564 1.545 . . . . 0.0 110.528 170.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.0 -2.13 2.05 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.203 3.935 . . . . 0.0 116.064 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.5 t -72.94 -22.65 60.68 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.136 1.374 . . . . 0.0 113.145 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 36.1 m -139.66 -8.62 1.24 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 t -147.91 -179.47 6.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.272 1.029 . . . . 0.0 110.833 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 p -160.81 156.29 21.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.057 0.943 . . . . 0.0 113.16 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.69 -55.68 3.88 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.747 3.631 . . . . 0.0 116.129 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 m -67.26 -34.17 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.097 1.317 . . . . 0.0 112.053 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.22 89.54 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.967 0.907 . . . . 0.0 111.661 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.7 mt -66.22 -43.81 85.59 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.849 0.86 . . . . 0.0 111.494 171.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -57.93 -44.76 87.09 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.237 0.926 . . . . 0.0 110.815 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -70.09 -31.2 68.65 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.368 1.067 . . . . 0.0 113.557 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.42 -51.77 27.09 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.952 0.901 . . . . 0.0 112.486 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.417 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.4 pt -74.29 -32.47 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -174.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.16 -30.01 69.02 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.59 7.08 40.99 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.08 -55.04 37.77 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.385 -1.293 . . . . 0.0 112.885 170.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 92.1 Cg_endo -72.2 169.36 21.72 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.992 2.461 . . . . 0.0 111.492 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.12 51.95 3.32 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 125.245 3.964 . . . . 0.0 112.404 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.43 63.28 4.21 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -173.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -130.3 -58.1 1.06 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.42 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 20.4 m-85 -93.22 124.67 37.36 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -97.55 162.94 13.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.015 0.926 . . . . 0.0 110.452 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 p -140.82 137.25 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.0 m -118.85 139.39 51.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.142 2.177 . . . . 0.0 110.767 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 124.575 1.15 . . . . 0.0 111.584 175.268 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.26 5.7 t . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.459 0.171 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.4 m 49.8 93.16 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 166.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 p -133.92 141.44 47.33 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.476 -1.39 . . . . 0.0 111.211 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 44.2 m -97.46 134.42 40.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.664 1.12 . . . . 0.0 110.176 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.4 158.16 45.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.209 1.004 . . . . 0.0 113.067 175.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.22 136.51 45.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.323 2.249 . . . . 0.0 111.025 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.0 mm -128.58 134.4 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.963 1.705 . . . . 0.0 108.348 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.08 130.1 45.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.185 0.994 . . . . 0.0 109.486 172.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.35 147.53 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.47 -1.394 . . . . 0.0 110.921 -168.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -134.97 58.67 1.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.29 1.436 . . . . 0.0 113.221 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.1 48.74 0.3 Allowed Glycine 0 N--CA 1.469 0.846 0 O-C-N 120.889 -1.132 . . . . 0.0 113.696 166.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . 0.408 ' O ' HG22 ' A' ' 132' ' ' THR . 74.3 mtm -102.14 -55.51 2.46 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 117.562 -1.209 . . . . 0.0 111.716 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 131' ' ' MET 0.256 6.0 t 67.44 -38.64 0.35 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 129.647 3.179 . . . . 0.0 114.619 174.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 87.3 m -135.47 153.56 51.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.502 2.321 . . . . 0.0 111.529 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.56 76.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.353 1.061 . . . . 0.0 113.401 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.4 p -53.19 -35.29 59.69 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.813 0.733 . . . . 0.0 112.565 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.4 t -62.89 -25.8 68.48 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.2 t -58.94 -57.29 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.93 0.786 . . . . 0.0 109.076 169.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -65.54 -23.75 66.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.254 0.479 . . . . 0.0 112.16 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.1 m -69.9 -47.97 60.47 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.647 -0.658 . . . . 0.0 112.242 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.83 -53.68 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 119.725 1.148 . . . . 0.0 110.826 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -54.43 -31.01 54.37 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.673 1.989 . . . . 0.0 111.314 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.46 -61.74 2.71 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.3 1.429 . . . . 0.0 114.469 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 74.3 mmm -70.38 -41.81 72.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.844 1.258 . . . . 0.0 114.073 -168.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.8 mm -70.85 -27.57 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.714 -0.617 . . . . 0.0 110.66 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.411 ' HA ' HG11 ' A' ' 150' ' ' VAL . 2.7 t -65.73 0.39 1.73 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -99.48 -5.35 29.49 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -104.51 173.98 6.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.396 1.479 . . . . 0.0 111.821 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -79.14 142.87 36.0 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.079 -1.013 . . . . 0.0 111.712 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 94.09 11.47 57.49 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 117.133 -1.926 . . . . 0.0 116.947 175.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' A' ' 145' ' ' SER . 10.1 p -111.85 -29.27 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.638 1.719 . . . . 0.0 114.775 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 39.07 -71.3 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 129.988 3.315 . . . . 0.0 117.602 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -133.74 124.74 27.17 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.619 1.1 . . . . 0.0 110.373 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.7 tt -129.41 136.12 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.7 1.2 . . . . 0.0 111.24 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 24.5 t -136.38 126.56 26.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.218 1.807 . . . . 0.0 109.253 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.1 t -141.69 139.21 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.725 -1.234 . . . . 0.0 110.436 -168.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.1 m -145.39 140.17 27.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.211 0.604 . . . . 0.0 112.021 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.9 mt -65.63 -30.63 71.37 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.44 -56.36 5.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.754 2.021 . . . . 0.0 113.199 -170.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -101.39 -5.7 25.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.151 1.38 . . . . 0.0 111.198 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.27 35.53 77.08 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 125.248 1.404 . . . . 0.0 112.286 -175.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.4 p -116.7 139.17 50.85 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 124.697 1.199 . . . . 0.0 113.615 -167.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.65 138.72 41.37 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.664 1.586 . . . . 0.0 108.965 167.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.8 t -123.01 126.38 47.03 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 166.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.47 142.93 28.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 123.525 0.73 . . . . 0.0 111.313 -166.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -93.06 93.52 8.36 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.868 2.067 . . . . 0.0 106.601 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -94.62 158.12 15.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.96 0.886 . . . . 0.0 111.234 -174.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -95.77 106.98 30.98 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 121.701 -0.624 . . . . 0.0 109.975 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.15 -17.74 24.34 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.135 1.89 . . . . 0.0 112.856 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.71 41.0 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.457 1.103 . . . . 0.0 113.766 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.57 -27.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.097 1.759 . . . . 0.0 113.342 -171.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 21.3 tt -145.38 147.09 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 120.488 1.494 . . . . 0.0 112.457 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 35.3 m -98.5 144.71 28.61 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.279 1.032 . . . . 0.0 110.654 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.77 -33.51 32.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.315 3.344 . . . . 0.0 115.02 176.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -60.75 -28.59 68.82 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.5 -28.33 59.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.041 1.336 . . . . 0.0 113.07 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.23 -48.5 78.0 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.022 0.828 . . . . 0.0 109.104 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -52.66 -47.62 67.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.017 1.327 . . . . 0.0 111.068 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.46 -30.14 69.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.371 1.068 . . . . 0.0 113.712 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.38 -38.83 68.39 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.989 1.268 . . . . 0.0 113.001 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.63 -36.19 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.64 0.776 . . . . 0.0 110.391 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -69.66 -31.09 68.96 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.6 -0.688 . . . . 0.0 112.426 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.18 -28.76 65.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.663 1.985 . . . . 0.0 112.637 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.8 ttt -70.89 -36.69 72.87 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.34 1.056 . . . . 0.0 111.107 172.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 134.14 16.78 1.06 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.517 1.532 . . . . 0.0 116.117 169.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -113.08 -159.31 0.68 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.696 1.248 . . . . 0.0 110.216 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -128.27 140.63 51.78 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.525 1.13 . . . . 0.0 110.066 169.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -132.22 151.37 51.85 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.513 1.525 . . . . 0.0 111.875 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.2 t -133.41 132.49 41.22 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.394 1.478 . . . . 0.0 111.997 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.5 m -84.54 80.8 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.986 0.898 . . . . 0.0 110.722 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 126.654 1.982 . . . . 0.0 111.817 174.007 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.676 0.751 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -99.16 137.63 37.4 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.568 1.947 . . . . 0.0 110.002 -169.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tt -142.25 139.21 31.86 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.597 1.159 . . . . 0.0 110.62 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.539 ' NE2' HE22 ' A' ' 61' ' ' GLN . 1.2 mp0 -98.35 133.94 42.05 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.692 1.997 . . . . 0.0 110.716 -176.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.11 134.07 24.01 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.794 170.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -100.05 113.64 26.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 mt -77.73 128.99 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 121.548 0.69 . . . . 0.0 109.577 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.2 107.85 19.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.235 2.214 . . . . 0.0 109.894 -171.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.09 10.52 34.2 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.676 1.131 . . . . 0.0 114.074 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.3 ptp -57.99 -35.58 71.41 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.155 1.478 . . . . 0.0 114.334 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 t60 68.06 -44.06 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 129.202 3.001 . . . . 0.0 113.294 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.8 p -166.74 166.88 15.58 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.647 2.379 . . . . 0.0 110.344 -173.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.55 -35.92 61.28 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.7 m -57.73 -23.09 50.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 t -49.39 -40.42 35.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.643 1.177 . . . . 0.0 112.004 168.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -12.34 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 117.83 -1.081 . . . . 0.0 113.565 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.87 -49.73 71.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.536 1.516 . . . . 0.0 111.884 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -40.94 68.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.144 0.884 . . . . 0.0 110.716 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mt -65.3 -52.31 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.311 1.444 . . . . 0.0 109.775 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -60.84 -33.32 72.86 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.936 2.495 . . . . 0.0 113.478 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -67.31 -45.05 77.64 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.517 1.127 . . . . 0.0 111.763 173.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -95.22 -29.43 14.52 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -170.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.415 ' CD1' HG22 ' A' ' 78' ' ' ILE . 47.3 mm -108.14 113.46 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.108 0.963 . . . . 0.0 109.577 -170.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.23 -22.55 7.06 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 125.857 1.694 . . . . 0.0 114.015 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -78.65 -10.68 59.84 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 118.188 0.994 . . . . 0.0 112.094 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.5 mt -67.81 -177.69 0.84 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.609 3.164 . . . . 0.0 112.404 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tt -82.12 -70.21 0.56 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.406 -0.809 . . . . 0.0 110.992 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.94 -44.44 78.67 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.118 -1.379 . . . . 0.0 112.483 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.14 117.82 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.65 1.725 . . . . 0.0 108.617 171.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -97.32 -41.47 8.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.153 0.981 . . . . 0.0 110.494 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 t -145.56 167.3 23.36 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.042 0.937 . . . . 0.0 112.666 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.6 tp -135.85 142.46 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.7 2.0 . . . . 0.0 108.437 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -141.48 153.93 45.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.01 1.724 . . . . 0.0 110.015 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.445 HG13 HD13 ' A' ' 55' ' ' LEU . 12.6 t -108.83 144.46 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.71 2.004 . . . . 0.0 109.926 -176.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.5 t -140.37 54.14 1.62 Allowed 'General case' 0 CA--C 1.555 1.159 0 CA-C-O 122.806 1.288 . . . . 0.0 109.939 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.445 HD13 HG13 ' A' ' 53' ' ' VAL . 1.7 mp -64.11 -19.28 65.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.081 1.353 . . . . 0.0 113.973 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.46 -24.21 44.1 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.1 19.36 8.33 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.875 1.67 . . . . 0.0 111.799 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.8 mttt 60.75 16.85 7.08 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.271 1.828 . . . . 0.0 113.788 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 p -96.92 159.71 14.76 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 123.517 1.627 . . . . 0.0 110.123 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.43 154.09 38.22 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.042 2.137 . . . . 0.0 106.813 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.539 HE22 ' NE2' ' A' ' 23' ' ' GLN . 3.0 tp60 -131.03 119.03 21.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.864 1.266 . . . . 0.0 108.587 -168.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 p -106.87 141.4 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.745 -0.597 . . . . 0.0 110.633 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.15 95.51 5.42 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.64 1.576 . . . . 0.0 108.97 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -123.31 150.64 43.33 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.362 1.065 . . . . 0.0 112.567 -173.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.4 123.11 57.68 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.544 1.137 . . . . 0.0 107.997 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.35 -12.79 6.23 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.067 3.178 . . . . 0.0 114.801 175.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.8 m -58.41 -28.32 65.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.032 1.733 . . . . 0.0 114.93 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 99.0 m -137.94 -12.17 1.48 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -148.2 177.14 9.65 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.869 1.267 . . . . 0.0 111.282 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.5 p -158.64 160.7 29.28 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.279 1.432 . . . . 0.0 111.893 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -53.99 -48.81 19.64 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.09 2.527 . . . . 0.0 115.398 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.2 m -69.31 -32.85 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 120.135 1.334 . . . . 0.0 112.938 177.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.55 -35.19 78.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.448 0.699 . . . . 0.0 111.643 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.96 -48.63 57.53 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.339 1.055 . . . . 0.0 111.213 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.41 HE21 HG23 ' A' ' 88' ' ' VAL . 33.7 tt0 -54.59 -57.18 12.42 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.476 1.034 . . . . 0.0 111.555 -178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -60.51 -31.11 70.19 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.439 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.04 -61.94 1.61 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.009 0.924 . . . . 0.0 112.824 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.415 HG22 ' CD1' ' A' ' 42' ' ' ILE . 8.8 pt -70.48 -29.85 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -169.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -59.48 -35.07 73.41 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.996 0.919 . . . . 0.0 111.471 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.05 13.63 33.39 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mt -59.23 -55.99 40.63 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.909 166.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.56 171.27 18.09 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.524 2.816 . . . . 0.0 112.36 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.31 59.91 6.2 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.584 3.523 . . . . 0.0 110.975 171.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.32 35.58 92.14 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.999 1.285 . . . . 0.0 113.118 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -101.19 -41.17 6.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.685 0.742 . . . . 0.0 112.734 -169.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -115.78 117.02 29.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.611 1.164 . . . . 0.0 109.118 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -99.37 170.39 8.67 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.301 1.44 . . . . 0.0 111.337 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.41 HG23 HE21 ' A' ' 75' ' ' GLN . 32.7 m -135.26 130.28 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.064 -1.022 . . . . 0.0 110.902 173.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.9 m -103.75 117.78 35.16 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.146 0.978 . . . . 0.0 110.579 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.335 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 122.563 1.173 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 29.3 p -163.84 142.41 7.66 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.084 2.153 . . . . 0.0 110.958 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.2 t -144.98 158.41 43.82 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.311 -0.868 . . . . 0.0 111.094 172.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 98.6 m -98.53 140.52 32.64 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.86 149.64 40.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.514 1.126 . . . . 0.0 110.603 173.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 tt -115.25 136.79 52.73 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.986 1.714 . . . . 0.0 109.084 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.7 mm -119.66 138.07 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.737 2.015 . . . . 0.0 108.255 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.58 136.58 38.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.507 1.123 . . . . 0.0 108.91 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.26 139.2 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 120.729 -1.232 . . . . 0.0 110.134 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.39 57.86 1.0 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.359 2.264 . . . . 0.0 112.016 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.05 52.36 0.23 Allowed Glycine 0 N--CA 1.465 0.592 0 C-N-CA 124.435 1.017 . . . . 0.0 111.354 168.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.1 mtm -136.1 126.34 26.45 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.854 1.262 . . . . 0.0 108.788 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.2 t -144.7 -24.83 0.51 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.703 1.601 . . . . 0.0 111.457 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 96.6 m -116.01 142.54 46.66 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.552 1.941 . . . . 0.0 110.8 170.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -48.93 -32.81 9.66 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.112 1.365 . . . . 0.0 113.837 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.9 p -58.2 -22.54 52.24 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.6 t -61.87 -28.66 69.66 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.214 -0.928 . . . . 0.0 112.358 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.9 -51.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 121.627 -0.671 . . . . 0.0 110.722 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -70.13 -19.14 63.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.6 m -74.62 -56.09 5.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.376 1.07 . . . . 0.0 112.077 167.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.78 -57.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 121.123 -0.986 . . . . 0.0 111.153 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.43 -25.57 66.06 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.239 1.016 . . . . 0.0 110.912 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.49 -57.97 5.23 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.886 1.232 . . . . 0.0 113.611 174.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.2 -46.32 42.75 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.976 0.888 . . . . 0.0 113.337 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.0 mm -72.71 -24.09 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.635 0.774 . . . . 0.0 112.501 -172.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.9 p -65.6 -15.74 63.03 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.1 -10.87 43.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -168.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.99 -177.8 6.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.324 1.049 . . . . 0.0 113.253 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -93.63 127.11 39.16 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.256 1.022 . . . . 0.0 109.845 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 103.5 16.98 18.69 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 117.683 -1.621 . . . . 0.0 116.517 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.34 100.41 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 127.212 2.205 . . . . 0.0 112.475 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -78.12 -49.21 14.32 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.401 -0.812 . . . . 0.0 112.232 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -140.51 141.25 35.36 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.225 1.81 . . . . 0.0 108.669 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.5 tt -144.2 131.04 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.235 1.014 . . . . 0.0 111.545 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.38 122.65 13.88 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.691 0.797 . . . . 0.0 112.105 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.86 138.37 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.039 0.935 . . . . 0.0 111.854 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.5 t -141.55 134.56 29.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.28 1.432 . . . . 0.0 111.488 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.15 -17.96 61.32 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.81 63.61 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.338 1.455 . . . . 0.0 112.969 -173.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -113.41 -5.73 13.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.209 1.804 . . . . 0.0 111.566 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 72.08 49.76 20.45 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.554 1.55 . . . . 0.0 112.078 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.6 p -139.27 149.46 44.31 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -168.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.16 140.06 47.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.628 1.571 . . . . 0.0 110.741 169.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.8 t -116.9 127.71 54.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.58 141.42 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.544 0.738 . . . . 0.0 110.571 -171.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.96 108.74 21.52 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.242 1.817 . . . . 0.0 106.9 175.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -114.65 159.57 20.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.98 0.895 . . . . 0.0 112.767 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -97.84 113.4 63.62 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.101 0.96 . . . . 0.0 109.858 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.08 -7.1 17.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.961 2.441 . . . . 0.0 115.093 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.42 -37.17 20.11 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.717 1.144 . . . . 0.0 111.018 168.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 86.7 t -85.44 -32.46 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.461 1.104 . . . . 0.0 113.192 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.5 tt -148.96 151.72 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 120.268 1.394 . . . . 0.0 113.678 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.07 145.78 31.11 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.779 1.632 . . . . 0.0 112.456 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.67 -33.47 93.67 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.838 2.358 . . . . 0.0 115.286 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.74 -22.41 61.62 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.364 0.984 . . . . 0.0 113.135 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -72.62 -38.02 67.87 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.741 -1.224 . . . . 0.0 111.57 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 82.9 mt -55.44 -54.41 44.13 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.773 0.829 . . . . 0.0 109.908 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -51.22 -55.27 18.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.998 1.319 . . . . 0.0 111.299 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.5 -18.84 65.63 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.62 -33.33 68.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.942 1.247 . . . . 0.0 112.23 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.1 -39.72 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.396 1.078 . . . . 0.0 110.532 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.65 -31.77 72.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.241 0.616 . . . . 0.0 112.375 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.19 -5.11 39.93 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.539 1.936 . . . . 0.0 114.441 169.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.46 -47.98 5.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.126 1.37 . . . . 0.0 111.466 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 157.45 15.8 0.04 OUTLIER Glycine 0 N--CA 1.469 0.867 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -133.27 -163.46 1.35 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.987 1.394 . . . . 0.0 108.954 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.58 147.02 49.93 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.198 0.999 . . . . 0.0 109.357 169.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -138.97 160.18 40.38 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.0 t -138.36 141.67 39.68 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.485 1.914 . . . . 0.0 109.168 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.3 128.83 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.331 -0.856 . . . . 0.0 108.866 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 122.873 1.32 . . . . 0.0 108.733 -178.866 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.11 138.25 45.13 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.64 -0.663 . . . . 0.0 112.583 -173.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.56 163.72 25.38 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -109.71 133.25 53.34 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 127.819 2.448 . . . . 0.0 110.04 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -146.46 155.05 42.27 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.374 0.67 . . . . 0.0 112.327 171.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -116.98 107.51 14.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.557 0.694 . . . . 0.0 111.09 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.6 mt -88.62 143.42 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.795 2.038 . . . . 0.0 110.938 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -97.46 142.85 28.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.013 2.525 . . . . 0.0 110.137 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.95 -13.64 65.56 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.902 1.239 . . . . 0.0 114.506 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.5 ptp -62.12 -23.23 66.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.517 1.158 . . . . 0.0 113.925 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -69.51 -15.77 63.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.33 0.968 . . . . 0.0 113.599 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 87.7 m -75.49 -6.04 48.15 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 120.586 1.539 . . . . 0.0 112.18 166.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp 71.74 -52.24 0.69 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 130.415 3.486 . . . . 0.0 113.397 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -54.22 -23.28 14.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.564 1.146 . . . . 0.0 113.937 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.4 t -57.99 -47.41 83.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.359 1.864 . . . . 0.0 112.543 169.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -73.64 -24.63 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 118.555 0.616 . . . . 0.0 112.464 -173.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.6 tp -57.32 -53.9 52.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.021 0.928 . . . . 0.0 111.746 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -37.68 76.22 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.821 -0.549 . . . . 0.0 110.962 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.1 mt -66.11 -49.6 75.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.372 0.669 . . . . 0.0 110.579 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -60.25 -36.12 77.05 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.046 1.738 . . . . 0.0 112.914 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -68.31 -39.91 81.85 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.308 -0.87 . . . . 0.0 112.346 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -95.26 -37.52 10.97 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.9 mm -93.04 119.64 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 120.389 -1.445 . . . . 0.0 108.699 -168.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.07 -17.83 6.24 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.019 1.771 . . . . 0.0 112.609 -167.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -87.72 -4.03 58.93 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.257 1.028 . . . . 0.0 112.443 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.67 178.26 8.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.593 1.957 . . . . 0.0 112.028 -170.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tp -59.52 -74.94 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.384 1.874 . . . . 0.0 112.31 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.58 52.42 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 117.483 -1.732 . . . . 0.0 115.671 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.5 t -87.51 113.56 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.589 2.194 . . . . 0.0 109.451 168.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -86.39 -43.37 12.9 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.485 1.114 . . . . 0.0 111.791 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.3 t -147.86 178.03 8.84 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.436 1.095 . . . . 0.0 111.649 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.6 tp -139.74 140.78 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.907 1.683 . . . . 0.0 108.611 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -129.36 120.53 25.74 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.213 1.405 . . . . 0.0 108.083 -173.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.87 86.97 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.394 1.478 . . . . 0.0 110.627 -166.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 p -98.67 54.29 1.03 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.569 1.948 . . . . 0.0 113.03 -170.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.9 mt -61.82 -26.3 68.03 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -172.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.32 -33.96 63.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.579 1.152 . . . . 0.0 113.148 173.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -94.81 -0.29 54.26 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.795 0.838 . . . . 0.0 112.572 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? 68.06 -0.34 2.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.883 2.473 . . . . 0.0 113.167 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.0 p -99.68 167.73 10.38 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 127.577 2.351 . . . . 0.0 109.881 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.53 149.21 41.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 168.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -116.0 125.92 53.13 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.245 1.418 . . . . 0.0 108.49 -172.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.73 135.0 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.001 -1.062 . . . . 0.0 111.0 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -99.26 95.82 7.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.048 1.739 . . . . 0.0 107.822 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -122.97 -179.32 4.22 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.075 1.75 . . . . 0.0 112.989 -168.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -129.22 136.12 28.66 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 125.612 1.565 . . . . 0.0 109.978 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -84.08 15.06 2.24 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.433 2.756 . . . . 0.0 113.317 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.1 t -111.33 -35.65 5.79 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.32 1.048 . . . . 0.0 111.082 173.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.1 m -90.58 -18.64 24.86 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . 0.252 2.8 t -148.49 -175.79 5.06 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.1 0.96 . . . . 0.0 112.163 175.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.1 p -153.72 167.59 13.33 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.046 1.739 . . . . 0.0 110.91 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.39 -44.09 24.69 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.593 2.196 . . . . 0.0 113.204 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.94 -37.87 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 118.92 0.782 . . . . 0.0 112.839 172.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.56 89.13 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.666 -0.646 . . . . 0.0 112.244 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.35 -55.77 30.51 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.111 1.765 . . . . 0.0 109.838 168.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -61.28 -39.82 91.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.87 0.868 . . . . 0.0 111.644 -173.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -70.8 -36.92 73.2 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.439 1.096 . . . . 0.0 112.804 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.66 -60.4 2.27 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.782 0.719 . . . . 0.0 112.681 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 pt -70.25 -26.78 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -167.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -70.81 -15.47 62.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.4 9.52 33.67 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.999 -1.063 . . . . 0.0 113.523 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.23 -47.95 97.26 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.145 165.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -77.56 171.57 17.31 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.646 2.231 . . . . 0.0 110.429 167.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -76.54 51.61 3.35 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 124.127 3.218 . . . . 0.0 110.978 170.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.16 28.51 68.14 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 120.996 -1.065 . . . . 0.0 113.756 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -97.32 -45.42 6.49 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.967 0.884 . . . . 0.0 112.459 -172.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -97.01 102.19 13.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.243 1.017 . . . . 0.0 108.73 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -96.52 141.42 29.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.265 1.026 . . . . 0.0 111.474 -170.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 p -130.27 134.66 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -172.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.3 m -118.95 144.41 46.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.461 1.504 . . . . 0.0 111.803 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 CA--C 1.539 0.549 0 C-N-CA 126.348 1.859 . . . . 0.0 112.21 -172.127 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.2 m -138.05 127.61 24.98 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.556 1.542 . . . . 0.0 111.81 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.0 m -146.34 152.63 39.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.925 1.29 . . . . 0.0 111.531 171.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 92.5 m -109.18 140.47 42.74 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.123 0.969 . . . . 0.0 109.58 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.22 158.54 43.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 168.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.89 127.46 48.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.488 2.315 . . . . 0.0 109.469 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.8 mm -113.28 136.37 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.438 1.095 . . . . 0.0 108.827 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -101.25 122.49 43.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.771 0.714 . . . . 0.0 109.33 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.66 135.2 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.065 0.946 . . . . 0.0 110.237 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -115.02 56.3 0.74 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.985 1.714 . . . . 0.0 112.09 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.02 54.86 0.32 Allowed Glycine 0 N--CA 1.465 0.6 0 C-N-CA 124.151 0.881 . . . . 0.0 112.076 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 39.6 mtm -148.35 138.25 22.38 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.033 0.933 . . . . 0.0 110.942 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.3 t -160.34 -32.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.122 1.369 . . . . 0.0 111.841 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 93.4 m -105.48 138.8 41.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.315 1.846 . . . . 0.0 109.937 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.07 -27.32 31.87 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.601 1.16 . . . . 0.0 113.751 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.6 t -56.34 -32.19 64.45 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.202 1.001 . . . . 0.0 112.969 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.5 t -60.65 -20.75 61.65 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.53 -59.62 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.005 168.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -63.31 -22.14 66.69 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.144 1.338 . . . . 0.0 112.815 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.6 m -70.65 -60.16 2.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.243 1.017 . . . . 0.0 112.153 170.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.0 mt -69.33 -51.28 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.581 -1.324 . . . . 0.0 110.897 -174.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -58.17 -30.98 66.84 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.136 1.374 . . . . 0.0 110.896 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.06 -62.34 2.64 Favored Glycine 0 C--N 1.343 0.967 0 C-N-CA 125.657 1.598 . . . . 0.0 114.615 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -44.98 62.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.483 1.113 . . . . 0.0 113.098 -172.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.2 mm -72.99 -29.51 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.09 0.556 . . . . 0.0 112.034 -172.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.5 p -64.86 0.99 0.98 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -106.9 -9.24 16.38 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -168.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.41 11.28 31.2 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -171.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 70.2 163.87 0.26 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.277 2.631 . . . . 0.0 114.191 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.98 -39.19 1.13 Allowed Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.486 -1.384 . . . . 0.0 112.977 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.52 98.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 127.462 2.305 . . . . 0.0 111.213 169.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -86.53 -54.72 4.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.853 0.861 . . . . 0.0 112.455 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -141.52 121.4 13.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.735 1.214 . . . . 0.0 109.045 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.0 tt -133.3 128.14 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.208 1.003 . . . . 0.0 110.92 -170.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.74 155.83 44.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.642 1.177 . . . . 0.0 109.9 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.69 142.31 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.433 1.015 . . . . 0.0 111.934 -171.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 45.0 m -115.28 86.98 2.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.832 2.453 . . . . 0.0 109.16 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.27 -27.55 69.09 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.376 -1.453 . . . . 0.0 111.451 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.8 -30.79 1.77 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.303 2.641 . . . . 0.0 114.824 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -118.07 -20.75 8.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.423 1.489 . . . . 0.0 111.772 173.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.37 36.56 8.72 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.592 1.567 . . . . 0.0 111.964 -174.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.6 p -128.28 140.6 51.8 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.803 1.301 . . . . 0.0 112.798 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.94 137.79 42.17 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.538 1.135 . . . . 0.0 110.736 169.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.9 t -111.49 121.95 46.53 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.24 140.91 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -169.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.03 115.93 28.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.122 2.169 . . . . 0.0 106.599 171.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -117.47 157.52 26.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.78 1.232 . . . . 0.0 111.71 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -99.75 105.79 36.49 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.716 1.206 . . . . 0.0 110.981 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -67.44 -13.33 38.86 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.253 2.635 . . . . 0.0 114.023 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.77 -10.73 58.75 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.282 0.946 . . . . 0.0 113.127 171.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.33 -34.04 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.556 1.543 . . . . 0.0 112.08 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.5 tt -159.93 147.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.886 1.221 . . . . 0.0 112.507 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.7 t -97.02 149.9 36.22 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.606 1.162 . . . . 0.0 112.528 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -49.99 -30.42 24.35 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.907 3.738 . . . . 0.0 114.19 168.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -67.02 -33.9 76.55 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.369 0.986 . . . . 0.0 112.39 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -75.29 -35.41 61.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.228 . . . . 0.0 110.404 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.04 -58.2 9.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.676 2.39 . . . . 0.0 111.48 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.54 -38.81 78.56 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.114 0.87 . . . . 0.0 112.35 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.98 -26.53 68.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.96 -30.42 63.83 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.461 1.028 . . . . 0.0 112.53 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.16 -34.52 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.306 1.042 . . . . 0.0 110.969 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -63.91 -39.34 93.94 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.674 0.67 . . . . 0.0 111.893 172.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.65 -31.44 72.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.52 1.928 . . . . 0.0 112.942 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 21.9 ttt -69.78 -37.18 76.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.156 0.982 . . . . 0.0 111.386 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 130.96 15.43 1.71 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.494 1.521 . . . . 0.0 116.306 169.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.92 -158.08 0.65 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.426 1.613 . . . . 0.0 108.923 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -133.52 142.7 48.33 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.032 0.933 . . . . 0.0 109.885 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -137.32 137.99 39.51 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.282 1.433 . . . . 0.0 112.975 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.2 t -123.07 131.35 53.66 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.834 1.654 . . . . 0.0 111.339 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 m -85.64 71.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.266 1.026 . . . . 0.0 110.661 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.582 -176.813 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.422 HG13 ' CE1' ' A' ' 64' ' ' TYR . 11.0 p . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 p -112.56 166.56 11.21 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.613 1.965 . . . . 0.0 112.049 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.56 137.42 31.96 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.837 1.255 . . . . 0.0 111.711 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -99.15 120.1 38.95 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.961 0.886 . . . . 0.0 109.679 168.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.25 139.21 30.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.512 -1.676 . . . . 0.0 112.825 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -101.49 143.22 31.76 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.932 1.293 . . . . 0.0 109.03 171.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mm -107.32 153.14 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.763 1.625 . . . . 0.0 109.807 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -106.1 140.27 39.34 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.654 1.582 . . . . 0.0 110.652 170.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.61 3.21 88.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.879 1.228 . . . . 0.0 114.033 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.5 ptm -70.53 -3.6 18.79 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -50.8 -26.18 5.36 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.806 1.242 . . . . 0.0 114.345 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.4 p -114.04 137.74 51.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.962 1.305 . . . . 0.0 111.033 169.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -65.07 -15.7 62.65 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -50.79 -31.95 18.46 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.992 -1.068 . . . . 0.0 113.21 169.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.1 t -67.99 -57.91 5.38 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.337 1.055 . . . . 0.0 111.678 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 p -62.79 -29.62 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.407 1.003 . . . . 0.0 112.056 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.72 -61.01 2.93 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.264 1.026 . . . . 0.0 112.289 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -65.46 -31.28 72.28 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.785 -0.572 . . . . 0.0 111.821 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.01 -52.42 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 118.795 0.725 . . . . 0.0 109.48 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -38.3 90.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.567 1.147 . . . . 0.0 113.184 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -65.76 -34.95 79.36 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.332 0.653 . . . . 0.0 111.982 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -92.91 -24.41 18.44 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.435 ' CD1' HG22 ' A' ' 78' ' ' ILE . 47.2 mm -105.75 122.85 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.385 0.993 . . . . 0.0 109.669 -171.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.25 -22.81 5.28 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 125.581 1.562 . . . . 0.0 113.956 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -84.65 -0.65 54.21 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.652 1.581 . . . . 0.0 113.165 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.43 -172.33 4.11 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.779 2.032 . . . . 0.0 113.959 -171.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 tp -68.87 -82.78 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.427 2.291 . . . . 0.0 111.974 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.32 -30.32 60.78 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 120.12 1.327 . . . . 0.0 114.241 -173.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 t -84.07 127.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.044 1.422 . . . . 0.0 110.339 169.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -114.51 -23.1 9.48 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.4 t -145.63 166.08 26.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.226 0.921 . . . . 0.0 111.069 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 tp -140.71 142.31 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.417 1.087 . . . . 0.0 110.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -142.92 156.32 44.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.656 1.183 . . . . 0.0 110.579 -171.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.28 133.02 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.312 1.445 . . . . 0.0 108.348 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.3 m -122.6 52.8 1.3 Allowed 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.488 1.137 . . . . 0.0 110.086 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -19.33 64.03 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -172.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -57.77 -36.6 72.36 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.769 1.168 . . . . 0.0 111.066 168.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -97.47 -8.02 30.25 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.036 2.134 . . . . 0.0 112.484 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 70.75 15.64 6.89 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.605 2.362 . . . . 0.0 112.28 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 p -98.78 163.7 12.52 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.68 1.592 . . . . 0.0 110.621 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.18 169.09 9.63 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -139.6 114.25 9.29 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 121.043 -1.036 . . . . 0.0 111.186 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.58 133.2 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 121.529 0.68 . . . . 0.0 111.847 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -109.74 99.17 8.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.267 1.427 . . . . 0.0 108.784 -169.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.422 ' CE1' HG13 ' A' ' 20' ' ' VAL . 17.3 p90 -131.45 -178.87 5.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.821 1.248 . . . . 0.0 112.25 -168.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.99 140.05 33.84 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.509 1.124 . . . . 0.0 108.258 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.06 11.41 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.029 2.486 . . . . 0.0 112.826 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.4 p -92.21 -19.04 22.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.889 1.276 . . . . 0.0 113.481 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 72.6 m -126.82 -20.43 4.26 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.703 1.601 . . . . 0.0 114.457 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.1 t -145.07 -177.86 5.75 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.16 1.784 . . . . 0.0 111.338 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -160.62 156.6 22.46 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.487 1.515 . . . . 0.0 112.95 174.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -43.64 -45.38 10.82 Favored 'Trans proline' 0 C--N 1.352 0.756 1 C-N-CA 126.425 4.75 . . . . 0.0 117.974 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.6 m -64.78 -37.67 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 119.825 1.193 . . . . 0.0 112.537 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.67 -40.28 69.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.705 0.802 . . . . 0.0 111.058 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.38 -47.64 84.91 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.758 1.223 . . . . 0.0 112.011 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.455 HE21 ' HB ' ' A' ' 88' ' ' VAL . 35.8 tt0 -53.05 -54.54 33.91 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.79 0.723 . . . . 0.0 109.775 175.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -61.89 -33.74 74.76 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.202 1.001 . . . . 0.0 113.349 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.02 -56.99 5.53 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.056 0.943 . . . . 0.0 111.847 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.435 HG22 ' CD1' ' A' ' 42' ' ' ILE . 10.1 pt -72.56 -27.09 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.86 -28.55 67.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.9 6.49 41.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.7 mt -53.92 -52.51 67.28 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 117.392 -1.29 . . . . 0.0 112.187 169.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.41 163.44 36.56 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.241 2.627 . . . . 0.0 112.717 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -81.42 50.99 3.71 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.852 3.702 . . . . 0.0 111.302 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.19 53.68 5.55 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.328 0.966 . . . . 0.0 112.103 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -132.82 -45.08 0.87 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -171.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -101.64 134.77 44.25 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.667 0.787 . . . . 0.0 109.32 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -111.74 152.32 27.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.786 1.634 . . . . 0.0 110.171 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.455 ' HB ' HE21 ' A' ' 75' ' ' GLN . 2.1 t -101.52 138.11 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.675 1.125 . . . . 0.0 109.608 168.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -110.2 113.12 25.55 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.224 1.01 . . . . 0.0 108.811 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 126.373 1.869 . . . . 0.0 109.939 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 8.5 p -137.9 126.13 23.08 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.446 1.898 . . . . 0.0 113.473 -169.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.7 t -141.02 154.83 46.19 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.877 1.671 . . . . 0.0 110.424 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.4 m -111.35 137.72 48.75 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.786 0.721 . . . . 0.0 110.397 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.5 163.53 30.92 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.391 1.076 . . . . 0.0 112.068 169.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -109.8 128.06 55.06 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.511 1.924 . . . . 0.0 110.366 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.2 mm -112.28 144.54 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.227 1.011 . . . . 0.0 109.694 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.63 122.82 47.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.709 1.604 . . . . 0.0 109.71 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.52 140.87 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.049 -1.657 . . . . 0.0 111.896 -167.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.34 66.63 1.45 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.32 1.448 . . . . 0.0 114.065 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -172.88 49.89 0.17 Allowed Glycine 0 N--CA 1.466 0.659 0 CA-C-O 118.921 -0.933 . . . . 0.0 114.09 166.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 74.0 mtm -110.86 -57.08 2.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 117.498 -1.239 . . . . 0.0 113.768 -171.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.0 t 55.32 -26.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 130.339 3.456 . . . . 0.0 118.273 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 36.0 t -131.73 139.94 49.12 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.543 1.537 . . . . 0.0 111.718 -170.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.01 -35.26 69.04 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.747 -0.596 . . . . 0.0 111.671 171.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.4 m -64.03 -31.79 73.1 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.789 -1.195 . . . . 0.0 112.105 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 26.2 t -70.59 -39.76 73.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.911 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.63 -54.52 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 119.63 1.105 . . . . 0.0 110.094 170.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -58.54 -34.71 71.3 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.029 0.377 . . . . 0.0 111.582 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.2 m -71.0 -43.35 68.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.048 0.939 . . . . 0.0 113.078 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 84.9 mt -64.49 -51.12 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.788 1.176 . . . . 0.0 109.714 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -53.14 -37.66 62.03 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.497 1.519 . . . . 0.0 111.164 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.1 -58.42 4.36 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.001 1.286 . . . . 0.0 113.467 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.0 mtp -67.91 -46.81 70.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.657 1.583 . . . . 0.0 113.677 -170.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 35.5 mm -66.58 -36.94 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 118.124 0.42 . . . . 0.0 110.066 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 t -56.67 -9.34 0.74 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -89.02 -8.49 53.93 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.475 -1.391 . . . . 0.0 113.755 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -107.82 177.3 4.86 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.276 1.398 . . . . 0.0 114.158 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -56.5 152.41 11.73 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.698 1.599 . . . . 0.0 115.314 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.21 -30.3 0.32 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.351 1.453 . . . . 0.0 116.676 169.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.3 p -78.91 92.86 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.463 1.632 . . . . 0.0 111.008 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -79.56 -40.02 30.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.872 1.669 . . . . 0.0 111.916 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -144.99 144.81 31.23 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.011 0.925 . . . . 0.0 109.478 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.5 tt -140.36 138.37 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 121.255 -0.903 . . . . 0.0 111.55 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t -139.18 136.31 34.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.78 1.632 . . . . 0.0 109.157 171.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.22 148.93 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.827 1.251 . . . . 0.0 111.396 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.8 t -142.62 148.52 37.6 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.43 -22.67 61.82 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.633 1.173 . . . . 0.0 113.707 172.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -50.86 -41.58 58.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.006 1.322 . . . . 0.0 112.372 -169.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -127.38 -1.96 6.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.007 1.323 . . . . 0.0 111.906 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.06 42.26 37.25 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 125.487 1.518 . . . . 0.0 111.981 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.5 p -130.93 146.07 52.22 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.404 1.102 . . . . 0.0 113.053 -168.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -118.84 119.69 35.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.757 1.623 . . . . 0.0 112.037 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 t -99.32 112.26 24.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.962 1.305 . . . . 0.0 107.8 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 139.11 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.588 0.755 . . . . 0.0 110.885 -168.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.95 107.96 20.29 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.97 2.108 . . . . 0.0 107.117 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -113.17 162.9 15.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.147 1.379 . . . . 0.0 111.762 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -94.79 112.16 57.03 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.846 0.859 . . . . 0.0 108.941 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.51 -10.54 17.32 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.035 2.49 . . . . 0.0 113.051 -173.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.4 -32.9 25.91 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.259 0.936 . . . . 0.0 112.618 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.68 -46.97 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.865 1.266 . . . . 0.0 113.448 -173.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.5 tt -124.75 149.41 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 120.384 1.447 . . . . 0.0 112.094 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.9 t -96.99 146.96 32.2 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.203 1.401 . . . . 0.0 112.833 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.33 -26.12 42.17 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.09 2.527 . . . . 0.0 113.49 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -68.23 -35.66 78.29 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.526 -0.734 . . . . 0.0 112.548 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.46 -31.83 67.62 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.148 0.979 . . . . 0.0 111.643 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.04 -57.65 11.61 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.198 0.999 . . . . 0.0 110.035 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -61.23 -41.67 97.28 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.779 -0.575 . . . . 0.0 112.307 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.44 -34.08 70.42 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.15 -34.73 71.27 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -73.56 -39.44 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.281 1.033 . . . . 0.0 111.579 171.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -62.92 -32.25 73.5 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.182 -0.949 . . . . 0.0 111.641 172.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.93 -13.9 60.97 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.713 2.405 . . . . 0.0 114.503 169.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 14.7 ttt -83.62 -20.95 32.77 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.986 -1.071 . . . . 0.0 112.148 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 111.82 19.03 7.53 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.949 1.737 . . . . 0.0 114.934 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -115.09 -159.06 0.69 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.215 1.406 . . . . 0.0 109.878 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.77 140.32 51.09 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 124.554 1.142 . . . . 0.0 109.555 170.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.01 147.71 42.47 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.126 1.37 . . . . 0.0 112.348 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.1 t -142.74 140.49 31.48 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.174 1.789 . . . . 0.0 109.011 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.2 p -90.49 130.56 39.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.327 0.584 . . . . 0.0 110.811 -171.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 166.743 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 121.058 0.456 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -109.26 134.86 51.24 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.195 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.02 133.04 43.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.152 1.381 . . . . 0.0 110.724 -174.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -96.19 137.59 35.04 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.148 1.779 . . . . 0.0 111.576 -171.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.73 152.18 39.99 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 173.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -100.11 113.91 26.88 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.498 1.119 . . . . 0.0 109.683 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 mt -88.46 140.81 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.714 1.205 . . . . 0.0 109.973 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -99.11 141.26 32.1 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.46 1.504 . . . . 0.0 111.341 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.14 -13.09 65.13 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.511 1.529 . . . . 0.0 113.809 -176.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.7 ptp -63.85 -14.63 54.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -60.06 -24.4 64.55 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.45 1.477 . . . . 0.0 112.384 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 59.2 m -78.4 -4.66 49.37 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.929 0.892 . . . . 0.0 113.372 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.55 -56.37 0.51 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.649 3.18 . . . . 0.0 113.224 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m -55.11 -25.16 29.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.64 1.176 . . . . 0.0 113.246 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.4 -50.12 70.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.003 1.721 . . . . 0.0 112.361 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -77.14 -30.71 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 36' ' ' LEU . 5.0 tt -52.73 -57.19 10.93 Favored 'General case' 0 C--N 1.345 0.391 0 C-N-CA 124.309 1.043 . . . . 0.0 110.916 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -60.02 -45.25 93.41 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 118.591 -0.719 . . . . 0.0 109.866 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.81 -36.68 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.919 1.236 . . . . 0.0 111.133 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.98 -22.26 64.11 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.978 0.911 . . . . 0.0 112.317 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -71.9 -52.96 14.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.78 1.232 . . . . 0.0 113.024 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -93.82 -17.39 23.14 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -167.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.49 ' CD1' HG22 ' A' ' 78' ' ' ILE . 23.9 mm -96.23 133.03 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 119.813 1.188 . . . . 0.0 108.042 173.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.08 -5.7 10.31 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 125.317 1.437 . . . . 0.0 114.749 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -126.68 17.02 7.49 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.2 1.8 . . . . 0.0 112.329 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.14 156.63 18.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.864 1.266 . . . . 0.0 109.971 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.4 tp -21.96 -64.56 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.534 2.734 . . . . 0.0 114.714 173.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.86 -15.92 20.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 116.527 -2.263 . . . . 0.0 116.011 175.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.6 t -82.64 124.0 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 122.588 3.194 . . . . 0.0 111.123 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.45 -31.9 11.41 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 172.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.6 t -148.62 163.58 36.83 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.063 -1.023 . . . . 0.0 112.705 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 tp -132.6 130.64 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.58 1.952 . . . . 0.0 106.445 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -129.91 161.73 30.18 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 172.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.47 164.62 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 120.954 -1.091 . . . . 0.0 112.84 -172.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 t -140.57 70.85 1.36 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 123.264 1.507 . . . . 0.0 109.37 170.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.9 mt -61.52 -21.57 64.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.642 1.177 . . . . 0.0 112.814 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.01 -30.82 48.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.694 1.197 . . . . 0.0 113.818 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -108.9 -7.95 15.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.469 1.908 . . . . 0.0 112.53 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mttm 77.05 15.96 1.8 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 127.576 2.351 . . . . 0.0 112.743 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.15 150.15 21.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.6 1.191 . . . . 0.0 110.806 177.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.82 151.06 40.08 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.415 1.886 . . . . 0.0 107.172 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -137.56 124.14 20.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.472 1.033 . . . . 0.0 113.446 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.8 p -97.12 136.12 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.52 1.128 . . . . 0.0 110.615 -170.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -110.67 102.4 10.96 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.625 1.57 . . . . 0.0 108.221 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -135.38 160.01 39.79 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -168.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -93.59 113.41 60.2 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 126.065 1.746 . . . . 0.0 108.218 173.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.33 -3.7 12.92 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.025 2.483 . . . . 0.0 112.761 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.4 p -81.75 -11.8 58.86 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.703 1.601 . . . . 0.0 112.388 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 37.3 m -121.74 -33.03 3.67 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.778 1.231 . . . . 0.0 113.044 -173.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.4 t -145.06 -179.36 6.57 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.886 1.675 . . . . 0.0 111.32 -174.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.9 p -160.8 155.19 19.71 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.457 1.103 . . . . 0.0 112.821 -170.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.9 -49.16 15.78 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.14 3.226 . . . . 0.0 116.668 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -70.22 -33.51 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 120.332 1.424 . . . . 0.0 112.638 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.66 81.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.481 0.712 . . . . 0.0 111.099 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.16 -46.89 75.81 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.321 1.448 . . . . 0.0 112.342 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.582 HE21 HG23 ' A' ' 88' ' ' VAL . 12.3 tt0 -53.58 -52.26 60.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.401 1.0 . . . . 0.0 109.778 175.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -65.65 -24.94 67.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.776 1.23 . . . . 0.0 113.676 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.39 -60.67 2.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.315 0.961 . . . . 0.0 112.581 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.49 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.0 pt -74.02 -29.71 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -167.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -71.28 -23.56 61.99 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.496 1.044 . . . . 0.0 113.705 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.16 17.8 9.05 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.001 -1.062 . . . . 0.0 113.675 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.75 -58.74 15.16 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 117.715 -1.136 . . . . 0.0 109.955 166.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -69.82 168.15 22.45 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.498 2.798 . . . . 0.0 112.337 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.4 42.16 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.459 3.439 . . . . 0.0 112.434 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.99 63.83 2.34 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -169.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -148.74 -16.71 0.31 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 -169.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -124.43 130.6 52.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 169.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -110.4 142.48 42.04 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.867 1.267 . . . . 0.0 111.766 -173.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.582 HG23 HE21 ' A' ' 75' ' ' GLN . 13.6 m -117.56 134.5 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 120.084 1.311 . . . . 0.0 111.178 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.0 m -128.97 120.93 26.94 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.916 0.865 . . . . 0.0 111.975 176.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.033 0 C-N-CA 127.727 2.411 . . . . 0.0 112.202 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 58.2 m 48.41 82.11 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.038 2.135 . . . . 0.0 115.715 168.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.3 p -133.13 143.8 49.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.596 1.959 . . . . 0.0 112.929 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.6 m -98.1 129.46 44.92 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.015 0.825 . . . . 0.0 111.18 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.63 164.6 21.68 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.608 0.763 . . . . 0.0 111.162 169.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.16 132.13 54.55 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.251 1.421 . . . . 0.0 109.982 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.0 mm -117.91 137.99 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.067 1.747 . . . . 0.0 109.014 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.6 125.46 49.33 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.527 1.531 . . . . 0.0 109.215 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.1 mt -126.21 127.15 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 120.393 -1.442 . . . . 0.0 111.241 -170.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.07 74.21 1.03 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.796 2.039 . . . . 0.0 112.609 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -179.12 52.89 0.09 OUTLIER Glycine 0 N--CA 1.466 0.677 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.938 165.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 65.4 mtm -137.54 91.85 2.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.47 0.708 . . . . 0.0 109.826 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.5 t -94.57 -29.19 15.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.672 1.189 . . . . 0.0 113.191 -173.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 91.6 m -125.11 154.56 41.23 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.514 1.526 . . . . 0.0 110.112 175.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.15 65.69 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.3 p -54.91 -24.32 22.99 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.079 -1.013 . . . . 0.0 113.615 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 95.2 m -57.13 -29.27 63.43 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.693 -1.254 . . . . 0.0 112.592 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.22 -49.88 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.612 0.765 . . . . 0.0 110.523 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.14 -21.05 66.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.255 0.934 . . . . 0.0 113.228 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 t -74.1 -62.11 1.62 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.453 0.701 . . . . 0.0 111.304 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 47.4 mt -70.78 -48.54 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.83 -1.169 . . . . 0.0 111.494 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.19 -26.15 68.67 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.223 0.609 . . . . 0.0 111.711 176.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.35 -59.77 4.05 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.531 1.062 . . . . 0.0 112.178 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 92.7 mmm -71.57 -39.5 70.57 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.923 1.689 . . . . 0.0 114.208 -172.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.3 mm -70.96 -32.45 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.366 -0.834 . . . . 0.0 111.084 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.7 t -65.36 0.55 1.42 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -96.35 -11.24 26.09 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.479 -1.388 . . . . 0.0 114.589 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 pp -93.07 166.04 12.55 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.485 1.514 . . . . 0.0 111.429 174.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.18 138.23 31.69 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.449 -0.782 . . . . 0.0 112.537 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 101.16 15.6 27.66 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.556 1.55 . . . . 0.0 115.029 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.8 94.43 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.705 2.002 . . . . 0.0 110.502 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -68.0 -56.98 6.94 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.165 0.986 . . . . 0.0 111.02 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -140.0 131.44 26.92 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.475 1.11 . . . . 0.0 109.147 -171.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -136.47 131.33 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.865 0.866 . . . . 0.0 110.452 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.1 t -138.25 138.77 38.79 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.239 1.816 . . . . 0.0 108.686 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.5 p -143.45 145.55 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.962 1.305 . . . . 0.0 111.73 -175.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 t -135.19 135.38 40.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -172.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.93 -18.91 64.7 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.058 2.143 . . . . 0.0 113.959 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.19 78.98 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.545 1.138 . . . . 0.0 113.114 -176.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -130.87 -8.05 3.97 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.419 1.488 . . . . 0.0 112.336 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.6 41.3 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.595 1.093 . . . . 0.0 111.502 -171.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 71.3 p -130.17 145.86 51.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.513 1.156 . . . . 0.0 113.559 -168.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -115.06 141.19 48.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.915 1.686 . . . . 0.0 112.459 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.1 t -110.39 124.19 51.26 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 167.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.27 136.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.828 -0.545 . . . . 0.0 111.366 -171.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.15 101.86 13.63 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.932 2.093 . . . . 0.0 106.485 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -104.18 164.2 11.88 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.597 1.159 . . . . 0.0 112.629 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -107.02 93.34 8.96 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.089 1.356 . . . . 0.0 110.849 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.19 -19.19 50.93 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.586 2.857 . . . . 0.0 112.26 -172.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.15 -15.87 63.01 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.77 -38.5 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 126.463 1.905 . . . . 0.0 113.422 -168.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.7 tt -141.93 151.71 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.878 1.271 . . . . 0.0 111.53 -171.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.9 t -101.07 143.38 26.48 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 170.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.37 -26.49 27.95 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.784 2.989 . . . . 0.0 113.935 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -70.49 -40.65 73.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.462 0.705 . . . . 0.0 111.551 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -78.23 -24.29 47.06 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 168.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.23 -50.8 72.61 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.955 1.302 . . . . 0.0 109.325 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -50.62 -46.63 58.29 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.371 1.468 . . . . 0.0 111.433 168.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.07 -21.35 66.49 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.58 65.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.449 1.022 . . . . 0.0 112.367 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.2 mp -74.27 -40.43 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.216 1.007 . . . . 0.0 111.158 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -65.71 -27.58 68.43 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.996 0.816 . . . . 0.0 112.846 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.24 -42.53 68.75 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.0 1.32 . . . . 0.0 112.362 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.1 tpt -61.23 -31.96 71.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.071 0.851 . . . . 0.0 111.434 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 109.0 44.16 1.13 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 126.584 2.04 . . . . 0.0 113.187 172.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -124.24 -159.73 0.89 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.92 149.6 47.43 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.692 -1.255 . . . . 0.0 109.212 168.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.55 155.0 44.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.502 1.144 . . . . 0.0 113.542 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.9 t -142.62 138.27 30.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.379 1.872 . . . . 0.0 108.99 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.3 m -88.11 128.68 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 121.47 -0.769 . . . . 0.0 109.108 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . 0.288 2.7 p . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 124.698 2.19 . . . . 0.0 107.675 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.41 150.95 22.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.317 2.247 . . . . 0.0 111.86 176.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 tt -146.24 143.65 29.35 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.264 2.226 . . . . 0.0 112.135 -169.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -95.2 121.76 37.18 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.387 1.089 . . . . 0.0 110.454 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -130.69 127.45 38.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.118 -1.401 . . . . 0.0 113.296 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -106.84 110.27 22.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.058 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 mm -77.15 157.37 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.236 1.014 . . . . 0.0 109.935 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -135.54 147.63 48.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.542 1.137 . . . . 0.0 110.959 168.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 11.24 84.72 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.63 1.109 . . . . 0.0 113.353 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.4 ptm -68.01 -33.07 73.92 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.993 1.396 . . . . 0.0 113.912 -169.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 69.08 -51.77 0.59 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.693 2.397 . . . . 0.0 112.474 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 31.0 p -173.37 -173.74 0.93 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.829 2.052 . . . . 0.0 112.388 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -46.44 -33.41 3.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.941 1.697 . . . . 0.0 113.503 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.5 m -53.25 -30.05 36.12 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.553 1.07 . . . . 0.0 113.703 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.5 t -64.46 -42.07 96.15 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.965 -1.084 . . . . 0.0 113.817 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.269 4.8 p -73.62 -6.31 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.34 -59.09 5.17 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.186 1.357 . . . . 0.0 111.712 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -61.33 -31.66 71.52 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.263 0.938 . . . . 0.0 111.989 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.1 mt -59.44 -56.5 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.33 -35.48 73.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.034 1.733 . . . . 0.0 114.424 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.01 -41.01 97.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.305 1.042 . . . . 0.0 111.534 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -96.35 -33.65 11.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.441 ' CD1' HG22 ' A' ' 78' ' ' ILE . 38.2 mm -107.09 111.92 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.616 1.166 . . . . 0.0 110.346 -167.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.08 -18.64 6.97 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.497 1.523 . . . . 0.0 113.877 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -85.53 -6.01 59.23 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.5 -1.0 . . . . 0.0 112.542 169.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.8 mt -79.49 -179.13 6.65 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.9 2.08 . . . . 0.0 113.538 -170.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.81 -77.97 0.06 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.306 2.243 . . . . 0.0 111.806 170.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.5 -36.47 58.96 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.589 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -92.51 118.59 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.246 1.523 . . . . 0.0 110.249 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -101.7 -24.62 14.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.742 0.817 . . . . 0.0 113.179 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.8 m -149.97 156.06 41.06 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.587 -1.32 . . . . 0.0 113.661 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 tp -125.94 147.06 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.011 1.324 . . . . 0.0 109.914 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -142.8 166.92 23.32 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.356 1.862 . . . . 0.0 108.471 -172.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -139.38 160.52 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 119.687 -1.883 . . . . 0.0 113.365 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.0 t -140.95 56.61 1.56 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.39 1.876 . . . . 0.0 108.244 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.7 mt -61.52 -33.99 74.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -168.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.17 -17.11 64.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.162 1.346 . . . . 0.0 113.388 172.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -104.02 -1.4 27.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.657 1.583 . . . . 0.0 111.807 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 70.12 9.57 7.09 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.27 2.628 . . . . 0.0 113.586 173.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.51 152.79 18.64 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.701 2.001 . . . . 0.0 109.325 176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.46 171.7 7.26 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.012 1.325 . . . . 0.0 107.551 165.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -141.92 137.79 31.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.915 0.486 . . . . 0.0 110.367 -169.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.35 132.65 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 118.795 0.725 . . . . 0.0 112.059 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -105.36 94.2 5.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.727 2.011 . . . . 0.0 107.702 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -131.23 162.73 29.34 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -168.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -97.57 114.12 64.43 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 128.106 2.562 . . . . 0.0 110.919 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.29 25.24 0.53 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.564 2.843 . . . . 0.0 113.617 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.8 t -117.82 -26.36 6.53 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.369 -1.457 . . . . 0.0 112.8 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.6 m -93.66 -29.01 15.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.128 0.971 . . . . 0.0 113.524 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -144.6 -179.07 6.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.97 1.708 . . . . 0.0 112.223 -171.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.6 p -157.81 163.0 26.09 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.133 1.373 . . . . 0.0 112.47 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -51.21 -50.68 13.14 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 124.771 3.647 . . . . 0.0 115.82 -171.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.28 -37.23 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 119.216 0.916 . . . . 0.0 112.59 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.57 79.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.257 0.623 . . . . 0.0 110.855 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.7 mt -64.37 -45.06 89.34 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.571 0.748 . . . . 0.0 112.142 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -52.06 -55.82 18.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.879 0.872 . . . . 0.0 110.545 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -70.21 -22.56 62.91 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.01 -56.47 6.09 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.316 0.962 . . . . 0.0 112.273 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.441 HG22 ' CD1' ' A' ' 42' ' ' ILE . 9.6 pt -71.54 -31.4 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -172.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -60.71 -30.23 69.83 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.29 13.79 26.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.6 mt -62.41 -49.27 84.54 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 117.305 -1.331 . . . . 0.0 112.662 167.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.61 172.07 16.43 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.707 2.938 . . . . 0.0 112.997 174.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.94 63.0 6.73 Favored 'Trans proline' 0 CA--C 1.541 0.847 1 C-N-CA 125.462 4.108 . . . . 0.0 111.109 173.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.87 32.5 82.15 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.011 1.291 . . . . 0.0 112.986 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -105.49 -48.17 3.74 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -166.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -95.6 128.53 42.54 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.01 157.56 15.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.51 1.524 . . . . 0.0 109.384 173.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.24 136.85 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 119.533 1.06 . . . . 0.0 111.636 170.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.3 m -124.36 140.37 53.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.686 1.595 . . . . 0.0 112.919 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.615 0 C-N-CA 126.462 1.905 . . . . 0.0 111.556 -163.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 5.7 m -144.03 138.8 28.61 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 p -142.35 154.82 44.98 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 127.44 2.296 . . . . 0.0 110.266 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 54.5 m -101.64 145.39 29.14 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.554 -0.716 . . . . 0.0 109.978 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.16 150.88 38.75 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.201 1.001 . . . . 0.0 111.058 172.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.76 137.96 50.3 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.583 1.553 . . . . 0.0 109.054 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.3 mm -119.12 137.29 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.554 1.942 . . . . 0.0 108.525 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -100.33 128.05 46.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.109 1.363 . . . . 0.0 109.288 170.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.02 136.21 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 120.702 -1.249 . . . . 0.0 110.909 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.68 61.7 1.23 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.965 1.706 . . . . 0.0 111.755 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.31 56.23 0.19 Allowed Glycine 0 N--CA 1.463 0.459 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.721 169.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.9 mtm -138.74 74.9 1.49 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.205 1.002 . . . . 0.0 110.499 -177.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.2 t -79.84 -19.99 47.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.72 1.208 . . . . 0.0 112.513 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 95.0 m -128.23 153.02 47.39 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.454 1.901 . . . . 0.0 111.06 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.77 -24.46 61.76 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.361 -0.837 . . . . 0.0 112.848 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.6 p -51.11 -37.36 45.49 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.987 -1.071 . . . . 0.0 111.97 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.4 m -54.15 -36.32 63.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.779 1.632 . . . . 0.0 113.336 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 t -59.85 -56.3 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -69.34 -17.61 63.72 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 m -72.52 -54.84 8.08 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.617 1.167 . . . . 0.0 111.788 167.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.81 -58.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.778 0.831 . . . . 0.0 110.198 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -57.32 -28.63 63.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.997 2.119 . . . . 0.0 112.014 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.62 -56.96 4.76 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 125.842 1.687 . . . . 0.0 114.239 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 13.1 mmt -71.29 -45.79 62.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.909 0.884 . . . . 0.0 112.093 -172.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.7 -39.68 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -169.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -2.25 2.7 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.96 -16.65 27.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.041 1.336 . . . . 0.0 113.814 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -95.75 162.55 13.55 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.908 1.231 . . . . 0.0 111.844 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -77.1 166.37 23.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.279 1.038 . . . . 0.0 113.596 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.9 -41.84 1.77 Allowed Glycine 0 CA--C 1.531 1.077 0 O-C-N 120.822 -1.174 . . . . 0.0 114.069 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 p -78.14 97.44 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.135 1.468 . . . . 0.0 111.394 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -68.87 -52.24 31.85 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.304 1.441 . . . . 0.0 111.545 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -143.52 144.68 32.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.868 0.867 . . . . 0.0 109.94 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.9 tt -135.93 140.17 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.14 0.976 . . . . 0.0 110.077 172.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 42.0 t -138.95 136.44 35.42 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.641 1.576 . . . . 0.0 109.946 175.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.5 p -143.79 147.39 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 119.665 1.12 . . . . 0.0 112.394 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.1 t -143.45 151.37 40.26 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.838 1.255 . . . . 0.0 112.658 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.6 mt -72.85 -29.3 63.1 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -46.21 -38.85 8.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.816 2.047 . . . . 0.0 115.303 -168.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -125.0 -1.14 7.82 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.194 1.798 . . . . 0.0 111.383 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 68.28 50.95 35.43 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 128.228 2.823 . . . . 0.0 112.019 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.8 p -141.66 145.12 34.56 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -114.99 144.87 42.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.043 1.737 . . . . 0.0 111.506 171.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.3 t -120.98 127.69 52.03 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.792 1.237 . . . . 0.0 108.208 168.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.26 140.18 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.024 0.93 . . . . 0.0 111.461 -167.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.34 116.25 30.17 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.431 2.292 . . . . 0.0 107.774 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -136.7 158.77 43.67 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -96.93 116.57 66.11 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.35 1.46 . . . . 0.0 110.606 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -82.25 -0.43 10.23 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.956 3.104 . . . . 0.0 114.121 -173.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.05 -37.48 12.14 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.678 1.191 . . . . 0.0 112.311 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 82.0 t -89.87 -31.69 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 126.668 1.987 . . . . 0.0 112.436 -176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.426 ' CG1' ' H ' ' A' ' 172' ' ' SER . 14.6 tt -138.2 -178.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.522 1.129 . . . . 0.0 110.773 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . 0.426 ' H ' ' CG1' ' A' ' 171' ' ' ILE . 21.6 t -140.6 148.2 52.2 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 126.497 1.919 . . . . 0.0 110.23 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.57 -27.12 31.49 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.684 2.256 . . . . 0.0 113.664 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.51 -31.53 69.83 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.982 0.81 . . . . 0.0 111.385 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.03 -36.52 64.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.971 1.709 . . . . 0.0 111.615 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.6 mt -58.04 -57.14 14.15 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.049 0.939 . . . . 0.0 109.743 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -38.9 93.0 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 177.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.91 -30.44 67.82 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.97 0.804 . . . . 0.0 113.034 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.57 -31.9 69.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.367 0.985 . . . . 0.0 112.45 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.07 -35.67 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.979 0.912 . . . . 0.0 111.256 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.38 -29.11 65.68 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.866 0.757 . . . . 0.0 112.895 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.51 -29.61 63.77 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.643 1.177 . . . . 0.0 113.078 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 53.4 ttm -69.63 -48.84 58.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.848 0.859 . . . . 0.0 110.257 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 134.76 43.46 0.12 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.051 1.31 . . . . 0.0 114.882 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -140.8 -155.67 0.61 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.467 1.507 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -133.07 143.83 49.59 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.511 1.124 . . . . 0.0 111.368 172.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -141.5 145.0 34.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.756 1.222 . . . . 0.0 112.337 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.4 t -133.23 141.2 47.92 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.41 1.484 . . . . 0.0 109.95 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.9 m -82.48 132.23 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 O-C-N 122.042 -0.411 . . . . 0.0 111.2 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . 0.264 5.0 p . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 124.673 2.177 . . . . 0.0 107.212 169.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.4 m -126.97 134.84 50.3 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 123.357 0.663 . . . . 0.0 110.909 -168.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.56 166.75 23.87 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 115.591 1.701 . . . . 0.0 115.591 175.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -120.45 128.17 52.91 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.088 2.155 . . . . 0.0 110.938 -169.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.05 138.35 29.87 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.74 109.91 22.58 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -177.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 mt -83.25 134.21 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.254 1.422 . . . . 0.0 109.293 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -101.69 127.45 48.43 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.371 1.468 . . . . 0.0 110.882 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.4 -5.76 38.47 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.192 1.377 . . . . 0.0 113.626 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.6 ptp -61.15 -10.41 6.4 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -53.35 -12.99 0.48 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.216 1.407 . . . . 0.0 113.623 167.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.2 t -119.41 127.88 53.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.409 1.884 . . . . 0.0 108.893 167.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -58.24 -31.68 67.62 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.941 -1.099 . . . . 0.0 113.343 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 m -50.32 -30.65 12.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.719 1.207 . . . . 0.0 113.617 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.0 t -63.48 -58.19 7.8 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.546 1.138 . . . . 0.0 111.759 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 p -70.01 -25.35 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.231 0.923 . . . . 0.0 111.82 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.33 -61.34 2.7 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.041 0.936 . . . . 0.0 111.885 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -62.88 -32.5 73.77 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.969 -0.457 . . . . 0.0 111.673 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.05 -50.37 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.751 0.705 . . . . 0.0 110.32 172.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.66 -31.84 73.14 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.949 1.3 . . . . 0.0 112.528 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -70.18 -46.94 63.6 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.256 -0.902 . . . . 0.0 112.067 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -91.46 -13.13 32.8 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -170.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.564 ' CD1' HG22 ' A' ' 78' ' ' ILE . 44.9 mm -105.16 121.79 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.924 1.238 . . . . 0.0 111.421 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.98 -19.77 7.74 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.899 1.714 . . . . 0.0 114.185 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -77.35 -3.19 38.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.767 1.227 . . . . 0.0 112.599 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.7 mt -84.52 -175.76 5.93 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.88 2.872 . . . . 0.0 111.966 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.9 tp -85.82 -79.85 0.24 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.066 1.746 . . . . 0.0 111.256 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.54 -30.98 65.9 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 117.857 -1.524 . . . . 0.0 113.576 -171.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.38 117.39 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 119.173 1.486 . . . . 0.0 107.734 167.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -108.09 -36.46 6.32 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -170.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -147.62 168.12 22.82 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.31 1.044 . . . . 0.0 111.229 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.5 tp -140.68 141.65 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.546 1.138 . . . . 0.0 110.085 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -137.24 155.4 49.54 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.954 2.102 . . . . 0.0 107.47 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.4 m -123.66 145.63 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.627 -1.921 . . . . 0.0 110.914 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m -128.15 54.45 1.73 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.574 1.15 . . . . 0.0 108.135 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.13 -30.04 71.13 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.685 1.594 . . . . 0.0 112.365 -171.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.68 -37.41 63.19 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.4 0.68 . . . . 0.0 111.994 170.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -102.51 2.53 36.44 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.608 1.563 . . . . 0.0 112.925 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? 68.18 12.38 8.74 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.149 2.579 . . . . 0.0 114.209 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.1 p -99.92 162.75 12.79 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.723 1.249 . . . . 0.0 110.273 169.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.1 161.93 14.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 165.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.458 HE21 ' HA ' ' A' ' 61' ' ' GLN . 2.3 tp60 -137.08 127.15 26.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -169.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.16 140.48 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.444 -1.41 . . . . 0.0 111.915 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.36 108.85 21.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.067 1.347 . . . . 0.0 108.601 173.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -131.09 178.64 6.54 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.132 1.373 . . . . 0.0 110.26 -175.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -124.44 134.49 25.58 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.53 1.132 . . . . 0.0 109.445 170.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.49 20.06 0.8 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.215 3.277 . . . . 0.0 114.307 -169.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 p -121.96 -51.76 2.0 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.813 2.045 . . . . 0.0 110.586 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 90.2 m -77.46 -25.32 50.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.562 1.545 . . . . 0.0 114.463 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 t -145.28 -177.36 5.51 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.42 1.888 . . . . 0.0 109.318 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.7 p -149.57 162.17 29.37 Favored Pre-proline 0 C--N 1.321 -0.674 0 C-N-CA 125.211 1.404 . . . . 0.0 110.155 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.19 -56.37 3.11 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.42 2.747 . . . . 0.0 113.05 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.25 -35.64 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.42 -52.68 12.86 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.378 0.671 . . . . 0.0 111.606 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -37.47 82.97 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.212 1.405 . . . . 0.0 111.071 -177.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.9 -57.86 10.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.523 1.129 . . . . 0.0 111.539 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -63.29 -32.16 73.5 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.49 -52.71 64.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.299 0.64 . . . . 0.0 110.659 174.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.564 HG22 ' CD1' ' A' ' 42' ' ' ILE . 4.8 pt -73.41 -31.37 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -70.17 -23.91 63.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.64 10.63 39.45 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 176.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 mt -56.71 -59.14 13.23 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.063 168.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.09 173.28 14.36 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.623 2.215 . . . . 0.0 111.001 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.89 67.5 5.82 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.731 2.954 . . . . 0.0 110.135 169.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 56.22 46.03 86.88 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 125.594 1.568 . . . . 0.0 112.741 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -115.39 -21.22 9.94 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -165.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -133.12 116.78 16.72 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.154 1.382 . . . . 0.0 110.75 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -99.19 139.42 34.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.21 1.404 . . . . 0.0 112.091 -173.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.5 140.43 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 120.5 1.5 . . . . 0.0 112.932 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.8 t -122.94 128.69 50.61 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.225 1.81 . . . . 0.0 110.89 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 125.79 1.636 . . . . 0.0 112.598 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 24.7 p -157.01 132.88 9.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.607 1.563 . . . . 0.0 113.56 -168.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.0 p -148.0 145.26 28.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.905 2.082 . . . . 0.0 110.041 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 90.2 m -105.26 135.58 46.37 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.471 1.032 . . . . 0.0 110.499 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.68 149.23 44.92 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.987 1.315 . . . . 0.0 110.974 172.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tt -96.46 141.21 30.03 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.095 2.158 . . . . 0.0 110.042 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mt -127.91 134.4 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.626 1.571 . . . . 0.0 109.246 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.2 130.76 44.39 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.27 1.028 . . . . 0.0 108.266 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 90.6 mt -132.94 136.09 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.48 -0.763 . . . . 0.0 111.144 -168.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.07 72.27 1.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.882 1.673 . . . . 0.0 111.882 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -177.49 52.13 0.1 Allowed Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.242 -0.89 . . . . 0.0 114.399 167.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -104.41 -58.08 1.94 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.274 5.6 t 54.84 -56.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 129.433 3.093 . . . . 0.0 115.757 -169.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 92.3 m -112.99 150.82 31.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.744 2.418 . . . . 0.0 111.095 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.6 73.43 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.865 1.266 . . . . 0.0 112.614 -177.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.5 p -43.49 -47.53 7.2 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.218 1.407 . . . . 0.0 112.385 169.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 5.6 t -71.5 -25.08 62.11 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.54 -53.39 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.43 -33.29 73.47 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.1 m -67.17 -51.72 50.28 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.708 0.803 . . . . 0.0 112.898 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 83.8 mt -62.01 -46.54 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-N 119.965 1.257 . . . . 0.0 110.665 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -58.74 -28.77 66.18 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.814 1.645 . . . . 0.0 112.164 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.48 -61.05 3.28 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.969 1.271 . . . . 0.0 113.281 170.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -47.74 69.74 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.319 1.448 . . . . 0.0 113.139 -169.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.0 mm -71.67 -34.67 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.157 -0.339 . . . . 0.0 111.735 -169.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.0 t -50.96 -21.99 2.04 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.487 1.915 . . . . 0.0 115.313 176.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -86.18 -19.82 29.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.122 1.769 . . . . 0.0 115.163 -167.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.1 pp -92.92 151.28 20.04 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.181 0.901 . . . . 0.0 112.403 -173.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -59.38 135.22 57.59 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.952 0.882 . . . . 0.0 112.49 -169.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.27 -27.56 9.21 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.064 -1.965 . . . . 0.0 115.343 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.97 94.05 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 121.214 2.507 . . . . 0.0 108.778 169.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -74.84 -44.07 51.11 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.345 1.058 . . . . 0.0 111.374 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -141.95 147.18 36.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.476 1.034 . . . . 0.0 109.96 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.46 148.54 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.109 0.956 . . . . 0.0 113.272 175.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 47.5 t -134.39 136.84 43.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 129.031 2.932 . . . . 0.0 108.513 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.77 143.9 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.616 1.553 . . . . 0.0 112.766 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 42.0 m -141.51 148.71 39.83 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.195 1.398 . . . . 0.0 113.233 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.43 -26.43 55.49 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.813 1.645 . . . . 0.0 114.133 172.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.25 -33.48 58.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.834 1.653 . . . . 0.0 113.894 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -123.83 -10.54 7.75 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.276 1.83 . . . . 0.0 111.087 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.72 44.61 19.8 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.406 1.003 . . . . 0.0 110.793 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 49.0 p -133.74 146.63 50.93 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.073 0.949 . . . . 0.0 111.863 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -121.82 161.2 23.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.77 1.628 . . . . 0.0 111.057 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.8 t -141.46 139.21 33.32 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 124.191 0.996 . . . . 0.0 109.173 168.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.63 142.86 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.226 -167.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.38 98.62 11.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 173.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -100.22 154.52 18.39 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.9 0.88 . . . . 0.0 111.67 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -98.81 109.11 52.31 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.161 0.984 . . . . 0.0 110.087 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.78 -10.88 23.64 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.438 2.092 . . . . 0.0 112.472 -170.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.26 -17.42 46.01 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 93.6 t -120.45 -29.12 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.911 1.284 . . . . 0.0 114.02 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.3 tt -141.1 147.25 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.186 0.903 . . . . 0.0 110.324 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.63 150.04 36.32 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.939 0.895 . . . . 0.0 111.004 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.43 -39.47 36.1 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.246 2.631 . . . . 0.0 113.924 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -65.01 -25.25 67.78 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.7 -27.79 55.64 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.614 1.165 . . . . 0.0 113.875 174.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.6 mt -59.77 -53.76 54.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -65.2 -34.68 78.95 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.18 -27.63 68.56 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.05 -36.44 72.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.89 0.768 . . . . 0.0 112.723 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.4 mp -72.41 -37.45 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.286 1.035 . . . . 0.0 110.837 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -63.43 -34.05 76.9 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.817 -0.552 . . . . 0.0 111.485 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -71.88 -24.4 61.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.008 1.323 . . . . 0.0 113.336 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 21.2 ttt -74.85 -29.46 61.05 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.673 1.189 . . . . 0.0 112.609 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 115.5 30.99 2.08 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 126.084 1.802 . . . . 0.0 114.875 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -133.76 -158.51 0.89 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.842 1.657 . . . . 0.0 109.18 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -137.57 143.17 41.41 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.287 1.035 . . . . 0.0 111.459 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -140.88 152.22 44.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.027 1.731 . . . . 0.0 112.065 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.5 t -141.36 130.99 24.02 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.006 1.323 . . . . 0.0 112.232 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.55 81.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.127 0.971 . . . . 0.0 111.412 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 125.025 1.33 . . . . 0.0 112.457 179.526 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.484 HG13 ' CE1' ' A' ' 64' ' ' TYR . 9.9 p . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -118.36 144.9 45.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.501 1.121 . . . . 0.0 111.399 -170.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.38 128.71 19.98 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.496 1.519 . . . . 0.0 109.85 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -96.3 135.69 37.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.355 1.462 . . . . 0.0 112.237 -176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -142.87 146.91 34.54 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.92 109.62 19.85 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.449 1.499 . . . . 0.0 109.146 174.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.7 mt -85.41 147.21 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.199 1.799 . . . . 0.0 111.676 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -98.19 139.84 33.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.984 1.313 . . . . 0.0 111.07 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.27 -6.89 81.04 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.196 1.379 . . . . 0.0 114.101 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 ptp -64.19 -15.75 60.53 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -63.82 -13.5 44.99 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.62 1.554 . . . . 0.0 113.223 170.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.1 m -77.03 -14.72 59.79 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.15 -1.594 . . . . 0.0 114.155 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 70.8 -50.9 0.68 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 128.139 2.576 . . . . 0.0 111.955 -172.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 m -60.0 -17.97 42.49 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.766 -1.209 . . . . 0.0 113.583 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 t -64.38 -53.05 54.7 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.548 1.139 . . . . 0.0 111.565 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.72 -27.92 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 118.638 0.654 . . . . 0.0 112.281 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.1 tp -53.65 -49.54 67.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 112.376 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -39.18 88.51 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.478 0.581 . . . . 0.0 111.914 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.1 mt -65.51 -49.5 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.263 1.025 . . . . 0.0 109.264 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.69 -41.6 98.12 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.68 1.592 . . . . 0.0 111.938 -176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.7 -39.22 87.97 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.031 -0.509 . . . . 0.0 111.49 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -91.6 -25.01 19.39 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -172.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.426 ' CD1' HG22 ' A' ' 78' ' ' ILE . 47.8 mm -102.91 118.64 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.874 0.87 . . . . 0.0 110.431 -173.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.23 -17.5 3.57 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.866 1.698 . . . . 0.0 115.215 -177.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -88.54 -5.33 58.27 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.091 1.356 . . . . 0.0 111.919 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -76.4 170.4 16.43 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.006 2.122 . . . . 0.0 111.247 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.57 -62.88 1.31 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.427 -0.795 . . . . 0.0 110.964 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.04 -43.13 17.85 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.853 -0.97 . . . . 0.0 113.237 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.26 123.92 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.221 1.511 . . . . 0.0 110.502 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -94.74 -46.22 7.0 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.186 0.994 . . . . 0.0 111.31 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.8 t -149.41 172.04 15.59 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.563 0.745 . . . . 0.0 112.481 -169.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 tp -142.39 125.2 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.561 1.944 . . . . 0.0 107.434 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -120.23 149.45 42.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.554 0.741 . . . . 0.0 109.65 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.8 m -106.62 155.87 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.201 -0.937 . . . . 0.0 111.03 -170.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.4 t -139.73 57.82 1.62 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 123.138 1.447 . . . . 0.0 108.182 175.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.86 -24.13 65.22 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.611 1.564 . . . . 0.0 112.714 -171.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.21 -11.88 35.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.003 1.321 . . . . 0.0 113.61 169.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -122.84 7.59 9.35 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.172 2.189 . . . . 0.0 111.649 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 mptt 62.2 14.17 6.46 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.383 2.273 . . . . 0.0 113.746 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.73 167.14 10.08 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.634 1.574 . . . . 0.0 111.76 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.67 152.79 45.64 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 127.157 2.183 . . . . 0.0 107.207 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.63 133.65 46.31 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 172.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 p -96.22 136.86 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.519 0.676 . . . . 0.0 109.732 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -107.19 87.89 2.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.59 1.956 . . . . 0.0 107.51 -172.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.484 ' CE1' HG13 ' A' ' 20' ' ' VAL . 8.8 p90 -116.33 -179.3 3.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.481 1.512 . . . . 0.0 110.42 -175.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.13 142.17 36.05 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 168.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.08 7.19 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.388 2.058 . . . . 0.0 114.308 -168.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -74.96 -51.38 13.85 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.28 -1.512 . . . . 0.0 112.369 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 90.0 m -95.46 -15.81 22.69 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -172.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.9 t -147.81 175.69 10.73 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.647 1.179 . . . . 0.0 112.448 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.4 p -155.46 161.54 29.23 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.606 1.162 . . . . 0.0 112.754 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.85 -45.71 38.98 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.131 2.554 . . . . 0.0 115.583 -170.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.91 -41.18 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 118.814 0.734 . . . . 0.0 111.945 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.48 86.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.954 0.901 . . . . 0.0 112.268 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.56 -40.56 92.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.989 0.916 . . . . 0.0 111.799 173.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.48 HE21 HG23 ' A' ' 88' ' ' VAL . 37.8 tt0 -58.69 -45.64 89.04 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.256 173.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -61.59 -36.79 81.66 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.542 1.065 . . . . 0.0 112.892 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.18 -60.33 2.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.23 1.012 . . . . 0.0 113.43 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.426 HG22 ' CD1' ' A' ' 42' ' ' ILE . 8.6 pt -73.2 -32.65 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -169.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -70.0 -19.62 63.32 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.84 0.856 . . . . 0.0 112.684 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.59 11.21 37.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.997 1.319 . . . . 0.0 113.934 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -60.61 -50.46 85.29 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.371 -1.3 . . . . 0.0 111.631 167.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 73.4 Cg_endo -70.25 172.84 12.35 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.583 2.855 . . . . 0.0 112.22 170.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.56 43.25 1.18 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.217 3.278 . . . . 0.0 112.236 170.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.41 58.05 5.23 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 121.155 -0.966 . . . . 0.0 111.149 -174.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -133.8 -42.33 0.83 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.41 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 14.9 m-85 -97.9 115.53 28.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -102.4 158.46 16.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.016 0.926 . . . . 0.0 111.772 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.48 HG23 HE21 ' A' ' 75' ' ' GLN . 4.0 m -126.86 139.25 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.364 0.984 . . . . 0.0 112.037 175.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.8 t -128.9 130.5 46.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.012 0.925 . . . . 0.0 111.945 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 CA--C 1.552 1.021 0 C-N-CA 125.355 1.462 . . . . 0.0 111.461 -175.887 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 87.1 m 58.53 92.63 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.237 1.815 . . . . 0.0 112.758 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 t -140.15 154.04 46.85 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.882 -1.136 . . . . 0.0 111.727 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.1 m -99.27 129.84 45.52 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -176.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.82 153.59 43.85 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.087 0.946 . . . . 0.0 110.126 168.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tt -102.55 130.5 49.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.705 2.002 . . . . 0.0 109.447 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.3 mm -115.12 138.55 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.174 1.789 . . . . 0.0 109.187 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -104.51 125.04 50.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.923 0.889 . . . . 0.0 110.044 169.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.9 mp -115.85 139.85 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.457 1.026 . . . . 0.0 112.369 -169.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.31 70.55 0.72 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.229 2.211 . . . . 0.0 111.539 171.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -176.2 54.09 0.11 Allowed Glycine 0 N--CA 1.466 0.659 0 C-N-CA 124.86 1.219 . . . . 0.0 112.753 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.9 mtm -134.98 157.78 46.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.514 1.526 . . . . 0.0 109.869 170.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.8 t -174.94 -45.34 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.593 1.557 . . . . 0.0 110.74 -171.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 67.0 m -104.68 146.05 29.48 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.863 1.265 . . . . 0.0 109.127 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.89 -27.69 68.34 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.622 -0.674 . . . . 0.0 112.605 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 79.9 p -56.06 -23.9 36.47 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.913 -1.117 . . . . 0.0 113.468 172.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 73.2 m -56.16 -27.82 55.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.372 1.069 . . . . 0.0 113.49 170.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.2 t -54.33 -52.58 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 118.91 0.777 . . . . 0.0 109.492 173.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -70.6 -14.8 62.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.232 1.013 . . . . 0.0 113.098 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.3 m -73.41 -56.14 5.44 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.064 -1.023 . . . . 0.0 109.65 167.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.5 mt -68.17 -59.23 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.695 1.198 . . . . 0.0 110.568 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -54.55 -29.52 51.21 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.646 1.578 . . . . 0.0 111.63 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.58 -62.65 3.15 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.373 0.987 . . . . 0.0 112.727 176.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 86.6 mmm -75.56 -42.49 52.09 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.771 1.396 . . . . 0.0 114.771 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 31.8 mm -72.32 -30.51 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.596 0.759 . . . . 0.0 111.829 -172.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.6 p -63.82 -9.37 14.44 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 175.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -107.92 22.95 15.22 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.028 1.331 . . . . 0.0 113.577 -171.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 pp -115.56 163.72 15.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.759 1.223 . . . . 0.0 111.544 169.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -65.57 135.8 55.56 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.12 16.57 74.17 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 117.891 -1.505 . . . . 0.0 115.89 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.75 -23.56 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 125.507 1.523 . . . . 0.0 114.292 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 42.65 -76.31 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 129.841 3.256 . . . . 0.0 117.37 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -128.28 127.91 43.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.55 1.523 . . . . 0.0 111.375 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.6 tt -134.6 137.66 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 121.188 -0.945 . . . . 0.0 111.164 -169.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 21.9 t -143.26 133.37 24.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.869 2.067 . . . . 0.0 108.248 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.58 143.62 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 119.785 1.175 . . . . 0.0 111.711 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -141.38 133.45 27.72 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -59.05 -22.08 60.16 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.041 2.137 . . . . 0.0 113.23 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.06 -31.17 62.93 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.792 1.237 . . . . 0.0 112.724 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -133.3 -16.7 2.4 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.185 1.394 . . . . 0.0 113.555 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.1 26.74 65.72 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.803 1.192 . . . . 0.0 112.112 -169.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.4 p -121.42 148.85 43.85 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.64 1.176 . . . . 0.0 111.693 -171.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.64 137.48 50.85 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.786 1.234 . . . . 0.0 110.771 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.0 t -112.66 121.13 43.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 167.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.59 141.28 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 121.906 -0.496 . . . . 0.0 110.614 -169.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.31 101.93 14.64 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.637 1.975 . . . . 0.0 105.887 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -97.65 157.8 15.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.293 1.044 . . . . 0.0 111.718 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -101.42 94.49 4.16 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.713 1.205 . . . . 0.0 110.267 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.55 -35.71 94.87 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.118 2.545 . . . . 0.0 111.372 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.57 -8.18 18.63 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.36 -28.98 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 126.181 1.792 . . . . 0.0 112.535 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.8 tt -155.91 158.02 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 119.943 1.247 . . . . 0.0 112.351 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.5 t -98.1 145.27 29.51 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.854 1.262 . . . . 0.0 113.104 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.42 -33.23 66.06 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.102 2.535 . . . . 0.0 112.546 167.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.42 -27.07 66.76 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.982 0.81 . . . . 0.0 112.432 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -76.38 -37.07 57.73 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.323 1.049 . . . . 0.0 111.953 168.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.43 -53.59 56.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.286 1.834 . . . . 0.0 110.641 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -59.83 -37.82 80.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.74 0.7 . . . . 0.0 112.809 173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.63 -23.91 67.32 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.26 -35.63 71.47 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.111 1.323 . . . . 0.0 112.731 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.65 -38.18 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.574 1.149 . . . . 0.0 110.191 171.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -69.39 -26.76 64.8 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.41 1.084 . . . . 0.0 112.734 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.66 -44.51 64.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.182 1.393 . . . . 0.0 111.393 168.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 22.6 ttt -61.72 -27.67 68.88 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.654 1.582 . . . . 0.0 112.396 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 115.23 38.79 0.99 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.478 1.514 . . . . 0.0 114.024 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -130.7 -160.54 1.05 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.236 1.414 . . . . 0.0 108.266 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -131.51 146.86 52.44 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.904 -1.123 . . . . 0.0 110.335 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.93 141.53 31.49 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.8 t -124.36 135.5 53.36 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.5 1.12 . . . . 0.0 112.021 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 m -87.07 80.63 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.908 0.883 . . . . 0.0 110.768 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.476 0.839 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.603 -178.082 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -98.85 153.46 18.77 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.479 2.711 . . . . 0.0 112.927 -174.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.5 tt -143.96 139.31 29.02 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.221 1.409 . . . . 0.0 112.991 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -98.46 110.33 22.94 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 122.689 1.233 . . . . 0.0 111.928 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -138.17 133.73 33.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.472 -1.695 . . . . 0.0 112.667 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -98.6 119.38 37.22 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.7 mt -96.83 137.34 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.031 0.932 . . . . 0.0 109.146 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -96.64 117.8 31.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.904 0.882 . . . . 0.0 110.913 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.62 -12.36 12.13 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.306 1.432 . . . . 0.0 113.689 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 12.9 ptp -56.52 -22.17 31.1 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.939 1.87 . . . . 0.0 114.075 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -58.64 -25.97 63.28 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 169.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -80.42 -8.49 59.56 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.606 -1.309 . . . . 0.0 113.52 173.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.7 tptt 70.08 -56.0 0.59 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 129.025 2.93 . . . . 0.0 111.781 -170.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -48.86 -27.35 2.98 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.718 2.407 . . . . 0.0 114.567 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 t -53.59 -49.06 68.57 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.951 1.7 . . . . 0.0 113.265 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.9 -28.24 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -170.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.69 -51.86 45.5 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.215 1.406 . . . . 0.0 111.343 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.19 -54.12 49.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -60.69 -37.0 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.591 0.756 . . . . 0.0 111.34 -173.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -64.08 -28.65 69.93 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.402 -0.811 . . . . 0.0 112.399 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.24 -50.3 34.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.24 1.016 . . . . 0.0 112.085 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -92.57 -24.29 18.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.549 1.54 . . . . 0.0 115.076 -171.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.424 ' CD1' HG22 ' A' ' 78' ' ' ILE . 33.4 mm -98.86 125.84 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 120.345 1.429 . . . . 0.0 109.746 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.41 -14.24 7.32 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.039 1.78 . . . . 0.0 114.636 -174.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -96.65 -1.88 45.82 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.749 1.274 . . . . 0.0 113.092 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 mp -71.03 178.59 3.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.567 1.947 . . . . 0.0 110.71 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -58.6 4.31 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.854 -1.154 . . . . 0.0 111.569 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.74 -31.28 7.49 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.729 -1.595 . . . . 0.0 113.519 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.74 113.08 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.938 2.369 . . . . 0.0 109.46 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -98.4 -39.8 8.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.066 0.946 . . . . 0.0 111.894 -175.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.0 t -147.36 159.72 43.37 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.489 -0.757 . . . . 0.0 112.165 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -133.59 121.14 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.414 1.485 . . . . 0.0 109.214 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -110.14 177.43 4.71 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.248 1.419 . . . . 0.0 108.695 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.8 166.96 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 169.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 t -141.48 59.81 1.5 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.324 1.85 . . . . 0.0 110.378 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.31 -22.77 61.74 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.685 2.394 . . . . 0.0 115.664 -173.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -61.52 -35.76 78.62 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.691 1.132 . . . . 0.0 111.058 171.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -104.25 -2.27 25.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.252 1.421 . . . . 0.0 114.049 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.1 mttp 81.98 4.5 1.23 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.122 2.169 . . . . 0.0 112.37 173.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.26 155.16 16.99 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.902 2.081 . . . . 0.0 109.976 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.48 -179.71 4.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 165.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -145.52 105.11 3.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.444 -0.785 . . . . 0.0 111.686 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 p -101.7 132.14 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.432 0.634 . . . . 0.0 111.544 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.0 94.96 6.55 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.085 1.754 . . . . 0.0 109.832 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -120.16 148.98 42.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.007 0.923 . . . . 0.0 111.957 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -96.06 115.62 65.68 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.157 1.383 . . . . 0.0 108.832 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.97 -8.94 24.86 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.036 2.49 . . . . 0.0 113.186 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 t -77.86 -11.15 59.86 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.855 0.752 . . . . 0.0 112.23 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 66.0 m -130.27 -18.33 3.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.3 t -145.14 -177.68 5.67 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.899 1.227 . . . . 0.0 111.177 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 p -151.82 161.34 29.8 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 125.195 1.398 . . . . 0.0 109.352 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -50.09 -46.0 30.44 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.332 2.688 . . . . 0.0 114.228 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.0 p -67.84 -40.96 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 120.429 1.468 . . . . 0.0 111.763 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.23 90.2 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.917 0.887 . . . . 0.0 112.273 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.37 -47.0 58.98 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.976 0.51 . . . . 0.0 111.86 173.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -68.41 -41.52 80.3 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.37 -0.831 . . . . 0.0 112.549 -169.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -56.79 -30.71 63.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.466 0.706 . . . . 0.0 112.291 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.96 -55.59 7.19 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.107 0.867 . . . . 0.0 111.674 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.424 HG22 ' CD1' ' A' ' 42' ' ' ILE . 1.9 pt -64.93 -30.04 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -168.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -59.85 -34.48 73.17 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.88 13.0 30.23 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.1 mt -55.92 -56.03 34.89 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.937 168.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.505 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 86.5 Cg_endo -73.02 -179.98 4.83 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.872 3.048 . . . . 0.0 111.768 171.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.02 41.4 0.47 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.766 3.644 . . . . 0.0 111.989 168.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.47 27.13 64.06 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.849 1.214 . . . . 0.0 113.196 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -95.81 -40.62 9.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.272 1.036 . . . . 0.0 113.538 -168.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.505 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 24.7 m-85 -98.17 113.94 26.01 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.027 1.331 . . . . 0.0 108.182 173.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -97.38 164.02 12.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.19 0.596 . . . . 0.0 109.963 -174.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.99 141.56 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.123 0.969 . . . . 0.0 110.067 171.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.1 t -128.18 128.57 45.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.475 1.11 . . . . 0.0 112.59 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 127.69 2.396 . . . . 0.0 111.057 174.838 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 20.5 p -162.51 118.03 1.88 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.03 2.132 . . . . 0.0 110.92 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.0 p -141.91 142.56 33.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.577 1.951 . . . . 0.0 109.228 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.7 m -102.73 139.99 37.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.664 0.665 . . . . 0.0 109.454 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.43 161.85 35.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.397 0.679 . . . . 0.0 111.141 169.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 tt -114.03 132.38 56.02 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.316 1.847 . . . . 0.0 109.287 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mt -127.79 134.6 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.519 1.128 . . . . 0.0 110.083 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.75 127.71 43.9 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.109 1.363 . . . . 0.0 108.766 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.3 mt -129.43 145.88 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.248 -0.907 . . . . 0.0 112.101 -167.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -113.99 57.73 0.69 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.283 1.833 . . . . 0.0 112.277 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.73 53.27 0.44 Allowed Glycine 0 CA--C 1.524 0.642 0 O-C-N 121.553 -0.717 . . . . 0.0 113.842 168.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -138.2 98.97 3.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.417 1.487 . . . . 0.0 108.274 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.7 t -93.42 -31.37 14.64 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.228 1.411 . . . . 0.0 112.327 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 5.2 m -144.04 169.36 17.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.872 2.469 . . . . 0.0 110.594 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.94 71.46 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.231 -0.918 . . . . 0.0 112.512 172.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.0 p -50.44 -36.16 32.0 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.874 -1.141 . . . . 0.0 113.048 169.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.7 t -72.53 -34.96 67.93 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.257 1.423 . . . . 0.0 112.521 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.29 -52.58 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.915 0.886 . . . . 0.0 109.249 169.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -61.47 -23.27 65.76 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.1 t -70.69 -51.12 29.7 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.612 -0.68 . . . . 0.0 112.114 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 52.5 mt -63.4 -54.08 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 120.822 1.646 . . . . 0.0 111.055 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -59.26 -25.41 64.05 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.589 1.955 . . . . 0.0 110.918 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.8 -62.46 2.37 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.829 1.68 . . . . 0.0 114.056 168.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 89.8 mmm -70.56 -40.7 73.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.239 1.416 . . . . 0.0 113.817 -169.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.9 mm -70.67 -31.51 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.387 -0.821 . . . . 0.0 110.315 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.6 t -66.83 1.83 1.68 Allowed 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -87.13 -18.14 31.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.432 1.493 . . . . 0.0 114.09 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -102.6 165.85 10.85 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.972 1.26 . . . . 0.0 113.4 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -64.31 163.33 13.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.319 1.533 . . . . 0.0 113.779 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.87 -36.35 0.39 Allowed Glycine 0 CA--C 1.533 1.161 0 CA-C-O 117.847 -1.529 . . . . 0.0 115.283 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.0 p -70.42 93.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.493 1.647 . . . . 0.0 110.458 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -73.83 -45.55 50.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.98 1.712 . . . . 0.0 111.221 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -143.41 140.9 30.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.301 1.44 . . . . 0.0 108.299 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.9 tt -133.9 130.99 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.465 0.706 . . . . 0.0 110.822 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 43.2 m -131.88 104.2 6.74 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.825 1.25 . . . . 0.0 110.44 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.69 138.55 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.689 1.196 . . . . 0.0 111.737 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.0 m -133.85 142.74 47.94 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.747 1.261 . . . . 0.0 112.423 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.76 -15.67 59.69 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.613 1.965 . . . . 0.0 115.348 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.98 -46.03 71.56 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.312 1.445 . . . . 0.0 111.943 -174.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.7 -14.94 8.99 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.041 1.736 . . . . 0.0 110.897 172.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.17 39.67 7.82 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.881 1.229 . . . . 0.0 111.722 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.9 p -129.2 148.43 51.14 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.124 0.97 . . . . 0.0 113.015 -169.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -122.13 129.93 52.77 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.384 1.874 . . . . 0.0 111.777 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.2 t -103.72 122.76 45.74 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 167.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.99 137.5 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 122.018 -0.426 . . . . 0.0 110.748 -169.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.27 114.12 25.83 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.998 1.719 . . . . 0.0 107.935 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -114.4 155.98 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.882 0.873 . . . . 0.0 112.523 176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -96.48 110.42 52.73 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.883 0.873 . . . . 0.0 109.758 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.26 -14.23 20.65 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.941 2.427 . . . . 0.0 112.554 -171.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.47 -17.27 60.8 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.456 1.026 . . . . 0.0 112.951 170.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 99.1 t -117.49 -34.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.538 1.535 . . . . 0.0 113.078 -170.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.7 tt -145.71 154.04 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.446 1.021 . . . . 0.0 112.59 -174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.8 t -101.65 151.79 37.95 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 125.829 1.652 . . . . 0.0 111.7 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.37 -32.47 42.23 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.232 2.621 . . . . 0.0 114.112 168.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -73.82 -24.21 59.76 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.778 0.717 . . . . 0.0 111.645 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.72 -38.02 58.92 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.941 1.296 . . . . 0.0 111.441 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.7 mt -56.36 -55.5 32.73 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -52.35 -51.53 58.33 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.625 1.57 . . . . 0.0 111.29 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.15 -25.14 68.21 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.52 68.14 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.713 1.597 . . . . 0.0 111.769 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.36 -38.2 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.443 1.097 . . . . 0.0 111.045 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.29 -40.12 95.3 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.696 0.68 . . . . 0.0 111.271 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.4 -23.53 62.78 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.163 2.185 . . . . 0.0 113.022 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 26.4 ttt -76.42 -40.83 49.63 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.733 1.213 . . . . 0.0 110.875 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 125.39 34.47 0.66 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.994 1.283 . . . . 0.0 115.661 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -129.02 -153.51 0.57 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.628 1.571 . . . . 0.0 108.68 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.52 148.29 49.11 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.356 -0.84 . . . . 0.0 112.118 169.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -136.07 151.52 49.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.038 1.335 . . . . 0.0 112.368 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.2 t -140.24 122.92 16.32 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.005 1.322 . . . . 0.0 111.357 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.4 m -84.39 78.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.651 1.215 . . . . 0.0 110.54 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 CA--C 1.547 0.843 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.751 172.991 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -98.0 142.13 30.1 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.683 1.593 . . . . 0.0 110.601 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tt -143.63 148.06 35.27 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.156 1.782 . . . . 0.0 111.886 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -96.51 130.74 43.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.452 1.12 . . . . 0.0 111.829 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.08 140.72 31.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 113.46 -1.7 . . . . 0.0 111.332 169.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -99.43 121.42 41.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.29 136.09 23.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 170.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.85 144.82 27.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.543 1.137 . . . . 0.0 109.094 171.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.1 -2.64 64.65 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.887 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -73.32 -63.83 1.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.612 1.165 . . . . 0.0 109.825 174.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.7 m80 58.47 -12.75 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.781 2.433 . . . . 0.0 115.528 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 32.0 p -164.39 155.62 15.54 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.837 1.255 . . . . 0.0 112.251 -169.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -32.38 23.23 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 175.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 m -60.16 -35.57 75.61 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.863 -1.148 . . . . 0.0 112.439 -174.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.8 m -74.75 -18.05 60.55 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.82 -8.61 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -56.89 -62.77 1.51 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.797 1.18 . . . . 0.0 112.387 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -53.84 -34.4 59.17 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.612 -0.68 . . . . 0.0 111.294 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.414 ' HA ' HD21 ' A' ' 81' ' ' LEU . 1.8 mt -63.39 -50.14 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 O-C-N 121.122 -0.986 . . . . 0.0 111.093 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -62.3 -32.48 73.23 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.289 0.95 . . . . 0.0 112.465 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -65.0 -54.59 28.04 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.541 1.064 . . . . 0.0 111.88 173.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -83.47 -33.75 25.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.185 1.394 . . . . 0.0 114.113 -170.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.1 mm -104.01 121.69 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 122.087 0.946 . . . . 0.0 110.47 -167.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.42 -28.55 5.0 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 125.807 1.67 . . . . 0.0 113.326 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -79.12 -0.55 32.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.619 -0.93 . . . . 0.0 112.692 174.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.39 -173.58 4.13 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.16 2.584 . . . . 0.0 112.756 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.02 -78.52 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.752 1.621 . . . . 0.0 111.932 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.61 -25.31 18.56 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.446 -1.752 . . . . 0.0 113.486 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -77.92 110.55 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 121.194 2.497 . . . . 0.0 107.819 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -104.41 -31.53 9.47 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.483 1.113 . . . . 0.0 112.137 -169.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 t -148.69 174.08 12.54 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 tp -144.79 136.78 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.83 1.652 . . . . 0.0 110.55 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -141.64 -178.08 5.48 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.675 1.19 . . . . 0.0 111.247 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.53 148.08 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 120.988 1.722 . . . . 0.0 114.581 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 m -130.36 57.88 1.7 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.657 1.583 . . . . 0.0 109.656 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.4 mt -64.93 -24.03 67.4 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.124 1.77 . . . . 0.0 115.333 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.77 -29.8 65.12 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.753 0.821 . . . . 0.0 111.963 170.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -120.7 13.05 11.54 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.817 1.647 . . . . 0.0 112.668 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 72.64 4.87 5.11 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.303 1.841 . . . . 0.0 115.298 168.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 p -96.47 152.74 18.33 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.604 1.192 . . . . 0.0 110.646 177.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.75 157.13 17.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 164.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.31 112.21 14.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.515 -0.741 . . . . 0.0 110.438 -168.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 p -96.74 136.15 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -117.83 82.9 1.9 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.535 1.534 . . . . 0.0 106.871 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -117.89 153.97 32.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.349 -170.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -97.1 109.42 49.26 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 127.332 2.253 . . . . 0.0 108.705 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.49 -3.15 10.47 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.339 2.693 . . . . 0.0 113.458 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.7 t -80.16 -18.77 48.82 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.39 0.995 . . . . 0.0 111.974 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 14.6 m -122.86 -16.03 7.23 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 t -146.3 -175.63 4.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.638 1.175 . . . . 0.0 111.409 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.7 m -153.87 156.34 32.0 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 126.567 1.947 . . . . 0.0 109.611 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -52.96 -56.9 2.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.26 2.64 . . . . 0.0 115.775 -169.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.16 -36.84 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 120.961 1.71 . . . . 0.0 112.711 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.84 -41.42 71.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.651 1.18 . . . . 0.0 112.256 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.94 -38.28 76.13 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.925 0.89 . . . . 0.0 111.279 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -69.78 -41.19 75.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.53 1.132 . . . . 0.0 111.848 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -50.18 -35.91 28.22 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.744 1.218 . . . . 0.0 113.13 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.17 -61.92 1.59 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.162 0.892 . . . . 0.0 112.198 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.411 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 30.4 pt -60.68 -21.22 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.937 1.695 . . . . 0.0 114.659 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.36 -25.39 65.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.345 1.458 . . . . 0.0 113.227 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -126.66 25.62 6.4 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.6 1.56 . . . . 0.0 113.397 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.414 HD21 ' HA ' ' A' ' 38' ' ' ILE . 11.3 tp -53.56 -55.62 33.18 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 127.248 2.219 . . . . 0.0 112.473 168.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 32.3 Cg_endo -84.45 -179.5 3.89 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.189 3.259 . . . . 0.0 111.163 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.76 56.72 2.4 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.681 3.587 . . . . 0.0 111.855 168.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.14 15.92 65.97 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.197 1.38 . . . . 0.0 114.183 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -83.92 -34.01 24.59 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.953 0.876 . . . . 0.0 112.387 -168.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.48 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 8.9 m-85 -121.56 129.77 53.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.04 2.136 . . . . 0.0 107.688 174.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -120.09 173.16 7.26 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.299 1.44 . . . . 0.0 110.309 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.06 131.48 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 119.964 1.256 . . . . 0.0 113.479 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -118.37 118.43 31.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.491 1.116 . . . . 0.0 110.617 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.958 1.303 . . . . 0.0 111.38 172.578 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 26.3 p -156.2 117.35 3.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.312 1.045 . . . . 0.0 113.358 -167.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.7 p -145.29 145.04 31.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.623 1.169 . . . . 0.0 111.381 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 88.3 m -96.98 140.91 30.8 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.41 149.98 36.95 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.418 1.087 . . . . 0.0 110.692 173.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tt -117.58 142.41 47.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.002 2.121 . . . . 0.0 110.331 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 mt -134.1 135.28 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.105 1.762 . . . . 0.0 110.754 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.88 128.57 45.96 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.769 1.628 . . . . 0.0 110.467 171.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.51 118.44 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 120.958 -1.089 . . . . 0.0 111.241 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.05 55.94 2.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.525 1.13 . . . . 0.0 110.917 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.54 53.29 0.32 Allowed Glycine 0 N--CA 1.462 0.415 0 C-N-CA 124.612 1.101 . . . . 0.0 111.139 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.8 mtm -145.36 145.6 31.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.676 0.79 . . . . 0.0 111.097 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.8 t -163.34 -43.94 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.425 0.69 . . . . 0.0 112.425 -168.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 83.5 m -114.26 152.03 31.95 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.393 1.477 . . . . 0.0 110.516 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.54 -25.53 68.09 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.872 -1.143 . . . . 0.0 113.14 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.7 p -59.18 -22.26 60.7 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.236 -1.54 . . . . 0.0 113.274 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 74.4 m -61.18 -30.22 70.28 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.754 -1.216 . . . . 0.0 112.052 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.73 -53.29 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.646 0.778 . . . . 0.0 109.914 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -65.27 -25.18 67.54 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.469 0.577 . . . . 0.0 111.847 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.5 m -70.58 -59.95 2.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.623 0.769 . . . . 0.0 111.943 170.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.1 mt -69.09 -42.28 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.056 1.342 . . . . 0.0 112.854 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -56.4 -34.28 66.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.358 0.663 . . . . 0.0 109.831 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.58 -34.31 67.45 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.037 -1.424 . . . . 0.0 114.088 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -47.42 72.52 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 121.244 2.522 . . . . 0.0 110.389 172.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 mm -75.52 -50.63 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.489 0.716 . . . . 0.0 112.192 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -71.32 -5.97 36.41 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.4 -1.438 . . . . 0.0 114.65 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -85.7 -21.7 28.19 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.24 -155.95 0.53 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -167.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -117.63 149.99 39.77 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.738 1.615 . . . . 0.0 111.816 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.56 18.91 59.34 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 117.638 -1.645 . . . . 0.0 114.584 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.0 p -112.03 97.22 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.844 2.058 . . . . 0.0 111.305 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.73 -47.56 8.15 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.195 -0.941 . . . . 0.0 112.53 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -142.48 145.58 33.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.607 1.163 . . . . 0.0 108.385 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.29 143.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 118.53 0.604 . . . . 0.0 111.036 167.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.5 t -140.37 149.75 43.07 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.049 2.14 . . . . 0.0 109.834 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.42 140.93 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.291 1.036 . . . . 0.0 111.329 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 67.2 m -121.87 77.69 1.39 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.116 2.167 . . . . 0.0 108.1 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.8 tt -53.59 -29.03 35.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.723 2.009 . . . . 0.0 112.383 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -41.48 -51.12 3.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.858 2.463 . . . . 0.0 112.882 167.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -90.43 -29.42 17.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.553 1.941 . . . . 0.0 111.125 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 93.09 27.93 12.77 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.143 1.83 . . . . 0.0 112.741 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.3 p -132.99 139.02 47.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.232 1.016 . . . . 0.0 112.457 -168.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.92 147.24 29.0 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.092 1.357 . . . . 0.0 111.113 173.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.2 t -131.29 133.89 45.83 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.509 1.124 . . . . 0.0 109.484 172.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.92 142.93 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.505 1.122 . . . . 0.0 110.927 -168.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.22 103.22 15.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.115 1.766 . . . . 0.0 106.773 169.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -108.9 156.66 19.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.002 0.921 . . . . 0.0 112.845 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -99.08 110.17 56.87 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.874 0.869 . . . . 0.0 111.148 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.08 -11.54 21.34 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.247 2.631 . . . . 0.0 113.761 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.89 -11.21 59.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.222 1.009 . . . . 0.0 113.356 171.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.3 t -120.09 -42.89 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.495 1.518 . . . . 0.0 111.895 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.1 tt -134.52 143.6 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 123.685 0.794 . . . . 0.0 111.596 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.9 t -97.11 151.49 37.73 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.404 1.082 . . . . 0.0 112.695 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.14 -28.96 53.74 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.729 2.286 . . . . 0.0 112.672 167.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -67.57 -30.82 70.54 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.414 -0.804 . . . . 0.0 112.857 173.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.08 -31.81 64.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.538 1.135 . . . . 0.0 112.044 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 63.0 mt -60.59 -53.39 58.09 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.082 0.953 . . . . 0.0 109.447 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -57.28 -49.21 76.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.857 0.863 . . . . 0.0 111.605 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.69 -27.59 66.56 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.63 -41.04 80.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.655 1.116 . . . . 0.0 112.073 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.69 -39.03 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.473 0.709 . . . . 0.0 110.835 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -65.3 -24.46 67.29 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.99 -21.55 59.95 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 172.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -50.06 9.21 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.185 0.594 . . . . 0.0 109.572 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 131.28 50.73 0.1 OUTLIER Glycine 0 N--CA 1.467 0.755 0 C-N-CA 124.658 1.123 . . . . 0.0 113.81 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -136.34 -167.18 2.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.326 1.85 . . . . 0.0 108.72 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -127.14 129.57 48.14 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 121.016 -1.053 . . . . 0.0 110.212 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -116.26 149.15 39.67 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.301 1.44 . . . . 0.0 109.472 172.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.3 t -140.66 133.67 29.3 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.34 1.056 . . . . 0.0 109.325 172.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 24.9 m -84.73 121.97 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.38 0.609 . . . . 0.0 109.432 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 126.171 1.788 . . . . 0.0 109.51 -172.627 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.0 m -120.46 151.36 39.44 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.475 1.11 . . . . 0.0 110.523 -171.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.96 176.42 8.95 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.182 0.993 . . . . 0.0 113.453 172.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -112.76 136.91 51.82 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.727 1.211 . . . . 0.0 113.093 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -147.17 142.43 27.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.636 168.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -104.77 111.98 24.92 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.914 1.286 . . . . 0.0 108.361 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 mt -85.12 139.43 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.657 0.783 . . . . 0.0 109.593 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.99 123.05 43.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.047 1.339 . . . . 0.0 111.304 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.14 -9.36 24.89 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.884 1.23 . . . . 0.0 114.886 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.2 ptp -57.35 -7.64 0.62 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -56.87 -24.65 53.13 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.828 -1.17 . . . . 0.0 112.839 168.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.8 m -97.38 119.18 35.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 167.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -58.04 -28.04 64.13 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.522 1.055 . . . . 0.0 113.454 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.6 p -53.13 -28.55 26.34 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 170.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.25 -51.52 68.59 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.877 0.762 . . . . 0.0 111.215 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -74.6 -27.64 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.54 -56.19 24.42 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.088 0.955 . . . . 0.0 111.847 -175.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -65.15 -33.94 77.2 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.732 -0.605 . . . . 0.0 112.285 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.3 mt -58.96 -47.95 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 118.885 0.766 . . . . 0.0 111.012 169.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -63.32 -33.8 76.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.578 1.151 . . . . 0.0 112.518 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -68.48 -41.37 80.22 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.34 -0.85 . . . . 0.0 112.295 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.62 -31.2 15.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -170.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.465 ' CD1' HG22 ' A' ' 78' ' ' ILE . 35.3 mm -96.35 119.14 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.78 1.173 . . . . 0.0 109.293 -171.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 132.54 -8.16 5.28 Favored Glycine 0 CA--C 1.541 1.719 0 C-N-CA 125.72 1.628 . . . . 0.0 113.626 -168.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -100.95 -13.88 18.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.502 1.921 . . . . 0.0 112.574 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.42 149.81 30.01 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.08 1.752 . . . . 0.0 111.539 -167.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.6 tp -17.46 -64.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.65 2.78 . . . . 0.0 114.411 170.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.29 19.1 13.4 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 116.333 -2.371 . . . . 0.0 115.868 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.3 t -115.47 118.19 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 121.683 2.742 . . . . 0.0 110.444 169.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -90.82 -40.54 11.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.777 0.831 . . . . 0.0 112.503 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.4 m -147.91 166.21 28.34 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.796 -1.19 . . . . 0.0 113.855 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.2 tp -126.82 145.67 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.996 1.318 . . . . 0.0 111.5 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -142.16 159.31 42.49 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.103 2.161 . . . . 0.0 109.774 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -140.71 144.29 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.338 -1.476 . . . . 0.0 112.206 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.0 m -138.77 58.32 1.66 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.184 1.394 . . . . 0.0 111.136 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.13 -30.14 69.09 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.817 2.047 . . . . 0.0 115.212 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -61.71 -20.36 63.4 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.654 1.116 . . . . 0.0 113.147 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -114.63 1.22 14.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.469 1.908 . . . . 0.0 112.303 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt 57.34 22.2 7.56 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.901 1.68 . . . . 0.0 112.876 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.77 153.13 18.06 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.343 1.068 . . . . 0.0 108.565 171.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.1 155.82 27.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 168.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.72 128.24 45.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -169.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -117.74 134.99 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 121.843 -0.535 . . . . 0.0 110.352 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -106.12 79.07 1.36 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -100.39 175.39 5.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.305 1.842 . . . . 0.0 109.53 -172.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.45 142.64 40.9 Favored Pre-proline 0 N--CA 1.477 0.89 0 CA-C-N 121.528 1.967 . . . . 0.0 111.501 168.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.89 5.67 6.28 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.972 2.448 . . . . 0.0 112.637 -172.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.2 t -87.39 -48.41 7.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.446 1.021 . . . . 0.0 110.168 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 85.1 m -101.3 -16.28 16.99 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.7 t -145.76 -178.35 6.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.381 1.072 . . . . 0.0 111.079 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 p -162.47 158.31 19.79 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.786 1.234 . . . . 0.0 111.83 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -46.79 -43.51 23.57 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.699 3.6 . . . . 0.0 116.368 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.8 m -70.64 -35.84 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.267 1.394 . . . . 0.0 112.388 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.42 85.45 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.153 0.981 . . . . 0.0 110.934 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.58 -48.2 73.16 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.257 1.023 . . . . 0.0 111.888 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -56.43 -52.06 66.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.121 0.873 . . . . 0.0 110.364 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -53.2 -42.95 66.79 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.649 1.18 . . . . 0.0 113.214 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.31 -59.24 2.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.602 1.161 . . . . 0.0 112.697 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.465 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.7 pt -71.94 -33.48 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -168.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -70.19 -12.01 61.29 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.26 0.624 . . . . 0.0 112.55 174.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.7 6.74 30.01 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.561 -1.337 . . . . 0.0 113.699 176.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt -56.42 -57.71 21.4 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.283 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.34 169.88 18.6 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.972 1.781 . . . . 0.0 110.459 168.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -76.21 55.65 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.269 3.313 . . . . 0.0 110.656 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.86 27.02 71.42 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.095 0.855 . . . . 0.0 113.898 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -100.46 -14.22 18.38 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 -167.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -135.26 114.03 11.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.051 1.34 . . . . 0.0 108.88 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -93.68 157.25 16.26 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.178 -0.951 . . . . 0.0 111.054 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.28 136.54 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 118.219 0.463 . . . . 0.0 111.859 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -111.38 121.54 45.49 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.195 0.998 . . . . 0.0 111.822 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.555 1.162 0 C-N-CA 128.241 2.617 . . . . 0.0 111.023 179.174 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.6 p -150.79 128.07 11.3 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.418 1.487 . . . . 0.0 113.609 -168.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.2 m -143.94 143.23 31.16 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.371 1.068 . . . . 0.0 111.649 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 84.8 m -100.2 144.31 29.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.546 0.738 . . . . 0.0 110.221 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.11 167.52 21.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.429 1.092 . . . . 0.0 110.903 166.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.04 133.45 55.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.457 1.903 . . . . 0.0 110.142 -176.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.7 mm -120.82 137.06 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.278 1.831 . . . . 0.0 109.306 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.03 125.44 48.72 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.957 1.303 . . . . 0.0 110.391 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.44 131.33 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.182 0.993 . . . . 0.0 111.52 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.44 53.68 0.87 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.815 1.646 . . . . 0.0 112.581 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.0 53.76 0.33 Allowed Glycine 0 N--CA 1.464 0.525 0 C-N-CA 124.926 1.251 . . . . 0.0 110.963 173.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.5 mtm -133.3 142.94 48.72 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.849 0.824 . . . . 0.0 112.01 -175.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 t -165.28 124.62 1.76 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.495 1.918 . . . . 0.0 107.775 -172.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 72.31 160.8 0.23 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.542 1.937 . . . . 0.0 115.409 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.42 -32.58 67.02 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.31 170.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 p -65.76 -28.37 68.98 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.601 -1.312 . . . . 0.0 112.837 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 52.2 t -68.4 -46.17 70.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.028 1.285 . . . . 0.0 111.154 170.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.1 t -52.78 -55.42 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.143 0.429 . . . . 0.0 110.085 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -71.17 -17.41 62.54 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -176.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 m -74.58 -47.41 32.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.071 0.948 . . . . 0.0 111.492 167.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.8 -54.19 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.795 -1.191 . . . . 0.0 110.69 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -55.06 -30.68 60.12 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.82 2.048 . . . . 0.0 111.866 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.86 -51.17 8.07 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.874 1.702 . . . . 0.0 113.851 173.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 79.5 mmm -74.97 -53.87 8.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.5 1.52 . . . . 0.0 114.049 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.2 mm -71.24 -19.38 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.458 1.103 . . . . 0.0 112.437 -169.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 65.6 p -70.64 0.6 6.6 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 171.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -121.55 33.71 5.43 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.19 10.79 6.91 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.669 2.099 . . . . 0.0 116.669 -172.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 76.2 118.81 0.05 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.922 2.489 . . . . 0.0 113.968 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 97.12 21.74 19.52 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.106 -1.385 . . . . 0.0 114.398 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.34 94.94 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.181 2.192 . . . . 0.0 110.251 -178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -75.62 -56.53 4.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.032 0.933 . . . . 0.0 111.776 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -141.9 129.94 22.0 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.227 1.411 . . . . 0.0 109.007 -172.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -140.88 129.11 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.907 1.283 . . . . 0.0 110.517 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.2 t -142.23 129.65 21.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.21 1.004 . . . . 0.0 111.527 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.03 139.27 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.113 1.765 . . . . 0.0 110.522 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 74.5 p -143.3 146.3 33.46 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.5 mt -72.77 -24.27 60.92 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.63 -42.57 71.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.147 1.779 . . . . 0.0 113.535 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -111.09 -13.36 14.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.552 1.141 . . . . 0.0 110.409 168.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.57 49.7 7.08 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 125.453 1.501 . . . . 0.0 110.653 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.1 p -138.56 147.09 42.65 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -168.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -113.7 139.38 49.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.98 1.712 . . . . 0.0 112.297 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 7.5 t -112.25 125.62 54.35 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 166.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.59 134.74 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 122.153 -0.342 . . . . 0.0 110.852 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.93 113.77 25.53 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.768 2.427 . . . . 0.0 106.402 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -111.71 163.0 14.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.247 1.019 . . . . 0.0 112.95 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -97.11 98.1 4.37 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.417 1.887 . . . . 0.0 109.171 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.87 -12.13 33.66 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.137 1.891 . . . . 0.0 115.148 -169.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.36 -24.25 46.54 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.329 0.968 . . . . 0.0 112.447 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.8 t -95.7 -50.83 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.926 1.69 . . . . 0.0 111.046 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.33 149.5 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 122.095 0.95 . . . . 0.0 112.231 -170.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.5 t -97.68 143.43 26.2 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.673 1.589 . . . . 0.0 112.295 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.75 -16.12 51.93 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.62 2.214 . . . . 0.0 113.91 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -70.31 -27.36 64.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.696 1.134 . . . . 0.0 111.388 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -76.29 -20.29 57.47 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.764 2.026 . . . . 0.0 112.664 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 97.0 mt -67.37 -56.03 11.38 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.937 0.895 . . . . 0.0 111.32 -175.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -56.6 -38.33 71.87 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.788 -0.57 . . . . 0.0 112.406 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.86 -28.41 68.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.942 0.897 . . . . 0.0 112.974 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.37 69.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.462 1.028 . . . . 0.0 112.907 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.5 mp -72.48 -40.47 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.078 0.951 . . . . 0.0 110.867 171.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.14 -26.34 65.73 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.806 -0.559 . . . . 0.0 112.173 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.73 -26.75 62.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.503 1.521 . . . . 0.0 112.396 169.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 23.1 ttt -75.19 -38.32 60.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.225 1.01 . . . . 0.0 111.75 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.04 11.4 1.06 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.179 1.371 . . . . 0.0 116.338 172.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -111.11 -165.64 1.01 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.459 1.504 . . . . 0.0 110.049 -176.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -125.19 133.47 52.74 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.367 1.067 . . . . 0.0 111.364 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -136.43 143.8 44.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.991 1.316 . . . . 0.0 112.52 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -129.57 139.72 51.41 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.139 1.376 . . . . 0.0 109.036 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.2 p -87.89 111.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 125.491 1.517 . . . . 0.0 107.787 -173.39 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 120.658 0.266 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -95.71 151.82 19.02 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.424 1.489 . . . . 0.0 111.11 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -137.47 128.38 27.31 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 127.03 2.132 . . . . 0.0 109.012 -172.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLN . . . . . 0.522 ' HG3' HG21 ' A' ' 59' ' ' THR . 3.5 tp-100 -103.89 115.54 30.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.088 0.858 . . . . 0.0 112.01 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.454 ' HB3' HD21 ' A' ' 90' ' ' LEU . 1.7 pt? -135.83 142.08 44.78 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -172.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -109.14 107.36 17.63 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.709 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mm -80.0 152.25 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.966 1.706 . . . . 0.0 111.415 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -105.18 140.37 38.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.383 1.473 . . . . 0.0 110.283 168.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.65 -8.96 76.49 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.908 1.242 . . . . 0.0 114.142 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 ptm -66.26 -6.32 13.45 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.284 1.542 . . . . 0.0 115.153 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.13 -24.08 66.94 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.169 -0.957 . . . . 0.0 110.834 165.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -99.5 114.91 28.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.577 1.551 . . . . 0.0 107.466 167.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -59.09 -30.78 68.34 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.633 -1.292 . . . . 0.0 112.213 -173.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.4 m -51.31 -21.91 2.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.641 1.576 . . . . 0.0 114.227 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.7 t -58.59 -49.36 77.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.618 1.167 . . . . 0.0 112.804 170.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -73.85 -28.22 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.49 -47.96 83.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.491 1.116 . . . . 0.0 111.468 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -41.59 76.66 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.505 -0.747 . . . . 0.0 111.309 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.4 mt -65.6 -47.03 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 122.947 0.499 . . . . 0.0 109.912 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HA ' HG21 ' A' ' 51' ' ' ILE . 14.9 tm-20 -65.9 -29.64 70.1 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.423 1.489 . . . . 0.0 113.32 -175.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.56 -52.09 24.02 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.829 -0.544 . . . . 0.0 112.401 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -91.63 -7.95 48.57 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -166.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.466 ' CD1' HG22 ' A' ' 78' ' ' ILE . 46.6 mm -122.48 128.62 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.089 1.356 . . . . 0.0 108.504 172.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.76 -5.33 4.05 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.94 1.257 . . . . 0.0 115.397 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -114.98 -5.47 12.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.394 1.477 . . . . 0.0 112.976 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.34 152.14 44.47 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.916 1.287 . . . . 0.0 111.605 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -48.29 -30.7 5.08 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.86 7.72 27.6 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 116.548 -2.251 . . . . 0.0 115.67 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.87 116.67 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 121.466 2.633 . . . . 0.0 110.414 169.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -71.89 -51.28 23.05 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.631 0.372 . . . . 0.0 110.203 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 p -151.08 155.23 38.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.542 1.137 . . . . 0.0 113.149 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.489 HG21 ' HA ' ' A' ' 39' ' ' GLU . 10.7 tp -98.26 155.07 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.083 1.353 . . . . 0.0 109.199 169.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -138.26 144.63 40.62 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.53 1.059 . . . . 0.0 111.117 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.9 t -108.38 127.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.315 1.446 . . . . 0.0 108.842 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.9 m -133.82 54.28 1.96 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.512 0.672 . . . . 0.0 111.967 -172.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.3 mt -68.66 -25.99 65.09 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.413 -1.429 . . . . 0.0 113.35 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -74.17 -17.65 60.88 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 171.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -95.7 -8.17 35.38 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.101 1.361 . . . . 0.0 110.81 168.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 mptt 74.89 14.2 3.28 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.975 2.51 . . . . 0.0 113.004 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.522 HG21 ' HG3' ' A' ' 23' ' ' GLN . 17.7 p -124.16 175.23 7.15 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.285 2.234 . . . . 0.0 110.331 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.96 167.58 10.14 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.035 1.334 . . . . 0.0 107.981 165.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -140.62 143.35 35.15 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.717 0.407 . . . . 0.0 110.932 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 p -140.31 133.48 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.545 0.611 . . . . 0.0 111.511 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.39 81.44 2.53 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.993 1.717 . . . . 0.0 108.519 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -101.32 148.82 24.69 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.103 1.361 . . . . 0.0 111.825 -174.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.26 122.09 49.55 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.719 0.808 . . . . 0.0 110.482 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -60.28 0.47 0.7 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 124.659 3.573 . . . . 0.0 115.252 173.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.4 m -65.39 -35.0 79.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.527 1.531 . . . . 0.0 112.79 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 81.7 m -122.32 -23.06 5.36 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -170.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -143.07 -178.24 5.74 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.213 1.405 . . . . 0.0 111.181 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.9 t -163.17 143.39 7.07 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.429 1.892 . . . . 0.0 109.344 -171.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -40.57 -49.31 4.16 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 125.007 3.804 . . . . 0.0 117.263 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.6 m -70.0 -36.65 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.327 1.421 . . . . 0.0 113.362 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.34 -36.31 66.14 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.242 1.017 . . . . 0.0 110.839 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -67.61 -48.87 65.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.733 2.013 . . . . 0.0 110.787 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -53.25 -52.97 57.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.3 1.04 . . . . 0.0 110.836 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -57.84 -38.67 76.05 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.341 1.057 . . . . 0.0 112.493 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.1 -43.51 74.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.581 0.752 . . . . 0.0 112.776 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.466 HG22 ' CD1' ' A' ' 42' ' ' ILE . 7.2 pt -74.56 -37.42 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.91 -33.64 75.75 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -171.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.37 12.93 23.1 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.2 mt -53.61 -47.58 96.04 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.194 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.45 169.93 16.55 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.289 2.659 . . . . 0.0 112.566 171.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.88 64.2 7.62 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 124.893 3.729 . . . . 0.0 110.037 169.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.57 23.48 72.13 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.324 1.44 . . . . 0.0 114.602 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -94.46 -30.81 14.25 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -167.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -122.2 115.96 23.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.706 1.202 . . . . 0.0 108.893 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.79 157.09 16.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.082 0.953 . . . . 0.0 111.842 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.5 t -112.01 137.92 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.725 0.81 . . . . 0.0 110.478 167.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.4 m -113.29 129.61 56.48 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.113 0.565 . . . . 0.0 111.042 166.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.454 HD21 ' HB3' ' A' ' 24' ' ' LEU . 14.4 mt . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 127.512 2.325 . . . . 0.0 112.398 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.732 0.301 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' CYS . . . . . 0.548 ' HB2' HD11 ' A' ' 165' ' ' LEU . 11.9 p 178.44 139.08 0.09 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.176 1.79 . . . . 0.0 113.269 -171.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 p -147.61 143.5 27.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.841 1.656 . . . . 0.0 111.515 168.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.78 147.26 24.57 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 120.058 1.299 . . . . 0.0 111.982 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.26 165.21 28.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.257 1.423 . . . . 0.0 113.127 173.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.17 135.36 46.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.683 1.993 . . . . 0.0 111.345 173.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.9 mm -120.34 136.12 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.716 1.206 . . . . 0.0 107.994 168.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.15 136.14 39.53 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.5 mt -130.07 142.21 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.707 -1.246 . . . . 0.0 110.884 -168.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.4 61.56 1.6 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.125 1.77 . . . . 0.0 112.939 -174.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.08 49.2 0.19 Allowed Glycine 0 N--CA 1.466 0.687 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.01 164.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 77.1 mtm -117.22 143.87 45.41 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.256 1.027 . . . . 0.0 111.505 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.0 t -159.82 127.45 4.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 127.185 2.194 . . . . 0.0 106.156 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 2.3 t 74.8 148.13 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.902 1.681 . . . . 0.0 113.034 -175.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.44 -29.6 49.94 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.453 -0.779 . . . . 0.0 112.29 171.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.9 p -61.93 -34.14 75.55 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.733 -1.23 . . . . 0.0 112.512 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 30.4 t -68.32 -37.56 80.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.305 1.411 . . . . 0.0 112.181 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 t -58.05 -56.52 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 118.883 -0.579 . . . . 0.0 109.888 169.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -62.95 -23.3 67.33 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.977 0.808 . . . . 0.0 112.798 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 m -70.33 -55.33 9.42 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.715 1.206 . . . . 0.0 111.966 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.86 -48.74 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 119.47 1.032 . . . . 0.0 110.837 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -60.42 -25.27 65.82 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.362 2.265 . . . . 0.0 111.844 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.5 -58.25 3.64 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 127.547 2.498 . . . . 0.0 114.094 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 21.5 mmt -71.73 -53.29 13.93 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.398 1.479 . . . . 0.0 113.204 -169.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.5 mm -66.0 -30.06 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.892 -0.505 . . . . 0.0 110.618 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.0 t -57.12 -19.71 21.52 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -96.69 17.38 16.61 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -167.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.89 169.59 9.74 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.476 1.51 . . . . 0.0 110.55 169.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -64.32 163.35 13.15 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.935 1.35 . . . . 0.0 114.501 -171.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.07 -32.21 1.31 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.62 1.581 . . . . 0.0 116.788 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.9 p -78.0 97.6 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 119.968 1.884 . . . . 0.0 112.935 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLN . . . . . 0.517 ' HB3' HD12 ' A' ' 165' ' ' LEU . 26.8 tt0 -76.66 -39.27 52.75 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.982 1.313 . . . . 0.0 112.84 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -144.58 140.75 28.97 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.33 1.052 . . . . 0.0 110.099 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -144.96 129.85 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 119.306 0.957 . . . . 0.0 111.571 172.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.19 124.6 20.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.699 1.2 . . . . 0.0 110.677 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.6 t -126.53 149.64 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 120.616 -1.302 . . . . 0.0 110.279 -169.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.7 t -142.94 145.47 33.05 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.185 0.993 . . . . 0.0 112.943 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.01 -18.33 61.97 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.525 1.93 . . . . 0.0 114.362 171.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.88 -48.24 67.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.227 1.411 . . . . 0.0 111.949 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -108.7 -17.47 13.94 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.27 1.828 . . . . 0.0 111.949 170.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.73 50.97 5.03 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.084 1.326 . . . . 0.0 111.622 -171.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 43.0 p -138.79 147.68 42.87 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.397 1.099 . . . . 0.0 113.677 -169.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -111.2 134.89 52.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.213 1.805 . . . . 0.0 111.402 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.1 t -109.07 118.37 36.59 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.5 138.21 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -167.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 121' ' ' CYS . 0.4 OUTLIER -96.8 118.73 33.88 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.079 2.152 . . . . 0.0 108.1 175.675 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -119.08 158.42 25.89 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.649 1.179 . . . . 0.0 112.45 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -95.69 115.06 65.22 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.066 1.346 . . . . 0.0 108.568 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.59 -6.7 17.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.41 2.74 . . . . 0.0 113.798 -170.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.06 -45.59 10.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.077 0.951 . . . . 0.0 112.007 169.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 72.2 t -83.38 -28.57 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.343 1.457 . . . . 0.0 112.52 -171.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 tt -147.27 144.87 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.517 1.127 . . . . 0.0 110.558 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.3 m -106.42 147.94 35.83 Favored Pre-proline 0 CA--C 1.551 1.002 0 O-C-N 121.244 -0.91 . . . . 0.0 111.319 173.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -53.53 -32.49 63.77 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.712 3.608 . . . . 0.0 116.177 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.53 -27.73 64.79 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.47 -32.99 66.68 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 112.241 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 65.6 mt -59.09 -50.47 73.93 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.616 1.166 . . . . 0.0 108.977 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -54.23 -48.35 71.19 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.95 1.3 . . . . 0.0 111.86 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.6 -30.48 71.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.71 -32.83 71.62 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.087 0.955 . . . . 0.0 112.938 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.6 mt -74.55 -32.9 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.195 0.998 . . . . 0.0 112.093 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -68.25 -34.13 75.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.899 0.772 . . . . 0.0 111.525 168.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.33 -30.01 70.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.429 1.091 . . . . 0.0 112.445 171.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.4 ttt -75.4 -28.73 59.57 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.351 -0.843 . . . . 0.0 112.491 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 116.82 30.56 1.95 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.648 1.594 . . . . 0.0 115.32 169.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -125.66 -156.88 0.76 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.466 1.507 . . . . 0.0 109.379 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -133.68 147.14 51.37 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.998 -1.064 . . . . 0.0 111.118 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.42 136.35 34.59 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.119 1.368 . . . . 0.0 112.592 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -114.45 125.91 54.36 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.344 1.858 . . . . 0.0 110.231 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.84 59.78 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.482 1.134 . . . . 0.0 109.759 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.014 0.925 . . . . 0.0 111.857 -169.782 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.5 m . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 122.084 0.945 . . . . 0.0 112.091 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 8.2 m -109.21 135.1 50.87 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 114.054 -1.43 . . . . 0.0 110.846 -170.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.288 0.1 OUTLIER -134.5 160.08 39.13 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 168.326 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -120.05 134.79 55.15 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 127.529 2.332 . . . . 0.0 108.563 -171.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 pp -146.49 160.52 42.01 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 172.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 41.2 mmm-85 -102.04 155.64 18.05 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 124.67 1.188 . . . . 0.0 110.439 168.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.9 mt -135.16 141.29 43.19 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.827 0 C-N-CA 126.658 1.983 . . . . 0.0 110.822 -178.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -97.22 129.9 44.5 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 125.366 1.466 . . . . 0.0 109.195 171.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.24 -19.65 50.49 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.181 1.372 . . . . 0.0 113.627 -173.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -64.66 -14.01 56.46 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 119.426 1.613 . . . . 0.0 113.224 174.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -49.37 -37.45 24.98 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.766 1.627 . . . . 0.0 111.859 166.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 93.1 m -78.76 -1.11 33.13 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 71.25 -60.21 0.52 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 129.162 2.985 . . . . 0.0 112.19 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.2 m -53.03 -27.57 20.25 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 125.91 1.684 . . . . 0.0 114.551 -177.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -46.68 -37.85 8.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.909 1.684 . . . . 0.0 112.985 169.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.98 -19.07 19.78 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 113.611 0.967 . . . . 0.0 113.611 -177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.421 HD13 ' C ' ' A' ' 36' ' ' LEU . 3.1 tm? -69.67 -54.09 15.54 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.758 1.223 . . . . 0.0 112.143 -171.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -65.2 -28.59 69.49 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 124.311 1.044 . . . . 0.0 111.894 177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 55.3 mt -65.5 -56.08 16.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 CA-C-N 118.895 0.77 . . . . 0.0 109.734 167.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.36 -39.77 61.17 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 125.237 1.415 . . . . 0.0 112.506 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.5 tt0 -62.28 -40.94 97.89 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.347 0.659 . . . . 0.0 112.554 -178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 60.0 m-80 -90.82 -28.44 18.2 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.594 1.158 . . . . 0.0 113.209 -175.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.467 ' CD1' HG22 ' A' ' 78' ' ' ILE . 34.3 mm -97.46 117.49 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 O-C-N 121.149 -0.969 . . . . 0.0 109.235 -173.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 124.64 -17.17 7.35 Favored Glycine 0 CA--C 1.534 1.28 0 C-N-CA 125.031 1.3 . . . . 0.0 115.648 -172.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -96.49 0.74 50.7 Favored 'General case' 0 N--CA 1.479 0.979 0 CA-C-N 118.506 1.153 . . . . 0.0 113.228 172.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 46.4 mt -92.08 154.63 18.61 Favored 'General case' 0 C--O 1.233 0.207 0 C-N-CA 125.676 1.59 . . . . 0.0 113.081 -169.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -51.27 -34.18 31.73 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 -173.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -109.59 4.87 31.06 Favored Glycine 0 CA--C 1.534 1.266 0 CA-C-O 117.715 -1.603 . . . . 0.0 115.845 177.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.3 t -134.32 119.62 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 120.905 2.353 . . . . 0.0 109.73 175.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 -26.81 13.25 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -169.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.3 p -149.11 173.18 13.68 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.69 1.196 . . . . 0.0 111.17 172.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 tp -138.78 145.95 27.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.054 0.942 . . . . 0.0 110.082 176.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -134.78 148.17 50.16 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 125.353 1.461 . . . . 0.0 108.394 179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 30.5 m -117.92 150.62 20.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 O-C-N 120.624 -1.297 . . . . 0.0 110.762 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.2 t -141.45 58.36 1.51 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 122.881 1.324 . . . . 0.0 110.405 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.2 mt -69.83 -26.98 64.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.56 1.544 . . . . 0.0 113.641 -169.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -69.48 -24.02 63.72 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.34 1.456 . . . . 0.0 113.206 170.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.9 t30 -91.25 -25.11 19.64 Favored 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 125.751 1.62 . . . . 0.0 111.429 169.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 13.0 mptt 98.21 3.93 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.037 1 C-N-CA 132.577 4.351 . . . . 0.0 111.961 176.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 18.3 p -107.61 166.99 10.26 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 124.855 1.262 . . . . 0.0 112.578 -172.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -111.42 145.0 39.72 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.189 0.995 . . . . 0.0 108.534 167.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.407 HE21 ' HA ' ' A' ' 61' ' ' GLN . 2.9 tp60 -124.82 106.31 9.94 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.806 1.242 . . . . 0.0 110.695 -169.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 5.2 p -101.3 143.53 14.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 CA-C-O 121.188 0.518 . . . . 0.0 111.826 -173.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 52.7 mttt -114.43 90.36 3.32 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.858 2.063 . . . . 0.0 107.235 -175.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.4 p90 -115.62 154.42 29.49 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 115.929 1.826 . . . . 0.0 115.929 -166.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -97.22 117.51 65.57 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 126.848 2.059 . . . . 0.0 109.286 176.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -71.65 5.6 2.38 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 123.368 2.712 . . . . 0.0 114.672 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 p -84.81 -30.26 24.72 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.694 1.198 . . . . 0.0 113.585 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 64.1 m -113.43 -21.89 10.65 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.439 1.095 . . . . 0.0 113.63 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.9 t -144.41 179.81 7.02 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-O 122.067 0.937 . . . . 0.0 111.943 -169.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 90.8 p -166.03 164.7 11.21 Favored Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 126.878 2.071 . . . . 0.0 109.476 -169.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.86 -49.25 16.53 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.334 2.689 . . . . 0.0 114.546 -174.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 6.0 p -66.33 -38.22 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 N-CA-C 113.518 0.933 . . . . 0.0 113.518 176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.11 -40.13 75.09 Favored 'General case' 0 CA--C 1.539 0.542 0 O-C-N 121.588 -0.695 . . . . 0.0 111.442 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 80.6 mt -58.8 -53.34 59.46 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 125.561 1.544 . . . . 0.0 110.408 169.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -50.8 -53.26 33.48 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.652 1.181 . . . . 0.0 110.758 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -69.1 -25.76 64.58 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.6 -60.28 2.31 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 120.166 1.348 . . . . 0.0 111.349 173.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.467 HG22 ' CD1' ' A' ' 42' ' ' ILE . 7.9 pt -72.23 -32.22 42.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -168.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -65.84 -19.42 65.87 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 119.06 0.845 . . . . 0.0 112.92 177.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -102.37 10.42 39.09 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 114.706 1.372 . . . . 0.0 114.706 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.1 mt -60.22 -50.56 85.45 Favored Pre-proline 0 CA--C 1.545 0.773 0 CA-C-O 117.899 -1.048 . . . . 0.0 110.76 165.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -81.05 172.79 12.58 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.084 2.522 . . . . 0.0 112.071 171.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -76.78 65.47 7.59 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 124.609 3.54 . . . . 0.0 110.627 169.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 60.7 33.15 81.36 Favored Glycine 0 N--CA 1.473 1.154 0 O-C-N 121.246 -0.909 . . . . 0.0 112.95 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 3.8 t-20 -107.05 -19.49 13.6 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 116.007 1.855 . . . . 0.0 116.007 -166.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -130.47 105.85 8.14 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.293 1.437 . . . . 0.0 108.603 179.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 32.8 ttpt -99.07 136.11 39.52 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.913 1.285 . . . . 0.0 112.372 -169.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.8 m -99.17 156.72 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-N 119.735 1.152 . . . . 0.0 112.737 -178.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.6 m -134.72 116.93 15.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 124.44 1.096 . . . . 0.0 110.159 167.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.9 mm? . . . . . 0 CA--C 1.547 0.828 0 C-N-CA 126.896 2.078 . . . . 0.0 110.594 -178.226 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.3 t . . . . . 0 N--CA 1.472 0.632 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 27.6 p -144.21 145.69 32.23 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 -168.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 31.7 t -146.43 160.0 42.66 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.543 1.937 . . . . 0.0 109.407 167.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.55 138.12 54.44 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.289 0.636 . . . . 0.0 109.659 178.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -142.78 160.0 41.17 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 118.955 0.798 . . . . 0.0 112.778 174.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.5 tt -116.26 140.41 49.35 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 125.752 1.621 . . . . 0.0 110.248 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.6 mm -127.34 139.85 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 127.647 2.379 . . . . 0.0 108.777 -169.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -104.57 133.58 49.19 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.913 1.285 . . . . 0.0 110.261 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.7 mp -123.27 137.67 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 O-C-N 120.533 -1.354 . . . . 0.0 110.913 -173.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.45 58.55 1.13 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.314 1.845 . . . . 0.0 111.554 179.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.34 55.86 0.24 Allowed Glycine 0 CA--C 1.521 0.432 0 C-N-CA 125.222 1.391 . . . . 0.0 111.183 168.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 64.7 mtm -131.94 111.57 11.67 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.738 1.215 . . . . 0.0 109.495 176.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.9 t -116.0 -12.17 11.36 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.241 1.816 . . . . 0.0 112.989 -169.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 52.7 m -156.04 161.5 40.43 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 127.773 2.429 . . . . 0.0 110.398 178.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.64 -31.06 65.9 Favored 'General case' 0 N--CA 1.474 0.737 0 O-C-N 120.864 -1.147 . . . . 0.0 113.947 176.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 17.0 p -53.65 -22.26 8.47 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.364 1.466 . . . . 0.0 114.626 173.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 75.4 m -56.15 -36.75 68.65 Favored 'General case' 0 CA--C 1.537 0.467 0 O-C-N 121.37 -0.831 . . . . 0.0 111.97 169.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 65.5 t -61.83 -53.43 48.15 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 118.843 -0.599 . . . . 0.0 110.793 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -69.14 -24.04 64.04 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 119.093 0.86 . . . . 0.0 111.55 -174.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 16.1 m -72.54 -51.75 18.56 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.323 1.449 . . . . 0.0 111.598 173.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.5 mt -68.87 -55.45 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 121.008 -1.057 . . . . 0.0 111.296 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -55.13 -30.73 60.39 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 124.704 1.202 . . . . 0.0 111.059 178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.17 -62.12 2.68 Favored Glycine 0 CA--C 1.531 1.037 0 C-N-CA 125.021 1.296 . . . . 0.0 114.505 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 94.2 mmm -71.31 -38.21 71.75 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -169.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.1 mm -72.53 -23.95 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 123.056 0.542 . . . . 0.0 111.353 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 22.6 t -67.22 1.69 1.99 Allowed 'General case' 0 CA--C 1.553 1.083 0 N-CA-C 115.11 1.522 . . . . 0.0 115.11 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -106.23 -3.54 21.19 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -169.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -105.12 17.08 24.71 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 116.69 2.108 . . . . 0.0 116.69 -168.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 77.76 160.59 0.21 Allowed 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 127.456 2.303 . . . . 0.0 112.663 175.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 68.73 -24.46 0.29 Allowed Glycine 0 CA--C 1.539 1.578 0 O-C-N 120.48 -1.388 . . . . 0.0 115.811 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.5 p -69.85 96.47 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 127.79 2.436 . . . . 0.0 111.165 172.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -79.74 -47.43 15.29 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.779 0.832 . . . . 0.0 111.946 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -143.97 137.07 27.49 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.688 0.795 . . . . 0.0 110.414 179.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.9 tt -137.36 134.39 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 O-C-N 120.849 -1.157 . . . . 0.0 110.933 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 30.0 t -139.24 141.39 37.85 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.881 1.672 . . . . 0.0 109.205 177.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.2 p -145.27 142.68 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.706 1.202 . . . . 0.0 112.015 -176.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 27.0 t -140.58 139.23 34.91 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.441 1.096 . . . . 0.0 112.736 178.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.08 -17.18 62.01 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 126.266 1.826 . . . . 0.0 115.44 174.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.26 -42.54 77.55 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.021 1.328 . . . . 0.0 112.836 -171.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -113.17 -8.39 13.56 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.749 1.619 . . . . 0.0 111.355 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 76.45 48.39 9.29 Favored Glycine 0 C--N 1.343 0.949 0 C-N-CA 125.289 1.423 . . . . 0.0 112.619 -174.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 p -141.14 146.42 37.0 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -167.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -115.22 150.93 35.37 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.175 1.79 . . . . 0.0 111.844 173.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.7 t -125.11 130.03 51.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 125.479 1.512 . . . . 0.0 108.695 169.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.75 136.85 31.32 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.741 -0.599 . . . . 0.0 111.211 -169.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.57 112.96 24.61 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 127.876 2.471 . . . . 0.0 106.628 177.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -118.97 158.98 24.69 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.628 1.171 . . . . 0.0 112.506 -174.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -93.46 112.94 58.72 Favored Pre-proline 0 CA--C 1.546 0.803 0 C-N-CA 124.773 1.229 . . . . 0.0 108.18 175.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.51 -11.17 18.85 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 123.218 2.612 . . . . 0.0 113.005 -172.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -76.07 -45.97 31.46 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.851 1.205 . . . . 0.0 110.7 168.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 69.8 t -79.5 -42.43 23.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 125.369 1.467 . . . . 0.0 113.431 -174.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.4 tt -140.35 150.44 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 CA-C-N 119.211 0.914 . . . . 0.0 113.254 -169.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 60.0 m -112.76 150.71 43.19 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 125.285 1.434 . . . . 0.0 112.005 174.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_exo -48.69 -41.16 38.35 Favored 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.424 3.416 . . . . 0.0 115.009 -179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -63.43 -20.27 65.42 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -75.36 -31.91 60.68 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.104 1.362 . . . . 0.0 113.735 170.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 73.5 mt -60.0 -50.73 72.59 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 124.033 0.933 . . . . 0.0 108.876 176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 46.9 ttt180 -51.69 -51.01 59.28 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 124.195 0.998 . . . . 0.0 111.522 173.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -57.2 -31.67 65.7 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 113.436 0.902 . . . . 0.0 113.436 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.14 -38.98 69.1 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.155 0.982 . . . . 0.0 113.265 178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.1 mp -70.24 -35.53 63.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 O-C-N 121.55 -0.718 . . . . 0.0 110.498 172.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 80.2 mt-10 -64.0 -36.19 83.19 Favored 'General case' 0 CA--C 1.544 0.742 0 O-C-N 121.881 -0.512 . . . . 0.0 111.739 172.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -71.89 -29.5 64.41 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.155 1.782 . . . . 0.0 113.797 172.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 18.1 ttt -65.92 -30.17 70.71 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.322 1.049 . . . . 0.0 111.953 172.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 124.3 13.8 3.83 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 125.943 1.735 . . . . 0.0 115.362 174.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 40.1 m-85 -119.75 -156.46 0.66 Allowed 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.158 1.383 . . . . 0.0 109.568 -173.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -136.06 137.47 41.15 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.928 1.291 . . . . 0.0 109.009 176.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -131.75 156.21 46.36 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.065 1.346 . . . . 0.0 111.627 176.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.1 t -141.96 140.57 32.77 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 126.27 1.828 . . . . 0.0 109.218 179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.4 m -96.05 121.56 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 O-C-N 121.452 -0.78 . . . . 0.0 110.059 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.1 m . . . . . 0 N--CA 1.482 1.163 0 CA-C-O 123.327 1.537 . . . . 0.0 110.829 -177.307 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.4 m . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -97.69 153.03 18.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.237 1.415 . . . . 0.0 110.53 171.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.7 tt -145.64 135.5 23.53 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 125.733 1.613 . . . . 0.0 110.88 -172.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 4.8 tp-100 -98.27 123.54 42.41 Favored 'General case' 0 N--CA 1.462 0.128 0 O-C-N 121.793 -0.567 . . . . 0.0 111.596 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -144.47 138.67 27.81 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.334 1.054 . . . . 0.0 113.593 -178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 26.3 tpt180 -97.64 123.8 41.68 Favored 'General case' 0 C--O 1.226 -0.137 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 169.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.9 mt -95.37 138.63 20.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.417 1.487 . . . . 0.0 107.631 168.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -95.54 142.78 27.48 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 124.548 1.139 . . . . 0.0 110.598 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.94 -4.73 83.36 Favored Glycine 0 CA--C 1.533 1.157 0 C-N-CA 124.661 1.124 . . . . 0.0 113.953 -178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.7 ptp -68.44 0.09 4.37 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -177.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 48.9 t60 -63.94 -13.77 48.49 Favored 'General case' 0 CA--C 1.547 0.843 0 CA-C-N 119.543 1.065 . . . . 0.0 113.213 169.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.9 t -105.33 125.33 50.86 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 120.239 1.381 . . . . 0.0 107.795 165.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.73 -31.16 47.27 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.838 1.255 . . . . 0.0 114.021 -176.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.7 m -63.34 -21.87 66.53 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 121.042 -1.036 . . . . 0.0 113.079 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 63.5 m -71.86 -47.21 54.57 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 119.095 0.861 . . . . 0.0 111.881 -179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 4.3 p -72.4 -23.09 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.108 0.867 . . . . 0.0 112.427 178.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -58.8 -61.35 2.69 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.123 0.969 . . . . 0.0 111.854 -176.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -62.03 -26.4 68.22 Favored 'General case' 0 CA--C 1.548 0.872 0 O-C-N 121.532 -0.73 . . . . 0.0 112.824 -179.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.7 mt -65.93 -53.07 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 O-C-N 120.506 -1.371 . . . . 0.0 110.521 169.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -60.86 -30.07 69.9 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.836 1.255 . . . . 0.0 112.305 -179.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -70.0 -39.78 75.67 Favored 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.008 -1.057 . . . . 0.0 112.546 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -93.69 -19.92 20.64 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.79 1.774 . . . . 0.0 115.79 -173.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.587 HD12 HG22 ' A' ' 78' ' ' ILE . 38.5 mm -102.81 123.6 56.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 122.314 1.054 . . . . 0.0 111.55 -172.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.37 -10.09 2.97 Favored Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.105 1.812 . . . . 0.0 114.57 -176.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -109.5 4.55 22.42 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.839 1.656 . . . . 0.0 113.101 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.9 mp -76.13 176.39 8.05 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.394 1.078 . . . . 0.0 112.216 -173.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.7 tp -38.24 -64.2 0.43 Allowed 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 127.325 2.25 . . . . 0.0 114.058 173.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -117.7 -12.83 7.66 Favored Glycine 0 CA--C 1.53 0.995 0 CA-C-O 117.073 -1.959 . . . . 0.0 115.643 176.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.9 t -79.34 112.72 17.73 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.175 0 CA-C-N 121.57 2.685 . . . . 0.0 109.438 175.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -95.32 -35.45 11.78 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.073 1.349 . . . . 0.0 112.099 -175.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 21.1 t -145.18 169.57 17.92 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 121.853 0.835 . . . . 0.0 112.523 176.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 11.3 tp -138.16 144.83 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 126.115 1.766 . . . . 0.0 108.96 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.4 tt0 -142.63 157.93 44.18 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 126.083 1.753 . . . . 0.0 108.784 -172.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.1 m -127.53 138.69 54.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 O-C-N 120.348 -1.47 . . . . 0.0 111.931 178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.2 m -124.48 56.52 1.28 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.746 1.619 . . . . 0.0 107.855 -177.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 87.2 mt -65.36 -30.69 71.55 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -71.56 -16.91 62.33 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -95.1 -5.67 43.73 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.314 1.445 . . . . 0.0 111.726 169.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 69.5 mmtt 73.39 7.38 5.18 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 128.022 2.529 . . . . 0.0 112.214 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.9 p -110.94 167.07 10.52 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 127.022 2.129 . . . . 0.0 110.787 -179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.97 -179.7 4.24 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.067 165.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -143.86 133.22 23.27 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 121.175 -0.953 . . . . 0.0 109.594 173.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.3 p -127.94 137.36 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 119.38 0.991 . . . . 0.0 111.387 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 37.9 mtpt -114.71 87.11 2.57 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.666 1.586 . . . . 0.0 108.37 -169.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -119.65 155.12 32.95 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.768 1.227 . . . . 0.0 113.478 -171.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -96.57 113.27 62.33 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 126.617 1.967 . . . . 0.0 109.375 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -71.62 -6.89 20.1 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.353 2.702 . . . . 0.0 112.88 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.8 t -86.08 -5.98 59.11 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 124.268 1.027 . . . . 0.0 111.988 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 94.2 m -119.03 -42.4 2.7 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 125.257 1.423 . . . . 0.0 113.464 175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -128.51 -176.31 3.79 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 125.672 1.589 . . . . 0.0 110.232 -177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -160.94 154.2 18.15 Favored Pre-proline 0 CA--C 1.544 0.728 0 CA-C-O 117.484 -1.246 . . . . 0.0 110.24 -176.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -45.05 -56.88 2.4 Favored 'Trans proline' 0 C--N 1.355 0.879 0 C-N-CA 124.069 3.179 . . . . 0.0 116.21 -168.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.8 m -62.7 -36.05 73.48 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 121.059 1.754 . . . . 0.0 113.438 -178.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.43 -41.12 61.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.222 1.009 . . . . 0.0 111.909 -178.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.19 -36.17 74.44 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.719 1.208 . . . . 0.0 110.886 177.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.436 HE21 ' HB ' ' A' ' 88' ' ' VAL . 66.0 tt0 -66.89 -47.69 71.04 Favored 'General case' 0 CA--C 1.537 0.469 0 O-C-N 121.365 -0.834 . . . . 0.0 111.327 175.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 54.6 mtt85 -59.65 -28.86 67.61 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.343 1.057 . . . . 0.0 112.937 172.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.71 -56.06 12.26 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.069 0.85 . . . . 0.0 111.51 169.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.587 HG22 HD12 ' A' ' 42' ' ' ILE . 6.0 pt -72.47 -33.47 45.45 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 114.012 1.116 . . . . 0.0 114.012 -172.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -68.77 -17.99 64.13 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 -177.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.35 8.13 44.94 Favored 'General case' 0 C--O 1.239 0.501 0 O-C-N 120.691 -1.256 . . . . 0.0 113.977 178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 25.5 mt -59.36 -51.06 84.11 Favored Pre-proline 0 CA--C 1.544 0.748 0 CA-C-O 117.723 -1.132 . . . . 0.0 110.018 166.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -80.15 173.73 12.26 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.026 2.484 . . . . 0.0 111.1 168.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_endo -75.18 52.1 3.03 Favored 'Trans proline' 0 CA--C 1.547 1.136 0 C-N-CA 124.418 3.412 . . . . 0.0 111.486 169.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.64 37.64 92.63 Favored Glycine 0 C--N 1.341 0.849 0 C-N-CA 124.803 1.192 . . . . 0.0 112.09 -176.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -102.26 -46.45 4.81 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.894 1.072 . . . . 0.0 113.894 -168.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -97.72 101.02 12.42 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 125.229 1.412 . . . . 0.0 107.402 176.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -99.72 144.4 28.84 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 -167.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.436 ' HB ' HE21 ' A' ' 75' ' ' GLN . 3.5 t -103.0 138.56 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 C-N-CA 123.722 0.809 . . . . 0.0 111.744 -172.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 22.8 m -133.55 121.1 21.63 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.549 1.14 . . . . 0.0 112.121 168.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 CA--C 1.549 0.91 0 C-N-CA 126.223 1.809 . . . . 0.0 112.254 173.234 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.483 1.199 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 95.3 m -143.02 136.02 28.0 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.366 1.466 . . . . 0.0 112.541 -174.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 41.8 t -143.97 154.89 43.77 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.403 1.881 . . . . 0.0 109.229 168.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 13.4 m -114.53 141.16 48.09 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 118.634 0.652 . . . . 0.0 110.051 176.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -142.12 157.35 44.99 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-O 121.519 0.676 . . . . 0.0 112.415 168.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -101.32 136.36 41.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 126.357 1.863 . . . . 0.0 110.029 175.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.7 mt -127.92 133.68 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 C-N-CA 125.717 1.607 . . . . 0.0 109.06 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.68 143.05 30.36 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.434 1.094 . . . . 0.0 109.842 170.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.6 mp -132.04 131.8 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-N 119.395 0.998 . . . . 0.0 112.024 -175.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -102.3 80.72 1.99 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.474 1.51 . . . . 0.0 111.998 173.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 178.49 55.01 0.07 OUTLIER Glycine 0 N--CA 1.467 0.766 0 C-N-CA 124.543 1.068 . . . . 0.0 113.996 165.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.6 mpp? -137.41 145.47 43.24 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.406 0.891 . . . . 0.0 113.406 176.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.4 t -151.72 -28.2 0.18 Allowed 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 126.623 1.969 . . . . 0.0 112.387 -168.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 77.4 m -125.76 136.73 53.49 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 125.968 1.707 . . . . 0.0 111.637 177.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -50.65 -27.38 6.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 125.517 1.527 . . . . 0.0 114.529 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.7 p -55.53 -31.64 62.27 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 125.14 1.376 . . . . 0.0 113.241 178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 1.3 t -62.04 -19.44 62.89 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 112.989 0.737 . . . . 0.0 112.989 -177.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.6 t -57.95 -59.53 3.33 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 O-C-N 121.636 -0.665 . . . . 0.0 109.972 169.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -65.52 -22.37 66.71 Favored 'General case' 0 CA--C 1.548 0.87 0 CA-C-N 118.434 0.561 . . . . 0.0 112.155 -176.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 38.0 m -72.24 -60.49 2.21 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.981 1.313 . . . . 0.0 112.893 169.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 94.4 mt -67.13 -54.48 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 CA-C-N 120.362 1.437 . . . . 0.0 110.583 -177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -59.28 -29.96 67.95 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.792 1.237 . . . . 0.0 111.304 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.63 -62.57 2.66 Favored Glycine 0 C--N 1.343 0.948 0 C-N-CA 124.226 0.917 . . . . 0.0 113.998 173.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 82.1 mmm -70.03 -36.26 74.92 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 -168.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.0 mm -68.02 -31.55 52.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 CA-C-N 118.317 0.508 . . . . 0.0 110.659 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -66.11 -0.42 2.45 Favored 'General case' 0 CA--C 1.557 1.245 0 N-CA-C 114.938 1.459 . . . . 0.0 114.938 175.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.6 mt-30 -92.59 -7.38 47.27 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.389 -1.444 . . . . 0.0 113.915 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 pp -99.91 170.18 8.7 Favored 'General case' 0 CA--C 1.547 0.844 0 C-N-CA 124.723 1.209 . . . . 0.0 112.046 171.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -79.05 166.34 22.42 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 -174.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 71.76 -34.3 0.6 Allowed Glycine 0 CA--C 1.534 1.26 0 CA-C-O 118.592 -1.116 . . . . 0.0 115.779 177.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -74.31 91.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.102 0 CA-C-N 119.448 1.624 . . . . 0.0 110.601 172.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 13.6 tt0 -72.71 -45.67 57.59 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 125.114 1.366 . . . . 0.0 111.819 -176.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -143.3 143.49 31.72 Favored 'General case' 0 CA--C 1.521 -0.138 0 C-N-CA 123.455 0.702 . . . . 0.0 109.175 -178.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -142.06 138.68 30.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.301 0.572 . . . . 0.0 110.462 174.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 67.6 m -138.52 108.67 6.41 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.847 1.259 . . . . 0.0 109.701 -174.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 59.6 t -109.71 133.9 53.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 O-C-N 120.728 -1.232 . . . . 0.0 110.519 -171.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 40.2 t -119.71 93.33 4.03 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.142 2.177 . . . . 0.0 107.457 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 5.0 tt -66.83 -29.23 69.1 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.013 0.925 . . . . 0.0 110.597 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -49.6 -39.82 36.75 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 127.366 2.266 . . . . 0.0 113.629 167.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -100.26 -13.29 18.93 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.614 1.966 . . . . 0.0 112.123 177.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.76 26.93 73.19 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 127.735 2.588 . . . . 0.0 113.344 -172.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 21.0 p -129.28 143.25 50.78 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 118.662 1.231 . . . . 0.0 114.27 -168.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.2 131.33 51.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.47 1.508 . . . . 0.0 109.505 169.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.9 t -113.55 124.09 51.55 Favored 'General case' 0 N--CA 1.474 0.774 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 169.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.66 139.83 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -165.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -98.25 111.22 23.63 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 127.68 2.392 . . . . 0.0 107.422 176.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 19.2 p90 -120.62 156.12 32.33 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.602 1.161 . . . . 0.0 112.685 -176.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -98.6 109.8 54.43 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.695 1.198 . . . . 0.0 111.014 176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.58 -13.43 30.02 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.206 2.604 . . . . 0.0 112.616 -172.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -80.36 -13.84 58.83 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 119.463 1.028 . . . . 0.0 113.719 172.303 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.3 t -118.63 -33.85 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 124.91 1.284 . . . . 0.0 112.481 -170.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.7 tt -143.27 151.17 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.851 1.26 . . . . 0.0 110.504 -178.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 6.5 t -104.7 144.17 28.19 Favored Pre-proline 0 N--CA 1.477 0.894 0 O-C-N 120.951 -1.093 . . . . 0.0 110.978 169.365 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.69 -27.86 27.77 Favored 'Trans proline' 0 CA--C 1.54 0.785 0 C-N-CA 123.698 2.932 . . . . 0.0 114.358 171.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -70.43 -41.73 72.51 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 118.534 0.606 . . . . 0.0 111.386 -178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -75.57 -28.05 58.83 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 170.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.0 tt -57.49 -55.16 38.41 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.598 1.559 . . . . 0.0 110.4 176.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -62.08 -30.36 70.95 Favored 'General case' 0 N--CA 1.472 0.64 0 O-C-N 121.402 -0.811 . . . . 0.0 112.533 175.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -68.85 -16.12 63.69 Favored 'General case' 0 CA--C 1.546 0.798 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 176.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -74.94 -35.08 62.16 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 119.361 0.982 . . . . 0.0 112.232 171.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.5 mp -71.84 -33.73 49.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 124.027 0.931 . . . . 0.0 110.461 171.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -66.37 -31.04 71.56 Favored 'General case' 0 CA--C 1.549 0.928 0 CA-C-N 118.939 0.791 . . . . 0.0 112.084 170.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -70.86 -29.96 66.22 Favored 'General case' 0 CA--C 1.547 0.858 0 O-C-N 120.593 -1.317 . . . . 0.0 112.137 168.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 10.6 ttt -71.85 -27.44 62.89 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.679 1.192 . . . . 0.0 111.725 172.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 124.23 14.2 3.74 Favored Glycine 0 CA--C 1.525 0.657 0 C-N-CA 126.362 1.934 . . . . 0.0 116.886 168.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -128.03 147.09 50.5 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 118.828 1.314 . . . . 0.0 111.046 -169.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -95.17 101.01 12.73 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 123.414 1.578 . . . . 0.0 110.525 -170.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -98.42 143.99 28.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 112.54 -2.118 . . . . 0.0 111.529 -174.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.4 t -141.28 132.22 26.04 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.538 1.535 . . . . 0.0 111.812 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.8 m -86.04 72.66 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 124.329 1.052 . . . . 0.0 110.533 -172.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.2 p . . . . . 0 N--CA 1.477 0.882 0 C-N-CA 124.2 1.0 . . . . 0.0 111.375 178.677 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.4 m . . . . . 0 N--CA 1.477 0.899 0 N-CA-C 111.746 0.276 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 6.7 p -96.65 146.02 25.23 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.56 1.544 . . . . 0.0 112.192 -178.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -142.95 126.44 16.79 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.935 1.694 . . . . 0.0 109.654 174.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.19 131.69 45.05 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.807 1.243 . . . . 0.0 110.192 178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -144.17 155.48 43.93 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.538 -0.756 . . . . 0.0 111.977 169.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -99.91 129.66 46.02 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.319 -0.855 . . . . 0.0 108.704 175.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.8 mt -104.27 147.04 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 C-N-CA 124.835 1.254 . . . . 0.0 110.923 173.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' HB3' ' H ' ' A' ' 87' ' ' LYS . 36.6 t70 -96.18 140.33 31.04 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.956 2.102 . . . . 0.0 110.575 174.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.8 -8.13 73.8 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 124.641 1.115 . . . . 0.0 113.696 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 13.2 ptp -66.08 -13.25 59.72 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 53.9 t-80 -54.23 -32.12 55.11 Favored 'General case' 0 CA--C 1.548 0.869 0 CA-C-N 119.145 0.884 . . . . 0.0 111.85 168.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 48.7 t -70.61 -17.45 62.89 Favored 'General case' 0 CA--C 1.551 0.989 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 176.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 32.8 mmtm 76.31 -57.17 0.56 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 128.76 2.824 . . . . 0.0 112.394 -177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 31.4 p -53.79 -23.04 10.81 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.906 1.282 . . . . 0.0 113.822 -179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.5 t -47.17 -46.92 24.03 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.147 1.779 . . . . 0.0 111.949 168.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -74.17 -17.57 16.97 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 N-CA-C 113.723 1.008 . . . . 0.0 113.723 -177.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.5 tt -67.19 -56.25 10.67 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.464 1.106 . . . . 0.0 110.339 -176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.14 -36.87 73.61 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 121.688 -0.632 . . . . 0.0 111.434 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 47.3 mt -62.28 -48.19 89.54 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.787 0 CA-C-O 118.532 -0.747 . . . . 0.0 111.525 173.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -60.17 -36.14 76.9 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 124.865 1.266 . . . . 0.0 112.849 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -64.95 -40.4 94.97 Favored 'General case' 0 N--CA 1.471 0.609 0 O-C-N 121.33 -0.856 . . . . 0.0 112.351 175.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -91.45 -35.58 14.26 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 114.66 1.355 . . . . 0.0 114.66 -172.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.457 ' CD1' HG22 ' A' ' 78' ' ' ILE . 38.5 mm -99.28 113.28 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 119.417 1.008 . . . . 0.0 110.686 -168.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.96 -21.68 0.89 Allowed Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.477 1.037 . . . . 0.0 115.136 -170.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -108.92 -5.09 16.28 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 118.362 1.081 . . . . 0.0 113.34 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mp -69.72 153.12 43.82 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.992 1.717 . . . . 0.0 111.069 -176.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 30.8 tp -11.12 -69.88 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 128.827 2.851 . . . . 0.0 114.642 174.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -114.48 9.76 22.01 Favored Glycine 0 CA--C 1.533 1.201 0 CA-C-O 115.734 -2.704 . . . . 0.0 117.469 176.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.0 t -88.42 130.62 37.65 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.082 0 CA-C-N 123.117 3.459 . . . . 0.0 108.434 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -100.13 -43.69 6.24 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 123.174 0.59 . . . . 0.0 111.261 175.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.1 p -148.98 164.02 35.8 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.479 1.112 . . . . 0.0 113.028 179.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.6 tp -120.82 149.76 23.7 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.177 1.391 . . . . 0.0 111.625 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -142.64 154.4 44.33 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.259 1.824 . . . . 0.0 110.157 -177.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 76.4 t -133.12 137.68 53.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 O-C-N 120.793 -1.192 . . . . 0.0 110.446 -171.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.1 t -134.35 55.26 1.9 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 125.542 1.537 . . . . 0.0 109.435 175.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.6 -33.36 74.85 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 125.91 1.684 . . . . 0.0 112.952 -169.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -47.89 -34.95 9.67 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.766 2.026 . . . . 0.0 112.504 169.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -116.53 23.22 12.2 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.023 1.329 . . . . 0.0 112.497 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 46.5 mttp 67.37 9.7 7.19 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 128.287 2.635 . . . . 0.0 115.481 169.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.5 p -107.96 145.36 33.95 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.72 1.208 . . . . 0.0 112.44 -176.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -105.19 157.93 16.94 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.613 1.165 . . . . 0.0 108.764 167.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -139.81 118.46 12.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 122.487 0.315 . . . . 0.0 110.263 -169.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.8 p -114.24 132.55 62.98 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 O-C-N 121.782 -0.574 . . . . 0.0 111.11 -174.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.11 93.4 5.7 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.595 1.158 . . . . 0.0 109.008 178.525 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -118.19 152.44 35.66 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 124.353 1.061 . . . . 0.0 112.45 -173.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -100.33 114.98 65.89 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.715 1.606 . . . . 0.0 109.829 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.67 5.69 3.21 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.359 3.372 . . . . 0.0 113.955 -176.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 t -68.0 -34.79 77.19 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.026 0.93 . . . . 0.0 111.444 171.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 74.9 m -114.94 -25.42 8.18 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -168.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.6 t -144.4 -178.38 5.95 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 124.929 1.291 . . . . 0.0 111.839 -173.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 87.6 p -152.6 161.06 30.25 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 125.57 1.548 . . . . 0.0 111.919 -175.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -48.72 -46.46 24.26 Favored 'Trans proline' 0 C--N 1.352 0.757 0 C-N-CA 123.547 2.831 . . . . 0.0 115.137 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.3 m -70.21 -33.52 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 CA-C-N 120.208 1.367 . . . . 0.0 113.262 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.86 -38.0 79.47 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.6 -0.688 . . . . 0.0 111.419 175.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 90.0 mt -67.36 -44.09 79.85 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 124.335 1.054 . . . . 0.0 111.409 173.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -53.66 -55.66 24.06 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 124.303 1.041 . . . . 0.0 110.557 174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.3 mtm-85 -52.79 -48.34 66.94 Favored 'General case' 0 N--CA 1.465 0.325 0 C-N-CA 123.52 0.728 . . . . 0.0 112.714 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.36 -58.44 8.59 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.608 0.763 . . . . 0.0 111.935 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.457 HG22 ' CD1' ' A' ' 42' ' ' ILE . 5.8 pt -74.31 -31.13 27.88 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -172.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -54.65 -39.12 67.69 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.483 1.113 . . . . 0.0 112.533 -176.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -99.23 23.08 9.62 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 23.0 mt -60.16 -55.41 45.64 Favored Pre-proline 0 CA--C 1.547 0.859 0 CA-C-O 117.738 -1.125 . . . . 0.0 109.483 164.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -71.77 170.9 17.61 Favored 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 123.696 2.931 . . . . 0.0 112.163 173.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -72.59 35.79 0.33 Allowed 'Trans proline' 0 CA--C 1.549 1.263 0 C-N-CA 125.03 3.82 . . . . 0.0 112.903 171.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.28 28.02 34.8 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 125.191 1.377 . . . . 0.0 113.115 -175.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -104.02 -42.74 5.47 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.912 1.079 . . . . 0.0 113.912 -168.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -96.35 117.07 30.08 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 174.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.434 ' H ' ' HB3' ' A' ' 27' ' ' ASP . 16.1 ttmm -102.16 135.51 43.62 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 126.363 1.865 . . . . 0.0 111.733 -173.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 26.9 m -98.66 150.25 5.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 119.868 1.213 . . . . 0.0 111.675 175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.1 t -134.13 107.98 8.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.235 1.414 . . . . 0.0 110.067 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.2 mp . . . . . 0 CA--C 1.549 0.905 0 CA-C-N 114.482 -1.235 . . . . 0.0 113.113 -174.744 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.469 0.524 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.512 ' HB2' HD11 ' A' ' 165' ' ' LEU . 29.1 p -155.75 142.48 18.83 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.502 1.121 . . . . 0.0 112.544 -175.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 30.8 t -142.9 160.17 40.84 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.948 1.699 . . . . 0.0 109.547 170.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 98.4 m -113.07 143.55 44.14 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 123.783 0.833 . . . . 0.0 109.484 171.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.71 165.29 27.89 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.687 0.795 . . . . 0.0 111.457 167.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -119.87 130.33 54.8 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.858 1.663 . . . . 0.0 110.048 -175.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.7 mt -118.47 140.88 40.41 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 126.292 1.837 . . . . 0.0 108.694 -170.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.22 132.24 52.51 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.723 1.609 . . . . 0.0 109.952 172.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp -126.86 136.79 59.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.214 1.006 . . . . 0.0 110.3 -172.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.79 57.91 1.43 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.994 1.718 . . . . 0.0 112.715 -172.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -162.58 52.23 0.31 Allowed Glycine 0 N--CA 1.467 0.739 0 C-N-CA 124.387 0.994 . . . . 0.0 112.533 168.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 68.0 mtm -131.71 150.86 52.01 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.471 1.108 . . . . 0.0 110.862 -177.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.8 t -157.39 -30.46 0.08 Allowed 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.039 1.336 . . . . 0.0 111.877 -168.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 64.7 m -128.28 140.7 51.74 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.036 1.734 . . . . 0.0 111.948 177.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -48.58 -33.86 10.51 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.162 1.785 . . . . 0.0 114.246 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.9 p -50.35 -32.29 16.92 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.422 1.089 . . . . 0.0 113.754 176.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 11.5 t -61.36 -21.87 64.42 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 42.3 t -59.5 -60.23 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 CA-C-N 119.423 1.011 . . . . 0.0 109.54 169.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -62.48 -27.74 69.34 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.029 0.532 . . . . 0.0 111.772 -176.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 55.7 m -71.71 -46.8 57.56 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 123.75 0.82 . . . . 0.0 113.139 172.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 79.3 mt -68.06 -54.37 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 CA-C-N 119.986 1.266 . . . . 0.0 110.081 176.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -52.31 -31.8 34.75 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.624 1.57 . . . . 0.0 112.03 175.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.14 -61.87 2.57 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 125.632 1.587 . . . . 0.0 115.694 173.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 92.9 mmm -73.38 -35.1 65.87 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.5 mm -71.29 -29.07 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 O-C-N 121.778 -0.576 . . . . 0.0 111.272 -177.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.6 t -56.57 -12.22 1.68 Allowed 'General case' 0 CA--C 1.555 1.172 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 172.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -84.42 -0.38 52.55 Favored 'General case' 0 N--CA 1.474 0.77 0 O-C-N 119.671 -1.893 . . . . 0.0 115.763 -174.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.3 pp -116.54 8.46 13.96 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 117.923 2.564 . . . . 0.0 117.923 -167.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 74.71 161.4 0.24 Allowed 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 128.127 2.571 . . . . 0.0 115.707 175.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.25 -44.08 1.59 Allowed Glycine 0 CA--C 1.533 1.167 0 O-C-N 120.345 -1.472 . . . . 0.0 113.22 -174.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 p -62.11 97.89 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.183 0 C-N-CA 127.295 2.238 . . . . 0.0 111.922 170.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.9 -61.58 1.79 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.472 1.109 . . . . 0.0 111.02 -177.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -123.49 133.55 54.01 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.354 1.461 . . . . 0.0 108.495 -175.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 11.5 tt -140.09 137.04 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.385 0 CA-C-O 121.991 0.901 . . . . 0.0 110.799 -173.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.0 t -142.23 152.49 43.13 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.859 1.664 . . . . 0.0 109.991 -176.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.58 139.07 35.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.439 1.096 . . . . 0.0 110.238 -177.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 18.3 t -122.46 84.81 2.31 Favored 'General case' 0 C--O 1.235 0.317 0 C-N-CA 127.119 2.168 . . . . 0.0 108.708 174.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 2.9 tt -59.7 -28.35 67.24 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.961 1.704 . . . . 0.0 111.519 -178.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.2 -53.26 8.44 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.794 2.438 . . . . 0.0 112.887 168.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -95.16 -7.87 37.97 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.506 1.122 . . . . 0.0 111.707 177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 70.55 42.13 64.21 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 126.059 1.79 . . . . 0.0 111.729 -177.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.4 p -130.92 155.86 46.05 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.33 1.052 . . . . 0.0 111.51 -171.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -133.29 129.93 38.25 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 124.525 1.13 . . . . 0.0 110.93 175.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.3 t -109.84 124.83 52.01 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 124.223 1.009 . . . . 0.0 108.962 -179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.76 138.58 28.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -169.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.512 HD11 ' HB2' ' A' ' 121' ' ' CYS . 0.7 OUTLIER -96.43 114.49 26.16 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 127.897 2.479 . . . . 0.0 107.296 174.508 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -124.31 162.91 22.79 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.672 1.589 . . . . 0.0 112.022 -176.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -96.79 112.62 60.96 Favored Pre-proline 0 CA--C 1.547 0.85 0 CA-C-O 118.168 -0.92 . . . . 0.0 109.259 172.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.13 -9.6 24.71 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.717 2.945 . . . . 0.0 115.456 -171.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -88.36 -37.44 15.92 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 119.718 1.144 . . . . 0.0 112.084 169.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 90.6 t -79.65 -36.87 17.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 C-N-CA 124.678 1.191 . . . . 0.0 112.209 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.2 tt -146.05 150.19 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 O-C-N 121.054 -1.029 . . . . 0.0 112.623 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.71 150.43 46.92 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 126.096 1.758 . . . . 0.0 110.535 -173.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_exo -51.93 -37.56 67.21 Favored 'Trans proline' 0 CA--C 1.54 0.797 0 C-N-CA 123.398 2.732 . . . . 0.0 114.77 -179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -66.25 -27.68 68.14 Favored 'General case' 0 N--CA 1.476 0.854 0 N-CA-C 113.264 0.838 . . . . 0.0 113.264 175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -74.56 -36.55 63.09 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.706 1.203 . . . . 0.0 112.149 172.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 91.0 mt -58.29 -52.93 63.53 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.775 0.83 . . . . 0.0 111.206 -178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 48.1 ptt85 -61.81 -38.74 89.24 Favored 'General case' 0 CA--C 1.539 0.556 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 -178.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.13 -29.54 69.84 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.711 0.804 . . . . 0.0 112.469 -175.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -67.44 -31.07 70.99 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.318 1.047 . . . . 0.0 113.045 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.26 -32.35 37.57 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 124.475 1.11 . . . . 0.0 111.362 175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.06 -33.43 73.56 Favored 'General case' 0 N--CA 1.468 0.464 0 O-C-N 121.462 -0.774 . . . . 0.0 112.381 172.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -71.11 -30.42 66.5 Favored 'General case' 0 CA--C 1.545 0.762 0 CA-C-N 118.842 0.746 . . . . 0.0 112.558 169.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 23.4 ttt -65.94 -43.3 88.44 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.123 0.969 . . . . 0.0 111.165 174.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 142.32 21.58 0.23 Allowed Glycine 0 CA--C 1.533 1.182 0 N-CA-C 117.43 1.732 . . . . 0.0 117.43 169.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -131.4 -155.16 0.67 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.111 1.365 . . . . 0.0 110.392 -171.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -129.44 140.57 51.27 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 125.426 1.491 . . . . 0.0 110.462 171.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.85 150.69 40.22 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 124.882 1.273 . . . . 0.0 114.404 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 23.7 t -141.8 146.95 36.51 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 125.252 1.421 . . . . 0.0 110.716 171.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 21.3 m -92.78 125.38 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.297 0.953 . . . . 0.0 109.665 172.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 3.6 p . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 124.384 2.04 . . . . 0.0 107.949 -177.305 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 121.47 0.652 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.9 m -99.01 164.4 12.19 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 125.782 1.633 . . . . 0.0 109.369 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -140.21 139.81 35.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 124.278 1.031 . . . . 0.0 110.315 175.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 32.5 mm-40 -98.51 123.85 42.9 Favored 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 121.753 0.787 . . . . 0.0 109.09 169.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -145.13 136.66 25.29 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 113.943 -1.48 . . . . 0.0 113.538 176.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.7 tpt180 -107.65 108.12 19.24 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.472 1.109 . . . . 0.0 110.053 176.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.1 mt -92.99 145.74 7.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.678 1.591 . . . . 0.0 109.837 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -100.56 150.34 22.79 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.532 2.333 . . . . 0.0 111.29 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.98 -11.53 71.85 Favored Glycine 0 CA--C 1.536 1.356 0 C-N-CA 124.944 1.259 . . . . 0.0 114.348 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 2.7 ptp -70.29 -0.3 7.79 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -178.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 66.0 m170 -60.23 -23.96 64.48 Favored 'General case' 0 CA--C 1.547 0.848 0 CA-C-N 120.315 1.416 . . . . 0.0 111.503 167.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 67.2 m -98.11 128.64 44.73 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.918 0.781 . . . . 0.0 110.377 169.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 19.8 tptp -56.49 -40.72 75.42 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.934 0.874 . . . . 0.0 112.392 -176.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.8 p -59.39 -23.09 62.31 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.724 1.21 . . . . 0.0 113.907 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 74.8 m -72.97 -40.87 64.96 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.801 0.84 . . . . 0.0 112.149 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 14.2 p -74.59 -30.18 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 174.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.436 ' C ' HD23 ' A' ' 36' ' ' LEU . 5.0 tt -49.87 -60.74 2.63 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 125.266 1.426 . . . . 0.0 112.177 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -61.1 -24.15 66.02 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 121.304 -0.872 . . . . 0.0 113.266 -177.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.4 mt -70.5 -48.95 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 O-C-N 121.138 -0.976 . . . . 0.0 110.281 168.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -68.06 -26.43 65.85 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.345 1.058 . . . . 0.0 112.372 -176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -66.58 -39.26 88.37 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.764 1.225 . . . . 0.0 112.039 171.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -94.68 -23.92 17.38 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 -172.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.48 ' CD1' HG22 ' A' ' 78' ' ' ILE . 44.3 mm -108.7 113.54 44.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.73 0 C-N-CA 123.869 0.868 . . . . 0.0 109.981 -169.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.5 -14.76 4.47 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.076 1.322 . . . . 0.0 114.739 -169.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -100.86 7.49 43.66 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.508 1.123 . . . . 0.0 113.326 174.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 55.0 mt -90.96 159.69 16.04 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.906 1.682 . . . . 0.0 112.932 -173.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.15 -23.7 62.4 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -171.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -128.99 3.79 6.39 Favored Glycine 0 CA--C 1.529 0.946 0 CA-C-O 117.181 -1.899 . . . . 0.0 115.067 173.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -113.68 117.47 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 121.105 2.452 . . . . 0.0 109.006 169.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -100.34 -29.72 12.26 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 45.7 m -147.59 158.61 44.07 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.681 -1.262 . . . . 0.0 112.955 -175.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.1 tp -137.96 137.99 44.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 C-N-CA 125.497 1.519 . . . . 0.0 109.707 -175.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -141.02 159.58 41.9 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.883 2.073 . . . . 0.0 107.944 -171.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 18.6 m -123.19 152.34 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 O-C-N 120.627 -1.296 . . . . 0.0 110.79 168.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 58.0 m -125.54 56.22 1.38 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 106.45 -1.685 . . . . 0.0 106.45 168.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.09 -28.14 68.59 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 126.386 1.875 . . . . 0.0 112.567 -168.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -57.16 -20.15 24.6 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 169.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.7 t30 -115.68 -2.89 12.35 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 127.349 2.26 . . . . 0.0 112.541 172.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 45.0 mtmt 73.27 15.67 4.31 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 127.144 2.178 . . . . 0.0 112.672 174.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -95.96 147.32 23.81 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 124.922 1.289 . . . . 0.0 109.1 170.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -100.04 158.08 16.09 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 166.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -134.73 116.86 15.38 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 -168.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.5 p -113.91 133.58 59.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.142 0 O-C-N 121.836 -0.54 . . . . 0.0 110.883 -179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -107.61 96.21 6.23 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.02 2.128 . . . . 0.0 106.676 -172.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -126.03 154.6 42.75 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.62 108.56 40.65 Favored Pre-proline 0 CA--C 1.549 0.908 0 C-N-CA 127.073 2.149 . . . . 0.0 107.192 -175.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -71.26 1.73 5.12 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.672 2.914 . . . . 0.0 114.474 -169.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 p -83.01 -23.82 33.11 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.927 1.291 . . . . 0.0 112.33 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 85.5 m -120.1 -18.38 8.11 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -169.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 10.3 t -147.88 -178.6 6.36 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.814 1.246 . . . . 0.0 111.422 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.8 m -168.35 161.47 8.97 Favored Pre-proline 0 CA--C 1.544 0.738 0 C-N-CA 125.923 1.689 . . . . 0.0 112.596 -176.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -49.72 -52.9 7.95 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 124.199 3.266 . . . . 0.0 117.289 -168.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 27.1 m -68.19 -32.33 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 CA-C-N 120.742 1.61 . . . . 0.0 113.083 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.53 -40.05 85.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.55 0.74 . . . . 0.0 111.381 174.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.8 mt -66.83 -44.53 80.85 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 124.342 1.057 . . . . 0.0 111.875 173.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -55.36 -51.73 65.83 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.63 0.65 . . . . 0.0 110.019 178.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -67.78 -28.79 67.91 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.134 0.974 . . . . 0.0 113.299 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -66.37 -60.25 2.94 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.122 0.874 . . . . 0.0 111.308 170.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.48 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.2 pt -72.74 -32.92 42.57 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.627 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -169.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -66.12 -22.08 66.38 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 -177.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -103.6 16.17 27.09 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.2 mt -62.31 -57.36 23.43 Favored Pre-proline 0 CA--C 1.544 0.745 0 CA-C-O 117.12 -1.419 . . . . 0.0 109.838 165.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -73.53 171.18 18.26 Favored 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 124.122 3.215 . . . . 0.0 111.963 172.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -80.96 45.72 2.07 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 124.045 3.163 . . . . 0.0 112.664 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.95 58.61 3.97 Favored Glycine 0 N--CA 1.469 0.875 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -173.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 30.8 t30 -135.62 -25.07 1.31 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 116.483 2.031 . . . . 0.0 116.483 -173.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.09 98.0 5.87 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 120.279 1.399 . . . . 0.0 108.283 177.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.8 tptt -92.31 128.65 38.23 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.737 1.215 . . . . 0.0 110.94 -167.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.7 p -114.59 135.3 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.257 1.023 . . . . 0.0 112.063 -174.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 52.0 m -127.13 133.34 50.39 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.553 1.541 . . . . 0.0 111.347 -177.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 23.4 mt . . . . . 0 CA--C 1.547 0.86 0 C-N-CA 124.736 1.214 . . . . 0.0 110.207 176.529 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 5.2 t . . . . . 0 N--CA 1.472 0.657 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 23.0 p -155.53 115.61 3.73 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.973 1.101 . . . . 0.0 113.973 -167.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 13.9 p -144.7 147.3 32.84 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.138 1.375 . . . . 0.0 111.209 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 86.2 m -98.79 141.49 31.52 Favored 'General case' 0 N--CA 1.473 0.722 0 O-C-N 121.493 -0.755 . . . . 0.0 110.204 -178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -141.31 164.12 31.1 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.23 1.012 . . . . 0.0 112.04 169.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.44 133.95 54.92 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 126.715 2.006 . . . . 0.0 109.531 179.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.4 mm -119.82 133.26 67.17 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.297 1.039 . . . . 0.0 108.662 177.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.53 128.91 45.05 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.438 1.095 . . . . 0.0 109.001 173.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 89.9 mt -129.69 136.08 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 O-C-N 121.195 -0.941 . . . . 0.0 110.529 -169.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -119.68 56.89 0.93 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.752 1.621 . . . . 0.0 111.849 -176.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -160.57 51.81 0.35 Allowed Glycine 0 N--CA 1.462 0.389 0 O-C-N 121.865 -0.522 . . . . 0.0 112.746 169.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 72.0 mtm -128.86 119.3 24.19 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 123.587 0.755 . . . . 0.0 109.189 171.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.92 -41.15 5.96 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.62 1.968 . . . . 0.0 110.34 176.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 86.7 m -134.32 157.66 45.78 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.308 1.843 . . . . 0.0 110.733 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -58.47 -28.49 65.38 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -48.99 -36.66 18.13 Favored 'General case' 0 CA--C 1.541 0.631 0 O-C-N 121.1 -1.0 . . . . 0.0 111.938 169.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 62.5 m -61.27 -42.66 99.01 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.485 1.114 . . . . 0.0 113.266 174.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 t -59.09 -54.98 26.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 N-CA-C 108.328 -0.989 . . . . 0.0 108.328 174.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -66.98 -28.86 68.6 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 -171.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 25.6 m -65.63 -52.62 50.45 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.077 1.351 . . . . 0.0 112.074 171.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.2 mt -69.95 -51.08 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 O-C-N 121.03 -1.044 . . . . 0.0 110.547 -177.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -52.81 -34.79 55.29 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 126.205 1.802 . . . . 0.0 110.86 173.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.31 -61.33 3.45 Favored Glycine 0 CA--C 1.528 0.901 0 C-N-CA 125.125 1.345 . . . . 0.0 113.306 173.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 5.7 mmt -63.51 -41.3 98.52 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.479 1.112 . . . . 0.0 112.799 -171.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.5 mm -70.86 -35.86 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 CA-C-N 117.759 0.254 . . . . 0.0 110.901 -177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -63.18 -9.2 10.11 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.133 1.16 . . . . 0.0 114.133 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -77.08 -18.84 57.73 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.224 -1.548 . . . . 0.0 114.086 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -99.63 164.98 11.83 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 120.144 1.338 . . . . 0.0 113.514 -174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -76.29 151.34 36.78 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -173.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 86.04 -25.72 6.66 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.838 1.208 . . . . 0.0 113.978 178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.4 p -82.58 96.25 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 CA-C-N 119.263 1.531 . . . . 0.0 109.955 169.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 41.4 tt0 -74.47 -47.17 34.98 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.396 1.478 . . . . 0.0 111.806 -173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -144.05 135.82 26.14 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 126.471 1.908 . . . . 0.0 108.669 -176.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.5 tt -140.13 135.66 37.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 CA-C-N 119.778 1.172 . . . . 0.0 111.34 172.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.3 t -140.61 126.09 18.91 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 125.018 1.327 . . . . 0.0 111.487 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.1 t -126.11 147.58 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 O-C-N 120.695 -1.253 . . . . 0.0 111.285 -169.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 30.4 t -140.77 144.31 35.4 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.954 0.883 . . . . 0.0 112.939 175.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.8 -20.22 62.61 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.798 1.639 . . . . 0.0 115.019 174.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.44 -35.6 52.64 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 125.395 1.478 . . . . 0.0 113.595 -172.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -125.25 -10.93 6.99 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 125.79 1.636 . . . . 0.0 112.382 171.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.33 47.97 6.63 Favored Glycine 0 C--N 1.343 0.924 0 C-N-CA 125.235 1.398 . . . . 0.0 111.365 -176.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 57.4 p -139.03 144.39 38.82 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -168.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.57 142.58 35.06 Favored 'General case' 0 C--O 1.234 0.282 0 C-N-CA 126.414 1.885 . . . . 0.0 111.361 172.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 9.0 t -116.94 124.87 50.48 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 167.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.84 142.1 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 122.955 0.502 . . . . 0.0 111.841 -168.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.35 109.42 21.94 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 126.65 1.98 . . . . 0.0 107.097 172.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 15.2 p90 -106.08 156.06 18.79 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.042 0.937 . . . . 0.0 111.969 174.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -95.33 109.63 46.16 Favored Pre-proline 0 CA--C 1.541 0.628 0 C-N-CA 124.271 1.028 . . . . 0.0 108.531 175.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -76.67 -12.69 18.28 Favored 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.763 2.308 . . . . 0.0 112.518 -170.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.04 -36.49 40.92 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.165 0.986 . . . . 0.0 112.306 169.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.7 t -96.24 -34.11 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.682 1.193 . . . . 0.0 113.893 -170.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 18.2 tt -137.16 152.99 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 CA-C-N 120.118 1.326 . . . . 0.0 112.19 -174.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 1.4 m -99.84 141.09 22.14 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 125.358 1.463 . . . . 0.0 110.892 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_exo -51.46 -35.72 56.27 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.445 2.764 . . . . 0.0 114.412 172.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -62.49 -28.45 69.84 Favored 'General case' 0 CA--C 1.547 0.856 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 173.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -71.93 -33.68 68.45 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 120.896 -1.127 . . . . 0.0 111.802 172.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 70.0 mt -59.94 -58.82 6.91 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.407 0.683 . . . . 0.0 109.899 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 6.6 ppt_? -61.35 -37.66 84.13 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 122.009 -0.432 . . . . 0.0 112.025 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.47 -30.14 71.04 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 177.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.83 -31.52 68.28 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-N 119.18 0.9 . . . . 0.0 112.376 179.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.7 mp -71.72 -39.82 69.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 C-N-CA 124.267 1.027 . . . . 0.0 111.177 170.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -62.89 -35.37 79.83 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 123.007 0.523 . . . . 0.0 111.869 173.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.92 -23.38 61.46 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.486 1.514 . . . . 0.0 113.958 170.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 26.2 ttt -74.7 -46.82 35.19 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.313 -0.867 . . . . 0.0 110.946 176.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.96 42.99 0.09 OUTLIER Glycine 0 CA--C 1.531 1.089 0 C-N-CA 125.064 1.316 . . . . 0.0 115.373 174.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -143.66 -159.16 0.95 Allowed 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.867 1.667 . . . . 0.0 109.68 -179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.6 142.04 50.82 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.12 1.368 . . . . 0.0 110.163 169.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -140.67 147.5 39.37 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 126.5 1.92 . . . . 0.0 112.504 -177.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.3 t -138.62 134.19 33.41 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 125.632 1.573 . . . . 0.0 111.966 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.4 m -83.92 78.26 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-O 122.116 0.96 . . . . 0.0 110.444 179.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 N--CA 1.475 0.806 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.441 174.629 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.9 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.81 97.06 10.76 Favored 'General case' 0 N--CA 1.465 0.287 0 N-CA-C 104.146 -2.538 . . . . 0.0 104.146 166.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.767 HD12 ' H ' ' A' ' 23' ' ' GLN . 4.5 tp -112.16 165.43 12.16 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.102 1.361 . . . . 0.0 107.902 176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.767 ' H ' HD12 ' A' ' 22' ' ' LEU . 2.7 pt20 -147.0 161.97 39.72 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 119.774 -1.829 . . . . 0.0 114.078 179.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.445 HD22 ' N ' ' A' ' 24' ' ' LEU . 0.0 OUTLIER -140.72 150.41 43.41 Favored 'General case' 0 C--O 1.234 0.286 0 C-N-CA 125.941 1.697 . . . . 0.0 109.652 168.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -98.7 103.35 15.3 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 168.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.5 mm -76.37 146.77 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.475 1.51 . . . . 0.0 110.539 -176.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -98.91 137.22 37.78 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.984 2.114 . . . . 0.0 110.968 173.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.44 -9.46 75.46 Favored Glycine 0 CA--C 1.531 1.038 0 C-N-CA 125.106 1.336 . . . . 0.0 113.697 -178.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -64.94 -6.16 7.79 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 116.109 1.892 . . . . 0.0 116.109 -176.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 9.2 m170 -60.16 -27.11 66.83 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 119.945 1.248 . . . . 0.0 110.758 165.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 40.1 t -88.58 119.62 29.2 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 166.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 tmtp? -58.92 -33.48 70.61 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 121.352 -0.843 . . . . 0.0 111.685 -173.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 m -54.89 -31.0 59.5 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.733 1.213 . . . . 0.0 112.822 176.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 64.6 m -72.2 -40.48 67.83 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.974 1.309 . . . . 0.0 112.774 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.7 p -76.31 -31.66 21.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 N-CA-C 112.599 0.592 . . . . 0.0 112.599 171.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -55.86 -55.14 36.04 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.585 1.154 . . . . 0.0 112.235 -175.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 9.0 p30 -59.97 -31.3 69.76 Favored 'General case' 0 CA--C 1.546 0.824 0 O-C-N 121.535 -0.728 . . . . 0.0 112.594 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mt -64.01 -47.76 88.97 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.403 -0.811 . . . . 0.0 109.995 171.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -63.99 -25.93 68.35 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.686 1.594 . . . . 0.0 113.795 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -75.64 -37.46 59.66 Favored 'General case' 0 CA--C 1.546 0.796 0 O-C-N 120.753 -1.217 . . . . 0.0 113.862 170.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -91.13 -35.11 14.76 Favored 'General case' 0 N--CA 1.474 0.762 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 -173.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.492 ' CD1' HG22 ' A' ' 78' ' ' ILE . 39.5 mm -95.88 112.17 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 O-C-N 120.818 -1.176 . . . . 0.0 107.968 -170.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.59 -15.26 3.62 Favored Glycine 0 CA--C 1.536 1.372 0 C-N-CA 124.378 0.989 . . . . 0.0 115.285 -168.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -104.32 11.58 34.58 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 118.589 1.194 . . . . 0.0 113.029 169.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.9 mt -96.88 149.72 21.54 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.391 1.476 . . . . 0.0 113.143 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 40.2 tp -32.21 -58.73 0.31 Allowed 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 127.16 2.184 . . . . 0.0 114.016 179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -108.86 19.01 31.05 Favored Glycine 0 CA--C 1.531 1.043 0 CA-C-O 117.181 -1.9 . . . . 0.0 115.704 179.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -138.1 109.58 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.084 2.442 . . . . 0.0 108.873 168.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.66 -16.12 15.08 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -171.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 26.5 t -146.1 168.08 21.82 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.016 1.326 . . . . 0.0 110.875 172.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.0 tp -143.51 146.51 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.292 1.037 . . . . 0.0 111.64 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -144.16 157.92 44.02 Favored 'General case' 0 CA--C 1.55 0.947 0 C-N-CA 125.5 1.52 . . . . 0.0 109.825 -170.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 29.0 m -138.79 156.47 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 O-C-N 119.801 -1.812 . . . . 0.0 112.564 -179.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 2.9 t -136.22 56.21 1.82 Allowed 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 126.249 1.82 . . . . 0.0 108.04 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 51.6 mt -66.03 -23.03 66.47 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.583 1.153 . . . . 0.0 112.908 -170.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -66.13 -14.79 62.39 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 124.942 1.297 . . . . 0.0 113.76 174.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.1 m-20 -126.12 11.46 7.62 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 127.274 2.23 . . . . 0.0 112.5 169.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 71.16 7.33 6.12 Favored 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.765 2.026 . . . . 0.0 115.382 171.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -97.32 157.74 15.82 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.808 1.243 . . . . 0.0 110.412 172.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -119.83 144.11 47.52 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.987 1.315 . . . . 0.0 109.426 171.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.1 tp-100 -112.29 119.17 37.4 Favored 'General case' 0 CA--C 1.538 0.514 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 -170.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -97.35 140.75 17.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 120.924 -1.11 . . . . 0.0 108.089 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -110.09 82.97 1.68 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.757 1.223 . . . . 0.0 107.752 177.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -106.0 152.1 23.78 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 113.213 0.82 . . . . 0.0 113.213 -169.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -98.81 103.02 16.84 Favored Pre-proline 0 CA--C 1.55 0.97 0 C-N-CA 126.708 2.003 . . . . 0.0 110.113 176.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -63.94 0.74 1.86 Allowed 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.705 2.937 . . . . 0.0 114.944 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 98.5 p -74.91 -15.65 60.69 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.887 -1.133 . . . . 0.0 113.226 174.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.3 m -137.09 -24.44 1.1 Allowed 'General case' 0 CA--C 1.546 0.804 0 N-CA-C 115.948 1.833 . . . . 0.0 115.948 -171.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.7 t -144.53 178.16 8.15 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 125.355 1.462 . . . . 0.0 111.374 -174.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 86.3 p -148.18 158.56 41.29 Favored Pre-proline 0 CA--C 1.548 0.886 0 C-N-CA 124.825 1.25 . . . . 0.0 113.008 -175.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -56.7 -52.31 7.18 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 123.661 2.907 . . . . 0.0 114.648 -170.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.3 m -62.96 -30.16 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.879 1.218 . . . . 0.0 113.516 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.65 -46.48 58.83 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.474 0.71 . . . . 0.0 111.257 175.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 74.9 mt -58.2 -42.52 86.33 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.646 0.778 . . . . 0.0 111.482 172.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -57.57 -37.99 74.06 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 123.167 0.587 . . . . 0.0 111.638 176.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 58.2 mtp180 -72.2 -40.28 67.98 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 119.433 1.015 . . . . 0.0 112.626 173.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -61.51 -60.2 4.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 124.033 0.933 . . . . 0.0 112.411 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.492 HG22 ' CD1' ' A' ' 42' ' ' ILE . 9.1 pt -70.53 -28.59 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -168.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -69.98 -12.99 62.02 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 125.615 1.566 . . . . 0.0 113.326 177.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -107.0 6.43 29.06 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 114.03 1.122 . . . . 0.0 114.03 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 24.3 mt -55.7 -49.83 90.56 Favored Pre-proline 0 CA--C 1.542 0.672 0 CA-C-O 117.307 -1.33 . . . . 0.0 110.985 166.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -75.62 172.08 17.0 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.298 2.665 . . . . 0.0 111.311 168.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -75.47 44.35 1.22 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 124.323 3.349 . . . . 0.0 111.64 170.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.28 30.54 41.12 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.101 1.334 . . . . 0.0 113.746 -176.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -95.1 -47.99 6.14 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 118.65 1.225 . . . . 0.0 112.22 -169.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.2 m-85 -100.58 123.37 44.7 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.127 1.371 . . . . 0.0 109.025 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -101.46 165.48 11.23 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 124.051 0.94 . . . . 0.0 111.888 177.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.2 m -131.01 139.47 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 123.503 0.721 . . . . 0.0 111.802 174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.9 m -110.92 134.88 52.21 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.656 1.183 . . . . 0.0 110.949 175.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 CA--C 1.542 0.67 0 C-N-CA 126.862 2.065 . . . . 0.0 111.169 177.986 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.471 0.587 0 CA-C-O 121.295 0.569 . . . . 0.0 111.064 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 21.8 p -125.38 152.14 45.19 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.404 1.882 . . . . 0.0 113.148 175.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.0 t -140.6 149.95 42.99 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 126.791 2.036 . . . . 0.0 107.395 167.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 3.8 m -99.88 142.05 31.87 Favored 'General case' 0 CA--C 1.518 -0.264 0 CA-C-O 121.15 0.5 . . . . 0.0 110.819 -170.234 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.25 145.25 31.92 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 123.596 0.758 . . . . 0.0 110.394 169.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 3.4 tt -114.69 137.83 51.44 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 126.676 1.99 . . . . 0.0 108.346 -179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.9 mt -133.36 138.4 51.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 C-N-CA 125.622 1.569 . . . . 0.0 109.768 -168.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.33 130.87 45.65 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.246 1.818 . . . . 0.0 109.296 172.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mp -126.38 122.43 61.22 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.08 0 O-C-N 121.274 -0.892 . . . . 0.0 111.855 -171.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.48 61.47 3.76 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 126.212 1.805 . . . . 0.0 111.24 173.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.59 54.96 0.27 Allowed Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.175 -0.921 . . . . 0.0 112.628 169.454 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 73.8 mtm -138.78 121.09 15.93 Favored 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 123.628 0.771 . . . . 0.0 110.57 178.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 t -125.25 -30.19 3.19 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 125.747 1.619 . . . . 0.0 112.513 -173.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 11.8 m -147.74 163.49 36.52 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.682 1.993 . . . . 0.0 111.057 179.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.3 -30.51 70.54 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 114.493 1.294 . . . . 0.0 114.493 -172.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 69.2 m -57.53 -20.94 34.98 Favored 'General case' 0 CA--C 1.545 0.781 0 O-C-N 120.763 -1.21 . . . . 0.0 112.933 170.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 93.0 m -63.06 -44.1 96.75 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 120.931 -1.105 . . . . 0.0 112.286 168.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.4 t -59.66 -54.43 34.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -65.73 -24.5 66.98 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-N 117.998 0.363 . . . . 0.0 111.741 -176.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.9 m -70.84 -53.11 16.44 Favored 'General case' 0 N--CA 1.47 0.546 0 O-C-N 120.747 -1.22 . . . . 0.0 111.792 170.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 82.8 mt -65.1 -50.41 74.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 O-C-N 120.507 -1.371 . . . . 0.0 110.696 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -58.19 -33.01 68.8 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.808 2.043 . . . . 0.0 111.494 176.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.5 -61.89 2.85 Favored Glycine 0 CA--C 1.531 1.073 0 C-N-CA 124.856 1.217 . . . . 0.0 113.913 174.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.24 -44.83 67.73 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.75 1.22 . . . . 0.0 112.844 -169.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.4 mm -70.74 -21.0 22.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 O-C-N 121.543 -0.723 . . . . 0.0 111.502 -173.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.4 -2.91 18.12 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 115.35 1.611 . . . . 0.0 115.35 169.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 82.9 mt-30 -80.96 -13.77 58.59 Favored 'General case' 0 N--CA 1.475 0.822 0 O-C-N 119.591 -1.943 . . . . 0.0 115.403 -174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.1 pp -95.25 -177.17 4.03 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 125.218 1.407 . . . . 0.0 113.445 -169.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -92.99 137.18 32.59 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.134 0.974 . . . . 0.0 111.49 172.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 99.9 12.03 41.45 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 117.658 -1.634 . . . . 0.0 115.894 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.9 p -120.93 93.6 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 119.802 1.801 . . . . 0.0 110.863 -175.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.73 -49.76 28.98 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.669 1.188 . . . . 0.0 110.122 -175.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 70.5 tp60 -147.31 142.72 27.45 Favored 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 124.751 1.221 . . . . 0.0 110.505 176.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 9.2 tt -135.83 140.51 44.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.581 0 CA-C-N 119.426 1.012 . . . . 0.0 110.452 169.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 12.5 t -140.16 145.26 37.28 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 125.898 1.679 . . . . 0.0 109.667 171.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.3 t -141.01 146.4 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 119.659 1.118 . . . . 0.0 110.579 -178.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 77.4 p -142.45 132.71 24.78 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 121.147 -0.971 . . . . 0.0 113.17 175.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.21 -19.64 63.15 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 125.514 1.526 . . . . 0.0 112.614 171.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -48.88 -52.84 22.19 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.997 1.319 . . . . 0.0 111.64 170.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -96.23 -25.07 15.94 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.894 1.278 . . . . 0.0 112.321 178.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.76 25.53 55.99 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.791 1.186 . . . . 0.0 112.319 -170.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.4 p -136.02 147.12 47.81 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 118.526 1.163 . . . . 0.0 113.813 -169.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -99.63 145.67 27.33 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.847 1.659 . . . . 0.0 110.366 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.9 t -127.95 129.36 46.67 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 123.647 0.779 . . . . 0.0 109.257 168.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.8 140.81 30.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 C-N-CA 123.572 0.749 . . . . 0.0 111.181 -168.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 16.3 mt -94.15 107.02 18.98 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 126.08 1.752 . . . . 0.0 106.947 169.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 33.3 p90 -101.79 157.04 17.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.423 0.689 . . . . 0.0 111.633 175.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.1 t-20 -95.98 111.71 57.05 Favored Pre-proline 0 CA--C 1.542 0.673 0 O-C-N 121.242 -0.911 . . . . 0.0 110.285 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_endo -73.95 -10.52 23.07 Favored 'Trans proline' 0 CA--C 1.54 0.817 0 C-N-CA 122.468 2.112 . . . . 0.0 112.823 -170.492 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.41 -8.64 59.76 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.143 0.977 . . . . 0.0 113.168 169.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 73.5 t -120.93 -42.25 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 124.994 1.318 . . . . 0.0 111.972 -174.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 16.2 tt -143.39 165.09 15.25 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 124.212 1.005 . . . . 0.0 111.507 -170.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -125.46 154.01 72.45 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 126.0 1.72 . . . . 0.0 110.947 -175.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_exo -50.19 -44.82 36.5 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 124.025 3.15 . . . . 0.0 114.962 -179.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.53 -19.54 62.89 Favored 'General case' 0 N--CA 1.477 0.889 0 O-C-N 121.39 -0.819 . . . . 0.0 113.11 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -73.85 -29.14 61.95 Favored 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.844 -1.16 . . . . 0.0 111.944 171.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 38.1 mt -62.75 -51.3 67.69 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 123.552 0.741 . . . . 0.0 109.296 170.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 33.3 ttt180 -50.64 -51.12 51.98 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.64 1.176 . . . . 0.0 111.686 172.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.45 -27.32 68.48 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.74 -34.9 64.96 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.824 0.85 . . . . 0.0 112.146 178.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.7 -38.59 66.97 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 C-N-CA 123.877 0.871 . . . . 0.0 111.235 171.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -64.96 -35.87 82.57 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 118.986 0.812 . . . . 0.0 112.693 170.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -66.96 -35.28 79.63 Favored 'General case' 0 CA--C 1.54 0.584 0 O-C-N 121.197 -0.94 . . . . 0.0 111.72 173.472 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.66 -43.48 80.15 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 123.758 0.823 . . . . 0.0 111.37 175.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 140.56 21.25 0.32 Allowed Glycine 0 CA--C 1.53 0.973 0 N-CA-C 117.156 1.623 . . . . 0.0 117.156 169.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -114.95 -156.61 0.61 Allowed 'General case' 0 CA--C 1.543 0.705 0 CA-C-N 119.838 1.819 . . . . 0.0 110.272 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -131.54 140.7 49.55 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 124.992 1.317 . . . . 0.0 109.179 169.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -137.62 150.28 47.28 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 35.4 t -138.81 137.35 36.56 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 125.258 1.423 . . . . 0.0 109.577 169.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.5 m -78.77 135.05 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 O-C-N 121.513 -0.742 . . . . 0.0 110.308 175.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.474 0.738 0 CA-C-O 124.095 1.903 . . . . 0.0 107.484 175.827 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 17.5 m . . . . . 0 N--CA 1.47 0.555 0 CA-C-O 120.93 0.395 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.4 132.0 47.21 Favored 'General case' 0 CA--C 1.514 -0.431 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.932 176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -123.52 136.72 54.71 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 124.954 1.302 . . . . 0.0 109.657 178.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -97.09 128.66 44.23 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 125.852 1.661 . . . . 0.0 110.88 -169.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.74 141.16 33.25 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 113.253 0.835 . . . . 0.0 113.253 174.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 2.8 tmm_? -109.55 116.33 31.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 172.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 4.4 mt -76.58 133.76 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-O 122.413 1.101 . . . . 0.0 110.136 -176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -102.88 104.97 15.26 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.625 2.37 . . . . 0.0 108.298 -175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 100.61 16.68 25.95 Favored Glycine 0 CA--C 1.536 1.377 0 N-CA-C 115.956 1.142 . . . . 0.0 115.956 -179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 5.5 ptp -64.42 -36.21 83.41 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 119.659 1.73 . . . . 0.0 115.141 -178.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.6 t60 67.53 -46.16 0.49 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 129.027 2.931 . . . . 0.0 113.83 -172.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 96.0 m -153.63 163.78 39.39 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 127.949 2.5 . . . . 0.0 110.432 -175.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.5 tmmt? -53.81 -31.32 48.66 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.223 -0.923 . . . . 0.0 112.884 173.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.1 p -49.0 -18.82 0.33 Allowed 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 127.387 2.275 . . . . 0.0 115.48 173.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 4.3 t -57.6 -44.85 85.75 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.537 1.535 . . . . 0.0 112.466 167.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -69.63 -6.32 6.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.344 1.458 . . . . 0.0 114.075 -170.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tt -64.09 -59.19 4.76 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.987 0.915 . . . . 0.0 110.761 178.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -59.11 -36.16 74.69 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.617 -0.677 . . . . 0.0 110.901 177.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.2 mt -58.11 -46.72 88.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 O-C-N 121.229 -0.92 . . . . 0.0 111.93 173.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -65.94 -31.52 72.49 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.677 1.191 . . . . 0.0 112.974 175.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 66.8 mm-40 -66.44 -34.52 78.13 Favored 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.635 0.976 . . . . 0.0 113.635 174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -94.64 -45.13 7.51 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 31.6 mm -99.48 112.95 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-O 122.178 0.989 . . . . 0.0 109.995 -165.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.84 5.93 5.17 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 124.839 1.209 . . . . 0.0 114.383 -169.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -125.62 1.69 7.55 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.583 1.153 . . . . 0.0 113.609 173.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.1 mp -68.76 171.2 8.15 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.087 1.355 . . . . 0.0 111.502 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -54.53 -37.84 65.88 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 171.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -125.2 11.95 7.63 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-O 117.445 -1.753 . . . . 0.0 115.918 -178.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.6 t -127.87 120.27 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 121.005 2.402 . . . . 0.0 109.303 169.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.29 -21.15 12.36 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -178.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.0 t -142.78 166.72 23.88 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 119.882 1.219 . . . . 0.0 112.663 177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.7 tp -140.88 138.65 34.68 Favored 'Isoleucine or valine' 0 C--O 1.239 0.506 0 C-N-CA 126.591 1.956 . . . . 0.0 108.433 -177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -125.4 129.52 50.05 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.169 1.388 . . . . 0.0 109.51 -169.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 51.2 t -99.4 112.4 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.315 1.446 . . . . 0.0 108.161 -170.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.3 m -125.8 49.58 1.93 Allowed 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 121.829 0.823 . . . . 0.0 110.613 -169.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.62 -15.18 60.8 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.255 1.822 . . . . 0.0 114.803 -170.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -43.7 -32.84 1.09 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 127.614 2.366 . . . . 0.0 115.538 173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -125.33 23.39 7.59 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 124.666 1.186 . . . . 0.0 112.874 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp 63.39 24.72 14.3 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 126.035 1.734 . . . . 0.0 112.263 -169.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.28 164.4 13.05 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 126.075 1.75 . . . . 0.0 110.036 -178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -142.33 151.31 41.82 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 127.677 2.391 . . . . 0.0 106.8 170.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -124.71 134.53 52.81 Favored 'General case' 0 C--N 1.329 -0.298 0 O-C-N 121.415 -0.803 . . . . 0.0 111.292 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.8 p -102.52 139.74 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-N 117.847 0.294 . . . . 0.0 111.089 176.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 24.6 mmmt -102.8 95.73 6.38 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.708 1.603 . . . . 0.0 108.857 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -120.8 152.48 38.3 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -170.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -97.34 112.0 59.83 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 127.85 2.46 . . . . 0.0 109.772 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -63.03 -2.74 3.97 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.838 3.025 . . . . 0.0 115.658 177.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.9 p -84.24 -16.66 42.44 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.71 1.204 . . . . 0.0 113.019 178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 92.4 m -124.43 -28.4 3.63 Favored 'General case' 0 CA--C 1.539 0.545 0 N-CA-C 114.47 1.285 . . . . 0.0 114.47 179.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.6 t -142.18 179.2 7.05 Favored 'General case' 0 N--CA 1.478 0.93 0 CA-C-N 119.684 1.129 . . . . 0.0 113.064 -169.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 97.6 p -165.61 162.53 13.27 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.7 1.6 . . . . 0.0 112.164 -171.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -52.63 -49.33 17.85 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.728 2.952 . . . . 0.0 115.472 -172.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.9 p -65.32 -37.61 80.54 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.107 0 CA-C-N 119.326 0.966 . . . . 0.0 112.459 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.47 87.93 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.299 1.039 . . . . 0.0 111.438 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.7 mt -67.33 -47.4 70.61 Favored 'General case' 0 N--CA 1.463 0.208 0 C-N-CA 123.863 0.865 . . . . 0.0 111.778 174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 42.1 tt0 -55.72 -47.96 75.98 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 119.087 0.858 . . . . 0.0 111.484 -177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.1 mtt180 -63.94 -29.64 70.8 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.25 -62.43 1.52 Allowed 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 118.932 0.787 . . . . 0.0 112.277 170.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.8 pt -72.61 -17.3 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.74 0 N-CA-C 114.454 1.279 . . . . 0.0 114.454 -170.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -73.81 -35.78 64.9 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-N 121.64 2.018 . . . . 0.0 113.156 168.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.41 13.7 26.94 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 120.944 -1.097 . . . . 0.0 112.261 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 34.2 tp -48.86 -54.39 28.29 Favored Pre-proline 0 CA--C 1.548 0.902 0 C-N-CA 129.331 3.052 . . . . 0.0 113.202 170.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -91.05 176.22 2.28 Favored 'Trans proline' 0 CA--C 1.55 1.285 0 C-N-CA 124.092 3.195 . . . . 0.0 111.879 169.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.35 53.01 3.75 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 124.663 3.575 . . . . 0.0 113.099 175.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.8 52.38 5.88 Favored Glycine 0 N--CA 1.471 1.011 0 O-C-N 120.689 -1.257 . . . . 0.0 111.823 177.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.6 t-20 -127.74 -33.04 2.31 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 124.467 1.107 . . . . 0.0 113.875 -170.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 16.4 m-85 -135.01 113.94 11.97 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.126 1.77 . . . . 0.0 109.556 -173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 42.1 mtpt -98.43 173.92 6.72 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.36 1.464 . . . . 0.0 110.516 173.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.24 135.21 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 O-C-N 120.783 -1.198 . . . . 0.0 111.025 174.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 42.0 m -107.62 124.74 50.41 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 124.13 0.972 . . . . 0.0 109.831 167.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.0 mt . . . . . 0 CA--C 1.546 0.796 0 C-N-CA 124.239 1.016 . . . . 0.0 109.569 176.856 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.472 0.638 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 1.9 t 73.03 113.85 0.06 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.804 2.442 . . . . 0.0 114.835 174.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 60.9 m -145.37 148.6 33.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.109 2.163 . . . . 0.0 108.905 166.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 12.4 m -99.13 145.96 26.62 Favored 'General case' 0 N--CA 1.478 0.964 0 O-C-N 121.037 -1.039 . . . . 0.0 110.256 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.87 155.06 43.26 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 124.917 1.287 . . . . 0.0 110.978 172.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.0 tt -114.6 136.01 53.51 Favored 'General case' 0 CA--C 1.551 1.003 0 C-N-CA 126.789 2.036 . . . . 0.0 110.745 178.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.6 mm -123.57 141.08 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 127.174 2.19 . . . . 0.0 109.697 -172.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.23 127.42 53.21 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.147 1.379 . . . . 0.0 110.706 172.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.1 mp -117.23 143.72 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.085 0 O-C-N 120.801 -1.187 . . . . 0.0 111.566 -172.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -124.85 56.46 1.31 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.195 1.798 . . . . 0.0 113.258 -179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -165.68 45.92 0.28 Allowed Glycine 0 N--CA 1.469 0.87 0 O-C-N 121.209 -0.932 . . . . 0.0 112.714 167.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 29.6 mtm -133.5 96.8 3.79 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.222 1.009 . . . . 0.0 110.024 -178.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 t -98.99 -26.51 14.22 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.315 1.846 . . . . 0.0 112.939 -179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 95.7 m -125.62 150.43 47.56 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.188 1.395 . . . . 0.0 110.934 -176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.1 -23.79 67.46 Favored 'General case' 0 CA--C 1.541 0.634 0 O-C-N 120.918 -1.113 . . . . 0.0 113.312 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 34.1 p -53.55 -30.87 44.05 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 125.01 1.324 . . . . 0.0 113.429 169.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 71.8 m -57.17 -32.66 66.66 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.724 1.21 . . . . 0.0 112.3 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 41.5 t -57.07 -53.87 37.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 123.685 0.794 . . . . 0.0 109.988 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -66.31 -23.28 66.35 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 122.973 0.509 . . . . 0.0 112.21 -175.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 70.5 m -71.19 -52.72 17.55 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.568 -0.707 . . . . 0.0 111.148 170.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 85.7 mt -70.37 -52.23 31.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 120.741 -1.225 . . . . 0.0 111.315 -177.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -51.46 -42.08 61.32 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.82 1.248 . . . . 0.0 111.082 172.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.42 -62.42 2.9 Favored Glycine 0 C--N 1.34 0.795 0 C-N-CA 123.558 0.599 . . . . 0.0 113.127 -176.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.5 -38.59 71.14 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 125.033 1.333 . . . . 0.0 113.026 -170.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.8 mm -71.04 -35.3 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 O-C-N 121.73 -0.606 . . . . 0.0 110.539 -175.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.9 t -65.0 3.07 0.62 Allowed 'General case' 0 CA--C 1.551 0.995 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 173.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 85.2 mt-30 -94.44 -11.28 30.07 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.686 1.194 . . . . 0.0 113.546 178.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -106.25 167.59 9.72 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 120.026 1.285 . . . . 0.0 112.87 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 52.2 mm-40 -68.38 161.38 27.65 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-O 123.213 1.482 . . . . 0.0 114.705 -174.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 78.82 -32.41 1.94 Allowed Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.36 1.457 . . . . 0.0 114.911 176.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -80.51 98.61 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 CA-C-N 119.106 1.453 . . . . 0.0 112.435 177.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -72.32 -45.89 58.0 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.196 0.998 . . . . 0.0 112.135 178.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -144.61 132.49 21.34 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 125.141 1.376 . . . . 0.0 109.783 -177.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -130.71 142.3 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.745 1.157 . . . . 0.0 112.854 170.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 31.2 t -131.45 142.62 50.03 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 128.55 2.74 . . . . 0.0 109.224 174.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.27 146.97 18.59 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 119.89 1.223 . . . . 0.0 111.781 174.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 43.1 t -139.29 136.34 34.78 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 -178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.02 -16.83 63.22 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 127.36 2.264 . . . . 0.0 113.514 171.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -63.28 -43.74 97.05 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.783 1.233 . . . . 0.0 111.969 179.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -116.37 -16.05 10.9 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.7 1.6 . . . . 0.0 112.605 -178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.94 28.51 56.44 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 125.177 1.37 . . . . 0.0 112.855 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.1 p -128.89 151.54 49.52 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 118.077 0.939 . . . . 0.0 113.26 -169.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -113.32 146.71 38.97 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.25 1.42 . . . . 0.0 111.906 172.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 3.4 m -118.52 126.19 51.48 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.852 1.661 . . . . 0.0 107.342 168.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.77 137.33 42.96 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 123.321 0.649 . . . . 0.0 110.65 -171.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.25 109.69 21.78 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.75 2.02 . . . . 0.0 105.78 173.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -111.29 155.67 22.68 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 124.023 0.929 . . . . 0.0 111.993 178.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -97.4 107.05 36.57 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 124.725 1.21 . . . . 0.0 109.139 174.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -66.97 -15.86 48.06 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 121.8 1.667 . . . . 0.0 113.537 -174.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -73.85 -14.84 61.15 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 171.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.45 -31.67 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 126.165 1.786 . . . . 0.0 112.494 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.0 tt -151.77 152.31 11.12 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 O-C-N 120.865 -1.147 . . . . 0.0 112.964 -170.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 73.5 m -114.49 159.32 37.33 Favored Pre-proline 0 N--CA 1.481 1.12 0 C-N-CA 124.55 1.14 . . . . 0.0 112.858 171.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -49.8 -37.64 45.55 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 124.48 3.453 . . . . 0.0 115.103 173.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -57.82 -35.82 71.39 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 119.449 1.022 . . . . 0.0 113.066 173.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -73.28 -32.49 64.69 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.234 1.013 . . . . 0.0 111.564 176.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 87.6 mt -59.64 -51.93 67.7 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.689 -0.632 . . . . 0.0 110.089 174.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.9 ptt180 -62.28 -41.82 98.81 Favored 'General case' 0 CA--C 1.542 0.642 0 O-C-N 121.733 -0.605 . . . . 0.0 111.617 175.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.15 -35.25 73.18 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 177.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.8 -34.79 69.68 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 -178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mp -70.86 -38.97 74.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 123.705 0.802 . . . . 0.0 110.115 173.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -59.97 -46.73 88.48 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.331 0.653 . . . . 0.0 110.249 172.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -66.84 -22.49 65.99 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.4 1.48 . . . . 0.0 114.507 176.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.23 -39.58 78.44 Favored 'General case' 0 N--CA 1.472 0.664 0 O-C-N 121.459 -0.775 . . . . 0.0 110.95 172.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 138.71 24.58 0.34 Allowed Glycine 0 CA--C 1.527 0.834 0 CA-C-O 118.443 -1.198 . . . . 0.0 115.512 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -124.41 -153.36 0.56 Allowed 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.162 1.481 . . . . 0.0 109.263 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -140.07 141.7 36.19 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 125.745 1.618 . . . . 0.0 108.018 168.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.97 154.88 47.3 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 39.9 t -138.88 143.53 38.77 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 127.024 2.13 . . . . 0.0 109.9 -174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.5 m -90.39 131.16 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.393 -0.817 . . . . 0.0 111.13 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.4 m . . . . . 0 N--CA 1.48 1.029 0 C-N-CA 126.074 1.749 . . . . 0.0 109.903 -176.463 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 20.8 m . . . . . 0 N--CA 1.474 0.766 0 CA-C-O 120.651 0.263 . . . . 0.0 110.358 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -107.37 145.82 32.41 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 123.646 0.778 . . . . 0.0 110.945 -176.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.1 tt -121.4 136.44 54.96 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 124.377 1.071 . . . . 0.0 111.918 -177.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -96.55 122.84 39.9 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 122.597 1.189 . . . . 0.0 110.295 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -148.82 143.04 26.06 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.323 -1.762 . . . . 0.0 113.203 176.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -113.49 118.02 33.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.618 1.167 . . . . 0.0 108.86 174.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 1.8 mm -83.11 147.69 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.135 0 C-N-CA 124.818 1.247 . . . . 0.0 110.916 177.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.69 156.82 18.23 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 125.943 1.697 . . . . 0.0 112.014 176.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.27 -7.26 64.66 Favored Glycine 0 CA--C 1.535 1.319 0 C-N-CA 124.585 1.088 . . . . 0.0 113.957 -177.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 33.0 mtm -65.7 0.37 1.73 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 114.882 1.438 . . . . 0.0 114.882 -179.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.9 p80 -58.96 -23.23 61.41 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-N 119.672 1.124 . . . . 0.0 112.412 167.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.6 m -84.9 -6.77 59.34 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 124.915 1.286 . . . . 0.0 113.814 171.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 20.3 tptm 59.54 -57.89 0.06 Allowed 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 130.729 3.612 . . . . 0.0 116.123 178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.8 m -56.32 -13.4 2.15 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 126.568 1.947 . . . . 0.0 113.589 -174.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.2 m -48.76 -39.67 25.89 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 127.837 2.455 . . . . 0.0 112.678 167.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 8.2 p -70.58 -20.74 22.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.851 0 N-CA-C 113.481 0.919 . . . . 0.0 113.481 -172.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.3 tp -60.63 -56.92 15.56 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.147 0.979 . . . . 0.0 112.039 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -61.91 -28.82 69.79 Favored 'General case' 0 CA--C 1.543 0.694 0 O-C-N 121.655 -0.653 . . . . 0.0 111.921 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.2 mt -61.86 -54.97 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 119.521 1.055 . . . . 0.0 110.005 168.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 54.8 tt0 -61.82 -32.38 72.68 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.2 1.0 . . . . 0.0 113.081 -179.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -67.75 -42.12 82.3 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.123 1.369 . . . . 0.0 112.252 177.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 -92.75 -17.41 24.23 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -174.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.471 ' CD1' HG22 ' A' ' 78' ' ' ILE . 50.4 mm -117.25 128.51 74.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.484 0 C-N-CA 124.342 1.057 . . . . 0.0 110.131 -176.019 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.16 -6.17 1.74 Allowed Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.621 1.581 . . . . 0.0 115.703 174.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -119.0 -1.27 10.99 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.853 2.061 . . . . 0.0 112.71 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.89 160.26 9.95 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.316 1.446 . . . . 0.0 110.279 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.464 ' H ' HD23 ' A' ' 46' ' ' LEU . 1.4 pt? -55.22 -39.74 70.03 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.773 1.027 . . . . 0.0 113.773 -173.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -98.51 -32.65 5.93 Favored Glycine 0 CA--C 1.534 1.243 0 CA-C-O 116.876 -2.069 . . . . 0.0 115.009 175.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.3 t -82.62 118.02 29.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.117 0 CA-C-N 121.235 2.517 . . . . 0.0 110.529 175.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -105.55 -17.4 14.43 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 175.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.7 m -148.91 148.09 29.43 Favored 'General case' 0 N--CA 1.472 0.638 0 O-C-N 120.491 -1.38 . . . . 0.0 113.364 169.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 7.7 tp -110.21 131.98 59.78 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 123.956 0.902 . . . . 0.0 109.866 167.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -120.52 143.45 48.56 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.432 1.493 . . . . 0.0 109.148 176.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.403 ' CG1' HD23 ' A' ' 55' ' ' LEU . 95.1 t -120.09 120.58 63.48 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 124.658 1.183 . . . . 0.0 109.804 -169.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.3 m -119.66 55.32 0.97 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 125.432 1.493 . . . . 0.0 112.635 -168.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.403 HD23 ' CG1' ' A' ' 53' ' ' VAL . 1.2 mm? -68.47 -13.97 62.68 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 115.243 1.572 . . . . 0.0 115.243 -169.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.0 tt0 -60.27 -33.4 72.27 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 124.286 1.034 . . . . 0.0 112.94 174.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -113.25 15.87 19.22 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.421 1.488 . . . . 0.0 111.725 171.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 81.0 mttt 66.89 11.54 8.38 Favored 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 127.217 2.207 . . . . 0.0 113.056 176.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -95.58 174.29 7.07 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 127.173 2.189 . . . . 0.0 110.29 -174.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.04 164.67 24.9 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.756 1.623 . . . . 0.0 108.47 167.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.5 mm-40 -135.73 109.45 8.05 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.089 1.355 . . . . 0.0 108.048 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 14.9 p -98.64 133.59 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 121.856 -0.528 . . . . 0.0 110.069 177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.03 96.11 7.92 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.382 1.473 . . . . 0.0 109.805 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -125.25 148.22 48.75 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 -171.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -98.87 118.35 63.02 Favored Pre-proline 0 CA--C 1.545 0.783 0 C-N-CA 125.272 1.429 . . . . 0.0 109.43 171.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -70.57 2.16 4.26 Favored 'Trans proline' 0 CA--C 1.538 0.677 0 C-N-CA 123.836 3.024 . . . . 0.0 113.095 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.3 t -71.37 -28.05 63.77 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 121.103 -0.998 . . . . 0.0 112.289 171.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 82.6 m -113.0 -20.45 11.53 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.84 1.422 . . . . 0.0 114.84 -171.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.6 t -145.13 -176.25 5.02 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.853 1.661 . . . . 0.0 111.178 -171.07 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 88.8 p -158.38 155.39 25.51 Favored Pre-proline 0 CA--C 1.55 0.948 0 C-N-CA 125.635 1.574 . . . . 0.0 110.919 173.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -48.51 -46.35 23.96 Favored 'Trans proline' 0 C--N 1.353 0.798 0 C-N-CA 124.132 3.221 . . . . 0.0 116.907 -173.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 35.5 m -69.39 -32.16 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-N 120.472 1.487 . . . . 0.0 113.065 -179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.22 -30.09 67.08 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.93 0.892 . . . . 0.0 111.849 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 95.7 mt -71.9 -53.16 14.02 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.661 0.784 . . . . 0.0 111.125 169.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.546 HE21 HG23 ' A' ' 88' ' ' VAL . 14.5 tt0 -49.77 -57.32 7.56 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.944 1.298 . . . . 0.0 110.889 -178.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -68.6 -27.15 65.78 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.25 -55.42 9.3 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.23 0.923 . . . . 0.0 111.356 174.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.471 HG22 ' CD1' ' A' ' 42' ' ' ILE . 8.7 pt -71.81 -31.85 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 N-CA-C 112.819 0.674 . . . . 0.0 112.819 -171.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -69.86 -17.66 63.38 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.852 1.056 . . . . 0.0 113.852 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -101.73 10.77 39.73 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 120.549 -1.344 . . . . 0.0 113.724 175.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 35.1 mt -59.17 -54.04 60.33 Favored Pre-proline 0 CA--C 1.542 0.668 0 CA-C-O 117.562 -1.209 . . . . 0.0 109.759 166.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -76.5 174.45 12.81 Favored 'Trans proline' 0 CA--C 1.543 0.934 0 C-N-CA 123.237 2.624 . . . . 0.0 110.849 168.467 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -74.74 54.49 3.53 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.142 3.228 . . . . 0.0 111.209 169.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.45 23.5 68.55 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.304 0.954 . . . . 0.0 112.999 -175.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -90.14 -30.37 17.68 Favored 'General case' 0 N--CA 1.477 0.898 0 CA-C-N 117.554 0.677 . . . . 0.0 112.473 -169.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -109.49 116.0 30.99 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.282 1.433 . . . . 0.0 107.89 172.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.4 tptp -96.91 157.02 16.1 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.666 1.186 . . . . 0.0 110.592 -175.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.546 HG23 HE21 ' A' ' 75' ' ' GLN . 3.9 m -124.2 133.81 68.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 120.756 1.616 . . . . 0.0 111.659 170.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.6 p -110.58 127.45 55.23 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.026 0.93 . . . . 0.0 110.528 168.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 CA--C 1.549 0.925 0 C-N-CA 125.355 1.462 . . . . 0.0 109.514 170.384 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.8 t . . . . . 0 CA--C 1.532 0.266 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 84.8 m 59.0 92.91 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 116.859 2.17 . . . . 0.0 116.859 167.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 68.1 m -141.18 158.51 43.81 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.334 1.453 . . . . 0.0 110.804 173.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 52.9 m -99.22 142.51 30.62 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.734 0.814 . . . . 0.0 110.76 -173.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -144.68 143.65 30.83 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 124.065 0.946 . . . . 0.0 111.312 170.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -102.68 135.72 43.82 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.277 1.431 . . . . 0.0 110.166 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.4 mm -113.83 136.04 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 126.552 1.941 . . . . 0.0 108.304 177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -105.36 124.48 49.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.271 1.429 . . . . 0.0 109.306 175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 88.3 mt -122.55 143.7 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 O-C-N 120.486 -1.384 . . . . 0.0 112.21 -166.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -126.62 56.39 1.48 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 125.298 1.439 . . . . 0.0 112.984 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.95 50.63 0.18 Allowed Glycine 0 N--CA 1.462 0.393 0 C-N-CA 125.17 1.367 . . . . 0.0 111.902 166.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.499 ' SD ' HD22 ' A' ' 157' ' ' LEU . 10.6 ptp -126.35 142.05 51.67 Favored 'General case' 0 C--O 1.235 0.295 0 CA-C-O 121.869 0.842 . . . . 0.0 110.637 168.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.0 t -155.72 143.03 19.33 Favored 'General case' 0 CA--C 1.514 -0.435 0 C-N-CA 128.152 2.581 . . . . 0.0 105.604 -176.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 81.5 m 70.13 141.8 0.05 OUTLIER 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.489 1.516 . . . . 0.0 113.422 176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -52.41 -35.83 52.82 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.164 -0.96 . . . . 0.0 113.194 -178.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 57.1 p -61.05 -25.22 66.77 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.109 -0.994 . . . . 0.0 113.373 -178.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 14.3 t -65.91 -31.98 73.23 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.723 -0.611 . . . . 0.0 112.623 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.3 t -55.29 -60.5 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.305 0.642 . . . . 0.0 109.275 173.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 88.0 m-70 -66.5 -20.01 65.93 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 112.622 0.601 . . . . 0.0 112.622 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.5 t -71.08 -58.26 3.73 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.587 1.155 . . . . 0.0 111.764 171.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.5 mt -70.5 -49.41 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 C-N-CA 125.002 1.321 . . . . 0.0 111.245 -176.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -53.16 -26.96 18.87 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.167 1.787 . . . . 0.0 111.775 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -75.62 -60.66 3.14 Favored Glycine 0 CA--C 1.531 1.042 0 C-N-CA 125.648 1.594 . . . . 0.0 113.321 167.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 70.1 mmm -54.29 -41.96 69.49 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.843 1.257 . . . . 0.0 114.001 -172.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.3 mm -71.79 -32.82 46.23 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 123.425 0.69 . . . . 0.0 111.97 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.0 t -64.9 1.11 0.97 Allowed 'General case' 0 CA--C 1.557 1.212 0 C-N-CA 125.256 1.423 . . . . 0.0 114.803 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 39.8 mt-30 -90.38 -30.31 17.49 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 120.357 -1.464 . . . . 0.0 114.031 -178.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -83.86 176.77 8.67 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.216 1.006 . . . . 0.0 112.261 -174.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 33.0 mm-40 -86.84 154.45 20.88 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 122.489 1.138 . . . . 0.0 113.934 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 88.0 2.54 80.79 Favored Glycine 0 CA--C 1.537 1.417 0 CA-C-N 113.146 -1.843 . . . . 0.0 116.528 -179.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 8.7 p -104.24 96.2 4.42 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 120.99 2.395 . . . . 0.0 112.231 -174.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.514 ' NE2' ' H ' ' A' ' 151' ' ' GLN . 2.7 mp0 -65.49 -50.28 65.91 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.88 0.872 . . . . 0.0 109.922 173.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.42 141.67 30.94 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.356 0.663 . . . . 0.0 111.427 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.48 138.98 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 CA-C-O 121.961 0.886 . . . . 0.0 111.298 166.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 6.8 t -142.22 147.07 35.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 127.365 2.266 . . . . 0.0 109.05 -173.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.3 t -134.75 136.44 52.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-N 119.314 0.961 . . . . 0.0 110.566 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 35.1 m -113.93 99.31 7.58 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 124.771 1.229 . . . . 0.0 111.149 175.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . 0.499 HD22 ' SD ' ' A' ' 131' ' ' MET . 0.2 OUTLIER -53.6 -30.99 45.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.952 1.701 . . . . 0.0 110.973 169.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -49.57 -34.21 17.08 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 127.043 2.137 . . . . 0.0 114.597 174.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -130.59 -5.24 4.16 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.187 0.995 . . . . 0.0 113.065 -176.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.44 30.85 57.82 Favored Glycine 0 CA--C 1.528 0.861 0 CA-C-N 119.46 1.027 . . . . 0.0 112.355 -178.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 61.0 p -118.66 152.98 35.07 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 117.869 0.834 . . . . 0.0 110.676 -170.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -125.26 124.3 41.36 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 123.675 0.79 . . . . 0.0 109.488 171.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 13.4 t -106.66 132.56 52.52 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 122.969 0.508 . . . . 0.0 110.18 177.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.82 138.67 31.39 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.318 0 C-N-CA 123.068 0.547 . . . . 0.0 111.375 -171.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.16 96.1 8.21 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 169.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -98.78 159.92 14.62 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.625 0.77 . . . . 0.0 111.964 -177.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -98.68 102.68 15.56 Favored Pre-proline 0 C--O 1.241 0.653 0 C-N-CA 124.935 1.294 . . . . 0.0 109.324 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -65.7 -16.93 55.37 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.612 1.541 . . . . 0.0 113.075 -176.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -75.21 -12.94 60.4 Favored 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 114.566 1.321 . . . . 0.0 114.566 173.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 76.4 t -119.78 -41.12 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 126.069 1.748 . . . . 0.0 111.858 -178.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 13.4 tt -137.05 149.03 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 C-N-CA 124.211 1.004 . . . . 0.0 112.05 -172.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 55.5 m -112.71 153.19 45.14 Favored Pre-proline 0 N--CA 1.478 0.926 0 C-N-CA 124.461 1.104 . . . . 0.0 111.991 178.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -52.28 -38.94 73.29 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.453 2.769 . . . . 0.0 114.559 -179.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -60.34 -29.25 68.77 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 175.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -72.05 -31.44 66.15 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.998 0.919 . . . . 0.0 112.532 172.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 42.7 mt -64.39 -49.93 69.64 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 123.512 0.725 . . . . 0.0 109.351 173.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 74.3 ttt-85 -52.7 -50.57 63.07 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.929 1.292 . . . . 0.0 111.834 173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.94 -30.94 69.41 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 177.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.59 -31.78 65.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.637 0.977 . . . . 0.0 113.637 179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -74.34 -39.52 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 123.606 0.762 . . . . 0.0 110.91 170.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -65.61 -29.17 69.73 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 122.869 0.468 . . . . 0.0 111.746 173.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -67.07 -36.69 82.56 Favored 'General case' 0 CA--C 1.534 0.359 0 O-C-N 120.265 -1.522 . . . . 0.0 112.678 172.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 17.5 ttt -67.11 -28.66 68.34 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 123.86 0.864 . . . . 0.0 112.024 174.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 118.59 20.39 4.26 Favored Glycine 0 CA--C 1.529 0.955 0 C-N-CA 125.557 1.551 . . . . 0.0 115.747 169.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -106.46 -154.66 0.52 Allowed 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.487 1.515 . . . . 0.0 109.69 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -135.58 138.13 42.67 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 125.119 1.367 . . . . 0.0 109.009 169.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -126.67 158.49 36.24 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 125.4 1.48 . . . . 0.0 111.545 176.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 12.2 t -140.51 136.11 32.59 Favored 'General case' 0 C--N 1.32 -0.702 0 C-N-CA 126.947 2.099 . . . . 0.0 107.98 175.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.2 m -84.21 129.73 37.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 O-C-N 121.762 -0.586 . . . . 0.0 109.876 176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 124.829 2.252 . . . . 0.0 107.151 171.095 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.429 HG13 ' CE1' ' A' ' 64' ' ' TYR . 9.0 p . . . . . 0 CA--C 1.542 0.671 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -125.59 144.01 50.76 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 123.951 0.9 . . . . 0.0 111.367 -170.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.3 140.27 29.06 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.024 2.13 . . . . 0.0 109.205 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.528 ' NE2' HE22 ' A' ' 61' ' ' GLN . 2.3 pt20 -131.01 146.21 52.31 Favored 'General case' 0 N--CA 1.462 0.153 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 173.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.404 ' H ' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -132.6 158.13 43.01 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.592 1.957 . . . . 0.0 110.707 174.058 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -95.12 101.57 13.33 Favored 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 174.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 3.5 mt -77.1 133.8 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.253 1.021 . . . . 0.0 110.814 175.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -97.84 136.24 38.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.472 1.509 . . . . 0.0 111.256 172.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 101.38 -9.45 57.51 Favored Glycine 0 CA--C 1.536 1.358 0 C-N-CA 125.252 1.406 . . . . 0.0 114.256 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 10.2 ptp -60.81 -17.89 52.25 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.716 1.376 . . . . 0.0 114.716 177.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 15.1 t-160 -63.35 -15.53 57.69 Favored 'General case' 0 CA--C 1.554 1.097 0 CA-C-N 119.4 1.0 . . . . 0.0 113.499 172.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 72.6 m -79.55 -9.97 59.71 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 168.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? 71.09 -59.78 0.53 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 128.68 2.792 . . . . 0.0 111.482 -173.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 36.9 p -45.27 -35.84 3.66 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 127.335 2.254 . . . . 0.0 114.055 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -45.68 -45.76 14.35 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.7 1.6 . . . . 0.0 112.492 174.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -75.69 -18.43 15.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -174.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 35.1 tp -63.49 -50.92 67.75 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 119.203 0.911 . . . . 0.0 111.087 -179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -52.89 -39.84 63.02 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.65 0.738 . . . . 0.0 111.072 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.5 mt -69.38 -52.54 31.89 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.452 1.101 . . . . 0.0 109.977 -178.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -58.41 -34.63 70.97 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 125.646 1.579 . . . . 0.0 113.701 176.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.7 mm-40 -66.59 -41.1 89.01 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 119.637 1.108 . . . . 0.0 111.68 176.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 43.4 m-80 -94.12 -36.55 12.03 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -171.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.458 ' CD1' HG22 ' A' ' 78' ' ' ILE . 33.2 mm -98.22 114.77 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 O-C-N 121.177 -0.952 . . . . 0.0 109.04 -170.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.45 -27.36 2.38 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.183 0.897 . . . . 0.0 114.84 -169.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 26.3 pt20 -106.02 3.68 28.51 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.615 0.969 . . . . 0.0 113.615 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.5 mt -87.78 163.67 16.35 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.815 1.246 . . . . 0.0 112.784 -170.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 47.1 tp -29.5 -62.01 0.14 Allowed 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 127.802 2.441 . . . . 0.0 114.902 -179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -97.83 -23.78 13.02 Favored Glycine 0 CA--C 1.529 0.953 0 CA-C-O 118.218 -1.323 . . . . 0.0 114.626 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.8 t -81.86 126.3 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 CA-C-N 120.14 1.97 . . . . 0.0 110.601 -176.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.4 tt0 -97.52 -40.32 8.71 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.798 0.839 . . . . 0.0 111.733 178.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.8 t -149.95 -178.56 6.55 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 124.413 1.085 . . . . 0.0 113.706 175.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.9 tp -132.63 145.3 34.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 127.462 2.305 . . . . 0.0 109.097 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -132.98 118.69 19.15 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-O 122.635 1.207 . . . . 0.0 109.561 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 84.4 t -104.82 95.07 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 C-N-CA 126.274 1.83 . . . . 0.0 109.385 -168.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.1 t -113.17 55.63 0.7 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.401 1.481 . . . . 0.0 111.345 -174.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 68.4 mt -58.6 -28.82 65.94 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -168.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -54.5 -25.42 25.39 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.232 1.413 . . . . 0.0 113.589 176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -102.23 -0.36 33.16 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.056 1.343 . . . . 0.0 113.733 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 90.1 mttt 69.6 -15.86 0.28 Allowed 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 127.746 2.418 . . . . 0.0 114.543 -175.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.64 131.28 42.04 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.845 1.658 . . . . 0.0 108.702 177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.37 145.29 27.53 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 124.594 1.158 . . . . 0.0 109.698 173.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.528 HE22 ' NE2' ' A' ' 23' ' ' GLN . 8.4 tp-100 -114.86 134.19 55.35 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.705 1.202 . . . . 0.0 109.246 -169.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 p -118.39 140.46 41.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 CA-C-N 119.976 1.262 . . . . 0.0 111.045 171.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt -113.51 101.4 9.31 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.234 1.813 . . . . 0.0 108.499 -173.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.429 ' CE1' HG13 ' A' ' 20' ' ' VAL . 16.1 p90 -128.62 -179.37 5.02 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.842 1.657 . . . . 0.0 111.63 -168.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -120.23 138.12 26.79 Favored Pre-proline 0 CA--C 1.547 0.86 0 C-N-CA 124.803 1.241 . . . . 0.0 108.569 169.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -80.57 5.51 6.07 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.966 2.444 . . . . 0.0 113.556 -169.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 76.9 p -75.12 -29.1 60.46 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 124.413 1.085 . . . . 0.0 113.197 -172.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 82.8 m -121.63 -21.65 6.11 Favored 'General case' 0 CA--C 1.545 0.761 0 N-CA-C 114.813 1.412 . . . . 0.0 114.813 -170.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -146.71 -179.21 6.62 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.956 1.702 . . . . 0.0 110.93 -174.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 52.8 p -165.58 170.24 6.26 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.969 1.308 . . . . 0.0 111.882 -175.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -45.61 -51.28 8.31 Favored 'Trans proline' 0 C--N 1.355 0.894 0 C-N-CA 124.612 3.541 . . . . 0.0 116.122 -177.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 20.3 m -70.16 -35.26 62.58 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 119.714 1.143 . . . . 0.0 112.879 -177.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.88 -42.1 77.46 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.471 0.708 . . . . 0.0 110.929 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 83.7 mt -63.22 -48.33 78.76 Favored 'General case' 0 N--CA 1.463 0.2 0 C-N-CA 124.336 1.054 . . . . 0.0 111.28 173.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 58.5 tt0 -52.32 -54.65 28.81 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 119.191 0.905 . . . . 0.0 110.987 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -65.53 -36.13 82.9 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.305 1.042 . . . . 0.0 111.785 -176.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -64.42 -53.98 39.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.472 0.709 . . . . 0.0 112.164 174.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.458 HG22 ' CD1' ' A' ' 42' ' ' ILE . 7.9 pt -72.4 -30.34 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -172.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -66.23 -27.39 67.93 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 119.139 0.881 . . . . 0.0 113.07 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.89 8.11 42.48 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.79 -51.52 80.28 Favored Pre-proline 0 N--CA 1.472 0.65 0 CA-C-O 117.688 -1.149 . . . . 0.0 112.4 168.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.408 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 76.6 Cg_endo -71.75 167.47 26.46 Favored 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.221 1.947 . . . . 0.0 111.48 171.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -76.16 62.81 6.86 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 124.074 3.183 . . . . 0.0 110.019 169.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 62.56 53.8 38.81 Favored Glycine 0 C--N 1.341 0.84 0 C-N-CA 124.943 1.258 . . . . 0.0 112.814 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -125.7 -50.79 1.6 Allowed 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -171.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.408 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 13.5 m-85 -97.52 118.92 35.1 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -177.597 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -99.13 149.76 22.72 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.244 1.018 . . . . 0.0 111.578 -175.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 1.2 m -123.92 142.58 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.4 m -121.38 134.22 55.11 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.38 1.472 . . . . 0.0 111.561 -177.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 54.0 mt . . . . . 0 CA--C 1.546 0.816 0 C-N-CA 126.865 2.066 . . . . 0.0 110.948 174.838 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.0 t . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 12.7 p -147.92 131.7 17.0 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 -167.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.3 p -144.22 146.34 32.61 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 126.109 1.764 . . . . 0.0 111.504 172.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 22.1 m -99.31 147.53 25.09 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.502 1.121 . . . . 0.0 109.981 177.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -146.49 141.85 27.49 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.072 0.949 . . . . 0.0 110.497 168.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.3 tt -108.74 144.55 36.4 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.07 1.348 . . . . 0.0 110.738 176.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 5.4 mt -134.2 137.24 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.162 0 C-N-CA 126.374 1.87 . . . . 0.0 110.39 -169.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.83 133.73 42.71 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.308 1.443 . . . . 0.0 109.793 172.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 55.4 mt -140.33 130.53 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 CA-C-N 119.462 1.028 . . . . 0.0 110.866 -171.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -105.19 53.43 0.72 Allowed 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.344 1.058 . . . . 0.0 112.755 -179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -156.41 53.13 0.42 Allowed Glycine 0 N--CA 1.47 0.907 0 O-C-N 120.932 -1.105 . . . . 0.0 113.815 173.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -131.1 154.0 48.75 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.513 1.125 . . . . 0.0 109.903 170.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.4 t -157.33 -37.13 0.07 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.841 1.656 . . . . 0.0 111.217 -169.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 57.3 m -133.78 159.25 41.17 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.94 1.696 . . . . 0.0 111.577 176.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.85 -31.99 70.27 Favored 'General case' 0 N--CA 1.472 0.647 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 -175.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -51.52 -26.3 8.22 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 124.898 1.279 . . . . 0.0 113.49 171.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 79.0 m -58.48 -26.42 63.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 124.519 1.128 . . . . 0.0 113.595 171.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.7 t -58.91 -47.33 89.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 CA-C-N 118.892 0.769 . . . . 0.0 109.818 173.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 98.4 m-70 -71.17 -13.89 62.09 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 15.4 m -70.98 -56.48 6.1 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.803 0.841 . . . . 0.0 109.686 168.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.14 -54.26 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 124.846 1.258 . . . . 0.0 110.614 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -54.49 -32.82 58.66 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.22 1.008 . . . . 0.0 111.004 172.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -64.74 -49.53 63.39 Favored Glycine 0 C--N 1.34 0.781 0 C-N-CA 124.171 0.891 . . . . 0.0 112.422 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 96.8 mmm -66.86 -46.99 73.32 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 118.689 1.244 . . . . 0.0 111.822 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 17.6 mm -73.19 -54.08 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.74 0 C-N-CA 123.394 0.677 . . . . 0.0 112.707 -174.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.5 t -62.46 -16.18 53.87 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -168.254 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 34.5 mt-30 -74.8 -30.84 61.55 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.978 1.311 . . . . 0.0 114.135 -179.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 pp -89.28 -179.37 5.85 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.116 0.871 . . . . 0.0 111.407 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -87.39 -172.55 3.97 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 122.112 0.958 . . . . 0.0 111.6 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 75.63 -45.64 1.88 Allowed Glycine 0 CA--C 1.531 1.058 0 O-C-N 120.272 -1.517 . . . . 0.0 113.711 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 6.1 p -65.35 99.21 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 127.213 2.205 . . . . 0.0 112.096 175.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -81.23 -39.9 24.65 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.503 -0.748 . . . . 0.0 111.713 169.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -140.16 144.07 36.46 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.2 1.0 . . . . 0.0 110.461 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -144.45 138.32 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-O 121.997 0.903 . . . . 0.0 113.133 169.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 14.4 t -140.01 146.77 39.48 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.851 2.46 . . . . 0.0 110.691 -169.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 87.1 t -143.63 138.03 25.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.28 0 O-C-N 120.913 -1.117 . . . . 0.0 111.02 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 70.0 m -124.94 89.58 3.09 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.759 1.624 . . . . 0.0 111.126 177.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -53.53 -29.92 39.13 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 127.104 2.161 . . . . 0.0 113.242 174.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -47.7 -31.31 4.58 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 128.079 2.552 . . . . 0.0 115.259 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -130.18 -3.48 4.46 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.134 1.773 . . . . 0.0 112.237 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 71.29 36.32 63.48 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 117.852 -1.527 . . . . 0.0 112.882 179.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.8 p -124.1 153.74 41.0 Favored 'General case' 0 N--CA 1.477 0.925 0 CA-C-N 119.126 1.463 . . . . 0.0 112.082 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -119.28 148.73 42.82 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.537 1.535 . . . . 0.0 109.722 169.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.9 t -138.39 133.55 33.02 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.585 0.754 . . . . 0.0 110.835 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.62 143.0 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 123.677 0.791 . . . . 0.0 111.451 -168.14 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -97.6 106.57 18.91 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 125.556 1.542 . . . . 0.0 107.371 169.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -108.38 158.09 17.82 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.957 1.303 . . . . 0.0 111.701 177.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -95.9 116.62 66.35 Favored Pre-proline 0 CA--C 1.545 0.752 0 O-C-N 121.061 -1.024 . . . . 0.0 109.536 175.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -75.41 -10.22 20.48 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.326 2.017 . . . . 0.0 113.199 -170.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.15 -7.74 58.93 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 124.132 0.973 . . . . 0.0 113.418 169.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 73.6 t -113.97 -35.44 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 125.51 1.524 . . . . 0.0 112.348 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.0 tt -156.66 159.2 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-N 119.349 0.977 . . . . 0.0 112.205 -174.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -112.76 150.72 43.2 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 126.213 1.805 . . . . 0.0 112.214 -177.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -49.54 -43.87 37.39 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 124.3 3.334 . . . . 0.0 114.908 177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -72.22 -15.94 61.94 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -74.68 -30.72 61.68 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 121.078 -1.014 . . . . 0.0 112.35 170.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 66.9 mt -59.04 -51.6 69.34 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.796 1.238 . . . . 0.0 110.406 174.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 39.7 ttt180 -49.73 -47.92 50.36 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.181 1.392 . . . . 0.0 112.512 177.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.02 -23.68 66.6 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 -173.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -73.63 -35.8 65.36 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.531 0.732 . . . . 0.0 112.207 177.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.3 mt -74.36 -41.36 50.21 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 C-N-CA 124.75 1.22 . . . . 0.0 110.646 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -63.84 -28.27 69.74 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.011 0.924 . . . . 0.0 112.579 171.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -69.88 -35.46 74.68 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.177 0.991 . . . . 0.0 112.645 173.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 19.8 ttt -73.03 -34.06 66.1 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.871 0.868 . . . . 0.0 112.433 176.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 120.26 35.91 0.84 Allowed Glycine 0 CA--C 1.527 0.808 0 C-N-CA 125.205 1.383 . . . . 0.0 114.741 176.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -134.48 147.56 50.39 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.82 1.648 . . . . 0.0 110.314 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.0 mt-10 -101.37 102.36 13.17 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 120.833 -1.167 . . . . 0.0 111.232 -167.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -99.98 147.34 25.69 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.284 2.234 . . . . 0.0 112.514 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 31.5 t -142.52 144.24 32.87 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 124.822 1.249 . . . . 0.0 109.999 168.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 16.2 m -71.71 136.39 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 O-C-N 121.702 -0.624 . . . . 0.0 110.675 176.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 31.5 m . . . . . 0 N--CA 1.475 0.81 0 C-N-CA 125.766 1.626 . . . . 0.0 107.57 169.858 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 6.4 m . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.05 133.05 42.22 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 125.324 1.45 . . . . 0.0 109.373 174.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.4 tt -126.53 128.83 47.5 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 127.307 2.243 . . . . 0.0 107.952 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -96.99 135.7 38.61 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 124.947 1.299 . . . . 0.0 110.344 -176.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.6 pp -145.06 157.56 44.07 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 124.427 1.091 . . . . 0.0 113.736 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 14.5 tpt180 -116.06 125.39 52.36 Favored 'General case' 0 C--O 1.222 -0.352 0 C-N-CA 125.02 1.328 . . . . 0.0 110.476 178.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.3 mt -100.86 150.23 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.017 0 C-N-CA 126.169 1.788 . . . . 0.0 111.734 178.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -97.67 133.97 41.49 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 125.797 1.639 . . . . 0.0 110.923 173.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.43 1.25 81.35 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.853 1.216 . . . . 0.0 114.287 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.2 ptm -72.37 -6.78 45.83 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 116.196 1.925 . . . . 0.0 116.196 -173.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 30.8 m170 -60.21 -18.87 51.49 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.425 1.011 . . . . 0.0 112.658 170.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 51.5 t -89.98 119.4 30.3 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 165.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -61.55 -19.95 62.71 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.254 1.022 . . . . 0.0 113.397 -175.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 65.3 m -63.59 -23.9 67.58 Favored 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 114.336 1.235 . . . . 0.0 114.336 169.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 6.1 t -61.52 -52.38 64.71 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 120.902 1.683 . . . . 0.0 110.862 178.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.46 -15.77 19.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 113.077 0.769 . . . . 0.0 113.077 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -69.65 -60.81 2.08 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 119.426 1.012 . . . . 0.0 111.264 179.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.11 -26.07 68.65 Favored 'General case' 0 CA--C 1.548 0.892 0 O-C-N 121.34 -0.85 . . . . 0.0 112.117 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 92.3 mt -64.8 -50.94 72.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 120.913 -1.117 . . . . 0.0 111.048 167.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -61.0 -31.32 70.94 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 124.771 1.228 . . . . 0.0 113.658 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -56.03 -46.29 78.89 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 119.465 1.03 . . . . 0.0 110.541 173.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -90.29 -29.15 18.31 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.417 ' CD1' HG22 ' A' ' 78' ' ' ILE . 44.3 mm -110.09 113.43 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 124.34 1.056 . . . . 0.0 111.034 -169.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.27 -15.87 4.44 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 125.986 1.755 . . . . 0.0 114.45 -174.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.2 pt20 -101.77 5.66 41.34 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.79 1.236 . . . . 0.0 112.296 176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.13 178.52 4.35 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.61 1.564 . . . . 0.0 112.142 179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 tt -63.9 -69.29 0.29 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.022 1.329 . . . . 0.0 111.333 174.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.69 -37.66 16.19 Favored Glycine 0 CA--C 1.529 0.964 0 CA-C-O 117.774 -1.57 . . . . 0.0 112.547 -175.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 58.0 t -80.15 120.96 32.64 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 CA-C-N 119.593 1.697 . . . . 0.0 110.126 175.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -116.29 -17.33 10.79 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -175.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 74.4 m -145.47 163.62 34.1 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 119.33 0.968 . . . . 0.0 111.324 169.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.5 tp -129.1 124.54 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 C-N-CA 124.279 1.032 . . . . 0.0 109.045 168.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -114.13 142.14 46.61 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.408 1.483 . . . . 0.0 108.305 -176.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.9 m -115.08 137.87 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 123.806 0.842 . . . . 0.0 109.687 -174.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.0 t -136.12 55.53 1.85 Allowed 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 123.967 1.842 . . . . 0.0 107.69 -176.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 59.8 mt -68.9 -24.49 64.31 Favored 'General case' 0 N--CA 1.466 0.361 0 C-N-CA 126.009 1.724 . . . . 0.0 114.516 -167.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -55.61 -52.42 63.85 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.317 1.047 . . . . 0.0 110.421 177.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -91.79 19.02 6.89 Favored 'General case' 0 CA--C 1.553 1.067 0 C-N-CA 124.676 1.191 . . . . 0.0 111.942 174.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 49.5 mttp 65.12 28.01 12.32 Favored 'General case' 0 N--CA 1.48 1.041 0 C-N-CA 126.569 1.948 . . . . 0.0 112.76 171.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.6 152.29 27.77 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 125.604 1.561 . . . . 0.0 111.447 -176.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -127.49 154.78 44.69 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 166.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -141.7 116.41 9.74 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -163.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.1 p -98.79 137.38 26.43 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 CA-C-O 120.97 0.414 . . . . 0.0 111.236 -172.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -108.3 97.65 7.3 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.812 2.045 . . . . 0.0 108.713 -177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -129.63 155.74 45.35 Favored 'General case' 0 N--CA 1.472 0.658 0 C-N-CA 124.875 1.27 . . . . 0.0 113.921 -169.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.9 t0 -99.17 118.53 62.42 Favored Pre-proline 0 CA--C 1.556 1.18 0 C-N-CA 125.564 1.545 . . . . 0.0 110.528 170.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -61.0 -2.13 2.05 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 125.203 3.935 . . . . 0.0 116.064 174.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.5 t -72.94 -22.65 60.68 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 125.136 1.374 . . . . 0.0 113.145 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 36.1 m -139.66 -8.62 1.24 Allowed 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 116.558 2.058 . . . . 0.0 116.558 -168.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.0 t -147.91 -179.47 6.93 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.272 1.029 . . . . 0.0 110.833 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.4 p -160.81 156.29 21.44 Favored Pre-proline 0 CA--C 1.548 0.891 0 C-N-CA 124.057 0.943 . . . . 0.0 113.16 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -48.69 -55.68 3.88 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 124.747 3.631 . . . . 0.0 116.129 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 22.0 m -67.26 -34.17 67.47 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 120.097 1.317 . . . . 0.0 112.053 -176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.42 -41.22 89.54 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.967 0.907 . . . . 0.0 111.661 177.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 73.7 mt -66.22 -43.81 85.59 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.849 0.86 . . . . 0.0 111.494 171.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 57.1 tt0 -57.93 -44.76 87.09 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.237 0.926 . . . . 0.0 110.815 178.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 84.3 mmt-85 -70.09 -31.2 68.65 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.368 1.067 . . . . 0.0 113.557 175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.42 -51.77 27.09 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.952 0.901 . . . . 0.0 112.486 174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.417 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.4 pt -74.29 -32.47 31.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 113.823 1.045 . . . . 0.0 113.823 -174.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -68.16 -30.01 69.02 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 -173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -90.59 7.08 40.99 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 39.8 mt -53.08 -55.04 37.77 Favored Pre-proline 0 CA--C 1.542 0.666 0 CA-C-O 117.385 -1.293 . . . . 0.0 112.885 170.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.42 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 92.1 Cg_endo -72.2 169.36 21.72 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.992 2.461 . . . . 0.0 111.492 174.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -76.12 51.95 3.32 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 125.245 3.964 . . . . 0.0 112.404 175.508 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 65.43 63.28 4.21 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.635 -0.986 . . . . 0.0 110.635 -173.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -130.3 -58.1 1.06 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.42 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 20.4 m-85 -93.22 124.67 37.36 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 3.5 mppt? -97.55 162.94 13.06 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.015 0.926 . . . . 0.0 110.452 176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 4.0 p -140.82 137.25 35.12 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 N-CA-C 113.164 0.802 . . . . 0.0 113.164 172.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.0 m -118.85 139.39 51.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.142 2.177 . . . . 0.0 110.767 177.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 CA--C 1.545 0.766 0 C-N-CA 124.575 1.15 . . . . 0.0 111.584 175.268 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.26 5.7 t . . . . . 0 N--CA 1.475 0.811 0 CA-C-O 120.459 0.171 . . . . 0.0 110.621 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 69.4 m 49.8 93.16 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 117.368 2.358 . . . . 0.0 117.368 166.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.7 p -133.92 141.44 47.33 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 120.476 -1.39 . . . . 0.0 111.211 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 44.2 m -97.46 134.42 40.73 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 119.664 1.12 . . . . 0.0 110.176 -174.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -135.4 158.16 45.08 Favored 'General case' 0 N--CA 1.473 0.676 0 C-N-CA 124.209 1.004 . . . . 0.0 113.067 175.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -106.22 136.51 45.81 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.323 2.249 . . . . 0.0 111.025 -177.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 10.0 mm -128.58 134.4 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 125.963 1.705 . . . . 0.0 108.348 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.08 130.1 45.39 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.185 0.994 . . . . 0.0 109.486 172.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 97.1 mt -128.35 147.53 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 120.47 -1.394 . . . . 0.0 110.921 -168.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -134.97 58.67 1.76 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.29 1.436 . . . . 0.0 113.221 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -164.1 48.74 0.3 Allowed Glycine 0 N--CA 1.469 0.846 0 O-C-N 120.889 -1.132 . . . . 0.0 113.696 166.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . 0.408 ' O ' HG22 ' A' ' 132' ' ' THR . 74.3 mtm -102.14 -55.51 2.46 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 117.562 -1.209 . . . . 0.0 111.716 177.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 131' ' ' MET 0.256 6.0 t 67.44 -38.64 0.35 Allowed 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 129.647 3.179 . . . . 0.0 114.619 174.072 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 87.3 m -135.47 153.56 51.72 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 127.502 2.321 . . . . 0.0 111.529 -177.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -56.78 -40.56 76.11 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 124.353 1.061 . . . . 0.0 113.401 -176.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.4 p -53.19 -35.29 59.69 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.813 0.733 . . . . 0.0 112.565 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.4 t -62.89 -25.8 68.48 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -179.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 10.2 t -58.94 -57.29 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 CA-C-N 118.93 0.786 . . . . 0.0 109.076 169.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -65.54 -23.75 66.95 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 118.254 0.479 . . . . 0.0 112.16 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.1 m -69.9 -47.97 60.47 Favored 'General case' 0 CA--C 1.54 0.575 0 O-C-N 121.647 -0.658 . . . . 0.0 112.242 170.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.5 mt -70.83 -53.68 20.92 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 CA-C-N 119.725 1.148 . . . . 0.0 110.826 178.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -54.43 -31.01 54.37 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 126.673 1.989 . . . . 0.0 111.314 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.46 -61.74 2.71 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.3 1.429 . . . . 0.0 114.469 171.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 74.3 mmm -70.38 -41.81 72.58 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.844 1.258 . . . . 0.0 114.073 -168.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.8 mm -70.85 -27.57 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 O-C-N 121.714 -0.617 . . . . 0.0 110.66 -178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.411 ' HA ' HG11 ' A' ' 150' ' ' VAL . 2.7 t -65.73 0.39 1.73 Allowed 'General case' 0 CA--C 1.55 0.971 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 177.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 72.9 mt-30 -99.48 -5.35 29.49 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 115.413 1.634 . . . . 0.0 115.413 -172.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.1 pp -104.51 173.98 6.07 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.396 1.479 . . . . 0.0 111.821 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -79.14 142.87 36.0 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.079 -1.013 . . . . 0.0 111.712 174.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 94.09 11.47 57.49 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 117.133 -1.926 . . . . 0.0 116.947 175.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . 0.411 HG11 ' HA ' ' A' ' 145' ' ' SER . 10.1 p -111.85 -29.27 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 CA-C-N 119.638 1.719 . . . . 0.0 114.775 -175.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 39.9 tt0 39.07 -71.3 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 129.988 3.315 . . . . 0.0 117.602 178.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -133.74 124.74 27.17 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 119.619 1.1 . . . . 0.0 110.373 -178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.7 tt -129.41 136.12 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.7 1.2 . . . . 0.0 111.24 -176.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 24.5 t -136.38 126.56 26.32 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.218 1.807 . . . . 0.0 109.253 -179.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 11.1 t -141.69 139.21 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 O-C-N 120.725 -1.234 . . . . 0.0 110.436 -168.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.1 m -145.39 140.17 27.47 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.211 0.604 . . . . 0.0 112.021 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.9 mt -65.63 -30.63 71.37 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 -177.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.44 -56.36 5.1 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.754 2.021 . . . . 0.0 113.199 -170.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -101.39 -5.7 25.0 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.151 1.38 . . . . 0.0 111.198 174.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 69.27 35.53 77.08 Favored Glycine 0 C--N 1.342 0.914 0 C-N-CA 125.248 1.404 . . . . 0.0 112.286 -175.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 19.4 p -116.7 139.17 50.85 Favored 'General case' 0 CA--C 1.514 -0.442 0 C-N-CA 124.697 1.199 . . . . 0.0 113.615 -167.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.65 138.72 41.37 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 125.664 1.586 . . . . 0.0 108.965 167.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.8 t -123.01 126.38 47.03 Favored 'General case' 0 N--CA 1.47 0.547 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 166.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.47 142.93 28.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 C-N-CA 123.525 0.73 . . . . 0.0 111.313 -166.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -93.06 93.52 8.36 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 126.868 2.067 . . . . 0.0 106.601 -177.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -94.62 158.12 15.67 Favored 'General case' 0 C--O 1.237 0.396 0 CA-C-O 121.96 0.886 . . . . 0.0 111.234 -174.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.6 t-20 -95.77 106.98 30.98 Favored Pre-proline 0 CA--C 1.543 0.695 0 O-C-N 121.701 -0.624 . . . . 0.0 109.975 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -73.15 -17.74 24.34 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.135 1.89 . . . . 0.0 112.856 -174.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.71 41.0 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.457 1.103 . . . . 0.0 113.766 175.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 91.4 t -111.57 -27.66 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 C-N-CA 126.097 1.759 . . . . 0.0 113.342 -171.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 21.3 tt -145.38 147.09 19.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 CA-C-N 120.488 1.494 . . . . 0.0 112.457 -174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 35.3 m -98.5 144.71 28.61 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.279 1.032 . . . . 0.0 110.654 174.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_exo -49.77 -33.51 32.69 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 124.315 3.344 . . . . 0.0 115.02 176.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -60.75 -28.59 68.82 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 173.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -75.5 -28.33 59.13 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.041 1.336 . . . . 0.0 113.07 171.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.23 -48.5 78.0 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 119.022 0.828 . . . . 0.0 109.104 169.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.7 ttp180 -52.66 -47.62 67.0 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.017 1.327 . . . . 0.0 111.068 176.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.46 -30.14 69.48 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.371 1.068 . . . . 0.0 113.712 177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.38 -38.83 68.39 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 119.989 1.268 . . . . 0.0 113.001 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -71.63 -36.19 58.71 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.64 0.776 . . . . 0.0 110.391 173.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 74.7 mt-10 -69.66 -31.09 68.96 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.6 -0.688 . . . . 0.0 112.426 174.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -70.18 -28.76 65.57 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 126.663 1.985 . . . . 0.0 112.637 172.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.8 ttt -70.89 -36.69 72.87 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.34 1.056 . . . . 0.0 111.107 172.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 134.14 16.78 1.06 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 125.517 1.532 . . . . 0.0 116.117 169.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -113.08 -159.31 0.68 Allowed 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 118.696 1.248 . . . . 0.0 110.216 -173.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -128.27 140.63 51.78 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 124.525 1.13 . . . . 0.0 110.066 169.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -132.22 151.37 51.85 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.513 1.525 . . . . 0.0 111.875 177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.2 t -133.41 132.49 41.22 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 125.394 1.478 . . . . 0.0 111.997 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.5 m -84.54 80.8 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 CA-C-O 121.986 0.898 . . . . 0.0 110.722 -177.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.485 1.299 0 C-N-CA 126.654 1.982 . . . . 0.0 111.817 174.007 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 N--CA 1.469 0.504 0 CA-C-O 121.676 0.751 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.6 m -99.16 137.63 37.4 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.568 1.947 . . . . 0.0 110.002 -169.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.6 tt -142.25 139.21 31.86 Favored 'General case' 0 C--O 1.239 0.51 0 C-N-CA 124.597 1.159 . . . . 0.0 110.62 -177.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.539 ' NE2' HE22 ' A' ' 61' ' ' GLN . 1.2 mp0 -98.35 133.94 42.05 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 126.692 1.997 . . . . 0.0 110.716 -176.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -144.11 134.07 24.01 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-N 114.981 -1.009 . . . . 0.0 110.794 170.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -100.05 113.64 26.38 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 170.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 2.4 mt -77.73 128.99 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-O 121.548 0.69 . . . . 0.0 109.577 -178.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -107.2 107.85 19.0 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 127.235 2.214 . . . . 0.0 109.894 -171.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 104.09 10.52 34.2 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 124.676 1.131 . . . . 0.0 114.074 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 8.3 ptp -57.99 -35.58 71.41 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 119.155 1.478 . . . . 0.0 114.334 -177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 13.1 t60 68.06 -44.06 0.49 Allowed 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 129.202 3.001 . . . . 0.0 113.294 -175.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.8 p -166.74 166.88 15.58 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 127.647 2.379 . . . . 0.0 110.344 -173.104 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -53.55 -35.92 61.28 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 113.841 1.052 . . . . 0.0 113.841 -170.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 38.7 m -57.73 -23.09 50.11 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 114.622 1.341 . . . . 0.0 114.622 -172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.5 t -49.39 -40.42 35.93 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.643 1.177 . . . . 0.0 112.004 168.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -72.14 -12.34 15.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 117.83 -1.081 . . . . 0.0 113.565 -175.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 54.8 tp -63.87 -49.73 71.59 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 120.536 1.516 . . . . 0.0 111.884 178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.3 -40.94 68.39 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 119.144 0.884 . . . . 0.0 110.716 177.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 mt -65.3 -52.31 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.696 0 C-N-CA 125.311 1.444 . . . . 0.0 109.775 179.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -60.84 -33.32 72.86 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 127.936 2.495 . . . . 0.0 113.478 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 93.6 mt-10 -67.31 -45.05 77.64 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 124.517 1.127 . . . . 0.0 111.763 173.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 26.3 m-80 -95.22 -29.43 14.52 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 115.491 1.663 . . . . 0.0 115.491 -170.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.415 ' CD1' HG22 ' A' ' 78' ' ' ILE . 47.3 mm -108.14 113.46 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 C-N-CA 124.108 0.963 . . . . 0.0 109.577 -170.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 123.23 -22.55 7.06 Favored Glycine 0 N--CA 1.475 1.257 0 C-N-CA 125.857 1.694 . . . . 0.0 114.015 -172.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -78.65 -10.68 59.84 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 118.188 0.994 . . . . 0.0 112.094 170.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.5 mt -67.81 -177.69 0.84 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 129.609 3.164 . . . . 0.0 112.404 177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 tt -82.12 -70.21 0.56 Allowed 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.406 -0.809 . . . . 0.0 110.992 -179.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -67.94 -44.44 78.67 Favored Glycine 0 CA--C 1.526 0.743 0 CA-C-O 118.118 -1.379 . . . . 0.0 112.483 -174.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -71.14 117.82 14.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.65 1.725 . . . . 0.0 108.617 171.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.2 tt0 -97.32 -41.47 8.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 124.153 0.981 . . . . 0.0 110.494 -178.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 t -145.56 167.3 23.36 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.042 0.937 . . . . 0.0 112.666 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.6 tp -135.85 142.46 39.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 C-N-CA 126.7 2.0 . . . . 0.0 108.437 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -141.48 153.93 45.24 Favored 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 126.01 1.724 . . . . 0.0 110.015 -171.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.445 HG13 HD13 ' A' ' 55' ' ' LEU . 12.6 t -108.83 144.46 17.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 126.71 2.004 . . . . 0.0 109.926 -176.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 28.5 t -140.37 54.14 1.62 Allowed 'General case' 0 CA--C 1.555 1.159 0 CA-C-O 122.806 1.288 . . . . 0.0 109.939 168.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.445 HD13 HG13 ' A' ' 53' ' ' VAL . 1.7 mp -64.11 -19.28 65.15 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.081 1.353 . . . . 0.0 113.973 -176.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -56.46 -24.21 44.1 Favored 'General case' 0 CA--C 1.546 0.81 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 169.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -125.1 19.36 8.33 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 125.875 1.67 . . . . 0.0 111.799 170.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 86.8 mttt 60.75 16.85 7.08 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.271 1.828 . . . . 0.0 113.788 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 1.2 p -96.92 159.71 14.76 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 123.517 1.627 . . . . 0.0 110.123 177.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.43 154.09 38.22 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 127.042 2.137 . . . . 0.0 106.813 168.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.539 HE22 ' NE2' ' A' ' 23' ' ' GLN . 3.0 tp60 -131.03 119.03 21.43 Favored 'General case' 0 N--CA 1.446 -0.639 0 C-N-CA 124.864 1.266 . . . . 0.0 108.587 -168.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 p -106.87 141.4 22.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 O-C-N 121.745 -0.597 . . . . 0.0 110.633 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.15 95.51 5.42 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.64 1.576 . . . . 0.0 108.97 178.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -123.31 150.64 43.33 Favored 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 124.362 1.065 . . . . 0.0 112.567 -173.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -95.4 123.11 57.68 Favored Pre-proline 0 CA--C 1.543 0.697 0 C-N-CA 124.544 1.137 . . . . 0.0 107.997 174.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -55.35 -12.79 6.23 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 124.067 3.178 . . . . 0.0 114.801 175.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 67.8 m -58.41 -28.32 65.11 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.032 1.733 . . . . 0.0 114.93 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 99.0 m -137.94 -12.17 1.48 Allowed 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 116.125 1.898 . . . . 0.0 116.125 -169.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -148.2 177.14 9.65 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.869 1.267 . . . . 0.0 111.282 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 85.5 p -158.64 160.7 29.28 Favored Pre-proline 0 N--CA 1.476 0.873 0 C-N-CA 125.279 1.432 . . . . 0.0 111.893 -174.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_exo -53.99 -48.81 19.64 Favored 'Trans proline' 0 C--N 1.352 0.725 0 C-N-CA 123.09 2.527 . . . . 0.0 115.398 -172.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 28.2 m -69.31 -32.85 55.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-N 120.135 1.334 . . . . 0.0 112.938 177.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.55 -35.19 78.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.448 0.699 . . . . 0.0 111.643 175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 88.3 mt -69.96 -48.63 57.53 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.339 1.055 . . . . 0.0 111.213 171.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.41 HE21 HG23 ' A' ' 88' ' ' VAL . 33.7 tt0 -54.59 -57.18 12.42 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.476 1.034 . . . . 0.0 111.555 -178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 40.3 mmt180 -60.51 -31.11 70.19 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 118.941 -0.552 . . . . 0.0 112.439 -178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.04 -61.94 1.61 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.009 0.924 . . . . 0.0 112.824 174.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.415 HG22 ' CD1' ' A' ' 42' ' ' ILE . 8.8 pt -70.48 -29.85 40.36 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 -169.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 19.2 tt0 -59.48 -35.07 73.41 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 123.996 0.919 . . . . 0.0 111.471 174.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -100.05 13.63 33.39 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -175.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 9.8 mt -59.23 -55.99 40.63 Favored Pre-proline 0 CA--C 1.546 0.802 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.909 166.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -73.56 171.27 18.09 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 123.524 2.816 . . . . 0.0 112.36 175.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -76.31 59.91 6.2 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 124.584 3.523 . . . . 0.0 110.975 171.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 64.32 35.58 92.14 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 124.999 1.285 . . . . 0.0 113.118 -178.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 31.0 t-20 -101.19 -41.17 6.83 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 117.685 0.742 . . . . 0.0 112.734 -169.093 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -115.78 117.02 29.07 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.611 1.164 . . . . 0.0 109.118 -177.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 83.6 mttt -99.37 170.39 8.67 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.301 1.44 . . . . 0.0 111.337 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.41 HG23 HE21 ' A' ' 75' ' ' GLN . 32.7 m -135.26 130.28 50.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.839 0 O-C-N 121.064 -1.022 . . . . 0.0 110.902 173.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.9 m -103.75 117.78 35.16 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 124.146 0.978 . . . . 0.0 110.579 173.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 30.4 mt . . . . . 0 CA--C 1.548 0.879 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.335 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 23.9 m . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 122.563 1.173 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 29.3 p -163.84 142.41 7.66 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.084 2.153 . . . . 0.0 110.958 -177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 48.2 t -144.98 158.41 43.82 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 121.311 -0.868 . . . . 0.0 111.094 172.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 98.6 m -98.53 140.52 32.64 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 171.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.86 149.64 40.54 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 124.514 1.126 . . . . 0.0 110.603 173.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.5 tt -115.25 136.79 52.73 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.986 1.714 . . . . 0.0 109.084 -179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 31.7 mm -119.66 138.07 51.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 126.737 2.015 . . . . 0.0 108.255 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -98.58 136.58 38.47 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.507 1.123 . . . . 0.0 108.91 169.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 mp -123.26 139.2 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 O-C-N 120.729 -1.232 . . . . 0.0 110.134 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -121.39 57.86 1.0 Allowed 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 127.359 2.264 . . . . 0.0 112.016 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -168.05 52.36 0.23 Allowed Glycine 0 N--CA 1.465 0.592 0 C-N-CA 124.435 1.017 . . . . 0.0 111.354 168.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.1 mtm -136.1 126.34 26.45 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 124.854 1.262 . . . . 0.0 108.788 176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 8.2 t -144.7 -24.83 0.51 Allowed 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.703 1.601 . . . . 0.0 111.457 -177.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 96.6 m -116.01 142.54 46.66 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.552 1.941 . . . . 0.0 110.8 170.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -48.93 -32.81 9.66 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.112 1.365 . . . . 0.0 113.837 175.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 70.9 p -58.2 -22.54 52.24 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 7.6 t -61.87 -28.66 69.66 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 121.214 -0.928 . . . . 0.0 112.358 174.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.1 t -58.9 -51.92 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 O-C-N 121.627 -0.671 . . . . 0.0 110.722 176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -70.13 -19.14 63.24 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 -175.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 23.6 m -74.62 -56.09 5.19 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.376 1.07 . . . . 0.0 112.077 167.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.1 mt -66.78 -57.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.969 0 O-C-N 121.123 -0.986 . . . . 0.0 111.153 -177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -60.43 -25.57 66.06 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 124.239 1.016 . . . . 0.0 110.912 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.49 -57.97 5.23 Favored Glycine 0 C--N 1.341 0.842 0 C-N-CA 124.886 1.232 . . . . 0.0 113.611 174.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.2 -46.32 42.75 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 117.976 0.888 . . . . 0.0 113.337 -176.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 34.0 mm -72.71 -24.09 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.635 0.774 . . . . 0.0 112.501 -172.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 77.9 p -65.6 -15.74 63.03 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 175.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 45.0 mt-30 -90.1 -10.87 43.06 Favored 'General case' 0 N--CA 1.474 0.768 0 N-CA-C 114.989 1.478 . . . . 0.0 114.989 -168.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.6 pp -79.99 -177.8 6.18 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 124.324 1.049 . . . . 0.0 113.253 -174.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 15.1 mp0 -93.63 127.11 39.16 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.256 1.022 . . . . 0.0 109.845 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 103.5 16.98 18.69 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 117.683 -1.621 . . . . 0.0 116.517 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.8 p -121.34 100.41 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 C-N-CA 127.212 2.205 . . . . 0.0 112.475 -176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -78.12 -49.21 14.32 Favored 'General case' 0 CA--C 1.544 0.718 0 O-C-N 121.401 -0.812 . . . . 0.0 112.232 179.278 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -140.51 141.25 35.36 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 126.225 1.81 . . . . 0.0 108.669 -176.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 13.5 tt -144.2 131.04 16.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 C-N-CA 124.235 1.014 . . . . 0.0 111.545 177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.38 122.65 13.88 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.691 0.797 . . . . 0.0 112.105 176.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.9 p -121.86 138.37 52.35 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.301 0 C-N-CA 124.039 0.935 . . . . 0.0 111.854 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 39.5 t -141.55 134.56 29.05 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.28 1.432 . . . . 0.0 111.488 -169.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.15 -17.96 61.32 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -51.68 -45.81 63.61 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.338 1.455 . . . . 0.0 112.969 -173.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 56.6 mm-40 -113.41 -5.73 13.52 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 126.209 1.804 . . . . 0.0 111.566 173.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 72.08 49.76 20.45 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 125.554 1.55 . . . . 0.0 112.078 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.6 p -139.27 149.46 44.31 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 114.176 1.176 . . . . 0.0 114.176 -168.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.16 140.06 47.17 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.628 1.571 . . . . 0.0 110.741 169.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 1.8 t -116.9 127.71 54.52 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 167.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.58 141.42 27.74 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 123.544 0.738 . . . . 0.0 110.571 -171.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -96.96 108.74 21.52 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 126.242 1.817 . . . . 0.0 106.9 175.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.6 p90 -114.65 159.57 20.33 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 121.98 0.895 . . . . 0.0 112.767 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -97.84 113.4 63.62 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 124.101 0.96 . . . . 0.0 109.858 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -76.08 -7.1 17.96 Favored 'Trans proline' 0 CA--C 1.54 0.799 0 C-N-CA 122.961 2.441 . . . . 0.0 115.093 -174.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -85.42 -37.17 20.11 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 119.717 1.144 . . . . 0.0 111.018 168.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 86.7 t -85.44 -32.46 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 124.461 1.104 . . . . 0.0 113.192 -175.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.5 tt -148.96 151.72 12.8 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 CA-C-N 120.268 1.394 . . . . 0.0 113.678 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -102.07 145.78 31.11 Favored Pre-proline 0 CA--C 1.546 0.799 0 C-N-CA 125.779 1.632 . . . . 0.0 112.456 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -56.67 -33.47 93.67 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 122.838 2.358 . . . . 0.0 115.286 179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -71.74 -22.41 61.62 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-N 119.364 0.984 . . . . 0.0 113.135 172.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -72.62 -38.02 67.87 Favored 'General case' 0 N--CA 1.469 0.486 0 O-C-N 120.741 -1.224 . . . . 0.0 111.57 170.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 82.9 mt -55.44 -54.41 44.13 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.773 0.829 . . . . 0.0 109.908 171.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 56.9 ttp180 -51.22 -55.27 18.94 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.998 1.319 . . . . 0.0 111.299 176.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.5 -18.84 65.63 Favored 'General case' 0 CA--C 1.546 0.793 0 N-CA-C 113.993 1.109 . . . . 0.0 113.993 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.62 -33.33 68.87 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 119.942 1.247 . . . . 0.0 112.23 176.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.2 mp -70.1 -39.72 77.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 124.396 1.078 . . . . 0.0 110.532 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -65.65 -31.77 72.98 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.241 0.616 . . . . 0.0 112.375 174.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.19 -5.11 39.93 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 126.539 1.936 . . . . 0.0 114.441 169.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.46 -47.98 5.19 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.126 1.37 . . . . 0.0 111.466 178.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 157.45 15.8 0.04 OUTLIER Glycine 0 N--CA 1.469 0.867 0 N-CA-C 117.194 1.638 . . . . 0.0 117.194 176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -133.27 -163.46 1.35 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.987 1.394 . . . . 0.0 108.954 -170.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -126.58 147.02 49.93 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 124.198 0.999 . . . . 0.0 109.357 169.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -138.97 160.18 40.38 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 46.0 t -138.36 141.67 39.68 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 126.485 1.914 . . . . 0.0 109.168 174.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 8.4 p -87.3 128.83 39.58 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.638 0 O-C-N 121.331 -0.856 . . . . 0.0 108.866 174.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.472 0.669 0 CA-C-O 122.873 1.32 . . . . 0.0 108.733 -178.866 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.7 p . . . . . 0 CA--C 1.541 0.624 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -134.11 138.25 45.13 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.64 -0.663 . . . . 0.0 112.583 -173.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -129.56 163.72 25.38 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 115.345 1.609 . . . . 0.0 115.345 175.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -109.71 133.25 53.34 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 127.819 2.448 . . . . 0.0 110.04 -178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.7 pp -146.46 155.05 42.27 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 123.374 0.67 . . . . 0.0 112.327 171.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -116.98 107.51 14.65 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-O 121.557 0.694 . . . . 0.0 111.09 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 6.6 mt -88.62 143.42 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.795 2.038 . . . . 0.0 110.938 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -97.46 142.85 28.8 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.013 2.525 . . . . 0.0 110.137 172.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 90.95 -13.64 65.56 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.902 1.239 . . . . 0.0 114.506 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 3.5 ptp -62.12 -23.23 66.42 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 118.517 1.158 . . . . 0.0 113.925 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 39.8 m170 -69.51 -15.77 63.31 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 119.33 0.968 . . . . 0.0 113.599 174.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 87.7 m -75.49 -6.04 48.15 Favored 'General case' 0 CA--C 1.55 0.951 0 CA-C-N 120.586 1.539 . . . . 0.0 112.18 166.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 22.0 mmtp 71.74 -52.24 0.69 Allowed 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 130.415 3.486 . . . . 0.0 113.397 177.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 51.1 m -54.22 -23.28 14.03 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.564 1.146 . . . . 0.0 113.937 179.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.4 t -57.99 -47.41 83.09 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.359 1.864 . . . . 0.0 112.543 169.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -73.64 -24.63 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.442 0 CA-C-N 118.555 0.616 . . . . 0.0 112.464 -173.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 40.6 tp -57.32 -53.9 52.88 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.021 0.928 . . . . 0.0 111.746 176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -58.55 -37.68 76.22 Favored 'General case' 0 N--CA 1.471 0.61 0 O-C-N 121.821 -0.549 . . . . 0.0 110.962 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 11.1 mt -66.11 -49.6 75.15 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 123.372 0.669 . . . . 0.0 110.579 176.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -60.25 -36.12 77.05 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.046 1.738 . . . . 0.0 112.914 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 14.8 mm-40 -68.31 -39.91 81.85 Favored 'General case' 0 CA--C 1.541 0.629 0 O-C-N 121.308 -0.87 . . . . 0.0 112.346 178.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -95.26 -37.52 10.97 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.157 1.539 . . . . 0.0 115.157 -172.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 38.9 mm -93.04 119.64 41.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 O-C-N 120.389 -1.445 . . . . 0.0 108.699 -168.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 127.07 -17.83 6.24 Favored Glycine 0 CA--C 1.534 1.243 0 C-N-CA 126.019 1.771 . . . . 0.0 112.609 -167.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -87.72 -4.03 58.93 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 118.257 1.028 . . . . 0.0 112.443 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.5 mp -80.67 178.26 8.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.593 1.957 . . . . 0.0 112.028 -170.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 6.3 tp -59.52 -74.94 0.06 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.384 1.874 . . . . 0.0 112.31 173.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.2 -19.58 52.42 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-O 117.483 -1.732 . . . . 0.0 115.671 -175.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 91.5 t -87.51 113.56 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 120.589 2.194 . . . . 0.0 109.451 168.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.5 tt0 -86.39 -43.37 12.9 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.485 1.114 . . . . 0.0 111.791 -177.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.3 t -147.86 178.03 8.84 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.436 1.095 . . . . 0.0 111.649 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.6 tp -139.74 140.78 35.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 C-N-CA 125.907 1.683 . . . . 0.0 108.611 -178.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -129.36 120.53 25.74 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.213 1.405 . . . . 0.0 108.083 -173.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 59.6 t -99.87 86.97 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 125.394 1.478 . . . . 0.0 110.627 -166.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.4 p -98.67 54.29 1.03 Allowed 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.569 1.948 . . . . 0.0 113.03 -170.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 49.9 mt -61.82 -26.3 68.03 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -172.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -55.32 -33.96 63.76 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.579 1.152 . . . . 0.0 113.148 173.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -94.81 -0.29 54.26 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 123.795 0.838 . . . . 0.0 112.572 176.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 2.5 mppt? 68.06 -0.34 2.13 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 127.883 2.473 . . . . 0.0 113.167 -179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.0 p -99.68 167.73 10.38 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 127.577 2.351 . . . . 0.0 109.881 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -118.53 149.21 41.7 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 108.107 -1.071 . . . . 0.0 108.107 168.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.4 tp-100 -116.0 125.92 53.13 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.245 1.418 . . . . 0.0 108.49 -172.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.8 p -113.73 135.0 54.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.001 -1.062 . . . . 0.0 111.0 -177.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -99.26 95.82 7.33 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.048 1.739 . . . . 0.0 107.822 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -122.97 -179.32 4.22 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 126.075 1.75 . . . . 0.0 112.989 -168.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -129.22 136.12 28.66 Favored Pre-proline 0 N--CA 1.475 0.822 0 C-N-CA 125.612 1.565 . . . . 0.0 109.978 169.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -84.08 15.06 2.24 Favored 'Trans proline' 0 CA--C 1.542 0.881 0 C-N-CA 123.433 2.756 . . . . 0.0 113.317 -171.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.1 t -111.33 -35.65 5.79 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.32 1.048 . . . . 0.0 111.082 173.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 34.1 m -90.58 -18.64 24.86 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . 0.252 2.8 t -148.49 -175.79 5.06 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.1 0.96 . . . . 0.0 112.163 175.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 54.1 p -153.72 167.59 13.33 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 126.046 1.739 . . . . 0.0 110.91 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.39 -44.09 24.69 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 122.593 2.196 . . . . 0.0 113.204 -179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -63.94 -37.87 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 118.92 0.782 . . . . 0.0 112.839 172.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.39 -39.56 89.13 Favored 'General case' 0 CA--C 1.542 0.657 0 O-C-N 121.666 -0.646 . . . . 0.0 112.244 176.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.35 -55.77 30.51 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 126.111 1.765 . . . . 0.0 109.838 168.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -61.28 -39.82 91.83 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.87 0.868 . . . . 0.0 111.644 -173.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 59.7 mtp180 -70.8 -36.92 73.2 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 124.439 1.096 . . . . 0.0 112.804 176.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.66 -60.4 2.27 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.782 0.719 . . . . 0.0 112.681 179.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 12.5 pt -70.25 -26.78 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 -167.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -70.81 -15.47 62.66 Favored 'General case' 0 CA--C 1.545 0.753 0 N-CA-C 114.448 1.277 . . . . 0.0 114.448 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -105.4 9.52 33.67 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 120.999 -1.063 . . . . 0.0 113.523 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.6 mt -59.23 -47.95 97.26 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-O 117.37 -1.3 . . . . 0.0 110.145 165.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -77.56 171.57 17.31 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.646 2.231 . . . . 0.0 110.429 167.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -76.54 51.61 3.35 Favored 'Trans proline' 0 CA--C 1.545 1.054 0 C-N-CA 124.127 3.218 . . . . 0.0 110.978 170.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.16 28.51 68.14 Favored Glycine 0 CA--C 1.531 1.087 0 O-C-N 120.996 -1.065 . . . . 0.0 113.756 -178.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -97.32 -45.42 6.49 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.967 0.884 . . . . 0.0 112.459 -172.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -97.01 102.19 13.92 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.243 1.017 . . . . 0.0 108.73 -178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -96.52 141.42 29.82 Favored 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 124.265 1.026 . . . . 0.0 111.474 -170.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.5 p -130.27 134.66 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -172.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 67.3 m -118.95 144.41 46.47 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.461 1.504 . . . . 0.0 111.803 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 1.7 mm? . . . . . 0 CA--C 1.539 0.549 0 C-N-CA 126.348 1.859 . . . . 0.0 112.21 -172.127 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 33.2 m . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 85.2 m -138.05 127.61 24.98 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.556 1.542 . . . . 0.0 111.81 -176.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 69.0 m -146.34 152.63 39.43 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.925 1.29 . . . . 0.0 111.531 171.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 92.5 m -109.18 140.47 42.74 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.123 0.969 . . . . 0.0 109.58 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -144.22 158.54 43.67 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 168.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tt -101.89 127.46 48.71 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 127.488 2.315 . . . . 0.0 109.469 178.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 16.8 mm -113.28 136.37 49.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 124.438 1.095 . . . . 0.0 108.827 175.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -101.25 122.49 43.76 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 118.771 0.714 . . . . 0.0 109.33 169.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 5.1 mp -109.66 135.2 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 124.065 0.946 . . . . 0.0 110.237 -176.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -115.02 56.3 0.74 Allowed 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.985 1.714 . . . . 0.0 112.09 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.02 54.86 0.32 Allowed Glycine 0 N--CA 1.465 0.6 0 C-N-CA 124.151 0.881 . . . . 0.0 112.076 168.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 39.6 mtm -148.35 138.25 22.38 Favored 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.033 0.933 . . . . 0.0 110.942 -176.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.3 t -160.34 -32.49 0.06 Allowed 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.122 1.369 . . . . 0.0 111.841 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 93.4 m -105.48 138.8 41.08 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 126.315 1.846 . . . . 0.0 109.937 174.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.07 -27.32 31.87 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.601 1.16 . . . . 0.0 113.751 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.6 t -56.34 -32.19 64.45 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.202 1.001 . . . . 0.0 112.969 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.5 t -60.65 -20.75 61.65 Favored 'General case' 0 CA--C 1.545 0.777 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -178.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.3 t -62.53 -59.62 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.693 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.005 168.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -63.31 -22.14 66.69 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 120.144 1.338 . . . . 0.0 112.815 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 8.6 m -70.65 -60.16 2.41 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.243 1.017 . . . . 0.0 112.153 170.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 88.0 mt -69.33 -51.28 44.26 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 120.581 -1.324 . . . . 0.0 110.897 -174.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 -58.17 -30.98 66.84 Favored 'General case' 0 CA--C 1.552 1.022 0 C-N-CA 125.136 1.374 . . . . 0.0 110.896 176.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.06 -62.34 2.64 Favored Glycine 0 C--N 1.343 0.967 0 C-N-CA 125.657 1.598 . . . . 0.0 114.615 175.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.25 -44.98 62.04 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.483 1.113 . . . . 0.0 113.098 -172.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 36.2 mm -72.99 -29.51 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 123.09 0.556 . . . . 0.0 112.034 -172.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 95.5 p -64.86 0.99 0.98 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -106.9 -9.24 16.38 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 -168.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.41 11.28 31.2 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -171.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 70.2 163.87 0.26 Allowed 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 128.277 2.631 . . . . 0.0 114.191 177.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 74.98 -39.19 1.13 Allowed Glycine 0 CA--C 1.532 1.118 0 O-C-N 120.486 -1.384 . . . . 0.0 112.977 -170.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.52 98.21 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 127.462 2.305 . . . . 0.0 111.213 169.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -86.53 -54.72 4.24 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.853 0.861 . . . . 0.0 112.455 -174.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -141.52 121.4 13.59 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.735 1.214 . . . . 0.0 109.045 -174.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 12.0 tt -133.3 128.14 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 124.208 1.003 . . . . 0.0 110.92 -170.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -142.74 155.83 44.92 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.642 1.177 . . . . 0.0 109.9 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 94.7 t -138.69 142.31 34.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 CA-C-N 119.433 1.015 . . . . 0.0 111.934 -171.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 45.0 m -115.28 86.98 2.56 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.832 2.453 . . . . 0.0 109.16 170.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.3 tt -62.27 -27.55 69.09 Favored 'General case' 0 CA--C 1.542 0.658 0 O-C-N 120.376 -1.453 . . . . 0.0 111.451 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -45.8 -30.79 1.77 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 128.303 2.641 . . . . 0.0 114.824 167.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -118.07 -20.75 8.56 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 125.423 1.489 . . . . 0.0 111.772 173.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 87.37 36.56 8.72 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 125.592 1.567 . . . . 0.0 111.964 -174.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.6 p -128.28 140.6 51.8 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 118.803 1.301 . . . . 0.0 112.798 -169.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -104.94 137.79 42.17 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 124.538 1.135 . . . . 0.0 110.736 169.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.9 t -111.49 121.95 46.53 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 169.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.24 140.91 29.02 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -169.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.03 115.93 28.05 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.122 2.169 . . . . 0.0 106.599 171.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -117.47 157.52 26.11 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.78 1.232 . . . . 0.0 111.71 176.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 46.6 t-20 -99.75 105.79 36.49 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.716 1.206 . . . . 0.0 110.981 174.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -67.44 -13.33 38.86 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 123.253 2.635 . . . . 0.0 114.023 -176.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.77 -10.73 58.75 Favored 'General case' 0 CA--C 1.544 0.716 0 CA-C-N 119.282 0.946 . . . . 0.0 113.127 171.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 77.8 t -116.33 -34.04 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 C-N-CA 125.556 1.543 . . . . 0.0 112.08 -177.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.5 tt -159.93 147.79 6.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-N 119.886 1.221 . . . . 0.0 112.507 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.7 t -97.02 149.9 36.22 Favored Pre-proline 0 CA--C 1.548 0.89 0 C-N-CA 124.606 1.162 . . . . 0.0 112.528 175.017 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -49.99 -30.42 24.35 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 124.907 3.738 . . . . 0.0 114.19 168.351 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -67.02 -33.9 76.55 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 119.369 0.986 . . . . 0.0 112.39 175.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -75.29 -35.41 61.3 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.771 1.228 . . . . 0.0 110.404 173.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 tt -60.04 -58.2 9.55 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.676 2.39 . . . . 0.0 111.48 177.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -58.54 -38.81 78.56 Favored 'General case' 0 N--CA 1.475 0.793 0 CA-C-N 119.114 0.87 . . . . 0.0 112.35 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.98 -26.53 68.88 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 174.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.96 -30.42 63.83 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 119.461 1.028 . . . . 0.0 112.53 176.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mp -73.16 -34.52 45.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 124.306 1.042 . . . . 0.0 110.969 169.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -63.91 -39.34 93.94 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.674 0.67 . . . . 0.0 111.893 172.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -65.65 -31.44 72.46 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 126.52 1.928 . . . . 0.0 112.942 171.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 21.9 ttt -69.78 -37.18 76.25 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.156 0.982 . . . . 0.0 111.386 173.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 130.96 15.43 1.71 Allowed Glycine 0 CA--C 1.531 1.049 0 C-N-CA 125.494 1.521 . . . . 0.0 116.306 169.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -113.92 -158.08 0.65 Allowed 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 119.426 1.613 . . . . 0.0 108.923 -178.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -133.52 142.7 48.33 Favored 'General case' 0 N--CA 1.465 0.321 0 C-N-CA 124.032 0.933 . . . . 0.0 109.885 169.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -137.32 137.99 39.51 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.282 1.433 . . . . 0.0 112.975 -174.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 36.2 t -123.07 131.35 53.66 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.834 1.654 . . . . 0.0 111.339 -178.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 4.2 m -85.64 71.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 124.266 1.026 . . . . 0.0 110.661 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 N--CA 1.475 0.793 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.582 -176.813 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.422 HG13 ' CE1' ' A' ' 64' ' ' TYR . 11.0 p . . . . . 0 CA--C 1.545 0.779 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 p -112.56 166.56 11.21 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 126.613 1.965 . . . . 0.0 112.049 -177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.56 137.42 31.96 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.837 1.255 . . . . 0.0 111.711 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 56.4 mm-40 -99.15 120.1 38.95 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.961 0.886 . . . . 0.0 109.679 168.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.25 139.21 30.11 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 113.512 -1.676 . . . . 0.0 112.825 175.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -101.49 143.22 31.76 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.932 1.293 . . . . 0.0 109.03 171.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.2 mm -107.32 153.14 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 125.763 1.625 . . . . 0.0 109.807 178.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -106.1 140.27 39.34 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.654 1.582 . . . . 0.0 110.652 170.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 84.61 3.21 88.47 Favored Glycine 0 CA--C 1.535 1.325 0 C-N-CA 124.879 1.228 . . . . 0.0 114.033 -177.431 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.5 ptm -70.53 -3.6 18.79 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 115.609 1.707 . . . . 0.0 115.609 -176.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 27.4 p80 -50.8 -26.18 5.36 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.806 1.242 . . . . 0.0 114.345 174.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 25.4 p -114.04 137.74 51.31 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.962 1.305 . . . . 0.0 111.033 169.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.9 mptp? -65.07 -15.7 62.65 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -169.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.1 m -50.79 -31.95 18.46 Favored 'General case' 0 N--CA 1.47 0.554 0 O-C-N 120.992 -1.068 . . . . 0.0 113.21 169.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 26.1 t -67.99 -57.91 5.38 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.337 1.055 . . . . 0.0 111.678 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.0 p -62.79 -29.62 47.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 CA-C-N 119.407 1.003 . . . . 0.0 112.056 176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 tm? -58.72 -61.01 2.93 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 124.264 1.026 . . . . 0.0 112.289 -176.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -65.46 -31.28 72.28 Favored 'General case' 0 CA--C 1.539 0.551 0 O-C-N 121.785 -0.572 . . . . 0.0 111.821 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 65.2 mt -62.01 -52.42 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.712 0 CA-C-N 118.795 0.725 . . . . 0.0 109.48 172.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.47 -38.3 90.62 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.567 1.147 . . . . 0.0 113.184 -178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -65.76 -34.95 79.36 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.332 0.653 . . . . 0.0 111.982 -178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -92.91 -24.41 18.44 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 115.472 1.656 . . . . 0.0 115.472 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.435 ' CD1' HG22 ' A' ' 78' ' ' ILE . 47.2 mm -105.75 122.85 59.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-N 119.385 0.993 . . . . 0.0 109.669 -171.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 128.25 -22.81 5.28 Favored Glycine 0 N--CA 1.474 1.195 0 C-N-CA 125.581 1.562 . . . . 0.0 113.956 -175.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -84.65 -0.65 54.21 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 125.652 1.581 . . . . 0.0 113.165 177.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 84.0 mt -84.43 -172.33 4.11 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.779 2.032 . . . . 0.0 113.959 -171.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 12.6 tp -68.87 -82.78 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 127.427 2.291 . . . . 0.0 111.974 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -74.32 -30.32 60.78 Favored Glycine 0 CA--C 1.533 1.165 0 CA-C-N 120.12 1.327 . . . . 0.0 114.241 -173.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 27.8 t -84.07 127.76 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 CA-C-N 119.044 1.422 . . . . 0.0 110.339 169.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -114.51 -23.1 9.48 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 178.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.4 t -145.63 166.08 26.84 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 119.226 0.921 . . . . 0.0 111.069 176.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.5 tp -140.71 142.31 30.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.417 1.087 . . . . 0.0 110.416 -178.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.6 tt0 -142.92 156.32 44.87 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.656 1.183 . . . . 0.0 110.579 -171.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.28 133.02 62.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 C-N-CA 125.312 1.445 . . . . 0.0 108.348 -175.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.3 m -122.6 52.8 1.3 Allowed 'General case' 0 CA--C 1.548 0.891 0 CA-C-O 122.488 1.137 . . . . 0.0 110.086 177.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.13 -19.33 64.03 Favored 'General case' 0 N--CA 1.468 0.471 0 N-CA-C 114.671 1.36 . . . . 0.0 114.671 -172.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -57.77 -36.6 72.36 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-N 119.769 1.168 . . . . 0.0 111.066 168.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -97.47 -8.02 30.25 Favored 'General case' 0 CA--C 1.551 0.983 0 C-N-CA 127.036 2.134 . . . . 0.0 112.484 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 59.0 mttp 70.75 15.64 6.89 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 127.605 2.362 . . . . 0.0 112.28 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.1 p -98.78 163.7 12.52 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.68 1.592 . . . . 0.0 110.621 172.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -99.18 169.09 9.63 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 164.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -139.6 114.25 9.29 Favored 'General case' 0 C--N 1.332 -0.196 0 O-C-N 121.043 -1.036 . . . . 0.0 111.186 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.4 p -105.58 133.2 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.036 0 CA-C-O 121.529 0.68 . . . . 0.0 111.847 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -109.74 99.17 8.37 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.267 1.427 . . . . 0.0 108.784 -169.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.422 ' CE1' HG13 ' A' ' 20' ' ' VAL . 17.3 p90 -131.45 -178.87 5.05 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.821 1.248 . . . . 0.0 112.25 -168.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.99 140.05 33.84 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.509 1.124 . . . . 0.0 108.258 167.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.06 11.41 2.05 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 123.029 2.486 . . . . 0.0 112.826 -179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 55.4 p -92.21 -19.04 22.63 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.889 1.276 . . . . 0.0 113.481 -173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 72.6 m -126.82 -20.43 4.26 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.703 1.601 . . . . 0.0 114.457 -175.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.1 t -145.07 -177.86 5.75 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 126.16 1.784 . . . . 0.0 111.338 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.4 p -160.62 156.6 22.46 Favored Pre-proline 0 CA--C 1.555 1.146 0 C-N-CA 125.487 1.515 . . . . 0.0 112.95 174.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_exo -43.64 -45.38 10.82 Favored 'Trans proline' 0 C--N 1.352 0.756 1 C-N-CA 126.425 4.75 . . . . 0.0 117.974 -177.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.6 m -64.78 -37.67 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 CA-C-N 119.825 1.193 . . . . 0.0 112.537 178.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -71.67 -40.28 69.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.705 0.802 . . . . 0.0 111.058 175.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 85.7 mt -61.38 -47.64 84.91 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 124.758 1.223 . . . . 0.0 112.011 176.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.455 HE21 ' HB ' ' A' ' 88' ' ' VAL . 35.8 tt0 -53.05 -54.54 33.91 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 118.79 0.723 . . . . 0.0 109.775 175.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -61.89 -33.74 74.76 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.202 1.001 . . . . 0.0 113.349 -177.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.02 -56.99 5.53 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.056 0.943 . . . . 0.0 111.847 178.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.435 HG22 ' CD1' ' A' ' 42' ' ' ILE . 10.1 pt -72.56 -27.09 25.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.689 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -67.86 -28.55 67.64 Favored 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 -172.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -89.9 6.49 41.73 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 -178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 61.7 mt -53.92 -52.51 67.28 Favored Pre-proline 0 CA--C 1.545 0.787 0 CA-C-O 117.392 -1.29 . . . . 0.0 112.187 169.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -68.41 163.44 36.56 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.241 2.627 . . . . 0.0 112.717 169.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -81.42 50.99 3.71 Favored 'Trans proline' 0 CA--C 1.544 1.015 0 C-N-CA 124.852 3.702 . . . . 0.0 111.302 177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 76.19 53.68 5.55 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.328 0.966 . . . . 0.0 112.103 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -132.82 -45.08 0.87 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 116.006 1.854 . . . . 0.0 116.006 -171.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -101.64 134.77 44.25 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.667 0.787 . . . . 0.0 109.32 175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 28.0 tptt -111.74 152.32 27.91 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.786 1.634 . . . . 0.0 110.171 176.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.455 ' HB ' HE21 ' A' ' 75' ' ' GLN . 2.1 t -101.52 138.11 26.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.675 1.125 . . . . 0.0 109.608 168.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 43.9 m -110.2 113.12 25.55 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 124.224 1.01 . . . . 0.0 108.811 172.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.54 0.564 0 C-N-CA 126.373 1.869 . . . . 0.0 109.939 178.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.2 m . . . . . 0 N--CA 1.477 0.88 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 8.5 p -137.9 126.13 23.08 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 126.446 1.898 . . . . 0.0 113.473 -169.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 23.7 t -141.02 154.83 46.19 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.877 1.671 . . . . 0.0 110.424 171.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 15.4 m -111.35 137.72 48.75 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 118.786 0.721 . . . . 0.0 110.397 174.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -137.5 163.53 30.92 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.391 1.076 . . . . 0.0 112.068 169.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -109.8 128.06 55.06 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.511 1.924 . . . . 0.0 110.366 -179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.2 mm -112.28 144.54 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.215 0 C-N-CA 124.227 1.011 . . . . 0.0 109.694 177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -106.63 122.82 47.09 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.709 1.604 . . . . 0.0 109.71 177.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 78.2 mt -131.52 140.87 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 O-C-N 120.049 -1.657 . . . . 0.0 111.896 -167.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -129.34 66.63 1.45 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.32 1.448 . . . . 0.0 114.065 -179.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -172.88 49.89 0.17 Allowed Glycine 0 N--CA 1.466 0.659 0 CA-C-O 118.921 -0.933 . . . . 0.0 114.09 166.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 74.0 mtm -110.86 -57.08 2.28 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 117.498 -1.239 . . . . 0.0 113.768 -171.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 13.0 t 55.32 -26.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 C-N-CA 130.339 3.456 . . . . 0.0 118.273 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 36.0 t -131.73 139.94 49.12 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.543 1.537 . . . . 0.0 111.718 -170.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.01 -35.26 69.04 Favored 'General case' 0 CA--C 1.541 0.6 0 O-C-N 121.747 -0.596 . . . . 0.0 111.671 171.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.4 m -64.03 -31.79 73.1 Favored 'General case' 0 N--CA 1.472 0.655 0 O-C-N 120.789 -1.195 . . . . 0.0 112.105 175.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 26.2 t -70.59 -39.76 73.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.911 170.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.9 t -55.63 -54.52 25.03 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 119.63 1.105 . . . . 0.0 110.094 170.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 58.9 m-70 -58.54 -34.71 71.3 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 118.029 0.377 . . . . 0.0 111.582 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 49.2 m -71.0 -43.35 68.16 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.048 0.939 . . . . 0.0 113.078 176.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 84.9 mt -64.49 -51.12 71.97 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 119.788 1.176 . . . . 0.0 109.714 175.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -53.14 -37.66 62.03 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.497 1.519 . . . . 0.0 111.164 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.1 -58.42 4.36 Favored Glycine 0 CA--C 1.529 0.931 0 C-N-CA 125.001 1.286 . . . . 0.0 113.467 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 50.0 mtp -67.91 -46.81 70.5 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 125.657 1.583 . . . . 0.0 113.677 -170.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 35.5 mm -66.58 -36.94 78.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 118.124 0.42 . . . . 0.0 110.066 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 4.6 t -56.67 -9.34 0.74 Allowed 'General case' 0 CA--C 1.552 1.029 0 N-CA-C 115.387 1.625 . . . . 0.0 115.387 176.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -89.02 -8.49 53.93 Favored 'General case' 0 CA--C 1.547 0.85 0 O-C-N 120.475 -1.391 . . . . 0.0 113.755 -177.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.6 pp -107.82 177.3 4.86 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 120.276 1.398 . . . . 0.0 114.158 -178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -56.5 152.41 11.73 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.698 1.599 . . . . 0.0 115.314 -175.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.21 -30.3 0.32 Allowed Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.351 1.453 . . . . 0.0 116.676 169.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.3 p -78.91 92.86 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 119.463 1.632 . . . . 0.0 111.008 179.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 22.6 tt0 -79.56 -40.02 30.47 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.872 1.669 . . . . 0.0 111.916 -177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 49.1 tp60 -144.99 144.81 31.23 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.011 0.925 . . . . 0.0 109.478 175.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.5 tt -140.36 138.37 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 O-C-N 121.255 -0.903 . . . . 0.0 111.55 176.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 9.8 t -139.18 136.31 34.93 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.78 1.632 . . . . 0.0 109.157 171.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 8.1 p -144.22 148.93 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.827 1.251 . . . . 0.0 111.396 -176.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 11.8 t -142.62 148.52 37.6 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 37.1 mt -71.43 -22.67 61.82 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 124.633 1.173 . . . . 0.0 113.707 172.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -50.86 -41.58 58.14 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 125.006 1.322 . . . . 0.0 112.372 -169.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -127.38 -1.96 6.25 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 125.007 1.323 . . . . 0.0 111.906 172.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.06 42.26 37.25 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 125.487 1.518 . . . . 0.0 111.981 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 36.5 p -130.93 146.07 52.22 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 118.404 1.102 . . . . 0.0 113.053 -168.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -118.84 119.69 35.13 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.757 1.623 . . . . 0.0 112.037 -176.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 4.7 t -99.32 112.26 24.47 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.962 1.305 . . . . 0.0 107.8 171.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.45 139.11 48.58 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 123.588 0.755 . . . . 0.0 110.885 -168.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -95.95 107.96 20.29 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.97 2.108 . . . . 0.0 107.117 177.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.1 p90 -113.17 162.9 15.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.147 1.379 . . . . 0.0 111.762 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -94.79 112.16 57.03 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 123.846 0.859 . . . . 0.0 108.941 172.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -77.51 -10.54 17.32 Favored 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.035 2.49 . . . . 0.0 113.051 -173.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -83.4 -32.9 25.91 Favored 'General case' 0 CA--C 1.543 0.707 0 CA-C-N 119.259 0.936 . . . . 0.0 112.618 169.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 54.5 t -95.68 -46.97 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 C-N-CA 124.865 1.266 . . . . 0.0 113.448 -173.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.5 tt -124.75 149.41 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 120.384 1.447 . . . . 0.0 112.094 -173.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 30.9 t -96.99 146.96 32.2 Favored Pre-proline 0 CA--C 1.538 0.514 0 C-N-CA 125.203 1.401 . . . . 0.0 112.833 178.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.33 -26.12 42.17 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.09 2.527 . . . . 0.0 113.49 166.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -68.23 -35.66 78.29 Favored 'General case' 0 CA--C 1.542 0.64 0 O-C-N 121.526 -0.734 . . . . 0.0 112.548 172.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -71.46 -31.83 67.62 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.148 0.979 . . . . 0.0 111.643 178.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.2 mt -57.04 -57.65 11.61 Favored 'General case' 0 C--N 1.347 0.458 0 C-N-CA 124.198 0.999 . . . . 0.0 110.035 173.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 9.5 ptm180 -61.23 -41.67 97.28 Favored 'General case' 0 N--CA 1.473 0.7 0 O-C-N 121.779 -0.575 . . . . 0.0 112.307 179.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.44 -34.08 70.42 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 178.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.15 -34.73 71.27 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mp -73.56 -39.44 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 124.281 1.033 . . . . 0.0 111.579 171.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -62.92 -32.25 73.5 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.182 -0.949 . . . . 0.0 111.641 172.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -73.93 -13.9 60.97 Favored 'General case' 0 CA--C 1.548 0.904 0 C-N-CA 127.713 2.405 . . . . 0.0 114.503 169.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 14.7 ttt -83.62 -20.95 32.77 Favored 'General case' 0 N--CA 1.477 0.91 0 O-C-N 120.986 -1.071 . . . . 0.0 112.148 172.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 111.82 19.03 7.53 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 125.949 1.737 . . . . 0.0 114.934 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -115.09 -159.06 0.69 Allowed 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.215 1.406 . . . . 0.0 109.878 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -129.77 140.32 51.09 Favored 'General case' 0 N--CA 1.461 0.091 0 C-N-CA 124.554 1.142 . . . . 0.0 109.555 170.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.01 147.71 42.47 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 125.126 1.37 . . . . 0.0 112.348 178.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.1 t -142.74 140.49 31.48 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 126.174 1.789 . . . . 0.0 109.011 -172.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 6.2 p -90.49 130.56 39.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-O 121.327 0.584 . . . . 0.0 110.811 -171.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 CA--C 1.549 0.927 0 N-CA-C 104.901 -2.259 . . . . 0.0 104.901 166.743 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 121.058 0.456 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.9 m -109.26 134.86 51.24 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.688 -1.142 . . . . 0.0 110.195 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -132.02 133.04 43.97 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 125.152 1.381 . . . . 0.0 110.724 -174.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -96.19 137.59 35.04 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 126.148 1.779 . . . . 0.0 111.576 -171.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -144.73 152.18 39.99 Favored 'General case' 0 C--N 1.333 -0.141 0 N-CA-C 113.669 0.989 . . . . 0.0 113.669 173.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 10.7 tpt180 -100.11 113.91 26.88 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 124.498 1.119 . . . . 0.0 109.683 170.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 10.5 mt -88.46 140.81 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.714 1.205 . . . . 0.0 109.973 171.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -99.11 141.26 32.1 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.46 1.504 . . . . 0.0 111.341 169.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 97.14 -13.09 65.13 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.511 1.529 . . . . 0.0 113.809 -176.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.7 ptp -63.85 -14.63 54.72 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 -175.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -60.06 -24.4 64.55 Favored 'General case' 0 CA--C 1.548 0.881 0 CA-C-N 120.45 1.477 . . . . 0.0 112.384 170.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 59.2 m -78.4 -4.66 49.37 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.929 0.892 . . . . 0.0 113.372 176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 68.55 -56.37 0.51 Allowed 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 129.649 3.18 . . . . 0.0 113.224 176.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.8 m -55.11 -25.16 29.7 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.64 1.176 . . . . 0.0 113.246 177.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 1.3 t -55.4 -50.12 70.59 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 126.003 1.721 . . . . 0.0 112.361 171.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -77.14 -30.71 17.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 177.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.46 ' C ' HD23 ' A' ' 36' ' ' LEU . 5.0 tt -52.73 -57.19 10.93 Favored 'General case' 0 C--N 1.345 0.391 0 C-N-CA 124.309 1.043 . . . . 0.0 110.916 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 8.8 p30 -60.02 -45.25 93.41 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 118.591 -0.719 . . . . 0.0 109.866 -176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 53.7 mt -56.81 -36.68 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 CA-C-N 119.919 1.236 . . . . 0.0 111.133 177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.98 -22.26 64.11 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.978 0.911 . . . . 0.0 112.317 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -71.9 -52.96 14.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 124.78 1.232 . . . . 0.0 113.024 171.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 19.0 p30 -93.82 -17.39 23.14 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 116.852 2.167 . . . . 0.0 116.852 -167.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.49 ' CD1' HG22 ' A' ' 78' ' ' ILE . 23.9 mm -96.23 133.03 39.0 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 CA-C-N 119.813 1.188 . . . . 0.0 108.042 173.451 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.08 -5.7 10.31 Favored Glycine 0 N--CA 1.48 1.611 0 C-N-CA 125.317 1.437 . . . . 0.0 114.749 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -126.68 17.02 7.49 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.2 1.8 . . . . 0.0 112.329 -179.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.0 mp -89.14 156.63 18.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.864 1.266 . . . . 0.0 109.971 175.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 15.4 tp -21.96 -64.56 0.03 OUTLIER 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 128.534 2.734 . . . . 0.0 114.714 173.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -103.86 -15.92 20.89 Favored Glycine 0 CA--C 1.529 0.947 0 CA-C-O 116.527 -2.263 . . . . 0.0 116.011 175.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.6 t -82.64 124.0 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 CA-C-N 122.588 3.194 . . . . 0.0 111.123 -179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -99.45 -31.9 11.41 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 172.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 44.6 t -148.62 163.58 36.83 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.063 -1.023 . . . . 0.0 112.705 178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 4.7 tp -132.6 130.64 59.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.58 1.952 . . . . 0.0 106.445 168.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -129.91 161.73 30.18 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 172.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 35.6 m -130.47 164.62 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 O-C-N 120.954 -1.091 . . . . 0.0 112.84 -172.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 t -140.57 70.85 1.36 Allowed 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 123.264 1.507 . . . . 0.0 109.37 170.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 45.9 mt -61.52 -21.57 64.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.642 1.177 . . . . 0.0 112.814 -174.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -54.01 -30.82 48.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.694 1.197 . . . . 0.0 113.818 170.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -108.9 -7.95 15.36 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.469 1.908 . . . . 0.0 112.53 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 54.9 mttm 77.05 15.96 1.8 Allowed 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 127.576 2.351 . . . . 0.0 112.743 -175.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.15 150.15 21.77 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-O 122.6 1.191 . . . . 0.0 110.806 177.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -120.82 151.06 40.08 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 126.415 1.886 . . . . 0.0 107.172 168.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -137.56 124.14 20.94 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.472 1.033 . . . . 0.0 113.446 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 12.8 p -97.12 136.12 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 C-N-CA 124.52 1.128 . . . . 0.0 110.615 -170.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -110.67 102.4 10.96 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.625 1.57 . . . . 0.0 108.221 -173.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.7 p90 -135.38 160.01 39.79 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 -168.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -93.59 113.41 60.2 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 126.065 1.746 . . . . 0.0 108.218 173.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -70.33 -3.7 12.92 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.025 2.483 . . . . 0.0 112.761 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.4 p -81.75 -11.8 58.86 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.703 1.601 . . . . 0.0 112.388 175.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 37.3 m -121.74 -33.03 3.67 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.778 1.231 . . . . 0.0 113.044 -173.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.4 t -145.06 -179.36 6.57 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.886 1.675 . . . . 0.0 111.32 -174.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 24.9 p -160.8 155.19 19.71 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 124.457 1.103 . . . . 0.0 112.821 -170.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -48.9 -49.16 15.78 Favored 'Trans proline' 0 C--N 1.355 0.871 0 C-N-CA 124.14 3.226 . . . . 0.0 116.668 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 31.2 m -70.22 -33.51 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-N 120.332 1.424 . . . . 0.0 112.638 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -68.09 -37.66 81.47 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.481 0.712 . . . . 0.0 111.099 175.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 71.1 mt -66.16 -46.89 75.81 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.321 1.448 . . . . 0.0 112.342 173.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.582 HE21 HG23 ' A' ' 88' ' ' VAL . 12.3 tt0 -53.58 -52.26 60.33 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 119.401 1.0 . . . . 0.0 109.778 175.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.6 mtp180 -65.65 -24.94 67.14 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.776 1.23 . . . . 0.0 113.676 -179.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.39 -60.67 2.13 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.315 0.961 . . . . 0.0 112.581 169.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.49 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.0 pt -74.02 -29.71 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -167.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -71.28 -23.56 61.99 Favored 'General case' 0 CA--C 1.542 0.668 0 CA-C-N 119.496 1.044 . . . . 0.0 113.705 -175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -92.16 17.8 9.05 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.001 -1.062 . . . . 0.0 113.675 178.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 88.6 mt -62.75 -58.74 15.16 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 117.715 -1.136 . . . . 0.0 109.955 166.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -69.82 168.15 22.45 Favored 'Trans proline' 0 C--N 1.353 0.775 0 C-N-CA 123.498 2.798 . . . . 0.0 112.337 173.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -79.4 42.16 1.24 Allowed 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 124.459 3.439 . . . . 0.0 112.434 -179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.99 63.83 2.34 Favored Glycine 0 C--N 1.338 0.678 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -169.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -148.74 -16.71 0.31 Allowed 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 118.114 2.635 . . . . 0.0 118.114 -169.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -124.43 130.6 52.77 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 169.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.1 tptt -110.4 142.48 42.04 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.867 1.267 . . . . 0.0 111.766 -173.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.582 HG23 HE21 ' A' ' 75' ' ' GLN . 13.6 m -117.56 134.5 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-N 120.084 1.311 . . . . 0.0 111.178 179.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 71.0 m -128.97 120.93 26.94 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 121.916 0.865 . . . . 0.0 111.975 176.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.033 0 C-N-CA 127.727 2.411 . . . . 0.0 112.202 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 58.2 m 48.41 82.11 0.04 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 127.038 2.135 . . . . 0.0 115.715 168.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 38.3 p -133.13 143.8 49.5 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.596 1.959 . . . . 0.0 112.929 -170.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 9.6 m -98.1 129.46 44.92 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 119.015 0.825 . . . . 0.0 111.18 -175.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -127.63 164.6 21.68 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 123.608 0.763 . . . . 0.0 111.162 169.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.3 tt -111.16 132.13 54.55 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.251 1.421 . . . . 0.0 109.982 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 8.0 mm -117.91 137.99 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.067 1.747 . . . . 0.0 109.014 -179.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.6 125.46 49.33 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.527 1.531 . . . . 0.0 109.215 170.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 46.1 mt -126.21 127.15 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 120.393 -1.442 . . . . 0.0 111.241 -170.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -106.07 74.21 1.03 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.796 2.039 . . . . 0.0 112.609 179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -179.12 52.89 0.09 OUTLIER Glycine 0 N--CA 1.466 0.677 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.938 165.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 65.4 mtm -137.54 91.85 2.64 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.47 0.708 . . . . 0.0 109.826 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.5 t -94.57 -29.19 15.01 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 124.672 1.189 . . . . 0.0 113.191 -173.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 91.6 m -125.11 154.56 41.23 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.514 1.526 . . . . 0.0 110.112 175.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.92 -30.15 65.69 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.522 0.934 . . . . 0.0 113.522 177.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 94.3 p -54.91 -24.32 22.99 Favored 'General case' 0 CA--C 1.543 0.707 0 O-C-N 121.079 -1.013 . . . . 0.0 113.615 172.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 95.2 m -57.13 -29.27 63.43 Favored 'General case' 0 CA--C 1.542 0.647 0 O-C-N 120.693 -1.254 . . . . 0.0 112.592 171.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.9 t -61.22 -49.88 82.76 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 123.612 0.765 . . . . 0.0 110.523 176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -66.14 -21.05 66.32 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 119.255 0.934 . . . . 0.0 113.228 -178.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 t -74.1 -62.11 1.62 Allowed 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 123.453 0.701 . . . . 0.0 111.304 169.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 47.4 mt -70.78 -48.54 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 O-C-N 120.83 -1.169 . . . . 0.0 111.494 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.19 -26.15 68.67 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.223 0.609 . . . . 0.0 111.711 176.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -73.35 -59.77 4.05 Favored Glycine 0 CA--C 1.528 0.888 0 C-N-CA 124.531 1.062 . . . . 0.0 112.178 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 92.7 mmm -71.57 -39.5 70.57 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 125.923 1.689 . . . . 0.0 114.208 -172.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 33.3 mm -70.96 -32.45 48.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.776 0 O-C-N 121.366 -0.834 . . . . 0.0 111.084 -178.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 1.7 t -65.36 0.55 1.42 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 114.876 1.436 . . . . 0.0 114.876 176.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -96.35 -11.24 26.09 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 120.479 -1.388 . . . . 0.0 114.589 -175.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.5 pp -93.07 166.04 12.55 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.485 1.514 . . . . 0.0 111.429 174.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.18 138.23 31.69 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 121.449 -0.782 . . . . 0.0 112.537 -174.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 101.16 15.6 27.66 Favored Glycine 0 CA--C 1.536 1.345 0 C-N-CA 125.556 1.55 . . . . 0.0 115.029 179.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.5 p -122.8 94.43 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 126.705 2.002 . . . . 0.0 110.502 176.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 40.3 tt0 -68.0 -56.98 6.94 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.165 0.986 . . . . 0.0 111.02 -175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -140.0 131.44 26.92 Favored 'General case' 0 N--CA 1.461 0.088 0 C-N-CA 124.475 1.11 . . . . 0.0 109.147 -171.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -136.47 131.33 48.01 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.348 0 C-N-CA 123.865 0.866 . . . . 0.0 110.452 -177.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 23.1 t -138.25 138.77 38.79 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 126.239 1.816 . . . . 0.0 108.686 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.5 p -143.45 145.55 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.962 1.305 . . . . 0.0 111.73 -175.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.5 t -135.19 135.38 40.97 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -172.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -63.93 -18.91 64.7 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 127.058 2.143 . . . . 0.0 113.959 171.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -60.01 -37.19 78.98 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.545 1.138 . . . . 0.0 113.114 -176.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -130.87 -8.05 3.97 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.419 1.488 . . . . 0.0 112.336 176.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 74.86 38.6 41.3 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.595 1.093 . . . . 0.0 111.502 -171.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 71.3 p -130.17 145.86 51.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 118.513 1.156 . . . . 0.0 113.559 -168.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -115.06 141.19 48.33 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 125.915 1.686 . . . . 0.0 112.459 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 6.1 t -110.39 124.19 51.26 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 167.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.27 136.27 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 O-C-N 121.828 -0.545 . . . . 0.0 111.366 -171.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.15 101.86 13.63 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 126.932 2.093 . . . . 0.0 106.485 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -104.18 164.2 11.88 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.597 1.159 . . . . 0.0 112.629 -176.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -107.02 93.34 8.96 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.089 1.356 . . . . 0.0 110.849 -177.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -67.19 -19.19 50.93 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.586 2.857 . . . . 0.0 112.26 -172.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -70.15 -15.87 63.01 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 114.171 1.175 . . . . 0.0 114.171 169.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 46.6 t -122.77 -38.5 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 C-N-CA 126.463 1.905 . . . . 0.0 113.422 -168.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 19.7 tt -141.93 151.71 18.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 124.878 1.271 . . . . 0.0 111.53 -171.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 14.9 t -101.07 143.38 26.48 Favored Pre-proline 0 CA--C 1.546 0.819 0 N-CA-C 113.295 0.85 . . . . 0.0 113.295 170.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -52.37 -26.49 27.95 Favored 'Trans proline' 0 C--N 1.355 0.886 0 C-N-CA 123.784 2.989 . . . . 0.0 113.935 169.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -70.49 -40.65 73.45 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 123.462 0.705 . . . . 0.0 111.551 -177.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -78.23 -24.29 47.06 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 168.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.7 tt -59.23 -50.8 72.61 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 124.955 1.302 . . . . 0.0 109.325 169.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -50.62 -46.63 58.29 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.371 1.468 . . . . 0.0 111.433 168.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.07 -21.35 66.49 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 114.608 1.336 . . . . 0.0 114.608 178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -72.52 -31.58 65.43 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 119.449 1.022 . . . . 0.0 112.367 175.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.2 mp -74.27 -40.43 50.24 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 C-N-CA 124.216 1.007 . . . . 0.0 111.158 171.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -65.71 -27.58 68.43 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.996 0.816 . . . . 0.0 112.846 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -71.24 -42.53 68.75 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.0 1.32 . . . . 0.0 112.362 168.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.1 tpt -61.23 -31.96 71.75 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 119.071 0.851 . . . . 0.0 111.434 175.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 109.0 44.16 1.13 Allowed Glycine 0 C--N 1.336 0.529 0 C-N-CA 126.584 2.04 . . . . 0.0 113.187 172.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -124.24 -159.73 0.89 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 107.477 -1.305 . . . . 0.0 107.477 169.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -124.92 149.6 47.43 Favored 'General case' 0 N--CA 1.467 0.404 0 O-C-N 120.692 -1.255 . . . . 0.0 109.212 168.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.55 155.0 44.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 122.502 1.144 . . . . 0.0 113.542 -179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 17.9 t -142.62 138.27 30.61 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 126.379 1.872 . . . . 0.0 108.99 -177.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.3 m -88.11 128.68 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 O-C-N 121.47 -0.769 . . . . 0.0 109.108 174.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . 0.288 2.7 p . . . . . 0 N--CA 1.473 0.683 0 CA-C-O 124.698 2.19 . . . . 0.0 107.675 170.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.7 m . . . . . 0 N--CA 1.48 1.034 0 N-CA-C 113.43 0.9 . . . . 0.0 113.43 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -100.41 150.95 22.09 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 127.317 2.247 . . . . 0.0 111.86 176.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.0 tt -146.24 143.65 29.35 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.264 2.226 . . . . 0.0 112.135 -169.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -95.2 121.76 37.18 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 122.387 1.089 . . . . 0.0 110.454 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -130.69 127.45 38.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 114.118 -1.401 . . . . 0.0 113.296 175.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 8.2 tpt180 -106.84 110.27 22.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 114.916 -1.038 . . . . 0.0 110.058 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.8 mm -77.15 157.37 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 C-N-CA 124.236 1.014 . . . . 0.0 109.935 177.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -135.54 147.63 48.84 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.542 1.137 . . . . 0.0 110.959 168.525 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.97 11.24 84.72 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 124.63 1.109 . . . . 0.0 113.353 -174.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.4 ptm -68.01 -33.07 73.92 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 118.993 1.396 . . . . 0.0 113.912 -169.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 69.08 -51.77 0.59 Allowed 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 127.693 2.397 . . . . 0.0 112.474 -177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 31.0 p -173.37 -173.74 0.93 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.829 2.052 . . . . 0.0 112.388 -174.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 54.0 tptt -46.44 -33.41 3.93 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.941 1.697 . . . . 0.0 113.503 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.5 m -53.25 -30.05 36.12 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 119.553 1.07 . . . . 0.0 113.703 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 3.5 t -64.46 -42.07 96.15 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.965 -1.084 . . . . 0.0 113.817 175.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . 0.269 4.8 p -73.62 -6.31 8.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.748 0 N-CA-C 113.709 1.003 . . . . 0.0 113.709 -177.082 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.34 -59.09 5.17 Favored 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 120.186 1.357 . . . . 0.0 111.712 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -61.33 -31.66 71.52 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 119.263 0.938 . . . . 0.0 111.989 177.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.1 mt -59.44 -56.5 16.73 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.748 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 171.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -59.33 -35.48 73.91 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 126.034 1.733 . . . . 0.0 114.424 177.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -62.01 -41.01 97.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.305 1.042 . . . . 0.0 111.534 177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 57.1 m-80 -96.35 -33.65 11.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.441 ' CD1' HG22 ' A' ' 78' ' ' ILE . 38.2 mm -107.09 111.92 37.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.616 1.166 . . . . 0.0 110.346 -167.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.08 -18.64 6.97 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.497 1.523 . . . . 0.0 113.877 -172.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -85.53 -6.01 59.23 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 121.5 -1.0 . . . . 0.0 112.542 169.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 73.8 mt -79.49 -179.13 6.65 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.9 2.08 . . . . 0.0 113.538 -170.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 17.2 tp -66.81 -77.97 0.06 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 127.306 2.243 . . . . 0.0 111.806 170.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -72.5 -36.47 58.96 Favored Glycine 0 CA--C 1.53 0.987 0 CA-C-O 118.834 -0.981 . . . . 0.0 113.589 -174.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.4 t -92.51 118.59 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 CA-C-N 119.246 1.523 . . . . 0.0 110.249 174.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -101.7 -24.62 14.06 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.742 0.817 . . . . 0.0 113.179 178.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.8 m -149.97 156.06 41.06 Favored 'General case' 0 CA--C 1.537 0.444 0 O-C-N 120.587 -1.32 . . . . 0.0 113.661 178.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.2 tp -125.94 147.06 30.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.011 1.324 . . . . 0.0 109.914 174.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -142.8 166.92 23.32 Favored 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 126.356 1.862 . . . . 0.0 108.471 -172.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.7 m -139.38 160.52 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 O-C-N 119.687 -1.883 . . . . 0.0 113.365 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.0 t -140.95 56.61 1.56 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.39 1.876 . . . . 0.0 108.244 179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 80.7 mt -61.52 -33.99 74.77 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 -168.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -67.17 -17.11 64.7 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 120.162 1.346 . . . . 0.0 113.388 172.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -104.02 -1.4 27.54 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.657 1.583 . . . . 0.0 111.807 171.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 70.12 9.57 7.09 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.27 2.628 . . . . 0.0 113.586 173.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -97.51 152.79 18.64 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.701 2.001 . . . . 0.0 109.325 176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -108.46 171.7 7.26 Favored 'General case' 0 C--N 1.319 -0.751 0 C-N-CA 125.012 1.325 . . . . 0.0 107.551 165.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -141.92 137.79 31.55 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 122.915 0.486 . . . . 0.0 110.367 -169.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 8.6 p -128.35 132.65 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-N 118.795 0.725 . . . . 0.0 112.059 -177.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 49.7 mtpt -105.36 94.2 5.09 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.727 2.011 . . . . 0.0 107.702 -176.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 7.2 p90 -131.23 162.73 29.34 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 -168.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -97.57 114.12 64.43 Favored Pre-proline 0 CA--C 1.546 0.807 0 C-N-CA 128.106 2.562 . . . . 0.0 110.919 176.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -78.29 25.24 0.53 Allowed 'Trans proline' 0 CA--C 1.544 1.022 0 C-N-CA 123.564 2.843 . . . . 0.0 113.617 -179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 33.8 t -117.82 -26.36 6.53 Favored 'General case' 0 N--CA 1.479 1.021 0 O-C-N 120.369 -1.457 . . . . 0.0 112.8 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 80.6 m -93.66 -29.01 15.65 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.128 0.971 . . . . 0.0 113.524 171.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.1 t -144.6 -179.07 6.33 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.97 1.708 . . . . 0.0 112.223 -171.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 58.6 p -157.81 163.0 26.09 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 125.133 1.373 . . . . 0.0 112.47 178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_exo -51.21 -50.68 13.14 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 124.771 3.647 . . . . 0.0 115.82 -171.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 9.0 p -64.28 -37.23 79.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.974 0 CA-C-N 119.216 0.916 . . . . 0.0 112.59 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.81 -43.57 79.32 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.257 0.623 . . . . 0.0 110.855 177.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 66.7 mt -64.37 -45.06 89.34 Favored 'General case' 0 N--CA 1.465 0.308 0 C-N-CA 123.571 0.748 . . . . 0.0 112.142 175.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -52.06 -55.82 18.26 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.879 0.872 . . . . 0.0 110.545 178.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 32.9 mtp85 -70.21 -22.56 62.91 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -177.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.01 -56.47 6.09 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 119.316 0.962 . . . . 0.0 112.273 170.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.441 HG22 ' CD1' ' A' ' 42' ' ' ILE . 9.6 pt -71.54 -31.4 42.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -172.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -60.71 -30.23 69.83 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 -178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.29 13.79 26.39 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 114.203 1.186 . . . . 0.0 114.203 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 45.6 mt -62.41 -49.27 84.54 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 117.305 -1.331 . . . . 0.0 112.662 167.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.61 172.07 16.43 Favored 'Trans proline' 0 CA--C 1.543 0.965 0 C-N-CA 123.707 2.938 . . . . 0.0 112.997 174.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -75.94 63.0 6.73 Favored 'Trans proline' 0 CA--C 1.541 0.847 1 C-N-CA 125.462 4.108 . . . . 0.0 111.109 173.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 61.87 32.5 82.15 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 125.011 1.291 . . . . 0.0 112.986 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -105.49 -48.17 3.74 Favored 'General case' 0 N--CA 1.476 0.866 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 -166.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -95.6 128.53 42.54 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -97.01 157.56 15.85 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.51 1.524 . . . . 0.0 109.384 173.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 2.6 p -140.24 136.85 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 CA-C-N 119.533 1.06 . . . . 0.0 111.636 170.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 73.3 m -124.36 140.37 53.02 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.686 1.595 . . . . 0.0 112.919 -174.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.615 0 C-N-CA 126.462 1.905 . . . . 0.0 111.556 -163.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 18.0 m . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 5.7 m -144.03 138.8 28.61 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 113.921 1.082 . . . . 0.0 113.921 -172.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.5 p -142.35 154.82 44.98 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 127.44 2.296 . . . . 0.0 110.266 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 54.5 m -101.64 145.39 29.14 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 121.554 -0.716 . . . . 0.0 109.978 178.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -144.16 150.88 38.75 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.201 1.001 . . . . 0.0 111.058 172.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.76 137.96 50.3 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 125.583 1.553 . . . . 0.0 109.054 175.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 19.3 mm -119.12 137.29 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 126.554 1.942 . . . . 0.0 108.525 -177.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -100.33 128.05 46.49 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.109 1.363 . . . . 0.0 109.288 170.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 mp -123.02 136.21 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 O-C-N 120.702 -1.249 . . . . 0.0 110.909 -172.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -125.68 61.7 1.23 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.965 1.706 . . . . 0.0 111.755 -179.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -170.31 56.23 0.19 Allowed Glycine 0 N--CA 1.463 0.459 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.721 169.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.9 mtm -138.74 74.9 1.49 Allowed 'General case' 0 N--CA 1.469 0.513 0 CA-C-O 122.205 1.002 . . . . 0.0 110.499 -177.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.2 t -79.84 -19.99 47.09 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.72 1.208 . . . . 0.0 112.513 176.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 95.0 m -128.23 153.02 47.39 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.454 1.901 . . . . 0.0 111.06 -178.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.77 -24.46 61.76 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.361 -0.837 . . . . 0.0 112.848 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.6 p -51.11 -37.36 45.49 Favored 'General case' 0 N--CA 1.472 0.656 0 O-C-N 120.987 -1.071 . . . . 0.0 111.97 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 56.4 m -54.15 -36.32 63.2 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.779 1.632 . . . . 0.0 113.336 174.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 t -59.85 -56.3 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 174.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 28.3 m-70 -69.34 -17.61 63.72 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -175.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.1 m -72.52 -54.84 8.08 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.617 1.167 . . . . 0.0 111.788 167.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 90.8 mt -63.81 -58.65 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.778 0.831 . . . . 0.0 110.198 179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.4 tt0 -57.32 -28.63 63.25 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.997 2.119 . . . . 0.0 112.014 178.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.62 -56.96 4.76 Favored Glycine 0 C--N 1.341 0.83 0 C-N-CA 125.842 1.687 . . . . 0.0 114.239 174.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 13.1 mmt -71.29 -45.79 62.29 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.909 0.884 . . . . 0.0 112.093 -172.653 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 24.7 mm -68.7 -39.68 80.59 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 N-CA-C 111.662 0.245 . . . . 0.0 111.662 -169.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.11 -2.25 2.7 Favored 'General case' 0 CA--C 1.555 1.162 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -90.96 -16.65 27.68 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.041 1.336 . . . . 0.0 113.814 178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.3 pp -95.75 162.55 13.55 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 119.908 1.231 . . . . 0.0 111.844 177.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -77.1 166.37 23.36 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 122.279 1.038 . . . . 0.0 113.596 -174.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.9 -41.84 1.77 Allowed Glycine 0 CA--C 1.531 1.077 0 O-C-N 120.822 -1.174 . . . . 0.0 114.069 -175.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.6 p -78.14 97.44 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.181 0 CA-C-N 119.135 1.468 . . . . 0.0 111.394 173.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 36.5 tt0 -68.87 -52.24 31.85 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.304 1.441 . . . . 0.0 111.545 -178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -143.52 144.68 32.07 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.868 0.867 . . . . 0.0 109.94 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.9 tt -135.93 140.17 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 C-N-CA 124.14 0.976 . . . . 0.0 110.077 172.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 42.0 t -138.95 136.44 35.42 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.641 1.576 . . . . 0.0 109.946 175.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 5.5 p -143.79 147.39 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.327 0 CA-C-N 119.665 1.12 . . . . 0.0 112.394 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 23.1 t -143.45 151.37 40.26 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.838 1.255 . . . . 0.0 112.658 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 14.6 mt -72.85 -29.3 63.1 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.835 1.421 . . . . 0.0 114.835 177.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -46.21 -38.85 8.92 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.816 2.047 . . . . 0.0 115.303 -168.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 26.3 mm-40 -125.0 -1.14 7.82 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 126.194 1.798 . . . . 0.0 111.383 174.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 68.28 50.95 35.43 Favored Glycine 0 C--N 1.346 1.098 0 C-N-CA 128.228 2.823 . . . . 0.0 112.019 -178.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.8 p -141.66 145.12 34.56 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -167.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -114.99 144.87 42.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.043 1.737 . . . . 0.0 111.506 171.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 11.3 t -120.98 127.69 52.03 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.792 1.237 . . . . 0.0 108.208 168.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -140.26 140.18 35.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 124.024 0.93 . . . . 0.0 111.461 -167.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -98.34 116.25 30.17 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 127.431 2.292 . . . . 0.0 107.774 177.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -136.7 158.77 43.67 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -96.93 116.57 66.11 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 125.35 1.46 . . . . 0.0 110.606 177.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -82.25 -0.43 10.23 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.956 3.104 . . . . 0.0 114.121 -173.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -93.05 -37.48 12.14 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.678 1.191 . . . . 0.0 112.311 169.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 82.0 t -89.87 -31.69 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 C-N-CA 126.668 1.987 . . . . 0.0 112.436 -176.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.426 ' CG1' ' H ' ' A' ' 172' ' ' SER . 14.6 tt -138.2 -178.6 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.522 1.129 . . . . 0.0 110.773 176.563 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . 0.426 ' H ' ' CG1' ' A' ' 171' ' ' ILE . 21.6 t -140.6 148.2 52.2 Favored Pre-proline 0 C--O 1.236 0.385 0 C-N-CA 126.497 1.919 . . . . 0.0 110.23 -178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_exo -52.57 -27.12 31.49 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.684 2.256 . . . . 0.0 113.664 169.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -69.51 -31.53 69.83 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.982 0.81 . . . . 0.0 111.385 179.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -74.03 -36.52 64.42 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.971 1.709 . . . . 0.0 111.615 177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 92.6 mt -58.04 -57.14 14.15 Favored 'General case' 0 C--N 1.346 0.416 0 C-N-CA 124.049 0.939 . . . . 0.0 109.743 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.21 -38.9 93.0 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 112.891 0.701 . . . . 0.0 112.891 177.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -58.91 -30.44 67.82 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.97 0.804 . . . . 0.0 113.034 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.57 -31.9 69.09 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 119.367 0.985 . . . . 0.0 112.45 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.7 mp -72.07 -35.67 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.979 0.912 . . . . 0.0 111.256 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -70.38 -29.11 65.68 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 118.866 0.757 . . . . 0.0 112.895 172.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.51 -29.61 63.77 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.643 1.177 . . . . 0.0 113.078 169.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 53.4 ttm -69.63 -48.84 58.57 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.848 0.859 . . . . 0.0 110.257 172.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 134.76 43.46 0.12 Allowed Glycine 0 CA--C 1.528 0.906 0 C-N-CA 125.051 1.31 . . . . 0.0 114.882 173.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 -140.8 -155.67 0.61 Allowed 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 125.467 1.507 . . . . 0.0 109.447 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -133.07 143.83 49.59 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.511 1.124 . . . . 0.0 111.368 172.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -141.5 145.0 34.65 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.756 1.222 . . . . 0.0 112.337 179.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 41.4 t -133.23 141.2 47.92 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 125.41 1.484 . . . . 0.0 109.95 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 27.9 m -82.48 132.23 31.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.725 0 O-C-N 122.042 -0.411 . . . . 0.0 111.2 178.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . 0.264 5.0 p . . . . . 0 N--CA 1.473 0.708 0 CA-C-O 124.673 2.177 . . . . 0.0 107.212 169.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 9.0 p . . . . . 0 N--CA 1.45 -0.464 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.4 m -126.97 134.84 50.3 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 123.357 0.663 . . . . 0.0 110.909 -168.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.56 166.75 23.87 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 115.591 1.701 . . . . 0.0 115.591 175.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.9 tp-100 -120.45 128.17 52.91 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 127.088 2.155 . . . . 0.0 110.938 -169.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.05 138.35 29.87 Favored 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.74 109.91 22.58 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -177.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 mt -83.25 134.21 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.254 1.422 . . . . 0.0 109.293 177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -101.69 127.45 48.43 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 125.371 1.468 . . . . 0.0 110.882 176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 106.4 -5.76 38.47 Favored Glycine 0 CA--C 1.533 1.175 0 C-N-CA 125.192 1.377 . . . . 0.0 113.626 -173.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 9.6 ptp -61.15 -10.41 6.4 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 18.5 t60 -53.35 -12.99 0.48 Allowed 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 125.216 1.407 . . . . 0.0 113.623 167.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 41.2 t -119.41 127.88 53.52 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.409 1.884 . . . . 0.0 108.893 167.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 4.9 tmmm? -58.24 -31.68 67.62 Favored 'General case' 0 N--CA 1.479 0.99 0 O-C-N 120.941 -1.099 . . . . 0.0 113.343 -175.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 10.2 m -50.32 -30.65 12.51 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.719 1.207 . . . . 0.0 113.617 174.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 18.0 t -63.48 -58.19 7.8 Favored 'General case' 0 C--N 1.343 0.323 0 C-N-CA 124.546 1.138 . . . . 0.0 111.759 177.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.1 p -70.01 -25.35 27.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-N 119.231 0.923 . . . . 0.0 111.82 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -59.33 -61.34 2.7 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.041 0.936 . . . . 0.0 111.885 -178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -62.88 -32.5 73.77 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 121.969 -0.457 . . . . 0.0 111.673 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 61.9 mt -62.05 -50.37 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 CA-C-N 118.751 0.705 . . . . 0.0 110.32 172.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -63.66 -31.84 73.14 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.949 1.3 . . . . 0.0 112.528 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -70.18 -46.94 63.6 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.256 -0.902 . . . . 0.0 112.067 174.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 -91.46 -13.13 32.8 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 -170.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.564 ' CD1' HG22 ' A' ' 78' ' ' ILE . 44.9 mm -105.16 121.79 57.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.805 0 CA-C-N 119.924 1.238 . . . . 0.0 111.421 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 122.98 -19.77 7.74 Favored Glycine 0 CA--C 1.536 1.346 0 C-N-CA 125.899 1.714 . . . . 0.0 114.185 -177.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 17.9 pt20 -77.35 -3.19 38.79 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.767 1.227 . . . . 0.0 112.599 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.7 mt -84.52 -175.76 5.93 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 128.88 2.872 . . . . 0.0 111.966 178.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.9 tp -85.82 -79.85 0.24 Allowed 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.066 1.746 . . . . 0.0 111.256 -178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -71.54 -30.98 65.9 Favored Glycine 0 CA--C 1.526 0.728 0 CA-C-O 117.857 -1.524 . . . . 0.0 113.576 -171.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.0 p -90.38 117.39 33.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-N 119.173 1.486 . . . . 0.0 107.734 167.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -108.09 -36.46 6.32 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -170.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.7 t -147.62 168.12 22.82 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 124.31 1.044 . . . . 0.0 111.229 179.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 8.5 tp -140.68 141.65 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 124.546 1.138 . . . . 0.0 110.085 -171.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -137.24 155.4 49.54 Favored 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.954 2.102 . . . . 0.0 107.47 -173.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 23.4 m -123.66 145.63 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 119.627 -1.921 . . . . 0.0 110.914 178.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.3 m -128.15 54.45 1.73 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.574 1.15 . . . . 0.0 108.135 176.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 82.4 mt -64.13 -30.04 71.13 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.685 1.594 . . . . 0.0 112.365 -171.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -53.68 -37.41 63.19 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.4 0.68 . . . . 0.0 111.994 170.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -102.51 2.53 36.44 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.608 1.563 . . . . 0.0 112.925 175.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? 68.18 12.38 8.74 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 128.149 2.579 . . . . 0.0 114.209 174.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.1 p -99.92 162.75 12.79 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 122.723 1.249 . . . . 0.0 110.273 169.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -106.1 161.93 14.07 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 165.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.458 HE21 ' HA ' ' A' ' 61' ' ' GLN . 2.3 tp60 -137.08 127.15 26.03 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 -169.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 4.2 p -125.16 140.48 48.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 O-C-N 120.444 -1.41 . . . . 0.0 111.915 -169.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.36 108.85 21.65 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.067 1.347 . . . . 0.0 108.601 173.184 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -131.09 178.64 6.54 Favored 'General case' 0 CA--C 1.549 0.918 0 C-N-CA 125.132 1.373 . . . . 0.0 110.26 -175.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -124.44 134.49 25.58 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 124.53 1.132 . . . . 0.0 109.445 170.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -78.49 20.06 0.8 Allowed 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 124.215 3.277 . . . . 0.0 114.307 -169.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 16.4 p -121.96 -51.76 2.0 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 126.813 2.045 . . . . 0.0 110.586 -176.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 90.2 m -77.46 -25.32 50.46 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.562 1.545 . . . . 0.0 114.463 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.3 t -145.28 -177.36 5.51 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.42 1.888 . . . . 0.0 109.318 169.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 41.7 p -149.57 162.17 29.37 Favored Pre-proline 0 C--N 1.321 -0.674 0 C-N-CA 125.211 1.404 . . . . 0.0 110.155 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_exo -47.19 -56.37 3.11 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.42 2.747 . . . . 0.0 113.05 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.25 -35.64 72.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.42 -52.68 12.86 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.378 0.671 . . . . 0.0 111.606 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.15 -37.47 82.97 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.212 1.405 . . . . 0.0 111.071 -177.084 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.9 -57.86 10.68 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.523 1.129 . . . . 0.0 111.539 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 69.9 mtt180 -63.29 -32.16 73.5 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.49 -52.71 64.41 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.299 0.64 . . . . 0.0 110.659 174.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.564 HG22 ' CD1' ' A' ' 42' ' ' ILE . 4.8 pt -73.41 -31.37 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 N-CA-C 113.455 0.909 . . . . 0.0 113.455 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -70.17 -23.91 63.06 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.64 10.63 39.45 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 176.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 13.7 mt -56.71 -59.14 13.23 Favored Pre-proline 0 CA--C 1.544 0.74 0 CA-C-O 118.038 -0.982 . . . . 0.0 112.063 168.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -74.09 173.28 14.36 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 122.623 2.215 . . . . 0.0 111.001 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.89 67.5 5.82 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.731 2.954 . . . . 0.0 110.135 169.534 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 56.22 46.03 86.88 Favored Glycine 0 C--N 1.344 0.981 0 C-N-CA 125.594 1.568 . . . . 0.0 112.741 178.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -115.39 -21.22 9.94 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 117.089 2.255 . . . . 0.0 117.089 -165.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -133.12 116.78 16.72 Favored 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 125.154 1.382 . . . . 0.0 110.75 -175.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.9 ttpt -99.19 139.42 34.87 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 125.21 1.404 . . . . 0.0 112.091 -173.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.5 140.43 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 CA-C-N 120.5 1.5 . . . . 0.0 112.932 175.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.8 t -122.94 128.69 50.61 Favored 'General case' 0 C--O 1.239 0.517 0 C-N-CA 126.225 1.81 . . . . 0.0 110.89 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 125.79 1.636 . . . . 0.0 112.598 -178.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.8 t . . . . . 0 N--CA 1.479 1.004 0 N-CA-C 113.785 1.031 . . . . 0.0 113.785 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 24.7 p -157.01 132.88 9.49 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 125.607 1.563 . . . . 0.0 113.56 -168.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 5.0 p -148.0 145.26 28.45 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.905 2.082 . . . . 0.0 110.041 169.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 90.2 m -105.26 135.58 46.37 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 119.471 1.032 . . . . 0.0 110.499 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.68 149.23 44.92 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.987 1.315 . . . . 0.0 110.974 172.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.2 tt -96.46 141.21 30.03 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.095 2.158 . . . . 0.0 110.042 177.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.7 mt -127.91 134.4 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 125.626 1.571 . . . . 0.0 109.246 -176.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.2 130.76 44.39 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.27 1.028 . . . . 0.0 108.266 172.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 90.6 mt -132.94 136.09 56.07 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.48 -0.763 . . . . 0.0 111.144 -168.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -123.07 72.27 1.09 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.882 1.673 . . . . 0.0 111.882 179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -177.49 52.13 0.1 Allowed Glycine 0 C--N 1.335 0.484 0 CA-C-N 115.242 -0.89 . . . . 0.0 114.399 167.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 5.3 mpp? -104.41 -58.08 1.94 Allowed 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.963 1.098 . . . . 0.0 113.963 170.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . 0.274 5.6 t 54.84 -56.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 129.433 3.093 . . . . 0.0 115.757 -169.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 92.3 m -112.99 150.82 31.37 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 127.744 2.418 . . . . 0.0 111.095 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -59.92 -34.6 73.43 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.865 1.266 . . . . 0.0 112.614 -177.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 12.5 p -43.49 -47.53 7.2 Favored 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 125.218 1.407 . . . . 0.0 112.385 169.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 5.6 t -71.5 -25.08 62.11 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 1.3 t -62.54 -53.39 47.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 170.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.43 -33.29 73.47 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 178.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 39.1 m -67.17 -51.72 50.28 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.708 0.803 . . . . 0.0 112.898 174.165 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 83.8 mt -62.01 -46.54 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.203 0 CA-C-N 119.965 1.257 . . . . 0.0 110.665 -179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 7.7 tm-20 -58.74 -28.77 66.18 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.814 1.645 . . . . 0.0 112.164 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.48 -61.05 3.28 Favored Glycine 0 CA--C 1.529 0.945 0 C-N-CA 124.969 1.271 . . . . 0.0 113.281 170.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.29 -47.74 69.74 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.319 1.448 . . . . 0.0 113.139 -169.246 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 32.0 mm -71.67 -34.67 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 O-C-N 122.157 -0.339 . . . . 0.0 111.735 -169.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.0 t -50.96 -21.99 2.04 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 126.487 1.915 . . . . 0.0 115.313 176.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 18.5 mt-30 -86.18 -19.82 29.5 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 126.122 1.769 . . . . 0.0 115.163 -167.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.1 pp -92.92 151.28 20.04 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 119.181 0.901 . . . . 0.0 112.403 -173.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -59.38 135.22 57.59 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.952 0.882 . . . . 0.0 112.49 -169.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 91.27 -27.56 9.21 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 117.064 -1.965 . . . . 0.0 115.343 179.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.97 94.05 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.375 0 CA-C-N 121.214 2.507 . . . . 0.0 108.778 169.634 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -74.84 -44.07 51.11 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.345 1.058 . . . . 0.0 111.374 -175.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -141.95 147.18 36.6 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 119.476 1.034 . . . . 0.0 109.96 177.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.46 148.54 21.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-O 122.109 0.956 . . . . 0.0 113.272 175.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 47.5 t -134.39 136.84 43.63 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 129.031 2.932 . . . . 0.0 108.513 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.77 143.9 20.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 CA-C-N 120.616 1.553 . . . . 0.0 112.766 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 42.0 m -141.51 148.71 39.83 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.195 1.398 . . . . 0.0 113.233 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.43 -26.43 55.49 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 125.813 1.645 . . . . 0.0 114.133 172.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.25 -33.48 58.57 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.834 1.653 . . . . 0.0 113.894 -169.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -123.83 -10.54 7.75 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.276 1.83 . . . . 0.0 111.087 169.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.72 44.61 19.8 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.406 1.003 . . . . 0.0 110.793 -173.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 49.0 p -133.74 146.63 50.93 Favored 'General case' 0 CA--C 1.514 -0.411 0 C-N-CA 124.073 0.949 . . . . 0.0 111.863 -169.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -121.82 161.2 23.14 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 125.77 1.628 . . . . 0.0 111.057 172.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 8.8 t -141.46 139.21 33.32 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 124.191 0.996 . . . . 0.0 109.173 168.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -141.63 142.86 28.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.226 -167.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.38 98.62 11.01 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.67 -1.974 . . . . 0.0 105.67 173.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -100.22 154.52 18.39 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.9 0.88 . . . . 0.0 111.67 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -98.81 109.11 52.31 Favored Pre-proline 0 CA--C 1.541 0.619 0 C-N-CA 124.161 0.984 . . . . 0.0 110.087 178.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.78 -10.88 23.64 Favored 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 122.438 2.092 . . . . 0.0 112.472 -170.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -82.26 -17.42 46.01 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 169.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 93.6 t -120.45 -29.12 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.911 1.284 . . . . 0.0 114.02 -169.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.3 tt -141.1 147.25 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.574 0 CA-C-N 119.186 0.903 . . . . 0.0 110.324 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.63 150.04 36.32 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 123.939 0.895 . . . . 0.0 111.004 176.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_exo -48.43 -39.47 36.1 Favored 'Trans proline' 0 C--N 1.353 0.779 0 C-N-CA 123.246 2.631 . . . . 0.0 113.924 175.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -65.01 -25.25 67.78 Favored 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -76.7 -27.79 55.64 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 124.614 1.165 . . . . 0.0 113.875 174.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 88.6 mt -59.77 -53.76 54.22 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 179.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -65.2 -34.68 78.95 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 112.849 0.685 . . . . 0.0 112.849 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -61.18 -27.63 68.56 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.05 -36.44 72.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.89 0.768 . . . . 0.0 112.723 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.4 mp -72.41 -37.45 57.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 124.286 1.035 . . . . 0.0 110.837 172.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -63.43 -34.05 76.9 Favored 'General case' 0 CA--C 1.547 0.831 0 O-C-N 121.817 -0.552 . . . . 0.0 111.485 172.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -71.88 -24.4 61.66 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.008 1.323 . . . . 0.0 113.336 171.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 21.2 ttt -74.85 -29.46 61.05 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.673 1.189 . . . . 0.0 112.609 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 115.5 30.99 2.08 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 126.084 1.802 . . . . 0.0 114.875 177.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 32.7 m-85 -133.76 -158.51 0.89 Allowed 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 125.842 1.657 . . . . 0.0 109.18 -179.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -137.57 143.17 41.41 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 124.287 1.035 . . . . 0.0 111.459 173.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -140.88 152.22 44.9 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.027 1.731 . . . . 0.0 112.065 179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 45.5 t -141.36 130.99 24.02 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 125.006 1.323 . . . . 0.0 112.232 173.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.55 81.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.95 0 C-N-CA 124.127 0.971 . . . . 0.0 111.412 -178.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.477 0.906 0 C-N-CA 125.025 1.33 . . . . 0.0 112.457 179.526 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.484 HG13 ' CE1' ' A' ' 64' ' ' TYR . 9.9 p . . . . . 0 CA--C 1.545 0.762 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 1.3 m -118.36 144.9 45.55 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.501 1.121 . . . . 0.0 111.399 -170.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -142.38 128.71 19.98 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.496 1.519 . . . . 0.0 109.85 -179.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 3.5 tp-100 -96.3 135.69 37.79 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 125.355 1.462 . . . . 0.0 112.237 -176.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -142.87 146.91 34.54 Favored 'General case' 0 C--N 1.333 -0.119 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -110.92 109.62 19.85 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 125.449 1.499 . . . . 0.0 109.146 174.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 5.7 mt -85.41 147.21 5.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 126.199 1.799 . . . . 0.0 111.676 -176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -98.19 139.84 33.39 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.984 1.313 . . . . 0.0 111.07 169.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 91.27 -6.89 81.04 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.196 1.379 . . . . 0.0 114.101 -178.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.4 ptp -64.19 -15.75 60.53 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -63.82 -13.5 44.99 Favored 'General case' 0 CA--C 1.548 0.876 0 CA-C-N 120.62 1.554 . . . . 0.0 113.223 170.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 79.1 m -77.03 -14.72 59.79 Favored 'General case' 0 CA--C 1.545 0.757 0 O-C-N 120.15 -1.594 . . . . 0.0 114.155 177.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? 70.8 -50.9 0.68 Allowed 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 128.139 2.576 . . . . 0.0 111.955 -172.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 33.3 m -60.0 -17.97 42.49 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 120.766 -1.209 . . . . 0.0 113.583 174.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 2.4 t -64.38 -53.05 54.7 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 124.548 1.139 . . . . 0.0 111.565 174.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.8 p -70.72 -27.92 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 118.638 0.654 . . . . 0.0 112.281 -174.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 30.1 tp -53.65 -49.54 67.7 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.168 0.987 . . . . 0.0 112.376 -177.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.95 -39.18 88.51 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 118.478 0.581 . . . . 0.0 111.914 -178.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.1 mt -65.51 -49.5 77.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.453 0 C-N-CA 124.263 1.025 . . . . 0.0 109.264 177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -63.69 -41.6 98.12 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.68 1.592 . . . . 0.0 111.938 -176.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -66.7 -39.22 87.97 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-O 119.031 -0.509 . . . . 0.0 111.49 -179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -91.6 -25.01 19.39 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 115.496 1.665 . . . . 0.0 115.496 -172.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.426 ' CD1' HG22 ' A' ' 78' ' ' ILE . 47.8 mm -102.91 118.64 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.874 0.87 . . . . 0.0 110.431 -173.246 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.23 -17.5 3.57 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 125.866 1.698 . . . . 0.0 115.215 -177.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -88.54 -5.33 58.27 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 125.091 1.356 . . . . 0.0 111.919 175.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 56.1 mt -76.4 170.4 16.43 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 127.006 2.122 . . . . 0.0 111.247 -177.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 tt -64.57 -62.88 1.31 Allowed 'General case' 0 N--CA 1.47 0.539 0 O-C-N 121.427 -0.795 . . . . 0.0 110.964 -173.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.04 -43.13 17.85 Favored Glycine 0 CA--C 1.532 1.102 0 CA-C-O 118.853 -0.97 . . . . 0.0 113.237 -176.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 55.5 t -78.26 123.92 35.84 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 CA-C-N 119.221 1.511 . . . . 0.0 110.502 -179.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -94.74 -46.22 7.0 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 124.186 0.994 . . . . 0.0 111.31 175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 31.8 t -149.41 172.04 15.59 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 123.563 0.745 . . . . 0.0 112.481 -169.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 1.9 tp -142.39 125.2 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 C-N-CA 126.561 1.944 . . . . 0.0 107.434 176.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -120.23 149.45 42.25 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.554 0.741 . . . . 0.0 109.65 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 32.8 m -106.62 155.87 7.29 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 O-C-N 121.201 -0.937 . . . . 0.0 111.03 -170.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 35.4 t -139.73 57.82 1.62 Allowed 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 123.138 1.447 . . . . 0.0 108.182 175.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 55.6 mt -67.86 -24.13 65.22 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.611 1.564 . . . . 0.0 112.714 -171.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -64.21 -11.88 35.31 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.003 1.321 . . . . 0.0 113.61 169.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.8 t30 -122.84 7.59 9.35 Favored 'General case' 0 CA--C 1.556 1.19 0 C-N-CA 127.172 2.189 . . . . 0.0 111.649 172.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 14.1 mptt 62.2 14.17 6.46 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 127.383 2.273 . . . . 0.0 113.746 -176.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.73 167.14 10.08 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.634 1.574 . . . . 0.0 111.76 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -140.67 152.79 45.64 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 127.157 2.183 . . . . 0.0 107.207 169.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -130.63 133.65 46.31 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 172.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 11.0 p -96.22 136.86 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 121.519 0.676 . . . . 0.0 109.732 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -107.19 87.89 2.61 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.59 1.956 . . . . 0.0 107.51 -172.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.484 ' CE1' HG13 ' A' ' 20' ' ' VAL . 8.8 p90 -116.33 -179.3 3.63 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.481 1.512 . . . . 0.0 110.42 -175.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.13 142.17 36.05 Favored Pre-proline 0 CA--C 1.55 0.955 0 N-CA-C 106.44 -1.689 . . . . 0.0 106.44 168.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -84.08 7.19 5.33 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 122.388 2.058 . . . . 0.0 114.308 -168.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.8 t -74.96 -51.38 13.85 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 120.28 -1.512 . . . . 0.0 112.369 -176.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 90.0 m -95.46 -15.81 22.69 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -172.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.9 t -147.81 175.69 10.73 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.647 1.179 . . . . 0.0 112.448 -175.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 64.4 p -155.46 161.54 29.23 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.606 1.162 . . . . 0.0 112.754 -176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_exo -53.85 -45.71 38.98 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 123.131 2.554 . . . . 0.0 115.583 -170.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.6 p -62.91 -41.18 91.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 118.814 0.734 . . . . 0.0 111.945 177.481 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.81 -38.48 86.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 123.954 0.901 . . . . 0.0 112.268 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.56 -40.56 92.97 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 123.989 0.916 . . . . 0.0 111.799 173.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.48 HE21 HG23 ' A' ' 88' ' ' VAL . 37.8 tt0 -58.69 -45.64 89.04 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.296 -0.859 . . . . 0.0 111.256 173.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.7 mmt180 -61.59 -36.79 81.66 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 119.542 1.065 . . . . 0.0 112.892 174.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.18 -60.33 2.29 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.23 1.012 . . . . 0.0 113.43 -178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.426 HG22 ' CD1' ' A' ' 42' ' ' ILE . 8.6 pt -73.2 -32.65 39.07 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -169.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -70.0 -19.62 63.32 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.84 0.856 . . . . 0.0 112.684 -175.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -97.59 11.21 37.72 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.997 1.319 . . . . 0.0 113.934 178.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 21.3 mt -60.61 -50.46 85.29 Favored Pre-proline 0 CA--C 1.548 0.893 0 CA-C-O 117.371 -1.3 . . . . 0.0 111.631 167.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.41 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 73.4 Cg_endo -70.25 172.84 12.35 Favored 'Trans proline' 0 CA--C 1.541 0.862 0 C-N-CA 123.583 2.855 . . . . 0.0 112.22 170.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -76.56 43.25 1.18 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.217 3.278 . . . . 0.0 112.236 170.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.41 58.05 5.23 Favored Glycine 0 CA--C 1.527 0.801 0 O-C-N 121.155 -0.966 . . . . 0.0 111.149 -174.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -133.8 -42.33 0.83 Allowed 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 115.8 1.778 . . . . 0.0 115.8 -172.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.41 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 14.9 m-85 -97.9 115.53 28.3 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 172.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 50.5 mtmt -102.4 158.46 16.19 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.016 0.926 . . . . 0.0 111.772 -177.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.48 HG23 HE21 ' A' ' 75' ' ' GLN . 4.0 m -126.86 139.25 52.39 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 CA-C-N 119.364 0.984 . . . . 0.0 112.037 175.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.8 t -128.9 130.5 46.91 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.012 0.925 . . . . 0.0 111.945 174.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 12.9 mt . . . . . 0 CA--C 1.552 1.021 0 C-N-CA 125.355 1.462 . . . . 0.0 111.461 -175.887 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.9 t . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 110.127 -0.323 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 87.1 m 58.53 92.63 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.237 1.815 . . . . 0.0 112.758 178.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 t -140.15 154.04 46.85 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.882 -1.136 . . . . 0.0 111.727 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 25.1 m -99.27 129.84 45.52 Favored 'General case' 0 CA--C 1.52 -0.193 0 N-CA-C 110.194 -0.299 . . . . 0.0 110.194 -176.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.82 153.59 43.85 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 122.087 0.946 . . . . 0.0 110.126 168.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.7 tt -102.55 130.5 49.42 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.705 2.002 . . . . 0.0 109.447 178.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 18.3 mm -115.12 138.55 45.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 C-N-CA 126.174 1.789 . . . . 0.0 109.187 177.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -104.51 125.04 50.31 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.923 0.889 . . . . 0.0 110.044 169.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.9 mp -115.85 139.85 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 119.457 1.026 . . . . 0.0 112.369 -169.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -111.31 70.55 0.72 Allowed 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.229 2.211 . . . . 0.0 111.539 171.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -176.2 54.09 0.11 Allowed Glycine 0 N--CA 1.466 0.659 0 C-N-CA 124.86 1.219 . . . . 0.0 112.753 168.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 55.9 mtm -134.98 157.78 46.03 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 125.514 1.526 . . . . 0.0 109.869 170.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.8 t -174.94 -45.34 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.593 1.557 . . . . 0.0 110.74 -171.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 67.0 m -104.68 146.05 29.48 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.863 1.265 . . . . 0.0 109.127 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.89 -27.69 68.34 Favored 'General case' 0 CA--C 1.536 0.441 0 O-C-N 121.622 -0.674 . . . . 0.0 112.605 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 79.9 p -56.06 -23.9 36.47 Favored 'General case' 0 CA--C 1.542 0.663 0 O-C-N 120.913 -1.117 . . . . 0.0 113.468 172.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 73.2 m -56.16 -27.82 55.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.372 1.069 . . . . 0.0 113.49 170.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.2 t -54.33 -52.58 37.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 118.91 0.777 . . . . 0.0 109.492 173.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -70.6 -14.8 62.63 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.232 1.013 . . . . 0.0 113.098 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 7.3 m -73.41 -56.14 5.44 Favored 'General case' 0 N--CA 1.471 0.604 0 O-C-N 121.064 -1.023 . . . . 0.0 109.65 167.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.5 mt -68.17 -59.23 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 124.695 1.198 . . . . 0.0 110.568 -176.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -54.55 -29.52 51.21 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.646 1.578 . . . . 0.0 111.63 175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.58 -62.65 3.15 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 124.373 0.987 . . . . 0.0 112.727 176.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 86.6 mmm -75.56 -42.49 52.09 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.771 1.396 . . . . 0.0 114.771 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 31.8 mm -72.32 -30.51 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 123.596 0.759 . . . . 0.0 111.829 -172.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 88.6 p -63.82 -9.37 14.44 Favored 'General case' 0 CA--C 1.549 0.909 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 175.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -107.92 22.95 15.22 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.028 1.331 . . . . 0.0 113.577 -171.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.5 pp -115.56 163.72 15.37 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.759 1.223 . . . . 0.0 111.544 169.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -65.57 135.8 55.56 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 81.12 16.57 74.17 Favored Glycine 0 CA--C 1.532 1.117 0 CA-C-O 117.891 -1.505 . . . . 0.0 115.89 171.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 12.0 p -94.75 -23.56 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 C-N-CA 125.507 1.523 . . . . 0.0 114.292 -179.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 42.5 tt0 42.65 -76.31 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 129.841 3.256 . . . . 0.0 117.37 170.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -128.28 127.91 43.65 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 120.55 1.523 . . . . 0.0 111.375 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 7.6 tt -134.6 137.66 50.86 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 O-C-N 121.188 -0.945 . . . . 0.0 111.164 -169.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 21.9 t -143.26 133.37 24.36 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 126.869 2.067 . . . . 0.0 108.248 -179.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.8 p -143.58 143.62 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.192 0 CA-C-N 119.785 1.175 . . . . 0.0 111.711 -179.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.2 t -141.38 133.45 27.72 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.164 1.912 . . . . 0.0 116.164 -174.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -59.05 -22.08 60.16 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 127.041 2.137 . . . . 0.0 113.23 169.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -56.06 -31.17 62.93 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.792 1.237 . . . . 0.0 112.724 178.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 42.3 mm-40 -133.3 -16.7 2.4 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.185 1.394 . . . . 0.0 113.555 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 75.1 26.74 65.72 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.803 1.192 . . . . 0.0 112.112 -169.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 76.4 p -121.42 148.85 43.85 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.64 1.176 . . . . 0.0 111.693 -171.016 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -112.64 137.48 50.85 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.786 1.234 . . . . 0.0 110.771 171.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.0 t -112.66 121.13 43.85 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 167.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.59 141.28 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 O-C-N 121.906 -0.496 . . . . 0.0 110.614 -169.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -91.31 101.93 14.64 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 126.637 1.975 . . . . 0.0 105.887 -179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 12.2 p90 -97.65 157.8 15.84 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 122.293 1.044 . . . . 0.0 111.718 178.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -101.42 94.49 4.16 Favored Pre-proline 0 CA--C 1.543 0.681 0 C-N-CA 124.713 1.205 . . . . 0.0 110.267 176.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -59.55 -35.71 94.87 Favored 'Trans proline' 0 CA--C 1.534 0.504 0 C-N-CA 123.118 2.545 . . . . 0.0 111.372 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -65.57 -8.18 18.63 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 173.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 61.5 t -124.36 -28.98 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 126.181 1.792 . . . . 0.0 112.535 -175.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 17.8 tt -155.91 158.02 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.925 0 CA-C-N 119.943 1.247 . . . . 0.0 112.351 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 13.5 t -98.1 145.27 29.51 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 124.854 1.262 . . . . 0.0 113.104 173.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -53.42 -33.23 66.06 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.102 2.535 . . . . 0.0 112.546 167.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -67.42 -27.07 66.76 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 118.982 0.81 . . . . 0.0 112.432 177.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -76.38 -37.07 57.73 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.323 1.049 . . . . 0.0 111.953 168.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 2.5 tt -57.43 -53.59 56.44 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.286 1.834 . . . . 0.0 110.641 179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.6 ptt85 -59.83 -37.82 80.32 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 118.74 0.7 . . . . 0.0 112.809 173.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.63 -23.91 67.32 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 178.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.26 -35.63 71.47 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 120.111 1.323 . . . . 0.0 112.731 177.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.4 mp -70.65 -38.18 72.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.574 1.149 . . . . 0.0 110.191 171.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -69.39 -26.76 64.8 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 124.41 1.084 . . . . 0.0 112.734 177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -71.66 -44.51 64.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.182 1.393 . . . . 0.0 111.393 168.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 22.6 ttt -61.72 -27.67 68.88 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.654 1.582 . . . . 0.0 112.396 -177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 115.23 38.79 0.99 Allowed Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.478 1.514 . . . . 0.0 114.024 170.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 37.7 m-85 -130.7 -160.54 1.05 Allowed 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.236 1.414 . . . . 0.0 108.266 173.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -131.51 146.86 52.44 Favored 'General case' 0 N--CA 1.467 0.411 0 O-C-N 120.904 -1.123 . . . . 0.0 110.335 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -142.93 141.53 31.49 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 32.8 t -124.36 135.5 53.36 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.5 1.12 . . . . 0.0 112.021 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 2.9 m -87.07 80.63 1.84 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.908 0.883 . . . . 0.0 110.768 -178.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 10.9 m . . . . . 0 N--CA 1.476 0.839 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.603 -178.082 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.0 m . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.3 p -98.85 153.46 18.77 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 128.479 2.711 . . . . 0.0 112.927 -174.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.5 tt -143.96 139.31 29.02 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 125.221 1.409 . . . . 0.0 112.991 -177.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 68.5 mm-40 -98.46 110.33 22.94 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 122.689 1.233 . . . . 0.0 111.928 176.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -138.17 133.73 33.66 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 113.472 -1.695 . . . . 0.0 112.667 -179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 1.1 tmm_? -98.6 119.38 37.22 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 174.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 9.7 mt -96.83 137.34 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 124.031 0.932 . . . . 0.0 109.146 175.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -96.64 117.8 31.75 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 123.904 0.882 . . . . 0.0 110.913 179.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 118.62 -12.36 12.13 Favored Glycine 0 CA--C 1.526 0.74 0 C-N-CA 125.306 1.432 . . . . 0.0 113.689 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 12.9 ptp -56.52 -22.17 31.1 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 119.939 1.87 . . . . 0.0 114.075 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 58.9 t-80 -58.64 -25.97 63.28 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 113.278 0.844 . . . . 0.0 113.278 169.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -80.42 -8.49 59.56 Favored 'General case' 0 CA--C 1.545 0.756 0 O-C-N 120.606 -1.309 . . . . 0.0 113.52 173.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 36.7 tptt 70.08 -56.0 0.59 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 129.025 2.93 . . . . 0.0 111.781 -170.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.4 m -48.86 -27.35 2.98 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 127.718 2.407 . . . . 0.0 114.567 -176.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 7.3 t -53.59 -49.06 68.57 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 125.951 1.7 . . . . 0.0 113.265 171.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.3 p -74.9 -28.24 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 -170.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -50.69 -51.86 45.5 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 125.215 1.406 . . . . 0.0 111.343 -179.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.19 -54.12 49.65 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 -178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -60.69 -37.0 74.55 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 123.591 0.756 . . . . 0.0 111.34 -173.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -64.08 -28.65 69.93 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.402 -0.811 . . . . 0.0 112.399 177.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -71.24 -50.3 34.27 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.24 1.016 . . . . 0.0 112.085 178.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -92.57 -24.29 18.77 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.549 1.54 . . . . 0.0 115.076 -171.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.424 ' CD1' HG22 ' A' ' 78' ' ' ILE . 33.4 mm -98.86 125.84 52.2 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 CA-C-N 120.345 1.429 . . . . 0.0 109.746 177.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.41 -14.24 7.32 Favored Glycine 0 CA--C 1.536 1.386 0 C-N-CA 126.039 1.78 . . . . 0.0 114.636 -174.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -96.65 -1.88 45.82 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.749 1.274 . . . . 0.0 113.092 177.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.6 mp -71.03 178.59 3.15 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 126.567 1.947 . . . . 0.0 110.71 -178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -67.84 -58.6 4.31 Favored 'General case' 0 CA--C 1.538 0.493 0 O-C-N 120.854 -1.154 . . . . 0.0 111.569 -177.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -95.74 -31.28 7.49 Favored Glycine 0 CA--C 1.528 0.886 0 CA-C-O 117.729 -1.595 . . . . 0.0 113.519 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.5 t -76.74 113.08 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-N 120.938 2.369 . . . . 0.0 109.46 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 18.2 tt0 -98.4 -39.8 8.61 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.066 0.946 . . . . 0.0 111.894 -175.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 34.0 t -147.36 159.72 43.37 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 121.489 -0.757 . . . . 0.0 112.165 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 6.0 tp -133.59 121.14 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.414 1.485 . . . . 0.0 109.214 175.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 94.3 mm-40 -110.14 177.43 4.71 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.248 1.419 . . . . 0.0 108.695 174.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 16.1 m -141.8 166.96 16.54 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 169.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.7 t -141.48 59.81 1.5 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 126.324 1.85 . . . . 0.0 110.378 -173.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -59.31 -22.77 61.74 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 127.685 2.394 . . . . 0.0 115.664 -173.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -61.52 -35.76 78.62 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 119.691 1.132 . . . . 0.0 111.058 171.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 t30 -104.25 -2.27 25.9 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.252 1.421 . . . . 0.0 114.049 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 50.1 mttp 81.98 4.5 1.23 Allowed 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 127.122 2.169 . . . . 0.0 112.37 173.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -97.26 155.16 16.99 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.902 2.081 . . . . 0.0 109.976 -179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -97.48 -179.71 4.57 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 165.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -145.52 105.11 3.97 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.444 -0.785 . . . . 0.0 111.686 176.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.1 p -101.7 132.14 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 CA-C-O 121.432 0.634 . . . . 0.0 111.544 -172.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.0 94.96 6.55 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.085 1.754 . . . . 0.0 109.832 179.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 14.4 p90 -120.16 148.98 42.95 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.007 0.923 . . . . 0.0 111.957 -177.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -96.06 115.62 65.68 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.157 1.383 . . . . 0.0 108.832 177.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_endo -69.97 -8.94 24.86 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.036 2.49 . . . . 0.0 113.186 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.6 t -77.86 -11.15 59.86 Favored 'General case' 0 CA--C 1.546 0.826 0 CA-C-N 118.855 0.752 . . . . 0.0 112.23 178.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 66.0 m -130.27 -18.33 3.28 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.3 t -145.14 -177.68 5.67 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 119.899 1.227 . . . . 0.0 111.177 176.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.4 p -151.82 161.34 29.8 Favored Pre-proline 0 C--O 1.24 0.588 0 C-N-CA 125.195 1.398 . . . . 0.0 109.352 176.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_exo -50.09 -46.0 30.44 Favored 'Trans proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.332 2.688 . . . . 0.0 114.228 -175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 4.0 p -67.84 -40.96 84.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 120.429 1.468 . . . . 0.0 111.763 -179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.26 -41.23 90.2 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.917 0.887 . . . . 0.0 112.273 -176.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 3.4 pp -71.37 -47.0 58.98 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 122.976 0.51 . . . . 0.0 111.86 173.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.5 tm0? -68.41 -41.52 80.3 Favored 'General case' 0 C--N 1.328 -0.345 0 O-C-N 121.37 -0.831 . . . . 0.0 112.549 -169.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? -56.79 -30.71 63.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.466 0.706 . . . . 0.0 112.291 171.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.96 -55.59 7.19 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-N 119.107 0.867 . . . . 0.0 111.674 173.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.424 HG22 ' CD1' ' A' ' 42' ' ' ILE . 1.9 pt -64.93 -30.04 49.19 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 -168.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -59.85 -34.48 73.17 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -96.88 13.0 30.23 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -174.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 58.1 mt -55.92 -56.03 34.89 Favored Pre-proline 0 CA--C 1.548 0.895 0 CA-C-O 117.864 -1.065 . . . . 0.0 110.937 168.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.505 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 86.5 Cg_endo -73.02 -179.98 4.83 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.872 3.048 . . . . 0.0 111.768 171.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -72.02 41.4 0.47 Allowed 'Trans proline' 0 CA--C 1.549 1.226 0 C-N-CA 124.766 3.644 . . . . 0.0 111.989 168.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.47 27.13 64.06 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.849 1.214 . . . . 0.0 113.196 -174.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 17.3 t-20 -95.81 -40.62 9.25 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 118.272 1.036 . . . . 0.0 113.538 -168.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.505 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 24.7 m-85 -98.17 113.94 26.01 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 125.027 1.331 . . . . 0.0 108.182 173.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.6 mmmt -97.38 164.02 12.64 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 123.19 0.596 . . . . 0.0 109.963 -174.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 44.9 t -130.99 141.56 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.123 0.969 . . . . 0.0 110.067 171.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.1 t -128.18 128.57 45.02 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.475 1.11 . . . . 0.0 112.59 173.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.8 mp . . . . . 0 CA--C 1.548 0.892 0 C-N-CA 127.69 2.396 . . . . 0.0 111.057 174.838 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.482 1.151 0 N-CA-C 114.578 1.325 . . . . 0.0 114.578 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 20.5 p -162.51 118.03 1.88 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.03 2.132 . . . . 0.0 110.92 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 11.0 p -141.91 142.56 33.05 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 126.577 1.951 . . . . 0.0 109.228 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 1.7 m -102.73 139.99 37.6 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 118.664 0.665 . . . . 0.0 109.454 -177.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -138.43 161.85 35.96 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 123.397 0.679 . . . . 0.0 111.141 169.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.1 tt -114.03 132.38 56.02 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.316 1.847 . . . . 0.0 109.287 -175.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 4.5 mt -127.79 134.6 65.03 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 124.519 1.128 . . . . 0.0 110.083 -177.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -97.75 127.71 43.9 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 125.109 1.363 . . . . 0.0 108.766 170.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 67.3 mt -129.43 145.88 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 O-C-N 121.248 -0.907 . . . . 0.0 112.101 -167.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -113.99 57.73 0.69 Allowed 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.283 1.833 . . . . 0.0 112.277 177.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.73 53.27 0.44 Allowed Glycine 0 CA--C 1.524 0.642 0 O-C-N 121.553 -0.717 . . . . 0.0 113.842 168.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 3.9 mpp? -138.2 98.97 3.74 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.417 1.487 . . . . 0.0 108.274 174.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.7 t -93.42 -31.37 14.64 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.228 1.411 . . . . 0.0 112.327 175.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 5.2 m -144.04 169.36 17.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 127.872 2.469 . . . . 0.0 110.594 176.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -56.12 -38.94 71.46 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.231 -0.918 . . . . 0.0 112.512 172.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.0 p -50.44 -36.16 32.0 Favored 'General case' 0 N--CA 1.475 0.787 0 O-C-N 120.874 -1.141 . . . . 0.0 113.048 169.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 2.7 t -72.53 -34.96 67.93 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 125.257 1.423 . . . . 0.0 112.521 176.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.1 t -62.29 -52.58 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.915 0.886 . . . . 0.0 109.249 169.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 66.0 m-70 -61.47 -23.27 65.76 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -177.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 31.1 t -70.69 -51.12 29.7 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 121.612 -0.68 . . . . 0.0 112.114 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 52.5 mt -63.4 -54.08 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 CA-C-N 120.822 1.646 . . . . 0.0 111.055 177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -59.26 -25.41 64.05 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.589 1.955 . . . . 0.0 110.918 -179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.8 -62.46 2.37 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 125.829 1.68 . . . . 0.0 114.056 168.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 89.8 mmm -70.56 -40.7 73.19 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.239 1.416 . . . . 0.0 113.817 -169.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.9 mm -70.67 -31.51 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 O-C-N 121.387 -0.821 . . . . 0.0 110.315 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.6 t -66.83 1.83 1.68 Allowed 'General case' 0 CA--C 1.553 1.068 0 N-CA-C 115.068 1.507 . . . . 0.0 115.068 175.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 86.3 mt-30 -87.13 -18.14 31.15 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.432 1.493 . . . . 0.0 114.09 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 pp -102.6 165.85 10.85 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 119.972 1.26 . . . . 0.0 113.4 -170.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -64.31 163.33 13.17 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 123.319 1.533 . . . . 0.0 113.779 -175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.87 -36.35 0.39 Allowed Glycine 0 CA--C 1.533 1.161 0 CA-C-O 117.847 -1.529 . . . . 0.0 115.283 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.0 p -70.42 93.29 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 119.493 1.647 . . . . 0.0 110.458 173.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -73.83 -45.55 50.59 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.98 1.712 . . . . 0.0 111.221 -176.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 23.3 tp60 -143.41 140.9 30.65 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.301 1.44 . . . . 0.0 108.299 179.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 4.9 tt -133.9 130.99 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 123.465 0.706 . . . . 0.0 110.822 170.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 43.2 m -131.88 104.2 6.74 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 124.825 1.25 . . . . 0.0 110.44 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.3 p -115.69 138.55 45.75 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 C-N-CA 124.689 1.196 . . . . 0.0 111.737 -176.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.0 m -133.85 142.74 47.94 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 122.747 1.261 . . . . 0.0 112.423 -172.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.1 mt -76.76 -15.67 59.69 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 126.613 1.965 . . . . 0.0 115.348 177.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -53.98 -46.03 71.56 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.312 1.445 . . . . 0.0 111.943 -174.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -119.7 -14.94 8.99 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 126.041 1.736 . . . . 0.0 110.897 172.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 86.17 39.67 7.82 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.881 1.229 . . . . 0.0 111.722 -172.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 32.9 p -129.2 148.43 51.14 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 124.124 0.97 . . . . 0.0 113.015 -169.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -122.13 129.93 52.77 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 126.384 1.874 . . . . 0.0 111.777 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 10.2 t -103.72 122.76 45.74 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 167.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.99 137.5 30.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 O-C-N 122.018 -0.426 . . . . 0.0 110.748 -169.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -97.27 114.12 25.83 Favored 'General case' 0 C--O 1.232 0.173 0 C-N-CA 125.998 1.719 . . . . 0.0 107.935 -179.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -114.4 155.98 25.32 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.882 0.873 . . . . 0.0 112.523 176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -96.48 110.42 52.73 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 123.883 0.873 . . . . 0.0 109.758 174.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -75.26 -14.23 20.65 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.941 2.427 . . . . 0.0 112.554 -171.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -74.47 -17.27 60.8 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 119.456 1.026 . . . . 0.0 112.951 170.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 99.1 t -117.49 -34.11 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 C-N-CA 125.538 1.535 . . . . 0.0 113.078 -170.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 15.7 tt -145.71 154.04 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 CA-C-N 119.446 1.021 . . . . 0.0 112.59 -174.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 4.8 t -101.65 151.79 37.95 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 125.829 1.652 . . . . 0.0 111.7 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.37 -32.47 42.23 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 123.232 2.621 . . . . 0.0 114.112 168.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -73.82 -24.21 59.76 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 118.778 0.717 . . . . 0.0 111.645 179.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -75.72 -38.02 58.92 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.941 1.296 . . . . 0.0 111.441 172.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 54.7 mt -56.36 -55.5 32.73 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 169.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -52.35 -51.53 58.33 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.625 1.57 . . . . 0.0 111.29 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.15 -25.14 68.21 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -70.94 -31.52 68.14 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 120.713 1.597 . . . . 0.0 111.769 178.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.1 mp -72.36 -38.2 60.34 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 C-N-CA 124.443 1.097 . . . . 0.0 111.045 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -64.29 -40.12 95.3 Favored 'General case' 0 CA--C 1.55 0.954 0 CA-C-N 118.696 0.68 . . . . 0.0 111.271 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -70.4 -23.53 62.78 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 127.163 2.185 . . . . 0.0 113.022 175.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 26.4 ttt -76.42 -40.83 49.63 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.733 1.213 . . . . 0.0 110.875 171.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 125.39 34.47 0.66 Allowed Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.994 1.283 . . . . 0.0 115.661 172.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -129.02 -153.51 0.57 Allowed 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.628 1.571 . . . . 0.0 108.68 178.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.52 148.29 49.11 Favored 'General case' 0 N--CA 1.463 0.209 0 O-C-N 121.356 -0.84 . . . . 0.0 112.118 169.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -136.07 151.52 49.91 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.038 1.335 . . . . 0.0 112.368 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 27.2 t -140.24 122.92 16.32 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.005 1.322 . . . . 0.0 111.357 -179.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 5.4 m -84.39 78.53 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 122.651 1.215 . . . . 0.0 110.54 -177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 9.2 p . . . . . 0 CA--C 1.547 0.843 0 CA-C-N 114.223 -1.353 . . . . 0.0 111.751 172.991 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 3.2 m -98.0 142.13 30.1 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.683 1.593 . . . . 0.0 110.601 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 2.6 tt -143.63 148.06 35.27 Favored 'General case' 0 C--O 1.24 0.563 0 C-N-CA 126.156 1.782 . . . . 0.0 111.886 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 94.5 mm-40 -96.51 130.74 43.62 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 122.452 1.12 . . . . 0.0 111.829 175.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -143.08 140.72 31.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 113.46 -1.7 . . . . 0.0 111.332 169.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 28.9 tpt180 -99.43 121.42 41.11 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 170.524 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 7.2 mm -85.29 136.09 23.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 170.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -98.85 144.82 27.63 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.543 1.137 . . . . 0.0 109.094 171.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 78.1 -2.64 64.65 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.121 -0.822 . . . . 0.0 113.887 177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 6.4 tmm? -73.32 -63.83 1.11 Allowed 'General case' 0 N--CA 1.464 0.257 0 C-N-CA 124.612 1.165 . . . . 0.0 109.825 174.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 29.7 m80 58.47 -12.75 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 127.781 2.433 . . . . 0.0 115.528 -176.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 32.0 p -164.39 155.62 15.54 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 124.837 1.255 . . . . 0.0 112.251 -169.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -51.17 -32.38 23.23 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 175.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.4 m -60.16 -35.57 75.61 Favored 'General case' 0 CA--C 1.533 0.314 0 O-C-N 120.863 -1.148 . . . . 0.0 112.439 -174.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 93.8 m -74.75 -18.05 60.55 Favored 'General case' 0 CA--C 1.535 0.368 0 N-CA-C 114.172 1.175 . . . . 0.0 114.172 176.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -74.82 -8.61 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.675 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 173.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 14.0 tp -56.89 -62.77 1.51 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 119.797 1.18 . . . . 0.0 112.387 -178.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -53.84 -34.4 59.17 Favored 'General case' 0 CA--C 1.54 0.558 0 O-C-N 121.612 -0.68 . . . . 0.0 111.294 176.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.414 ' HA ' HD21 ' A' ' 81' ' ' LEU . 1.8 mt -63.39 -50.14 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 O-C-N 121.122 -0.986 . . . . 0.0 111.093 174.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -62.3 -32.48 73.23 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 119.289 0.95 . . . . 0.0 112.465 174.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -65.0 -54.59 28.04 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 119.541 1.064 . . . . 0.0 111.88 173.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -83.47 -33.75 25.55 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 125.185 1.394 . . . . 0.0 114.113 -170.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 33.1 mm -104.01 121.69 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 122.087 0.946 . . . . 0.0 110.47 -167.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 125.42 -28.55 5.0 Favored Glycine 0 N--CA 1.472 1.057 0 C-N-CA 125.807 1.67 . . . . 0.0 113.326 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 19.5 pt20 -79.12 -0.55 32.08 Favored 'General case' 0 N--CA 1.474 0.738 0 O-C-N 121.619 -0.93 . . . . 0.0 112.692 174.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.39 -173.58 4.13 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 128.16 2.584 . . . . 0.0 112.756 -176.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.02 -78.52 0.06 Allowed 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.752 1.621 . . . . 0.0 111.932 -174.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -93.61 -25.31 18.56 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 117.446 -1.752 . . . . 0.0 113.486 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.8 t -77.92 110.55 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 121.194 2.497 . . . . 0.0 107.819 169.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -104.41 -31.53 9.47 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.483 1.113 . . . . 0.0 112.137 -169.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.0 t -148.69 174.08 12.54 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 113.967 1.099 . . . . 0.0 113.967 169.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 9.0 tp -144.79 136.78 21.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.83 1.652 . . . . 0.0 110.55 179.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -141.64 -178.08 5.48 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 124.675 1.19 . . . . 0.0 111.247 176.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 8.5 m -140.53 148.08 22.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 120.988 1.722 . . . . 0.0 114.581 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.9 m -130.36 57.88 1.7 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.657 1.583 . . . . 0.0 109.656 -175.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 75.4 mt -64.93 -24.03 67.4 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 126.124 1.77 . . . . 0.0 115.333 -168.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -57.77 -29.8 65.12 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 123.753 0.821 . . . . 0.0 111.963 170.31 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 -120.7 13.05 11.54 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 125.817 1.647 . . . . 0.0 112.668 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 98.9 mttt 72.64 4.87 5.11 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 126.303 1.841 . . . . 0.0 115.298 168.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.9 p -96.47 152.74 18.33 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.604 1.192 . . . . 0.0 110.646 177.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -102.75 157.13 17.16 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.352 -1.721 . . . . 0.0 106.352 164.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.31 112.21 14.79 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 121.515 -0.741 . . . . 0.0 110.438 -168.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 10.7 p -96.74 136.15 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 -173.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -117.83 82.9 1.9 Allowed 'General case' 0 C--O 1.237 0.418 0 C-N-CA 125.535 1.534 . . . . 0.0 106.871 -170.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -117.89 153.97 32.66 Favored 'General case' 0 N--CA 1.466 0.375 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.349 -170.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 57.5 t0 -97.1 109.42 49.26 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 127.332 2.253 . . . . 0.0 108.705 177.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -68.49 -3.15 10.47 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.339 2.693 . . . . 0.0 113.458 -178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.7 t -80.16 -18.77 48.82 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 119.39 0.995 . . . . 0.0 111.974 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 14.6 m -122.86 -16.03 7.23 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.489 1.663 . . . . 0.0 115.489 -175.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.2 t -146.3 -175.63 4.85 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.638 1.175 . . . . 0.0 111.409 172.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.7 m -153.87 156.34 32.0 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 126.567 1.947 . . . . 0.0 109.611 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -52.96 -56.9 2.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 123.26 2.64 . . . . 0.0 115.775 -169.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 7.1 p -61.16 -36.84 75.35 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 120.961 1.71 . . . . 0.0 112.711 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.84 -41.42 71.5 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.651 1.18 . . . . 0.0 112.256 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.94 -38.28 76.13 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 123.925 0.89 . . . . 0.0 111.279 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 3.1 tm0? -69.78 -41.19 75.44 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.53 1.132 . . . . 0.0 111.848 -177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -50.18 -35.91 28.22 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.744 1.218 . . . . 0.0 113.13 175.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -71.17 -61.92 1.59 Allowed 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.162 0.892 . . . . 0.0 112.198 177.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.411 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 30.4 pt -60.68 -21.22 23.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 C-N-CA 125.937 1.695 . . . . 0.0 114.659 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -67.36 -25.39 65.95 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.345 1.458 . . . . 0.0 113.227 170.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -126.66 25.62 6.4 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.6 1.56 . . . . 0.0 113.397 174.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.414 HD21 ' HA ' ' A' ' 38' ' ' ILE . 11.3 tp -53.56 -55.62 33.18 Favored Pre-proline 0 CA--C 1.548 0.887 0 C-N-CA 127.248 2.219 . . . . 0.0 112.473 168.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.48 ' HG3' ' H ' ' A' ' 86' ' ' PHE . 32.3 Cg_endo -84.45 -179.5 3.89 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 124.189 3.259 . . . . 0.0 111.163 172.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.76 56.72 2.4 Favored 'Trans proline' 0 CA--C 1.549 1.265 0 C-N-CA 124.681 3.587 . . . . 0.0 111.855 168.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 67.14 15.92 65.97 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.197 1.38 . . . . 0.0 114.183 -177.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -83.92 -34.01 24.59 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 117.953 0.876 . . . . 0.0 112.387 -168.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.48 ' H ' ' HG3' ' A' ' 82' ' ' PRO . 8.9 m-85 -121.56 129.77 53.09 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.04 2.136 . . . . 0.0 107.688 174.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 29.5 mmmt -120.09 173.16 7.26 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 125.299 1.44 . . . . 0.0 110.309 -177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 55.9 t -132.06 131.48 61.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-N 119.964 1.256 . . . . 0.0 113.479 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 15.1 m -118.37 118.43 31.76 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 124.491 1.116 . . . . 0.0 110.617 176.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 29.2 mt . . . . . 0 CA--C 1.542 0.637 0 C-N-CA 124.958 1.303 . . . . 0.0 111.38 172.578 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 7.6 t . . . . . 0 N--CA 1.481 1.119 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 26.3 p -156.2 117.35 3.83 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.312 1.045 . . . . 0.0 113.358 -167.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 4.7 p -145.29 145.04 31.09 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.623 1.169 . . . . 0.0 111.381 176.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 88.3 m -96.98 140.91 30.8 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -144.41 149.98 36.95 Favored 'General case' 0 N--CA 1.463 0.21 0 C-N-CA 124.418 1.087 . . . . 0.0 110.692 173.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 2.4 tt -117.58 142.41 47.23 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.002 2.121 . . . . 0.0 110.331 -179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.4 mt -134.1 135.28 54.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.986 0 C-N-CA 126.105 1.762 . . . . 0.0 110.754 -169.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.88 128.57 45.96 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 125.769 1.628 . . . . 0.0 110.467 171.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 mp -121.51 118.44 55.88 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.26 0 O-C-N 120.958 -1.089 . . . . 0.0 111.241 -176.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -92.05 55.94 2.74 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.525 1.13 . . . . 0.0 110.917 174.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.54 53.29 0.32 Allowed Glycine 0 N--CA 1.462 0.415 0 C-N-CA 124.612 1.101 . . . . 0.0 111.139 174.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 50.8 mtm -145.36 145.6 31.25 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.676 0.79 . . . . 0.0 111.097 -177.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.8 t -163.34 -43.94 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.425 0.69 . . . . 0.0 112.425 -168.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 83.5 m -114.26 152.03 31.95 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.393 1.477 . . . . 0.0 110.516 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -62.54 -25.53 68.09 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 120.872 -1.143 . . . . 0.0 113.14 176.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.7 p -59.18 -22.26 60.7 Favored 'General case' 0 CA--C 1.546 0.791 0 O-C-N 120.236 -1.54 . . . . 0.0 113.274 169.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 74.4 m -61.18 -30.22 70.28 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.754 -1.216 . . . . 0.0 112.052 168.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.73 -53.29 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.646 0.778 . . . . 0.0 109.914 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -65.27 -25.18 67.54 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 118.469 0.577 . . . . 0.0 111.847 -173.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 73.5 m -70.58 -59.95 2.54 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.623 0.769 . . . . 0.0 111.943 170.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 98.1 mt -69.09 -42.28 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 125.056 1.342 . . . . 0.0 112.854 -173.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -56.4 -34.28 66.57 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.358 0.663 . . . . 0.0 109.831 170.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -70.58 -34.31 67.45 Favored Glycine 0 CA--C 1.533 1.193 0 CA-C-O 118.037 -1.424 . . . . 0.0 114.088 172.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.33 -47.42 72.52 Favored 'General case' 0 N--CA 1.484 1.258 0 CA-C-N 121.244 2.522 . . . . 0.0 110.389 172.24 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 2.3 mm -75.52 -50.63 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 C-N-CA 123.489 0.716 . . . . 0.0 112.192 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 t -71.32 -5.97 36.41 Favored 'General case' 0 CA--C 1.548 0.894 0 O-C-N 120.4 -1.438 . . . . 0.0 114.65 -169.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -85.7 -21.7 28.19 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 176.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.24 -155.95 0.53 Allowed 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -167.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -117.63 149.99 39.77 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 125.738 1.615 . . . . 0.0 111.816 176.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 85.56 18.91 59.34 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 117.638 -1.645 . . . . 0.0 114.584 -170.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 5.0 p -112.03 97.22 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.151 0 C-N-CA 126.844 2.058 . . . . 0.0 111.305 -174.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -88.73 -47.56 8.15 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 121.195 -0.941 . . . . 0.0 112.53 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 56.5 tt0 -142.48 145.58 33.86 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.607 1.163 . . . . 0.0 108.385 169.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.29 143.4 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 CA-C-N 118.53 0.604 . . . . 0.0 111.036 167.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 15.5 t -140.37 149.75 43.07 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 127.049 2.14 . . . . 0.0 109.834 -178.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 7.4 p -137.42 140.93 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 124.291 1.036 . . . . 0.0 111.329 169.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 67.2 m -121.87 77.69 1.39 Allowed 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 127.116 2.167 . . . . 0.0 108.1 178.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 1.8 tt -53.59 -29.03 35.61 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.723 2.009 . . . . 0.0 112.383 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -41.48 -51.12 3.9 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 127.858 2.463 . . . . 0.0 112.882 167.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -90.43 -29.42 17.99 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.553 1.941 . . . . 0.0 111.125 175.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 93.09 27.93 12.77 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 126.143 1.83 . . . . 0.0 112.741 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.3 p -132.99 139.02 47.03 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 118.232 1.016 . . . . 0.0 112.457 -168.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -105.92 147.24 29.0 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.092 1.357 . . . . 0.0 111.113 173.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 12.2 t -131.29 133.89 45.83 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.509 1.124 . . . . 0.0 109.484 172.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -140.92 142.93 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 C-N-CA 124.505 1.122 . . . . 0.0 110.927 -168.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -96.22 103.22 15.1 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 126.115 1.766 . . . . 0.0 106.773 169.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -108.9 156.66 19.43 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.002 0.921 . . . . 0.0 112.845 -178.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -99.08 110.17 56.87 Favored Pre-proline 0 CA--C 1.55 0.977 0 C-N-CA 123.874 0.869 . . . . 0.0 111.148 174.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -75.08 -11.54 21.34 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.247 2.631 . . . . 0.0 113.761 -171.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -81.89 -11.21 59.03 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.222 1.009 . . . . 0.0 113.356 171.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 71.3 t -120.09 -42.89 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 125.495 1.518 . . . . 0.0 111.895 -174.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 20.1 tt -134.52 143.6 37.4 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.441 0 C-N-CA 123.685 0.794 . . . . 0.0 111.596 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 24.9 t -97.11 151.49 37.73 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 124.404 1.082 . . . . 0.0 112.695 177.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -54.14 -28.96 53.74 Favored 'Trans proline' 0 CA--C 1.539 0.725 0 C-N-CA 122.729 2.286 . . . . 0.0 112.672 167.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -67.57 -30.82 70.54 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.414 -0.804 . . . . 0.0 112.857 173.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -73.08 -31.81 64.6 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.538 1.135 . . . . 0.0 112.044 175.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 63.0 mt -60.59 -53.39 58.09 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.082 0.953 . . . . 0.0 109.447 172.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 55.5 ttt180 -57.28 -49.21 76.79 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 123.857 0.863 . . . . 0.0 111.605 174.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.69 -27.59 66.56 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -68.63 -41.04 80.01 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.655 1.116 . . . . 0.0 112.073 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mp -71.69 -39.03 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.473 0.709 . . . . 0.0 110.835 176.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -65.3 -24.46 67.29 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 174.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -73.99 -21.55 59.95 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 172.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.55 -50.06 9.21 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.185 0.594 . . . . 0.0 109.572 174.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 131.28 50.73 0.1 OUTLIER Glycine 0 N--CA 1.467 0.755 0 C-N-CA 124.658 1.123 . . . . 0.0 113.81 175.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -136.34 -167.18 2.01 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.326 1.85 . . . . 0.0 108.72 172.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 93.1 mt-10 -127.14 129.57 48.14 Favored 'General case' 0 CA--C 1.52 -0.173 0 O-C-N 121.016 -1.053 . . . . 0.0 110.212 173.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -116.26 149.15 39.67 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 125.301 1.44 . . . . 0.0 109.472 172.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 29.3 t -140.66 133.67 29.3 Favored 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 124.34 1.056 . . . . 0.0 109.325 172.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 24.9 m -84.73 121.97 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 CA-C-O 121.38 0.609 . . . . 0.0 109.432 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 32.0 m . . . . . 0 N--CA 1.478 0.954 0 C-N-CA 126.171 1.788 . . . . 0.0 109.51 -172.627 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.448 -0.549 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 23.0 m -120.46 151.36 39.44 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.475 1.11 . . . . 0.0 110.523 -171.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.96 176.42 8.95 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.182 0.993 . . . . 0.0 113.453 172.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . . . . . . . . . 64.9 mm-40 -112.76 136.91 51.82 Favored 'General case' 0 CA--C 1.517 -0.299 0 C-N-CA 124.727 1.211 . . . . 0.0 113.093 178.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -147.17 142.43 27.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 113.958 -1.474 . . . . 0.0 113.636 168.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -104.77 111.98 24.92 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.914 1.286 . . . . 0.0 108.361 169.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.5 mt -85.12 139.43 17.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 123.657 0.783 . . . . 0.0 109.593 176.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.5 t70 -98.99 123.05 43.02 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.047 1.339 . . . . 0.0 111.304 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 113.14 -9.36 24.89 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 124.884 1.23 . . . . 0.0 114.886 177.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 11.2 ptp -57.35 -7.64 0.62 Allowed 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 116.625 2.083 . . . . 0.0 116.625 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -56.87 -24.65 53.13 Favored 'General case' 0 CA--C 1.552 1.039 0 O-C-N 120.828 -1.17 . . . . 0.0 112.839 168.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 85.8 m -97.38 119.18 35.45 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 167.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.7 tmmt? -58.04 -28.04 64.13 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 119.522 1.055 . . . . 0.0 113.454 -175.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 27.6 p -53.13 -28.55 26.34 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 115.705 1.742 . . . . 0.0 115.705 170.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 5.6 t -61.25 -51.52 68.59 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.877 0.762 . . . . 0.0 111.215 178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 p -74.6 -27.64 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 -177.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -56.54 -56.19 24.42 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.088 0.955 . . . . 0.0 111.847 -175.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -65.15 -33.94 77.2 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 121.732 -0.605 . . . . 0.0 112.285 -179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.3 mt -58.96 -47.95 88.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 CA-C-N 118.885 0.766 . . . . 0.0 111.012 169.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 -63.32 -33.8 76.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.578 1.151 . . . . 0.0 112.518 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -68.48 -41.37 80.22 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.34 -0.85 . . . . 0.0 112.295 176.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -91.62 -31.2 15.96 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 115.047 1.499 . . . . 0.0 115.047 -170.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.465 ' CD1' HG22 ' A' ' 78' ' ' ILE . 35.3 mm -96.35 119.14 44.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 CA-C-N 119.78 1.173 . . . . 0.0 109.293 -171.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 132.54 -8.16 5.28 Favored Glycine 0 CA--C 1.541 1.719 0 C-N-CA 125.72 1.628 . . . . 0.0 113.626 -168.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -100.95 -13.88 18.12 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.502 1.921 . . . . 0.0 112.574 179.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 mp -80.42 149.81 30.01 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 126.08 1.752 . . . . 0.0 111.539 -167.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 31.6 tp -17.46 -64.22 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 128.65 2.78 . . . . 0.0 114.411 170.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -116.29 19.1 13.4 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 116.333 -2.371 . . . . 0.0 115.868 178.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.3 t -115.47 118.19 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 CA-C-N 121.683 2.742 . . . . 0.0 110.444 169.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -90.82 -40.54 11.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.777 0.831 . . . . 0.0 112.503 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.4 m -147.91 166.21 28.34 Favored 'General case' 0 N--CA 1.471 0.605 0 O-C-N 120.796 -1.19 . . . . 0.0 113.855 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 10.2 tp -126.82 145.67 34.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 124.996 1.318 . . . . 0.0 111.5 178.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -142.16 159.31 42.49 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 127.103 2.161 . . . . 0.0 109.774 -170.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 33.0 m -140.71 144.29 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 O-C-N 120.338 -1.476 . . . . 0.0 112.206 -173.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 49.0 m -138.77 58.32 1.66 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 125.184 1.394 . . . . 0.0 111.136 -169.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -60.13 -30.14 69.09 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 126.817 2.047 . . . . 0.0 115.212 -169.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -61.71 -20.36 63.4 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 119.654 1.116 . . . . 0.0 113.147 175.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -114.63 1.22 14.17 Favored 'General case' 0 CA--C 1.551 1.005 0 C-N-CA 126.469 1.908 . . . . 0.0 112.303 174.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt 57.34 22.2 7.56 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.901 1.68 . . . . 0.0 112.876 -176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.77 153.13 18.06 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 122.343 1.068 . . . . 0.0 108.565 171.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -116.1 155.82 27.51 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 107.535 -1.283 . . . . 0.0 107.535 168.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -127.72 128.24 45.05 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -169.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 9.4 p -117.74 134.99 59.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 O-C-N 121.843 -0.535 . . . . 0.0 110.352 178.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -106.12 79.07 1.36 Allowed 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 106.196 -1.779 . . . . 0.0 106.196 -173.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -100.39 175.39 5.71 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 126.305 1.842 . . . . 0.0 109.53 -172.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.45 142.64 40.9 Favored Pre-proline 0 N--CA 1.477 0.89 0 CA-C-N 121.528 1.967 . . . . 0.0 111.501 168.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -82.89 5.67 6.28 Favored 'Trans proline' 0 N--CA 1.457 -0.66 0 C-N-CA 122.972 2.448 . . . . 0.0 112.637 -172.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.2 t -87.39 -48.41 7.99 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.446 1.021 . . . . 0.0 110.168 178.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 85.1 m -101.3 -16.28 16.99 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -169.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 6.7 t -145.76 -178.35 6.06 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 124.381 1.072 . . . . 0.0 111.079 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.9 p -162.47 158.31 19.79 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.786 1.234 . . . . 0.0 111.83 -175.598 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_exo -46.79 -43.51 23.57 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.699 3.6 . . . . 0.0 116.368 -174.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.8 m -70.64 -35.84 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 120.267 1.394 . . . . 0.0 112.388 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.42 85.45 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.153 0.981 . . . . 0.0 110.934 174.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 84.0 mt -65.58 -48.2 73.16 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.257 1.023 . . . . 0.0 111.888 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -56.43 -52.06 66.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.121 0.873 . . . . 0.0 110.364 178.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 48.7 mtp180 -53.2 -42.95 66.79 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.649 1.18 . . . . 0.0 113.214 175.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.31 -59.24 2.99 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.602 1.161 . . . . 0.0 112.697 179.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.465 HG22 ' CD1' ' A' ' 42' ' ' ILE . 6.7 pt -71.94 -33.48 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 112.776 0.658 . . . . 0.0 112.776 -168.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -70.19 -12.01 61.29 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 123.26 0.624 . . . . 0.0 112.55 174.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -106.7 6.74 30.01 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 120.561 -1.337 . . . . 0.0 113.699 176.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 15.0 mt -56.42 -57.71 21.4 Favored Pre-proline 0 N--CA 1.475 0.785 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.283 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -70.34 169.88 18.6 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 121.972 1.781 . . . . 0.0 110.459 168.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -76.21 55.65 4.66 Favored 'Trans proline' 0 CA--C 1.541 0.841 0 C-N-CA 124.269 3.313 . . . . 0.0 110.656 170.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.86 27.02 71.42 Favored Glycine 0 CA--C 1.536 1.374 0 C-N-CA 124.095 0.855 . . . . 0.0 113.898 -177.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -100.46 -14.22 18.38 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 -167.018 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 29.0 m-85 -135.26 114.03 11.87 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 125.051 1.34 . . . . 0.0 108.88 178.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -93.68 157.25 16.26 Favored 'General case' 0 N--CA 1.478 0.944 0 O-C-N 121.178 -0.951 . . . . 0.0 111.054 -175.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 5.3 m -124.28 136.54 60.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.377 0 CA-C-N 118.219 0.463 . . . . 0.0 111.859 170.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 17.7 t -111.38 121.54 45.49 Favored 'General case' 0 C--O 1.241 0.655 0 C-N-CA 124.195 0.998 . . . . 0.0 111.822 174.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 7.6 mp . . . . . 0 CA--C 1.555 1.162 0 C-N-CA 128.241 2.617 . . . . 0.0 111.023 179.174 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.2 t . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 113.69 0.996 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . . . . . . . . . 19.6 p -150.79 128.07 11.3 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.418 1.487 . . . . 0.0 113.609 -168.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.2 m -143.94 143.23 31.16 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.371 1.068 . . . . 0.0 111.649 178.878 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 84.8 m -100.2 144.31 29.37 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.546 0.738 . . . . 0.0 110.221 172.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -139.11 167.52 21.87 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.429 1.092 . . . . 0.0 110.903 166.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.04 133.45 55.9 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.457 1.903 . . . . 0.0 110.142 -176.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 22.7 mm -120.82 137.06 55.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 C-N-CA 126.278 1.831 . . . . 0.0 109.306 -177.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -102.03 125.44 48.72 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.957 1.303 . . . . 0.0 110.391 172.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.9 mp -121.44 131.33 73.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 C-N-CA 124.182 0.993 . . . . 0.0 111.52 -176.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -116.44 53.68 0.87 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.815 1.646 . . . . 0.0 112.581 -179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -161.0 53.76 0.33 Allowed Glycine 0 N--CA 1.464 0.525 0 C-N-CA 124.926 1.251 . . . . 0.0 110.963 173.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 46.5 mtm -133.3 142.94 48.72 Favored 'General case' 0 C--O 1.236 0.342 0 CA-C-N 117.849 0.824 . . . . 0.0 112.01 -175.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.7 t -165.28 124.62 1.76 Allowed 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 126.495 1.918 . . . . 0.0 107.775 -172.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 72.31 160.8 0.23 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.542 1.937 . . . . 0.0 115.409 -177.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -57.42 -32.58 67.02 Favored 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 114.283 -1.326 . . . . 0.0 112.31 170.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.7 p -65.76 -28.37 68.98 Favored 'General case' 0 CA--C 1.533 0.315 0 O-C-N 120.601 -1.312 . . . . 0.0 112.837 176.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 52.2 t -68.4 -46.17 70.69 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.028 1.285 . . . . 0.0 111.154 170.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 9.1 t -52.78 -55.42 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 CA-C-N 118.143 0.429 . . . . 0.0 110.085 173.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 83.3 m-70 -71.17 -17.41 62.54 Favored 'General case' 0 CA--C 1.544 0.746 0 N-CA-C 113.646 0.98 . . . . 0.0 113.646 -176.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 47.7 m -74.58 -47.41 32.66 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.071 0.948 . . . . 0.0 111.492 167.109 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 93.2 mt -66.8 -54.19 27.53 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.239 0 O-C-N 120.795 -1.191 . . . . 0.0 110.69 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -55.06 -30.68 60.12 Favored 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.82 2.048 . . . . 0.0 111.866 173.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.86 -51.17 8.07 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.874 1.702 . . . . 0.0 113.851 173.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 79.5 mmm -74.97 -53.87 8.21 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.5 1.52 . . . . 0.0 114.049 -177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 39.2 mm -71.24 -19.38 20.87 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 C-N-CA 124.458 1.103 . . . . 0.0 112.437 -169.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 65.6 p -70.64 0.6 6.6 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 171.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -121.55 33.71 5.43 Favored 'General case' 0 CA--C 1.549 0.935 0 N-CA-C 115.364 1.616 . . . . 0.0 115.364 -169.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.19 10.79 6.91 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 116.669 2.099 . . . . 0.0 116.669 -172.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 76.2 118.81 0.05 Allowed 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 127.922 2.489 . . . . 0.0 113.968 176.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 97.12 21.74 19.52 Favored Glycine 0 CA--C 1.53 1.02 0 CA-C-O 118.106 -1.385 . . . . 0.0 114.398 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 2.7 p -120.34 94.94 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 127.181 2.192 . . . . 0.0 110.251 -178.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . . . . . . . . . 29.0 tt0 -75.62 -56.53 4.61 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.032 0.933 . . . . 0.0 111.776 -170.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -141.9 129.94 22.0 Favored 'General case' 0 N--CA 1.465 0.297 0 C-N-CA 125.227 1.411 . . . . 0.0 109.007 -172.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 6.2 tt -140.88 129.11 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.907 1.283 . . . . 0.0 110.517 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.2 t -142.23 129.65 21.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.21 1.004 . . . . 0.0 111.527 177.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.8 p -137.03 139.27 44.7 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 C-N-CA 126.113 1.765 . . . . 0.0 110.522 -173.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 74.5 p -143.3 146.3 33.46 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -176.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 20.5 mt -72.77 -24.27 60.92 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 -176.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -54.63 -42.57 71.38 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 126.147 1.779 . . . . 0.0 113.535 -169.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -111.09 -13.36 14.06 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.552 1.141 . . . . 0.0 110.409 168.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 77.57 49.7 7.08 Favored Glycine 0 C--N 1.342 0.899 0 C-N-CA 125.453 1.501 . . . . 0.0 110.653 -177.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.1 p -138.56 147.09 42.65 Favored 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 -168.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -113.7 139.38 49.12 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 125.98 1.712 . . . . 0.0 112.297 173.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 7.5 t -112.25 125.62 54.35 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 106.703 -1.592 . . . . 0.0 106.703 166.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.59 134.74 29.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 O-C-N 122.153 -0.342 . . . . 0.0 110.852 -174.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.93 113.77 25.53 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 127.768 2.427 . . . . 0.0 106.402 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -111.71 163.0 14.61 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.247 1.019 . . . . 0.0 112.95 178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 6.6 m120 -97.11 98.1 4.37 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 126.417 1.887 . . . . 0.0 109.171 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -68.87 -12.13 33.66 Favored 'Trans proline' 0 C--N 1.353 0.763 0 C-N-CA 122.137 1.891 . . . . 0.0 115.148 -169.254 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -78.36 -24.25 46.54 Favored 'General case' 0 CA--C 1.545 0.787 0 CA-C-N 119.329 0.968 . . . . 0.0 112.447 168.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 94.8 t -95.7 -50.83 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.926 1.69 . . . . 0.0 111.046 -175.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 18.0 tt -134.33 149.5 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 122.095 0.95 . . . . 0.0 112.231 -170.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 29.5 t -97.68 143.43 26.2 Favored Pre-proline 0 CA--C 1.543 0.704 0 C-N-CA 125.673 1.589 . . . . 0.0 112.295 175.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -65.75 -16.12 51.93 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 122.62 2.214 . . . . 0.0 113.91 178.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -70.31 -27.36 64.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 119.696 1.134 . . . . 0.0 111.388 174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 46.6 mm-40 -76.29 -20.29 57.47 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 126.764 2.026 . . . . 0.0 112.664 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 97.0 mt -67.37 -56.03 11.38 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 123.937 0.895 . . . . 0.0 111.32 -175.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 8.2 ptm180 -56.6 -38.33 71.87 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 121.788 -0.57 . . . . 0.0 112.406 178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -60.86 -28.41 68.83 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.942 0.897 . . . . 0.0 112.974 179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.37 69.83 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 119.462 1.028 . . . . 0.0 112.907 176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 3.5 mp -72.48 -40.47 63.54 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 C-N-CA 124.078 0.951 . . . . 0.0 110.867 171.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -68.14 -26.34 65.73 Favored 'General case' 0 CA--C 1.547 0.852 0 O-C-N 121.806 -0.559 . . . . 0.0 112.173 174.149 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -71.73 -26.75 62.6 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.503 1.521 . . . . 0.0 112.396 169.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 23.1 ttt -75.19 -38.32 60.84 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.225 1.01 . . . . 0.0 111.75 177.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 137.04 11.4 1.06 Allowed Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.179 1.371 . . . . 0.0 116.338 172.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -111.11 -165.64 1.01 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.459 1.504 . . . . 0.0 110.049 -176.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -125.19 133.47 52.74 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.367 1.067 . . . . 0.0 111.364 174.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -136.43 143.8 44.12 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 124.991 1.316 . . . . 0.0 112.52 -174.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -129.57 139.72 51.41 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 125.139 1.376 . . . . 0.0 109.036 175.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 3.2 p -87.89 111.75 22.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 N-CA-C 107.845 -1.168 . . . . 0.0 107.845 175.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.473 0.721 0 C-N-CA 125.491 1.517 . . . . 0.0 107.787 -173.39 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 15.5 m . . . . . 0 N--CA 1.469 0.512 0 CA-C-O 120.658 0.266 . . . . 0.0 111.423 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 2.1 p -95.71 151.82 19.02 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.424 1.489 . . . . 0.0 111.11 179.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tt -137.47 128.38 27.31 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 127.03 2.132 . . . . 0.0 109.012 -172.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLN . . . . . 0.522 ' HG3' HG21 ' A' ' 59' ' ' THR . 3.5 tp-100 -103.89 115.54 30.64 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 119.088 0.858 . . . . 0.0 112.01 -179.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.454 ' HB3' HD21 ' A' ' 90' ' ' LEU . 1.7 pt? -135.83 142.08 44.78 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 114.656 1.354 . . . . 0.0 114.656 -172.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 20.2 tpt180 -109.14 107.36 17.63 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 114.103 -1.408 . . . . 0.0 110.709 -178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.2 mm -80.0 152.25 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 125.966 1.706 . . . . 0.0 111.415 178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -105.18 140.37 38.44 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.383 1.473 . . . . 0.0 110.283 168.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.65 -8.96 76.49 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.908 1.242 . . . . 0.0 114.142 -176.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 7.0 ptm -66.26 -6.32 13.45 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 119.284 1.542 . . . . 0.0 115.153 -178.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.13 -24.08 66.94 Favored 'General case' 0 CA--C 1.549 0.924 0 O-C-N 121.169 -0.957 . . . . 0.0 110.834 165.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . . . . . . . . . 45.8 t -99.5 114.91 28.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.577 1.551 . . . . 0.0 107.466 167.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.8 tmmt? -59.09 -30.78 68.34 Favored 'General case' 0 N--CA 1.476 0.828 0 O-C-N 120.633 -1.292 . . . . 0.0 112.213 -173.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 70.4 m -51.31 -21.91 2.48 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.641 1.576 . . . . 0.0 114.227 173.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' CYS . . . . . . . . . . . . . 14.7 t -58.59 -49.36 77.76 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.618 1.167 . . . . 0.0 112.804 170.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -73.85 -28.22 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 N-CA-C 113.219 0.822 . . . . 0.0 113.219 -169.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 tt -61.49 -47.96 83.25 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.491 1.116 . . . . 0.0 111.468 -174.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -56.43 -41.59 76.66 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.505 -0.747 . . . . 0.0 111.309 176.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.4 mt -65.6 -47.03 87.82 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 C-N-CA 122.947 0.499 . . . . 0.0 109.912 178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HA ' HG21 ' A' ' 51' ' ' ILE . 14.9 tm-20 -65.9 -29.64 70.1 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.423 1.489 . . . . 0.0 113.32 -175.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -70.56 -52.09 24.02 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.829 -0.544 . . . . 0.0 112.401 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASN . . . . . . . . . . . . . 67.3 m-80 -91.63 -7.95 48.57 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -166.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.466 ' CD1' HG22 ' A' ' 78' ' ' ILE . 46.6 mm -122.48 128.62 75.45 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 125.089 1.356 . . . . 0.0 108.504 172.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.76 -5.33 4.05 Favored Glycine 0 N--CA 1.476 1.327 0 C-N-CA 124.94 1.257 . . . . 0.0 115.397 -176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -114.98 -5.47 12.52 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.394 1.477 . . . . 0.0 112.976 176.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mp -70.34 152.14 44.47 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 124.916 1.287 . . . . 0.0 111.605 -170.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -48.29 -30.7 5.08 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 175.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -111.86 7.72 27.6 Favored Glycine 0 CA--C 1.534 1.227 0 CA-C-O 116.548 -2.251 . . . . 0.0 115.67 175.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.5 t -123.87 116.67 48.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 CA-C-N 121.466 2.633 . . . . 0.0 110.414 169.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -71.89 -51.28 23.05 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 122.631 0.372 . . . . 0.0 110.203 173.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 1.4 p -151.08 155.23 38.53 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.542 1.137 . . . . 0.0 113.149 178.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.489 HG21 ' HA ' ' A' ' 39' ' ' GLU . 10.7 tp -98.26 155.07 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.093 0 C-N-CA 125.083 1.353 . . . . 0.0 109.199 169.018 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 42.2 tt0 -138.26 144.63 40.62 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 119.53 1.059 . . . . 0.0 111.117 176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 94.9 t -108.38 127.15 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.315 1.446 . . . . 0.0 108.842 -176.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.9 m -133.82 54.28 1.96 Allowed 'General case' 0 CA--C 1.547 0.837 0 CA-C-O 121.512 0.672 . . . . 0.0 111.967 -172.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 50.3 mt -68.66 -25.99 65.09 Favored 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.413 -1.429 . . . . 0.0 113.35 -172.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -74.17 -17.65 60.88 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 171.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -95.7 -8.17 35.38 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 125.101 1.361 . . . . 0.0 110.81 168.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 3.9 mptt 74.89 14.2 3.28 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 127.975 2.51 . . . . 0.0 113.004 173.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.522 HG21 ' HG3' ' A' ' 23' ' ' GLN . 17.7 p -124.16 175.23 7.15 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 127.285 2.234 . . . . 0.0 110.331 178.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -110.96 167.58 10.14 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.035 1.334 . . . . 0.0 107.981 165.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -140.62 143.35 35.15 Favored 'General case' 0 C--N 1.33 -0.26 0 C-N-CA 122.717 0.407 . . . . 0.0 110.932 -172.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 13.4 p -140.31 133.48 33.93 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 118.545 0.611 . . . . 0.0 111.511 175.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.39 81.44 2.53 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.993 1.717 . . . . 0.0 108.519 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -101.32 148.82 24.69 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 125.103 1.361 . . . . 0.0 111.825 -174.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -101.26 122.09 49.55 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 123.719 0.808 . . . . 0.0 110.482 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_exo -60.28 0.47 0.7 Allowed 'Trans proline' 0 CA--C 1.544 1.02 0 C-N-CA 124.659 3.573 . . . . 0.0 115.252 173.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.4 m -65.39 -35.0 79.64 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 125.527 1.531 . . . . 0.0 112.79 175.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' CYS . . . . . . . . . . . . . 81.7 m -122.32 -23.06 5.36 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -170.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 9.1 t -143.07 -178.24 5.74 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.213 1.405 . . . . 0.0 111.181 -172.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.9 t -163.17 143.39 7.07 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 126.429 1.892 . . . . 0.0 109.344 -171.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -40.57 -49.31 4.16 Favored 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 125.007 3.804 . . . . 0.0 117.263 -169.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 24.6 m -70.0 -36.65 69.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 CA-C-N 120.327 1.421 . . . . 0.0 113.362 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.34 -36.31 66.14 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.242 1.017 . . . . 0.0 110.839 179.174 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -67.61 -48.87 65.56 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.733 2.013 . . . . 0.0 110.787 174.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -53.25 -52.97 57.26 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.3 1.04 . . . . 0.0 110.836 177.302 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -57.84 -38.67 76.05 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.341 1.057 . . . . 0.0 112.493 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.1 -43.51 74.33 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.581 0.752 . . . . 0.0 112.776 179.125 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.466 HG22 ' CD1' ' A' ' 42' ' ' ILE . 7.2 pt -74.56 -37.42 43.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -62.91 -33.64 75.75 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 -171.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -93.37 12.93 23.1 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.355 1.243 . . . . 0.0 114.355 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 16.2 mt -53.61 -47.58 96.04 Favored Pre-proline 0 N--CA 1.475 0.801 0 CA-C-O 117.918 -1.039 . . . . 0.0 112.194 167.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -80.45 169.93 16.55 Favored 'Trans proline' 0 CA--C 1.539 0.759 0 C-N-CA 123.289 2.659 . . . . 0.0 112.566 171.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -76.88 64.2 7.62 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 124.893 3.729 . . . . 0.0 110.037 169.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 66.57 23.48 72.13 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.324 1.44 . . . . 0.0 114.602 177.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -94.46 -30.81 14.25 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 -167.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -122.2 115.96 23.32 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.706 1.202 . . . . 0.0 108.893 -177.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -98.79 157.09 16.52 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.082 0.953 . . . . 0.0 111.842 -179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.5 t -112.01 137.92 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.588 0 C-N-CA 123.725 0.81 . . . . 0.0 110.478 167.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 75.4 m -113.29 129.61 56.48 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.113 0.565 . . . . 0.0 111.042 166.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.454 HD21 ' HB3' ' A' ' 24' ' ' LEU . 14.4 mt . . . . . 0 CA--C 1.552 1.053 0 C-N-CA 127.512 2.325 . . . . 0.0 112.398 -179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.473 0.687 0 CA-C-O 120.732 0.301 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' CYS . . . . . 0.548 ' HB2' HD11 ' A' ' 165' ' ' LEU . 11.9 p 178.44 139.08 0.09 Allowed 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 126.176 1.79 . . . . 0.0 113.269 -171.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 12.7 p -147.61 143.5 27.76 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.841 1.656 . . . . 0.0 111.515 168.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.78 147.26 24.57 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 120.058 1.299 . . . . 0.0 111.982 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -142.26 165.21 28.05 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.257 1.423 . . . . 0.0 113.127 173.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.17 135.36 46.67 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.683 1.993 . . . . 0.0 111.345 173.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 14.9 mm -120.34 136.12 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 124.716 1.206 . . . . 0.0 107.994 168.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -99.15 136.14 39.53 Favored 'General case' 0 N--CA 1.468 0.475 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 169.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 85.5 mt -130.07 142.21 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 O-C-N 120.707 -1.246 . . . . 0.0 110.884 -168.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ALA . . . . . . . . . . . . . . . -130.4 61.56 1.6 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.125 1.77 . . . . 0.0 112.939 -174.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -171.08 49.2 0.19 Allowed Glycine 0 N--CA 1.466 0.687 0 CA-C-N 115.296 -0.865 . . . . 0.0 113.01 164.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' MET . . . . . . . . . . . . . 77.1 mtm -117.22 143.87 45.41 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 122.256 1.027 . . . . 0.0 111.505 177.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.0 t -159.82 127.45 4.7 Favored 'General case' 0 C--O 1.233 0.209 0 C-N-CA 127.185 2.194 . . . . 0.0 106.156 178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' CYS . . . . . . . . . . . . . 2.3 t 74.8 148.13 0.09 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 125.902 1.681 . . . . 0.0 113.034 -175.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -54.44 -29.6 49.94 Favored 'General case' 0 CA--C 1.543 0.71 0 O-C-N 121.453 -0.779 . . . . 0.0 112.29 171.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 40.9 p -61.93 -34.14 75.55 Favored 'General case' 0 CA--C 1.533 0.311 0 O-C-N 120.733 -1.23 . . . . 0.0 112.512 176.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' CYS . . . . . . . . . . . . . 30.4 t -68.32 -37.56 80.69 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.305 1.411 . . . . 0.0 112.181 174.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.0 t -58.05 -56.52 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-O 118.883 -0.579 . . . . 0.0 109.888 169.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -62.95 -23.3 67.33 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-N 118.977 0.808 . . . . 0.0 112.798 -178.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.6 m -70.33 -55.33 9.42 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.715 1.206 . . . . 0.0 111.966 170.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 96.9 mt -64.86 -48.74 83.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 CA-C-N 119.47 1.032 . . . . 0.0 110.837 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -60.42 -25.27 65.82 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 127.362 2.265 . . . . 0.0 111.844 176.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.5 -58.25 3.64 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 127.547 2.498 . . . . 0.0 114.094 168.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . . . . . . . . . 21.5 mmt -71.73 -53.29 13.93 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.398 1.479 . . . . 0.0 113.204 -169.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 30.5 mm -66.0 -30.06 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 O-C-N 121.892 -0.505 . . . . 0.0 110.618 -171.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.0 t -57.12 -19.71 21.52 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 174.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -96.69 17.38 16.61 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 116.025 1.861 . . . . 0.0 116.025 -167.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.89 169.59 9.74 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.476 1.51 . . . . 0.0 110.55 169.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -64.32 163.35 13.15 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 122.935 1.35 . . . . 0.0 114.501 -171.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 76.07 -32.21 1.31 Allowed Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.62 1.581 . . . . 0.0 116.788 174.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' VAL . . . . . . . . . . . . . 3.9 p -78.0 97.6 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-N 119.968 1.884 . . . . 0.0 112.935 178.558 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.517 ' HB3' HD12 ' A' ' 165' ' ' LEU . 26.8 tt0 -76.66 -39.27 52.75 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.982 1.313 . . . . 0.0 112.84 -178.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 -144.58 140.75 28.97 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.33 1.052 . . . . 0.0 110.099 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 10.5 tt -144.96 129.85 13.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-N 119.306 0.957 . . . . 0.0 111.571 172.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -138.19 124.6 20.61 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.699 1.2 . . . . 0.0 110.677 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 12.6 t -126.53 149.64 31.66 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 O-C-N 120.616 -1.302 . . . . 0.0 110.279 -169.69 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 29.7 t -142.94 145.47 33.05 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-O 122.185 0.993 . . . . 0.0 112.943 173.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -72.01 -18.33 61.97 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 126.525 1.93 . . . . 0.0 114.362 171.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . . . . . . . . . . . -52.88 -48.24 67.29 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.227 1.411 . . . . 0.0 111.949 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLU . . . . . . . . . . . . . 33.6 mm-40 -108.7 -17.47 13.94 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 126.27 1.828 . . . . 0.0 111.949 170.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLY . . . . . . . . . . . . . . . 80.73 50.97 5.03 Favored Glycine 0 CA--C 1.529 0.947 0 C-N-CA 125.084 1.326 . . . . 0.0 111.622 -171.186 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 43.0 p -138.79 147.68 42.87 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 118.397 1.099 . . . . 0.0 113.677 -169.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -111.2 134.89 52.45 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.213 1.805 . . . . 0.0 111.402 172.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' THR . . . . . . . . . . . . . 14.1 t -109.07 118.37 36.59 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 167.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.5 138.21 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -167.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.548 HD11 ' HB2' ' A' ' 121' ' ' CYS . 0.4 OUTLIER -96.8 118.73 33.88 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.079 2.152 . . . . 0.0 108.1 175.675 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -119.08 158.42 25.89 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.649 1.179 . . . . 0.0 112.45 175.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -95.69 115.06 65.22 Favored Pre-proline 0 CA--C 1.546 0.8 0 C-N-CA 125.066 1.346 . . . . 0.0 108.568 173.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.59 -6.7 17.21 Favored 'Trans proline' 0 CA--C 1.537 0.632 0 C-N-CA 123.41 2.74 . . . . 0.0 113.798 -170.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -87.06 -45.59 10.59 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.077 0.951 . . . . 0.0 112.007 169.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 72.2 t -83.38 -28.57 7.73 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.343 1.457 . . . . 0.0 112.52 -171.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 11.7 tt -147.27 144.87 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.517 1.127 . . . . 0.0 110.558 178.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' SER . . . . . . . . . . . . . 69.3 m -106.42 147.94 35.83 Favored Pre-proline 0 CA--C 1.551 1.002 0 O-C-N 121.244 -0.91 . . . . 0.0 111.319 173.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_exo -53.53 -32.49 63.77 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 124.712 3.608 . . . . 0.0 116.177 -169.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -58.53 -27.73 64.79 Favored 'General case' 0 CA--C 1.544 0.718 0 N-CA-C 113.571 0.952 . . . . 0.0 113.571 176.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -72.47 -32.99 66.68 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 125.002 1.321 . . . . 0.0 112.241 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 65.6 mt -59.09 -50.47 73.93 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.616 1.166 . . . . 0.0 108.977 173.639 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 6.3 ttt85 -54.23 -48.35 71.19 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.95 1.3 . . . . 0.0 111.86 175.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.6 -30.48 71.37 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 179.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -69.71 -32.83 71.62 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.087 0.955 . . . . 0.0 112.938 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 6.6 mt -74.55 -32.9 30.93 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.661 0 C-N-CA 124.195 0.998 . . . . 0.0 112.093 173.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -68.25 -34.13 75.63 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.899 0.772 . . . . 0.0 111.525 168.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -65.33 -30.01 70.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.429 1.091 . . . . 0.0 112.445 171.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' MET . . . . . . . . . . . . . 15.4 ttt -75.4 -28.73 59.57 Favored 'General case' 0 N--CA 1.47 0.559 0 O-C-N 121.351 -0.843 . . . . 0.0 112.491 172.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 116.82 30.56 1.95 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 125.648 1.594 . . . . 0.0 115.32 169.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -125.66 -156.88 0.76 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.466 1.507 . . . . 0.0 109.379 -178.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 60.4 mt-10 -133.68 147.14 51.37 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 120.998 -1.064 . . . . 0.0 111.118 169.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -139.42 136.35 34.59 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.119 1.368 . . . . 0.0 112.592 -176.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 30.5 t -114.45 125.91 54.36 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.344 1.858 . . . . 0.0 110.231 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 8.7 p -85.84 59.78 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 CA-C-O 122.482 1.134 . . . . 0.0 109.759 -173.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.014 0.925 . . . . 0.0 111.857 -169.782 . . . . . . . . 0 0 . 1 stop_ save_